data_2l0b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l0b _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 72.5 Cg_endo . . . . . 0 N--CA 1.461 -0.383 0 CA-C-O 120.872 0.28 . . . . 73.02 112.553 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.6 153.36 65.11 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.608 2.205 . . . . 64.23 112.299 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.95 167.73 16.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.005 -0.543 . . . . 54.54 111.043 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -94.81 151.31 19.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.104 -0.498 . . . . 75.33 109.943 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HD2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -58.95 -37.56 77.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.493 -0.321 . . . . 74.12 110.494 -176.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -56.93 -41.87 78.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.972 -0.558 . . . . 72.31 111.125 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -72.25 -27.03 62.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 60.44 111.085 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 71' ' ' SER . 42.8 mt -82.86 -38.8 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.399 0.618 . . . . 71.3 110.516 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.68 -20.68 64.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.987 -0.551 . . . . 73.33 110.505 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.9 -3.81 55.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.772 -0.649 . . . . 51.22 111.378 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.4 152.34 85.67 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.553 -0.294 . . . . 72.24 110.453 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.93 122.91 11.64 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.715 2.277 . . . . 71.41 112.175 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -86.91 118.3 26.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.024 -0.535 . . . . 62.04 110.133 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.3 mt -110.19 103.63 15.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.82 -0.627 . . . . 61.51 110.264 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 68.9 tp -68.24 114.62 6.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.549 -0.538 . . . . 75.4 109.549 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 40.0 t -70.13 111.05 3.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.971 -0.381 . . . . 74.33 109.971 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.2 p -88.19 169.74 11.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 72.04 110.379 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.37 -8.34 56.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.027 0.38 . . . . 42.51 112.027 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -91.46 -2.42 57.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.154 0.502 . . . . 75.2 109.839 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -109.21 90.68 3.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.922 -0.581 . . . . 71.2 111.102 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.93 -26.82 48.03 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.909 -0.877 . . . . 74.03 110.909 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.19 140.46 41.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.482 -0.562 . . . . 75.24 109.482 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 t -118.86 90.8 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.765 0.317 . . . . 73.35 110.727 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.92 13.9 60.17 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.976 -0.556 . . . . 74.53 113.307 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.97 -155.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.61 -0.515 . . . . 50.44 109.61 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -68.94 177.63 2.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.815 -0.439 . . . . 73.43 109.815 173.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.613 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 1.8 pmm? -84.33 0.0 50.86 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.006 -0.278 . . . . 75.31 110.468 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.7 m -116.36 131.84 56.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.079 0.466 . . . . 72.34 112.038 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.5 t -83.48 107.93 11.61 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.595 -0.891 . . . . 63.53 108.595 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.22 -38.91 62.23 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.331 2.687 . . . . 73.01 112.878 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 51.7 mt -62.29 -29.48 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.961 -0.563 . . . . 71.22 111.347 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 61.2 m -110.12 -8.62 14.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.377 -0.374 . . . . 72.31 111.623 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.4 p 45.18 34.99 1.53 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.459 0.647 . . . . 71.11 110.949 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.1 t -133.82 159.82 39.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.496 -0.775 . . . . 63.23 110.0 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 41' ' ' MET . 4.6 pt-20 -83.96 172.57 11.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.736 0.643 . . . . 64.43 112.736 -171.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -98.05 123.91 42.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.374 -0.83 . . . . 75.22 110.289 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.26 164.83 28.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.178 -0.465 . . . . 74.24 110.411 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.2 ttpt -58.77 125.64 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 63.31 111.047 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.83 -23.96 6.5 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.669 -0.777 . . . . 60.41 112.702 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.57 161.53 18.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.031 -0.359 . . . . 64.2 110.031 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.88 115.25 49.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.927 0.394 . . . . 71.51 110.351 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -100.96 168.35 9.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.211 -0.45 . . . . 71.14 110.417 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.0 t -152.76 166.2 32.97 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.229 -0.656 . . . . 73.33 109.229 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -120.39 119.71 33.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.688 0.28 . . . . 61.11 110.691 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.469 HD22 HD13 ' A' ' 74' ' ' LEU . 88.2 mt -70.39 142.36 89.3 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 108.84 -0.8 . . . . 72.44 108.84 170.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.79 -20.84 13.68 Favored 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.663 2.908 . . . . 74.43 113.841 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.7 p -85.88 19.33 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 70.13 110.376 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 58.01 65.39 1.31 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.411 -0.813 . . . . 75.22 111.612 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -145.08 123.09 12.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.427 -0.806 . . . . 72.33 109.449 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.77 141.32 28.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.026 -0.533 . . . . 64.34 111.796 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -149.07 175.18 11.55 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.138 -1.06 . . . . 75.53 108.138 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.881 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 35.9 m170 -77.28 133.67 38.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.433 -0.951 . . . . 72.04 108.433 170.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 87.1 tttt -57.66 -50.74 86.45 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 119.481 -0.295 . . . . 55.52 111.319 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 6.6 Cg_endo -49.31 -46.88 24.32 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.566 2.177 . . . . 73.03 113.481 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.881 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 14.3 p -80.62 -34.06 35.33 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.492 -0.483 . . . . 74.12 111.933 -175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG13 ' HA ' ' A' ' 67' ' ' LYS . 5.5 p -73.77 -30.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.565 -0.454 . . . . 72.4 110.562 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.526 ' HA ' HG23 ' A' ' 22' ' ' ILE . 51.1 m -63.38 -32.99 74.57 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.977 0.418 . . . . 71.41 110.776 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.0 mt -79.42 -42.45 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 73.43 110.056 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -63.35 -43.82 96.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.896 -0.593 . . . . 74.52 111.363 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.49 HD11 ' CD2' ' A' ' 87' ' ' PHE . 95.7 mt -66.74 -24.34 66.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.642 -0.254 . . . . 75.43 111.666 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -92.49 0.55 57.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.904 0.383 . . . . 72.42 110.662 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -114.95 -41.72 3.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 74.13 111.398 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.9 m -120.94 -20.38 6.91 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.815 0.302 . . . . 73.3 111.815 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.58 26.64 60.08 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.37 -0.377 . . . . 62.03 114.018 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.26 145.09 40.9 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.339 -0.506 . . . . 63.02 111.79 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.451 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 24.3 t -75.03 110.69 10.7 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.741 -0.663 . . . . 73.13 109.251 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.22 -32.99 34.53 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.211 2.608 . . . . 64.14 113.993 -171.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.93 -28.64 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.393 0.516 . . . . 75.33 112.393 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 29.4 p -125.06 -13.13 6.87 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 121.818 -0.551 . . . . 64.32 112.093 -174.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 66.36 23.07 10.72 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.029 0.532 . . . . 73.01 111.237 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.3 t -85.01 145.31 27.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.939 -0.763 . . . . 43.24 108.939 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.473 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 58.7 ttp -75.51 150.51 38.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.926 0.393 . . . . 74.24 111.447 -175.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.562 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 81.1 t80 -129.5 125.98 22.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 108.791 -0.818 . . . . 72.1 108.791 170.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.562 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 30.9 Cg_endo -61.87 153.42 61.61 Favored 'Cis proline' 0 C--N 1.348 0.523 0 C-N-CA 123.988 -1.255 . . . . 73.22 113.019 3.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 42.7 Cg_exo -55.34 138.32 79.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.033 2.489 . . . . 73.21 112.61 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.453 ' HG3' ' HB3' ' A' ' 86' ' ' MET . 6.2 Cg_exo -72.24 177.5 7.18 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.665 2.243 . . . . 70.02 111.914 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.701 -0.666 . . . . 72.35 110.231 -176.736 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 20.4 Cg_endo . . . . . 0 C--O 1.236 0.391 0 N-CA-C 113.053 0.366 . . . . 72.12 113.053 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 38.0 Cg_exo -61.84 163.38 19.15 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.168 2.579 . . . . 62.04 112.239 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -86.06 153.87 21.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 72.24 110.714 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 22' ' ' ILE . 22.4 m -71.96 137.96 47.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.957 -0.565 . . . . 64.34 110.626 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -58.21 -41.43 84.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.105 -0.498 . . . . 64.4 110.57 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -52.17 -45.91 65.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.996 -1.002 . . . . 72.23 110.987 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.5 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 13.8 m -67.68 -42.33 82.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.083 -0.508 . . . . 72.52 110.679 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 18' ' ' SER . 66.4 mt -61.92 -40.93 88.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 73.1 110.81 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.16 -44.11 80.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.945 -0.571 . . . . 75.12 110.79 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.6 3.89 30.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.932 -0.576 . . . . 61.23 112.287 -174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.531 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 40.5 mt -57.85 127.78 79.56 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 116.89 -0.141 . . . . 74.44 111.027 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.13 126.3 21.15 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.161 2.574 . . . . 72.14 111.77 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.97 116.46 31.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.958 -0.564 . . . . 74.31 110.783 -172.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.9 mt -104.69 129.01 57.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.673 -0.694 . . . . 71.34 110.053 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 46.8 tp -82.23 120.4 25.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.123 -0.49 . . . . 72.12 110.367 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.965 HG11 ' HA2' ' A' ' 35' ' ' GLY . 97.9 t -90.28 128.3 42.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.998 -0.546 . . . . 73.13 111.032 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.421 HG22 ' HG3' ' A' ' 52' ' ' LYS . 17.7 p -137.35 172.95 12.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.463 -0.789 . . . . 74.54 109.825 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.442 ' OE1' ' HD3' ' A' ' 52' ' ' LYS . 4.5 mp0 -59.76 130.21 45.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.404 -0.221 . . . . 64.53 110.404 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 69.01 10.94 8.18 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.928 -0.578 . . . . 54.14 111.523 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -141.32 34.76 1.68 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.568 -1.271 . . . . 70.43 107.568 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.965 ' HA2' HG11 ' A' ' 30' ' ' VAL . . . -93.9 -56.81 1.37 Allowed Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.985 -1.007 . . . . 73.03 113.461 -172.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.33 -60.57 3.22 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.659 0.23 . . . . 74.4 111.23 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t 60.51 91.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.829 -0.623 . . . . 74.45 111.422 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . 99.4 -89.32 0.88 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.388 -0.911 . . . . 64.51 113.269 175.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -141.16 -52.65 0.46 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.833 0.317 . . . . 73.52 111.625 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.39 107.24 2.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.864 0.364 . . . . 74.42 111.082 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.425 ' HG2' ' SG ' ' A' ' 42' ' ' CYS . 1.8 pmm? -84.16 -18.3 37.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.098 0.475 . . . . 71.2 110.421 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.425 ' SG ' ' HG2' ' A' ' 41' ' ' MET . 78.2 m -136.82 159.22 42.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.639 -0.71 . . . . 73.21 109.739 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.6 t -105.56 102.21 36.53 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.501 -0.555 . . . . 71.12 109.501 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.55 -28.35 86.49 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.84 2.36 . . . . 73.22 111.788 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.0 mt -61.98 -29.69 46.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.437 -0.801 . . . . 75.42 111.762 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.3 p -121.38 2.4 10.24 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.87 -0.332 . . . . 74.14 111.313 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 76.9 m 50.66 62.13 2.86 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.415 0.626 . . . . 72.14 111.027 -175.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.8 t -159.43 152.81 22.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.428 -0.805 . . . . 72.23 109.708 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.49 ' HG3' HG11 ' A' ' 51' ' ' VAL . 11.4 pt-20 -77.75 -173.04 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.288 0.566 . . . . 70.13 110.889 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 37.0 m-85 -97.96 106.68 19.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.046 -0.525 . . . . 74.41 110.65 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' HG3' ' A' ' 49' ' ' GLU . 31.2 m -118.59 162.84 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.786 -0.643 . . . . 75.31 110.889 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 34.1 ttpt -62.78 112.91 2.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.609 . . . . 74.14 110.754 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.5 -31.48 2.85 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.885 -0.674 . . . . 60.32 111.726 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.2 133.34 34.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.675 0.274 . . . . 74.34 110.301 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.65 127.59 40.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.448 -0.342 . . . . 64.44 110.764 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.4 9.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.263 -0.426 . . . . 74.05 109.995 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 13.2 t -148.51 153.31 38.27 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.899 -0.408 . . . . 75.43 109.899 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -107.49 117.7 34.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.046 0.45 . . . . 74.51 110.335 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -80.75 140.69 51.03 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.893 -0.78 . . . . 73.3 108.893 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HB2' ' HG3' ' A' ' 89' ' ' PRO . 17.1 Cg_endo -58.81 -7.8 4.98 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.896 2.397 . . . . 71.23 112.106 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.6 t -87.42 21.34 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.241 -0.891 . . . . 74.22 109.784 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 57.44 40.33 27.37 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.803 -0.635 . . . . 72.11 111.321 176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -138.06 148.89 45.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.536 -0.302 . . . . 74.43 111.067 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.406 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 60.8 m-85 -124.39 133.51 53.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.148 -0.478 . . . . 74.1 111.084 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.521 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 92.5 m-85 -146.49 162.52 38.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.595 . . . . 73.33 109.798 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 33.9 m170 -67.13 123.16 19.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.478 -0.564 . . . . 72.53 109.478 174.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 83.2 tttt -57.57 -48.86 96.53 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 123.349 0.406 . . . . 72.33 111.866 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 12.2 Cg_endo -56.84 -27.16 70.72 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.162 1.908 . . . . 61.35 112.844 177.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 37.3 m -84.53 -52.77 5.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.142 0.496 . . . . 65.43 111.122 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.509 HG23 ' HG ' ' A' ' 74' ' ' LEU . 9.8 p -67.17 -25.6 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 70.43 111.404 -172.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.5 p -63.49 -30.38 71.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.807 0.337 . . . . 73.23 111.437 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.4 mt -78.88 -40.15 22.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.253 0.549 . . . . 74.55 109.917 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -65.82 -43.19 89.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.453 -0.794 . . . . 73.43 111.481 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.509 ' HG ' HG23 ' A' ' 70' ' ' VAL . 93.1 mt -67.03 -19.33 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.953 0.353 . . . . 73.32 111.953 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -74.28 -22.27 59.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.046 0.451 . . . . 72.15 110.327 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -91.19 -45.17 8.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.713 -0.676 . . . . 64.4 109.851 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -157.37 133.05 9.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.819 -0.628 . . . . 64.11 110.247 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.01 77.61 2.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.681 -0.771 . . . . 37.98 111.226 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 m -148.52 148.85 30.68 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.169 -0.308 . . . . 64.34 110.169 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 73.7 m -75.12 119.83 78.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 108.23 -1.026 . . . . 72.03 108.23 168.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.83 -12.07 20.47 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.468 2.112 . . . . 75.23 113.04 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.6 t -96.15 -50.21 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 111.861 0.319 . . . . 74.35 111.861 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 20.4 p -96.0 -18.88 19.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.761 0.315 . . . . 55.14 111.629 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 63.08 25.57 15.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.012 -0.54 . . . . 73.51 111.887 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -92.42 151.06 20.43 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.487 -0.56 . . . . 62.14 109.487 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 52.8 ttp -76.31 146.89 38.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.033 0.753 . . . . 61.24 113.033 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.553 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 76.6 t80 -133.16 124.47 18.42 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.803 -1.089 . . . . 73.41 108.527 170.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.553 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 32.7 Cg_exo -59.6 144.48 33.62 Favored 'Cis proline' 0 C--N 1.35 0.643 0 C-N-CA 124.558 -1.017 . . . . 72.41 113.181 3.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.444 ' HG3' ' HB2' ' A' ' 60' ' ' PRO . 52.9 Cg_endo -67.48 149.76 80.2 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.059 2.506 . . . . 63.31 112.611 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.5 178.71 5.31 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.709 2.273 . . . . 65.24 111.814 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.41 -0.805 . . . . 63.32 110.266 -179.747 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 N--CA 1.455 -0.782 0 CA-C-O 120.504 0.127 . . . . 61.12 112.056 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -73.88 136.85 23.54 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.91 1.74 . . . . 73.13 111.326 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -79.96 127.73 32.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.43 -0.35 . . . . 72.32 110.529 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 p -74.64 166.55 23.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.091 -0.504 . . . . 71.35 110.736 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -57.64 -35.17 70.15 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.248 -0.433 . . . . 62.41 110.946 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.42 -35.26 69.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.938 0.399 . . . . 65.11 111.181 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 m -85.83 -35.41 20.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.025 -0.534 . . . . 73.41 111.173 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 71' ' ' SER . 68.1 mt -82.89 -44.44 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.017 0.437 . . . . 75.24 111.903 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.75 -33.73 74.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.013 -0.54 . . . . 50.01 110.762 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.77 4.93 26.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.697 -0.683 . . . . 62.5 112.186 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.431 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 66.7 mt -70.75 136.17 85.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.609 0.242 . . . . 75.13 110.511 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.61 149.37 67.9 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.256 2.637 . . . . 71.44 112.782 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.64 121.33 44.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 71.13 110.4 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.3 mt -109.44 120.55 60.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.743 -0.662 . . . . 70.2 109.883 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.0 tp -79.93 107.67 12.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.796 -0.446 . . . . 73.54 109.796 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 50' ' ' TYR . 42.5 t -74.86 131.86 34.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.051 -0.522 . . . . 61.43 110.902 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.402 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 35.2 p -120.17 145.21 47.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.966 -0.561 . . . . 73.42 109.883 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG2' ' HD3' ' A' ' 52' ' ' LYS . 16.7 pt-20 -71.7 -17.43 62.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.705 0.288 . . . . 74.33 111.221 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -68.29 -23.03 64.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.466 -0.334 . . . . 74.2 110.382 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -90.76 -13.81 33.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 73.12 109.913 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.2 -80.38 0.98 Allowed Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.967 -0.56 . . . . 72.41 112.164 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.78 -172.8 2.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.78 -0.452 . . . . 62.01 109.78 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.87 95.42 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.085 0.469 . . . . 74.43 110.159 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.5 -110.44 3.49 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.794 -0.639 . . . . 71.14 111.756 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -98.48 -14.77 19.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.741 0.305 . . . . 72.55 111.19 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -99.36 133.69 43.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.247 0.546 . . . . 65.35 110.954 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.3 ptp -121.44 -5.04 9.33 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.489 -0.778 . . . . 75.41 111.61 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.2 p -150.48 151.77 33.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.329 . . . . 74.04 110.924 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.9 t -109.79 93.01 13.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 71.44 109.57 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.15 -18.29 57.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.375 2.717 . . . . 73.35 113.006 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.6 mt -63.94 -27.93 43.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.632 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.6 p -127.07 -7.4 5.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.622 -0.263 . . . . 60.04 111.107 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 71.0 m 61.4 35.9 17.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.128 -0.487 . . . . 74.35 110.784 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -124.38 159.25 30.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.805 -0.634 . . . . 73.34 110.299 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.85 -174.4 5.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.817 -0.629 . . . . 75.52 111.389 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.652 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 96.4 m-85 -108.58 118.68 37.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.26 -0.427 . . . . 75.22 110.168 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.18 174.67 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.392 -0.367 . . . . 60.52 111.293 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HD3' ' HG2' ' A' ' 32' ' ' GLU . 35.9 ttpt -76.87 124.22 27.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.097 -0.501 . . . . 73.44 110.652 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.67 0.73 55.33 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.885 -0.674 . . . . 61.11 111.711 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -87.24 157.83 19.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.531 -0.544 . . . . 73.31 109.531 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.45 114.47 47.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.342 0.592 . . . . 74.33 111.166 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.5 166.64 10.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.486 -0.779 . . . . 53.15 110.066 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.476 HG23 HG11 ' A' ' 70' ' ' VAL . 7.6 t -131.01 171.71 12.92 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.832 -0.433 . . . . 72.02 109.832 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.488 ' HG2' ' CE2' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -126.4 118.35 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.342 -0.614 . . . . 75.22 109.342 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 61' ' ' CYS . 90.8 mt -87.5 147.23 41.35 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.273 -0.421 . . . . 64.34 110.538 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.44 4.32 0.48 Allowed 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.048 2.499 . . . . 64.52 113.702 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.405 ' H ' ' C ' ' A' ' 59' ' ' LEU . 25.1 p -109.35 8.41 25.5 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.969 -0.382 . . . . 52.52 109.969 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.1 m170 66.59 89.13 0.1 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.757 -0.656 . . . . 73.34 110.371 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -172.53 125.4 0.49 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.52 -0.763 . . . . 72.12 110.126 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CE2' ' HG2' ' A' ' 58' ' ' GLU . 39.0 m-85 -103.83 133.28 49.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 72.24 110.047 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.652 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 90.0 m-85 -146.24 155.75 42.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.143 -0.48 . . . . 72.01 109.912 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 26.1 m170 -56.28 124.18 17.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.213 -0.662 . . . . 72.23 109.213 171.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 86.0 tttt -57.41 -49.27 94.82 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 119.297 -0.382 . . . . 70.01 111.462 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 77.6 Cg_exo -53.29 -36.22 77.44 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.865 1.71 . . . . 72.21 112.559 176.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 71.2 m -70.59 -51.59 27.31 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.428 -0.351 . . . . 62.21 111.13 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.476 HG11 HG23 ' A' ' 57' ' ' THR . 7.5 p -65.93 -26.73 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.001 -0.545 . . . . 63.45 110.3 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.476 ' HA ' HG21 ' A' ' 22' ' ' ILE . 50.3 m -60.96 -55.28 34.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.346 -0.388 . . . . 73.35 110.013 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.26 -40.63 84.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 74.03 110.789 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -64.94 -53.21 50.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 73.05 111.348 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 96.5 mt -66.41 -31.26 71.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.736 -0.211 . . . . 73.45 111.55 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 71' ' ' SER . 73.3 mt-30 -59.97 -30.71 69.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.759 0.314 . . . . 70.21 110.766 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.48 -40.29 10.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.838 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.7 p -153.79 115.21 4.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 62.14 110.683 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.83 71.38 2.88 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.864 -0.684 . . . . 73.11 112.643 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 1.3 m -146.43 141.14 26.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.781 -0.452 . . . . 73.42 109.781 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.0 t -74.56 113.01 19.98 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.091 -0.707 . . . . 74.33 109.091 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.78 -37.95 96.84 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.844 2.362 . . . . 71.02 113.378 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -71.42 -48.81 51.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.515 0.561 . . . . 74.12 112.515 -174.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.71 -8.81 13.22 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.62 -0.432 . . . . 72.55 111.992 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 63.67 91.71 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.629 0.728 . . . . 61.21 110.943 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 79' ' ' THR . 44.0 t -144.4 130.83 19.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.042 -0.981 . . . . 75.21 108.862 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.535 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 43.4 ttm -64.6 140.9 58.92 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.509 0.506 . . . . 72.43 110.391 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.431 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 70.3 t80 -131.83 116.26 15.83 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.035 -0.53 . . . . 74.41 109.69 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.99 155.12 99.74 Favored 'Cis proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.232 -1.57 . . . . 52.25 112.426 -0.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.39 151.55 29.43 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 123.264 2.643 . . . . 73.44 113.221 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 86.9 Cg_endo -80.6 170.63 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.786 2.324 . . . . 63.1 112.429 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.278 -0.868 . . . . 71.15 109.729 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 CA--C 1.532 0.389 0 CA-C-O 120.67 0.196 . . . . 71.23 112.341 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.11 149.87 41.96 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.858 2.372 . . . . 72.14 112.5 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.45 157.98 24.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.778 -0.646 . . . . 53.13 110.993 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -67.93 139.72 56.44 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.679 -0.489 . . . . 74.13 109.679 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -61.52 -37.36 83.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 74.21 111.178 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 20' ' ' GLU . 3.1 mp0 -60.0 -42.49 94.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.4 -0.364 . . . . 71.15 110.287 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.456 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.7 m -62.16 -40.04 94.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 71.43 110.823 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.14 -40.95 78.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.861 -0.609 . . . . 71.4 110.647 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.79 -32.89 65.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.16 -0.473 . . . . 64.44 111.179 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.65 -0.31 37.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.482 -0.326 . . . . 72.21 111.86 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.504 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 67.5 mt -64.99 123.3 83.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.605 0.241 . . . . 74.23 110.791 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.57 117.99 4.8 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.154 2.569 . . . . 72.45 112.332 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -78.4 121.99 25.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.087 -0.506 . . . . 72.53 110.808 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.4 mt -115.91 120.82 65.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.041 -0.527 . . . . 72.45 110.03 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.2 tp -75.71 119.51 19.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.74 -0.467 . . . . 73.23 109.74 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 40.3 t -85.91 121.56 37.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.072 0.463 . . . . 74.13 111.258 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' HG3' ' A' ' 52' ' ' LYS . 24.0 p -123.37 165.79 16.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.479 -0.782 . . . . 74.12 109.661 173.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.503 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 31.5 mt-10 -68.16 -30.22 69.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.937 0.398 . . . . 74.45 111.311 -173.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.31 -17.97 64.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.029 -0.532 . . . . 63.2 112.222 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -75.95 -17.52 59.7 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.044 0.387 . . . . 72.13 112.044 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.22 69.43 1.32 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.767 -0.73 . . . . 54.11 113.075 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 67.17 -2.83 1.11 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.328 0.651 . . . . 74.42 112.666 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.5 t 72.77 -64.84 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.193 0.597 . . . . 71.42 111.742 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.56 -161.57 9.06 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.657 -0.782 . . . . 74.2 112.496 -176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -62.27 -28.77 69.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.02 0.438 . . . . 55.33 110.803 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -80.52 110.6 16.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.43 -0.952 . . . . 75.44 108.43 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.1 ptp -103.8 -2.2 26.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.16 -0.473 . . . . 72.25 111.382 -173.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 82.0 m -146.42 147.52 31.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.341 -0.391 . . . . 75.14 110.571 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.0 t -103.78 94.74 6.62 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.081 -0.711 . . . . 65.1 109.081 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.87 -8.99 17.24 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.37 2.713 . . . . 61.25 112.84 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.5 mt -76.2 -32.92 23.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.019 -0.537 . . . . 75.44 110.508 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.8 p -114.86 -3.2 12.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.755 0.312 . . . . 74.42 111.045 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.0 t 67.64 23.37 8.79 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.564 -0.744 . . . . 71.04 111.103 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.1 m -129.47 158.78 38.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 64.43 110.405 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.9 OUTLIER -84.61 -169.67 2.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.171 -0.468 . . . . 64.15 111.1 -177.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 96.8 m-85 -93.94 94.23 8.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.483 0.659 . . . . 74.52 110.899 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.24 173.74 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.766 -1.106 . . . . 73.52 111.01 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 32.9 ttpt -75.48 123.24 25.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.969 -0.56 . . . . 75.11 110.806 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.63 -24.28 6.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.691 -0.766 . . . . 61.35 112.709 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -87.04 161.26 18.27 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.572 -0.529 . . . . 72.5 109.572 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.3 t -111.26 124.75 68.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.916 0.389 . . . . 74.22 110.056 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -111.73 172.69 6.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.315 -0.402 . . . . 63.13 110.777 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.504 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 12.7 t -152.76 161.13 42.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.903 -0.59 . . . . 74.4 109.59 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -108.31 117.59 34.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.85 0.357 . . . . 74.13 111.229 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.9 mt -76.84 152.94 82.98 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.913 -0.773 . . . . 73.23 108.913 171.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.83 51.04 0.62 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 122.959 2.439 . . . . 74.54 111.189 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 45.4 t -153.37 16.8 0.54 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.041 -0.982 . . . . 72.32 109.677 -172.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 56.95 18.16 3.76 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.54 -0.755 . . . . 72.14 111.775 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 3.3 m170 -111.13 115.63 29.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.189 -0.459 . . . . 71.41 110.563 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -91.99 133.26 35.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.617 -0.719 . . . . 72.3 109.728 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.599 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 74.9 m-85 -136.7 155.73 49.47 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.367 0.417 . . . . 75.23 110.143 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 32.2 m170 -65.71 121.21 14.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.225 -0.658 . . . . 75.14 109.225 174.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.5 tttt -56.57 -51.49 80.79 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 123.576 0.547 . . . . 74.41 111.966 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.0 Cg_endo -58.68 -27.97 84.89 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.237 1.958 . . . . 61.23 112.572 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.5 m -80.34 -50.61 9.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.069 -0.514 . . . . 74.35 110.419 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.523 HG22 ' HG ' ' A' ' 74' ' ' LEU . 9.1 p -72.52 -27.47 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.669 -0.696 . . . . 74.14 111.125 -172.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.6 t -59.3 -42.52 91.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.007 0.432 . . . . 71.25 110.448 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.93 -36.76 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.269 0.557 . . . . 73.12 110.204 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -72.29 -51.96 18.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.441 -0.799 . . . . 74.54 110.778 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.523 ' HG ' HG22 ' A' ' 70' ' ' VAL . 95.9 mt -60.03 -33.74 72.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.016 -0.538 . . . . 72.34 112.369 -174.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.5 -18.91 65.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.05 0.389 . . . . 73.44 112.05 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.65 ' HZ1' ' HB2' ' A' ' 76' ' ' LYS . 10.3 mtmp? -111.4 -16.69 13.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 73.15 110.925 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 t -172.33 117.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 74.25 109.763 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.12 91.53 1.7 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.556 -0.83 . . . . 63.43 111.681 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 2.8 p -149.28 155.03 39.92 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.3 0.481 . . . . 65.3 112.3 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 35.0 m -74.79 112.0 15.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.843 -1.169 . . . . 73.24 107.843 160.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.91 -15.6 22.63 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.53 2.153 . . . . 65.23 112.379 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.6 t -89.93 -48.85 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.007 -0.542 . . . . 75.34 111.847 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 20.0 p -107.81 -3.13 19.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.62 0.6 . . . . 70.43 112.62 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? 68.06 14.71 9.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.039 0.755 . . . . 74.55 113.039 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 79' ' ' THR . 17.2 p -79.92 150.85 30.4 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.92 -0.488 . . . . 73.14 110.249 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.535 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 40.1 ttm -81.32 144.36 31.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.123 0.487 . . . . 62.1 111.376 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -135.43 123.53 15.42 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.497 -0.774 . . . . 75.22 109.547 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.28 152.42 84.75 Favored 'Cis proline' 0 C--N 1.343 0.272 0 C-N-CA 123.339 -1.525 . . . . 71.11 111.528 -2.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.37 149.44 56.06 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.83 2.354 . . . . 73.03 112.412 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 96.0 Cg_endo -81.82 147.29 15.17 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.66 2.24 . . . . 74.34 111.406 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.344 -0.836 . . . . 74.02 110.011 179.658 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 CA--C 1.53 0.282 0 CA-C-O 120.479 0.116 . . . . 72.31 112.149 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.42 159.81 22.67 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.041 2.494 . . . . 72.43 112.154 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.38 160.16 15.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.279 -0.419 . . . . 61.24 110.487 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -88.91 158.38 18.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.614 -0.267 . . . . 61.12 110.417 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -58.16 -45.45 87.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.176 -0.465 . . . . 73.02 111.411 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -45.71 -54.64 7.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 75.41 112.163 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.99 -23.38 67.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.155 0.428 . . . . 71.44 112.155 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.519 HG21 ' HA ' ' A' ' 71' ' ' SER . 37.2 mt -87.16 -38.46 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.48 0.657 . . . . 53.42 110.1 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -68.39 -30.5 69.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.546 -0.752 . . . . 72.41 110.884 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -19.19 65.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.164 -0.471 . . . . 53.3 111.363 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.88 144.52 97.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 63.01 110.514 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.85 159.13 26.15 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.192 2.595 . . . . 63.35 113.153 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -120.17 110.09 16.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 74.11 110.035 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 54.0 mt -104.68 129.07 57.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.711 -0.677 . . . . 74.32 110.871 -175.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.2 tp -83.82 117.07 23.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.249 -0.648 . . . . 74.35 109.249 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 49.1 t -76.67 117.28 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.054 0.454 . . . . 73.3 111.634 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 p -112.22 148.0 35.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.643 -0.708 . . . . 71.12 110.307 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 27.4 mt-10 -78.47 -26.74 46.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.914 0.388 . . . . 72.41 111.76 -174.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.98 -4.23 27.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.275 0.843 . . . . 64.1 113.275 -168.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.677 ' HE1' ' HA ' ' A' ' 37' ' ' VAL . 22.3 p80 -113.08 9.24 18.56 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.233 -0.587 . . . . 74.4 110.537 176.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.5 -130.67 23.62 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.897 -0.592 . . . . 72.12 112.122 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.21 147.37 49.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.664 0.269 . . . . 61.2 110.52 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.677 ' HA ' ' HE1' ' A' ' 34' ' ' HIS . 60.9 t -80.76 97.91 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.052 0.454 . . . . 63.53 110.109 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.16 -80.35 0.85 Allowed Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.558 -0.746 . . . . 63.44 112.21 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.759 ' HG3' ' HG2' ' A' ' 40' ' ' GLU . 15.6 pt20 -138.73 -1.77 1.8 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.683 0.278 . . . . 63.33 111.343 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.759 ' HG2' ' HG3' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -128.34 144.48 51.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.26 -0.274 . . . . 74.51 110.26 -173.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.2 ptp -123.83 -8.16 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.499 -0.318 . . . . 72.41 111.271 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.673 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 81.5 m -132.73 151.95 51.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.051 0.453 . . . . 71.21 111.142 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 38.9 t -118.16 91.93 41.46 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.758 -0.656 . . . . 73.14 109.298 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.2 Cg_endo -51.74 -30.7 38.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.833 3.022 . . . . 65.53 113.562 -173.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.8 mt -56.99 -37.34 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.334 -0.394 . . . . 73.11 111.465 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.6 p -109.31 0.11 19.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 62.44 110.298 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.1 m 60.38 16.01 5.93 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.257 -0.883 . . . . 71.3 111.49 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.3 t -117.31 165.76 13.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.785 -0.45 . . . . 71.44 109.785 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.673 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 7.2 pt-20 -99.51 -170.08 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.266 -0.425 . . . . 71.22 111.296 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.475 ' HB3' HG13 ' A' ' 30' ' ' VAL . 55.9 m-85 -95.1 110.23 22.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.213 0.53 . . . . 75.42 111.539 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.17 167.24 12.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.337 -0.847 . . . . 72.32 110.367 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 40.0 ttmt -71.51 126.33 29.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.347 -0.388 . . . . 73.54 111.198 -174.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.61 -15.44 19.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.742 . . . . 71.23 112.301 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -86.8 162.92 17.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.94 -0.393 . . . . 53.01 109.94 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -112.82 121.18 64.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.984 0.421 . . . . 71.35 110.78 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -103.97 170.19 8.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.08 -0.509 . . . . 63.34 110.697 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 8.3 t -147.7 173.35 12.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.054 -0.521 . . . . 73.35 109.711 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -118.96 119.43 34.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.675 0.274 . . . . 74.14 110.462 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.08 137.72 35.1 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.653 -0.499 . . . . 73.03 109.653 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.55 -15.77 26.82 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.287 2.658 . . . . 53.54 113.448 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 p -87.24 11.8 13.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.442 0.163 . . . . 64.41 110.897 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.3 m80 69.22 62.44 0.3 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.287 0.565 . . . . 75.44 111.015 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -150.67 152.16 33.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.438 -0.801 . . . . 74.44 109.336 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -118.78 133.23 55.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.994 0.426 . . . . 64.55 110.641 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.421 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 47.7 m-85 -143.08 157.94 44.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.659 -0.7 . . . . 74.41 109.976 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 33.3 m170 -68.4 125.91 27.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.687 -0.857 . . . . 71.51 108.687 172.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.533 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 85.5 tttt -57.57 -50.3 88.9 Favored Pre-proline 0 CA--C 1.536 0.44 0 O-C-N 123.405 0.441 . . . . 63.43 112.061 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 73.6 Cg_exo -52.59 -42.48 61.82 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.686 1.591 . . . . 72.31 112.395 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 57.9 m -63.15 -53.13 58.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.0 0.428 . . . . 62.32 110.918 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 67' ' ' LYS . 8.7 p -67.56 -27.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 64.03 110.792 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 53.1 m -61.58 -51.03 70.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.699 0.285 . . . . 62.32 110.393 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.65 -37.31 79.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.379 0.609 . . . . 71.11 110.414 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -64.31 -55.0 24.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.504 -0.771 . . . . 75.44 111.302 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.408 HD11 ' CD2' ' A' ' 87' ' ' PHE . 96.8 mt -65.58 -27.78 68.67 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.034 0.383 . . . . 74.0 112.034 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.2 mt-30 -66.31 -20.84 66.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.66 0.267 . . . . 75.2 111.007 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -101.31 -37.32 8.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.245 -0.434 . . . . 72.52 110.809 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 t -153.65 118.2 4.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 75.33 109.972 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.433 ' C ' ' HG1' ' A' ' 79' ' ' THR . . . -81.68 74.79 2.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.89 -0.672 . . . . 64.34 111.889 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.433 ' HG1' ' C ' ' A' ' 78' ' ' GLY . 0.6 OUTLIER -147.29 139.19 24.27 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.69 -0.3 . . . . 71.13 110.474 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.8 t -74.44 116.16 50.37 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.371 -0.603 . . . . 71.5 109.371 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.8 -38.07 46.42 Favored 'Trans proline' 0 N--CA 1.474 0.344 0 C-N-CA 123.279 2.652 . . . . 74.34 113.773 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.09 -55.99 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.12 0.415 . . . . 74.03 112.12 -175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 28.3 p -96.13 -13.03 23.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.251 0.463 . . . . 75.32 112.251 -171.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 66.34 22.48 10.82 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.712 0.405 . . . . 74.51 111.523 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 28.3 t -74.63 141.6 44.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.077 -0.712 . . . . 65.11 109.077 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 58.7 ttp -77.41 142.18 39.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 75.41 111.301 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.532 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 61.9 t80 -129.85 126.31 22.48 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.789 -0.819 . . . . 75.24 108.789 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 34.4 Cg_endo -63.69 157.6 69.31 Favored 'Cis proline' 0 C--O 1.235 0.356 0 C-N-CA 123.823 -1.324 . . . . 71.01 112.978 2.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -47.98 147.41 7.76 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.193 3.262 . . . . 72.33 113.677 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.28 147.32 83.14 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.848 2.365 . . . . 61.3 112.649 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.411 -0.804 . . . . 75.13 109.642 178.781 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.741 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 65.3 Cg_endo . . . . . 0 N--CA 1.461 -0.39 0 N-CA-C 111.844 -0.098 . . . . 42.24 111.844 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.48 150.98 56.59 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.898 2.399 . . . . 74.52 112.685 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -79.85 146.17 32.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.907 -0.588 . . . . 74.01 110.925 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 m -74.8 142.86 44.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.631 -0.713 . . . . 73.03 110.649 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.415 ' HD2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.74 -37.48 79.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.301 -178.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.45 -40.06 89.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.019 -0.537 . . . . 74.34 110.697 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -67.43 -38.28 84.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.959 -0.564 . . . . 64.15 110.377 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.469 ' O ' ' HE3' ' A' ' 67' ' ' LYS . 65.6 mt -66.92 -41.45 87.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.51 . . . . 39.2 110.551 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.28 -32.52 73.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 73.01 110.427 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.52 -11.6 60.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.715 -0.675 . . . . 75.14 111.795 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.56 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 91.2 mt -65.4 133.1 95.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.469 -0.332 . . . . 73.44 110.703 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 149.64 84.08 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.092 2.528 . . . . 65.34 112.143 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 55.9 mt-10 -116.77 104.8 11.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.291 0.567 . . . . 75.24 110.75 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.0 mt -106.48 117.85 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.393 -0.821 . . . . 70.31 110.356 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.5 tp -68.03 118.85 11.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.305 -0.407 . . . . 74.0 109.956 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 28.8 t -81.5 135.17 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.997 0.427 . . . . 74.25 110.631 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p -131.99 173.01 11.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.647 -0.706 . . . . 73.41 109.848 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 15.3 mm-40 -70.31 -178.67 1.77 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.598 -0.274 . . . . 71.44 110.853 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 27.9 m-20 76.14 -51.51 0.61 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.43 0.692 . . . . 75.21 111.092 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -111.38 55.74 0.65 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.026 0.441 . . . . 72.41 109.839 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 50' ' ' TYR . . . -63.79 -31.04 79.46 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.667 -0.697 . . . . 74.3 111.618 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.38 84.22 6.06 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.248 -0.649 . . . . 73.2 109.248 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.26 -28.91 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 65.14 110.882 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.02 -142.48 3.57 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.035 -0.826 . . . . 72.12 111.035 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.97 -20.91 63.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.063 0.458 . . . . 62.25 110.397 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -103.97 130.55 51.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 64.12 110.849 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.6 ptp -102.66 -3.91 25.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.423 -0.808 . . . . 60.4 109.842 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 8.8 p -134.59 149.31 50.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.679 -0.691 . . . . 64.4 111.051 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 28.9 t -105.97 103.51 44.89 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.713 -0.676 . . . . 74.11 109.519 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 16.1 Cg_endo -56.94 -28.71 79.25 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 123.291 2.661 . . . . 63.33 112.907 -176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mt -68.27 -28.2 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.094 -0.503 . . . . 63.01 110.871 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 78.7 m -104.74 -18.7 14.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 60.53 110.579 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.8 t 61.65 24.94 14.95 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.252 -0.886 . . . . 73.51 109.471 -172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.9 m -128.32 171.81 11.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.166 -0.925 . . . . 75.45 109.266 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER -93.76 -171.75 2.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.844 0.354 . . . . 73.21 110.639 -178.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.554 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 90.5 m-85 -98.52 103.18 15.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.118 0.485 . . . . 75.0 110.578 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG13 ' HG2' ' A' ' 49' ' ' GLU . 25.2 m -121.87 167.13 15.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.648 -0.705 . . . . 64.43 111.062 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 22.8 ttpp -54.32 127.44 27.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.336 -0.847 . . . . 75.14 111.725 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.59 -34.38 3.8 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.793 -0.718 . . . . 75.41 113.031 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -86.97 165.3 15.96 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.704 -0.48 . . . . 72.14 109.704 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.42 121.13 66.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.797 0.332 . . . . 71.42 110.544 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -100.21 160.96 13.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.978 0.418 . . . . 72.14 111.075 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.56 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 11.2 t -137.25 167.49 21.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.859 -0.61 . . . . 64.01 109.646 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -120.65 118.09 29.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.011 0.434 . . . . 74.11 110.863 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.7 mt -87.0 143.42 34.99 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.846 -0.615 . . . . 64.51 109.517 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.39 -12.8 17.94 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.937 2.425 . . . . 64.43 111.687 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 45.5 t -76.0 9.17 2.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.99 -1.005 . . . . 75.1 110.592 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 65.69 28.45 11.1 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.524 0.678 . . . . 74.04 109.736 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 136.96 54.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.543 -0.753 . . . . 72.21 110.578 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -110.78 133.26 53.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.253 -0.43 . . . . 75.13 110.714 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.543 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 91.5 m-85 -145.02 175.31 10.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.365 -0.976 . . . . 73.34 108.365 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.946 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.4 m80 -88.41 130.19 35.23 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.8 -0.815 . . . . 73.23 108.8 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.58 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 84.8 tttt -57.02 -48.06 98.07 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 112.086 0.402 . . . . 75.01 112.086 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 10.0 Cg_endo -51.46 -46.2 32.99 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.486 2.124 . . . . 75.2 113.503 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.946 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 8.4 p -84.23 -34.96 23.77 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.199 0.444 . . . . 71.05 112.199 -175.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.504 HG23 ' HG ' ' A' ' 74' ' ' LEU . 5.7 p -71.72 -26.1 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 122.225 -0.297 . . . . 73.24 110.751 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -56.98 -39.71 75.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.142 0.496 . . . . 71.35 110.72 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.487 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 59.8 mt -69.65 -40.95 79.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.914 -0.584 . . . . 75.44 110.585 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -72.96 -38.91 66.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 74.43 111.326 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.504 ' HG ' HG23 ' A' ' 70' ' ' VAL . 88.8 mt -63.86 -32.84 74.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.601 -0.272 . . . . 75.43 111.252 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -77.08 -9.52 58.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.803 0.335 . . . . 74.45 111.104 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 67.9 mttm -80.92 -58.77 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 73.13 110.927 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.8 m -148.74 11.66 0.86 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.214 0.449 . . . . 71.43 112.214 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.69 65.27 3.29 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 123.25 0.343 . . . . 65.04 113.764 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.34 160.8 43.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.669 0.235 . . . . 64.12 111.142 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.706 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 84.4 m -79.34 123.28 84.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.806 -0.812 . . . . 73.11 108.806 168.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.58 -21.81 56.89 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.498 2.132 . . . . 74.05 112.522 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.4 t -84.58 -53.43 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 60.43 111.861 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 28.9 p -98.84 -19.75 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.838 0.31 . . . . 74.44 111.838 -170.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 66.65 19.78 10.77 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.034 -0.53 . . . . 62.02 111.654 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.46 143.44 33.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.923 -0.769 . . . . 71.31 108.923 171.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.741 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 51.1 ttp -75.78 145.02 41.06 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.757 0.66 . . . . 74.22 112.516 -171.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.538 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 91.5 t80 -131.21 125.05 20.78 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.139 -0.937 . . . . 73.31 109.061 171.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.538 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 31.7 Cg_exo -60.63 153.3 52.87 Favored 'Cis proline' 0 C--N 1.348 0.541 0 C-N-CA 124.03 -1.238 . . . . 74.15 112.787 0.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.57 154.41 9.07 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.606 2.871 . . . . 74.42 113.127 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.14 147.61 94.73 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.071 2.514 . . . . 44.1 112.704 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.526 -0.75 . . . . 71.22 109.934 179.144 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 N--CA 1.461 -0.393 0 CA-C-O 121.033 0.347 . . . . 63.32 112.733 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.43 148.43 79.22 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.67 2.246 . . . . 62.54 111.251 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -76.86 139.86 40.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.405 -0.361 . . . . 64.41 110.763 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.6 m -61.24 129.79 43.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.955 -0.566 . . . . 64.24 110.139 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.584 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 3.2 tmmm? -58.96 -30.5 67.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.499 -0.319 . . . . 72.41 110.562 -177.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.2 mp0 -54.9 -41.95 71.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.962 0.411 . . . . 75.21 110.223 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.509 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 18.0 m -77.42 -34.98 54.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.858 -0.61 . . . . 75.11 110.779 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.7 -42.44 95.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.3 0.571 . . . . 42.31 110.484 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -68.68 -37.48 79.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.687 -0.688 . . . . 71.33 110.968 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.63 -6.61 49.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.11 -0.495 . . . . 73.12 111.705 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.707 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 57.3 mt -63.68 125.34 87.37 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.681 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.431 ' O ' ' HA ' ' A' ' 57' ' ' THR . 19.4 Cg_endo -58.04 125.37 18.35 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.471 2.781 . . . . 64.22 113.228 -175.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -81.12 113.72 19.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.456 -0.793 . . . . 75.21 110.654 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.7 mt -112.56 109.42 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.279 -0.419 . . . . 72.44 110.101 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.92 118.29 10.19 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.908 -0.404 . . . . 62.03 109.908 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.451 ' CG1' ' HB3' ' A' ' 50' ' ' TYR . 53.0 t -81.63 128.96 38.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.166 0.508 . . . . 73.24 111.648 -173.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.46 HG21 ' HG3' ' A' ' 52' ' ' LYS . 17.0 p -126.01 138.16 53.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.376 -0.829 . . . . 73.05 109.269 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 52' ' ' LYS . 39.4 mt-10 -63.94 -10.7 22.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.357 . . . . 74.1 111.726 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.09 -33.11 74.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.89 -0.595 . . . . 75.44 109.759 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.489 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 40.3 t-80 -134.13 81.73 1.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.354 -0.839 . . . . 71.32 109.553 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.37 -36.07 31.59 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.917 -0.658 . . . . 74.54 112.942 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.37 86.0 6.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.25 0.548 . . . . 71.21 110.665 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.489 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 6.3 t -74.82 -23.73 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.685 -0.689 . . . . 71.14 110.302 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.07 -134.58 1.71 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.261 -0.736 . . . . 73.23 111.261 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -68.86 -42.41 77.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.463 0.649 . . . . 65.32 109.502 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -73.29 113.01 9.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.122 -0.945 . . . . 74.11 110.548 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -95.2 -5.05 44.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.644 0.735 . . . . 72.22 109.257 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.2 p -144.53 167.93 21.34 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.097 -0.956 . . . . 74.15 110.087 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.0 t -115.63 92.83 34.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.713 -0.477 . . . . 75.14 109.713 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.11 -28.14 86.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.979 2.453 . . . . 72.13 112.358 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.0 mt -56.16 -39.24 57.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.487 -0.779 . . . . 75.31 111.609 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.7 p -117.54 6.27 12.51 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.923 -0.311 . . . . 73.05 110.54 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.1 m 53.03 67.79 0.94 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.464 -0.789 . . . . 74.2 111.407 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 p -156.67 168.28 27.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.834 -0.621 . . . . 71.34 109.522 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.74 -170.0 2.75 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.4 -0.592 . . . . 73.42 109.4 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.571 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 61.6 m-85 -93.72 89.65 6.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.382 0.611 . . . . 71.14 110.773 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 m -85.94 158.12 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.101 -0.954 . . . . 75.41 111.251 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HG3' HG21 ' A' ' 31' ' ' THR . 38.8 ttmt -73.34 120.46 18.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.984 -0.553 . . . . 75.0 110.547 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.85 -19.66 6.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.635 -0.793 . . . . 71.31 112.491 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -84.99 166.5 16.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.981 -0.748 . . . . 72.41 108.981 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.9 t -115.19 131.18 68.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.774 -0.454 . . . . 74.21 109.774 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.57 175.46 5.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.839 0.352 . . . . 62.31 110.654 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.707 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.6 t -151.61 160.79 43.51 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.817 -0.629 . . . . 73.35 109.933 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.71 126.76 52.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.474 . . . . 74.44 110.301 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.2 mt -92.06 142.56 26.48 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 108.942 -0.762 . . . . 74.43 108.942 171.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.99 -10.61 12.85 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.203 2.602 . . . . 75.31 111.745 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.13 19.34 2.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.967 -1.015 . . . . 50.03 110.289 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 56.09 37.26 28.66 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.763 -0.653 . . . . 73.1 111.458 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -132.66 141.56 48.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.564 -0.744 . . . . 75.55 110.014 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -119.87 133.42 55.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.198 -0.456 . . . . 75.32 110.754 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.571 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 98.0 m-85 -143.84 168.1 20.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.983 -0.553 . . . . 74.11 109.841 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 33.1 m170 -64.02 128.17 34.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.299 -0.63 . . . . 72.1 109.299 171.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 64.1 tttp -56.77 -53.08 68.56 Favored Pre-proline 0 CA--C 1.535 0.386 0 O-C-N 123.342 0.401 . . . . 70.13 111.376 -177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 12.2 Cg_endo -56.97 -45.3 37.14 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.16 1.906 . . . . 62.21 112.232 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 66.2 m -61.38 -48.73 79.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.122 -0.49 . . . . 54.42 111.357 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.521 HG21 ' HG ' ' A' ' 74' ' ' LEU . 7.7 p -69.82 -27.58 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 71.34 110.618 -175.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.8 m -61.98 -37.05 83.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 51.45 110.361 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.3 mt -66.65 -43.32 90.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.514 . . . . 75.41 110.131 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -68.94 -47.15 66.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.017 -0.538 . . . . 74.15 110.904 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.521 ' HG ' HG21 ' A' ' 70' ' ' VAL . 94.4 mt -60.77 -36.39 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.105 0.409 . . . . 74.44 112.105 -175.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.26 -12.71 61.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.715 0.293 . . . . 74.4 111.184 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -98.77 -50.89 4.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.333 0.587 . . . . 62.32 109.593 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.7 p -151.77 113.3 4.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.383 -0.826 . . . . 72.14 109.858 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.92 85.92 0.38 Allowed Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.946 -0.645 . . . . 71.23 112.613 -176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 2.0 p -149.36 161.79 41.37 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.313 0.245 . . . . 73.13 111.271 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.77 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 95.8 m -79.24 120.52 80.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.32 -0.993 . . . . 73.31 108.32 165.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.46 -14.52 25.72 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.308 2.006 . . . . 71.53 113.044 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.23 -43.47 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.307 -0.406 . . . . 75.44 112.005 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.77 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.3 p -105.88 -17.35 14.39 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.809 -0.356 . . . . 71.41 111.599 -172.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 63.69 23.55 13.55 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.177 0.591 . . . . 73.52 111.973 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 79' ' ' THR . 34.6 t -89.05 155.53 19.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.219 -0.66 . . . . 72.34 109.219 173.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.53 ' HE1' ' HB3' ' A' ' 90' ' ' PRO . 25.7 ttm -82.28 149.61 27.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.556 0.576 . . . . 75.33 112.556 -167.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.496 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 66.0 t80 -136.93 120.22 11.89 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 114.934 -1.03 . . . . 73.13 108.803 168.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 34.0 Cg_endo -62.85 152.76 68.5 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 123.863 -1.307 . . . . 74.32 112.572 2.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.23 142.65 55.44 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.147 2.565 . . . . 72.34 112.944 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HB3' ' HE1' ' A' ' 86' ' ' MET . 39.4 Cg_endo -67.61 147.56 76.55 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.86 2.374 . . . . 72.35 112.232 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.42 -0.8 . . . . 62.35 110.255 -179.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.1 Cg_endo . . . . . 0 C--O 1.236 0.387 0 N-CA-C 113.071 0.374 . . . . 74.33 113.071 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 23.9 Cg_exo -64.27 152.28 81.95 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.934 2.423 . . . . 75.23 111.858 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -84.08 166.67 17.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.888 0.375 . . . . 42.12 110.831 -177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.421 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.3 p -87.24 144.31 26.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.072 -0.513 . . . . 72.4 110.574 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -62.47 -36.02 81.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 74.43 111.168 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.6 -28.48 69.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.022 -0.535 . . . . 61.13 111.131 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 t -82.94 -24.62 32.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.383 -0.372 . . . . 72.13 110.19 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 18' ' ' SER . 60.0 mt -79.76 -38.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.309 0.576 . . . . 74.33 110.304 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.04 -27.68 63.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.736 -0.666 . . . . 71.45 110.882 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.08 -4.36 55.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.52 111.871 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.496 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 64.3 mt -63.7 131.43 94.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.567 -0.288 . . . . 71.34 111.069 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.84 141.18 77.14 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.774 2.316 . . . . 71.53 112.094 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -104.7 119.09 38.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.184 0.516 . . . . 74.43 110.913 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 56' ' ' ALA . 65.4 mt -112.29 120.82 63.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.47 -0.786 . . . . 72.03 110.082 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.9 tp -74.61 122.54 23.32 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.94 -0.392 . . . . 75.11 109.94 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 43.1 t -92.13 127.46 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.863 0.363 . . . . 73.4 111.337 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.4 p -128.19 172.84 10.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.687 -0.688 . . . . 74.53 110.022 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -76.9 -10.16 59.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.795 0.331 . . . . 75.34 110.7 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -84.78 -10.21 57.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.168 -0.469 . . . . 73.12 110.186 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.487 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 21.1 t-80 -149.56 61.92 1.01 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.085 0.469 . . . . 71.51 110.349 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.36 -43.34 79.15 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.77 -0.65 . . . . 75.03 111.513 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.59 98.76 6.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.765 -0.457 . . . . 61.44 109.765 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.487 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 14.0 t -82.72 -20.81 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.254 0.549 . . . . 75.24 110.229 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.73 -140.38 2.87 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.178 -0.769 . . . . 50.42 111.178 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.81 -26.35 64.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.053 0.454 . . . . 74.55 110.071 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -111.68 160.75 16.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.775 -0.648 . . . . 72.53 110.269 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -141.13 13.09 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.331 . . . . 75.12 111.267 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 71.6 m -132.42 140.07 48.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.5 -0.318 . . . . 74.42 110.704 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.7 t -103.3 100.15 17.14 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.636 -0.505 . . . . 52.11 109.636 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.61 -24.76 69.59 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.921 2.414 . . . . 71.22 112.724 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.4 mt -61.14 -35.24 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.073 -0.512 . . . . 51.41 110.916 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 28.2 p -112.95 10.85 18.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.41 . . . . 74.13 109.918 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.0 p 40.33 51.76 2.82 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.174 0.921 . . . . 74.42 111.911 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.1 m -150.75 150.13 30.64 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.993 -0.548 . . . . 74.0 110.103 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 13.1 pt-20 -77.92 -169.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.123 0.487 . . . . 73.23 110.955 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.437 ' HB3' HG13 ' A' ' 30' ' ' VAL . 45.4 m-85 -90.12 113.07 24.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.193 0.521 . . . . 74.24 111.433 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.44 162.4 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.318 -0.856 . . . . 65.4 110.473 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 39.5 ttmt -65.84 128.52 36.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.115 -0.493 . . . . 72.52 110.934 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.49 -24.01 11.7 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.709 -0.757 . . . . 74.31 112.873 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -82.55 159.22 22.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.739 -0.467 . . . . 62.41 109.739 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.09 119.22 57.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.488 -0.324 . . . . 72.45 110.474 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -97.85 168.27 10.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.393 -0.367 . . . . 74.35 110.955 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 14.6 t -152.59 156.8 40.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.902 -0.59 . . . . 73.43 109.717 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -116.73 118.57 32.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.78 0.324 . . . . 72.12 110.496 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.96 148.67 81.97 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.138 -0.69 . . . . 75.53 109.138 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.79 -9.72 10.23 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.899 2.399 . . . . 70.33 112.067 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.3 9.15 11.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.364 -0.835 . . . . 74.23 109.938 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m170 58.85 37.43 24.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.838 -0.619 . . . . 62.54 111.469 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -121.07 145.06 48.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.741 -0.663 . . . . 74.14 109.495 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -114.09 132.8 55.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.253 0.549 . . . . 75.05 111.609 -172.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.9 175.41 10.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.279 -0.873 . . . . 73.23 108.721 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.728 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 37.4 m80 -87.07 135.46 33.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.8 -0.815 . . . . 75.33 108.8 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.487 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.0 tttt -59.48 -50.19 88.46 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.308 0.38 . . . . 75.43 111.841 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.6 Cg_endo -60.87 -18.51 57.15 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.03 1.82 . . . . 63.44 112.911 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.728 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 64.5 m -83.9 -53.03 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.225 0.536 . . . . 64.34 110.865 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 p -70.38 -27.25 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.54 -0.755 . . . . 74.22 111.216 -172.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.555 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 6.4 p -61.16 -32.34 72.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.467 -0.333 . . . . 71.31 111.193 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.0 mt -74.99 -44.45 44.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.177 0.513 . . . . 71.31 110.272 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -62.23 -43.93 97.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.598 -0.728 . . . . 75.42 111.182 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 91.7 mt -65.19 -23.9 67.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 55.41 111.687 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.6 mt-30 -73.94 -15.26 61.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 74.43 110.884 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -106.18 -43.81 4.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.342 0.591 . . . . 71.51 109.99 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.9 p -153.32 114.62 4.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.441 -0.799 . . . . 53.31 110.397 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.87 81.35 1.02 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.558 -0.829 . . . . 74.05 112.124 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.4 164.51 34.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.507 0.194 . . . . 64.11 111.495 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.619 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 68.5 m -74.87 116.82 57.51 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 107.953 -1.128 . . . . 71.44 107.953 162.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.63 -17.29 27.91 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 122.492 2.128 . . . . 74.31 112.526 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.23 -57.44 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.78 -0.645 . . . . 74.21 111.767 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.9 p -94.48 -12.67 27.25 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.36 0.504 . . . . 75.25 112.36 -169.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 83' ' ' CYS . 20.8 mmt180 74.24 4.9 4.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.004 0.521 . . . . 74.12 112.015 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.4 t -73.22 145.23 46.37 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.164 -0.214 . . . . 61.5 110.425 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.512 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 36.0 ttm -74.34 145.84 43.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 63.22 112.438 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.426 ' CZ ' HD22 ' A' ' 25' ' ' LEU . 74.1 t80 -128.8 121.43 20.98 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.409 -0.814 . . . . 73.44 109.85 171.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.07 157.41 99.55 Favored 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.999 -1.667 . . . . 73.42 111.731 -1.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.56 142.33 31.26 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.83 2.353 . . . . 64.24 112.508 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 28.5 Cg_endo -62.62 152.08 79.87 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.001 2.467 . . . . 64.11 112.185 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.541 -0.742 . . . . 73.32 110.187 -177.236 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 C--O 1.235 0.332 0 CA-C-O 120.593 0.164 . . . . 45.31 112.392 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.47 163.0 34.18 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.923 2.416 . . . . 71.13 112.754 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.83 177.57 6.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.105 -0.498 . . . . 71.13 110.694 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -90.25 143.05 27.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.371 -0.377 . . . . 73.43 109.987 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -57.09 -39.59 75.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.932 0.396 . . . . 72.31 110.618 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.66 -23.8 60.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 71.51 111.243 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.8 m -77.19 -31.04 55.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.999 0.428 . . . . 74.54 109.948 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.9 mt -78.38 -40.86 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 75.43 109.968 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.03 -35.8 73.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.888 -0.596 . . . . 73.22 110.607 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.28 -4.02 48.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.733 -0.667 . . . . 75.15 112.156 -176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.561 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 74.1 mt -65.89 126.34 91.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.66 0.266 . . . . 71.44 110.349 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.03 136.27 64.31 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.958 2.439 . . . . 64.34 112.324 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.83 113.4 26.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.128 -0.487 . . . . 75.53 110.193 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.5 mt -114.72 132.45 63.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.849 -0.614 . . . . 73.42 110.01 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 47.9 tp -86.81 116.7 25.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.166 -0.309 . . . . 70.12 110.166 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 54.0 t -71.21 135.74 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.29 -0.414 . . . . 73.31 109.893 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.8 p -128.64 172.83 10.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.271 -0.422 . . . . 72.45 110.423 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' ' HE3' ' A' ' 52' ' ' LYS . 42.5 mm-40 -70.34 -25.13 63.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 75.3 111.152 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.95 -7.08 58.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 60.31 111.131 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.671 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 59.9 t-80 -153.18 64.6 0.77 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.712 -0.477 . . . . 65.12 109.712 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.1 -59.61 7.26 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.81 -0.632 . . . . 75.1 112.297 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.28 92.81 1.82 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.056 0.455 . . . . 61.42 109.93 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.671 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 6.4 t -63.26 -49.33 83.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 74.33 109.894 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.11 -138.88 5.1 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.655 -1.378 . . . . 75.14 109.655 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.86 -11.41 59.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.611 0.705 . . . . 75.43 109.532 171.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -83.5 100.16 10.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 75.22 110.161 171.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -91.33 -12.5 34.8 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.603 0.716 . . . . 75.44 109.208 172.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 57.2 m -138.24 131.29 30.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.035 -0.984 . . . . 75.04 109.29 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.6 t -70.93 109.09 4.51 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 123.342 0.401 . . . . 71.1 110.018 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.71 -24.47 74.78 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.782 2.322 . . . . 75.35 112.185 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.83 -25.7 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.259 0.552 . . . . 71.02 110.675 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 40.0 m -117.46 2.3 12.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.174 -0.466 . . . . 70.22 110.879 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p 42.79 35.78 0.76 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.657 0.783 . . . . 62.55 111.674 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.4 t -136.43 148.14 47.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.97 -0.559 . . . . 42.04 110.036 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 9.9 pt-20 -79.21 168.56 19.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.565 0.58 . . . . 73.24 112.565 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.57 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.2 m-85 -98.02 130.35 44.85 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 75.4 110.666 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -132.7 177.87 6.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.016 -0.365 . . . . 64.11 110.016 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 40.0 ttmt -60.06 113.06 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 74.42 110.878 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.25 -11.02 7.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.623 . . . . 37.71 112.06 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.53 131.94 36.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.853 0.359 . . . . 72.53 111.088 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -88.07 110.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.212 -0.449 . . . . 73.42 109.956 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.1 155.66 22.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.086 -0.507 . . . . 71.03 110.394 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.9 t -132.43 159.3 39.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.065 -0.516 . . . . 74.13 109.839 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -109.3 123.07 48.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.918 0.39 . . . . 74.44 111.469 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.9 mt -87.05 140.03 32.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.319 -0.993 . . . . 71.01 108.319 167.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.69 -13.02 7.43 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.304 2.669 . . . . 73.11 113.802 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.2 p -90.42 19.88 4.92 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.801 0.334 . . . . 64.34 110.71 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 60.32 54.63 3.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.91 -0.586 . . . . 74.23 112.034 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -142.3 141.29 32.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.834 -0.621 . . . . 73.12 109.373 174.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -120.39 133.47 55.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.406 0.622 . . . . 75.14 111.934 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.57 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 65.2 m-85 -139.26 175.17 9.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.298 -0.864 . . . . 74.32 108.754 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.818 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 40.4 m80 -76.45 132.14 39.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.302 -0.999 . . . . 72.12 108.302 173.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.561 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 85.5 tttt -56.25 -48.96 95.88 Favored Pre-proline 0 C--N 1.32 -0.688 0 O-C-N 123.301 0.376 . . . . 75.4 111.913 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 7.2 Cg_endo -50.45 -51.38 11.14 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.454 2.103 . . . . 64.32 113.426 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.818 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 18.9 p -77.1 -30.46 55.33 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.627 -0.429 . . . . 74.25 111.815 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 67' ' ' LYS . 5.4 p -70.75 -26.48 28.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 120.329 -0.548 . . . . 70.34 109.752 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 41.3 m -60.84 -48.23 82.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.641 -0.503 . . . . 73.33 109.641 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.418 HG22 ' HE3' ' A' ' 76' ' ' LYS . 42.7 mt -62.75 -40.51 88.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.609 -0.723 . . . . 63.3 110.625 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -66.49 -50.96 61.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.004 -0.544 . . . . 74.31 111.126 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.09 -20.91 66.31 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.143 0.424 . . . . 75.21 112.143 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.9 mt-30 -79.44 -8.3 59.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 72.32 110.785 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HE3' HG22 ' A' ' 72' ' ' ILE . 10.1 mtmp? -114.43 -34.26 5.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.368 -0.378 . . . . 72.52 110.792 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 t -148.33 127.51 12.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.812 -0.44 . . . . 73.45 109.812 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.56 47.06 3.01 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.691 -0.766 . . . . 74.42 112.653 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.29 149.5 49.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.028 0.442 . . . . 71.23 111.318 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 38.6 t -74.65 114.36 33.43 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.471 -0.786 . . . . 65.15 109.512 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.24 -22.46 48.86 Favored 'Trans proline' 0 N--CA 1.474 0.326 0 C-N-CA 122.712 2.274 . . . . 70.05 112.84 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.7 t -82.86 -31.89 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.301 0.482 . . . . 60.25 112.301 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.0 p -130.27 -11.6 4.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.686 0.625 . . . . 45.21 112.686 -173.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 70.49 13.44 7.42 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.489 0.716 . . . . 72.32 111.832 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.8 t -73.08 144.07 47.18 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.152 -0.684 . . . . 70.13 109.152 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 60.9 ttp -79.12 151.57 31.28 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.369 0.418 . . . . 54.31 111.047 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -126.42 119.59 23.26 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.84 -0.618 . . . . 62.44 109.537 173.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.48 156.0 92.23 Favored 'Cis proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.45 -1.479 . . . . 63.12 112.399 -0.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.01 155.14 46.28 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.103 2.535 . . . . 65.43 112.798 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.46 -173.21 1.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.677 2.251 . . . . 64.21 112.178 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.375 -0.821 . . . . 62.42 110.394 -179.01 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo . . . . . 0 C--O 1.234 0.294 0 CA-C-O 120.932 0.305 . . . . 73.31 112.358 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.15 162.79 40.68 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.623 2.215 . . . . 70.11 112.127 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.87 143.61 26.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.256 -0.429 . . . . 61.33 110.277 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -70.92 147.67 48.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.952 -0.388 . . . . 72.13 109.952 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -53.02 -38.38 62.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.306 -0.407 . . . . 72.21 111.267 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.4 -42.49 91.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.875 -0.602 . . . . 64.54 111.901 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.5 m -70.66 -34.41 71.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.109 0.481 . . . . 74.44 110.714 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 71' ' ' SER . 68.6 mt -72.81 -42.85 61.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.978 -0.555 . . . . 64.25 111.059 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.3 -21.72 62.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.222 -0.445 . . . . 74.0 110.508 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.74 -3.89 54.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 71.03 111.622 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.438 HD11 HG22 ' A' ' 57' ' ' THR . 25.2 mt -56.52 135.32 77.11 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.602 -0.272 . . . . 73.22 111.379 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.39 129.99 36.85 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.137 2.558 . . . . 75.12 111.722 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -98.26 111.66 23.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.089 0.471 . . . . 71.43 110.732 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -112.71 109.99 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.588 -0.733 . . . . 74.42 109.758 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.79 123.52 20.37 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.514 -0.55 . . . . 74.45 109.514 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 47.2 t -74.18 114.38 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.046 0.451 . . . . 55.44 110.669 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.9 p -115.3 131.82 56.81 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.653 -0.703 . . . . 73.1 109.87 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 53.2 mt-10 -66.58 -13.97 61.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 64.42 111.251 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.23 -29.28 70.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.336 0.589 . . . . 74.03 110.012 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -92.7 -16.9 24.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.277 -0.874 . . . . 73.43 110.092 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.54 -113.72 4.36 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.41 -0.676 . . . . 75.53 111.41 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.66 132.01 40.3 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.7 -0.482 . . . . 74.43 109.7 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.57 -31.67 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.247 0.546 . . . . 64.25 110.217 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . -164.37 -118.23 0.44 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.176 -0.77 . . . . 74.22 111.176 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -64.45 -55.06 23.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.311 0.577 . . . . 74.0 110.435 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 142.02 28.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.417 -0.81 . . . . 71.22 111.702 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 ptp -112.73 7.37 18.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.496 -0.775 . . . . 72.45 109.545 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 19.6 p -126.6 149.55 49.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.401 -0.818 . . . . 74.04 109.926 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.3 t -110.32 101.01 46.83 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.042 -0.355 . . . . 65.43 110.042 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.41 -31.98 70.69 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.412 2.741 . . . . 65.15 112.583 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.2 -34.74 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.952 -0.567 . . . . 72.21 110.883 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.0 m -98.46 -18.9 17.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 74.35 111.354 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.2 m 65.89 22.23 11.37 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.444 0.64 . . . . 74.54 110.032 -172.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -130.51 175.43 8.99 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.264 -0.88 . . . . 74.11 109.524 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 8.5 pt-20 -98.96 -175.24 2.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.048 0.452 . . . . 74.32 111.477 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.519 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 56.0 m-85 -100.89 120.23 39.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.966 -0.561 . . . . 75.21 110.591 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.5 m -127.29 169.35 18.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.895 -0.593 . . . . 64.11 110.783 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 33.7 ttmt -74.36 110.92 9.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.886 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.61 -26.85 2.63 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.785 -0.721 . . . . 72.34 112.413 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -86.86 160.94 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.816 -0.439 . . . . 64.12 109.816 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -108.06 126.55 64.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.905 0.383 . . . . 64.15 110.711 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.05 170.7 7.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.174 -0.467 . . . . 72.1 110.567 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.438 HG22 HD11 ' A' ' 25' ' ' LEU . 13.5 t -148.98 156.65 42.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.06 -0.518 . . . . 63.1 109.647 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -110.55 117.47 33.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.49 -0.323 . . . . 74.32 110.376 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.9 mt -75.4 156.16 85.47 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.967 -0.753 . . . . 71.34 108.967 172.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.41 -23.82 14.89 Favored 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.095 2.53 . . . . 74.5 113.56 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.6 p -90.76 15.49 11.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.462 0.171 . . . . 71.43 111.462 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 44.8 m80 67.29 24.68 8.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.911 0.485 . . . . 74.35 112.061 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -102.83 133.25 48.21 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.741 -0.466 . . . . 72.34 109.741 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.502 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 80.5 m-85 -105.63 133.28 50.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.171 -0.468 . . . . 73.33 112.011 -171.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.519 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 99.2 m-85 -138.02 175.31 9.7 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.522 -0.918 . . . . 74.42 108.522 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.867 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.6 m80 -84.02 128.28 34.44 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.864 -0.791 . . . . 74.21 108.864 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.519 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 89.0 tttt -53.35 -48.32 92.99 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 123.578 0.549 . . . . 72.33 111.828 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 73.1 Cg_exo -53.47 -47.31 28.04 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 122.334 2.023 . . . . 74.23 113.801 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.867 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 25.8 p -82.79 -36.92 25.22 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.773 -0.371 . . . . 63.51 111.942 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.46 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 8.7 p -68.39 -24.99 30.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.77 -0.455 . . . . 74.1 109.77 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.528 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 47.5 t -55.07 -50.57 68.81 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.684 -0.689 . . . . 72.42 110.626 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.7 mt -66.0 -38.76 82.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 74.41 110.507 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -62.85 -47.1 84.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.922 -0.581 . . . . 73.4 110.634 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 97.1 mt -66.22 -29.26 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 75.13 111.258 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 71' ' ' SER . 78.6 mt-30 -71.24 -13.41 61.9 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.865 0.364 . . . . 73.45 110.73 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -101.82 -45.05 5.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 72.11 110.12 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.2 p -153.19 119.9 5.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.759 -0.655 . . . . 53.14 109.897 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.16 66.14 3.85 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.656 -0.783 . . . . 71.33 112.668 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.31 144.35 34.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.804 0.335 . . . . 72.22 111.241 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.01 104.74 1.46 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.995 -0.548 . . . . 63.33 109.78 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -48.37 -37.15 32.04 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.67 2.913 . . . . 75.05 114.322 -168.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.2 -28.42 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.304 0.483 . . . . 74.54 112.304 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.3 p -127.4 -26.74 3.0 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.986 -0.447 . . . . 51.52 111.801 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.452 ' HD2' ' HA ' ' A' ' 84' ' ' ARG . 5.1 tpt180 79.86 18.99 0.66 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.558 1.143 . . . . 75.42 110.635 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.2 t -69.0 138.34 54.43 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.605 -0.887 . . . . 75.05 108.605 169.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.52 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 41.1 ttm -80.8 148.42 30.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.966 0.413 . . . . 65.4 111.794 -171.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -133.65 116.5 13.84 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.705 -0.68 . . . . 74.54 109.448 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.05 151.95 96.44 Favored 'Cis proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.271 -1.554 . . . . 50.45 111.82 -0.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -50.08 147.64 14.94 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.272 2.648 . . . . 74.13 112.384 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 38.7 Cg_endo -65.28 149.63 88.27 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.363 2.042 . . . . 62.52 112.012 -174.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.873 -0.584 . . . . 73.44 110.213 -177.931 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo . . . . . 0 CA--C 1.532 0.396 0 CA-C-O 120.55 0.146 . . . . 64.15 111.87 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 155.43 61.87 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.644 2.229 . . . . 72.43 112.752 -175.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.92 144.76 26.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.898 -0.592 . . . . 52.41 110.641 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.3 m -65.52 145.02 56.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.978 -0.555 . . . . 74.15 110.882 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -58.22 -45.06 88.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 71.54 110.924 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -48.8 -48.12 41.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.745 -0.661 . . . . 71.24 111.259 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.0 m -67.88 -34.22 76.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 73.22 111.338 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.4 mt -72.94 -44.51 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.278 0.561 . . . . 71.03 110.393 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -62.96 -35.52 80.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.782 -0.645 . . . . 74.41 110.705 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.01 5.2 17.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.801 -0.636 . . . . 65.54 112.184 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.2 mt -69.69 142.28 91.18 Favored Pre-proline 0 C--O 1.237 0.419 0 N-CA-C 110.252 -0.277 . . . . 73.02 110.252 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.25 149.0 91.09 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.955 2.437 . . . . 72.2 112.353 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -113.04 105.81 13.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 70.44 110.451 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.7 mt -100.08 121.69 51.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.93 -0.577 . . . . 75.31 110.016 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.6 tp -81.2 122.29 27.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.835 0.35 . . . . 62.22 110.467 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 47.0 t -88.43 134.3 28.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.248 -0.433 . . . . 75.11 110.212 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.2 p -113.35 172.81 6.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.656 -0.702 . . . . 70.04 110.831 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.508 ' HG2' ' HE3' ' A' ' 52' ' ' LYS . 5.7 mm-40 -59.39 134.39 56.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.409 -0.359 . . . . 63.14 110.776 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.0 t70 53.44 74.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.322 -0.853 . . . . 73.32 110.579 -172.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -165.22 29.51 0.06 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.126 -0.943 . . . . 73.15 108.785 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 41' ' ' MET . . . -59.82 -36.65 90.67 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.468 -0.787 . . . . 53.14 111.628 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.59 84.27 5.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.31 0.576 . . . . 74.33 110.046 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.9 t -75.23 -23.25 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.571 -0.741 . . . . 71.42 109.986 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.45 -126.3 0.82 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.001 -0.84 . . . . 74.44 111.001 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.84 -3.5 41.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.342 0.591 . . . . 62.22 110.255 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -120.24 153.5 36.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.476 -0.784 . . . . 72.12 109.898 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.6 pmm? -134.92 9.79 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.113 -0.494 . . . . 71.54 110.262 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.6 p -147.61 151.01 35.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.149 -0.478 . . . . 60.35 111.045 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 37.4 t -101.49 100.96 15.29 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.488 -0.778 . . . . 72.33 109.296 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 16.3 Cg_endo -57.44 -31.62 91.78 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.931 2.421 . . . . 54.22 112.564 -176.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -60.95 -27.03 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 74.4 110.944 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.6 m -110.24 -15.35 14.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.33 -0.395 . . . . 75.43 111.103 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.0 m 58.32 45.1 17.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.186 -0.461 . . . . 61.31 109.964 -172.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.3 t -154.41 175.1 13.98 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.814 -0.63 . . . . 62.31 109.734 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -101.89 -169.87 1.74 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.743 0.306 . . . . 74.3 111.705 -173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.509 ' HB3' HG13 ' A' ' 30' ' ' VAL . 94.9 m-85 -111.07 134.18 52.87 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.077 -0.51 . . . . 75.54 110.781 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.9 m -136.89 -179.6 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.328 -0.397 . . . . 75.53 110.62 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.8 ttmt -56.73 133.28 53.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.058 0.456 . . . . 62.13 111.168 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.9 -8.65 59.65 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.798 -0.715 . . . . 71.32 112.04 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -78.58 129.11 34.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.833 0.349 . . . . 75.13 111.311 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.19 102.06 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.63 . . . . 54.04 109.463 174.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.69 162.76 13.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.827 -0.624 . . . . 75.21 110.458 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.5 t -140.58 155.48 46.56 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.655 -0.498 . . . . 74.13 109.655 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -116.02 117.54 30.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 51.22 110.64 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -79.29 150.2 73.64 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.988 -0.551 . . . . 72.43 109.88 176.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.8 -14.99 24.39 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.313 2.675 . . . . 72.3 113.083 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.4 p -87.24 10.99 15.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.249 -0.278 . . . . 74.23 110.249 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 62.24 77.79 0.32 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.731 -0.668 . . . . 65.32 111.161 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -160.94 149.64 16.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.258 -0.883 . . . . 72.32 109.226 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.75 132.87 55.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.943 0.402 . . . . 73.53 111.662 -173.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.469 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 91.6 m-85 -141.51 175.29 9.8 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.101 -0.703 . . . . 63.2 109.101 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.885 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 40.5 m80 -81.43 131.7 35.29 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.152 -1.055 . . . . 72.35 108.152 172.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 87.5 tttt -56.13 -49.94 90.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 O-C-N 123.334 0.396 . . . . 74.04 112.018 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 51.0 Cg_exo -56.9 -46.78 26.89 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.005 1.804 . . . . 73.53 113.537 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.885 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 25.1 p -74.57 -32.44 62.4 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.586 -0.446 . . . . 64.5 111.615 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 67' ' ' LYS . 7.5 p -73.01 -24.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.494 -0.483 . . . . 70.35 109.788 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.7 m -60.83 -43.07 98.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 72.35 110.431 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.05 -42.95 89.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 60.44 110.351 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.64 -46.24 83.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.641 -0.709 . . . . 75.24 111.42 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.37 -22.21 65.58 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.866 0.321 . . . . 75.4 111.866 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -81.15 -7.17 59.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.105 0.479 . . . . 74.22 110.714 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -109.82 -52.15 2.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.79 -0.641 . . . . 73.22 110.452 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.9 t -142.96 115.99 8.86 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.634 -0.506 . . . . 70.32 109.634 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.474 ' C ' ' HG1' ' A' ' 79' ' ' THR . . . -75.5 72.09 1.76 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.92 -0.657 . . . . 63.54 112.226 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.474 ' HG1' ' C ' ' A' ' 78' ' ' GLY . 1.7 m -147.11 137.49 23.46 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.901 -0.407 . . . . 63.31 109.901 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.5 t -74.77 110.03 8.82 Favored Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 109.137 -0.69 . . . . 71.33 109.137 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.69 -33.65 60.5 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 122.989 2.46 . . . . 74.14 113.832 -170.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.9 t -73.52 -53.31 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.266 0.469 . . . . 64.13 112.266 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.7 p -101.44 -16.32 16.89 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.84 -0.344 . . . . 71.32 111.433 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 69.18 23.93 6.21 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.589 -0.732 . . . . 70.2 111.993 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.6 m -80.91 149.27 29.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 74.52 109.355 170.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.5 ttp -76.39 143.67 40.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.247 -0.433 . . . . 75.25 111.871 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.632 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 78.2 t80 -137.42 126.71 15.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.924 -0.769 . . . . 75.14 108.924 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.632 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 51.7 Cg_exo -56.07 147.66 23.58 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.623 -0.99 . . . . 41.11 113.366 2.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.29 151.12 70.04 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.243 2.629 . . . . 53.22 112.596 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -70.42 178.79 4.61 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.677 2.252 . . . . 65.01 112.432 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.564 -0.744 . . . . 75.15 110.602 -179.234 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 CA--C 1.533 0.437 0 N-CA-C 112.817 0.276 . . . . 73.54 112.817 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.13 165.67 27.63 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.738 2.292 . . . . 63.43 112.745 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -90.17 154.01 20.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.793 -0.639 . . . . 50.24 110.433 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -70.2 135.73 49.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.453 -0.339 . . . . 63.01 110.567 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 5.5 tmmm? -58.87 -38.15 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.925 -0.579 . . . . 73.21 110.984 -176.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -59.31 -46.3 88.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.927 -0.579 . . . . 74.55 110.535 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.8 m -63.59 -34.16 77.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 61.14 110.632 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.04 -43.53 76.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.607 . . . . 73.14 110.413 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -66.54 -37.38 84.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.142 -0.481 . . . . 71.24 110.577 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.67 3.68 11.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.747 -0.661 . . . . 63.14 111.807 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.642 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 60.1 mt -70.18 131.82 88.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.475 -0.195 . . . . 75.1 110.475 175.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.63 135.24 66.06 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.152 2.568 . . . . 63.25 112.513 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -101.63 102.92 13.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.106 0.479 . . . . 73.53 110.006 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.1 mt -103.23 131.63 51.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.898 -0.592 . . . . 74.15 110.544 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.8 tp -79.38 121.74 25.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.893 0.378 . . . . 74.03 110.323 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 50' ' ' TYR . 42.6 t -87.46 132.33 33.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.074 -0.512 . . . . 71.44 110.67 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 36.9 p -128.59 151.42 49.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.264 -0.426 . . . . 62.35 110.297 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.654 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 30.4 mt-10 -84.51 0.6 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.23 0.538 . . . . 74.21 110.687 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.1 -22.11 29.03 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.847 -0.797 . . . . 74.05 108.847 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -133.4 55.57 1.89 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.89 -1.05 . . . . 73.1 109.265 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.95 160.1 34.97 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.38 -0.827 . . . . 72.32 112.272 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 41' ' ' MET . . . 60.16 76.62 0.35 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.399 0.618 . . . . 64.12 109.993 -174.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.71 93.77 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.45 -0.795 . . . . 73.43 111.145 -173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.42 -12.9 30.71 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.832 -0.622 . . . . 73.0 113.298 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 3.0 pt20 -156.93 -160.26 0.95 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.73 -0.276 . . . . 73.35 110.679 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.3 151.84 9.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.589 -0.732 . . . . 63.32 110.615 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.445 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 1.4 pmm? -88.77 11.91 16.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.309 -0.405 . . . . 52.44 111.645 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.1 m -118.4 141.53 48.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.208 0.528 . . . . 75.41 111.411 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.3 t -106.11 101.72 35.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.555 -0.748 . . . . 71.02 109.549 177.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.7 -26.68 82.9 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 123.246 2.631 . . . . 75.33 113.349 -174.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.9 mt -60.83 -41.26 87.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 75.02 111.469 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 21.0 p -119.88 13.96 12.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.557 -0.292 . . . . 75.21 110.909 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p 43.37 45.14 5.13 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.942 0.776 . . . . 72.51 112.22 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.0 p -120.85 -177.71 3.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.459 -0.571 . . . . 70.12 109.459 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -106.67 -175.13 2.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.795 0.331 . . . . 75.54 110.117 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.48 ' HB3' HG13 ' A' ' 30' ' ' VAL . 70.0 m-85 -103.0 109.92 21.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.378 -0.374 . . . . 75.21 110.538 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.1 m -107.08 165.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 74.35 111.68 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.654 ' HB2' ' H ' ' A' ' 32' ' ' GLU . 22.7 ttpp -73.5 113.69 10.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 72.21 111.008 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.02 -8.74 9.1 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.943 -0.646 . . . . 63.34 112.709 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.26 166.02 15.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 110.121 -0.326 . . . . 74.22 110.121 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -115.98 116.17 51.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.13 0.49 . . . . 75.31 110.745 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.43 166.95 10.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.028 -0.533 . . . . 73.01 110.784 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.8 t -136.45 155.16 50.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.747 -0.66 . . . . 73.21 110.114 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -107.75 117.8 35.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.98 -0.554 . . . . 73.44 109.925 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.87 146.38 59.55 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 109.031 -0.729 . . . . 74.54 109.031 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.71 -3.87 4.0 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.099 2.533 . . . . 65.14 113.807 -175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.7 p -103.22 29.29 5.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 75.03 110.472 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 63.12 31.73 15.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.878 -0.601 . . . . 74.41 112.188 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -126.52 135.01 50.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.776 0.322 . . . . 74.14 110.814 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.65 145.92 30.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.79 -0.641 . . . . 72.42 110.875 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -149.25 160.41 43.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.686 -0.688 . . . . 75.42 109.289 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.579 ' HB2' ' CB ' ' A' ' 69' ' ' CYS . 34.3 m170 -60.47 132.85 55.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.418 -0.956 . . . . 72.14 108.418 168.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -65.85 -61.51 5.55 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.943 0.719 . . . . 74.23 112.943 -171.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.36 -23.32 71.81 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.742 1.628 . . . . 62.41 111.197 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.579 ' CB ' ' HB2' ' A' ' 66' ' ' HIS . 7.7 t -67.36 -53.42 29.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.212 -1.358 . . . . 75.33 110.295 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.428 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 p -74.65 -24.7 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.782 -0.644 . . . . 72.35 110.524 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.606 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 43.6 t -54.29 -48.73 70.92 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.266 -0.424 . . . . 75.22 110.1 176.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.0 mt -57.51 -47.6 84.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.012 -0.54 . . . . 65.32 110.343 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -61.3 -44.75 96.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 74.42 111.116 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 96.8 mt -66.14 -23.07 66.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 74.34 111.456 -178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.606 ' HG3' ' O ' ' A' ' 71' ' ' SER . 78.0 mt-30 -72.33 -21.95 61.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.755 0.312 . . . . 71.3 110.485 177.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -89.56 -59.17 2.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.183 0.516 . . . . 70.32 109.625 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.0 m -140.11 124.78 18.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 71.35 110.343 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.03 75.55 2.27 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.176 -0.769 . . . . 75.53 111.176 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.455 HG21 ' HA ' ' A' ' 84' ' ' ARG . 4.0 m -147.68 135.29 20.89 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.374 -0.232 . . . . 74.42 110.374 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 34.9 t -75.18 107.39 3.93 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.181 -0.674 . . . . 63.25 109.181 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.18 -31.98 48.02 Favored 'Trans proline' 0 N--CA 1.476 0.497 0 C-N-CA 123.152 2.568 . . . . 74.21 114.207 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.5 t -71.69 -47.9 54.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.048 0.388 . . . . 63.53 112.048 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 20.5 p -103.51 -23.83 13.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.848 0.356 . . . . 74.13 111.031 -174.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.455 ' HA ' HG21 ' A' ' 79' ' ' THR . 35.9 mtp180 71.13 29.6 2.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.316 -0.856 . . . . 74.13 110.893 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 47.6 t -85.07 138.15 32.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.536 -0.756 . . . . 73.31 108.982 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.7 ttp -72.11 143.38 49.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 65.21 111.275 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.463 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 94.0 t80 -125.88 129.69 24.23 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.309 -0.859 . . . . 75.32 108.98 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 16.7 Cg_exo -67.59 157.42 85.0 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 123.851 -1.312 . . . . 71.24 112.721 2.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.51 134.38 63.6 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.065 2.51 . . . . 65.3 112.412 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.81 -172.18 1.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.016 2.477 . . . . 64.44 112.61 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--O 1.243 0.75 0 CA-C-O 118.6 -0.714 . . . . 73.41 109.859 178.049 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo . . . . . 0 C--O 1.234 0.287 0 CA-C-O 120.803 0.251 . . . . 64.32 112.321 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.54 156.15 67.26 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.986 2.458 . . . . 61.35 112.197 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.84 147.52 22.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.078 -0.51 . . . . 72.02 110.443 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -68.23 138.91 55.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.327 -0.397 . . . . 74.21 110.241 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -54.48 -33.58 60.01 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.81 0.338 . . . . 43.35 110.819 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -61.29 -28.12 68.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 64.3 111.159 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.5 t -86.82 -34.54 19.49 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.888 -0.412 . . . . 74.1 109.888 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -67.72 -49.38 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.053 -0.521 . . . . 62.24 110.837 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -72.63 -13.0 61.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 74.22 110.653 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.37 -6.43 58.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 73.25 111.173 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.512 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 84.3 mt -63.22 138.06 97.24 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.4 -0.364 . . . . 63.05 110.667 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.85 119.06 6.01 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.183 2.589 . . . . 54.01 112.359 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -88.66 105.34 17.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.387 0.613 . . . . 72.44 110.835 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.0 mt -96.41 109.39 22.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.221 -0.9 . . . . 75.33 109.383 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.99 117.38 9.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.086 -0.507 . . . . 74.43 110.052 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 15.7 t -82.17 127.49 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.582 -0.525 . . . . 74.24 109.582 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.5 p -117.3 170.21 8.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.019 -0.537 . . . . 75.42 109.858 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 24.3 mt-10 -85.19 7.64 21.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.655 0.741 . . . . 73.11 109.865 176.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -96.39 -13.35 23.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.043 -0.981 . . . . 62.41 109.139 173.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.593 ' HE1' ' HA ' ' A' ' 37' ' ' VAL . 28.8 t-80 -132.85 115.65 15.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.258 -0.883 . . . . 75.33 110.577 -173.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.61 -111.07 0.46 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.668 -0.777 . . . . 51.3 112.486 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.93 139.18 58.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.851 0.357 . . . . 75.24 110.975 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.593 ' HA ' ' HE1' ' A' ' 34' ' ' HIS . 10.9 t -89.21 -19.18 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.016 -0.538 . . . . 73.01 110.819 -176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.39 -145.16 7.05 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.646 -0.788 . . . . 71.33 111.968 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -59.99 -49.06 79.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.101 0.476 . . . . 72.12 110.716 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.91 113.4 16.99 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.452 -0.944 . . . . 74.32 108.452 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.7 ptp -101.07 4.67 42.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.262 -0.427 . . . . 71.14 111.893 -171.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.7 m -146.87 171.48 15.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.675 0.274 . . . . 74.41 110.575 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -122.41 91.02 49.41 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.203 -0.453 . . . . 71.5 109.859 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.39 -13.32 32.11 Favored 'Trans proline' 0 N--CA 1.475 0.422 0 C-N-CA 123.384 2.722 . . . . 72.2 113.019 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.3 mt -69.99 -22.28 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.063 0.458 . . . . 72.54 110.59 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 27.4 p -132.85 -14.9 2.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.946 0.351 . . . . 74.13 111.946 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 89.9 m 65.99 21.85 11.28 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 122.761 0.424 . . . . 64.0 111.309 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -104.62 142.3 34.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.22 -0.445 . . . . 75.52 109.832 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -79.04 177.36 8.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.078 0.466 . . . . 70.23 111.008 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.442 ' HB3' HG11 ' A' ' 30' ' ' VAL . 89.5 m-85 -89.64 106.27 18.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.133 0.492 . . . . 74.12 111.425 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 m -131.15 171.42 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.619 -0.719 . . . . 75.52 110.346 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -62.56 120.91 12.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 74.12 110.545 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.62 -40.92 1.51 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.776 -0.726 . . . . 51.44 112.211 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -86.96 161.52 18.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.629 -0.508 . . . . 74.54 109.629 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.89 122.9 69.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.349 -0.387 . . . . 74.41 110.278 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.1 163.44 13.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.435 -0.348 . . . . 74.33 110.397 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.512 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.5 t -144.49 155.51 43.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.955 -0.387 . . . . 54.0 109.955 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.29 117.53 34.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.269 -0.423 . . . . 73.03 110.073 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.76 142.17 32.34 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.308 -0.627 . . . . 71.15 109.308 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.13 -18.68 24.17 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.369 2.713 . . . . 74.53 112.83 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.6 p -88.32 24.32 1.93 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.243 -0.435 . . . . 74.03 110.899 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.7 m80 66.22 33.7 7.11 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.094 0.558 . . . . 73.13 111.604 171.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -127.35 141.42 51.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.678 0.275 . . . . 73.0 110.859 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.47 133.2 55.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.838 -0.619 . . . . 72.44 110.485 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -143.07 175.18 10.05 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.876 -0.787 . . . . 75.32 108.876 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.627 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 32.3 m170 -82.39 131.49 35.22 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.174 -0.676 . . . . 75.4 109.174 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 85.2 tttt -60.1 -49.52 90.58 Favored Pre-proline 0 C--N 1.323 -0.568 0 O-C-N 123.377 0.423 . . . . 70.31 111.892 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 18.4 Cg_endo -60.05 -20.73 62.24 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.013 1.809 . . . . 64.33 112.637 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 60.2 m -83.6 -45.66 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.161 0.505 . . . . 71.3 110.655 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.474 HG23 ' HG ' ' A' ' 74' ' ' LEU . 9.4 p -78.32 -25.66 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 73.42 111.199 -173.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 9.0 p -58.85 -48.76 80.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 72.42 110.97 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.04 -42.82 96.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 65.44 110.372 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -62.88 -43.81 97.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.753 -0.658 . . . . 74.25 111.266 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.474 ' HG ' HG23 ' A' ' 70' ' ' VAL . 93.1 mt -65.55 -24.92 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.515 -0.312 . . . . 72.02 111.599 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 71' ' ' SER . 76.3 mt-30 -75.49 -23.44 56.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.979 0.418 . . . . 74.41 110.427 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -85.36 -48.08 9.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.35 0.595 . . . . 64.04 109.487 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.7 p -158.51 123.88 4.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.281 -0.872 . . . . 75.42 109.891 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.452 ' C ' ' HG1' ' A' ' 79' ' ' THR . . . -78.46 74.85 2.03 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.64 -0.79 . . . . 73.33 111.834 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 84' ' ' ARG . 5.3 m -149.24 138.44 21.45 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.768 -0.254 . . . . 71.31 110.468 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 37.6 t -75.05 112.54 18.54 Favored Pre-proline 0 C--O 1.222 -0.387 0 N-CA-C 109.855 -0.424 . . . . 74.12 109.855 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.48 -38.48 64.08 Favored 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 123.13 2.553 . . . . 72.35 113.571 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.18 -31.81 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.852 0.686 . . . . 72.13 112.852 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.7 p -124.41 -16.23 6.42 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.315 -0.554 . . . . 64.14 111.894 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.495 ' HA ' HG21 ' A' ' 79' ' ' THR . 60.3 mtt180 69.4 26.24 5.3 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.222 0.609 . . . . 54.34 110.884 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.19 131.15 38.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.965 -0.754 . . . . 73.52 108.965 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 62.8 ttp -72.49 142.84 48.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.433 -0.348 . . . . 74.55 110.571 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 79.4 t80 -127.45 126.1 24.02 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.424 -0.584 . . . . 72.14 109.424 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 33.8 Cg_endo -65.24 155.39 77.51 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 123.597 -1.418 . . . . 71.41 112.68 1.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.38 142.89 21.57 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.465 2.777 . . . . 75.04 112.853 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.64 144.02 97.12 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.822 2.348 . . . . 64.45 112.155 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.454 -0.784 . . . . 71.15 110.119 -176.655 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 90.1 Cg_endo . . . . . 0 N--CA 1.459 -0.548 0 CA-C-O 120.732 0.221 . . . . 60.45 112.576 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.83 143.08 99.43 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.954 2.436 . . . . 74.42 112.228 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.15 150.99 41.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.89 -0.595 . . . . 74.31 111.276 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.517 ' O ' HG13 ' A' ' 22' ' ' ILE . 17.7 m -69.2 132.45 46.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.877 -0.601 . . . . 62.33 110.171 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -61.68 -36.66 81.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 73.15 112.09 -172.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -70.09 -36.98 75.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 74.13 110.389 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m -65.97 -29.14 69.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 54.05 110.566 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 18' ' ' SER . 69.5 mt -69.88 -40.7 79.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 72.13 110.713 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.488 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 34.1 t70 -70.93 -26.18 63.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.849 -0.341 . . . . 74.1 110.525 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -16.01 64.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 75.42 111.733 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.414 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 94.2 mt -63.2 141.84 97.77 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.383 -0.371 . . . . 65.34 110.798 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.68 129.39 26.19 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.059 2.506 . . . . 64.53 112.527 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -92.23 116.77 29.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.059 -0.518 . . . . 75.51 110.102 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.1 mt -114.44 130.27 69.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.142 -0.481 . . . . 73.14 109.833 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.4 tp -77.21 126.05 30.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.97 0.415 . . . . 73.42 110.317 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 53.5 t -82.12 134.14 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.012 -0.54 . . . . 73.44 110.046 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 20.4 p -126.17 126.86 44.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.311 -0.404 . . . . 73.02 110.57 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.672 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 10.7 pt-20 -80.64 -9.7 59.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 75.33 111.408 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.35 -2.05 56.45 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.199 -0.667 . . . . 74.11 109.199 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -113.97 118.4 34.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.978 -1.119 . . . . 64.12 107.978 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -41.49 -50.95 4.69 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 114.86 0.704 . . . . 71.2 114.86 -171.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 39' ' ' GLN . . . -159.17 134.96 8.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.979 0.39 . . . . 37.35 110.6 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.2 t -85.41 73.25 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.935 0.398 . . . . 70.53 110.696 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.47 18.62 56.31 Favored Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.741 -0.663 . . . . 72.21 113.605 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 7.6 tp-100 -159.06 171.99 18.98 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.756 -0.831 . . . . 74.52 108.756 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.24 144.83 39.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.063 -0.347 . . . . 72.33 110.063 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.1 ptp -76.37 22.45 0.17 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.091 0.404 . . . . 63.24 112.091 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.8 m -134.23 127.37 31.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.755 0.312 . . . . 43.22 110.551 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.3 t -96.64 106.88 33.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.571 -0.529 . . . . 61.02 109.571 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.92 -33.69 89.66 Favored 'Trans proline' 0 N--CA 1.474 0.328 0 C-N-CA 123.254 2.636 . . . . 64.24 113.071 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.56 -20.21 22.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.174 0.512 . . . . 74.24 110.845 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 88.3 m -108.12 -30.18 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 63.54 111.659 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.7 t 70.0 17.73 7.33 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.875 0.734 . . . . 64.23 109.449 -171.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -124.28 161.57 25.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.253 -0.885 . . . . 74.54 110.673 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -85.12 -178.32 6.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 74.41 111.798 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.45 ' HB3' ' CG1' ' A' ' 30' ' ' VAL . 47.3 m-85 -94.47 109.16 21.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.701 -0.681 . . . . 72.02 110.93 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.672 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . 27.0 m -107.64 165.0 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.984 -0.553 . . . . 75.54 110.87 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.643 ' HB2' ' H ' ' A' ' 32' ' ' GLU . 28.1 ttpp -78.41 117.47 19.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.884 0.373 . . . . 75.11 110.725 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.82 -7.23 10.24 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.846 -0.615 . . . . 41.31 111.628 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -84.31 158.58 21.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.407 -0.59 . . . . 64.45 109.407 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.3 116.67 53.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.886 0.374 . . . . 71.44 110.63 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.31 167.68 10.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.075 -0.512 . . . . 71.24 110.551 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 14.0 t -149.26 157.96 43.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.011 -0.54 . . . . 71.1 109.645 176.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -108.4 117.63 34.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.344 -0.389 . . . . 61.21 110.126 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.85 150.12 88.21 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.912 -0.585 . . . . 62.11 109.458 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.16 -14.33 23.39 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.135 2.556 . . . . 71.21 112.855 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 23.9 p -91.93 15.0 14.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.384 -0.371 . . . . 72.4 110.334 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 60.14 74.78 0.43 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.329 0.585 . . . . 73.04 110.974 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -157.22 127.81 6.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.472 -0.785 . . . . 74.53 109.674 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 57' ' ' THR . 85.6 m-85 -97.93 133.21 42.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.025 -0.534 . . . . 73.24 110.693 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.33 174.84 10.25 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.867 -1.16 . . . . 74.4 107.867 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.828 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 34.1 m170 -86.29 128.58 34.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.912 -0.773 . . . . 73.21 108.912 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.519 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 87.4 tttt -53.03 -48.3 92.46 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.546 0.529 . . . . 73.41 111.914 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 76.1 Cg_exo -53.7 -45.0 44.25 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.33 2.02 . . . . 73.15 113.851 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.828 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 19.7 p -84.51 -33.67 23.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.398 -0.521 . . . . 74.34 112.209 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 67' ' ' LYS . 9.8 p -72.24 -28.7 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.817 -0.353 . . . . 72.22 110.765 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.3 p -63.96 -26.91 68.8 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.052 0.453 . . . . 73.44 110.83 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.92 -54.16 18.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 73.33 110.017 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -62.63 -33.62 75.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.053 -0.521 . . . . 73.53 111.477 -176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 84.6 mt -66.74 -23.93 66.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.599 -0.273 . . . . 73.45 111.315 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -89.59 -11.29 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.212 0.529 . . . . 74.13 110.364 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -95.28 -57.17 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.815 -0.629 . . . . 75.23 110.761 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.2 t -110.83 -33.95 6.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.926 -0.579 . . . . 64.05 110.929 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.02 17.58 71.88 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.689 -0.767 . . . . 64.34 112.103 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 86' ' ' MET . 3.5 m -128.41 153.16 47.38 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.922 -0.399 . . . . 53.1 109.922 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.8 t -74.61 110.24 9.2 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.809 -0.811 . . . . 64.43 108.809 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.8 -25.93 63.75 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.174 2.582 . . . . 54.25 113.064 -171.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.73 -50.87 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.352 -0.386 . . . . 74.22 111.934 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.1 p -109.94 -2.55 17.08 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.267 0.469 . . . . 73.2 112.267 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? 66.53 21.57 10.74 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.29 0.478 . . . . 74.5 112.29 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.7 t -85.29 126.86 34.05 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.293 -0.632 . . . . 73.53 109.293 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.487 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 59.8 ttp -72.43 153.23 41.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.346 -0.388 . . . . 70.24 111.104 -176.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -124.77 118.61 25.84 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.563 -0.532 . . . . 74.24 109.563 173.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.34 156.76 96.6 Favored 'Cis proline' 0 C--N 1.344 0.322 0 C-N-CA 123.702 -1.374 . . . . 55.45 112.345 -0.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.24 139.6 63.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.081 2.521 . . . . 74.11 112.733 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 40.3 Cg_endo -65.64 141.7 67.61 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.72 2.28 . . . . 73.44 112.381 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.602 -0.713 . . . . 61.42 110.138 -177.112 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo . . . . . 0 C--O 1.235 0.34 0 CA-C-O 120.729 0.22 . . . . 74.01 111.856 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.29 146.41 90.06 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.844 2.363 . . . . 64.14 112.142 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 168.11 20.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.145 0.498 . . . . 75.04 111.622 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 m -78.09 150.89 33.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 65.22 110.826 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' HZ3' ' HG2' ' A' ' 19' ' ' LYS . 10.1 tttm -62.37 -39.23 92.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.054 -0.521 . . . . 75.34 110.452 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.83 -35.01 79.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.71 -0.677 . . . . 75.34 111.332 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 m -61.84 -44.81 96.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 65.35 110.282 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.519 HG21 ' HA ' ' A' ' 71' ' ' SER . 25.9 mt -75.15 -38.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.738 -0.665 . . . . 72.24 110.521 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.3 -31.22 72.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.434 -0.803 . . . . 73.24 110.982 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.76 -21.68 60.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.845 -0.616 . . . . 71.03 111.576 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 98.0 mt -63.76 132.46 95.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 73.44 110.902 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.08 137.06 55.21 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.16 2.573 . . . . 73.14 112.864 -175.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.469 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 44.2 mt-10 -90.17 116.52 28.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.187 0.518 . . . . 64.42 110.751 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -109.15 129.47 63.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.315 -0.857 . . . . 72.2 109.681 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.7 tp -80.13 122.03 26.29 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.017 -0.364 . . . . 72.23 110.017 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 41.9 t -79.14 123.46 36.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.27 -0.423 . . . . 70.04 110.225 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.7 p -119.16 140.86 49.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.148 -0.478 . . . . 63.53 110.332 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 30.5 mt-10 -79.57 177.69 8.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.169 -0.469 . . . . 65.2 110.278 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 1.1 m-20 71.5 8.74 6.31 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.818 0.699 . . . . 71.5 109.807 -168.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -127.58 108.82 11.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.12 -0.945 . . . . 72.02 109.394 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.62 95.03 0.52 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.755 -0.736 . . . . 72.12 112.055 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 72.33 138.34 0.05 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.535 0.734 . . . . 61.52 111.484 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.45 -38.76 83.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 64.12 110.363 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.73 32.01 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.777 -0.725 . . . . 73.52 112.034 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.67 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 8.4 tp-100 -172.17 -80.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.732 0.301 . . . . 60.3 110.648 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.75 152.56 35.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.062 -0.517 . . . . 75.34 110.705 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -103.78 3.52 34.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.627 -0.715 . . . . 73.04 110.001 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 30.4 p -124.42 151.86 43.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.032 -0.531 . . . . 74.41 110.03 175.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 50.4 t -116.7 101.99 53.37 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.444 -0.576 . . . . 75.31 109.444 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -56.92 -28.57 78.29 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.116 2.544 . . . . 73.12 112.622 -173.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.4 mt -67.0 -32.14 56.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.748 -0.66 . . . . 72.53 111.618 -175.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.7 p -113.89 -4.21 13.32 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.987 -0.285 . . . . 73.24 111.22 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.8 t 67.93 4.06 3.84 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.782 -0.645 . . . . 61.13 111.256 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.8 m -105.92 163.76 12.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.8 0.333 . . . . 63.54 110.332 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.8 OUTLIER -91.71 -170.22 2.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.049 0.452 . . . . 74.43 110.89 -177.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.642 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 29.9 m-85 -94.47 108.84 20.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.092 -0.503 . . . . 73.21 111.397 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.31 166.72 7.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.337 -0.847 . . . . 75.11 109.612 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 39.5 ttpt -73.37 138.38 45.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.943 0.401 . . . . 74.44 110.769 -176.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.9 -9.32 47.12 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.993 -0.623 . . . . 62.31 112.342 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.78 162.06 18.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.76 -0.459 . . . . 71.51 109.76 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -110.31 122.62 65.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.846 0.355 . . . . 64.33 110.319 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -112.21 171.02 7.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.864 0.364 . . . . 75.03 110.448 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 7.2 t -148.84 168.57 22.63 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.684 -0.488 . . . . 63.52 109.684 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -113.36 117.32 31.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.817 0.341 . . . . 73.12 110.942 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.05 138.23 39.95 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.188 -0.671 . . . . 64.31 109.188 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.02 -19.27 19.42 Favored 'Trans proline' 0 N--CA 1.474 0.325 0 C-N-CA 123.708 2.938 . . . . 64.21 113.158 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.1 p -86.42 22.55 1.81 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.744 0.307 . . . . 74.11 110.682 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 65.3 36.71 6.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.274 0.559 . . . . 73.43 111.711 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.67 ' HD2' ' HG2' ' A' ' 39' ' ' GLN . 4.8 m170 -125.11 122.62 37.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.888 -0.596 . . . . 73.44 110.315 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -99.0 133.13 43.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.239 -0.437 . . . . 71.14 110.124 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 72.9 m-85 -144.16 161.1 39.71 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.535 0.522 . . . . 75.42 110.261 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 38.2 m170 -61.88 121.26 12.49 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.367 -0.605 . . . . 74.11 109.367 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.6 tttt -58.78 -49.89 90.98 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 123.235 0.334 . . . . 70.1 111.676 -176.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 9.6 Cg_endo -53.91 -27.48 44.6 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.356 2.037 . . . . 72.41 112.613 176.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 68.2 m -82.89 -52.42 6.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 73.42 110.809 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 67' ' ' LYS . 7.1 p -69.95 -27.39 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 50.41 111.252 -173.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.519 ' HA ' HG21 ' A' ' 22' ' ' ILE . 18.4 p -64.47 -46.75 81.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.798 0.332 . . . . 72.14 110.579 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.484 HG22 ' HE2' ' A' ' 76' ' ' LYS . 75.1 mt -63.73 -37.85 80.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.152 -0.476 . . . . 73.41 110.291 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -64.65 -51.98 59.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 73.25 111.317 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.9 -24.38 66.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.388 -0.369 . . . . 72.12 111.664 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -77.5 -0.65 26.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.021 0.438 . . . . 75.34 110.756 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HE2' HG22 ' A' ' 72' ' ' ILE . 56.5 mttm -113.46 -52.26 2.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 73.42 109.856 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.1 m -132.87 125.64 30.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.046 -0.525 . . . . 64.4 110.035 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.7 57.25 4.68 Favored Glycine 0 CA--C 1.516 0.148 0 C-N-CA 120.951 -0.642 . . . . 70.12 112.899 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 84' ' ' ARG . 39.5 m -145.77 149.21 33.96 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.283 -0.266 . . . . 75.32 110.283 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.6 t -74.41 118.08 67.02 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.926 -0.768 . . . . 71.24 108.926 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.4 -24.84 54.3 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.295 2.663 . . . . 71.22 113.477 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.28 -61.16 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.425 -0.352 . . . . 64.32 111.853 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.9 p -90.04 -1.11 57.91 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.906 0.336 . . . . 64.21 111.906 -172.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.415 ' HA ' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER 47.58 39.94 10.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.619 0.768 . . . . 75.51 111.913 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.12 148.7 22.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.73 -0.841 . . . . 73.2 108.73 170.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.5 ttp -74.19 145.75 43.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.03 0.443 . . . . 63.33 111.839 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.554 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 57.6 t80 -129.2 131.05 23.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.837 -0.801 . . . . 73.3 108.837 172.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.554 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 31.0 Cg_endo -62.86 159.67 60.45 Favored 'Cis proline' 0 C--N 1.347 0.472 0 C-N-CA 124.067 -1.222 . . . . 74.03 112.984 2.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.5 138.75 74.85 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.193 2.595 . . . . 74.03 112.818 -175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.22 151.74 84.16 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.699 2.266 . . . . 74.22 112.314 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.628 -0.701 . . . . 73.25 109.913 -179.717 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 CA--C 1.534 0.481 0 CA-C-O 121.02 0.342 . . . . 74.13 112.782 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.46 168.22 24.16 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.732 2.288 . . . . 72.21 111.965 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.54 179.95 6.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.54 -0.3 . . . . 65.2 110.567 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 p -102.27 162.1 13.18 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.934 -0.395 . . . . 75.33 109.934 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -64.05 -43.9 94.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.969 0.414 . . . . 70.55 110.017 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -58.69 -47.28 85.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.414 -0.812 . . . . 72.52 112.063 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 p -64.17 -41.68 97.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.311 . . . . 73.41 110.978 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.62 -41.06 85.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.206 0.527 . . . . 74.3 110.584 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.1 -36.39 81.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 74.33 110.637 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.01 -6.25 51.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 50.21 112.187 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 34.5 mt -53.84 127.72 53.26 Favored Pre-proline 0 C--O 1.237 0.43 0 O-C-N 122.994 0.184 . . . . 75.03 111.2 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -53.77 142.5 62.24 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.377 2.718 . . . . 52.44 111.694 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -113.85 106.48 14.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.099 0.476 . . . . 74.2 111.158 -173.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.5 mt -110.78 111.58 36.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.865 -0.607 . . . . 74.33 109.979 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.7 117.14 10.03 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.894 -0.41 . . . . 72.24 109.894 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 35.7 t -75.74 118.14 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.312 -0.404 . . . . 65.33 110.785 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.2 p -120.76 167.81 12.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.455 -0.572 . . . . 72.32 109.455 173.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.21 4.18 15.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.942 0.401 . . . . 75.24 111.123 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -80.26 -45.5 17.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.544 . . . . 74.41 110.333 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -77.92 -34.99 51.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 73.34 110.387 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.35 -115.77 4.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.004 -0.617 . . . . 70.24 111.706 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.0 141.64 57.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.622 -0.51 . . . . 73.23 109.622 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.21 90.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.504 -0.478 . . . . 61.34 111.234 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . 76.07 -73.54 1.73 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.565 -0.743 . . . . 64.31 113.337 171.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.51 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 8.5 tp-100 -107.89 -49.24 3.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.637 0.256 . . . . 71.24 110.91 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.4 158.55 37.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.357 0.599 . . . . 61.3 111.585 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.1 ptp -103.22 -5.77 22.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.162 -0.926 . . . . 73.35 109.902 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.802 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 85.1 m -128.14 137.92 52.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.802 -0.635 . . . . 73.11 110.421 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -93.36 112.49 56.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.04 -0.527 . . . . 62.0 109.974 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -60.77 -33.52 92.86 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.619 2.213 . . . . 72.44 111.94 -176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.49 -22.87 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.663 -0.698 . . . . 71.21 110.686 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 79.8 m -107.94 -19.36 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.979 -0.555 . . . . 70.04 111.201 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.4 m 60.8 29.27 18.9 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.48 0.657 . . . . 71.33 109.537 -170.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.6 t -141.16 155.38 46.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.254 -0.885 . . . . 73.21 109.514 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 10.7 pt-20 -77.75 -179.75 6.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.334 0.587 . . . . 72.54 111.783 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 73.8 m-85 -91.87 112.52 24.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.647 -0.706 . . . . 72.35 110.383 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.69 169.49 11.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 70.24 110.632 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 24.9 ttpp -72.99 113.66 10.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.74 -0.664 . . . . 74.31 110.961 -176.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.56 -36.5 1.54 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.581 -0.818 . . . . 61.23 112.758 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -87.14 162.17 17.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.12 -0.326 . . . . 74.12 110.12 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.75 129.49 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.58 -0.282 . . . . 72.44 110.38 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -101.22 163.41 12.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.825 0.345 . . . . 75.11 110.965 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 8.7 t -147.68 170.07 18.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.879 -0.601 . . . . 71.42 109.585 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -123.39 123.24 40.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.535 -0.302 . . . . 74.42 110.694 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 61' ' ' CYS . 77.1 mt -86.02 141.16 35.18 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.416 -0.957 . . . . 73.31 108.416 169.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.93 36.19 0.17 Allowed 'Trans proline' 0 N--CA 1.479 0.623 0 C-N-CA 123.636 2.891 . . . . 73.21 113.922 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.446 ' H ' ' C ' ' A' ' 59' ' ' LEU . 29.5 p -140.06 28.07 2.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.388 -0.597 . . . . 63.0 109.388 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.8 m170 63.71 34.66 11.98 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.429 -0.805 . . . . 75.22 111.924 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.51 ' HD2' ' HG2' ' A' ' 39' ' ' GLN . 11.2 m170 -125.86 120.69 31.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.476 -0.329 . . . . 64.02 110.408 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 57.7 m-85 -101.88 137.17 40.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.954 -0.566 . . . . 72.24 111.29 -176.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.493 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 97.0 m-85 -140.72 175.36 9.67 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.738 -0.838 . . . . 74.02 108.738 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.871 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 39.1 m80 -82.61 131.79 35.2 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.172 -0.677 . . . . 74.33 109.172 173.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.512 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 86.7 tttt -55.61 -49.31 93.42 Favored Pre-proline 0 CA--C 1.539 0.532 0 O-C-N 123.49 0.494 . . . . 61.34 111.313 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 83.0 Cg_exo -51.23 -50.42 13.96 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.257 1.971 . . . . 72.41 113.52 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.871 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 21.9 p -79.69 -31.54 41.32 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.743 -0.383 . . . . 75.34 111.876 -174.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 67' ' ' LYS . 7.8 p -74.27 -28.81 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.719 -0.474 . . . . 75.23 109.719 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.7 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 27.7 t -58.46 -48.15 81.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.518 -0.549 . . . . 72.51 109.518 174.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -60.17 -40.78 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.651 -0.704 . . . . 75.54 110.705 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -67.43 -48.33 67.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.593 -0.731 . . . . 74.11 111.498 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 77' ' ' SER . 97.2 mt -67.25 -20.51 65.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.395 -0.366 . . . . 73.53 111.93 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.3 mt-30 -59.98 -40.29 88.6 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.581 -0.281 . . . . 74.0 111.391 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.77 -27.51 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.907 -0.317 . . . . 73.2 111.222 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 12.7 p -143.88 111.2 5.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.74 0.305 . . . . 64.42 110.872 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.56 65.46 4.1 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.187 -0.765 . . . . 54.22 111.187 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 m -143.5 145.4 32.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.645 -0.278 . . . . 73.42 110.383 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.5 t -74.88 113.64 26.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.79 -0.819 . . . . 64.41 108.79 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.34 -34.2 79.49 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.036 2.49 . . . . 72.45 113.76 -172.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -75.13 -62.98 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.069 0.396 . . . . 71.11 112.069 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.3 p -89.12 -18.11 27.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 73.5 111.346 -173.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 63.4 71.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.801 0.81 . . . . 62.32 110.557 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t -128.81 142.58 50.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.637 -1.165 . . . . 73.43 108.067 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.53 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 61.8 ttp -68.05 149.07 50.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.989 0.423 . . . . 64.12 111.147 -174.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -127.97 121.18 21.74 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.636 -0.711 . . . . 71.01 109.39 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.61 157.83 77.21 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 124.048 -1.23 . . . . 73.31 112.855 0.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.48 135.29 63.8 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.993 2.462 . . . . 73.12 112.612 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 43.3 Cg_endo -68.44 147.47 71.24 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.867 2.378 . . . . 72.33 112.488 -177.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.322 -0.846 . . . . 74.14 109.302 177.895 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 CA--C 1.531 0.361 0 CA-C-O 120.957 0.315 . . . . 50.03 112.796 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.57 141.76 38.82 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.169 1.913 . . . . 71.25 112.106 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . . . -81.75 149.21 28.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.991 -0.55 . . . . 44.1 110.167 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -58.97 116.44 3.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.259 -0.428 . . . . 70.11 110.478 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HA ' HD11 ' A' ' 22' ' ' ILE . 6.5 ttpm? -56.8 -45.32 82.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.711 -0.677 . . . . 75.13 111.518 -176.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -54.93 -37.85 66.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.624 -0.716 . . . . 70.44 111.307 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.4 t -67.63 -41.02 84.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.076 0.465 . . . . 70.24 110.106 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.494 HG23 ' HA ' ' A' ' 71' ' ' SER . 61.1 mt -62.61 -39.72 85.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.683 -0.689 . . . . 65.35 110.932 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -75.06 -29.18 60.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 74.23 110.759 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -12.81 60.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.332 -0.395 . . . . 73.11 111.517 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.11 145.54 85.01 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 116.409 -0.36 . . . . 72.4 111.044 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.88 160.37 49.92 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.914 2.409 . . . . 72.22 112.381 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -108.36 112.82 25.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.189 -0.459 . . . . 71.31 110.326 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.7 mt -101.68 101.74 12.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.247 -0.649 . . . . 74.44 109.247 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.55 122.54 19.25 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.813 -0.44 . . . . 64.45 109.813 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.735 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 21.4 t -77.46 105.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.123 -0.489 . . . . 72.53 110.134 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.4 p -103.68 168.2 9.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.783 -0.451 . . . . 73.5 109.783 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -76.82 -22.25 53.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.07 0.462 . . . . 74.43 110.303 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.81 -28.31 58.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.006 -0.543 . . . . 74.42 109.943 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -84.62 -44.3 13.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 74.53 109.527 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.2 -110.87 3.36 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.9 -0.591 . . . . 75.3 112.729 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.64 103.39 3.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.002 0.43 . . . . 72.11 110.376 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.2 t -68.64 -30.33 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.011 -0.541 . . . . 74.31 110.928 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.449 ' HA3' ' CD1' ' A' ' 64' ' ' TYR . . . -149.89 -150.27 5.22 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.79 -0.719 . . . . 64.32 111.898 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -82.04 -24.19 35.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.672 -0.492 . . . . 71.5 109.672 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -83.99 111.79 19.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.866 -0.606 . . . . 61.24 109.75 172.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -91.28 -0.09 57.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 53.11 110.316 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 70.7 m -141.2 149.73 41.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.778 -0.647 . . . . 64.04 110.338 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 36.9 t -104.73 96.12 9.99 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.359 -0.608 . . . . 73.04 109.359 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 18.5 Cg_endo -57.27 -27.26 74.28 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.466 2.777 . . . . 61.22 112.935 -172.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.1 mt -57.74 -43.78 84.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 72.33 111.212 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.8 p -108.44 -3.23 18.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.565 -0.289 . . . . 74.34 110.713 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.1 m 60.87 40.2 15.99 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.834 -0.621 . . . . 72.45 110.716 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.9 m -135.94 146.55 47.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 75.3 110.47 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 15.4 pt-20 -81.88 -169.86 2.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 72.45 111.735 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.631 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.5 m-85 -102.97 108.77 20.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.201 0.524 . . . . 74.43 111.604 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 m -134.64 173.07 15.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.333 -0.849 . . . . 64.42 109.546 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.735 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 31.0 ttmt -64.54 125.76 25.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.042 0.448 . . . . 72.52 111.097 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.41 -42.73 1.27 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.563 -0.744 . . . . 75.31 111.731 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -86.68 165.88 15.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.875 -0.417 . . . . 64.01 109.875 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.0 133.7 65.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.684 -0.487 . . . . 75.22 109.684 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -111.76 176.01 5.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.897 0.38 . . . . 75.31 110.618 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.4 t -150.35 163.06 39.29 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.544 -0.539 . . . . 53.42 109.544 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -107.86 117.34 33.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.765 0.317 . . . . 74.35 110.667 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.8 mt -84.32 137.34 39.59 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.957 -0.757 . . . . 64.13 108.957 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.81 -8.19 7.22 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.89 2.393 . . . . 75.33 111.905 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.8 t -84.66 18.24 2.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.043 -0.98 . . . . 70.41 110.046 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 57.18 39.43 28.86 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.907 -0.588 . . . . 70.55 111.147 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -138.61 144.99 40.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.716 -0.674 . . . . 61.12 109.957 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 49.3 m-85 -121.12 132.86 55.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.794 0.33 . . . . 73.02 111.248 -172.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.631 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 89.6 m-85 -142.58 162.78 34.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 74.05 110.35 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 35.0 m170 -63.83 129.38 39.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.615 -0.513 . . . . 74.11 109.615 174.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.495 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 48.3 tttm -60.62 -51.7 77.93 Favored Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 123.326 0.391 . . . . 75.15 111.622 -175.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 27.5 Cg_endo -62.22 -22.0 73.45 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.127 1.885 . . . . 73.51 112.925 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.2 m -84.21 -46.99 11.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.225 0.536 . . . . 74.22 110.464 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.519 HG21 ' HG ' ' A' ' 74' ' ' LEU . 5.8 p -73.62 -23.78 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.786 -0.643 . . . . 75.42 110.717 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.494 ' HA ' HG23 ' A' ' 22' ' ' ILE . 19.3 p -65.74 -30.52 71.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.338 . . . . 51.25 111.083 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.92 -41.38 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 73.22 109.989 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -63.11 -47.53 82.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.448 -0.796 . . . . 74.11 111.783 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.519 ' HG ' HG21 ' A' ' 70' ' ' VAL . 98.2 mt -65.82 -20.56 66.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.342 0.497 . . . . 75.23 112.342 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 71' ' ' SER . 71.0 mt-30 -77.09 -9.59 58.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.183 0.516 . . . . 63.12 110.496 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -113.07 -42.27 3.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.61 . . . . 74.4 109.896 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -142.4 110.05 5.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.671 -0.695 . . . . 62.13 109.954 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.08 65.85 3.71 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 51.42 112.122 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.486 ' HB ' ' HA ' ' A' ' 84' ' ' ARG . 1.4 p -149.29 157.54 43.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.453 0.168 . . . . 73.03 110.991 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.601 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 44.1 m -74.45 123.09 88.87 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 108.308 -0.997 . . . . 75.42 108.308 169.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HD2' ' CZ ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -53.22 -27.96 40.14 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.466 2.111 . . . . 74.25 112.474 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.9 t -80.23 -41.02 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.706 -0.679 . . . . 71.35 112.449 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.601 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 12.8 p -110.03 -30.15 7.91 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.699 -0.401 . . . . 73.25 111.857 -172.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.486 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 56.5 mtt85 57.23 77.14 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.749 0.785 . . . . 61.22 111.879 -168.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.2 t -131.93 140.75 49.12 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.838 -1.171 . . . . 73.51 107.838 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.5 ttp -73.97 131.53 41.5 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.988 0.736 . . . . 71.25 112.988 -165.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 88' ' ' PRO . 70.9 t80 -122.87 134.92 25.31 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.71 -1.132 . . . . 73.55 108.805 172.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 87' ' ' PHE . 9.5 Cg_exo -72.12 154.98 98.48 Favored 'Cis proline' 0 C--N 1.343 0.27 0 C-N-CA 123.855 -1.31 . . . . 73.11 112.186 -0.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.55 136.93 77.36 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.733 2.289 . . . . 71.13 112.03 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.62 153.17 76.7 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.954 2.436 . . . . 73.52 112.691 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.35 -0.833 . . . . 73.32 109.629 179.674 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--O 1.234 0.294 0 CA-C-O 121.098 0.374 . . . . 74.01 112.632 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.51 157.66 7.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.9 2.4 . . . . 62.12 113.369 -175.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.79 146.76 26.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.605 -0.725 . . . . 73.15 109.921 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 22' ' ' ILE . 14.3 m -73.23 140.28 46.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.266 -0.425 . . . . 74.51 110.201 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 34.7 ttpt -52.81 -44.97 67.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 64.02 111.131 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.14 -40.11 92.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.951 -0.568 . . . . 71.04 110.857 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 m -66.57 -32.88 74.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 73.11 110.799 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 71' ' ' SER . 54.8 mt -74.42 -39.24 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.37 0.605 . . . . 64.52 110.258 177.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.476 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 32.7 t70 -70.39 -21.41 62.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.957 -0.565 . . . . 75.04 110.667 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.57 -16.12 61.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.551 . . . . 45.23 111.227 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.54 143.01 96.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 65.02 110.84 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.37 136.62 75.6 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.104 2.536 . . . . 73.0 112.244 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -102.15 120.28 40.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.058 -0.519 . . . . 74.32 110.587 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.6 mt -112.08 111.99 38.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.091 -0.504 . . . . 64.12 109.927 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.01 118.8 10.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.86 -0.422 . . . . 64.42 109.86 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 49.0 t -71.23 114.52 9.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.141 -0.481 . . . . 64.32 110.177 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 p -95.36 147.3 23.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.728 -0.669 . . . . 63.25 110.258 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -69.67 -15.51 63.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.776 -0.647 . . . . 73.11 111.303 -174.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.34 -45.55 19.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.455 . . . . 74.11 111.248 -175.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -74.36 -47.93 31.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 72.03 110.881 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.17 -87.4 0.68 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.88 -0.676 . . . . 73.31 113.032 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 41' ' ' MET . . . -74.45 100.3 3.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.911 0.386 . . . . 72.25 110.96 -177.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.7 t -95.3 118.2 40.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.682 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.91 -64.85 2.36 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.876 -0.678 . . . . 61.32 112.919 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -154.3 -56.96 0.11 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.657 0.265 . . . . 71.14 111.013 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 42' ' ' CYS . 30.9 tt0 -101.76 155.01 18.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.248 -0.433 . . . . 70.45 110.054 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.532 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.7 pmm? -92.56 5.5 50.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.01 0.433 . . . . 44.44 110.255 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 19.6 t -130.8 156.0 45.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.885 -0.598 . . . . 73.45 109.926 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 30.8 t -107.35 106.32 58.08 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.703 -0.48 . . . . 71.04 109.703 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.7 Cg_endo -55.46 -29.35 68.5 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.29 2.66 . . . . 75.05 112.725 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -69.22 -27.77 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.083 -0.508 . . . . 74.42 110.74 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 96.5 m -103.49 -23.57 13.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.405 -0.361 . . . . 74.43 111.319 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.6 t 63.35 22.76 13.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.998 0.904 . . . . 54.3 108.577 -167.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.1 m -131.65 148.4 52.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.453 -1.249 . . . . 70.4 109.519 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.842 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 17.3 pt-20 -81.8 -178.25 6.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.276 0.56 . . . . 64.1 112.358 -172.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -91.04 117.2 29.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.471 -0.786 . . . . 74.22 111.021 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 m -132.42 166.78 28.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 74.41 109.48 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.8 ttpt -65.49 131.91 47.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.933 0.397 . . . . 62.1 110.717 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.43 -34.89 2.94 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.034 -0.603 . . . . 72.23 111.746 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -86.97 161.28 18.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.579 -0.526 . . . . 61.52 109.579 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.79 125.5 72.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.086 -0.339 . . . . 72.21 110.086 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -95.64 165.4 12.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.838 0.351 . . . . 54.51 110.485 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 7.5 t -146.78 172.56 13.45 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.584 -0.524 . . . . 53.14 109.584 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -125.55 117.66 24.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.691 -0.485 . . . . 73.25 109.691 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 61' ' ' CYS . 86.0 mt -90.03 139.51 27.36 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 110.186 -0.301 . . . . 72.25 110.186 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.51 12.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.481 0.778 0 C-N-CA 123.871 3.048 . . . . 75.41 114.623 -172.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.439 ' H ' ' C ' ' A' ' 59' ' ' LEU . 28.8 p -115.03 17.34 16.86 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.593 -0.521 . . . . 64.14 109.593 176.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 64.12 74.84 0.4 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.258 -0.883 . . . . 65.31 110.481 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -161.66 121.23 2.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.853 -0.612 . . . . 72.01 110.303 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -99.09 133.41 43.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 74.33 110.835 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -144.58 175.35 10.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.418 -0.956 . . . . 74.35 108.418 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.944 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 35.2 m170 -81.71 129.1 34.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.693 -0.854 . . . . 72.14 108.693 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.524 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 85.1 tttt -55.81 -50.99 83.95 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 123.448 0.467 . . . . 74.01 112.125 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 44.4 Cg_exo -58.33 -41.3 67.53 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.611 1.541 . . . . 51.13 113.183 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.944 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 30.2 p -80.95 -32.38 34.5 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.528 -0.469 . . . . 73.34 111.747 -175.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.93 -29.04 24.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.581 -0.526 . . . . 61.53 109.581 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.452 ' HA ' HG22 ' A' ' 22' ' ' ILE . 32.0 t -59.01 -42.49 90.24 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.0 -0.545 . . . . 61.35 109.817 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.4 ' O ' ' HE2' ' A' ' 76' ' ' LYS . 76.0 mt -55.6 -47.91 78.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 62.01 110.476 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 41.4 t-105 -69.7 -47.03 64.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.651 . . . . 72.55 110.946 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.43 -36.22 81.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.953 0.353 . . . . 70.53 111.953 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -64.44 -16.19 61.96 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.032 0.382 . . . . 73.3 112.032 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 76' ' ' LYS . 46.7 mtmt -118.34 -59.7 1.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.687 0.279 . . . . 72.43 111.645 -177.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.1 m -88.78 -25.15 22.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.305 -0.407 . . . . 71.24 111.624 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.21 43.47 93.53 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.322 -0.466 . . . . 55.51 113.194 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.03 165.56 27.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.979 0.418 . . . . 61.23 111.576 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 47.5 t -96.99 99.9 6.65 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.509 -0.552 . . . . 55.22 109.509 174.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -35.54 -48.93 0.95 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.578 3.519 . . . . 71.21 115.535 -169.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.82 -25.28 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.905 0.706 . . . . 74.44 112.905 -173.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 28.7 p -120.48 -25.48 5.57 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.771 -0.581 . . . . 75.5 111.423 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.5 mtm-85 72.08 15.11 5.59 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.546 0.738 . . . . 73.03 111.821 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.9 144.56 50.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.555 -0.906 . . . . 73.14 108.555 168.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.423 ' HE3' ' HB3' ' A' ' 90' ' ' PRO . 62.5 ttp -79.01 148.27 32.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.997 0.427 . . . . 61.34 112.01 -172.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.472 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 87.7 t80 -132.54 124.39 19.0 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.346 -0.843 . . . . 75.31 108.766 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 37.3 Cg_endo -65.58 147.69 73.23 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.768 -1.347 . . . . 75.24 112.918 2.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.48 137.57 65.49 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.597 2.865 . . . . 71.3 113.145 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HB3' ' HE3' ' A' ' 86' ' ' MET . 58.7 Cg_endo -73.79 151.58 46.15 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.746 2.297 . . . . 75.21 112.094 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.502 -0.761 . . . . 74.33 109.481 178.214 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 60.4 Cg_endo . . . . . 0 N--CA 1.461 -0.431 0 CA-C-O 120.955 0.315 . . . . 61.42 112.204 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 18.3 Cg_exo -66.89 146.14 76.86 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.484 2.123 . . . . 72.34 111.249 175.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -78.22 147.82 34.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.876 0.369 . . . . 65.35 110.915 -177.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.0 t -74.53 153.71 38.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.934 -0.576 . . . . 73.51 109.859 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -58.83 -38.12 77.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.263 0.554 . . . . 71.14 109.735 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -70.23 -28.72 65.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.357 -0.838 . . . . 74.44 110.911 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.506 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 13.8 m -66.68 -38.1 86.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.86 -0.422 . . . . 64.04 109.86 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -77.38 -36.04 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 72.11 110.259 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.81 -37.49 84.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.578 -0.737 . . . . 52.22 111.192 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.04 4.69 49.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.053 -0.521 . . . . 74.3 112.312 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 21' ' ' SER . 57.8 mt -70.34 128.96 90.89 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 121.247 -0.181 . . . . 42.1 110.946 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.17 153.12 47.93 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.033 2.489 . . . . 54.34 112.047 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -126.17 118.03 24.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.022 0.439 . . . . 73.41 110.857 -174.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.1 mt -120.5 118.35 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.769 -0.651 . . . . 73.52 110.366 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.45 121.05 15.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.729 -0.471 . . . . 60.32 109.729 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 45.0 t -86.05 129.88 37.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.332 -0.395 . . . . 72.03 111.228 -177.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 34' ' ' HIS . 20.3 p -117.09 141.14 48.64 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.825 -0.625 . . . . 64.24 109.792 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 52' ' ' LYS . 57.0 mt-10 -69.12 -27.78 65.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.191 0.52 . . . . 73.41 110.974 -176.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.07 -6.55 59.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.74 -0.664 . . . . 74.31 110.969 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.509 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 22.5 t60 -74.34 -47.56 33.64 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.823 -0.436 . . . . 73.3 109.823 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 -160.13 13.39 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.407 -0.677 . . . . 64.51 111.407 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.73 114.19 14.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.848 0.356 . . . . 70.34 110.723 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.21 95.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.909 -0.587 . . . . 73.41 110.607 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.83 -143.26 23.17 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.839 -0.696 . . . . 72.51 112.545 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.554 ' OE1' ' HA ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -85.2 -27.67 25.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.58 0.228 . . . . 74.23 111.275 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -96.2 125.54 40.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.757 -0.46 . . . . 63.34 109.757 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 22.7 ptp -107.72 0.04 22.1 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.477 -0.329 . . . . 71.42 111.395 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.3 m -143.39 157.67 44.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.487 . . . . 63.51 110.993 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 40.7 t -117.06 93.32 41.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.776 -0.647 . . . . 74.11 109.377 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 13.1 Cg_endo -56.49 -26.03 61.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.567 2.845 . . . . 73.04 113.078 -174.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.6 mt -60.09 -34.77 57.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 74.44 111.054 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.4 p -114.94 9.74 16.18 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.126 -0.324 . . . . 71.32 110.126 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p 41.12 46.25 2.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.02 0.928 . . . . 71.22 111.892 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -140.2 154.59 46.97 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.923 -0.58 . . . . 71.1 110.06 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.84 -169.9 1.95 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.925 -0.58 . . . . 74.14 110.923 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.439 ' HB3' HG13 ' A' ' 30' ' ' VAL . 40.4 m-85 -87.17 93.66 9.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.545 0.688 . . . . 73.53 111.497 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.93 162.73 2.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.836 -1.075 . . . . 73.41 110.321 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.9 ttpm? -79.68 133.57 36.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.02 0.438 . . . . 72.3 110.67 -176.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.65 -16.18 21.53 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.819 -0.705 . . . . 64.22 111.834 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -86.96 161.83 18.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.169 -0.678 . . . . 73.2 109.169 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.6 121.2 64.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.958 -0.386 . . . . 74.51 109.958 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.34 155.95 16.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.875 0.369 . . . . 63.2 110.742 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 12.8 t -138.11 156.01 48.18 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.961 -0.563 . . . . 74.34 109.783 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -111.61 117.46 33.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.296 -0.411 . . . . 64.43 109.92 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.4 mt -78.41 147.87 72.87 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.037 -0.529 . . . . 75.32 109.755 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.418 ' HD2' ' CE1' ' A' ' 87' ' ' PHE . 14.6 Cg_endo -59.38 -13.35 20.1 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.117 2.545 . . . . 73.11 112.136 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.0 t -79.49 4.33 15.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.415 -0.811 . . . . 63.2 109.655 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 56.93 63.74 1.84 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 122.127 0.965 . . . . 75.13 110.684 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.554 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 1.2 m80 -148.65 123.4 9.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.184 -1.371 . . . . 74.54 109.682 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -90.75 133.19 35.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.062 -0.517 . . . . 74.51 110.779 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -146.64 168.02 22.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.584 -0.735 . . . . 72.14 109.157 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.1 m170 -75.08 122.58 23.78 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.621 -0.511 . . . . 75.01 109.621 175.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 89.1 tttt -59.0 -51.11 84.18 Favored Pre-proline 0 CA--C 1.538 0.486 0 O-C-N 123.412 0.445 . . . . 41.31 112.093 -175.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.4 Cg_endo -60.74 -20.05 63.92 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.112 1.875 . . . . 64.14 112.956 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 61.3 m -84.38 -49.9 8.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.078 0.466 . . . . 74.02 110.43 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.9 p -73.37 -25.62 21.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.672 -0.695 . . . . 64.43 111.467 -171.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 13.0 p -59.81 -30.57 69.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.746 0.308 . . . . 62.31 111.597 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.98 -36.6 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.304 0.573 . . . . 75.13 110.419 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -74.66 -41.27 60.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.709 -0.678 . . . . 72.1 111.006 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 92.8 mt -62.24 -27.48 69.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.895 -0.593 . . . . 71.21 112.038 -175.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 71' ' ' SER . 73.9 mt-30 -65.77 -25.18 67.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.087 0.47 . . . . 73.44 110.736 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.96 -39.45 9.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 75.41 110.318 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 p -163.55 125.33 2.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 72.4 110.47 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.46 ' C ' ' HG1' ' A' ' 79' ' ' THR . . . -79.96 91.27 1.31 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.614 -0.803 . . . . 62.34 111.137 177.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.46 ' HG1' ' C ' ' A' ' 78' ' ' GLY . 2.4 m -149.66 144.55 26.21 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.677 -0.308 . . . . 73.51 110.869 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . 0.746 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 83.1 m -74.39 120.92 83.84 Favored Pre-proline 0 N--CA 1.464 0.247 0 N-CA-C 108.386 -0.968 . . . . 72.12 108.386 168.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.48 -21.81 56.05 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.551 2.168 . . . . 62.12 112.832 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.47 -51.44 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.395 -0.366 . . . . 65.22 111.861 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.9 p -94.4 -22.76 18.1 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.759 0.314 . . . . 51.12 111.712 -172.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.457 ' HA ' HG23 ' A' ' 79' ' ' THR . 59.2 mtt180 60.35 28.08 17.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.762 -0.654 . . . . 74.03 111.695 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.9 m -88.86 160.69 17.1 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.647 -0.501 . . . . 74.03 109.647 172.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 38.2 ttm -76.12 141.14 42.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.647 0.61 . . . . 72.31 112.647 -169.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CE1' ' HD2' ' A' ' 60' ' ' PRO . 54.6 t80 -132.74 121.39 17.1 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.282 -0.872 . . . . 74.12 109.539 170.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.51 159.37 85.74 Favored 'Cis proline' 0 C--O 1.232 0.196 0 C-N-CA 123.687 -1.38 . . . . 73.03 111.827 -1.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.57 149.09 14.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.041 2.494 . . . . 73.13 112.19 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.18 135.46 47.13 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.655 2.236 . . . . 73.35 112.114 -175.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 115.485 -0.78 . . . . 73.24 109.168 179.807 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 C--O 1.237 0.437 0 CA-C-O 120.62 0.175 . . . . 73.12 111.929 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.09 146.48 96.12 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.802 2.335 . . . . 60.31 112.155 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 22' ' ' ILE . . . -85.56 162.76 18.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.243 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.468 ' O ' HG13 ' A' ' 22' ' ' ILE . 14.1 m -67.25 126.06 28.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.345 -0.389 . . . . 73.02 110.786 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -45.14 82.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 72.52 111.546 -175.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.13 -36.46 83.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.748 0.309 . . . . 72.31 111.086 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -67.07 -34.72 78.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.097 0.475 . . . . 72.4 110.321 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 18' ' ' SER . 60.8 mt -74.18 -41.18 51.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 70.14 110.847 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -80.14 -12.18 59.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.024 0.44 . . . . 41.25 110.968 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.85 -13.06 60.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 65.44 110.75 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.34 138.36 94.19 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.864 -0.607 . . . . 71.15 110.328 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -58.42 134.01 58.52 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.342 2.695 . . . . 62.11 113.088 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.506 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 40.0 mt-10 -84.8 102.81 13.34 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.306 -0.628 . . . . 74.44 109.306 173.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.6 mt -92.09 117.18 34.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.119 -0.491 . . . . 73.12 110.934 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.2 tp -78.26 109.34 12.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.791 -0.64 . . . . 74.24 109.553 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 50' ' ' TYR . 49.1 t -83.05 124.82 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.938 0.399 . . . . 72.14 111.147 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.5 p -101.19 153.88 19.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.311 -0.626 . . . . 51.32 109.311 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -87.89 -177.84 5.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.229 0.455 . . . . 72.11 112.229 -168.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.7 t70 76.07 -0.09 3.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.034 -0.985 . . . . 74.34 110.92 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.438 ' HE1' ' O ' ' A' ' 50' ' ' TYR . 11.7 p-80 -71.25 -21.41 62.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.9 -0.591 . . . . 71.34 112.06 -177.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.04 -82.87 1.41 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.531 -0.843 . . . . 70.31 111.097 -174.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.12 154.28 33.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.705 -0.479 . . . . 73.33 109.705 174.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.15 -56.89 4.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.147 0.499 . . . . 74.34 110.014 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.626 ' O ' ' HG2' ' A' ' 39' ' ' GLN . . . -163.57 103.71 0.22 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.919 -0.872 . . . . 52.33 110.919 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 38' ' ' GLY . 8.6 pt20 56.87 -67.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.375 1.47 . . . . 65.3 112.297 -176.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.13 108.11 12.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.161 0.505 . . . . 43.1 109.679 173.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.2 ptp -81.41 -12.05 59.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.885 -0.598 . . . . 74.3 110.62 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 5.9 p -137.32 148.5 46.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.742 -0.663 . . . . 53.33 109.912 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.8 t -88.09 107.6 17.03 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.177 -0.465 . . . . 74.31 109.939 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.57 -28.69 86.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.173 2.582 . . . . 54.24 112.66 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.8 mt -65.05 -25.96 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.245 0.545 . . . . 64.02 110.951 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 19.8 m -119.96 -1.87 10.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.111 -0.495 . . . . 62.03 111.144 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.8 p 41.14 42.97 1.8 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.712 0.768 . . . . 71.44 110.558 -168.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 t -142.89 147.26 35.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.981 -1.008 . . . . 75.1 109.464 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 8.3 pt-20 -80.28 -169.8 2.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.457 0.646 . . . . 71.25 111.268 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.492 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.6 m-85 -102.54 109.85 21.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.572 -0.74 . . . . 72.45 109.328 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.87 170.0 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.207 -0.451 . . . . 73.23 111.994 -171.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -60.13 109.25 0.93 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.542 -0.754 . . . . 74.22 111.091 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.24 -0.49 43.87 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.665 -0.779 . . . . 65.11 112.535 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -82.18 147.29 29.09 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.244 -0.651 . . . . 74.01 109.244 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.97 114.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.248 0.547 . . . . 51.22 110.913 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.33 176.75 4.93 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.635 -0.711 . . . . 63.04 110.507 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 6.6 t -152.23 171.06 18.54 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.471 -0.566 . . . . 74.23 109.471 175.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -123.4 119.42 29.98 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.091 -0.336 . . . . 72.13 110.091 -174.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.0 150.08 54.59 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.088 -0.506 . . . . 74.34 111.125 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.09 -9.62 17.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.03 2.487 . . . . 45.21 112.979 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -95.44 8.92 41.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.54 -0.3 . . . . 74.41 110.205 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 65.33 93.0 0.07 Allowed 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 123.82 0.7 . . . . 75.45 109.72 -172.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -175.62 122.47 0.2 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.759 -0.655 . . . . 74.15 110.723 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 57' ' ' THR . 92.2 m-85 -95.53 133.26 39.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.466 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.492 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 86.8 m-85 -140.98 174.77 10.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.755 -0.832 . . . . 72.14 108.755 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.868 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 38.3 m80 -82.02 125.16 30.48 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.271 -1.011 . . . . 74.25 108.271 175.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 60.7 tttm -53.67 -47.68 95.79 Favored Pre-proline 0 C--N 1.322 -0.618 0 O-C-N 123.388 0.43 . . . . 73.34 112.022 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 10.0 Cg_endo -52.88 -50.53 13.74 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.222 1.948 . . . . 64.22 113.246 177.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.868 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 26.3 p -76.54 -35.47 58.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.806 -0.358 . . . . 73.52 111.95 -173.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -74.16 -28.65 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.337 . . . . 74.22 110.271 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.417 ' HA ' HG23 ' A' ' 22' ' ' ILE . 33.0 t -60.79 -50.01 75.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 63.34 109.941 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.1 mt -61.08 -37.43 77.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 65.1 110.615 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -68.45 -50.84 49.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.798 -0.637 . . . . 73.32 111.257 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.86 -25.55 67.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.776 0.322 . . . . 71.32 111.203 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -75.0 -1.4 22.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 62.2 110.793 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -112.24 -48.39 3.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.254 0.55 . . . . 61.4 109.676 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.9 m -145.65 119.55 9.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.669 . . . . 74.53 110.413 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.13 71.71 1.95 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.845 -0.693 . . . . 72.55 112.332 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.9 142.82 29.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.229 -0.286 . . . . 73.32 110.229 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 47.0 t -74.69 113.61 26.11 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.006 -0.738 . . . . 75.22 109.006 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.77 -24.78 77.09 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 123.073 2.516 . . . . 73.25 114.03 -171.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.47 -59.15 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.069 0.396 . . . . 64.12 112.069 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 30.6 p -95.32 -11.25 28.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.938 -0.305 . . . . 71.22 111.478 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 62.42 80.57 0.22 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.795 0.807 . . . . 61.34 111.057 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.5 t -137.82 135.94 36.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.531 -1.213 . . . . 73.52 108.24 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.524 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 50.5 ttm -72.97 141.09 47.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.837 0.351 . . . . 72.31 111.301 -173.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -133.82 114.31 13.01 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.848 -0.614 . . . . 74.02 109.856 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.26 153.13 98.58 Favored 'Cis proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.147 -1.605 . . . . 72.14 111.861 -2.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.82 148.5 45.78 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.808 2.339 . . . . 71.44 112.633 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 31.9 Cg_endo -63.72 153.39 75.57 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.826 2.351 . . . . 71.04 112.456 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 C--O 1.246 0.917 0 CA-C-N 115.816 -0.629 . . . . 71.1 109.746 178.834 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.25 -0.278 . . . . 62.34 110.25 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.77 68.73 0.22 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.277 -0.729 . . . . 52.2 111.277 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -84.42 -40.26 18.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.835 0.35 . . . . 74.13 110.292 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -111.49 120.8 43.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.152 -0.684 . . . . 75.1 109.152 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -98.27 93.88 6.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.354 -0.384 . . . . 75.43 111.69 -174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -90.44 82.79 5.87 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.105 -1.072 . . . . 73.13 108.105 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -70.62 -36.82 73.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.092 -0.958 . . . . 75.42 111.457 -170.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -96.01 100.52 12.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.452 -0.34 . . . . 64.41 110.403 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.451 ' O ' ' HB2' ' A' ' 10' ' ' HIS . 10.0 t -86.3 164.19 17.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.154 -0.476 . . . . 71.32 110.041 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 9' ' ' SER . 9.8 m170 72.3 143.65 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.703 0.627 . . . . 75.11 111.537 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 68.6 mtt -87.49 -29.99 20.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.257 -0.646 . . . . 71.42 109.257 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.1 134.28 63.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.383 -0.826 . . . . 74.02 109.554 175.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.3 151.49 29.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.983 0.421 . . . . 74.14 111.304 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 86' ' ' MET . 5.4 m-20 -87.94 131.66 42.43 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.833 -0.621 . . . . 62.43 110.236 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 72.5 Cg_endo -77.77 145.64 22.98 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.521 2.147 . . . . 73.02 112.553 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.6 153.36 65.11 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.608 2.205 . . . . 64.23 112.299 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.95 167.73 16.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.005 -0.543 . . . . 54.54 111.043 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -94.81 151.31 19.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.104 -0.498 . . . . 75.33 109.943 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HD2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -58.95 -37.56 77.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.493 -0.321 . . . . 74.12 110.494 -176.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -56.93 -41.87 78.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.972 -0.558 . . . . 72.31 111.125 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -72.25 -27.03 62.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 60.44 111.085 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.526 HG23 ' HA ' ' A' ' 71' ' ' SER . 42.8 mt -82.86 -38.8 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.399 0.618 . . . . 71.3 110.516 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.68 -20.68 64.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.987 -0.551 . . . . 73.33 110.505 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.9 -3.81 55.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.772 -0.649 . . . . 51.22 111.378 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.4 152.34 85.67 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.553 -0.294 . . . . 72.24 110.453 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.93 122.91 11.64 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.715 2.277 . . . . 71.41 112.175 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -86.91 118.3 26.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.024 -0.535 . . . . 62.04 110.133 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.3 mt -110.19 103.63 15.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.82 -0.627 . . . . 61.51 110.264 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 68.9 tp -68.24 114.62 6.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.549 -0.538 . . . . 75.4 109.549 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 40.0 t -70.13 111.05 3.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.971 -0.381 . . . . 74.33 109.971 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.2 p -88.19 169.74 11.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 72.04 110.379 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.37 -8.34 56.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.027 0.38 . . . . 42.51 112.027 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -91.46 -2.42 57.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.154 0.502 . . . . 75.2 109.839 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -109.21 90.68 3.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.922 -0.581 . . . . 71.2 111.102 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.93 -26.82 48.03 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.909 -0.877 . . . . 74.03 110.909 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.19 140.46 41.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.482 -0.562 . . . . 75.24 109.482 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 t -118.86 90.8 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.765 0.317 . . . . 73.35 110.727 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.92 13.9 60.17 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.976 -0.556 . . . . 74.53 113.307 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.97 -155.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.61 -0.515 . . . . 50.44 109.61 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -68.94 177.63 2.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.815 -0.439 . . . . 73.43 109.815 173.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.613 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 1.8 pmm? -84.33 0.0 50.86 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.006 -0.278 . . . . 75.31 110.468 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.7 m -116.36 131.84 56.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.079 0.466 . . . . 72.34 112.038 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 14.5 t -83.48 107.93 11.61 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.595 -0.891 . . . . 63.53 108.595 171.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.22 -38.91 62.23 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.331 2.687 . . . . 73.01 112.878 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 51.7 mt -62.29 -29.48 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.961 -0.563 . . . . 71.22 111.347 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 61.2 m -110.12 -8.62 14.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.377 -0.374 . . . . 72.31 111.623 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.4 p 45.18 34.99 1.53 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.459 0.647 . . . . 71.11 110.949 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.1 t -133.82 159.82 39.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.496 -0.775 . . . . 63.23 110.0 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.613 ' HA ' ' O ' ' A' ' 41' ' ' MET . 4.6 pt-20 -83.96 172.57 11.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.736 0.643 . . . . 64.43 112.736 -171.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -98.05 123.91 42.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.374 -0.83 . . . . 75.22 110.289 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.26 164.83 28.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.178 -0.465 . . . . 74.24 110.411 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.647 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.2 ttpt -58.77 125.64 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 63.31 111.047 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.83 -23.96 6.5 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.669 -0.777 . . . . 60.41 112.702 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.57 161.53 18.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.031 -0.359 . . . . 64.2 110.031 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.88 115.25 49.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.927 0.394 . . . . 71.51 110.351 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -100.96 168.35 9.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.211 -0.45 . . . . 71.14 110.417 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.0 t -152.76 166.2 32.97 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.229 -0.656 . . . . 73.33 109.229 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -120.39 119.71 33.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.688 0.28 . . . . 61.11 110.691 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.469 HD22 HD13 ' A' ' 74' ' ' LEU . 88.2 mt -70.39 142.36 89.3 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 108.84 -0.8 . . . . 72.44 108.84 170.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.79 -20.84 13.68 Favored 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.663 2.908 . . . . 74.43 113.841 -175.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.7 p -85.88 19.33 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 70.13 110.376 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 58.01 65.39 1.31 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.411 -0.813 . . . . 75.22 111.612 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -145.08 123.09 12.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.427 -0.806 . . . . 72.33 109.449 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.77 141.32 28.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.026 -0.533 . . . . 64.34 111.796 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -149.07 175.18 11.55 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.138 -1.06 . . . . 75.53 108.138 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.881 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 35.9 m170 -77.28 133.67 38.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.433 -0.951 . . . . 72.04 108.433 170.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 87.1 tttt -57.66 -50.74 86.45 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 119.481 -0.295 . . . . 55.52 111.319 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 6.6 Cg_endo -49.31 -46.88 24.32 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.566 2.177 . . . . 73.03 113.481 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.881 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 14.3 p -80.62 -34.06 35.33 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.492 -0.483 . . . . 74.12 111.933 -175.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG13 ' HA ' ' A' ' 67' ' ' LYS . 5.5 p -73.77 -30.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.565 -0.454 . . . . 72.4 110.562 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.526 ' HA ' HG23 ' A' ' 22' ' ' ILE . 51.1 m -63.38 -32.99 74.57 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.977 0.418 . . . . 71.41 110.776 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.0 mt -79.42 -42.45 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 73.43 110.056 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -63.35 -43.82 96.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.896 -0.593 . . . . 74.52 111.363 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.49 HD11 ' CD2' ' A' ' 87' ' ' PHE . 95.7 mt -66.74 -24.34 66.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.642 -0.254 . . . . 75.43 111.666 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -92.49 0.55 57.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.904 0.383 . . . . 72.42 110.662 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -114.95 -41.72 3.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 74.13 111.398 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.9 m -120.94 -20.38 6.91 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.815 0.302 . . . . 73.3 111.815 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.58 26.64 60.08 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.37 -0.377 . . . . 62.03 114.018 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.26 145.09 40.9 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.339 -0.506 . . . . 63.02 111.79 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.451 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 24.3 t -75.03 110.69 10.7 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.741 -0.663 . . . . 73.13 109.251 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.22 -32.99 34.53 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.211 2.608 . . . . 64.14 113.993 -171.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.93 -28.64 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.393 0.516 . . . . 75.33 112.393 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.451 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 29.4 p -125.06 -13.13 6.87 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 121.818 -0.551 . . . . 64.32 112.093 -174.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 66.36 23.07 10.72 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.029 0.532 . . . . 73.01 111.237 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.3 t -85.01 145.31 27.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.939 -0.763 . . . . 43.24 108.939 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.474 ' HB2' ' ND2' ' A' ' 14' ' ' ASN . 58.7 ttp -75.51 150.51 38.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.926 0.393 . . . . 74.24 111.447 -175.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.562 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 81.1 t80 -129.5 125.98 22.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 108.791 -0.818 . . . . 72.1 108.791 170.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.562 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 30.9 Cg_endo -61.87 153.42 61.61 Favored 'Cis proline' 0 C--N 1.348 0.523 0 C-N-CA 123.988 -1.255 . . . . 73.22 113.019 3.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 42.7 Cg_exo -55.34 138.32 79.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.033 2.489 . . . . 73.21 112.61 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.453 ' HG3' ' HB3' ' A' ' 86' ' ' MET . 6.2 Cg_exo -72.24 177.5 7.18 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.665 2.243 . . . . 70.02 111.914 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.701 -0.666 . . . . 72.35 110.231 -176.736 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.774 0.321 . . . . 74.05 110.564 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.49 116.05 3.38 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.991 -0.623 . . . . 71.51 111.703 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -147.52 146.02 29.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.581 0.229 . . . . 73.34 110.616 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -110.92 146.05 37.25 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.644 -0.502 . . . . 72.05 109.644 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -130.07 152.4 49.56 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.544 -0.298 . . . . 65.51 111.22 -174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -71.55 143.81 49.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.207 -0.451 . . . . 64.54 110.345 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -149.84 23.63 0.87 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.163 -0.68 . . . . 71.14 109.163 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -55.67 103.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.978 -1.01 . . . . 73.32 110.897 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.1 m -100.03 101.78 12.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.643 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -141.5 120.52 12.84 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.697 -0.482 . . . . 74.42 109.697 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.3 ttm 64.51 65.91 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.813 0.816 . . . . 73.12 110.385 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -126.09 108.51 19.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.005 -0.998 . . . . 54.34 110.078 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.46 -44.43 74.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.68 -0.691 . . . . 74.52 111.512 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.415 ' OD1' ' HD2' ' A' ' 15' ' ' PRO . 64.0 t30 -104.78 122.9 41.83 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.891 -0.411 . . . . 74.35 109.891 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 20.4 Cg_endo -60.15 151.23 74.5 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 123.162 2.575 . . . . 72.12 113.053 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 38.0 Cg_exo -61.84 163.38 19.15 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.168 2.579 . . . . 62.04 112.239 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -86.06 153.87 21.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 72.24 110.714 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.401 ' O ' HG13 ' A' ' 22' ' ' ILE . 22.4 m -71.96 137.96 47.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.957 -0.565 . . . . 64.34 110.626 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -58.21 -41.43 84.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.105 -0.498 . . . . 64.4 110.57 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -52.17 -45.91 65.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.996 -1.002 . . . . 72.23 110.987 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.5 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 13.8 m -67.68 -42.33 82.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.083 -0.508 . . . . 72.52 110.679 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 18' ' ' SER . 66.4 mt -61.92 -40.93 88.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 73.1 110.81 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.16 -44.11 80.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.945 -0.571 . . . . 75.12 110.79 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.6 3.89 30.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.932 -0.576 . . . . 61.23 112.287 -174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.531 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 40.5 mt -57.85 127.78 79.56 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 116.89 -0.141 . . . . 74.44 111.027 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.13 126.3 21.15 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.161 2.574 . . . . 72.14 111.77 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.97 116.46 31.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.958 -0.564 . . . . 74.31 110.783 -172.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.9 mt -104.69 129.01 57.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.673 -0.694 . . . . 71.34 110.053 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 46.8 tp -82.23 120.4 25.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.123 -0.49 . . . . 72.12 110.367 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.965 HG11 ' HA2' ' A' ' 35' ' ' GLY . 97.9 t -90.28 128.3 42.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.998 -0.546 . . . . 73.13 111.032 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.421 HG22 ' HG3' ' A' ' 52' ' ' LYS . 17.7 p -137.35 172.95 12.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.463 -0.789 . . . . 74.54 109.825 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.442 ' OE1' ' HD3' ' A' ' 52' ' ' LYS . 4.5 mp0 -59.76 130.21 45.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.404 -0.221 . . . . 64.53 110.404 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 69.01 10.94 8.18 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.928 -0.578 . . . . 54.14 111.523 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -141.32 34.76 1.68 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.568 -1.271 . . . . 70.43 107.568 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.965 ' HA2' HG11 ' A' ' 30' ' ' VAL . . . -93.9 -56.81 1.37 Allowed Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.985 -1.007 . . . . 73.03 113.461 -172.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.33 -60.57 3.22 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.659 0.23 . . . . 74.4 111.23 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t 60.51 91.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.829 -0.623 . . . . 74.45 111.422 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . 99.4 -89.32 0.88 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.388 -0.911 . . . . 64.51 113.269 175.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -141.16 -52.65 0.46 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.833 0.317 . . . . 73.52 111.625 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.39 107.24 2.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.864 0.364 . . . . 74.42 111.082 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.425 ' HG2' ' SG ' ' A' ' 42' ' ' CYS . 1.8 pmm? -84.16 -18.3 37.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.098 0.475 . . . . 71.2 110.421 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.425 ' SG ' ' HG2' ' A' ' 41' ' ' MET . 78.2 m -136.82 159.22 42.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.639 -0.71 . . . . 73.21 109.739 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.6 t -105.56 102.21 36.53 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.501 -0.555 . . . . 71.12 109.501 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.55 -28.35 86.49 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.84 2.36 . . . . 73.22 111.788 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.0 mt -61.98 -29.69 46.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.437 -0.801 . . . . 75.42 111.762 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.3 p -121.38 2.4 10.24 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.87 -0.332 . . . . 74.14 111.313 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 76.9 m 50.66 62.13 2.86 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.415 0.626 . . . . 72.14 111.027 -175.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.8 t -159.43 152.81 22.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.428 -0.805 . . . . 72.23 109.708 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.49 ' HG3' HG11 ' A' ' 51' ' ' VAL . 11.4 pt-20 -77.75 -173.04 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.288 0.566 . . . . 70.13 110.889 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.521 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 37.0 m-85 -97.96 106.68 19.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.046 -0.525 . . . . 74.41 110.65 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' HG3' ' A' ' 49' ' ' GLU . 31.2 m -118.59 162.84 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.786 -0.643 . . . . 75.31 110.889 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 34.1 ttpt -62.78 112.91 2.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.609 . . . . 74.14 110.754 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.5 -31.48 2.85 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.885 -0.674 . . . . 60.32 111.726 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.2 133.34 34.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.675 0.274 . . . . 74.34 110.301 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.65 127.59 40.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.448 -0.342 . . . . 64.44 110.764 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.4 9.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.263 -0.426 . . . . 74.05 109.995 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.531 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 13.2 t -148.51 153.31 38.27 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.899 -0.408 . . . . 75.43 109.899 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -107.49 117.7 34.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.046 0.45 . . . . 74.51 110.335 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -80.75 140.69 51.03 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.893 -0.78 . . . . 73.3 108.893 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HB2' ' HG3' ' A' ' 89' ' ' PRO . 17.1 Cg_endo -58.81 -7.8 4.98 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.896 2.397 . . . . 71.23 112.106 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.6 t -87.42 21.34 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.241 -0.891 . . . . 74.22 109.784 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 57.44 40.33 27.37 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.803 -0.635 . . . . 72.11 111.321 176.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -138.06 148.89 45.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.536 -0.302 . . . . 74.43 111.067 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.406 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 60.8 m-85 -124.39 133.51 53.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.148 -0.478 . . . . 74.1 111.084 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.521 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 92.5 m-85 -146.49 162.52 38.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.595 . . . . 73.33 109.798 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 33.9 m170 -67.13 123.16 19.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.478 -0.564 . . . . 72.53 109.478 174.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 83.2 tttt -57.57 -48.86 96.53 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 123.349 0.406 . . . . 72.33 111.866 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 12.2 Cg_endo -56.84 -27.16 70.72 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.162 1.908 . . . . 61.35 112.844 177.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 37.3 m -84.53 -52.77 5.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.142 0.496 . . . . 65.43 111.122 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.509 HG23 ' HG ' ' A' ' 74' ' ' LEU . 9.8 p -67.17 -25.6 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 70.43 111.404 -172.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.5 p -63.49 -30.38 71.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.807 0.337 . . . . 73.23 111.437 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.4 mt -78.88 -40.15 22.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.253 0.549 . . . . 74.55 109.917 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -65.82 -43.19 89.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.453 -0.794 . . . . 73.43 111.481 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.509 ' HG ' HG23 ' A' ' 70' ' ' VAL . 93.1 mt -67.03 -19.33 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.953 0.353 . . . . 73.32 111.953 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -74.28 -22.27 59.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.046 0.451 . . . . 72.15 110.327 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -91.19 -45.17 8.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.713 -0.676 . . . . 64.4 109.851 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -157.37 133.05 9.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.819 -0.628 . . . . 64.11 110.247 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.01 77.61 2.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.681 -0.771 . . . . 37.98 111.226 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 m -148.52 148.85 30.68 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.169 -0.308 . . . . 64.34 110.169 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.744 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 73.7 m -75.12 119.83 78.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 108.23 -1.026 . . . . 72.03 108.23 168.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.83 -12.07 20.47 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.468 2.112 . . . . 75.23 113.04 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.6 t -96.15 -50.21 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 111.861 0.319 . . . . 74.35 111.861 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.744 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 20.4 p -96.0 -18.88 19.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.761 0.315 . . . . 55.14 111.629 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 63.08 25.57 15.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.012 -0.54 . . . . 73.51 111.887 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -92.42 151.06 20.43 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.487 -0.56 . . . . 62.14 109.487 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 52.8 ttp -76.31 146.89 38.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.033 0.753 . . . . 61.24 113.033 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.553 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 76.6 t80 -133.16 124.47 18.42 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.803 -1.089 . . . . 73.41 108.527 170.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.553 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 32.7 Cg_exo -59.6 144.48 33.62 Favored 'Cis proline' 0 C--N 1.35 0.643 0 C-N-CA 124.558 -1.017 . . . . 72.41 113.181 3.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.444 ' HG3' ' HB2' ' A' ' 60' ' ' PRO . 52.9 Cg_endo -67.48 149.76 80.2 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.059 2.506 . . . . 63.31 112.611 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.5 178.71 5.31 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.709 2.273 . . . . 65.24 111.814 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.41 -0.805 . . . . 63.32 110.266 -179.747 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.096 -0.335 . . . . 70.13 110.096 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.56 115.47 2.98 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.205 -0.758 . . . . 63.22 111.205 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -105.03 27.46 8.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.088 0.471 . . . . 73.33 110.843 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -113.91 79.81 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.863 -0.792 . . . . 74.52 108.863 172.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -88.06 -9.22 54.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.135 -0.484 . . . . 74.44 111.162 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -101.62 88.39 3.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.9 0.381 . . . . 75.45 110.591 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -91.7 138.91 31.18 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.058 0.456 . . . . 75.03 110.646 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -83.04 80.62 8.99 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.159 -0.682 . . . . 71.54 109.159 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 t -78.3 86.31 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.38 -0.827 . . . . 74.51 110.124 -176.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.9 107.55 5.09 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.381 -0.97 . . . . 74.21 108.381 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.441 ' HG3' HG23 ' A' ' 12' ' ' VAL . 23.2 ptt? -55.93 -50.56 70.4 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.358 0.411 . . . . 53.22 111.958 -172.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.441 HG23 ' HG3' ' A' ' 11' ' ' MET . 24.6 t -92.52 81.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.321 -0.622 . . . . 70.44 109.321 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.471 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -68.59 -38.05 80.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.613 -0.721 . . . . 73.4 111.28 -176.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -89.51 110.08 36.41 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.284 -0.416 . . . . 63.02 110.72 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 13' ' ' ALA . 96.8 Cg_endo -89.37 167.84 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.873 2.382 . . . . 61.12 112.056 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -73.88 136.85 23.54 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.91 1.74 . . . . 73.13 111.326 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.456 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -79.96 127.73 32.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.43 -0.35 . . . . 72.32 110.529 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 p -74.64 166.55 23.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.091 -0.504 . . . . 71.35 110.736 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -57.64 -35.17 70.15 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.248 -0.433 . . . . 62.41 110.946 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.42 -35.26 69.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.938 0.399 . . . . 65.11 111.181 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 m -85.83 -35.41 20.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.025 -0.534 . . . . 73.41 111.173 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.476 HG21 ' HA ' ' A' ' 71' ' ' SER . 68.1 mt -82.89 -44.44 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.017 0.437 . . . . 75.24 111.903 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.75 -33.73 74.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.013 -0.54 . . . . 50.01 110.762 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.77 4.93 26.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.697 -0.683 . . . . 62.5 112.186 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.431 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 66.7 mt -70.75 136.17 85.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.609 0.242 . . . . 75.13 110.511 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.61 149.37 67.9 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.256 2.637 . . . . 71.44 112.782 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.64 121.33 44.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 71.13 110.4 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.3 mt -109.44 120.55 60.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.743 -0.662 . . . . 70.2 109.883 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.0 tp -79.93 107.67 12.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.796 -0.446 . . . . 73.54 109.796 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 50' ' ' TYR . 42.5 t -74.86 131.86 34.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.051 -0.522 . . . . 61.43 110.902 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.402 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 35.2 p -120.17 145.21 47.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.966 -0.561 . . . . 73.42 109.883 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.483 ' HG2' ' HD3' ' A' ' 52' ' ' LYS . 16.7 pt-20 -71.7 -17.43 62.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.705 0.288 . . . . 74.33 111.221 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -68.29 -23.03 64.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.466 -0.334 . . . . 74.2 110.382 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -90.76 -13.81 33.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 73.12 109.913 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.2 -80.38 0.98 Allowed Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.967 -0.56 . . . . 72.41 112.164 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.78 -172.8 2.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.78 -0.452 . . . . 62.01 109.78 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.87 95.42 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.085 0.469 . . . . 74.43 110.159 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.5 -110.44 3.49 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.794 -0.639 . . . . 71.14 111.756 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -98.48 -14.77 19.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.741 0.305 . . . . 72.55 111.19 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -99.36 133.69 43.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.247 0.546 . . . . 65.35 110.954 -174.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.3 ptp -121.44 -5.04 9.33 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.489 -0.778 . . . . 75.41 111.61 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.2 p -150.48 151.77 33.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.329 . . . . 74.04 110.924 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.9 t -109.79 93.01 13.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 71.44 109.57 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.15 -18.29 57.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.375 2.717 . . . . 73.35 113.006 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.6 mt -63.94 -27.93 43.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.632 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.6 p -127.07 -7.4 5.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.622 -0.263 . . . . 60.04 111.107 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 71.0 m 61.4 35.9 17.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.128 -0.487 . . . . 74.35 110.784 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -124.38 159.25 30.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.805 -0.634 . . . . 73.34 110.299 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.85 -174.4 5.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.817 -0.629 . . . . 75.52 111.389 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.652 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 96.4 m-85 -108.58 118.68 37.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.26 -0.427 . . . . 75.22 110.168 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.18 174.67 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.392 -0.367 . . . . 60.52 111.293 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HD3' ' HG2' ' A' ' 32' ' ' GLU . 35.9 ttpt -76.87 124.22 27.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.097 -0.501 . . . . 73.44 110.652 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.67 0.73 55.33 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.885 -0.674 . . . . 61.11 111.711 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -87.24 157.83 19.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.531 -0.544 . . . . 73.31 109.531 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.45 114.47 47.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.342 0.592 . . . . 74.33 111.166 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.5 166.64 10.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.486 -0.779 . . . . 53.15 110.066 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.476 HG23 HG11 ' A' ' 70' ' ' VAL . 7.6 t -131.01 171.71 12.92 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.832 -0.433 . . . . 72.02 109.832 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.488 ' HG2' ' CE2' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -126.4 118.35 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.342 -0.614 . . . . 75.22 109.342 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 61' ' ' CYS . 90.8 mt -87.5 147.23 41.35 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.273 -0.421 . . . . 64.34 110.538 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.44 4.32 0.48 Allowed 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.048 2.499 . . . . 64.52 113.702 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.405 ' H ' ' C ' ' A' ' 59' ' ' LEU . 25.1 p -109.35 8.41 25.5 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.969 -0.382 . . . . 52.52 109.969 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.1 m170 66.59 89.13 0.1 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.757 -0.656 . . . . 73.34 110.371 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -172.53 125.4 0.49 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.52 -0.763 . . . . 72.12 110.126 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CE2' ' HG2' ' A' ' 58' ' ' GLU . 39.0 m-85 -103.83 133.28 49.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 72.24 110.047 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.652 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 90.0 m-85 -146.24 155.75 42.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.143 -0.48 . . . . 72.01 109.912 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.44 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 26.1 m170 -56.28 124.18 17.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.213 -0.662 . . . . 72.23 109.213 171.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 86.0 tttt -57.41 -49.27 94.82 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 119.297 -0.382 . . . . 70.01 111.462 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 77.6 Cg_exo -53.29 -36.22 77.44 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.865 1.71 . . . . 72.21 112.559 176.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 71.2 m -70.59 -51.59 27.31 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.428 -0.351 . . . . 62.21 111.13 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.476 HG11 HG23 ' A' ' 57' ' ' THR . 7.5 p -65.93 -26.73 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.001 -0.545 . . . . 63.45 110.3 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.476 ' HA ' HG21 ' A' ' 22' ' ' ILE . 50.3 m -60.96 -55.28 34.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.346 -0.388 . . . . 73.35 110.013 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.26 -40.63 84.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 74.03 110.789 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -64.94 -53.21 50.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 73.05 111.348 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 96.5 mt -66.41 -31.26 71.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.736 -0.211 . . . . 73.45 111.55 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 71' ' ' SER . 73.3 mt-30 -59.97 -30.71 69.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.759 0.314 . . . . 70.21 110.766 176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.48 -40.29 10.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.838 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.7 p -153.79 115.21 4.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 62.14 110.683 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.83 71.38 2.88 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.864 -0.684 . . . . 73.11 112.643 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 1.3 m -146.43 141.14 26.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.781 -0.452 . . . . 73.42 109.781 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.0 t -74.56 113.01 19.98 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.091 -0.707 . . . . 74.33 109.091 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.78 -37.95 96.84 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.844 2.362 . . . . 71.02 113.378 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -71.42 -48.81 51.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.515 0.561 . . . . 74.12 112.515 -174.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.71 -8.81 13.22 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.62 -0.432 . . . . 72.55 111.992 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 63.67 91.71 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.629 0.728 . . . . 61.21 110.943 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 79' ' ' THR . 44.0 t -144.4 130.83 19.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.042 -0.981 . . . . 75.21 108.862 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.535 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 43.4 ttm -64.6 140.9 58.92 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.509 0.506 . . . . 72.43 110.391 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.431 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 70.3 t80 -131.83 116.26 15.83 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.035 -0.53 . . . . 74.41 109.69 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.99 155.12 99.74 Favored 'Cis proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.232 -1.57 . . . . 52.25 112.426 -0.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.39 151.55 29.43 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 123.264 2.643 . . . . 73.44 113.221 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 86.9 Cg_endo -80.6 170.63 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.786 2.324 . . . . 63.1 112.429 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.278 -0.868 . . . . 71.15 109.729 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.635 0.255 . . . . 72.3 110.617 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.39 22.29 75.99 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.104 -0.569 . . . . 75.32 113.254 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -106.58 134.87 49.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.508 -0.553 . . . . 74.45 109.508 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -78.8 150.64 32.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.248 -0.433 . . . . 74.42 111.414 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -85.7 24.34 1.25 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 72.4 110.771 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -65.94 -29.85 70.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.24 -0.437 . . . . 74.31 111.545 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -72.78 -8.69 56.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.033 0.445 . . . . 74.54 110.941 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -98.35 6.2 47.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.551 0.691 . . . . 72.01 109.662 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.7 t -107.76 106.02 16.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.668 -0.696 . . . . 74.42 110.435 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.3 m170 -91.2 83.8 5.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.955 -0.566 . . . . 73.41 109.546 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -119.23 19.62 12.79 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.865 -0.607 . . . . 72.13 110.413 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -66.99 108.55 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.527 0.68 . . . . 74.02 110.517 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.89 96.44 1.98 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.434 -0.803 . . . . 73.4 110.054 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' HA ' ' HE2' ' A' ' 86' ' ' MET . 55.3 m-20 70.32 101.54 0.04 OUTLIER Pre-proline 0 C--O 1.236 0.389 0 CA-C-N 115.466 -0.788 . . . . 71.45 111.287 176.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.79 172.63 13.28 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.406 2.738 . . . . 71.23 112.341 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.11 149.87 41.96 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.858 2.372 . . . . 72.14 112.5 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.45 157.98 24.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.778 -0.646 . . . . 53.13 110.993 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -67.93 139.72 56.44 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.679 -0.489 . . . . 74.13 109.679 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -61.52 -37.36 83.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 74.21 111.178 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 20' ' ' GLU . 3.1 mp0 -60.0 -42.49 94.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.4 -0.364 . . . . 71.15 110.287 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.456 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.7 m -62.16 -40.04 94.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 71.43 110.823 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.14 -40.95 78.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.861 -0.609 . . . . 71.4 110.647 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.79 -32.89 65.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.16 -0.473 . . . . 64.44 111.179 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.65 -0.31 37.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.482 -0.326 . . . . 72.21 111.86 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.504 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 67.5 mt -64.99 123.3 83.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.605 0.241 . . . . 74.23 110.791 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.57 117.99 4.8 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.154 2.569 . . . . 72.45 112.332 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -78.4 121.99 25.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.087 -0.506 . . . . 72.53 110.808 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.4 mt -115.91 120.82 65.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.041 -0.527 . . . . 72.45 110.03 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.2 tp -75.71 119.51 19.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.74 -0.467 . . . . 73.23 109.74 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 40.3 t -85.91 121.56 37.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.072 0.463 . . . . 74.13 111.258 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' HG3' ' A' ' 52' ' ' LYS . 24.0 p -123.37 165.79 16.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.479 -0.782 . . . . 74.12 109.661 173.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.503 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 31.5 mt-10 -68.16 -30.22 69.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.937 0.398 . . . . 74.45 111.311 -173.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.31 -17.97 64.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.029 -0.532 . . . . 63.2 112.222 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -75.95 -17.52 59.7 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.044 0.387 . . . . 72.13 112.044 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.22 69.43 1.32 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.767 -0.73 . . . . 54.11 113.075 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 67.17 -2.83 1.11 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.328 0.651 . . . . 74.42 112.666 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.5 t 72.77 -64.84 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.193 0.597 . . . . 71.42 111.742 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.56 -161.57 9.06 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.657 -0.782 . . . . 74.2 112.496 -176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -62.27 -28.77 69.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.02 0.438 . . . . 55.33 110.803 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -80.52 110.6 16.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.43 -0.952 . . . . 75.44 108.43 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.1 ptp -103.8 -2.2 26.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.16 -0.473 . . . . 72.25 111.382 -173.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 82.0 m -146.42 147.52 31.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.341 -0.391 . . . . 75.14 110.571 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.0 t -103.78 94.74 6.62 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.081 -0.711 . . . . 65.1 109.081 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.87 -8.99 17.24 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.37 2.713 . . . . 61.25 112.84 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.5 mt -76.2 -32.92 23.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.019 -0.537 . . . . 75.44 110.508 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.8 p -114.86 -3.2 12.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.755 0.312 . . . . 74.42 111.045 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.0 t 67.64 23.37 8.79 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.564 -0.744 . . . . 71.04 111.103 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.1 m -129.47 158.78 38.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 64.43 110.405 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.9 OUTLIER -84.61 -169.67 2.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.171 -0.468 . . . . 64.15 111.1 -177.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.599 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 96.8 m-85 -93.94 94.23 8.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.483 0.659 . . . . 74.52 110.899 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.24 173.74 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.766 -1.106 . . . . 73.52 111.01 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 32.9 ttpt -75.48 123.24 25.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.969 -0.56 . . . . 75.11 110.806 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.63 -24.28 6.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.691 -0.766 . . . . 61.35 112.709 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -87.04 161.26 18.27 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.572 -0.529 . . . . 72.5 109.572 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.3 t -111.26 124.75 68.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.916 0.389 . . . . 74.22 110.056 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -111.73 172.69 6.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.315 -0.402 . . . . 63.13 110.777 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.504 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 12.7 t -152.76 161.13 42.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.903 -0.59 . . . . 74.4 109.59 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -108.31 117.59 34.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.85 0.357 . . . . 74.13 111.229 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.9 mt -76.84 152.94 82.98 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.913 -0.773 . . . . 73.23 108.913 171.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.83 51.04 0.62 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 122.959 2.439 . . . . 74.54 111.189 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 45.4 t -153.37 16.8 0.54 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.041 -0.982 . . . . 72.32 109.677 -172.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 56.95 18.16 3.76 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.54 -0.755 . . . . 72.14 111.775 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 3.3 m170 -111.13 115.63 29.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.189 -0.459 . . . . 71.41 110.563 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -91.99 133.26 35.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.617 -0.719 . . . . 72.3 109.728 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.599 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 74.9 m-85 -136.7 155.73 49.47 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.367 0.417 . . . . 75.23 110.143 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 32.2 m170 -65.71 121.21 14.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.225 -0.658 . . . . 75.14 109.225 174.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.5 tttt -56.57 -51.49 80.79 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 123.576 0.547 . . . . 74.41 111.966 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.0 Cg_endo -58.68 -27.97 84.89 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.237 1.958 . . . . 61.23 112.572 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 57.5 m -80.34 -50.61 9.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.069 -0.514 . . . . 74.35 110.419 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.523 HG22 ' HG ' ' A' ' 74' ' ' LEU . 9.1 p -72.52 -27.47 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.669 -0.696 . . . . 74.14 111.125 -172.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.6 t -59.3 -42.52 91.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.007 0.432 . . . . 71.25 110.448 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.93 -36.76 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.269 0.557 . . . . 73.12 110.204 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -72.29 -51.96 18.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.441 -0.799 . . . . 74.54 110.778 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.523 ' HG ' HG22 ' A' ' 70' ' ' VAL . 95.9 mt -60.03 -33.74 72.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.016 -0.538 . . . . 72.34 112.369 -174.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.5 -18.91 65.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.05 0.389 . . . . 73.44 112.05 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.65 ' HZ1' ' HB2' ' A' ' 76' ' ' LYS . 10.3 mtmp? -111.4 -16.69 13.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 73.15 110.925 177.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.4 t -172.33 117.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 74.25 109.763 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.12 91.53 1.7 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.556 -0.83 . . . . 63.43 111.681 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 2.8 p -149.28 155.03 39.92 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.3 0.481 . . . . 65.3 112.3 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 35.0 m -74.79 112.0 15.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.843 -1.169 . . . . 73.24 107.843 160.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.91 -15.6 22.63 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.53 2.153 . . . . 65.23 112.379 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.6 t -89.93 -48.85 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.007 -0.542 . . . . 75.34 111.847 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 20.0 p -107.81 -3.13 19.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.62 0.6 . . . . 70.43 112.62 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? 68.06 14.71 9.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.039 0.755 . . . . 74.55 113.039 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.542 ' O ' ' HA ' ' A' ' 79' ' ' THR . 17.2 p -79.92 150.85 30.4 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.92 -0.488 . . . . 73.14 110.249 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.535 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 40.1 ttm -81.32 144.36 31.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.123 0.487 . . . . 62.1 111.376 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -135.43 123.53 15.42 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.497 -0.774 . . . . 75.22 109.547 172.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.28 152.42 84.75 Favored 'Cis proline' 0 C--N 1.343 0.272 0 C-N-CA 123.339 -1.525 . . . . 71.11 111.528 -2.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.37 149.44 56.06 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.83 2.354 . . . . 73.03 112.412 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 96.0 Cg_endo -81.82 147.29 15.17 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.66 2.24 . . . . 74.34 111.406 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.344 -0.836 . . . . 74.02 110.011 179.658 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.654 0.264 . . . . 70.22 110.304 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.4 -105.08 2.99 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.674 -0.774 . . . . 54.34 112.139 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -89.44 -7.13 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.966 0.412 . . . . 75.51 110.477 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.0 m170 -66.65 129.73 40.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.527 -0.545 . . . . 75.51 109.527 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.414 ' O ' ' HB3' ' A' ' 6' ' ' HIS . 46.7 t-80 -135.09 8.45 3.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.297 -0.411 . . . . 73.22 110.515 -171.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 5' ' ' HIS . 21.7 t-80 67.95 34.0 4.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.316 1.055 . . . . 71.24 108.651 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -105.76 129.26 53.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.785 -1.098 . . . . 73.03 110.87 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -65.27 110.63 2.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.907 -0.775 . . . . 63.52 108.907 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -132.61 110.86 10.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.516 0.562 . . . . 72.4 112.516 -171.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 70.86 -34.87 0.31 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.458 1.281 . . . . 74.2 114.458 167.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.2 ptm -68.74 -6.28 25.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.938 0.347 . . . . 64.2 111.938 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.3 t -75.39 -46.67 37.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.412 -0.358 . . . . 73.13 111.215 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.04 166.1 28.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.731 0.301 . . . . 72.34 111.027 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -97.43 144.87 28.69 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.973 -0.558 . . . . 74.01 110.246 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.92 162.8 34.3 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.675 2.25 . . . . 72.31 112.149 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.42 159.81 22.67 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.041 2.494 . . . . 72.43 112.154 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.38 160.16 15.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.279 -0.419 . . . . 61.24 110.487 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -88.91 158.38 18.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.614 -0.267 . . . . 61.12 110.417 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -58.16 -45.45 87.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.176 -0.465 . . . . 73.02 111.411 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -45.71 -54.64 7.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 75.41 112.163 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.99 -23.38 67.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.155 0.428 . . . . 71.44 112.155 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.519 HG21 ' HA ' ' A' ' 71' ' ' SER . 37.2 mt -87.16 -38.46 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.48 0.657 . . . . 53.42 110.1 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -68.39 -30.5 69.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.546 -0.752 . . . . 72.41 110.884 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -19.19 65.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.164 -0.471 . . . . 53.3 111.363 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.88 144.52 97.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 63.01 110.514 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.85 159.13 26.15 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.192 2.595 . . . . 63.35 113.153 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -120.17 110.09 16.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 74.11 110.035 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 54.0 mt -104.68 129.07 57.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.711 -0.677 . . . . 74.32 110.871 -175.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.2 tp -83.82 117.07 23.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.249 -0.648 . . . . 74.35 109.249 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 49.1 t -76.67 117.28 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.054 0.454 . . . . 73.3 111.634 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 p -112.22 148.0 35.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.643 -0.708 . . . . 71.12 110.307 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 27.4 mt-10 -78.47 -26.74 46.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.914 0.388 . . . . 72.41 111.76 -174.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.98 -4.23 27.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.275 0.843 . . . . 64.1 113.275 -168.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.677 ' HE1' ' HA ' ' A' ' 37' ' ' VAL . 22.3 p80 -113.08 9.24 18.56 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.233 -0.587 . . . . 74.4 110.537 176.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.5 -130.67 23.62 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.897 -0.592 . . . . 72.12 112.122 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.21 147.37 49.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.664 0.269 . . . . 61.2 110.52 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.677 ' HA ' ' HE1' ' A' ' 34' ' ' HIS . 60.9 t -80.76 97.91 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.052 0.454 . . . . 63.53 110.109 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.16 -80.35 0.85 Allowed Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.558 -0.746 . . . . 63.44 112.21 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.759 ' HG3' ' HG2' ' A' ' 40' ' ' GLU . 15.6 pt20 -138.73 -1.77 1.8 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.683 0.278 . . . . 63.33 111.343 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.759 ' HG2' ' HG3' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -128.34 144.48 51.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.26 -0.274 . . . . 74.51 110.26 -173.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.2 ptp -123.83 -8.16 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.499 -0.318 . . . . 72.41 111.271 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.673 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 81.5 m -132.73 151.95 51.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.051 0.453 . . . . 71.21 111.142 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 38.9 t -118.16 91.93 41.46 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.758 -0.656 . . . . 73.14 109.298 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.2 Cg_endo -51.74 -30.7 38.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.833 3.022 . . . . 65.53 113.562 -173.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.8 mt -56.99 -37.34 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.334 -0.394 . . . . 73.11 111.465 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.6 p -109.31 0.11 19.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 62.44 110.298 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.1 m 60.38 16.01 5.93 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.257 -0.883 . . . . 71.3 111.49 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.3 t -117.31 165.76 13.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.785 -0.45 . . . . 71.44 109.785 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.673 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 7.2 pt-20 -99.51 -170.08 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.266 -0.425 . . . . 71.22 111.296 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.475 ' HB3' HG13 ' A' ' 30' ' ' VAL . 55.9 m-85 -95.1 110.23 22.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.213 0.53 . . . . 75.42 111.539 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.17 167.24 12.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.337 -0.847 . . . . 72.32 110.367 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 40.0 ttmt -71.51 126.33 29.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.347 -0.388 . . . . 73.54 111.198 -174.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.61 -15.44 19.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.742 . . . . 71.23 112.301 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -86.8 162.92 17.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.94 -0.393 . . . . 53.01 109.94 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -112.82 121.18 64.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.984 0.421 . . . . 71.35 110.78 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -103.97 170.19 8.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.08 -0.509 . . . . 63.34 110.697 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.475 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 8.3 t -147.7 173.35 12.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.054 -0.521 . . . . 73.35 109.711 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -118.96 119.43 34.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.675 0.274 . . . . 74.14 110.462 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.08 137.72 35.1 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.653 -0.499 . . . . 73.03 109.653 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.55 -15.77 26.82 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.287 2.658 . . . . 53.54 113.448 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 p -87.24 11.8 13.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.442 0.163 . . . . 64.41 110.897 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.3 m80 69.22 62.44 0.3 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.287 0.565 . . . . 75.44 111.015 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -150.67 152.16 33.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.438 -0.801 . . . . 74.44 109.336 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -118.78 133.23 55.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.994 0.426 . . . . 64.55 110.641 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.421 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 47.7 m-85 -143.08 157.94 44.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.659 -0.7 . . . . 74.41 109.976 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 33.3 m170 -68.4 125.91 27.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.687 -0.857 . . . . 71.51 108.687 172.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.533 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 85.5 tttt -57.57 -50.3 88.9 Favored Pre-proline 0 CA--C 1.536 0.44 0 O-C-N 123.405 0.441 . . . . 63.43 112.061 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 73.6 Cg_exo -52.59 -42.48 61.82 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.686 1.591 . . . . 72.31 112.395 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 57.9 m -63.15 -53.13 58.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.0 0.428 . . . . 62.32 110.918 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.439 HG13 ' HA ' ' A' ' 67' ' ' LYS . 8.7 p -67.56 -27.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 64.03 110.792 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 53.1 m -61.58 -51.03 70.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.699 0.285 . . . . 62.32 110.393 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.65 -37.31 79.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.379 0.609 . . . . 71.11 110.414 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -64.31 -55.0 24.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.504 -0.771 . . . . 75.44 111.302 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.408 HD11 ' CD2' ' A' ' 87' ' ' PHE . 96.8 mt -65.58 -27.78 68.67 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.034 0.383 . . . . 74.0 112.034 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.2 mt-30 -66.31 -20.84 66.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.66 0.267 . . . . 75.2 111.007 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -101.31 -37.32 8.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.245 -0.434 . . . . 72.52 110.809 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 t -153.65 118.2 4.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 75.33 109.972 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.433 ' C ' ' HG1' ' A' ' 79' ' ' THR . . . -81.68 74.79 2.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.89 -0.672 . . . . 64.34 111.889 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.433 ' HG1' ' C ' ' A' ' 78' ' ' GLY . 0.6 OUTLIER -147.29 139.19 24.27 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.69 -0.3 . . . . 71.13 110.474 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.8 t -74.44 116.16 50.37 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.371 -0.603 . . . . 71.5 109.371 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.8 -38.07 46.42 Favored 'Trans proline' 0 N--CA 1.474 0.344 0 C-N-CA 123.279 2.652 . . . . 74.34 113.773 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.09 -55.99 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.12 0.415 . . . . 74.03 112.12 -175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 28.3 p -96.13 -13.03 23.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.251 0.463 . . . . 75.32 112.251 -171.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 66.34 22.48 10.82 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.712 0.405 . . . . 74.51 111.523 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 28.3 t -74.63 141.6 44.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.077 -0.712 . . . . 65.11 109.077 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 58.7 ttp -77.41 142.18 39.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 75.41 111.301 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.532 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 61.9 t80 -129.85 126.31 22.48 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.789 -0.819 . . . . 75.24 108.789 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 34.4 Cg_endo -63.69 157.6 69.31 Favored 'Cis proline' 0 C--O 1.235 0.356 0 C-N-CA 123.823 -1.324 . . . . 71.01 112.978 2.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -47.98 147.41 7.76 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.193 3.262 . . . . 72.33 113.677 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.28 147.32 83.14 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.848 2.365 . . . . 61.3 112.649 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.411 -0.804 . . . . 75.13 109.642 178.781 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.977 -0.379 . . . . 73.31 109.977 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.26 103.58 0.75 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.839 -0.696 . . . . 54.02 111.981 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -82.46 -11.03 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 75.22 110.44 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -104.23 82.16 1.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.445 -0.946 . . . . 75.44 108.445 170.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -150.72 112.42 4.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.868 -0.606 . . . . 73.0 110.341 -174.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -84.56 154.33 22.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 74.32 110.348 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -97.86 -68.69 0.79 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.153 -0.476 . . . . 74.3 110.981 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -86.73 84.24 7.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.74 -0.467 . . . . 72.45 109.74 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.5 m -93.42 -38.48 11.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 60.11 110.8 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -84.37 118.6 24.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.937 -0.574 . . . . 65.43 110.248 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ptm -82.63 161.19 22.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.242 -0.435 . . . . 71.24 110.128 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -81.37 117.49 27.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.274 -0.421 . . . . 65.24 110.34 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.08 140.89 52.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 71.03 110.018 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 86' ' ' MET . 9.5 m120 -116.58 100.11 53.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.617 -0.265 . . . . 75.33 111.161 -174.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.741 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 65.3 Cg_endo -79.0 151.38 23.93 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.502 2.135 . . . . 42.24 111.844 171.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -57.48 150.98 56.59 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.898 2.399 . . . . 74.52 112.685 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -79.85 146.17 32.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.907 -0.588 . . . . 74.01 110.925 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 m -74.8 142.86 44.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.631 -0.713 . . . . 73.03 110.649 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.415 ' HD2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.74 -37.48 79.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.301 -178.485 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.45 -40.06 89.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.019 -0.537 . . . . 74.34 110.697 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -67.43 -38.28 84.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.959 -0.564 . . . . 64.15 110.377 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.469 ' O ' ' HE3' ' A' ' 67' ' ' LYS . 65.6 mt -66.92 -41.45 87.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.51 . . . . 39.2 110.551 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.28 -32.52 73.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 73.01 110.427 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.52 -11.6 60.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.715 -0.675 . . . . 75.14 111.795 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.56 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 91.2 mt -65.4 133.1 95.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.469 -0.332 . . . . 73.44 110.703 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 149.64 84.08 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.092 2.528 . . . . 65.34 112.143 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 55.9 mt-10 -116.77 104.8 11.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.291 0.567 . . . . 75.24 110.75 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.0 mt -106.48 117.85 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.393 -0.821 . . . . 70.31 110.356 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.5 tp -68.03 118.85 11.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.305 -0.407 . . . . 74.0 109.956 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 28.8 t -81.5 135.17 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.997 0.427 . . . . 74.25 110.631 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p -131.99 173.01 11.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.647 -0.706 . . . . 73.41 109.848 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 15.3 mm-40 -70.31 -178.67 1.77 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.598 -0.274 . . . . 71.44 110.853 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 27.9 m-20 76.14 -51.51 0.61 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.43 0.692 . . . . 75.21 111.092 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -111.38 55.74 0.65 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.026 0.441 . . . . 72.41 109.839 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 50' ' ' TYR . . . -63.79 -31.04 79.46 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.667 -0.697 . . . . 74.3 111.618 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.38 84.22 6.06 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.248 -0.649 . . . . 73.2 109.248 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.26 -28.91 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 65.14 110.882 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.02 -142.48 3.57 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.035 -0.826 . . . . 72.12 111.035 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.97 -20.91 63.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.063 0.458 . . . . 62.25 110.397 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -103.97 130.55 51.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 64.12 110.849 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.6 ptp -102.66 -3.91 25.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.423 -0.808 . . . . 60.4 109.842 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 8.8 p -134.59 149.31 50.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.679 -0.691 . . . . 64.4 111.051 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 28.9 t -105.97 103.51 44.89 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.713 -0.676 . . . . 74.11 109.519 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 16.1 Cg_endo -56.94 -28.71 79.25 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 123.291 2.661 . . . . 63.33 112.907 -176.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mt -68.27 -28.2 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.094 -0.503 . . . . 63.01 110.871 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 78.7 m -104.74 -18.7 14.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 60.53 110.579 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.8 t 61.65 24.94 14.95 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.252 -0.886 . . . . 73.51 109.471 -172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.9 m -128.32 171.81 11.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.166 -0.925 . . . . 75.45 109.266 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER -93.76 -171.75 2.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.844 0.354 . . . . 73.21 110.639 -178.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.554 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 90.5 m-85 -98.52 103.18 15.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.118 0.485 . . . . 75.0 110.578 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG13 ' HG2' ' A' ' 49' ' ' GLU . 25.2 m -121.87 167.13 15.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.648 -0.705 . . . . 64.43 111.062 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.65 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 22.8 ttpp -54.32 127.44 27.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.336 -0.847 . . . . 75.14 111.725 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.59 -34.38 3.8 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.793 -0.718 . . . . 75.41 113.031 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -86.97 165.3 15.96 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.704 -0.48 . . . . 72.14 109.704 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.42 121.13 66.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.797 0.332 . . . . 71.42 110.544 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -100.21 160.96 13.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.978 0.418 . . . . 72.14 111.075 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.56 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 11.2 t -137.25 167.49 21.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.859 -0.61 . . . . 64.01 109.646 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -120.65 118.09 29.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.011 0.434 . . . . 74.11 110.863 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.7 mt -87.0 143.42 34.99 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.846 -0.615 . . . . 64.51 109.517 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.39 -12.8 17.94 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.937 2.425 . . . . 64.43 111.687 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 45.5 t -76.0 9.17 2.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.99 -1.005 . . . . 75.1 110.592 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 65.69 28.45 11.1 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.524 0.678 . . . . 74.04 109.736 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 136.96 54.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.543 -0.753 . . . . 72.21 110.578 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -110.78 133.26 53.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.253 -0.43 . . . . 75.13 110.714 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.543 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 91.5 m-85 -145.02 175.31 10.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.365 -0.976 . . . . 73.34 108.365 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.946 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.4 m80 -88.41 130.19 35.23 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.8 -0.815 . . . . 73.23 108.8 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.58 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 84.8 tttt -57.02 -48.06 98.07 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 112.086 0.402 . . . . 75.01 112.086 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 10.0 Cg_endo -51.46 -46.2 32.99 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.486 2.124 . . . . 75.2 113.503 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.946 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 8.4 p -84.23 -34.96 23.77 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.199 0.444 . . . . 71.05 112.199 -175.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.504 HG23 ' HG ' ' A' ' 74' ' ' LEU . 5.7 p -71.72 -26.1 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 122.225 -0.297 . . . . 73.24 110.751 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -56.98 -39.71 75.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.142 0.496 . . . . 71.35 110.72 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.487 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 59.8 mt -69.65 -40.95 79.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.914 -0.584 . . . . 75.44 110.585 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -72.96 -38.91 66.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 74.43 111.326 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.504 ' HG ' HG23 ' A' ' 70' ' ' VAL . 88.8 mt -63.86 -32.84 74.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.601 -0.272 . . . . 75.43 111.252 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -77.08 -9.52 58.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.803 0.335 . . . . 74.45 111.104 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 67.9 mttm -80.92 -58.77 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 73.13 110.927 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.8 m -148.74 11.66 0.86 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.214 0.449 . . . . 71.43 112.214 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.69 65.27 3.29 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 123.25 0.343 . . . . 65.04 113.764 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.34 160.8 43.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.669 0.235 . . . . 64.12 111.142 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.706 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 84.4 m -79.34 123.28 84.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.806 -0.812 . . . . 73.11 108.806 168.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.58 -21.81 56.89 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.498 2.132 . . . . 74.05 112.522 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.4 t -84.58 -53.43 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 60.43 111.861 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 28.9 p -98.84 -19.75 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.838 0.31 . . . . 74.44 111.838 -170.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 66.65 19.78 10.77 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.034 -0.53 . . . . 62.02 111.654 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.46 143.44 33.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.923 -0.769 . . . . 71.31 108.923 171.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.741 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 51.1 ttp -75.78 145.02 41.06 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.757 0.66 . . . . 74.22 112.516 -171.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.538 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 91.5 t80 -131.21 125.05 20.78 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.139 -0.937 . . . . 73.31 109.061 171.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.538 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 31.7 Cg_exo -60.63 153.3 52.87 Favored 'Cis proline' 0 C--N 1.348 0.541 0 C-N-CA 124.03 -1.238 . . . . 74.15 112.787 0.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.57 154.41 9.07 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.606 2.871 . . . . 74.42 113.127 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.14 147.61 94.73 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.071 2.514 . . . . 44.1 112.704 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.526 -0.75 . . . . 71.22 109.934 179.144 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.933 -0.395 . . . . 71.02 109.933 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.45 49.52 0.57 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.018 -0.611 . . . . 63.22 111.713 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 58.42 78.18 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.952 0.501 . . . . 61.04 111.419 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -160.42 133.68 6.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.1 -0.5 . . . . 75.4 111.038 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -147.95 101.56 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.758 -0.655 . . . . 74.32 110.482 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -113.22 122.17 46.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.377 -0.601 . . . . 74.21 109.377 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -153.05 -178.09 6.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.094 -0.503 . . . . 71.43 110.823 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -59.98 109.68 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.664 0.602 . . . . 73.02 112.073 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -171.17 112.23 0.36 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.729 -0.841 . . . . 64.13 108.729 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -90.11 103.33 16.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.635 0.731 . . . . 71.21 112.538 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.8 ptp -94.34 124.13 38.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.395 -0.82 . . . . 62.54 109.171 172.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.36 -39.04 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 111.761 0.282 . . . . 71.11 111.761 -174.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.28 176.63 5.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.894 0.378 . . . . 64.0 111.035 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -94.43 108.64 37.91 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 71.11 110.003 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.95 161.78 23.8 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.802 2.334 . . . . 63.32 112.733 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.43 148.43 79.22 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.67 2.246 . . . . 62.54 111.251 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -76.86 139.86 40.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.405 -0.361 . . . . 64.41 110.763 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.6 m -61.24 129.79 43.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.955 -0.566 . . . . 64.24 110.139 177.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.584 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 3.2 tmmm? -58.96 -30.5 67.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.499 -0.319 . . . . 72.41 110.562 -177.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.2 mp0 -54.9 -41.95 71.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.962 0.411 . . . . 75.21 110.223 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.509 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 18.0 m -77.42 -34.98 54.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.858 -0.61 . . . . 75.11 110.779 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.7 -42.44 95.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.3 0.571 . . . . 42.31 110.484 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -68.68 -37.48 79.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.687 -0.688 . . . . 71.33 110.968 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.63 -6.61 49.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.11 -0.495 . . . . 73.12 111.705 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.707 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 57.3 mt -63.68 125.34 87.37 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.681 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.431 ' O ' ' HA ' ' A' ' 57' ' ' THR . 19.4 Cg_endo -58.04 125.37 18.35 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.471 2.781 . . . . 64.22 113.228 -175.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -81.12 113.72 19.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.456 -0.793 . . . . 75.21 110.654 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.7 mt -112.56 109.42 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.279 -0.419 . . . . 72.44 110.101 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.92 118.29 10.19 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.908 -0.404 . . . . 62.03 109.908 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.451 ' CG1' ' HB3' ' A' ' 50' ' ' TYR . 53.0 t -81.63 128.96 38.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.166 0.508 . . . . 73.24 111.648 -173.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.46 HG21 ' HG3' ' A' ' 52' ' ' LYS . 17.0 p -126.01 138.16 53.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.376 -0.829 . . . . 73.05 109.269 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 52' ' ' LYS . 39.4 mt-10 -63.94 -10.7 22.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.357 . . . . 74.1 111.726 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.09 -33.11 74.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.89 -0.595 . . . . 75.44 109.759 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.489 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 40.3 t-80 -134.13 81.73 1.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.354 -0.839 . . . . 71.32 109.553 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.37 -36.07 31.59 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.917 -0.658 . . . . 74.54 112.942 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.37 86.0 6.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.25 0.548 . . . . 71.21 110.665 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.489 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 6.3 t -74.82 -23.73 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.685 -0.689 . . . . 71.14 110.302 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.07 -134.58 1.71 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.261 -0.736 . . . . 73.23 111.261 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -68.86 -42.41 77.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.463 0.649 . . . . 65.32 109.502 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -73.29 113.01 9.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.122 -0.945 . . . . 74.11 110.548 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -95.2 -5.05 44.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.644 0.735 . . . . 72.22 109.257 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.2 p -144.53 167.93 21.34 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.097 -0.956 . . . . 74.15 110.087 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 43.0 t -115.63 92.83 34.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.713 -0.477 . . . . 75.14 109.713 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.11 -28.14 86.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.979 2.453 . . . . 72.13 112.358 -177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.0 mt -56.16 -39.24 57.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.487 -0.779 . . . . 75.31 111.609 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.7 p -117.54 6.27 12.51 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.923 -0.311 . . . . 73.05 110.54 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.1 m 53.03 67.79 0.94 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.464 -0.789 . . . . 74.2 111.407 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 p -156.67 168.28 27.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.834 -0.621 . . . . 71.34 109.522 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.74 -170.0 2.75 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.4 -0.592 . . . . 73.42 109.4 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.571 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 61.6 m-85 -93.72 89.65 6.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.382 0.611 . . . . 71.14 110.773 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 m -85.94 158.12 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.101 -0.954 . . . . 75.41 111.251 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' HG3' HG21 ' A' ' 31' ' ' THR . 38.8 ttmt -73.34 120.46 18.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.984 -0.553 . . . . 75.0 110.547 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.85 -19.66 6.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.635 -0.793 . . . . 71.31 112.491 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -84.99 166.5 16.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.981 -0.748 . . . . 72.41 108.981 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.9 t -115.19 131.18 68.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.774 -0.454 . . . . 74.21 109.774 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.57 175.46 5.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.839 0.352 . . . . 62.31 110.654 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.707 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.6 t -151.61 160.79 43.51 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.817 -0.629 . . . . 73.35 109.933 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -107.71 126.76 52.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.474 . . . . 74.44 110.301 176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.2 mt -92.06 142.56 26.48 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 108.942 -0.762 . . . . 74.43 108.942 171.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.99 -10.61 12.85 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.203 2.602 . . . . 75.31 111.745 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.13 19.34 2.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.967 -1.015 . . . . 50.03 110.289 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 56.09 37.26 28.66 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.763 -0.653 . . . . 73.1 111.458 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -132.66 141.56 48.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.564 -0.744 . . . . 75.55 110.014 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -119.87 133.42 55.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.198 -0.456 . . . . 75.32 110.754 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.571 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 98.0 m-85 -143.84 168.1 20.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.983 -0.553 . . . . 74.11 109.841 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 33.1 m170 -64.02 128.17 34.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.299 -0.63 . . . . 72.1 109.299 171.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.473 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 64.1 tttp -56.77 -53.08 68.56 Favored Pre-proline 0 CA--C 1.535 0.386 0 O-C-N 123.342 0.401 . . . . 70.13 111.376 -177.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 12.2 Cg_endo -56.97 -45.3 37.14 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.16 1.906 . . . . 62.21 112.232 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 66.2 m -61.38 -48.73 79.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.122 -0.49 . . . . 54.42 111.357 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.521 HG21 ' HG ' ' A' ' 74' ' ' LEU . 7.7 p -69.82 -27.58 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 71.34 110.618 -175.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.8 m -61.98 -37.05 83.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 51.45 110.361 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.3 mt -66.65 -43.32 90.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.514 . . . . 75.41 110.131 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -68.94 -47.15 66.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.017 -0.538 . . . . 74.15 110.904 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.521 ' HG ' HG21 ' A' ' 70' ' ' VAL . 94.4 mt -60.77 -36.39 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.105 0.409 . . . . 74.44 112.105 -175.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.26 -12.71 61.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.715 0.293 . . . . 74.4 111.184 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -98.77 -50.89 4.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.333 0.587 . . . . 62.32 109.593 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.7 p -151.77 113.3 4.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.383 -0.826 . . . . 72.14 109.858 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.92 85.92 0.38 Allowed Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.946 -0.645 . . . . 71.23 112.613 -176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 2.0 p -149.36 161.79 41.37 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.313 0.245 . . . . 73.13 111.271 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.762 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 95.8 m -79.24 120.52 80.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.32 -0.993 . . . . 73.31 108.32 165.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.46 -14.52 25.72 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.308 2.006 . . . . 71.53 113.044 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.23 -43.47 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.307 -0.406 . . . . 75.44 112.005 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.3 p -105.88 -17.35 14.39 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.809 -0.356 . . . . 71.41 111.599 -172.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 63.69 23.55 13.55 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.177 0.591 . . . . 73.52 111.973 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 79' ' ' THR . 34.6 t -89.05 155.53 19.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.219 -0.66 . . . . 72.34 109.219 173.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.53 ' HE1' ' HB3' ' A' ' 90' ' ' PRO . 25.7 ttm -82.28 149.61 27.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.556 0.576 . . . . 75.33 112.556 -167.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.496 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 66.0 t80 -136.93 120.22 11.89 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 114.934 -1.03 . . . . 73.13 108.803 168.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.496 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 34.0 Cg_endo -62.85 152.76 68.5 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 123.863 -1.307 . . . . 74.32 112.572 2.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.23 142.65 55.44 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.147 2.565 . . . . 72.34 112.944 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HB3' ' HE1' ' A' ' 86' ' ' MET . 39.4 Cg_endo -67.61 147.56 76.55 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.86 2.374 . . . . 72.35 112.232 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.42 -0.8 . . . . 62.35 110.255 -179.7 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.159 -0.311 . . . . 63.03 110.159 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.25 -76.09 0.24 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.84 -0.695 . . . . 74.11 112.154 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -108.54 -169.89 1.58 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.624 0.25 . . . . 75.03 110.513 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -93.13 169.85 10.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.0 0.429 . . . . 73.41 111.245 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -115.47 145.49 42.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.494 -0.928 . . . . 73.5 108.494 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.59 103.89 1.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.041 0.448 . . . . 74.0 110.606 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -77.99 153.96 31.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.549 -0.751 . . . . 73.33 110.278 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -79.74 115.75 19.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.058 0.456 . . . . 74.05 110.996 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 m -67.84 109.57 3.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.982 -0.553 . . . . 74.21 109.914 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -100.05 -31.07 11.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.814 -0.354 . . . . 75.32 110.495 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.4 ttp 69.57 -63.3 0.39 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.858 0.724 . . . . 44.24 111.854 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.53 137.88 22.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.252 0.549 . . . . 74.0 111.234 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.37 148.71 47.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.518 -0.765 . . . . 75.31 109.27 173.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -74.0 134.25 78.01 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.201 -0.296 . . . . 60.5 110.201 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.1 Cg_endo -48.67 147.64 9.44 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.497 2.798 . . . . 74.33 113.071 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 23.9 Cg_exo -64.27 152.28 81.95 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.934 2.423 . . . . 75.23 111.858 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -84.08 166.67 17.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.888 0.375 . . . . 42.12 110.831 -177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.421 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.3 p -87.24 144.31 26.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.072 -0.513 . . . . 72.4 110.574 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -62.47 -36.02 81.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 74.43 111.168 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.6 -28.48 69.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.022 -0.535 . . . . 61.13 111.131 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 t -82.94 -24.62 32.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.383 -0.372 . . . . 72.13 110.19 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 18' ' ' SER . 60.0 mt -79.76 -38.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.309 0.576 . . . . 74.33 110.304 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.04 -27.68 63.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.736 -0.666 . . . . 71.45 110.882 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.08 -4.36 55.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.52 111.871 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.496 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 64.3 mt -63.7 131.43 94.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.567 -0.288 . . . . 71.34 111.069 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.84 141.18 77.14 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.774 2.316 . . . . 71.53 112.094 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -104.7 119.09 38.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.184 0.516 . . . . 74.43 110.913 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 56' ' ' ALA . 65.4 mt -112.29 120.82 63.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.47 -0.786 . . . . 72.03 110.082 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.9 tp -74.61 122.54 23.32 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.94 -0.392 . . . . 75.11 109.94 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 43.1 t -92.13 127.46 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.863 0.363 . . . . 73.4 111.337 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.4 p -128.19 172.84 10.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.687 -0.688 . . . . 74.53 110.022 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -76.9 -10.16 59.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.795 0.331 . . . . 75.34 110.7 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -84.78 -10.21 57.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.168 -0.469 . . . . 73.12 110.186 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.487 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 21.1 t-80 -149.56 61.92 1.01 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.085 0.469 . . . . 71.51 110.349 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.36 -43.34 79.15 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.77 -0.65 . . . . 75.03 111.513 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.59 98.76 6.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.765 -0.457 . . . . 61.44 109.765 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.487 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 14.0 t -82.72 -20.81 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.254 0.549 . . . . 75.24 110.229 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.73 -140.38 2.87 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.178 -0.769 . . . . 50.42 111.178 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.81 -26.35 64.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.053 0.454 . . . . 74.55 110.071 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -111.68 160.75 16.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.775 -0.648 . . . . 72.53 110.269 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -141.13 13.09 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.331 . . . . 75.12 111.267 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 71.6 m -132.42 140.07 48.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.5 -0.318 . . . . 74.42 110.704 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.7 t -103.3 100.15 17.14 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.636 -0.505 . . . . 52.11 109.636 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -63.61 -24.76 69.59 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.921 2.414 . . . . 71.22 112.724 -175.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.4 mt -61.14 -35.24 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.073 -0.512 . . . . 51.41 110.916 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 28.2 p -112.95 10.85 18.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.41 . . . . 74.13 109.918 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.0 p 40.33 51.76 2.82 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.174 0.921 . . . . 74.42 111.911 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.1 m -150.75 150.13 30.64 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.993 -0.548 . . . . 74.0 110.103 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 13.1 pt-20 -77.92 -169.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.123 0.487 . . . . 73.23 110.955 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.437 ' HB3' HG13 ' A' ' 30' ' ' VAL . 45.4 m-85 -90.12 113.07 24.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.193 0.521 . . . . 74.24 111.433 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.44 162.4 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.318 -0.856 . . . . 65.4 110.473 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 39.5 ttmt -65.84 128.52 36.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.115 -0.493 . . . . 72.52 110.934 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.49 -24.01 11.7 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.709 -0.757 . . . . 74.31 112.873 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -82.55 159.22 22.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.739 -0.467 . . . . 62.41 109.739 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.09 119.22 57.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.488 -0.324 . . . . 72.45 110.474 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -97.85 168.27 10.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.393 -0.367 . . . . 74.35 110.955 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 14.6 t -152.59 156.8 40.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.902 -0.59 . . . . 73.43 109.717 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -116.73 118.57 32.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.78 0.324 . . . . 72.12 110.496 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.96 148.67 81.97 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.138 -0.69 . . . . 75.53 109.138 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.79 -9.72 10.23 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.899 2.399 . . . . 70.33 112.067 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.3 9.15 11.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.364 -0.835 . . . . 74.23 109.938 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m170 58.85 37.43 24.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.838 -0.619 . . . . 62.54 111.469 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -121.07 145.06 48.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.741 -0.663 . . . . 74.14 109.495 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -114.09 132.8 55.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.253 0.549 . . . . 75.05 111.609 -172.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.9 175.41 10.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.279 -0.873 . . . . 73.23 108.721 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.728 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 37.4 m80 -87.07 135.46 33.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.8 -0.815 . . . . 75.33 108.8 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.487 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.0 tttt -59.48 -50.19 88.46 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.308 0.38 . . . . 75.43 111.841 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.6 Cg_endo -60.87 -18.51 57.15 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.03 1.82 . . . . 63.44 112.911 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.728 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 64.5 m -83.9 -53.03 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.225 0.536 . . . . 64.34 110.865 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.542 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 p -70.38 -27.25 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.54 -0.755 . . . . 74.22 111.216 -172.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.555 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 6.4 p -61.16 -32.34 72.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.467 -0.333 . . . . 71.31 111.193 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.0 mt -74.99 -44.45 44.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.177 0.513 . . . . 71.31 110.272 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -62.23 -43.93 97.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.598 -0.728 . . . . 75.42 111.182 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 91.7 mt -65.19 -23.9 67.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 55.41 111.687 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.6 mt-30 -73.94 -15.26 61.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 74.43 110.884 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -106.18 -43.81 4.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.342 0.591 . . . . 71.51 109.99 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.9 p -153.32 114.62 4.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.441 -0.799 . . . . 53.31 110.397 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.87 81.35 1.02 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.558 -0.829 . . . . 74.05 112.124 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.4 164.51 34.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.507 0.194 . . . . 64.11 111.495 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.619 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 68.5 m -74.87 116.82 57.51 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 107.953 -1.128 . . . . 71.44 107.953 162.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.63 -17.29 27.91 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 122.492 2.128 . . . . 74.31 112.526 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.23 -57.44 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.78 -0.645 . . . . 74.21 111.767 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.9 p -94.48 -12.67 27.25 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.36 0.504 . . . . 75.25 112.36 -169.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 83' ' ' CYS . 20.8 mmt180 74.24 4.9 4.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.004 0.521 . . . . 74.12 112.015 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.4 t -73.22 145.23 46.37 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.164 -0.214 . . . . 61.5 110.425 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.512 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 36.0 ttm -74.34 145.84 43.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 63.22 112.438 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.426 ' CZ ' HD22 ' A' ' 25' ' ' LEU . 74.1 t80 -128.8 121.43 20.98 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.409 -0.814 . . . . 73.44 109.85 171.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.07 157.41 99.55 Favored 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.999 -1.667 . . . . 73.42 111.731 -1.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.56 142.33 31.26 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.83 2.353 . . . . 64.24 112.508 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 28.5 Cg_endo -62.62 152.08 79.87 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.001 2.467 . . . . 64.11 112.185 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.541 -0.742 . . . . 73.32 110.187 -177.236 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.737 0.303 . . . . 74.12 111.101 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.25 -178.77 32.59 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.411 -0.676 . . . . 52.13 111.411 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -126.02 -57.48 1.42 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.915 0.357 . . . . 75.02 110.64 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.7 t60 57.0 71.6 0.56 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.812 -0.631 . . . . 73.52 111.353 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -143.59 147.76 34.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.844 -0.799 . . . . 75.31 108.844 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -79.87 156.8 27.16 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.702 -0.851 . . . . 64.33 108.702 174.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -70.21 119.05 13.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.868 0.366 . . . . 73.52 110.646 -173.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -80.23 88.12 5.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.896 -0.593 . . . . 75.14 110.537 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 m -139.28 163.66 31.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.957 -0.565 . . . . 71.3 110.12 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -154.77 107.59 2.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.222 -0.445 . . . . 65.11 109.917 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.613 ' HB2' ' HB3' ' A' ' 84' ' ' ARG . 25.5 mmt -112.6 137.43 50.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.039 -0.528 . . . . 74.04 110.192 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 p -150.79 -27.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.095 -0.502 . . . . 75.34 110.744 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.85 120.89 12.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.648 0.261 . . . . 61.34 110.381 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.57 134.0 13.94 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 110.081 -0.34 . . . . 73.31 110.081 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.64 153.03 25.26 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.17 2.58 . . . . 45.31 112.392 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.47 163.0 34.18 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.923 2.416 . . . . 71.13 112.754 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.83 177.57 6.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.105 -0.498 . . . . 71.13 110.694 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -90.25 143.05 27.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.371 -0.377 . . . . 73.43 109.987 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -57.09 -39.59 75.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.932 0.396 . . . . 72.31 110.618 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.66 -23.8 60.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 71.51 111.243 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.8 m -77.19 -31.04 55.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.999 0.428 . . . . 74.54 109.948 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.9 mt -78.38 -40.86 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 75.43 109.968 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.03 -35.8 73.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.888 -0.596 . . . . 73.22 110.607 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.28 -4.02 48.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.733 -0.667 . . . . 75.15 112.156 -176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.561 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 74.1 mt -65.89 126.34 91.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.66 0.266 . . . . 71.44 110.349 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.03 136.27 64.31 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.958 2.439 . . . . 64.34 112.324 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.83 113.4 26.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.128 -0.487 . . . . 75.53 110.193 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.5 mt -114.72 132.45 63.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.849 -0.614 . . . . 73.42 110.01 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 47.9 tp -86.81 116.7 25.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.166 -0.309 . . . . 70.12 110.166 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.605 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 54.0 t -71.21 135.74 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.29 -0.414 . . . . 73.31 109.893 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.8 p -128.64 172.83 10.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.271 -0.422 . . . . 72.45 110.423 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' ' HE3' ' A' ' 52' ' ' LYS . 42.5 mm-40 -70.34 -25.13 63.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 75.3 111.152 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.95 -7.08 58.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 60.31 111.131 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.671 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 59.9 t-80 -153.18 64.6 0.77 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.712 -0.477 . . . . 65.12 109.712 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.1 -59.61 7.26 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.81 -0.632 . . . . 75.1 112.297 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.28 92.81 1.82 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.056 0.455 . . . . 61.42 109.93 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.671 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 6.4 t -63.26 -49.33 83.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 74.33 109.894 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.11 -138.88 5.1 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.655 -1.378 . . . . 75.14 109.655 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.86 -11.41 59.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.611 0.705 . . . . 75.43 109.532 171.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -83.5 100.16 10.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 75.22 110.161 171.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -91.33 -12.5 34.8 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.603 0.716 . . . . 75.44 109.208 172.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 57.2 m -138.24 131.29 30.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.035 -0.984 . . . . 75.04 109.29 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.6 t -70.93 109.09 4.51 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 123.342 0.401 . . . . 71.1 110.018 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.71 -24.47 74.78 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.782 2.322 . . . . 75.35 112.185 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.83 -25.7 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.259 0.552 . . . . 71.02 110.675 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 40.0 m -117.46 2.3 12.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.174 -0.466 . . . . 70.22 110.879 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p 42.79 35.78 0.76 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.657 0.783 . . . . 62.55 111.674 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.4 t -136.43 148.14 47.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.97 -0.559 . . . . 42.04 110.036 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.704 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 9.9 pt-20 -79.21 168.56 19.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.565 0.58 . . . . 73.24 112.565 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.57 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.2 m-85 -98.02 130.35 44.85 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 75.4 110.666 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -132.7 177.87 6.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.016 -0.365 . . . . 64.11 110.016 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 40.0 ttmt -60.06 113.06 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 74.42 110.878 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.25 -11.02 7.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.623 . . . . 37.71 112.06 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.53 131.94 36.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.853 0.359 . . . . 72.53 111.088 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -88.07 110.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.212 -0.449 . . . . 73.42 109.956 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.1 155.66 22.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.086 -0.507 . . . . 71.03 110.394 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.9 t -132.43 159.3 39.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.065 -0.516 . . . . 74.13 109.839 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -109.3 123.07 48.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.918 0.39 . . . . 74.44 111.469 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.9 mt -87.05 140.03 32.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.319 -0.993 . . . . 71.01 108.319 167.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.69 -13.02 7.43 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.304 2.669 . . . . 73.11 113.802 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.2 p -90.42 19.88 4.92 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.801 0.334 . . . . 64.34 110.71 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 60.32 54.63 3.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.91 -0.586 . . . . 74.23 112.034 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -142.3 141.29 32.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.834 -0.621 . . . . 73.12 109.373 174.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -120.39 133.47 55.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.406 0.622 . . . . 75.14 111.934 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.57 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 65.2 m-85 -139.26 175.17 9.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.298 -0.864 . . . . 74.32 108.754 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.818 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 40.4 m80 -76.45 132.14 39.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.302 -0.999 . . . . 72.12 108.302 173.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.561 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 85.5 tttt -56.25 -48.96 95.88 Favored Pre-proline 0 C--N 1.32 -0.688 0 O-C-N 123.301 0.376 . . . . 75.4 111.913 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 7.2 Cg_endo -50.45 -51.38 11.14 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.454 2.103 . . . . 64.32 113.426 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.818 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 18.9 p -77.1 -30.46 55.33 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.627 -0.429 . . . . 74.25 111.815 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 67' ' ' LYS . 5.4 p -70.75 -26.48 28.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 120.329 -0.548 . . . . 70.34 109.752 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 41.3 m -60.84 -48.23 82.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.641 -0.503 . . . . 73.33 109.641 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.418 HG22 ' HE3' ' A' ' 76' ' ' LYS . 42.7 mt -62.75 -40.51 88.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.609 -0.723 . . . . 63.3 110.625 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -66.49 -50.96 61.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.004 -0.544 . . . . 74.31 111.126 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.9 mt -66.09 -20.91 66.31 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.143 0.424 . . . . 75.21 112.143 -175.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.9 mt-30 -79.44 -8.3 59.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 72.32 110.785 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HE3' HG22 ' A' ' 72' ' ' ILE . 10.1 mtmp? -114.43 -34.26 5.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.368 -0.378 . . . . 72.52 110.792 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 t -148.33 127.51 12.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.812 -0.44 . . . . 73.45 109.812 178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.56 47.06 3.01 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.691 -0.766 . . . . 74.42 112.653 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.29 149.5 49.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.028 0.442 . . . . 71.23 111.318 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 38.6 t -74.65 114.36 33.43 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.471 -0.786 . . . . 65.15 109.512 175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -57.24 -22.46 48.86 Favored 'Trans proline' 0 N--CA 1.474 0.326 0 C-N-CA 122.712 2.274 . . . . 70.05 112.84 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.7 t -82.86 -31.89 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.301 0.482 . . . . 60.25 112.301 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.0 p -130.27 -11.6 4.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.686 0.625 . . . . 45.21 112.686 -173.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.613 ' HB3' ' HB2' ' A' ' 11' ' ' MET . 0.4 OUTLIER 70.49 13.44 7.42 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.489 0.716 . . . . 72.32 111.832 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.8 t -73.08 144.07 47.18 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.152 -0.684 . . . . 70.13 109.152 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 60.9 ttp -79.12 151.57 31.28 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.369 0.418 . . . . 54.31 111.047 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -126.42 119.59 23.26 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.84 -0.618 . . . . 62.44 109.537 173.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.48 156.0 92.23 Favored 'Cis proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.45 -1.479 . . . . 63.12 112.399 -0.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.01 155.14 46.28 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.103 2.535 . . . . 65.43 112.798 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.46 -173.21 1.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.677 2.251 . . . . 64.21 112.178 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.375 -0.821 . . . . 62.42 110.394 -179.01 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 ttp . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 120.696 0.284 . . . . 52.33 110.326 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.46 -109.85 2.58 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.123 -0.489 . . . . 64.11 112.747 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -77.04 165.06 25.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.894 0.378 . . . . 74.13 110.626 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -79.08 104.27 9.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.909 -0.774 . . . . 72.22 108.909 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -68.63 112.22 5.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.148 -0.478 . . . . 74.14 110.915 -176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -77.4 69.0 3.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.672 0.749 . . . . 74.34 109.552 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -116.18 3.33 13.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.049 -0.978 . . . . 72.24 108.59 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -125.53 148.52 48.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.672 -1.149 . . . . 72.43 109.185 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 t -120.31 -24.75 5.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.008 0.433 . . . . 75.31 110.256 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -133.28 146.76 51.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 73.03 110.598 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 86.9 mtp -84.74 117.12 23.63 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.451 -0.574 . . . . 61.23 109.451 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.547 HG11 ' HG2' ' A' ' 84' ' ' ARG . 24.9 m -90.09 -18.14 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.503 -0.317 . . . . 75.15 111.658 -174.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.53 105.88 17.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.97 0.414 . . . . 74.22 110.769 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.508 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 17.7 p-10 -135.13 162.25 58.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.981 -0.554 . . . . 73.44 110.191 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 14' ' ' ASN . 21.5 Cg_endo -61.37 151.98 75.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.581 2.188 . . . . 73.31 112.358 176.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.15 162.79 40.68 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.623 2.215 . . . . 70.11 112.127 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.87 143.61 26.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.256 -0.429 . . . . 61.33 110.277 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -70.92 147.67 48.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.952 -0.388 . . . . 72.13 109.952 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -53.02 -38.38 62.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.306 -0.407 . . . . 72.21 111.267 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.4 -42.49 91.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.875 -0.602 . . . . 64.54 111.901 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.5 m -70.66 -34.41 71.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.109 0.481 . . . . 74.44 110.714 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.444 HG21 ' HA ' ' A' ' 71' ' ' SER . 68.6 mt -72.81 -42.85 61.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.978 -0.555 . . . . 64.25 111.059 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.3 -21.72 62.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.222 -0.445 . . . . 74.0 110.508 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.74 -3.89 54.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 71.03 111.622 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.438 HD11 HG22 ' A' ' 57' ' ' THR . 25.2 mt -56.52 135.32 77.11 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.602 -0.272 . . . . 73.22 111.379 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.39 129.99 36.85 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.137 2.558 . . . . 75.12 111.722 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -98.26 111.66 23.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.089 0.471 . . . . 71.43 110.732 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -112.71 109.99 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.588 -0.733 . . . . 74.42 109.758 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.79 123.52 20.37 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.514 -0.55 . . . . 74.45 109.514 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 47.2 t -74.18 114.38 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.046 0.451 . . . . 55.44 110.669 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.9 p -115.3 131.82 56.81 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.653 -0.703 . . . . 73.1 109.87 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.496 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 53.2 mt-10 -66.58 -13.97 61.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 64.42 111.251 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.23 -29.28 70.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.336 0.589 . . . . 74.03 110.012 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -92.7 -16.9 24.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.277 -0.874 . . . . 73.43 110.092 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.54 -113.72 4.36 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.41 -0.676 . . . . 75.53 111.41 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.66 132.01 40.3 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.7 -0.482 . . . . 74.43 109.7 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.57 -31.67 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.247 0.546 . . . . 64.25 110.217 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.502 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . -164.37 -118.23 0.44 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.176 -0.77 . . . . 74.22 111.176 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -64.45 -55.06 23.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.311 0.577 . . . . 74.0 110.435 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 142.02 28.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.417 -0.81 . . . . 71.22 111.702 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 ptp -112.73 7.37 18.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.496 -0.775 . . . . 72.45 109.545 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 19.6 p -126.6 149.55 49.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.401 -0.818 . . . . 74.04 109.926 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.3 t -110.32 101.01 46.83 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.042 -0.355 . . . . 65.43 110.042 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -54.41 -31.98 70.69 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.412 2.741 . . . . 65.15 112.583 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.2 -34.74 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.952 -0.567 . . . . 72.21 110.883 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.0 m -98.46 -18.9 17.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 74.35 111.354 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.2 m 65.89 22.23 11.37 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.444 0.64 . . . . 74.54 110.032 -172.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -130.51 175.43 8.99 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.264 -0.88 . . . . 74.11 109.524 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 8.5 pt-20 -98.96 -175.24 2.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.048 0.452 . . . . 74.32 111.477 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.519 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 56.0 m-85 -100.89 120.23 39.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.966 -0.561 . . . . 75.21 110.591 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.5 m -127.29 169.35 18.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.895 -0.593 . . . . 64.11 110.783 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 33.7 ttmt -74.36 110.92 9.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.886 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.61 -26.85 2.63 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.785 -0.721 . . . . 72.34 112.413 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -86.86 160.94 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.816 -0.439 . . . . 64.12 109.816 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -108.06 126.55 64.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.905 0.383 . . . . 64.15 110.711 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.05 170.7 7.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.174 -0.467 . . . . 72.1 110.567 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.438 HG22 HD11 ' A' ' 25' ' ' LEU . 13.5 t -148.98 156.65 42.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.06 -0.518 . . . . 63.1 109.647 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -110.55 117.47 33.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.49 -0.323 . . . . 74.32 110.376 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.9 mt -75.4 156.16 85.47 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.967 -0.753 . . . . 71.34 108.967 172.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.41 -23.82 14.89 Favored 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.095 2.53 . . . . 74.5 113.56 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.6 p -90.76 15.49 11.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.462 0.171 . . . . 71.43 111.462 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 44.8 m80 67.29 24.68 8.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.911 0.485 . . . . 74.35 112.061 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -102.83 133.25 48.21 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.741 -0.466 . . . . 72.34 109.741 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.502 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 80.5 m-85 -105.63 133.28 50.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.171 -0.468 . . . . 73.33 112.011 -171.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.519 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 99.2 m-85 -138.02 175.31 9.7 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.522 -0.918 . . . . 74.42 108.522 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.867 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.6 m80 -84.02 128.28 34.44 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.864 -0.791 . . . . 74.21 108.864 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.519 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 89.0 tttt -53.35 -48.32 92.99 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 123.578 0.549 . . . . 72.33 111.828 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 73.1 Cg_exo -53.47 -47.31 28.04 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 122.334 2.023 . . . . 74.23 113.801 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.867 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 25.8 p -82.79 -36.92 25.22 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.773 -0.371 . . . . 63.51 111.942 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.46 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 8.7 p -68.39 -24.99 30.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.77 -0.455 . . . . 74.1 109.77 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.528 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 47.5 t -55.07 -50.57 68.81 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.684 -0.689 . . . . 72.42 110.626 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.7 mt -66.0 -38.76 82.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 74.41 110.507 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -62.85 -47.1 84.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.922 -0.581 . . . . 73.4 110.634 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 97.1 mt -66.22 -29.26 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 75.13 111.258 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 71' ' ' SER . 78.6 mt-30 -71.24 -13.41 61.9 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.865 0.364 . . . . 73.45 110.73 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -101.82 -45.05 5.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 72.11 110.12 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.2 p -153.19 119.9 5.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.759 -0.655 . . . . 53.14 109.897 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.16 66.14 3.85 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.656 -0.783 . . . . 71.33 112.668 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.31 144.35 34.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.804 0.335 . . . . 72.22 111.241 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.01 104.74 1.46 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.995 -0.548 . . . . 63.33 109.78 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -48.37 -37.15 32.04 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.67 2.913 . . . . 75.05 114.322 -168.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.2 -28.42 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.304 0.483 . . . . 74.54 112.304 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.3 p -127.4 -26.74 3.0 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.986 -0.447 . . . . 51.52 111.801 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.547 ' HG2' HG11 ' A' ' 12' ' ' VAL . 5.1 tpt180 79.86 18.99 0.66 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.558 1.143 . . . . 75.42 110.635 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.2 t -69.0 138.34 54.43 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.605 -0.887 . . . . 75.05 108.605 169.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.52 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 41.1 ttm -80.8 148.42 30.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.966 0.413 . . . . 65.4 111.794 -171.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -133.65 116.5 13.84 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.705 -0.68 . . . . 74.54 109.448 172.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.05 151.95 96.44 Favored 'Cis proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.271 -1.554 . . . . 50.45 111.82 -0.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -50.08 147.64 14.94 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.272 2.648 . . . . 74.13 112.384 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 38.7 Cg_endo -65.28 149.63 88.27 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.363 2.042 . . . . 62.52 112.012 -174.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.873 -0.584 . . . . 73.44 110.213 -177.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.718 0.294 . . . . 74.31 110.824 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.8 -73.11 0.49 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.954 -0.859 . . . . 52.35 110.954 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -113.62 -170.62 1.73 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.384 -0.598 . . . . 70.55 109.384 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -117.34 51.13 1.04 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.665 0.745 . . . . 72.42 110.018 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -72.02 128.88 37.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.943 -1.026 . . . . 74.41 109.679 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -107.42 115.76 30.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.854 0.359 . . . . 72.44 111.024 -175.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -93.03 165.3 12.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.467 -0.568 . . . . 61.31 109.467 173.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -74.63 145.82 42.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.76 -0.459 . . . . 73.51 109.76 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.9 p -56.9 103.8 0.13 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.441 0.534 . . . . 64.01 112.441 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -158.62 119.39 3.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.079 -0.711 . . . . 73.43 109.079 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.8 ttt -88.53 115.18 25.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.947 -0.57 . . . . 71.34 111.284 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.15 124.15 72.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.903 -0.59 . . . . 55.12 109.703 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.64 -54.35 8.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.426 -0.352 . . . . 62.41 111.865 -174.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -128.96 157.57 75.35 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.533 -0.303 . . . . 74.41 111.086 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -57.68 151.15 57.13 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.914 2.41 . . . . 64.15 111.87 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 155.43 61.87 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.644 2.229 . . . . 72.43 112.752 -175.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.92 144.76 26.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.898 -0.592 . . . . 52.41 110.641 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.3 m -65.52 145.02 56.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.978 -0.555 . . . . 74.15 110.882 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -58.22 -45.06 88.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 71.54 110.924 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -48.8 -48.12 41.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.745 -0.661 . . . . 71.24 111.259 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.0 m -67.88 -34.22 76.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 73.22 111.338 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.4 mt -72.94 -44.51 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.278 0.561 . . . . 71.03 110.393 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -62.96 -35.52 80.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.782 -0.645 . . . . 74.41 110.705 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.01 5.2 17.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.801 -0.636 . . . . 65.54 112.184 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 74.2 mt -69.69 142.28 91.18 Favored Pre-proline 0 C--O 1.237 0.419 0 N-CA-C 110.252 -0.277 . . . . 73.02 110.252 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.25 149.0 91.09 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.955 2.437 . . . . 72.2 112.353 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -113.04 105.81 13.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 70.44 110.451 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.7 mt -100.08 121.69 51.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.93 -0.577 . . . . 75.31 110.016 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.6 tp -81.2 122.29 27.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.835 0.35 . . . . 62.22 110.467 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 47.0 t -88.43 134.3 28.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.248 -0.433 . . . . 75.11 110.212 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.2 p -113.35 172.81 6.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.656 -0.702 . . . . 70.04 110.831 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.508 ' HG2' ' HE3' ' A' ' 52' ' ' LYS . 5.7 mm-40 -59.39 134.39 56.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.409 -0.359 . . . . 63.14 110.776 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.0 t70 53.44 74.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.322 -0.853 . . . . 73.32 110.579 -172.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -165.22 29.51 0.06 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.126 -0.943 . . . . 73.15 108.785 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 41' ' ' MET . . . -59.82 -36.65 90.67 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.468 -0.787 . . . . 53.14 111.628 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.59 84.27 5.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.31 0.576 . . . . 74.33 110.046 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.9 t -75.23 -23.25 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.571 -0.741 . . . . 71.42 109.986 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.45 -126.3 0.82 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.001 -0.84 . . . . 74.44 111.001 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.84 -3.5 41.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.342 0.591 . . . . 62.22 110.255 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -120.24 153.5 36.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.476 -0.784 . . . . 72.12 109.898 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.6 pmm? -134.92 9.79 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.113 -0.494 . . . . 71.54 110.262 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.6 p -147.61 151.01 35.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.149 -0.478 . . . . 60.35 111.045 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 37.4 t -101.49 100.96 15.29 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.488 -0.778 . . . . 72.33 109.296 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 16.3 Cg_endo -57.44 -31.62 91.78 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.931 2.421 . . . . 54.22 112.564 -176.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -60.95 -27.03 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 74.4 110.944 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.6 m -110.24 -15.35 14.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.33 -0.395 . . . . 75.43 111.103 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.0 m 58.32 45.1 17.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.186 -0.461 . . . . 61.31 109.964 -172.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.3 t -154.41 175.1 13.98 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.814 -0.63 . . . . 62.31 109.734 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -101.89 -169.87 1.74 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.743 0.306 . . . . 74.3 111.705 -173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.509 ' HB3' HG13 ' A' ' 30' ' ' VAL . 94.9 m-85 -111.07 134.18 52.87 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.077 -0.51 . . . . 75.54 110.781 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.9 m -136.89 -179.6 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.328 -0.397 . . . . 75.53 110.62 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.8 ttmt -56.73 133.28 53.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.058 0.456 . . . . 62.13 111.168 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.9 -8.65 59.65 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.798 -0.715 . . . . 71.32 112.04 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -78.58 129.11 34.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.833 0.349 . . . . 75.13 111.311 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.19 102.06 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.63 . . . . 54.04 109.463 174.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.69 162.76 13.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.827 -0.624 . . . . 75.21 110.458 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 10.5 t -140.58 155.48 46.56 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.655 -0.498 . . . . 74.13 109.655 178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -116.02 117.54 30.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 51.22 110.64 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -79.29 150.2 73.64 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.988 -0.551 . . . . 72.43 109.88 176.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.8 -14.99 24.39 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.313 2.675 . . . . 72.3 113.083 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.4 p -87.24 10.99 15.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.249 -0.278 . . . . 74.23 110.249 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 62.24 77.79 0.32 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.731 -0.668 . . . . 65.32 111.161 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -160.94 149.64 16.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.258 -0.883 . . . . 72.32 109.226 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.75 132.87 55.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.943 0.402 . . . . 73.53 111.662 -173.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.469 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 91.6 m-85 -141.51 175.29 9.8 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.101 -0.703 . . . . 63.2 109.101 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.885 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 40.5 m80 -81.43 131.7 35.29 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.152 -1.055 . . . . 72.35 108.152 172.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 87.5 tttt -56.13 -49.94 90.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 O-C-N 123.334 0.396 . . . . 74.04 112.018 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 51.0 Cg_exo -56.9 -46.78 26.89 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.005 1.804 . . . . 73.53 113.537 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.885 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 25.1 p -74.57 -32.44 62.4 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.586 -0.446 . . . . 64.5 111.615 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.428 HG12 ' O ' ' A' ' 67' ' ' LYS . 7.5 p -73.01 -24.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.494 -0.483 . . . . 70.35 109.788 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.7 m -60.83 -43.07 98.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 72.35 110.431 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.05 -42.95 89.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 60.44 110.351 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.64 -46.24 83.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.641 -0.709 . . . . 75.24 111.42 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.37 -22.21 65.58 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.866 0.321 . . . . 75.4 111.866 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -81.15 -7.17 59.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.105 0.479 . . . . 74.22 110.714 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -109.82 -52.15 2.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.79 -0.641 . . . . 73.22 110.452 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.9 t -142.96 115.99 8.86 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.634 -0.506 . . . . 70.32 109.634 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.474 ' C ' ' HG1' ' A' ' 79' ' ' THR . . . -75.5 72.09 1.76 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.92 -0.657 . . . . 63.54 112.226 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.474 ' HG1' ' C ' ' A' ' 78' ' ' GLY . 1.7 m -147.11 137.49 23.46 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.901 -0.407 . . . . 63.31 109.901 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.5 t -74.77 110.03 8.82 Favored Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 109.137 -0.69 . . . . 71.33 109.137 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.69 -33.65 60.5 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 122.989 2.46 . . . . 74.14 113.832 -170.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.9 t -73.52 -53.31 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.266 0.469 . . . . 64.13 112.266 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.7 p -101.44 -16.32 16.89 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.84 -0.344 . . . . 71.32 111.433 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 71.2 mtt180 69.18 23.93 6.21 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.589 -0.732 . . . . 70.2 111.993 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.6 m -80.91 149.27 29.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 74.52 109.355 170.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.5 ttp -76.39 143.67 40.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.247 -0.433 . . . . 75.25 111.871 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.632 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 78.2 t80 -137.42 126.71 15.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.924 -0.769 . . . . 75.14 108.924 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.632 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 51.7 Cg_exo -56.07 147.66 23.58 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.623 -0.99 . . . . 41.11 113.366 2.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.29 151.12 70.04 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.243 2.629 . . . . 53.22 112.596 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -70.42 178.79 4.61 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.677 2.252 . . . . 65.01 112.432 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.564 -0.744 . . . . 75.15 110.602 -179.234 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.7 mtp . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.003 -0.369 . . . . 75.22 110.003 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.68 -7.01 49.05 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.939 -0.648 . . . . 73.13 111.937 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -73.45 102.13 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 74.13 110.115 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.421 ' HD2' ' O ' ' A' ' 5' ' ' HIS . 3.4 t-160 -117.82 111.39 19.0 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.994 -0.548 . . . . 74.43 110.316 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.421 ' O ' ' HD2' ' A' ' 4' ' ' HIS . 51.0 t-80 -69.89 137.65 51.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.416 -0.587 . . . . 75.31 109.416 176.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -100.64 136.83 39.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.794 0.331 . . . . 74.25 111.059 -171.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -130.11 99.31 5.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.718 -0.674 . . . . 74.32 109.497 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -62.34 107.7 0.96 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 74.32 110.917 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.0 p -154.42 160.67 41.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 73.24 110.097 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -66.2 129.63 40.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.31 . . . . 75.41 110.644 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 89.2 mmm -90.19 85.15 6.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.061 0.458 . . . . 72.12 110.772 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.53 136.89 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.979 -0.555 . . . . 75.42 110.135 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.4 92.9 5.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.082 0.468 . . . . 64.12 110.237 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -75.74 138.26 70.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.58 -0.737 . . . . 73.15 110.455 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.15 157.88 12.94 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.215 2.61 . . . . 73.54 112.817 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.13 165.67 27.63 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.738 2.292 . . . . 63.43 112.745 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -90.17 154.01 20.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.793 -0.639 . . . . 50.24 110.433 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -70.2 135.73 49.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.453 -0.339 . . . . 63.01 110.567 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 5.5 tmmm? -58.87 -38.15 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.925 -0.579 . . . . 73.21 110.984 -176.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -59.31 -46.3 88.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.927 -0.579 . . . . 74.55 110.535 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.8 m -63.59 -34.16 77.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 61.14 110.632 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.04 -43.53 76.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.607 . . . . 73.14 110.413 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -66.54 -37.38 84.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.142 -0.481 . . . . 71.24 110.577 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.67 3.68 11.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.747 -0.661 . . . . 63.14 111.807 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.642 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 60.1 mt -70.18 131.82 88.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.475 -0.195 . . . . 75.1 110.475 175.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.63 135.24 66.06 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.152 2.568 . . . . 63.25 112.513 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -101.63 102.92 13.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.106 0.479 . . . . 73.53 110.006 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.1 mt -103.23 131.63 51.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.898 -0.592 . . . . 74.15 110.544 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.8 tp -79.38 121.74 25.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.893 0.378 . . . . 74.03 110.323 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.48 HG13 ' HB3' ' A' ' 50' ' ' TYR . 42.6 t -87.46 132.33 33.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.074 -0.512 . . . . 71.44 110.67 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 36.9 p -128.59 151.42 49.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.264 -0.426 . . . . 62.35 110.297 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.654 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 30.4 mt-10 -84.51 0.6 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.23 0.538 . . . . 74.21 110.687 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.1 -22.11 29.03 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.847 -0.797 . . . . 74.05 108.847 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -133.4 55.57 1.89 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.89 -1.05 . . . . 73.1 109.265 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.95 160.1 34.97 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.38 -0.827 . . . . 72.32 112.272 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 41' ' ' MET . . . 60.16 76.62 0.35 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.399 0.618 . . . . 64.12 109.993 -174.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.71 93.77 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.45 -0.795 . . . . 73.43 111.145 -173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.42 -12.9 30.71 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.832 -0.622 . . . . 73.0 113.298 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.425 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 3.0 pt20 -156.93 -160.26 0.95 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.73 -0.276 . . . . 73.35 110.679 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.3 151.84 9.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.589 -0.732 . . . . 63.32 110.615 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.445 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 1.4 pmm? -88.77 11.91 16.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.309 -0.405 . . . . 52.44 111.645 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.1 m -118.4 141.53 48.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.208 0.528 . . . . 75.41 111.411 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 21.3 t -106.11 101.72 35.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.555 -0.748 . . . . 71.02 109.549 177.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.7 -26.68 82.9 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 123.246 2.631 . . . . 75.33 113.349 -174.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.9 mt -60.83 -41.26 87.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 75.02 111.469 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 21.0 p -119.88 13.96 12.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.557 -0.292 . . . . 75.21 110.909 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p 43.37 45.14 5.13 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.942 0.776 . . . . 72.51 112.22 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.0 p -120.85 -177.71 3.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.459 -0.571 . . . . 70.12 109.459 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -106.67 -175.13 2.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.795 0.331 . . . . 75.54 110.117 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.48 ' HB3' HG13 ' A' ' 30' ' ' VAL . 70.0 m-85 -103.0 109.92 21.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.378 -0.374 . . . . 75.21 110.538 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.1 m -107.08 165.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 74.35 111.68 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.654 ' HB2' ' H ' ' A' ' 32' ' ' GLU . 22.7 ttpp -73.5 113.69 10.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 72.21 111.008 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.02 -8.74 9.1 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.943 -0.646 . . . . 63.34 112.709 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.26 166.02 15.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 110.121 -0.326 . . . . 74.22 110.121 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -115.98 116.17 51.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.13 0.49 . . . . 75.31 110.745 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.43 166.95 10.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.028 -0.533 . . . . 73.01 110.784 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.8 t -136.45 155.16 50.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.747 -0.66 . . . . 73.21 110.114 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 tt0 -107.75 117.8 35.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.98 -0.554 . . . . 73.44 109.925 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.87 146.38 59.55 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 109.031 -0.729 . . . . 74.54 109.031 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.71 -3.87 4.0 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.099 2.533 . . . . 65.14 113.807 -175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.7 p -103.22 29.29 5.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 75.03 110.472 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 63.12 31.73 15.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.878 -0.601 . . . . 74.41 112.188 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -126.52 135.01 50.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.776 0.322 . . . . 74.14 110.814 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.65 145.92 30.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.79 -0.641 . . . . 72.42 110.875 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -149.25 160.41 43.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.686 -0.688 . . . . 75.42 109.289 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.579 ' HB2' ' CB ' ' A' ' 69' ' ' CYS . 34.3 m170 -60.47 132.85 55.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.418 -0.956 . . . . 72.14 108.418 168.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -65.85 -61.51 5.55 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.943 0.719 . . . . 74.23 112.943 -171.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.36 -23.32 71.81 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.742 1.628 . . . . 62.41 111.197 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.579 ' CB ' ' HB2' ' A' ' 66' ' ' HIS . 7.7 t -67.36 -53.42 29.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.212 -1.358 . . . . 75.33 110.295 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.428 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 p -74.65 -24.7 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.782 -0.644 . . . . 72.35 110.524 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.606 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 43.6 t -54.29 -48.73 70.92 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.266 -0.424 . . . . 75.22 110.1 176.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.0 mt -57.51 -47.6 84.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.012 -0.54 . . . . 65.32 110.343 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -61.3 -44.75 96.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 74.42 111.116 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 96.8 mt -66.14 -23.07 66.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 74.34 111.456 -178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.606 ' HG3' ' O ' ' A' ' 71' ' ' SER . 78.0 mt-30 -72.33 -21.95 61.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.755 0.312 . . . . 71.3 110.485 177.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -89.56 -59.17 2.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.183 0.516 . . . . 70.32 109.625 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.0 m -140.11 124.78 18.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 71.35 110.343 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.03 75.55 2.27 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.176 -0.769 . . . . 75.53 111.176 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.455 HG21 ' HA ' ' A' ' 84' ' ' ARG . 4.0 m -147.68 135.29 20.89 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.374 -0.232 . . . . 74.42 110.374 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 34.9 t -75.18 107.39 3.93 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.181 -0.674 . . . . 63.25 109.181 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.18 -31.98 48.02 Favored 'Trans proline' 0 N--CA 1.476 0.497 0 C-N-CA 123.152 2.568 . . . . 74.21 114.207 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.5 t -71.69 -47.9 54.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.048 0.388 . . . . 63.53 112.048 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 20.5 p -103.51 -23.83 13.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.848 0.356 . . . . 74.13 111.031 -174.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.455 ' HA ' HG21 ' A' ' 79' ' ' THR . 35.9 mtp180 71.13 29.6 2.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.316 -0.856 . . . . 74.13 110.893 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 47.6 t -85.07 138.15 32.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.536 -0.756 . . . . 73.31 108.982 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.7 ttp -72.11 143.38 49.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 65.21 111.275 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.463 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 94.0 t80 -125.88 129.69 24.23 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.309 -0.859 . . . . 75.32 108.98 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 16.7 Cg_exo -67.59 157.42 85.0 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 123.851 -1.312 . . . . 71.24 112.721 2.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.51 134.38 63.6 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.065 2.51 . . . . 65.3 112.412 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.81 -172.18 1.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.016 2.477 . . . . 64.44 112.61 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--O 1.243 0.75 0 CA-C-O 118.6 -0.714 . . . . 73.41 109.859 178.049 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.857 -0.423 . . . . 70.53 109.857 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 145.04 -43.73 0.93 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.347 -0.701 . . . . 74.33 111.347 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -88.75 102.77 15.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.059 0.457 . . . . 75.21 110.087 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -103.7 147.98 26.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.719 -0.673 . . . . 74.31 110.362 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -73.75 -40.5 63.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 75.21 110.686 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -129.0 158.81 37.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.362 -0.381 . . . . 72.14 110.939 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -164.39 122.96 1.82 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.709 -0.678 . . . . 72.44 109.898 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -132.08 98.91 4.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.006 -0.543 . . . . 71.21 109.991 176.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -94.07 89.25 5.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.423 0.63 . . . . 63.15 110.673 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -134.08 116.64 15.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.55 -0.907 . . . . 74.53 108.55 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.5 mmt -54.23 -56.45 18.21 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.561 0.538 . . . . 72.04 111.321 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.6 t -112.62 124.64 69.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.407 -0.59 . . . . 73.01 109.407 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.08 -72.72 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.802 0.334 . . . . 74.32 111.444 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.549 ' HB2' ' OG1' ' A' ' 79' ' ' THR . 80.2 m-20 -135.83 163.39 50.8 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.266 -0.425 . . . . 73.23 109.997 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 14' ' ' ASN . 10.0 Cg_endo -54.17 143.74 62.12 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.917 2.411 . . . . 64.32 112.321 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.54 156.15 67.26 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.986 2.458 . . . . 61.35 112.197 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.84 147.52 22.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.078 -0.51 . . . . 72.02 110.443 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -68.23 138.91 55.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.327 -0.397 . . . . 74.21 110.241 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -54.48 -33.58 60.01 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.81 0.338 . . . . 43.35 110.819 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -61.29 -28.12 68.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 64.3 111.159 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.5 t -86.82 -34.54 19.49 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.888 -0.412 . . . . 74.1 109.888 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -67.72 -49.38 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.053 -0.521 . . . . 62.24 110.837 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -72.63 -13.0 61.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 74.22 110.653 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.37 -6.43 58.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 73.25 111.173 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.512 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 84.3 mt -63.22 138.06 97.24 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.4 -0.364 . . . . 63.05 110.667 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.85 119.06 6.01 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.183 2.589 . . . . 54.01 112.359 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -88.66 105.34 17.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.387 0.613 . . . . 72.44 110.835 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.0 mt -96.41 109.39 22.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.221 -0.9 . . . . 75.33 109.383 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.99 117.38 9.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.086 -0.507 . . . . 74.43 110.052 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 15.7 t -82.17 127.49 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.582 -0.525 . . . . 74.24 109.582 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.5 p -117.3 170.21 8.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.019 -0.537 . . . . 75.42 109.858 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 24.3 mt-10 -85.19 7.64 21.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.655 0.741 . . . . 73.11 109.865 176.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -96.39 -13.35 23.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.043 -0.981 . . . . 62.41 109.139 173.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.593 ' HE1' ' HA ' ' A' ' 37' ' ' VAL . 28.8 t-80 -132.85 115.65 15.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.258 -0.883 . . . . 75.33 110.577 -173.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.61 -111.07 0.46 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.668 -0.777 . . . . 51.3 112.486 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.93 139.18 58.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.851 0.357 . . . . 75.24 110.975 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.593 ' HA ' ' HE1' ' A' ' 34' ' ' HIS . 10.9 t -89.21 -19.18 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.016 -0.538 . . . . 73.01 110.819 -176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.39 -145.16 7.05 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.646 -0.788 . . . . 71.33 111.968 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -59.99 -49.06 79.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.101 0.476 . . . . 72.12 110.716 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.91 113.4 16.99 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.452 -0.944 . . . . 74.32 108.452 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.7 ptp -101.07 4.67 42.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.262 -0.427 . . . . 71.14 111.893 -171.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.7 m -146.87 171.48 15.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.675 0.274 . . . . 74.41 110.575 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -122.41 91.02 49.41 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.203 -0.453 . . . . 71.5 109.859 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.39 -13.32 32.11 Favored 'Trans proline' 0 N--CA 1.475 0.422 0 C-N-CA 123.384 2.722 . . . . 72.2 113.019 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.3 mt -69.99 -22.28 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.063 0.458 . . . . 72.54 110.59 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 27.4 p -132.85 -14.9 2.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.946 0.351 . . . . 74.13 111.946 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 89.9 m 65.99 21.85 11.28 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 122.761 0.424 . . . . 64.0 111.309 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -104.62 142.3 34.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.22 -0.445 . . . . 75.52 109.832 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -79.04 177.36 8.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.078 0.466 . . . . 70.23 111.008 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.442 ' HB3' HG11 ' A' ' 30' ' ' VAL . 89.5 m-85 -89.64 106.27 18.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.133 0.492 . . . . 74.12 111.425 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 m -131.15 171.42 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.619 -0.719 . . . . 75.52 110.346 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -62.56 120.91 12.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 74.12 110.545 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.62 -40.92 1.51 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.776 -0.726 . . . . 51.44 112.211 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -86.96 161.52 18.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.629 -0.508 . . . . 74.54 109.629 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.89 122.9 69.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.349 -0.387 . . . . 74.41 110.278 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.1 163.44 13.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.435 -0.348 . . . . 74.33 110.397 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.512 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.5 t -144.49 155.51 43.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.955 -0.387 . . . . 54.0 109.955 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -107.29 117.53 34.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.269 -0.423 . . . . 73.03 110.073 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.76 142.17 32.34 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.308 -0.627 . . . . 71.15 109.308 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.13 -18.68 24.17 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.369 2.713 . . . . 74.53 112.83 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.6 p -88.32 24.32 1.93 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.243 -0.435 . . . . 74.03 110.899 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.7 m80 66.22 33.7 7.11 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.094 0.558 . . . . 73.13 111.604 171.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -127.35 141.42 51.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.678 0.275 . . . . 73.0 110.859 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.47 133.2 55.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.838 -0.619 . . . . 72.44 110.485 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -143.07 175.18 10.05 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.876 -0.787 . . . . 75.32 108.876 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.627 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 32.3 m170 -82.39 131.49 35.22 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.174 -0.676 . . . . 75.4 109.174 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 85.2 tttt -60.1 -49.52 90.58 Favored Pre-proline 0 C--N 1.323 -0.568 0 O-C-N 123.377 0.423 . . . . 70.31 111.892 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 18.4 Cg_endo -60.05 -20.73 62.24 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.013 1.809 . . . . 64.33 112.637 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.627 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 60.2 m -83.6 -45.66 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.161 0.505 . . . . 71.3 110.655 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.474 HG23 ' HG ' ' A' ' 74' ' ' LEU . 9.4 p -78.32 -25.66 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 73.42 111.199 -173.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 9.0 p -58.85 -48.76 80.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 72.42 110.97 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.04 -42.82 96.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 65.44 110.372 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -62.88 -43.81 97.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.753 -0.658 . . . . 74.25 111.266 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.474 ' HG ' HG23 ' A' ' 70' ' ' VAL . 93.1 mt -65.55 -24.92 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.515 -0.312 . . . . 72.02 111.599 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.446 ' HG3' ' O ' ' A' ' 71' ' ' SER . 76.3 mt-30 -75.49 -23.44 56.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.979 0.418 . . . . 74.41 110.427 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -85.36 -48.08 9.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.35 0.595 . . . . 64.04 109.487 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.7 p -158.51 123.88 4.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.281 -0.872 . . . . 75.42 109.891 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.452 ' C ' ' HG1' ' A' ' 79' ' ' THR . . . -78.46 74.85 2.03 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.64 -0.79 . . . . 73.33 111.834 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 14' ' ' ASN . 5.3 m -149.24 138.44 21.45 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.768 -0.254 . . . . 71.31 110.468 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 37.6 t -75.05 112.54 18.54 Favored Pre-proline 0 C--O 1.222 -0.387 0 N-CA-C 109.855 -0.424 . . . . 74.12 109.855 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.48 -38.48 64.08 Favored 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 123.13 2.553 . . . . 72.35 113.571 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.18 -31.81 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.852 0.686 . . . . 72.13 112.852 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.7 p -124.41 -16.23 6.42 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.315 -0.554 . . . . 64.14 111.894 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.495 ' HA ' HG21 ' A' ' 79' ' ' THR . 60.3 mtt180 69.4 26.24 5.3 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.222 0.609 . . . . 54.34 110.884 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.19 131.15 38.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.965 -0.754 . . . . 73.52 108.965 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 62.8 ttp -72.49 142.84 48.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.433 -0.348 . . . . 74.55 110.571 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 79.4 t80 -127.45 126.1 24.02 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.424 -0.584 . . . . 72.14 109.424 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.487 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 33.8 Cg_endo -65.24 155.39 77.51 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 123.597 -1.418 . . . . 71.41 112.68 1.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.38 142.89 21.57 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.465 2.777 . . . . 75.04 112.853 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.64 144.02 97.12 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.822 2.348 . . . . 64.45 112.155 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.454 -0.784 . . . . 71.15 110.119 -176.655 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.497 0.189 . . . . 73.31 111.012 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 53.31 -103.94 0.17 Allowed Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.816 -0.629 . . . . 74.24 114.261 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -80.94 122.56 27.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.999 0.428 . . . . 71.33 111.431 -174.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.89 -29.94 44.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.005 -0.739 . . . . 73.14 109.005 170.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -85.0 83.08 8.18 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.715 -1.217 . . . . 72.35 107.715 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -71.9 -27.78 63.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.434 -0.803 . . . . 73.25 109.717 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -85.56 178.98 7.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.5 -0.773 . . . . 73.52 109.0 172.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -99.01 95.13 6.93 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.396 -0.522 . . . . 74.32 109.813 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 m -70.49 141.66 51.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.564 -0.744 . . . . 74.32 110.765 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -114.97 85.29 2.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.798 0.809 . . . . 63.44 110.136 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.6 mtp -113.17 106.09 14.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.268 -0.878 . . . . 72.44 109.545 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.1 t -115.59 -74.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.847 -0.615 . . . . 60.31 110.864 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.73 122.52 17.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.016 -0.538 . . . . 72.34 110.076 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -96.85 136.54 21.59 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.912 -0.586 . . . . 65.54 110.372 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 90.1 Cg_endo -84.0 150.99 12.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.752 2.301 . . . . 60.45 112.576 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.83 143.08 99.43 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.954 2.436 . . . . 74.42 112.228 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.15 150.99 41.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.89 -0.595 . . . . 74.31 111.276 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.517 ' O ' HG13 ' A' ' 22' ' ' ILE . 17.7 m -69.2 132.45 46.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.877 -0.601 . . . . 62.33 110.171 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -61.68 -36.66 81.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 73.15 112.09 -172.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -70.09 -36.98 75.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 74.13 110.389 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m -65.97 -29.14 69.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 54.05 110.566 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 18' ' ' SER . 69.5 mt -69.88 -40.7 79.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 72.13 110.713 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.488 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 34.1 t70 -70.93 -26.18 63.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.849 -0.341 . . . . 74.1 110.525 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -16.01 64.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 75.42 111.733 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.414 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 94.2 mt -63.2 141.84 97.77 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.383 -0.371 . . . . 65.34 110.798 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.68 129.39 26.19 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.059 2.506 . . . . 64.53 112.527 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -92.23 116.77 29.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.059 -0.518 . . . . 75.51 110.102 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.1 mt -114.44 130.27 69.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.142 -0.481 . . . . 73.14 109.833 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.4 tp -77.21 126.05 30.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.97 0.415 . . . . 73.42 110.317 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 53.5 t -82.12 134.14 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.012 -0.54 . . . . 73.44 110.046 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 20.4 p -126.17 126.86 44.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.311 -0.404 . . . . 73.02 110.57 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.672 ' HB3' ' HA ' ' A' ' 51' ' ' VAL . 10.7 pt-20 -80.64 -9.7 59.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 75.33 111.408 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.35 -2.05 56.45 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.199 -0.667 . . . . 74.11 109.199 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -113.97 118.4 34.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.978 -1.119 . . . . 64.12 107.978 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -41.49 -50.95 4.69 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 114.86 0.704 . . . . 71.2 114.86 -171.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 39' ' ' GLN . . . -159.17 134.96 8.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.979 0.39 . . . . 37.35 110.6 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.2 t -85.41 73.25 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.935 0.398 . . . . 70.53 110.696 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.47 18.62 56.31 Favored Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.741 -0.663 . . . . 72.21 113.605 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 7.6 tp-100 -159.06 171.99 18.98 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.756 -0.831 . . . . 74.52 108.756 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.24 144.83 39.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.063 -0.347 . . . . 72.33 110.063 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.1 ptp -76.37 22.45 0.17 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.091 0.404 . . . . 63.24 112.091 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.8 m -134.23 127.37 31.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.755 0.312 . . . . 43.22 110.551 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.3 t -96.64 106.88 33.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.571 -0.529 . . . . 61.02 109.571 177.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.92 -33.69 89.66 Favored 'Trans proline' 0 N--CA 1.474 0.328 0 C-N-CA 123.254 2.636 . . . . 64.24 113.071 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.56 -20.21 22.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.174 0.512 . . . . 74.24 110.845 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 88.3 m -108.12 -30.18 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 63.54 111.659 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.7 t 70.0 17.73 7.33 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.875 0.734 . . . . 64.23 109.449 -171.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -124.28 161.57 25.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.253 -0.885 . . . . 74.54 110.673 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -85.12 -178.32 6.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 74.41 111.798 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.45 ' HB3' ' CG1' ' A' ' 30' ' ' VAL . 47.3 m-85 -94.47 109.16 21.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.701 -0.681 . . . . 72.02 110.93 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.672 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . 27.0 m -107.64 165.0 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.984 -0.553 . . . . 75.54 110.87 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.643 ' HB2' ' H ' ' A' ' 32' ' ' GLU . 28.1 ttpp -78.41 117.47 19.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.884 0.373 . . . . 75.11 110.725 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.82 -7.23 10.24 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.846 -0.615 . . . . 41.31 111.628 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -84.31 158.58 21.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.407 -0.59 . . . . 64.45 109.407 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.3 116.67 53.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.886 0.374 . . . . 71.44 110.63 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.31 167.68 10.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.075 -0.512 . . . . 71.24 110.551 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 14.0 t -149.26 157.96 43.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.011 -0.54 . . . . 71.1 109.645 176.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -108.4 117.63 34.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.344 -0.389 . . . . 61.21 110.126 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.85 150.12 88.21 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.912 -0.585 . . . . 62.11 109.458 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.16 -14.33 23.39 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.135 2.556 . . . . 71.21 112.855 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 23.9 p -91.93 15.0 14.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.384 -0.371 . . . . 72.4 110.334 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 60.14 74.78 0.43 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.329 0.585 . . . . 73.04 110.974 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -157.22 127.81 6.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.472 -0.785 . . . . 74.53 109.674 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 57' ' ' THR . 85.6 m-85 -97.93 133.21 42.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.025 -0.534 . . . . 73.24 110.693 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.33 174.84 10.25 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.867 -1.16 . . . . 74.4 107.867 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.828 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 34.1 m170 -86.29 128.58 34.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.912 -0.773 . . . . 73.21 108.912 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.519 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 87.4 tttt -53.03 -48.3 92.46 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.546 0.529 . . . . 73.41 111.914 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 76.1 Cg_exo -53.7 -45.0 44.25 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.33 2.02 . . . . 73.15 113.851 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.828 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 19.7 p -84.51 -33.67 23.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.398 -0.521 . . . . 74.34 112.209 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 67' ' ' LYS . 9.8 p -72.24 -28.7 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.817 -0.353 . . . . 72.22 110.765 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.3 p -63.96 -26.91 68.8 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.052 0.453 . . . . 73.44 110.83 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.92 -54.16 18.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 73.33 110.017 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -62.63 -33.62 75.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.053 -0.521 . . . . 73.53 111.477 -176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 84.6 mt -66.74 -23.93 66.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.599 -0.273 . . . . 73.45 111.315 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -89.59 -11.29 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.212 0.529 . . . . 74.13 110.364 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -95.28 -57.17 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.815 -0.629 . . . . 75.23 110.761 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.2 t -110.83 -33.95 6.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.926 -0.579 . . . . 64.05 110.929 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.02 17.58 71.88 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.689 -0.767 . . . . 64.34 112.103 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 86' ' ' MET . 3.5 m -128.41 153.16 47.38 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.922 -0.399 . . . . 53.1 109.922 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.8 t -74.61 110.24 9.2 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.809 -0.811 . . . . 64.43 108.809 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.8 -25.93 63.75 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.174 2.582 . . . . 54.25 113.064 -171.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.73 -50.87 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.352 -0.386 . . . . 74.22 111.934 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.1 p -109.94 -2.55 17.08 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.267 0.469 . . . . 73.2 112.267 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? 66.53 21.57 10.74 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.29 0.478 . . . . 74.5 112.29 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.7 t -85.29 126.86 34.05 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.293 -0.632 . . . . 73.53 109.293 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.487 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 59.8 ttp -72.43 153.23 41.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.346 -0.388 . . . . 70.24 111.104 -176.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -124.77 118.61 25.84 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.563 -0.532 . . . . 74.24 109.563 173.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.34 156.76 96.6 Favored 'Cis proline' 0 C--N 1.344 0.322 0 C-N-CA 123.702 -1.374 . . . . 55.45 112.345 -0.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.24 139.6 63.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.081 2.521 . . . . 74.11 112.733 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 40.3 Cg_endo -65.64 141.7 67.61 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.72 2.28 . . . . 73.44 112.381 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.602 -0.713 . . . . 61.42 110.138 -177.112 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.575 -0.528 . . . . 55.14 109.575 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.14 107.65 3.57 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.889 -0.672 . . . . 64.04 112.153 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -88.54 108.65 19.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.374 0.607 . . . . 61.43 110.804 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -149.44 99.19 2.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.448 -0.796 . . . . 72.51 109.541 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -102.72 -44.99 5.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.146 -0.479 . . . . 72.2 110.695 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.9 m170 -116.92 158.18 24.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.867 -0.606 . . . . 72.22 109.424 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -129.46 59.64 1.59 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.351 0.596 . . . . 75.44 111.465 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -85.8 97.2 10.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.869 -0.605 . . . . 75.43 109.413 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.3 p -76.02 124.9 28.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.607 -0.724 . . . . 74.0 111.662 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -130.54 91.13 3.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.498 -0.927 . . . . 74.44 108.498 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -63.45 -24.52 67.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 63.32 112.434 -171.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.48 92.05 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.165 0.507 . . . . 74.41 109.847 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.94 -18.06 14.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.8 -0.636 . . . . 52.42 110.996 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 68.29 152.07 0.13 Allowed Pre-proline 0 N--CA 1.468 0.439 0 O-C-N 123.854 0.722 . . . . 73.52 111.511 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.01 150.64 83.14 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.36 2.04 . . . . 74.01 111.856 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.29 146.41 90.06 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.844 2.363 . . . . 64.14 112.142 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 168.11 20.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.145 0.498 . . . . 75.04 111.622 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 m -78.09 150.89 33.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 65.22 110.826 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' HZ3' ' HG2' ' A' ' 19' ' ' LYS . 10.1 tttm -62.37 -39.23 92.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.054 -0.521 . . . . 75.34 110.452 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.83 -35.01 79.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.71 -0.677 . . . . 75.34 111.332 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 m -61.84 -44.81 96.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 65.35 110.282 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.519 HG21 ' HA ' ' A' ' 71' ' ' SER . 25.9 mt -75.15 -38.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.738 -0.665 . . . . 72.24 110.521 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.3 -31.22 72.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.434 -0.803 . . . . 73.24 110.982 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.76 -21.68 60.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.845 -0.616 . . . . 71.03 111.576 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 98.0 mt -63.76 132.46 95.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 73.44 110.902 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.08 137.06 55.21 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.16 2.573 . . . . 73.14 112.864 -175.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.469 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 44.2 mt-10 -90.17 116.52 28.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.187 0.518 . . . . 64.42 110.751 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -109.15 129.47 63.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.315 -0.857 . . . . 72.2 109.681 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.7 tp -80.13 122.03 26.29 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.017 -0.364 . . . . 72.23 110.017 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 41.9 t -79.14 123.46 36.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.27 -0.423 . . . . 70.04 110.225 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.7 p -119.16 140.86 49.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.148 -0.478 . . . . 63.53 110.332 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 30.5 mt-10 -79.57 177.69 8.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.169 -0.469 . . . . 65.2 110.278 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 1.1 m-20 71.5 8.74 6.31 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.818 0.699 . . . . 71.5 109.807 -168.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -127.58 108.82 11.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.12 -0.945 . . . . 72.02 109.394 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.62 95.03 0.52 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.755 -0.736 . . . . 72.12 112.055 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 72.33 138.34 0.05 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.535 0.734 . . . . 61.52 111.484 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.45 -38.76 83.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 64.12 110.363 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.73 32.01 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.777 -0.725 . . . . 73.52 112.034 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.67 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 8.4 tp-100 -172.17 -80.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.732 0.301 . . . . 60.3 110.648 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.75 152.56 35.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.062 -0.517 . . . . 75.34 110.705 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -103.78 3.52 34.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.627 -0.715 . . . . 73.04 110.001 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 30.4 p -124.42 151.86 43.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.032 -0.531 . . . . 74.41 110.03 175.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 50.4 t -116.7 101.99 53.37 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.444 -0.576 . . . . 75.31 109.444 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -56.92 -28.57 78.29 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.116 2.544 . . . . 73.12 112.622 -173.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.4 mt -67.0 -32.14 56.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.748 -0.66 . . . . 72.53 111.618 -175.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.7 p -113.89 -4.21 13.32 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.987 -0.285 . . . . 73.24 111.22 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.8 t 67.93 4.06 3.84 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.782 -0.645 . . . . 61.13 111.256 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.8 m -105.92 163.76 12.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.8 0.333 . . . . 63.54 110.332 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.8 OUTLIER -91.71 -170.22 2.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.049 0.452 . . . . 74.43 110.89 -177.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.642 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 29.9 m-85 -94.47 108.84 20.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.092 -0.503 . . . . 73.21 111.397 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.31 166.72 7.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.337 -0.847 . . . . 75.11 109.612 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 39.5 ttpt -73.37 138.38 45.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.943 0.401 . . . . 74.44 110.769 -176.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.9 -9.32 47.12 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.993 -0.623 . . . . 62.31 112.342 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.78 162.06 18.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.76 -0.459 . . . . 71.51 109.76 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -110.31 122.62 65.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.846 0.355 . . . . 64.33 110.319 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -112.21 171.02 7.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.864 0.364 . . . . 75.03 110.448 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 7.2 t -148.84 168.57 22.63 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.684 -0.488 . . . . 63.52 109.684 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -113.36 117.32 31.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.817 0.341 . . . . 73.12 110.942 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.05 138.23 39.95 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.188 -0.671 . . . . 64.31 109.188 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.02 -19.27 19.42 Favored 'Trans proline' 0 N--CA 1.474 0.325 0 C-N-CA 123.708 2.938 . . . . 64.21 113.158 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.1 p -86.42 22.55 1.81 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.744 0.307 . . . . 74.11 110.682 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 65.3 36.71 6.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.274 0.559 . . . . 73.43 111.711 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.67 ' HD2' ' HG2' ' A' ' 39' ' ' GLN . 4.8 m170 -125.11 122.62 37.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.888 -0.596 . . . . 73.44 110.315 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -99.0 133.13 43.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.239 -0.437 . . . . 71.14 110.124 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 72.9 m-85 -144.16 161.1 39.71 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.535 0.522 . . . . 75.42 110.261 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 38.2 m170 -61.88 121.26 12.49 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.367 -0.605 . . . . 74.11 109.367 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.6 tttt -58.78 -49.89 90.98 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 123.235 0.334 . . . . 70.1 111.676 -176.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 9.6 Cg_endo -53.91 -27.48 44.6 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.356 2.037 . . . . 72.41 112.613 176.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 68.2 m -82.89 -52.42 6.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 73.42 110.809 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.481 HG13 ' HA ' ' A' ' 67' ' ' LYS . 7.1 p -69.95 -27.39 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 50.41 111.252 -173.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.519 ' HA ' HG21 ' A' ' 22' ' ' ILE . 18.4 p -64.47 -46.75 81.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.798 0.332 . . . . 72.14 110.579 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.484 HG22 ' HE2' ' A' ' 76' ' ' LYS . 75.1 mt -63.73 -37.85 80.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.152 -0.476 . . . . 73.41 110.291 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -64.65 -51.98 59.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 73.25 111.317 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.9 -24.38 66.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.388 -0.369 . . . . 72.12 111.664 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -77.5 -0.65 26.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.021 0.438 . . . . 75.34 110.756 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.484 ' HE2' HG22 ' A' ' 72' ' ' ILE . 56.5 mttm -113.46 -52.26 2.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 73.42 109.856 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.1 m -132.87 125.64 30.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.046 -0.525 . . . . 64.4 110.035 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.7 57.25 4.68 Favored Glycine 0 CA--C 1.516 0.148 0 C-N-CA 120.951 -0.642 . . . . 70.12 112.899 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.415 HG22 ' HA ' ' A' ' 84' ' ' ARG . 39.5 m -145.77 149.21 33.96 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.283 -0.266 . . . . 75.32 110.283 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.6 t -74.41 118.08 67.02 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.926 -0.768 . . . . 71.24 108.926 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.4 -24.84 54.3 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.295 2.663 . . . . 71.22 113.477 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.28 -61.16 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.425 -0.352 . . . . 64.32 111.853 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.9 p -90.04 -1.11 57.91 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.906 0.336 . . . . 64.21 111.906 -172.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.415 ' HA ' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER 47.58 39.94 10.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.619 0.768 . . . . 75.51 111.913 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.12 148.7 22.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.73 -0.841 . . . . 73.2 108.73 170.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.5 ttp -74.19 145.75 43.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.03 0.443 . . . . 63.33 111.839 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.554 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 57.6 t80 -129.2 131.05 23.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.837 -0.801 . . . . 73.3 108.837 172.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.554 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 31.0 Cg_endo -62.86 159.67 60.45 Favored 'Cis proline' 0 C--N 1.347 0.472 0 C-N-CA 124.067 -1.222 . . . . 74.03 112.984 2.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.5 138.75 74.85 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.193 2.595 . . . . 74.03 112.818 -175.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.22 151.74 84.16 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.699 2.266 . . . . 74.22 112.314 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.628 -0.701 . . . . 73.25 109.913 -179.717 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.717 0.294 . . . . 73.41 110.603 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.99 64.78 4.01 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.725 -0.75 . . . . 52.3 113.205 -173.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -100.68 119.45 38.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.017 0.437 . . . . 75.54 110.266 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -143.45 146.67 33.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.925 -0.58 . . . . 74.42 109.719 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -126.72 73.45 1.4 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.283 0.563 . . . . 72.41 111.526 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -134.2 10.07 3.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.541 -0.754 . . . . 74.12 109.208 172.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -128.56 127.52 42.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.085 -0.961 . . . . 74.12 109.886 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.439 ' O ' ' HD2' ' A' ' 10' ' ' HIS . 20.0 t-80 -153.82 158.92 41.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.167 -0.679 . . . . 74.1 109.167 175.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 m -61.77 94.71 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.917 0.389 . . . . 53.11 111.683 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.439 ' HD2' ' O ' ' A' ' 8' ' ' HIS . 16.6 m-70 -64.47 -29.02 70.07 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.704 0.764 . . . . 75.22 109.428 173.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 11' ' ' MET . 1.3 pmm? -98.74 38.09 1.41 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.704 -1.135 . . . . 71.12 110.541 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.88 -35.51 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.794 -0.639 . . . . 64.22 111.126 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.72 -61.86 1.04 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.321 -0.4 . . . . 73.25 110.029 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.7 t30 73.05 129.8 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.421 0 O-C-N 124.012 0.82 . . . . 72.03 111.65 176.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 14' ' ' ASN . 16.8 Cg_exo -67.75 166.09 25.48 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.107 2.538 . . . . 74.13 112.782 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.46 168.22 24.16 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.732 2.288 . . . . 72.21 111.965 175.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.54 179.95 6.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.54 -0.3 . . . . 65.2 110.567 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 p -102.27 162.1 13.18 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.934 -0.395 . . . . 75.33 109.934 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -64.05 -43.9 94.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.969 0.414 . . . . 70.55 110.017 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -58.69 -47.28 85.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.414 -0.812 . . . . 72.52 112.063 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 p -64.17 -41.68 97.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.311 . . . . 73.41 110.978 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.62 -41.06 85.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.206 0.527 . . . . 74.3 110.584 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.1 -36.39 81.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 74.33 110.637 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.01 -6.25 51.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 50.21 112.187 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 34.5 mt -53.84 127.72 53.26 Favored Pre-proline 0 C--O 1.237 0.43 0 O-C-N 122.994 0.184 . . . . 75.03 111.2 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 25' ' ' LEU . 9.8 Cg_endo -53.77 142.5 62.24 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.377 2.718 . . . . 52.44 111.694 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -113.85 106.48 14.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.099 0.476 . . . . 74.2 111.158 -173.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.5 mt -110.78 111.58 36.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.865 -0.607 . . . . 74.33 109.979 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.7 117.14 10.03 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.894 -0.41 . . . . 72.24 109.894 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.693 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 35.7 t -75.74 118.14 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.312 -0.404 . . . . 65.33 110.785 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.2 p -120.76 167.81 12.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.455 -0.572 . . . . 72.32 109.455 173.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.21 4.18 15.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.942 0.401 . . . . 75.24 111.123 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -80.26 -45.5 17.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.544 . . . . 74.41 110.333 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -77.92 -34.99 51.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 73.34 110.387 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.35 -115.77 4.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.004 -0.617 . . . . 70.24 111.706 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.0 141.64 57.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.622 -0.51 . . . . 73.23 109.622 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.21 90.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.504 -0.478 . . . . 61.34 111.234 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.496 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . 76.07 -73.54 1.73 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.565 -0.743 . . . . 64.31 113.337 171.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.51 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 8.5 tp-100 -107.89 -49.24 3.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.637 0.256 . . . . 71.24 110.91 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.4 158.55 37.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.357 0.599 . . . . 61.3 111.585 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.1 ptp -103.22 -5.77 22.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.162 -0.926 . . . . 73.35 109.902 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.802 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 85.1 m -128.14 137.92 52.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.802 -0.635 . . . . 73.11 110.421 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -93.36 112.49 56.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.04 -0.527 . . . . 62.0 109.974 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -60.77 -33.52 92.86 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.619 2.213 . . . . 72.44 111.94 -176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.49 -22.87 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.663 -0.698 . . . . 71.21 110.686 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 79.8 m -107.94 -19.36 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.979 -0.555 . . . . 70.04 111.201 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.4 m 60.8 29.27 18.9 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.48 0.657 . . . . 71.33 109.537 -170.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.6 t -141.16 155.38 46.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.254 -0.885 . . . . 73.21 109.514 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.802 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 10.7 pt-20 -77.75 -179.75 6.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.334 0.587 . . . . 72.54 111.783 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 73.8 m-85 -91.87 112.52 24.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.647 -0.706 . . . . 72.35 110.383 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.69 169.49 11.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 70.24 110.632 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.693 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 24.9 ttpp -72.99 113.66 10.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.74 -0.664 . . . . 74.31 110.961 -176.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.56 -36.5 1.54 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.581 -0.818 . . . . 61.23 112.758 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -87.14 162.17 17.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.12 -0.326 . . . . 74.12 110.12 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.75 129.49 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.58 -0.282 . . . . 72.44 110.38 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -101.22 163.41 12.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.825 0.345 . . . . 75.11 110.965 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 8.7 t -147.68 170.07 18.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.879 -0.601 . . . . 71.42 109.585 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -123.39 123.24 40.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.535 -0.302 . . . . 74.42 110.694 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.446 ' C ' ' H ' ' A' ' 61' ' ' CYS . 77.1 mt -86.02 141.16 35.18 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.416 -0.957 . . . . 73.31 108.416 169.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.93 36.19 0.17 Allowed 'Trans proline' 0 N--CA 1.479 0.623 0 C-N-CA 123.636 2.891 . . . . 73.21 113.922 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.446 ' H ' ' C ' ' A' ' 59' ' ' LEU . 29.5 p -140.06 28.07 2.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.388 -0.597 . . . . 63.0 109.388 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.8 m170 63.71 34.66 11.98 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.429 -0.805 . . . . 75.22 111.924 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.51 ' HD2' ' HG2' ' A' ' 39' ' ' GLN . 11.2 m170 -125.86 120.69 31.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.476 -0.329 . . . . 64.02 110.408 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.496 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 57.7 m-85 -101.88 137.17 40.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.954 -0.566 . . . . 72.24 111.29 -176.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.493 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 97.0 m-85 -140.72 175.36 9.67 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.738 -0.838 . . . . 74.02 108.738 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.871 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 39.1 m80 -82.61 131.79 35.2 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.172 -0.677 . . . . 74.33 109.172 173.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.512 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 86.7 tttt -55.61 -49.31 93.42 Favored Pre-proline 0 CA--C 1.539 0.532 0 O-C-N 123.49 0.494 . . . . 61.34 111.313 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.512 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 83.0 Cg_exo -51.23 -50.42 13.96 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.257 1.971 . . . . 72.41 113.52 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.871 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 21.9 p -79.69 -31.54 41.32 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.743 -0.383 . . . . 75.34 111.876 -174.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 67' ' ' LYS . 7.8 p -74.27 -28.81 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.719 -0.474 . . . . 75.23 109.719 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.7 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 27.7 t -58.46 -48.15 81.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.518 -0.549 . . . . 72.51 109.518 174.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -60.17 -40.78 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.651 -0.704 . . . . 75.54 110.705 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -67.43 -48.33 67.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.593 -0.731 . . . . 74.11 111.498 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 77' ' ' SER . 97.2 mt -67.25 -20.51 65.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.395 -0.366 . . . . 73.53 111.93 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.3 mt-30 -59.98 -40.29 88.6 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.581 -0.281 . . . . 74.0 111.391 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.77 -27.51 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.907 -0.317 . . . . 73.2 111.222 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 12.7 p -143.88 111.2 5.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.74 0.305 . . . . 64.42 110.872 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -82.56 65.46 4.1 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.187 -0.765 . . . . 54.22 111.187 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 m -143.5 145.4 32.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.645 -0.278 . . . . 73.42 110.383 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.5 t -74.88 113.64 26.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.79 -0.819 . . . . 64.41 108.79 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.34 -34.2 79.49 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.036 2.49 . . . . 72.45 113.76 -172.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -75.13 -62.98 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.069 0.396 . . . . 71.11 112.069 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.3 p -89.12 -18.11 27.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 73.5 111.346 -173.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 11' ' ' MET . 17.3 mtp180 63.4 71.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.801 0.81 . . . . 62.32 110.557 -175.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t -128.81 142.58 50.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.637 -1.165 . . . . 73.43 108.067 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.53 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 61.8 ttp -68.05 149.07 50.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.989 0.423 . . . . 64.12 111.147 -174.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -127.97 121.18 21.74 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.636 -0.711 . . . . 71.01 109.39 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.61 157.83 77.21 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 124.048 -1.23 . . . . 73.31 112.855 0.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.48 135.29 63.8 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.993 2.462 . . . . 73.12 112.612 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 43.3 Cg_endo -68.44 147.47 71.24 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.867 2.378 . . . . 72.33 112.488 -177.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.322 -0.846 . . . . 74.14 109.302 177.895 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.782 0.325 . . . . 72.21 110.712 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.68 140.07 5.28 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.001 -0.619 . . . . 72.13 112.499 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -102.23 169.67 8.57 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.415 -0.217 . . . . 72.31 110.415 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -155.69 145.18 21.03 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.009 -0.367 . . . . 74.11 110.009 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -101.58 -169.77 1.73 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.862 -0.421 . . . . 73.2 109.862 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -100.8 167.74 10.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.104 -0.702 . . . . 72.21 109.104 172.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -82.17 153.05 26.19 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.302 -0.999 . . . . 75.01 108.302 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.9 80.96 2.15 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.726 -0.842 . . . . 74.44 108.726 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 t -46.86 -48.36 21.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.784 -1.098 . . . . 74.21 112.105 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -125.17 110.52 14.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.212 0.53 . . . . 73.22 110.219 174.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -125.6 148.73 48.85 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.131 -0.941 . . . . 63.01 109.532 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 14' ' ' ASN . 14.5 p -131.08 128.89 62.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.075 0.464 . . . . 72.21 110.9 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.19 63.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 63.33 109.419 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.467 ' N ' HG23 ' A' ' 12' ' ' VAL . 22.9 t-20 71.67 136.37 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 114.846 -1.07 . . . . 72.54 112.004 172.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 14' ' ' ASN . 31.7 Cg_exo -60.97 159.45 29.5 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.06 2.507 . . . . 50.03 112.796 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.57 141.76 38.82 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.169 1.913 . . . . 71.25 112.106 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 74' ' ' LEU . . . -81.75 149.21 28.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.991 -0.55 . . . . 44.1 110.167 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -58.97 116.44 3.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.259 -0.428 . . . . 70.11 110.478 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' HA ' HD11 ' A' ' 22' ' ' ILE . 6.5 ttpm? -56.8 -45.32 82.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.711 -0.677 . . . . 75.13 111.518 -176.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -54.93 -37.85 66.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.624 -0.716 . . . . 70.44 111.307 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.4 t -67.63 -41.02 84.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.076 0.465 . . . . 70.24 110.106 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.494 HG23 ' HA ' ' A' ' 71' ' ' SER . 61.1 mt -62.61 -39.72 85.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.683 -0.689 . . . . 65.35 110.932 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -75.06 -29.18 60.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 74.23 110.759 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -12.81 60.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.332 -0.395 . . . . 73.11 111.517 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.11 145.54 85.01 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 116.409 -0.36 . . . . 72.4 111.044 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.88 160.37 49.92 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.914 2.409 . . . . 72.22 112.381 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -108.36 112.82 25.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.189 -0.459 . . . . 71.31 110.326 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.7 mt -101.68 101.74 12.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.247 -0.649 . . . . 74.44 109.247 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.55 122.54 19.25 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.813 -0.44 . . . . 64.45 109.813 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.735 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 21.4 t -77.46 105.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.123 -0.489 . . . . 72.53 110.134 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.4 p -103.68 168.2 9.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.783 -0.451 . . . . 73.5 109.783 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -76.82 -22.25 53.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.07 0.462 . . . . 74.43 110.303 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.81 -28.31 58.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.006 -0.543 . . . . 74.42 109.943 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -84.62 -44.3 13.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 74.53 109.527 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.2 -110.87 3.36 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.9 -0.591 . . . . 75.3 112.729 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.64 103.39 3.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.002 0.43 . . . . 72.11 110.376 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.2 t -68.64 -30.33 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.011 -0.541 . . . . 74.31 110.928 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.449 ' HA3' ' CD1' ' A' ' 64' ' ' TYR . . . -149.89 -150.27 5.22 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.79 -0.719 . . . . 64.32 111.898 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -82.04 -24.19 35.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.672 -0.492 . . . . 71.5 109.672 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -83.99 111.79 19.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.866 -0.606 . . . . 61.24 109.75 172.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -91.28 -0.09 57.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 53.11 110.316 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.67 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 70.7 m -141.2 149.73 41.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.778 -0.647 . . . . 64.04 110.338 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 36.9 t -104.73 96.12 9.99 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.359 -0.608 . . . . 73.04 109.359 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 18.5 Cg_endo -57.27 -27.26 74.28 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.466 2.777 . . . . 61.22 112.935 -172.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.1 mt -57.74 -43.78 84.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 72.33 111.212 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.8 p -108.44 -3.23 18.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.565 -0.289 . . . . 74.34 110.713 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.1 m 60.87 40.2 15.99 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.834 -0.621 . . . . 72.45 110.716 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.9 m -135.94 146.55 47.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 75.3 110.47 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.67 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 15.4 pt-20 -81.88 -169.86 2.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 72.45 111.735 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.631 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.5 m-85 -102.97 108.77 20.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.201 0.524 . . . . 74.43 111.604 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 m -134.64 173.07 15.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.333 -0.849 . . . . 64.42 109.546 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.735 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 31.0 ttmt -64.54 125.76 25.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.042 0.448 . . . . 72.52 111.097 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.41 -42.73 1.27 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.563 -0.744 . . . . 75.31 111.731 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -86.68 165.88 15.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.875 -0.417 . . . . 64.01 109.875 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.0 133.7 65.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.684 -0.487 . . . . 75.22 109.684 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -111.76 176.01 5.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.897 0.38 . . . . 75.31 110.618 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.4 t -150.35 163.06 39.29 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.544 -0.539 . . . . 53.42 109.544 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -107.86 117.34 33.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.765 0.317 . . . . 74.35 110.667 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.8 mt -84.32 137.34 39.59 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.957 -0.757 . . . . 64.13 108.957 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.81 -8.19 7.22 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.89 2.393 . . . . 75.33 111.905 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.8 t -84.66 18.24 2.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.043 -0.98 . . . . 70.41 110.046 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 57.18 39.43 28.86 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.907 -0.588 . . . . 70.55 111.147 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -138.61 144.99 40.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.716 -0.674 . . . . 61.12 109.957 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.449 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 49.3 m-85 -121.12 132.86 55.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.794 0.33 . . . . 73.02 111.248 -172.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.631 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 89.6 m-85 -142.58 162.78 34.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 74.05 110.35 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 35.0 m170 -63.83 129.38 39.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.615 -0.513 . . . . 74.11 109.615 174.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.495 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 48.3 tttm -60.62 -51.7 77.93 Favored Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 123.326 0.391 . . . . 75.15 111.622 -175.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 27.5 Cg_endo -62.22 -22.0 73.45 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.127 1.885 . . . . 73.51 112.925 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.2 m -84.21 -46.99 11.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.225 0.536 . . . . 74.22 110.464 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.519 HG21 ' HG ' ' A' ' 74' ' ' LEU . 5.8 p -73.62 -23.78 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.786 -0.643 . . . . 75.42 110.717 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.494 ' HA ' HG23 ' A' ' 22' ' ' ILE . 19.3 p -65.74 -30.52 71.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.338 . . . . 51.25 111.083 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.92 -41.38 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 73.22 109.989 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -63.11 -47.53 82.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.448 -0.796 . . . . 74.11 111.783 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.519 ' HG ' HG21 ' A' ' 70' ' ' VAL . 98.2 mt -65.82 -20.56 66.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.342 0.497 . . . . 75.23 112.342 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.413 ' HG3' ' O ' ' A' ' 71' ' ' SER . 71.0 mt-30 -77.09 -9.59 58.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.183 0.516 . . . . 63.12 110.496 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -113.07 -42.27 3.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.61 . . . . 74.4 109.896 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -142.4 110.05 5.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.671 -0.695 . . . . 62.13 109.954 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.08 65.85 3.71 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 51.42 112.122 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.486 ' HB ' ' HA ' ' A' ' 84' ' ' ARG . 1.4 p -149.29 157.54 43.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.453 0.168 . . . . 73.03 110.991 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.596 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 44.1 m -74.45 123.09 88.87 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 108.308 -0.997 . . . . 75.42 108.308 169.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HD2' ' CZ ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -53.22 -27.96 40.14 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.466 2.111 . . . . 74.25 112.474 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.9 t -80.23 -41.02 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.706 -0.679 . . . . 71.35 112.449 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 12.8 p -110.03 -30.15 7.91 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.699 -0.401 . . . . 73.25 111.857 -172.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.486 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 56.5 mtt85 57.23 77.14 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.749 0.785 . . . . 61.22 111.879 -168.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.2 t -131.93 140.75 49.12 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.838 -1.171 . . . . 73.51 107.838 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.5 ttp -73.97 131.53 41.5 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.988 0.736 . . . . 71.25 112.988 -165.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 88' ' ' PRO . 70.9 t80 -122.87 134.92 25.31 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.71 -1.132 . . . . 73.55 108.805 172.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.47 ' HA ' ' CD1' ' A' ' 87' ' ' PHE . 9.5 Cg_exo -72.12 154.98 98.48 Favored 'Cis proline' 0 C--N 1.343 0.27 0 C-N-CA 123.855 -1.31 . . . . 73.11 112.186 -0.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.55 136.93 77.36 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.733 2.289 . . . . 71.13 112.03 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.62 153.17 76.7 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.954 2.436 . . . . 73.52 112.691 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.35 -0.833 . . . . 73.32 109.629 179.674 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.486 ' SD ' ' HA ' ' A' ' 48' ' ' SER . 24.3 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.651 0.262 . . . . 74.13 110.93 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.601 ' HA3' ' SG ' ' A' ' 47' ' ' CYS . . . -91.2 100.57 2.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.745 -0.741 . . . . 64.0 111.67 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -73.6 -33.66 64.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.66 0.267 . . . . 73.13 110.624 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -154.87 157.14 37.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.267 -0.424 . . . . 75.45 110.43 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -168.27 145.2 4.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.443 -0.577 . . . . 63.33 109.443 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -72.16 104.89 3.78 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.136 -0.32 . . . . 73.21 110.136 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -134.32 83.91 2.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.91 0.862 . . . . 72.32 112.403 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -129.62 55.46 1.77 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.305 -1.369 . . . . 73.1 107.305 165.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.9 p -99.12 -179.27 4.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.422 -1.263 . . . . 73.21 111.895 -169.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -138.14 122.3 18.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.281 -0.872 . . . . 74.31 109.526 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 54.2 ttp -71.42 112.01 7.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.306 -0.406 . . . . 70.31 110.138 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.71 126.62 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.987 -0.551 . . . . 74.1 111.624 -176.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.18 85.3 7.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.982 -0.748 . . . . 64.35 108.982 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -128.17 146.67 60.36 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.413 -0.812 . . . . 64.11 109.982 -170.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -42.15 127.66 4.05 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.631 2.887 . . . . 74.01 112.632 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -87.51 157.66 7.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.9 2.4 . . . . 62.12 113.369 -175.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.79 146.76 26.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.605 -0.725 . . . . 73.15 109.921 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 22' ' ' ILE . 14.3 m -73.23 140.28 46.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.266 -0.425 . . . . 74.51 110.201 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 34.7 ttpt -52.81 -44.97 67.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 64.02 111.131 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.14 -40.11 92.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.951 -0.568 . . . . 71.04 110.857 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 m -66.57 -32.88 74.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 73.11 110.799 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 71' ' ' SER . 54.8 mt -74.42 -39.24 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.37 0.605 . . . . 64.52 110.258 177.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.476 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 32.7 t70 -70.39 -21.41 62.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.957 -0.565 . . . . 75.04 110.667 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.57 -16.12 61.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.551 . . . . 45.23 111.227 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.54 143.01 96.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 65.02 110.84 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.37 136.62 75.6 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.104 2.536 . . . . 73.0 112.244 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -102.15 120.28 40.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.058 -0.519 . . . . 74.32 110.587 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.6 mt -112.08 111.99 38.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.091 -0.504 . . . . 64.12 109.927 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.01 118.8 10.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.86 -0.422 . . . . 64.42 109.86 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 49.0 t -71.23 114.52 9.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.141 -0.481 . . . . 64.32 110.177 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 p -95.36 147.3 23.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.728 -0.669 . . . . 63.25 110.258 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -69.67 -15.51 63.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.776 -0.647 . . . . 73.11 111.303 -174.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.34 -45.55 19.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.455 . . . . 74.11 111.248 -175.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -74.36 -47.93 31.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 72.03 110.881 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.17 -87.4 0.68 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.88 -0.676 . . . . 73.31 113.032 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 41' ' ' MET . . . -74.45 100.3 3.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.911 0.386 . . . . 72.25 110.96 -177.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.7 t -95.3 118.2 40.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.682 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.91 -64.85 2.36 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.876 -0.678 . . . . 61.32 112.919 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -154.3 -56.96 0.11 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.657 0.265 . . . . 71.14 111.013 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 42' ' ' CYS . 30.9 tt0 -101.76 155.01 18.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.248 -0.433 . . . . 70.45 110.054 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.532 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.7 pmm? -92.56 5.5 50.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.01 0.433 . . . . 44.44 110.255 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 19.6 t -130.8 156.0 45.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.885 -0.598 . . . . 73.45 109.926 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.423 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 30.8 t -107.35 106.32 58.08 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.703 -0.48 . . . . 71.04 109.703 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.7 Cg_endo -55.46 -29.35 68.5 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.29 2.66 . . . . 75.05 112.725 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -69.22 -27.77 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.083 -0.508 . . . . 74.42 110.74 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 96.5 m -103.49 -23.57 13.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.405 -0.361 . . . . 74.43 111.319 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.601 ' SG ' ' HA3' ' A' ' 2' ' ' GLY . 31.6 t 63.35 22.76 13.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.998 0.904 . . . . 54.3 108.577 -167.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.486 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 15.1 m -131.65 148.4 52.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.453 -1.249 . . . . 70.4 109.519 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.842 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 17.3 pt-20 -81.8 -178.25 6.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.276 0.56 . . . . 64.1 112.358 -172.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -91.04 117.2 29.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.471 -0.786 . . . . 74.22 111.021 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 m -132.42 166.78 28.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 74.41 109.48 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.8 ttpt -65.49 131.91 47.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.933 0.397 . . . . 62.1 110.717 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.43 -34.89 2.94 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.034 -0.603 . . . . 72.23 111.746 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -86.97 161.28 18.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.579 -0.526 . . . . 61.52 109.579 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.79 125.5 72.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.086 -0.339 . . . . 72.21 110.086 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -95.64 165.4 12.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.838 0.351 . . . . 54.51 110.485 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 7.5 t -146.78 172.56 13.45 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.584 -0.524 . . . . 53.14 109.584 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -125.55 117.66 24.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.691 -0.485 . . . . 73.25 109.691 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 61' ' ' CYS . 86.0 mt -90.03 139.51 27.36 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 110.186 -0.301 . . . . 72.25 110.186 178.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.51 12.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.481 0.778 0 C-N-CA 123.871 3.048 . . . . 75.41 114.623 -172.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.439 ' H ' ' C ' ' A' ' 59' ' ' LEU . 28.8 p -115.03 17.34 16.86 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.593 -0.521 . . . . 64.14 109.593 176.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 64.12 74.84 0.4 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.258 -0.883 . . . . 65.31 110.481 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -161.66 121.23 2.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.853 -0.612 . . . . 72.01 110.303 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -99.09 133.41 43.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 74.33 110.835 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -144.58 175.35 10.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.418 -0.956 . . . . 74.35 108.418 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.944 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 35.2 m170 -81.71 129.1 34.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.693 -0.854 . . . . 72.14 108.693 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.524 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 85.1 tttt -55.81 -50.99 83.95 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 123.448 0.467 . . . . 74.01 112.125 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 44.4 Cg_exo -58.33 -41.3 67.53 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.611 1.541 . . . . 51.13 113.183 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.944 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 30.2 p -80.95 -32.38 34.5 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.528 -0.469 . . . . 73.34 111.747 -175.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.93 -29.04 24.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.581 -0.526 . . . . 61.53 109.581 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.452 ' HA ' HG22 ' A' ' 22' ' ' ILE . 32.0 t -59.01 -42.49 90.24 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.0 -0.545 . . . . 61.35 109.817 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.4 ' O ' ' HE2' ' A' ' 76' ' ' LYS . 76.0 mt -55.6 -47.91 78.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 62.01 110.476 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 41.4 t-105 -69.7 -47.03 64.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.651 . . . . 72.55 110.946 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.43 -36.22 81.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.953 0.353 . . . . 70.53 111.953 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -64.44 -16.19 61.96 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.032 0.382 . . . . 73.3 112.032 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 76' ' ' LYS . 46.7 mtmt -118.34 -59.7 1.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.687 0.279 . . . . 72.43 111.645 -177.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.1 m -88.78 -25.15 22.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.305 -0.407 . . . . 71.24 111.624 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.21 43.47 93.53 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.322 -0.466 . . . . 55.51 113.194 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.03 165.56 27.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.979 0.418 . . . . 61.23 111.576 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.538 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 47.5 t -96.99 99.9 6.65 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.509 -0.552 . . . . 55.22 109.509 174.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -35.54 -48.93 0.95 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.578 3.519 . . . . 71.21 115.535 -169.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.82 -25.28 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.905 0.706 . . . . 74.44 112.905 -173.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 28.7 p -120.48 -25.48 5.57 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.771 -0.581 . . . . 75.5 111.423 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.5 mtm-85 72.08 15.11 5.59 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.546 0.738 . . . . 73.03 111.821 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.9 144.56 50.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.555 -0.906 . . . . 73.14 108.555 168.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.423 ' HE3' ' HB3' ' A' ' 90' ' ' PRO . 62.5 ttp -79.01 148.27 32.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.997 0.427 . . . . 61.34 112.01 -172.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.472 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 87.7 t80 -132.54 124.39 19.0 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.346 -0.843 . . . . 75.31 108.766 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.472 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 37.3 Cg_endo -65.58 147.69 73.23 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.768 -1.347 . . . . 75.24 112.918 2.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.48 137.57 65.49 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.597 2.865 . . . . 71.3 113.145 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HB3' ' HE3' ' A' ' 86' ' ' MET . 58.7 Cg_endo -73.79 151.58 46.15 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.746 2.297 . . . . 75.21 112.094 178.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.502 -0.761 . . . . 74.33 109.481 178.214 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 109.925 -0.398 . . . . 72.11 109.925 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.42 -170.3 46.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.612 -0.804 . . . . 72.02 111.241 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -58.48 -68.56 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.049 0.425 . . . . 74.12 110.92 178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -159.34 119.33 3.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.05 0.452 . . . . 73.32 110.847 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -177.06 150.62 0.76 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.223 -0.899 . . . . 75.35 108.921 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -79.46 167.63 20.55 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.548 -0.461 . . . . 65.34 109.786 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -71.82 8.15 1.29 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.45 0.907 . . . . 72.33 113.45 -167.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -134.13 112.19 10.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.913 0.387 . . . . 73.04 110.352 175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 t -143.19 133.85 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.687 -0.486 . . . . 74.3 109.687 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -88.25 119.42 28.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.414 -0.357 . . . . 73.44 110.389 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -75.36 147.96 39.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.181 -0.463 . . . . 74.15 110.073 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.1 t -113.8 89.21 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.96 0.41 . . . . 73.41 110.682 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.03 3.57 55.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.208 0.528 . . . . 55.25 110.419 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -100.97 108.16 53.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.595 -0.73 . . . . 63.33 110.013 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 60.4 Cg_endo -73.46 148.72 43.28 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.447 2.098 . . . . 61.42 112.204 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 18.3 Cg_exo -66.89 146.14 76.86 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.484 2.123 . . . . 72.34 111.249 175.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -78.22 147.82 34.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.876 0.369 . . . . 65.35 110.915 -177.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.0 t -74.53 153.71 38.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.934 -0.576 . . . . 73.51 109.859 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -58.83 -38.12 77.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.263 0.554 . . . . 71.14 109.735 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -70.23 -28.72 65.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.357 -0.838 . . . . 74.44 110.911 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.506 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 13.8 m -66.68 -38.1 86.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.86 -0.422 . . . . 64.04 109.86 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -77.38 -36.04 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 72.11 110.259 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.81 -37.49 84.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.578 -0.737 . . . . 52.22 111.192 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.04 4.69 49.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.053 -0.521 . . . . 74.3 112.312 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 21' ' ' SER . 57.8 mt -70.34 128.96 90.89 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 121.247 -0.181 . . . . 42.1 110.946 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -58.17 153.12 47.93 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.033 2.489 . . . . 54.34 112.047 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -126.17 118.03 24.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.022 0.439 . . . . 73.41 110.857 -174.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.1 mt -120.5 118.35 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.769 -0.651 . . . . 73.52 110.366 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.45 121.05 15.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.729 -0.471 . . . . 60.32 109.729 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 45.0 t -86.05 129.88 37.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.332 -0.395 . . . . 72.03 111.228 -177.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 34' ' ' HIS . 20.3 p -117.09 141.14 48.64 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.825 -0.625 . . . . 64.24 109.792 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 52' ' ' LYS . 57.0 mt-10 -69.12 -27.78 65.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.191 0.52 . . . . 73.41 110.974 -176.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.07 -6.55 59.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.74 -0.664 . . . . 74.31 110.969 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.509 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 22.5 t60 -74.34 -47.56 33.64 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.823 -0.436 . . . . 73.3 109.823 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 -160.13 13.39 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.407 -0.677 . . . . 64.51 111.407 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.73 114.19 14.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.848 0.356 . . . . 70.34 110.723 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.21 95.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.909 -0.587 . . . . 73.41 110.607 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.83 -143.26 23.17 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.839 -0.696 . . . . 72.51 112.545 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.554 ' OE1' ' HA ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -85.2 -27.67 25.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.58 0.228 . . . . 74.23 111.275 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -96.2 125.54 40.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.757 -0.46 . . . . 63.34 109.757 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 22.7 ptp -107.72 0.04 22.1 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.477 -0.329 . . . . 71.42 111.395 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.3 m -143.39 157.67 44.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.487 . . . . 63.51 110.993 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 40.7 t -117.06 93.32 41.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.776 -0.647 . . . . 74.11 109.377 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 13.1 Cg_endo -56.49 -26.03 61.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.567 2.845 . . . . 73.04 113.078 -174.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.6 mt -60.09 -34.77 57.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 74.44 111.054 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.4 p -114.94 9.74 16.18 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.126 -0.324 . . . . 71.32 110.126 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p 41.12 46.25 2.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.02 0.928 . . . . 71.22 111.892 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -140.2 154.59 46.97 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.923 -0.58 . . . . 71.1 110.06 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.84 -169.9 1.95 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.925 -0.58 . . . . 74.14 110.923 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.439 ' HB3' HG13 ' A' ' 30' ' ' VAL . 40.4 m-85 -87.17 93.66 9.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.545 0.688 . . . . 73.53 111.497 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.93 162.73 2.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.836 -1.075 . . . . 73.41 110.321 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.9 ttpm? -79.68 133.57 36.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.02 0.438 . . . . 72.3 110.67 -176.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.65 -16.18 21.53 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.819 -0.705 . . . . 64.22 111.834 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -86.96 161.83 18.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.169 -0.678 . . . . 73.2 109.169 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.6 121.2 64.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.958 -0.386 . . . . 74.51 109.958 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.34 155.95 16.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.875 0.369 . . . . 63.2 110.742 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 12.8 t -138.11 156.01 48.18 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.961 -0.563 . . . . 74.34 109.783 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -111.61 117.46 33.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.296 -0.411 . . . . 64.43 109.92 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.4 mt -78.41 147.87 72.87 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.037 -0.529 . . . . 75.32 109.755 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.418 ' HD2' ' CE1' ' A' ' 87' ' ' PHE . 14.6 Cg_endo -59.38 -13.35 20.1 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.117 2.545 . . . . 73.11 112.136 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.0 t -79.49 4.33 15.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.415 -0.811 . . . . 63.2 109.655 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 56.93 63.74 1.84 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 122.127 0.965 . . . . 75.13 110.684 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.554 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 1.2 m80 -148.65 123.4 9.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.184 -1.371 . . . . 74.54 109.682 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -90.75 133.19 35.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.062 -0.517 . . . . 74.51 110.779 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -146.64 168.02 22.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.584 -0.735 . . . . 72.14 109.157 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.1 m170 -75.08 122.58 23.78 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.621 -0.511 . . . . 75.01 109.621 175.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 89.1 tttt -59.0 -51.11 84.18 Favored Pre-proline 0 CA--C 1.538 0.486 0 O-C-N 123.412 0.445 . . . . 41.31 112.093 -175.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.4 Cg_endo -60.74 -20.05 63.92 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.112 1.875 . . . . 64.14 112.956 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 61.3 m -84.38 -49.9 8.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.078 0.466 . . . . 74.02 110.43 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.595 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.9 p -73.37 -25.62 21.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.672 -0.695 . . . . 64.43 111.467 -171.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 13.0 p -59.81 -30.57 69.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.746 0.308 . . . . 62.31 111.597 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.98 -36.6 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.304 0.573 . . . . 75.13 110.419 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -74.66 -41.27 60.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.709 -0.678 . . . . 72.1 111.006 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 92.8 mt -62.24 -27.48 69.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.895 -0.593 . . . . 71.21 112.038 -175.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 71' ' ' SER . 73.9 mt-30 -65.77 -25.18 67.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.087 0.47 . . . . 73.44 110.736 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.96 -39.45 9.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 75.41 110.318 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 p -163.55 125.33 2.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 72.4 110.47 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.46 ' C ' ' HG1' ' A' ' 79' ' ' THR . . . -79.96 91.27 1.31 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.614 -0.803 . . . . 62.34 111.137 177.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.46 ' HG1' ' C ' ' A' ' 78' ' ' GLY . 2.4 m -149.66 144.55 26.21 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.677 -0.308 . . . . 73.51 110.869 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . 0.741 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 83.1 m -74.39 120.92 83.84 Favored Pre-proline 0 N--CA 1.464 0.247 0 N-CA-C 108.386 -0.968 . . . . 72.12 108.386 168.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.48 -21.81 56.05 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.551 2.168 . . . . 62.12 112.832 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.47 -51.44 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.395 -0.366 . . . . 65.22 111.861 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.741 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.9 p -94.4 -22.76 18.1 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.759 0.314 . . . . 51.12 111.712 -172.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.457 ' HA ' HG23 ' A' ' 79' ' ' THR . 59.2 mtt180 60.35 28.08 17.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.762 -0.654 . . . . 74.03 111.695 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.9 m -88.86 160.69 17.1 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.647 -0.501 . . . . 74.03 109.647 172.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 38.2 ttm -76.12 141.14 42.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.647 0.61 . . . . 72.31 112.647 -169.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.418 ' CE1' ' HD2' ' A' ' 60' ' ' PRO . 54.6 t80 -132.74 121.39 17.1 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.282 -0.872 . . . . 74.12 109.539 170.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.51 159.37 85.74 Favored 'Cis proline' 0 C--O 1.232 0.196 0 C-N-CA 123.687 -1.38 . . . . 73.03 111.827 -1.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.57 149.09 14.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.041 2.494 . . . . 73.13 112.19 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.18 135.46 47.13 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.655 2.236 . . . . 73.35 112.114 -175.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 115.485 -0.78 . . . . 73.24 109.168 179.807 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.672 0.272 . . . . 55.14 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.26 65.78 3.56 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.158 -0.544 . . . . 41.45 113.067 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -119.2 90.83 3.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.962 0.41 . . . . 61.21 109.921 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -79.23 124.96 28.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.78 -0.645 . . . . 75.14 111.032 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -100.23 116.53 32.44 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.033 -0.729 . . . . 73.34 109.033 172.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -80.89 128.02 33.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.244 0.545 . . . . 74.4 110.9 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.402 ' CE1' ' HB3' ' A' ' 9' ' ' SER . 7.2 t-80 -144.22 111.09 5.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.285 -0.871 . . . . 72.44 108.689 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -60.93 -22.7 64.64 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.008 0.432 . . . . 74.34 110.862 -175.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.402 ' HB3' ' CE1' ' A' ' 7' ' ' HIS . 39.8 t -91.23 74.22 6.2 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.196 -1.039 . . . . 75.32 108.196 167.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -67.21 -27.21 67.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.611 -0.722 . . . . 73.21 111.797 -172.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.444 ' SD ' ' HB2' ' A' ' 86' ' ' MET . 47.3 ttm 41.18 87.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.369 1.043 . . . . 73.32 113.814 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.46 176.12 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.988 -0.551 . . . . 74.43 110.415 175.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.49 17.2 10.61 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.658 0.599 . . . . 51.21 111.702 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -65.98 139.09 96.55 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 72.54 111.02 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.01 161.85 40.77 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.7 2.267 . . . . 73.12 111.929 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.09 146.48 96.12 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.802 2.335 . . . . 60.31 112.155 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 22' ' ' ILE . . . -85.56 162.76 18.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.243 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.468 ' O ' HG13 ' A' ' 22' ' ' ILE . 14.1 m -67.25 126.06 28.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.345 -0.389 . . . . 73.02 110.786 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -45.14 82.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 72.52 111.546 -175.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.13 -36.46 83.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.748 0.309 . . . . 72.31 111.086 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -67.07 -34.72 78.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.097 0.475 . . . . 72.4 110.321 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 18' ' ' SER . 60.8 mt -74.18 -41.18 51.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 70.14 110.847 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -80.14 -12.18 59.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.024 0.44 . . . . 41.25 110.968 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.85 -13.06 60.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 65.44 110.75 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.34 138.36 94.19 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.864 -0.607 . . . . 71.15 110.328 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -58.42 134.01 58.52 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.342 2.695 . . . . 62.11 113.088 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.506 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 40.0 mt-10 -84.8 102.81 13.34 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.306 -0.628 . . . . 74.44 109.306 173.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.6 mt -92.09 117.18 34.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.119 -0.491 . . . . 73.12 110.934 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.2 tp -78.26 109.34 12.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.791 -0.64 . . . . 74.24 109.553 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.459 HG13 ' HB3' ' A' ' 50' ' ' TYR . 49.1 t -83.05 124.82 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.938 0.399 . . . . 72.14 111.147 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.5 p -101.19 153.88 19.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.311 -0.626 . . . . 51.32 109.311 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -87.89 -177.84 5.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.229 0.455 . . . . 72.11 112.229 -168.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.7 t70 76.07 -0.09 3.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.034 -0.985 . . . . 74.34 110.92 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.438 ' HE1' ' O ' ' A' ' 50' ' ' TYR . 11.7 p-80 -71.25 -21.41 62.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.9 -0.591 . . . . 71.34 112.06 -177.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.04 -82.87 1.41 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.531 -0.843 . . . . 70.31 111.097 -174.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.12 154.28 33.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.705 -0.479 . . . . 73.33 109.705 174.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.15 -56.89 4.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.147 0.499 . . . . 74.34 110.014 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.626 ' O ' ' HG2' ' A' ' 39' ' ' GLN . . . -163.57 103.71 0.22 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.919 -0.872 . . . . 52.33 110.919 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.626 ' HG2' ' O ' ' A' ' 38' ' ' GLY . 8.6 pt20 56.87 -67.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.375 1.47 . . . . 65.3 112.297 -176.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.13 108.11 12.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.161 0.505 . . . . 43.1 109.679 173.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.2 ptp -81.41 -12.05 59.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.885 -0.598 . . . . 74.3 110.62 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 5.9 p -137.32 148.5 46.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.742 -0.663 . . . . 53.33 109.912 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 35.8 t -88.09 107.6 17.03 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.177 -0.465 . . . . 74.31 109.939 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.57 -28.69 86.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.173 2.582 . . . . 54.24 112.66 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.8 mt -65.05 -25.96 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.245 0.545 . . . . 64.02 110.951 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 19.8 m -119.96 -1.87 10.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.111 -0.495 . . . . 62.03 111.144 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.8 p 41.14 42.97 1.8 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.712 0.768 . . . . 71.44 110.558 -168.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 t -142.89 147.26 35.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.981 -1.008 . . . . 75.1 109.464 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 8.3 pt-20 -80.28 -169.8 2.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.457 0.646 . . . . 71.25 111.268 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.492 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.6 m-85 -102.54 109.85 21.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.572 -0.74 . . . . 72.45 109.328 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.87 170.0 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.207 -0.451 . . . . 73.23 111.994 -171.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -60.13 109.25 0.93 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.542 -0.754 . . . . 74.22 111.091 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.24 -0.49 43.87 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.665 -0.779 . . . . 65.11 112.535 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -82.18 147.29 29.09 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.244 -0.651 . . . . 74.01 109.244 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.97 114.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.248 0.547 . . . . 51.22 110.913 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.33 176.75 4.93 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.635 -0.711 . . . . 63.04 110.507 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 6.6 t -152.23 171.06 18.54 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.471 -0.566 . . . . 74.23 109.471 175.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -123.4 119.42 29.98 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.091 -0.336 . . . . 72.13 110.091 -174.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.0 150.08 54.59 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.088 -0.506 . . . . 74.34 111.125 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.09 -9.62 17.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.03 2.487 . . . . 45.21 112.979 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -95.44 8.92 41.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.54 -0.3 . . . . 74.41 110.205 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 65.33 93.0 0.07 Allowed 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 123.82 0.7 . . . . 75.45 109.72 -172.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -175.62 122.47 0.2 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.759 -0.655 . . . . 74.15 110.723 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 57' ' ' THR . 92.2 m-85 -95.53 133.26 39.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.466 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.492 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 86.8 m-85 -140.98 174.77 10.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.755 -0.832 . . . . 72.14 108.755 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.868 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 38.3 m80 -82.02 125.16 30.48 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.271 -1.011 . . . . 74.25 108.271 175.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 60.7 tttm -53.67 -47.68 95.79 Favored Pre-proline 0 C--N 1.322 -0.618 0 O-C-N 123.388 0.43 . . . . 73.34 112.022 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 10.0 Cg_endo -52.88 -50.53 13.74 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.222 1.948 . . . . 64.22 113.246 177.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.868 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 26.3 p -76.54 -35.47 58.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.806 -0.358 . . . . 73.52 111.95 -173.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -74.16 -28.65 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.337 . . . . 74.22 110.271 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.417 ' HA ' HG23 ' A' ' 22' ' ' ILE . 33.0 t -60.79 -50.01 75.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 63.34 109.941 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.1 mt -61.08 -37.43 77.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 65.1 110.615 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -68.45 -50.84 49.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.798 -0.637 . . . . 73.32 111.257 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.86 -25.55 67.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.776 0.322 . . . . 71.32 111.203 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -75.0 -1.4 22.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 62.2 110.793 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -112.24 -48.39 3.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.254 0.55 . . . . 61.4 109.676 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.9 m -145.65 119.55 9.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.669 . . . . 74.53 110.413 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.13 71.71 1.95 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.845 -0.693 . . . . 72.55 112.332 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.9 142.82 29.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.229 -0.286 . . . . 73.32 110.229 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 47.0 t -74.69 113.61 26.11 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.006 -0.738 . . . . 75.22 109.006 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.77 -24.78 77.09 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 123.073 2.516 . . . . 73.25 114.03 -171.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.47 -59.15 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.069 0.396 . . . . 64.12 112.069 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 30.6 p -95.32 -11.25 28.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.938 -0.305 . . . . 71.22 111.478 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 62.42 80.57 0.22 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.795 0.807 . . . . 61.34 111.057 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.5 t -137.82 135.94 36.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.531 -1.213 . . . . 73.52 108.24 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.524 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 50.5 ttm -72.97 141.09 47.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.837 0.351 . . . . 72.31 111.301 -173.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -133.82 114.31 13.01 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.848 -0.614 . . . . 74.02 109.856 176.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.26 153.13 98.58 Favored 'Cis proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.147 -1.605 . . . . 72.14 111.861 -2.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.82 148.5 45.78 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.808 2.339 . . . . 71.44 112.633 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 31.9 Cg_endo -63.72 153.39 75.57 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.826 2.351 . . . . 71.04 112.456 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 C--O 1.246 0.917 0 CA-C-N 115.816 -0.629 . . . . 71.1 109.746 178.834 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 72.5 Cg_endo . . . . . 0 N--CA 1.461 -0.383 0 CA-C-O 120.872 0.28 . . . . 73.02 112.553 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.6 153.36 65.11 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.608 2.205 . . . . 64.23 112.299 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.95 167.73 16.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.005 -0.543 . . . . 54.54 111.043 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -94.81 151.31 19.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.104 -0.498 . . . . 75.33 109.943 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HD2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -58.95 -37.56 77.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.493 -0.321 . . . . 74.12 110.494 -176.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -56.93 -41.87 78.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.972 -0.558 . . . . 72.31 111.125 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -72.25 -27.03 62.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 60.44 111.085 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.549 HG21 ' HA ' ' A' ' 71' ' ' SER . 42.8 mt -82.86 -38.8 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.399 0.618 . . . . 71.3 110.516 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.68 -20.68 64.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.987 -0.551 . . . . 71.22 110.505 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.9 -3.81 55.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.772 -0.649 . . . . 51.22 111.378 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.4 152.34 85.67 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.553 -0.294 . . . . 72.24 110.453 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.93 122.91 11.64 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.715 2.277 . . . . 71.41 112.175 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -86.91 118.3 26.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.024 -0.535 . . . . 62.04 110.133 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.3 mt -110.19 103.63 15.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.82 -0.627 . . . . 61.51 110.264 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 68.9 tp -68.24 114.62 6.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.549 -0.538 . . . . 75.4 109.549 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 40.0 t -70.13 111.05 3.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.971 -0.381 . . . . 74.33 109.971 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.2 p -88.19 169.74 11.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 65.13 110.379 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.37 -8.34 56.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.027 0.38 . . . . 40.31 112.027 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -91.46 -2.42 57.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.154 0.502 . . . . 75.2 109.839 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -109.21 90.68 3.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.922 -0.581 . . . . 71.2 111.102 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.93 -26.82 48.03 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.909 -0.877 . . . . 74.03 110.909 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.19 140.46 41.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.482 -0.562 . . . . 74.4 109.482 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 t -118.86 90.8 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.765 0.317 . . . . 60.41 110.727 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.92 13.9 60.17 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.976 -0.556 . . . . 74.53 113.307 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.97 -155.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.61 -0.515 . . . . 50.44 109.61 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -68.94 177.63 2.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.815 -0.439 . . . . 70.24 109.815 173.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 1.8 pmm? -84.33 0.0 50.86 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.006 -0.278 . . . . 75.31 110.468 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.7 m -116.36 131.84 56.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.079 0.466 . . . . 65.13 112.038 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 14.5 t -83.48 107.93 11.61 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.595 -0.891 . . . . 63.53 108.595 171.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 9.8 Cg_endo -51.22 -38.91 62.23 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.331 2.687 . . . . 73.01 112.878 -173.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 51.7 mt -62.29 -29.48 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.961 -0.563 . . . . 71.22 111.347 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 61.2 m -110.12 -8.62 14.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.377 -0.374 . . . . 72.31 111.623 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.4 p 45.18 34.99 1.53 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.459 0.647 . . . . 52.11 110.949 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.1 t -133.82 159.82 39.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.496 -0.775 . . . . 61.43 110.0 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 41' ' ' MET . 4.6 pt-20 -83.96 172.57 11.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.736 0.643 . . . . 64.43 112.736 -171.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -98.05 123.91 42.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.374 -0.83 . . . . 75.22 110.289 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.26 164.83 28.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.178 -0.465 . . . . 74.24 110.411 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.657 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.2 ttpt -58.77 125.64 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 60.2 111.047 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.83 -23.96 6.5 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.669 -0.777 . . . . 60.41 112.702 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.57 161.53 18.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.031 -0.359 . . . . 64.2 110.031 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.88 115.25 49.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.927 0.394 . . . . 71.51 110.351 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -100.96 168.35 9.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.211 -0.45 . . . . 62.11 110.417 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.0 t -152.76 166.2 32.97 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.229 -0.656 . . . . 73.33 109.229 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -120.39 119.71 33.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.688 0.28 . . . . 61.11 110.691 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.496 HD21 HD11 ' A' ' 74' ' ' LEU . 88.2 mt -70.39 142.36 89.3 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 108.84 -0.8 . . . . 62.31 108.84 170.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 9.6 Cg_endo -52.79 -20.84 13.68 Favored 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.663 2.908 . . . . 74.43 113.841 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.7 p -85.88 19.33 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 70.13 110.376 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 58.01 65.39 1.31 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.411 -0.813 . . . . 75.22 111.612 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -145.08 123.09 12.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.427 -0.806 . . . . 64.42 109.449 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.77 141.32 28.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.026 -0.533 . . . . 63.53 111.796 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -149.07 175.18 11.55 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.138 -1.06 . . . . 75.53 108.138 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.887 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 35.9 m170 -77.28 133.67 38.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.433 -0.951 . . . . 63.45 108.433 170.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 87.1 tttt -57.66 -50.74 86.45 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 119.481 -0.295 . . . . 55.52 111.319 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 6.6 Cg_endo -49.31 -46.88 24.32 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.566 2.177 . . . . 73.03 113.481 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.887 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 14.3 p -80.62 -34.06 35.33 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.492 -0.483 . . . . 71.32 111.933 -175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 67' ' ' LYS . 5.5 p -73.77 -30.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.565 -0.454 . . . . 72.4 110.562 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.549 ' HA ' HG21 ' A' ' 22' ' ' ILE . 51.1 m -63.38 -32.99 74.57 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.977 0.418 . . . . 71.41 110.776 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.0 mt -79.42 -42.45 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 73.43 110.056 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -63.35 -43.82 96.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.896 -0.593 . . . . 74.52 111.363 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 87' ' ' PHE . 95.7 mt -66.74 -24.34 66.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.642 -0.254 . . . . 75.43 111.666 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -92.49 0.55 57.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.904 0.383 . . . . 72.42 110.662 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -114.95 -41.72 3.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 73.31 111.398 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.9 m -120.94 -20.38 6.91 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.815 0.302 . . . . 63.42 111.815 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.58 26.64 60.08 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.37 -0.377 . . . . 62.03 114.018 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.26 145.09 40.9 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.339 -0.506 . . . . 63.02 111.79 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.45 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 24.3 t -75.03 110.69 10.7 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.741 -0.663 . . . . 73.13 109.251 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.22 -32.99 34.53 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.211 2.608 . . . . 64.14 113.993 -171.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.93 -28.64 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.393 0.516 . . . . 75.33 112.393 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 29.4 p -125.06 -13.13 6.87 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 121.818 -0.551 . . . . 64.32 112.093 -174.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 66.36 23.07 10.72 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.029 0.532 . . . . 73.01 111.237 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.3 t -85.01 145.31 27.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.939 -0.763 . . . . 43.04 108.939 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.479 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 58.7 ttp -75.51 150.51 38.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.926 0.393 . . . . 74.24 111.447 -175.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.552 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 81.1 t80 -129.5 125.98 22.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 108.791 -0.818 . . . . 71.45 108.791 170.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.552 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 30.9 Cg_endo -61.87 153.42 61.61 Favored 'Cis proline' 0 C--N 1.348 0.523 0 C-N-CA 123.988 -1.255 . . . . 73.22 113.019 3.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 42.7 Cg_exo -55.34 138.32 79.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.033 2.489 . . . . 73.21 112.61 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.479 ' HG3' ' HB3' ' A' ' 86' ' ' MET . 6.2 Cg_exo -72.24 177.5 7.18 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.665 2.243 . . . . 70.02 111.914 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.701 -0.666 . . . . 72.35 110.231 -176.736 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 20.4 Cg_endo . . . . . 0 C--O 1.236 0.391 0 N-CA-C 113.053 0.366 . . . . 72.12 113.053 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 38.0 Cg_exo -61.84 163.38 19.15 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.168 2.579 . . . . 62.04 112.239 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -86.06 153.87 21.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 72.24 110.714 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.404 ' O ' HG13 ' A' ' 22' ' ' ILE . 22.4 m -71.96 137.96 47.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.957 -0.565 . . . . 62.02 110.626 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -58.21 -41.43 84.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.105 -0.498 . . . . 63.42 110.57 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -52.17 -45.91 65.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.996 -1.002 . . . . 72.23 110.987 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.506 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 13.8 m -67.68 -42.33 82.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.083 -0.508 . . . . 72.52 110.679 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 18' ' ' SER . 66.4 mt -61.92 -40.93 88.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 73.1 110.81 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.16 -44.11 80.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.945 -0.571 . . . . 74.1 110.79 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.6 3.89 30.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.932 -0.576 . . . . 61.23 112.287 -174.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.544 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 40.5 mt -57.85 127.78 79.56 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 116.89 -0.141 . . . . 74.44 111.027 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.13 126.3 21.15 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.161 2.574 . . . . 72.14 111.77 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.97 116.46 31.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.958 -0.564 . . . . 74.31 110.783 -172.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.9 mt -104.69 129.01 57.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.673 -0.694 . . . . 71.34 110.053 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 46.8 tp -82.23 120.4 25.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.123 -0.49 . . . . 72.12 110.367 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.992 HG13 ' HA2' ' A' ' 35' ' ' GLY . 97.9 t -90.28 128.3 42.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.998 -0.546 . . . . 63.02 111.032 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' HG3' ' A' ' 52' ' ' LYS . 17.7 p -137.35 172.95 12.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.463 -0.789 . . . . 74.54 109.825 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.438 ' OE1' ' HD3' ' A' ' 52' ' ' LYS . 4.5 mp0 -59.76 130.21 45.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.404 -0.221 . . . . 64.53 110.404 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 69.01 10.94 8.18 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.928 -0.578 . . . . 54.13 111.523 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -141.32 34.76 1.68 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.568 -1.271 . . . . 63.0 107.568 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.992 ' HA2' HG13 ' A' ' 30' ' ' VAL . . . -93.9 -56.81 1.37 Allowed Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.985 -1.007 . . . . 61.04 113.461 -172.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.33 -60.57 3.22 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.659 0.23 . . . . 74.4 111.23 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t 60.51 91.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.829 -0.623 . . . . 74.45 111.422 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . 99.4 -89.32 0.88 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.388 -0.911 . . . . 64.51 113.269 175.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -141.16 -52.65 0.46 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.833 0.317 . . . . 73.52 111.625 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.39 107.24 2.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.864 0.364 . . . . 55.21 111.082 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.438 ' HG2' ' SG ' ' A' ' 42' ' ' CYS . 1.8 pmm? -84.16 -18.3 37.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.098 0.475 . . . . 71.2 110.421 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.438 ' SG ' ' HG2' ' A' ' 41' ' ' MET . 78.2 m -136.82 159.22 42.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.639 -0.71 . . . . 73.21 109.739 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.6 t -105.56 102.21 36.53 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.501 -0.555 . . . . 65.41 109.501 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.55 -28.35 86.49 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.84 2.36 . . . . 73.22 111.788 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.0 mt -61.98 -29.69 46.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.437 -0.801 . . . . 54.0 111.762 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.3 p -121.38 2.4 10.24 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.87 -0.332 . . . . 74.14 111.313 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 76.9 m 50.66 62.13 2.86 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.415 0.626 . . . . 72.14 111.027 -175.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.8 t -159.43 152.81 22.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.428 -0.805 . . . . 71.33 109.708 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.512 ' HG3' HG13 ' A' ' 51' ' ' VAL . 11.4 pt-20 -77.75 -173.04 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.288 0.566 . . . . 62.5 110.889 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.52 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 37.0 m-85 -97.96 106.68 19.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.046 -0.525 . . . . 63.54 110.65 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.512 HG13 ' HG3' ' A' ' 49' ' ' GLU . 31.2 m -118.59 162.84 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.786 -0.643 . . . . 75.31 110.889 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 34.1 ttpt -62.78 112.91 2.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.609 . . . . 71.23 110.754 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.5 -31.48 2.85 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.885 -0.674 . . . . 60.32 111.726 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.2 133.34 34.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.675 0.274 . . . . 74.34 110.301 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.65 127.59 40.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.448 -0.342 . . . . 64.44 110.764 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.4 9.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.263 -0.426 . . . . 65.01 109.995 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.544 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 13.2 t -148.51 153.31 38.27 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.899 -0.408 . . . . 75.43 109.899 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -107.49 117.7 34.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.046 0.45 . . . . 74.51 110.335 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -80.75 140.69 51.03 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.893 -0.78 . . . . 73.3 108.893 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.47 ' HB2' ' HG3' ' A' ' 89' ' ' PRO . 17.1 Cg_endo -58.81 -7.8 4.98 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.896 2.397 . . . . 71.23 112.106 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.6 t -87.42 21.34 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.241 -0.891 . . . . 74.22 109.784 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 57.44 40.33 27.37 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.803 -0.635 . . . . 72.11 111.321 176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -138.06 148.89 45.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.536 -0.302 . . . . 72.51 111.067 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 60.8 m-85 -124.39 133.51 53.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.148 -0.478 . . . . 74.1 111.084 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.52 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 92.5 m-85 -146.49 162.52 38.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.595 . . . . 65.21 109.798 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 33.9 m170 -67.13 123.16 19.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.478 -0.564 . . . . 72.53 109.478 174.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.539 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 83.2 tttt -57.57 -48.86 96.53 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 123.349 0.406 . . . . 72.33 111.866 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 12.2 Cg_endo -56.84 -27.16 70.72 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.162 1.908 . . . . 61.35 112.844 177.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 37.3 m -84.53 -52.77 5.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.142 0.496 . . . . 65.43 111.122 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.534 HG22 ' HG ' ' A' ' 74' ' ' LEU . 9.8 p -67.17 -25.6 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 62.13 111.404 -172.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.5 p -63.49 -30.38 71.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.807 0.337 . . . . 73.23 111.437 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.4 mt -78.88 -40.15 22.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.253 0.549 . . . . 74.55 109.917 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -65.82 -43.19 89.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.453 -0.794 . . . . 71.51 111.481 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 93.1 mt -67.03 -19.33 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.953 0.353 . . . . 73.32 111.953 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -74.28 -22.27 59.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.046 0.451 . . . . 72.15 110.327 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -91.19 -45.17 8.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.713 -0.676 . . . . 64.4 109.851 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -157.37 133.05 9.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.819 -0.628 . . . . 64.11 110.247 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.01 77.61 2.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.681 -0.771 . . . . 35.45 111.226 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 m -148.52 148.85 30.68 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.169 -0.308 . . . . 54.3 110.169 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.752 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 73.7 m -75.12 119.83 78.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 108.23 -1.026 . . . . 72.03 108.23 168.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.83 -12.07 20.47 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.468 2.112 . . . . 75.23 113.04 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.6 t -96.15 -50.21 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 111.861 0.319 . . . . 74.35 111.861 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 20.4 p -96.0 -18.88 19.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.761 0.315 . . . . 55.14 111.629 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 63.08 25.57 15.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.012 -0.54 . . . . 73.51 111.887 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -92.42 151.06 20.43 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.487 -0.56 . . . . 44.05 109.487 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 52.8 ttp -76.31 146.89 38.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.033 0.753 . . . . 61.24 113.033 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.545 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 76.6 t80 -133.16 124.47 18.42 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.803 -1.089 . . . . 73.41 108.527 170.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 32.7 Cg_exo -59.6 144.48 33.62 Favored 'Cis proline' 0 C--N 1.35 0.643 0 C-N-CA 124.558 -1.017 . . . . 72.41 113.181 3.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.47 ' HG3' ' HB2' ' A' ' 60' ' ' PRO . 52.9 Cg_endo -67.48 149.76 80.2 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.059 2.506 . . . . 63.31 112.611 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.5 178.71 5.31 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.709 2.273 . . . . 65.24 111.814 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.41 -0.805 . . . . 63.32 110.266 -179.747 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 N--CA 1.455 -0.782 0 CA-C-O 120.504 0.127 . . . . 61.12 112.056 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -73.88 136.85 23.54 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.91 1.74 . . . . 73.13 111.326 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -79.96 127.73 32.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.43 -0.35 . . . . 72.32 110.529 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 p -74.64 166.55 23.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.091 -0.504 . . . . 71.35 110.736 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -57.64 -35.17 70.15 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.248 -0.433 . . . . 62.41 110.946 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.42 -35.26 69.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.938 0.399 . . . . 65.11 111.181 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 m -85.83 -35.41 20.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.025 -0.534 . . . . 64.41 111.173 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.512 HG21 ' HA ' ' A' ' 71' ' ' SER . 68.1 mt -82.89 -44.44 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.017 0.437 . . . . 75.24 111.903 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.75 -33.73 74.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.013 -0.54 . . . . 50.01 110.762 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.77 4.93 26.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.697 -0.683 . . . . 43.32 112.186 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.44 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 66.7 mt -70.75 136.17 85.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.609 0.242 . . . . 62.13 110.511 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.61 149.37 67.9 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.256 2.637 . . . . 71.44 112.782 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.64 121.33 44.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 71.13 110.4 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.3 mt -109.44 120.55 60.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.743 -0.662 . . . . 70.2 109.883 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.0 tp -79.93 107.67 12.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.796 -0.446 . . . . 73.54 109.796 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' ' 50' ' ' TYR . 42.5 t -74.86 131.86 34.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.051 -0.522 . . . . 61.1 110.902 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 35.2 p -120.17 145.21 47.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.966 -0.561 . . . . 73.42 109.883 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.488 ' HG2' ' HD3' ' A' ' 52' ' ' LYS . 16.7 pt-20 -71.7 -17.43 62.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.705 0.288 . . . . 74.33 111.221 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -68.29 -23.03 64.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.466 -0.334 . . . . 61.23 110.382 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -90.76 -13.81 33.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 65.11 109.913 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.2 -80.38 0.98 Allowed Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.967 -0.56 . . . . 72.41 112.164 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.78 -172.8 2.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.78 -0.452 . . . . 62.01 109.78 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.87 95.42 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.085 0.469 . . . . 74.43 110.159 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.5 -110.44 3.49 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.794 -0.639 . . . . 71.14 111.756 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -98.48 -14.77 19.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.741 0.305 . . . . 72.55 111.19 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HG3' ' H ' ' A' ' 64' ' ' TYR . 58.1 mm-40 -99.36 133.69 43.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.247 0.546 . . . . 65.35 110.954 -174.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.3 ptp -121.44 -5.04 9.33 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.489 -0.778 . . . . 75.41 111.61 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.2 p -150.48 151.77 33.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.329 . . . . 74.04 110.924 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.9 t -109.79 93.01 13.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 71.44 109.57 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.15 -18.29 57.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.375 2.717 . . . . 73.35 113.006 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.6 mt -63.94 -27.93 43.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.17 -0.468 . . . . 64.23 110.632 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.6 p -127.07 -7.4 5.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.622 -0.263 . . . . 60.04 111.107 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 71.0 m 61.4 35.9 17.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.128 -0.487 . . . . 74.35 110.784 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -124.38 159.25 30.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.805 -0.634 . . . . 73.34 110.299 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.85 -174.4 5.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.817 -0.629 . . . . 75.52 111.389 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.655 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 96.4 m-85 -108.58 118.68 37.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.26 -0.427 . . . . 75.22 110.168 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.18 174.67 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.392 -0.367 . . . . 60.52 111.293 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HD3' ' HG2' ' A' ' 32' ' ' GLU . 35.9 ttpt -76.87 124.22 27.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.097 -0.501 . . . . 73.44 110.652 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.67 0.73 55.33 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.885 -0.674 . . . . 61.11 111.711 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -87.24 157.83 19.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.531 -0.544 . . . . 72.12 109.531 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.45 114.47 47.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.342 0.592 . . . . 74.33 111.166 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.5 166.64 10.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.486 -0.779 . . . . 53.15 110.066 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.491 HG21 HG11 ' A' ' 70' ' ' VAL . 7.6 t -131.01 171.71 12.92 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.832 -0.433 . . . . 72.02 109.832 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.509 ' HG2' ' CE2' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -126.4 118.35 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.342 -0.614 . . . . 75.22 109.342 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.8 mt -87.5 147.23 41.35 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.273 -0.421 . . . . 64.34 110.538 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.44 4.32 0.48 Allowed 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.048 2.499 . . . . 64.52 113.702 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.1 p -109.35 8.41 25.5 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.969 -0.382 . . . . 51.34 109.969 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.1 m170 66.59 89.13 0.1 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.757 -0.656 . . . . 73.34 110.371 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -172.53 125.4 0.49 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.52 -0.763 . . . . 72.12 110.126 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CE2' ' HG2' ' A' ' 58' ' ' GLU . 39.0 m-85 -103.83 133.28 49.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 72.24 110.047 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.655 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 90.0 m-85 -146.24 155.75 42.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.143 -0.48 . . . . 72.01 109.912 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 26.1 m170 -56.28 124.18 17.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.213 -0.662 . . . . 72.23 109.213 171.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.51 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 86.0 tttt -57.41 -49.27 94.82 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 119.297 -0.382 . . . . 70.01 111.462 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 77.6 Cg_exo -53.29 -36.22 77.44 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.865 1.71 . . . . 72.21 112.559 176.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 71.2 m -70.59 -51.59 27.31 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.428 -0.351 . . . . 62.21 111.13 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.491 HG11 HG21 ' A' ' 57' ' ' THR . 7.5 p -65.93 -26.73 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.001 -0.545 . . . . 43.43 110.3 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.512 ' HA ' HG21 ' A' ' 22' ' ' ILE . 50.3 m -60.96 -55.28 34.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.346 -0.388 . . . . 73.35 110.013 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.26 -40.63 84.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 74.03 110.789 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -64.94 -53.21 50.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 71.24 111.348 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 96.5 mt -66.41 -31.26 71.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.736 -0.211 . . . . 62.34 111.55 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -59.97 -30.71 69.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.759 0.314 . . . . 70.21 110.766 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.48 -40.29 10.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.838 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.7 p -153.79 115.21 4.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 62.14 110.683 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.83 71.38 2.88 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.864 -0.684 . . . . 73.11 112.643 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 1.3 m -146.43 141.14 26.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.781 -0.452 . . . . 73.42 109.781 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.0 t -74.56 113.01 19.98 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.091 -0.707 . . . . 74.33 109.091 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.78 -37.95 96.84 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.844 2.362 . . . . 71.02 113.378 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -71.42 -48.81 51.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.515 0.561 . . . . 74.12 112.515 -174.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.71 -8.81 13.22 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.62 -0.432 . . . . 72.55 111.992 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 63.67 91.71 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.629 0.728 . . . . 61.21 110.943 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 79' ' ' THR . 44.0 t -144.4 130.83 19.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.042 -0.981 . . . . 54.1 108.862 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.556 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 43.4 ttm -64.6 140.9 58.92 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.509 0.506 . . . . 72.43 110.391 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.44 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 70.3 t80 -131.83 116.26 15.83 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.035 -0.53 . . . . 74.41 109.69 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.99 155.12 99.74 Favored 'Cis proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.232 -1.57 . . . . 52.25 112.426 -0.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.39 151.55 29.43 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 123.264 2.643 . . . . 73.44 113.221 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 86.9 Cg_endo -80.6 170.63 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.786 2.324 . . . . 63.1 112.429 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.278 -0.868 . . . . 71.15 109.729 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 CA--C 1.532 0.389 0 CA-C-O 120.67 0.196 . . . . 71.23 112.341 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.11 149.87 41.96 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.858 2.372 . . . . 72.14 112.5 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.45 157.98 24.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.778 -0.646 . . . . 53.13 110.993 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -67.93 139.72 56.44 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.679 -0.489 . . . . 74.13 109.679 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -61.52 -37.36 83.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 74.21 111.178 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 3.1 mp0 -60.0 -42.49 94.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.4 -0.364 . . . . 71.15 110.287 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.462 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.7 m -62.16 -40.04 94.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 65.33 110.823 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.14 -40.95 78.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.861 -0.609 . . . . 71.4 110.647 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.79 -32.89 65.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.16 -0.473 . . . . 64.44 111.179 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.65 -0.31 37.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.482 -0.326 . . . . 72.21 111.86 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.514 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 67.5 mt -64.99 123.3 83.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.605 0.241 . . . . 73.5 110.791 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.57 117.99 4.8 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.154 2.569 . . . . 72.45 112.332 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -78.4 121.99 25.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.087 -0.506 . . . . 72.53 110.808 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.4 mt -115.91 120.82 65.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.041 -0.527 . . . . 72.45 110.03 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.2 tp -75.71 119.51 19.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.74 -0.467 . . . . 73.23 109.74 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 40.3 t -85.91 121.56 37.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.072 0.463 . . . . 40.2 111.258 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.432 HG22 ' HG3' ' A' ' 52' ' ' LYS . 24.0 p -123.37 165.79 16.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.479 -0.782 . . . . 74.12 109.661 173.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.543 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 31.5 mt-10 -68.16 -30.22 69.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.937 0.398 . . . . 74.45 111.311 -173.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.31 -17.97 64.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.029 -0.532 . . . . 63.2 112.222 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -75.95 -17.52 59.7 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.044 0.387 . . . . 72.13 112.044 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.22 69.43 1.32 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.767 -0.73 . . . . 54.11 113.075 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 67.17 -2.83 1.11 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.328 0.651 . . . . 74.42 112.666 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.5 t 72.77 -64.84 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.193 0.597 . . . . 71.42 111.742 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.56 -161.57 9.06 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.657 -0.782 . . . . 74.2 112.496 -176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -62.27 -28.77 69.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.02 0.438 . . . . 55.33 110.803 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -80.52 110.6 16.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.43 -0.952 . . . . 75.44 108.43 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.1 ptp -103.8 -2.2 26.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.16 -0.473 . . . . 72.25 111.382 -173.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 82.0 m -146.42 147.52 31.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.341 -0.391 . . . . 75.14 110.571 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.0 t -103.78 94.74 6.62 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.081 -0.711 . . . . 65.1 109.081 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.87 -8.99 17.24 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.37 2.713 . . . . 43.2 112.84 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.5 mt -76.2 -32.92 23.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.019 -0.537 . . . . 75.44 110.508 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.8 p -114.86 -3.2 12.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.755 0.312 . . . . 70.55 111.045 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.0 t 67.64 23.37 8.79 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.564 -0.744 . . . . 71.04 111.103 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.1 m -129.47 158.78 38.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 63.11 110.405 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.9 OUTLIER -84.61 -169.67 2.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.171 -0.468 . . . . 64.15 111.1 -177.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 96.8 m-85 -93.94 94.23 8.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.483 0.659 . . . . 74.52 110.899 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.24 173.74 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.766 -1.106 . . . . 73.52 111.01 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 32.9 ttpt -75.48 123.24 25.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.969 -0.56 . . . . 75.11 110.806 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.63 -24.28 6.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.691 -0.766 . . . . 61.35 112.709 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -87.04 161.26 18.27 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.572 -0.529 . . . . 72.5 109.572 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.3 t -111.26 124.75 68.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.916 0.389 . . . . 74.22 110.056 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -111.73 172.69 6.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.315 -0.402 . . . . 63.13 110.777 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 12.7 t -152.76 161.13 42.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.903 -0.59 . . . . 74.4 109.59 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -108.31 117.59 34.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.85 0.357 . . . . 74.13 111.229 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.9 mt -76.84 152.94 82.98 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.913 -0.773 . . . . 73.23 108.913 171.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.83 51.04 0.62 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 122.959 2.439 . . . . 74.54 111.189 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 45.4 t -153.37 16.8 0.54 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.041 -0.982 . . . . 72.32 109.677 -172.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 56.95 18.16 3.76 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.54 -0.755 . . . . 72.14 111.775 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 3.3 m170 -111.13 115.63 29.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.189 -0.459 . . . . 71.41 110.563 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -91.99 133.26 35.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.617 -0.719 . . . . 72.3 109.728 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.605 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 74.9 m-85 -136.7 155.73 49.47 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.367 0.417 . . . . 75.23 110.143 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 32.2 m170 -65.71 121.21 14.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.225 -0.658 . . . . 75.14 109.225 174.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.5 tttt -56.57 -51.49 80.79 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 123.576 0.547 . . . . 74.41 111.966 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.0 Cg_endo -58.68 -27.97 84.89 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.237 1.958 . . . . 61.23 112.572 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 57.5 m -80.34 -50.61 9.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.069 -0.514 . . . . 74.35 110.419 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.1 p -72.52 -27.47 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.669 -0.696 . . . . 74.14 111.125 -172.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.6 t -59.3 -42.52 91.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.007 0.432 . . . . 63.35 110.448 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.93 -36.76 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.269 0.557 . . . . 73.12 110.204 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -72.29 -51.96 18.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.441 -0.799 . . . . 71.5 110.778 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 95.9 mt -60.03 -33.74 72.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.016 -0.538 . . . . 72.34 112.369 -174.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.5 -18.91 65.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.05 0.389 . . . . 63.41 112.05 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -111.4 -16.69 13.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 73.15 110.925 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 26.4 t -172.33 117.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 74.25 109.763 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.12 91.53 1.7 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.556 -0.83 . . . . 63.42 111.681 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 2.8 p -149.28 155.03 39.92 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.3 0.481 . . . . 65.3 112.3 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 35.0 m -74.79 112.0 15.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.843 -1.169 . . . . 73.24 107.843 160.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.91 -15.6 22.63 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.53 2.153 . . . . 65.23 112.379 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.6 t -89.93 -48.85 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.007 -0.542 . . . . 75.34 111.847 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 20.0 p -107.81 -3.13 19.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.62 0.6 . . . . 70.43 112.62 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? 68.06 14.71 9.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.039 0.755 . . . . 70.52 113.039 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 79' ' ' THR . 17.2 p -79.92 150.85 30.4 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.92 -0.488 . . . . 73.14 110.249 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.556 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 40.1 ttm -81.32 144.36 31.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.123 0.487 . . . . 61.41 111.376 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 77.8 t80 -135.43 123.53 15.42 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.497 -0.774 . . . . 74.01 109.547 172.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.28 152.42 84.75 Favored 'Cis proline' 0 C--N 1.343 0.272 0 C-N-CA 123.339 -1.525 . . . . 70.13 111.528 -2.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.37 149.44 56.06 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.83 2.354 . . . . 73.03 112.412 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 96.0 Cg_endo -81.82 147.29 15.17 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.66 2.24 . . . . 74.34 111.406 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.344 -0.836 . . . . 74.02 110.011 179.658 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 CA--C 1.53 0.282 0 CA-C-O 120.479 0.116 . . . . 72.31 112.149 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.42 159.81 22.67 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.041 2.494 . . . . 72.43 112.154 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.38 160.16 15.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.279 -0.419 . . . . 61.24 110.487 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -88.91 158.38 18.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.614 -0.267 . . . . 44.54 110.417 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -58.16 -45.45 87.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.176 -0.465 . . . . 73.02 111.411 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -45.71 -54.64 7.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 75.41 112.163 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.99 -23.38 67.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.155 0.428 . . . . 71.44 112.155 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.538 HG21 ' HA ' ' A' ' 71' ' ' SER . 37.2 mt -87.16 -38.46 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.48 0.657 . . . . 53.42 110.1 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -68.39 -30.5 69.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.546 -0.752 . . . . 72.41 110.884 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -19.19 65.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.164 -0.471 . . . . 53.3 111.363 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.88 144.52 97.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 63.01 110.514 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.85 159.13 26.15 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.192 2.595 . . . . 63.35 113.153 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -120.17 110.09 16.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 74.11 110.035 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 54.0 mt -104.68 129.07 57.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.711 -0.677 . . . . 74.32 110.871 -175.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.2 tp -83.82 117.07 23.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.249 -0.648 . . . . 74.35 109.249 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 49.1 t -76.67 117.28 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.054 0.454 . . . . 73.3 111.634 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 p -112.22 148.0 35.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.643 -0.708 . . . . 64.52 110.307 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 27.4 mt-10 -78.47 -26.74 46.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.914 0.388 . . . . 72.41 111.76 -174.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.98 -4.23 27.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.275 0.843 . . . . 64.1 113.275 -168.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -113.08 9.24 18.56 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.233 -0.587 . . . . 74.4 110.537 176.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.5 -130.67 23.62 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.897 -0.592 . . . . 72.12 112.122 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.21 147.37 49.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.664 0.269 . . . . 61.2 110.52 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.76 97.91 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.052 0.454 . . . . 63.53 110.109 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.16 -80.35 0.85 Allowed Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.558 -0.746 . . . . 63.44 112.21 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.794 ' HG3' ' HG2' ' A' ' 40' ' ' GLU . 15.6 pt20 -138.73 -1.77 1.8 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.683 0.278 . . . . 63.33 111.343 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.794 ' HG2' ' HG3' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -128.34 144.48 51.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.26 -0.274 . . . . 64.23 110.26 -173.401 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.2 ptp -123.83 -8.16 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.499 -0.318 . . . . 72.41 111.271 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 81.5 m -132.73 151.95 51.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.051 0.453 . . . . 71.21 111.142 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 38.9 t -118.16 91.93 41.46 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.758 -0.656 . . . . 73.14 109.298 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.2 Cg_endo -51.74 -30.7 38.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.833 3.022 . . . . 65.53 113.562 -173.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.8 mt -56.99 -37.34 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.334 -0.394 . . . . 71.22 111.465 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.6 p -109.31 0.11 19.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 62.44 110.298 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.1 m 60.38 16.01 5.93 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.257 -0.883 . . . . 71.3 111.49 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.3 t -117.31 165.76 13.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.785 -0.45 . . . . 71.44 109.785 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 7.2 pt-20 -99.51 -170.08 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.266 -0.425 . . . . 63.34 111.296 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.477 ' HB3' HG11 ' A' ' 30' ' ' VAL . 55.9 m-85 -95.1 110.23 22.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.213 0.53 . . . . 75.42 111.539 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.17 167.24 12.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.337 -0.847 . . . . 72.32 110.367 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 40.0 ttmt -71.51 126.33 29.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.347 -0.388 . . . . 73.54 111.198 -174.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.61 -15.44 19.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.742 . . . . 71.23 112.301 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -86.8 162.92 17.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.94 -0.393 . . . . 52.13 109.94 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -112.82 121.18 64.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.984 0.421 . . . . 71.35 110.78 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -103.97 170.19 8.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.08 -0.509 . . . . 63.34 110.697 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 8.3 t -147.7 173.35 12.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.054 -0.521 . . . . 73.35 109.711 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -118.96 119.43 34.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.675 0.274 . . . . 74.14 110.462 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.08 137.72 35.1 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.653 -0.499 . . . . 72.12 109.653 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.55 -15.77 26.82 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.287 2.658 . . . . 53.54 113.448 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 p -87.24 11.8 13.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.442 0.163 . . . . 64.41 110.897 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.3 m80 69.22 62.44 0.3 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.287 0.565 . . . . 74.22 111.015 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -150.67 152.16 33.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.438 -0.801 . . . . 74.44 109.336 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -118.78 133.23 55.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.994 0.426 . . . . 64.22 110.641 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.416 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 47.7 m-85 -143.08 157.94 44.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.659 -0.7 . . . . 74.41 109.976 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.609 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 33.3 m170 -68.4 125.91 27.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.687 -0.857 . . . . 71.51 108.687 172.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 85.5 tttt -57.57 -50.3 88.9 Favored Pre-proline 0 CA--C 1.536 0.44 0 O-C-N 123.405 0.441 . . . . 63.43 112.061 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 73.6 Cg_exo -52.59 -42.48 61.82 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.686 1.591 . . . . 72.31 112.395 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 57.9 m -63.15 -53.13 58.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.0 0.428 . . . . 62.32 110.918 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 67' ' ' LYS . 8.7 p -67.56 -27.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 64.03 110.792 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 53.1 m -61.58 -51.03 70.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.699 0.285 . . . . 53.5 110.393 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.65 -37.31 79.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.379 0.609 . . . . 71.11 110.414 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -64.31 -55.0 24.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.504 -0.771 . . . . 73.22 111.302 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.415 HD13 ' CD2' ' A' ' 87' ' ' PHE . 96.8 mt -65.58 -27.78 68.67 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.034 0.383 . . . . 74.0 112.034 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.2 mt-30 -66.31 -20.84 66.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.66 0.267 . . . . 75.2 111.007 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -101.31 -37.32 8.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.245 -0.434 . . . . 72.52 110.809 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 t -153.65 118.2 4.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 55.23 109.972 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.68 74.79 2.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.89 -0.672 . . . . 64.34 111.889 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.29 139.19 24.27 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.69 -0.3 . . . . 61.41 110.474 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.8 t -74.44 116.16 50.37 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.371 -0.603 . . . . 64.3 109.371 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.8 -38.07 46.42 Favored 'Trans proline' 0 N--CA 1.474 0.344 0 C-N-CA 123.279 2.652 . . . . 74.34 113.773 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.09 -55.99 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.12 0.415 . . . . 74.03 112.12 -175.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 28.3 p -96.13 -13.03 23.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.251 0.463 . . . . 60.22 112.251 -171.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 66.34 22.48 10.82 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.712 0.405 . . . . 74.51 111.523 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 28.3 t -74.63 141.6 44.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.077 -0.712 . . . . 65.11 109.077 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 58.7 ttp -77.41 142.18 39.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 75.41 111.301 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.519 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 61.9 t80 -129.85 126.31 22.48 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.789 -0.819 . . . . 74.41 108.789 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 34.4 Cg_endo -63.69 157.6 69.31 Favored 'Cis proline' 0 C--O 1.235 0.356 0 C-N-CA 123.823 -1.324 . . . . 71.01 112.978 2.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -47.98 147.41 7.76 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.193 3.262 . . . . 72.33 113.677 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.28 147.32 83.14 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.848 2.365 . . . . 61.3 112.649 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.411 -0.804 . . . . 75.13 109.642 178.781 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.763 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 65.3 Cg_endo . . . . . 0 N--CA 1.461 -0.39 0 N-CA-C 111.844 -0.098 . . . . 40.02 111.844 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 38.1 Cg_exo -57.48 150.98 56.59 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.898 2.399 . . . . 74.52 112.685 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -79.85 146.17 32.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.907 -0.588 . . . . 74.01 110.925 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 m -74.8 142.86 44.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.631 -0.713 . . . . 73.03 110.649 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.74 -37.48 79.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 61.12 110.301 -178.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.45 -40.06 89.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.019 -0.537 . . . . 74.34 110.697 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -67.43 -38.28 84.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.959 -0.564 . . . . 64.15 110.377 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.485 ' O ' ' HE3' ' A' ' 67' ' ' LYS . 65.6 mt -66.92 -41.45 87.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.51 . . . . 33.13 110.551 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.28 -32.52 73.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 64.31 110.427 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.52 -11.6 60.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.715 -0.675 . . . . 75.14 111.795 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 91.2 mt -65.4 133.1 95.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.469 -0.332 . . . . 73.44 110.703 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 149.64 84.08 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.092 2.528 . . . . 65.34 112.143 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 55.9 mt-10 -116.77 104.8 11.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.291 0.567 . . . . 64.32 110.75 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.0 mt -106.48 117.85 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.393 -0.821 . . . . 70.31 110.356 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.5 tp -68.03 118.85 11.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.305 -0.407 . . . . 74.0 109.956 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 28.8 t -81.5 135.17 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.997 0.427 . . . . 74.25 110.631 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p -131.99 173.01 11.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.647 -0.706 . . . . 73.41 109.848 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 15.3 mm-40 -70.31 -178.67 1.77 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.598 -0.274 . . . . 71.44 110.853 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 27.9 m-20 76.14 -51.51 0.61 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.43 0.692 . . . . 70.31 111.092 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -111.38 55.74 0.65 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.026 0.441 . . . . 72.13 109.839 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 50' ' ' TYR . . . -63.79 -31.04 79.46 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.667 -0.697 . . . . 74.3 111.618 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.38 84.22 6.06 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.248 -0.649 . . . . 43.51 109.248 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.26 -28.91 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 65.14 110.882 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.02 -142.48 3.57 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.035 -0.826 . . . . 72.12 111.035 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -69.97 -20.91 63.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.063 0.458 . . . . 61.42 110.397 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -103.97 130.55 51.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 64.12 110.849 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.6 ptp -102.66 -3.91 25.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.423 -0.808 . . . . 60.4 109.842 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 8.8 p -134.59 149.31 50.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.679 -0.691 . . . . 64.33 111.051 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 28.9 t -105.97 103.51 44.89 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.713 -0.676 . . . . 74.11 109.519 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 16.1 Cg_endo -56.94 -28.71 79.25 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 123.291 2.661 . . . . 63.33 112.907 -176.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mt -68.27 -28.2 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.094 -0.503 . . . . 63.01 110.871 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 78.7 m -104.74 -18.7 14.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 60.53 110.579 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.8 t 61.65 24.94 14.95 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.252 -0.886 . . . . 73.1 109.471 -172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.9 m -128.32 171.81 11.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.166 -0.925 . . . . 75.45 109.266 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER -93.76 -171.75 2.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.844 0.354 . . . . 73.21 110.639 -178.134 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.564 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 90.5 m-85 -98.52 103.18 15.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.118 0.485 . . . . 75.0 110.578 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG13 ' HG2' ' A' ' 49' ' ' GLU . 25.2 m -121.87 167.13 15.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.648 -0.705 . . . . 64.43 111.062 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 22.8 ttpp -54.32 127.44 27.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.336 -0.847 . . . . 75.14 111.725 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.59 -34.38 3.8 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.793 -0.718 . . . . 75.41 113.031 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -86.97 165.3 15.96 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.704 -0.48 . . . . 72.14 109.704 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.42 121.13 66.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.797 0.332 . . . . 71.42 110.544 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -100.21 160.96 13.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.978 0.418 . . . . 72.14 111.075 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 11.2 t -137.25 167.49 21.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.859 -0.61 . . . . 64.01 109.646 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -120.65 118.09 29.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.011 0.434 . . . . 74.11 110.863 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.7 mt -87.0 143.42 34.99 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.846 -0.615 . . . . 64.51 109.517 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.39 -12.8 17.94 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.937 2.425 . . . . 64.43 111.687 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 45.5 t -76.0 9.17 2.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.99 -1.005 . . . . 75.1 110.592 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 65.69 28.45 11.1 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.524 0.678 . . . . 74.04 109.736 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 136.96 54.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.543 -0.753 . . . . 72.21 110.578 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -110.78 133.26 53.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.253 -0.43 . . . . 64.11 110.714 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 91.5 m-85 -145.02 175.31 10.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.365 -0.976 . . . . 73.34 108.365 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.96 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.4 m80 -88.41 130.19 35.23 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.8 -0.815 . . . . 73.23 108.8 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 84.8 tttt -57.02 -48.06 98.07 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 112.086 0.402 . . . . 75.01 112.086 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 10.0 Cg_endo -51.46 -46.2 32.99 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.486 2.124 . . . . 75.2 113.503 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.96 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 8.4 p -84.23 -34.96 23.77 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.199 0.444 . . . . 71.05 112.199 -175.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.513 HG22 ' HG ' ' A' ' 74' ' ' LEU . 5.7 p -71.72 -26.1 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 122.225 -0.297 . . . . 73.24 110.751 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -56.98 -39.71 75.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.142 0.496 . . . . 71.35 110.72 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.494 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 59.8 mt -69.65 -40.95 79.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.914 -0.584 . . . . 75.44 110.585 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -72.96 -38.91 66.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 74.43 111.326 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.513 ' HG ' HG22 ' A' ' 70' ' ' VAL . 88.8 mt -63.86 -32.84 74.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.601 -0.272 . . . . 75.43 111.252 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -77.08 -9.52 58.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.803 0.335 . . . . 74.45 111.104 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 67.9 mttm -80.92 -58.77 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 73.13 110.927 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.8 m -148.74 11.66 0.86 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.214 0.449 . . . . 71.43 112.214 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.69 65.27 3.29 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 123.25 0.343 . . . . 65.04 113.764 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.34 160.8 43.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.669 0.235 . . . . 64.12 111.142 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.71 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 84.4 m -79.34 123.28 84.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.806 -0.812 . . . . 73.11 108.806 168.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.58 -21.81 56.89 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.498 2.132 . . . . 74.05 112.522 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.4 t -84.58 -53.43 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 60.43 111.861 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 28.9 p -98.84 -19.75 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.838 0.31 . . . . 74.44 111.838 -170.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 66.65 19.78 10.77 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.034 -0.53 . . . . 62.02 111.654 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.46 143.44 33.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.923 -0.769 . . . . 71.31 108.923 171.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.763 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 51.1 ttp -75.78 145.02 41.06 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.757 0.66 . . . . 74.22 112.516 -171.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.525 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 91.5 t80 -131.21 125.05 20.78 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.139 -0.937 . . . . 73.31 109.061 171.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 31.7 Cg_exo -60.63 153.3 52.87 Favored 'Cis proline' 0 C--N 1.348 0.541 0 C-N-CA 124.03 -1.238 . . . . 74.15 112.787 0.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.57 154.41 9.07 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.606 2.871 . . . . 74.42 113.127 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.14 147.61 94.73 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.071 2.514 . . . . 44.1 112.704 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.526 -0.75 . . . . 71.22 109.934 179.144 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 N--CA 1.461 -0.393 0 CA-C-O 121.033 0.347 . . . . 63.32 112.733 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.43 148.43 79.22 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.67 2.246 . . . . 62.54 111.251 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -76.86 139.86 40.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.405 -0.361 . . . . 64.41 110.763 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.405 ' HB3' ' OE1' ' A' ' 20' ' ' GLU . 14.6 m -61.24 129.79 43.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.955 -0.566 . . . . 64.24 110.139 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.59 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 3.2 tmmm? -58.96 -30.5 67.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.499 -0.319 . . . . 72.41 110.562 -177.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 29.2 mp0 -54.9 -41.95 71.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.962 0.411 . . . . 75.21 110.223 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.517 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 18.0 m -77.42 -34.98 54.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.858 -0.61 . . . . 75.11 110.779 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.7 -42.44 95.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.3 0.571 . . . . 42.31 110.484 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -68.68 -37.48 79.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.687 -0.688 . . . . 71.33 110.968 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.63 -6.61 49.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.11 -0.495 . . . . 21.5 111.705 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.717 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 57.3 mt -63.68 125.34 87.37 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.681 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' A' ' 57' ' ' THR . 19.4 Cg_endo -58.04 125.37 18.35 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.471 2.781 . . . . 64.22 113.228 -175.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -81.12 113.72 19.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.456 -0.793 . . . . 75.21 110.654 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.7 mt -112.56 109.42 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.279 -0.419 . . . . 54.54 110.101 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.92 118.29 10.19 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.908 -0.404 . . . . 62.03 109.908 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 50' ' ' TYR . 53.0 t -81.63 128.96 38.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.166 0.508 . . . . 73.24 111.648 -173.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.479 HG22 ' HG3' ' A' ' 52' ' ' LYS . 17.0 p -126.01 138.16 53.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.376 -0.829 . . . . 73.05 109.269 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 52' ' ' LYS . 39.4 mt-10 -63.94 -10.7 22.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.357 . . . . 74.1 111.726 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.09 -33.11 74.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.89 -0.595 . . . . 74.24 109.759 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -134.13 81.73 1.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.354 -0.839 . . . . 71.32 109.553 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.37 -36.07 31.59 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.917 -0.658 . . . . 74.54 112.942 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.37 86.0 6.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.25 0.548 . . . . 51.41 110.665 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.82 -23.73 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.685 -0.689 . . . . 71.14 110.302 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.07 -134.58 1.71 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.261 -0.736 . . . . 73.23 111.261 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -68.86 -42.41 77.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.463 0.649 . . . . 65.32 109.502 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -73.29 113.01 9.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.122 -0.945 . . . . 74.11 110.548 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -95.2 -5.05 44.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.644 0.735 . . . . 72.22 109.257 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.2 p -144.53 167.93 21.34 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.097 -0.956 . . . . 74.15 110.087 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 43.0 t -115.63 92.83 34.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.713 -0.477 . . . . 75.14 109.713 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 19.8 Cg_endo -59.11 -28.14 86.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.979 2.453 . . . . 72.13 112.358 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.0 mt -56.16 -39.24 57.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.487 -0.779 . . . . 75.31 111.609 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.7 p -117.54 6.27 12.51 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.923 -0.311 . . . . 61.22 110.54 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.1 m 53.03 67.79 0.94 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.464 -0.789 . . . . 63.52 111.407 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 p -156.67 168.28 27.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.834 -0.621 . . . . 71.34 109.522 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.74 -170.0 2.75 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.4 -0.592 . . . . 73.42 109.4 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.572 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 61.6 m-85 -93.72 89.65 6.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.382 0.611 . . . . 62.22 110.773 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 m -85.94 158.12 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.101 -0.954 . . . . 75.41 111.251 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' HG3' HG22 ' A' ' 31' ' ' THR . 38.8 ttmt -73.34 120.46 18.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.984 -0.553 . . . . 75.0 110.547 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.85 -19.66 6.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.635 -0.793 . . . . 71.31 112.491 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -84.99 166.5 16.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.981 -0.748 . . . . 72.41 108.981 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.9 t -115.19 131.18 68.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.774 -0.454 . . . . 74.21 109.774 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.57 175.46 5.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.839 0.352 . . . . 60.44 110.654 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.717 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.6 t -151.61 160.79 43.51 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.817 -0.629 . . . . 73.35 109.933 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 31.7 tt0 -107.71 126.76 52.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.474 . . . . 73.4 110.301 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.2 mt -92.06 142.56 26.48 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 108.942 -0.762 . . . . 74.43 108.942 171.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.99 -10.61 12.85 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.203 2.602 . . . . 75.31 111.745 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.13 19.34 2.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.967 -1.015 . . . . 50.03 110.289 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 56.09 37.26 28.66 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.763 -0.653 . . . . 64.0 111.458 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -132.66 141.56 48.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.564 -0.744 . . . . 75.55 110.014 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -119.87 133.42 55.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.198 -0.456 . . . . 73.12 110.754 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 98.0 m-85 -143.84 168.1 20.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.983 -0.553 . . . . 74.11 109.841 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 33.1 m170 -64.02 128.17 34.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.299 -0.63 . . . . 71.45 109.299 171.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 64.1 tttp -56.77 -53.08 68.56 Favored Pre-proline 0 CA--C 1.535 0.386 0 O-C-N 123.342 0.401 . . . . 70.13 111.376 -177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 12.2 Cg_endo -56.97 -45.3 37.14 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.16 1.906 . . . . 62.21 112.232 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 66.2 m -61.38 -48.73 79.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.122 -0.49 . . . . 54.42 111.357 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.534 HG22 ' HG ' ' A' ' 74' ' ' LEU . 7.7 p -69.82 -27.58 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 53.53 110.618 -175.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.8 m -61.98 -37.05 83.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 51.45 110.361 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.3 mt -66.65 -43.32 90.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.514 . . . . 75.41 110.131 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -68.94 -47.15 66.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.017 -0.538 . . . . 71.43 110.904 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 94.4 mt -60.77 -36.39 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.105 0.409 . . . . 72.52 112.105 -175.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.26 -12.71 61.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.715 0.293 . . . . 74.4 111.184 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -98.77 -50.89 4.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.333 0.587 . . . . 62.32 109.593 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.7 p -151.77 113.3 4.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.383 -0.826 . . . . 62.52 109.858 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.92 85.92 0.38 Allowed Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.946 -0.645 . . . . 71.23 112.613 -176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 2.0 p -149.36 161.79 41.37 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.313 0.245 . . . . 73.13 111.271 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.772 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 95.8 m -79.24 120.52 80.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.32 -0.993 . . . . 73.31 108.32 165.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.46 -14.52 25.72 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.308 2.006 . . . . 71.53 113.044 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.23 -43.47 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.307 -0.406 . . . . 75.44 112.005 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.772 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.3 p -105.88 -17.35 14.39 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.809 -0.356 . . . . 71.41 111.599 -172.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 63.69 23.55 13.55 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.177 0.591 . . . . 73.52 111.973 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 79' ' ' THR . 34.6 t -89.05 155.53 19.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.219 -0.66 . . . . 72.22 109.219 173.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.517 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 25.7 ttm -82.28 149.61 27.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.556 0.576 . . . . 75.33 112.556 -167.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.477 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 66.0 t80 -136.93 120.22 11.89 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 114.934 -1.03 . . . . 73.13 108.803 168.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 34.0 Cg_endo -62.85 152.76 68.5 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 123.863 -1.307 . . . . 74.32 112.572 2.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.23 142.65 55.44 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.147 2.565 . . . . 72.34 112.944 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 39.4 Cg_endo -67.61 147.56 76.55 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.86 2.374 . . . . 72.35 112.232 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.42 -0.8 . . . . 62.33 110.255 -179.7 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.1 Cg_endo . . . . . 0 C--O 1.236 0.387 0 N-CA-C 113.071 0.374 . . . . 74.33 113.071 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 23.9 Cg_exo -64.27 152.28 81.95 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.934 2.423 . . . . 75.23 111.858 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -84.08 166.67 17.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.888 0.375 . . . . 42.12 110.831 -177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.3 p -87.24 144.31 26.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.072 -0.513 . . . . 54.01 110.574 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -62.47 -36.02 81.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 74.43 111.168 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.6 -28.48 69.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.022 -0.535 . . . . 61.13 111.131 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 t -82.94 -24.62 32.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.383 -0.372 . . . . 61.45 110.19 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 18' ' ' SER . 60.0 mt -79.76 -38.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.309 0.576 . . . . 74.33 110.304 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.04 -27.68 63.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.736 -0.666 . . . . 71.45 110.882 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.08 -4.36 55.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.52 111.871 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 64.3 mt -63.7 131.43 94.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.567 -0.288 . . . . 71.34 111.069 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.84 141.18 77.14 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.774 2.316 . . . . 71.53 112.094 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -104.7 119.09 38.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.184 0.516 . . . . 73.24 110.913 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 65.4 mt -112.29 120.82 63.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.47 -0.786 . . . . 72.03 110.082 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.9 tp -74.61 122.54 23.32 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.94 -0.392 . . . . 75.11 109.94 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 43.1 t -92.13 127.46 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.863 0.363 . . . . 73.4 111.337 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.4 p -128.19 172.84 10.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.687 -0.688 . . . . 74.53 110.022 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -76.9 -10.16 59.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.795 0.331 . . . . 75.34 110.7 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -84.78 -10.21 57.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.168 -0.469 . . . . 73.12 110.186 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -149.56 61.92 1.01 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.085 0.469 . . . . 71.51 110.349 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.36 -43.34 79.15 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.77 -0.65 . . . . 75.03 111.513 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.59 98.76 6.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.765 -0.457 . . . . 31.13 109.765 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.0 t -82.72 -20.81 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.254 0.549 . . . . 75.24 110.229 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.73 -140.38 2.87 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.178 -0.769 . . . . 42.45 111.178 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.81 -26.35 64.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.053 0.454 . . . . 74.55 110.071 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -111.68 160.75 16.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.775 -0.648 . . . . 72.53 110.269 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -141.13 13.09 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.331 . . . . 75.12 111.267 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 71.6 m -132.42 140.07 48.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.5 -0.318 . . . . 74.42 110.704 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 41.7 t -103.3 100.15 17.14 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.636 -0.505 . . . . 52.11 109.636 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 32.1 Cg_endo -63.61 -24.76 69.59 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.921 2.414 . . . . 71.22 112.724 -175.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.4 mt -61.14 -35.24 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.073 -0.512 . . . . 51.41 110.916 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 28.2 p -112.95 10.85 18.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.41 . . . . 74.13 109.918 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.0 p 40.33 51.76 2.82 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.174 0.921 . . . . 64.51 111.911 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.1 m -150.75 150.13 30.64 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.993 -0.548 . . . . 74.0 110.103 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 13.1 pt-20 -77.92 -169.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.123 0.487 . . . . 73.23 110.955 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.476 ' HB3' HG11 ' A' ' 30' ' ' VAL . 45.4 m-85 -90.12 113.07 24.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.193 0.521 . . . . 71.33 111.433 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.44 162.4 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.318 -0.856 . . . . 65.4 110.473 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 39.5 ttmt -65.84 128.52 36.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.115 -0.493 . . . . 72.52 110.934 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.49 -24.01 11.7 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.709 -0.757 . . . . 54.34 112.873 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -82.55 159.22 22.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.739 -0.467 . . . . 62.41 109.739 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.09 119.22 57.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.488 -0.324 . . . . 72.45 110.474 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -97.85 168.27 10.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.393 -0.367 . . . . 74.31 110.955 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.51 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 14.6 t -152.59 156.8 40.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.902 -0.59 . . . . 73.43 109.717 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -116.73 118.57 32.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.78 0.324 . . . . 72.12 110.496 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.96 148.67 81.97 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.138 -0.69 . . . . 75.53 109.138 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.79 -9.72 10.23 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.899 2.399 . . . . 70.33 112.067 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.3 9.15 11.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.364 -0.835 . . . . 74.23 109.938 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m170 58.85 37.43 24.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.838 -0.619 . . . . 62.05 111.469 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -121.07 145.06 48.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.741 -0.663 . . . . 73.34 109.495 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -114.09 132.8 55.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.253 0.549 . . . . 75.05 111.609 -172.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.9 175.41 10.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.279 -0.873 . . . . 73.23 108.721 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.745 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 37.4 m80 -87.07 135.46 33.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.8 -0.815 . . . . 73.52 108.8 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.495 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.0 tttt -59.48 -50.19 88.46 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.308 0.38 . . . . 75.43 111.841 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.6 Cg_endo -60.87 -18.51 57.15 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.03 1.82 . . . . 63.44 112.911 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 64.5 m -83.9 -53.03 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.225 0.536 . . . . 63.44 110.865 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 p -70.38 -27.25 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.54 -0.755 . . . . 74.22 111.216 -172.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.555 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 6.4 p -61.16 -32.34 72.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.467 -0.333 . . . . 71.31 111.193 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.0 mt -74.99 -44.45 44.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.177 0.513 . . . . 54.42 110.272 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -62.23 -43.93 97.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.598 -0.728 . . . . 75.14 111.182 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 91.7 mt -65.19 -23.9 67.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 55.41 111.687 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.6 mt-30 -73.94 -15.26 61.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 74.43 110.884 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -106.18 -43.81 4.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.342 0.591 . . . . 65.12 109.99 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.9 p -153.32 114.62 4.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.441 -0.799 . . . . 53.31 110.397 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.87 81.35 1.02 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.558 -0.829 . . . . 74.05 112.124 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.4 164.51 34.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.507 0.194 . . . . 64.11 111.495 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.626 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 68.5 m -74.87 116.82 57.51 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 107.953 -1.128 . . . . 71.44 107.953 162.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.63 -17.29 27.91 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 122.492 2.128 . . . . 74.31 112.526 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.23 -57.44 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.78 -0.645 . . . . 74.21 111.767 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.9 p -94.48 -12.67 27.25 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.36 0.504 . . . . 64.11 112.36 -169.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' CYS . 20.8 mmt180 74.24 4.9 4.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.004 0.521 . . . . 74.12 112.015 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.4 t -73.22 145.23 46.37 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.164 -0.214 . . . . 61.5 110.425 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.545 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 36.0 ttm -74.34 145.84 43.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 63.22 112.438 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.435 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 74.1 t80 -128.8 121.43 20.98 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.409 -0.814 . . . . 73.44 109.85 171.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.07 157.41 99.55 Favored 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.999 -1.667 . . . . 73.42 111.731 -1.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.56 142.33 31.26 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.83 2.353 . . . . 64.24 112.508 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 28.5 Cg_endo -62.62 152.08 79.87 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.001 2.467 . . . . 64.11 112.185 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.541 -0.742 . . . . 73.32 110.187 -177.236 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 C--O 1.235 0.332 0 CA-C-O 120.593 0.164 . . . . 45.31 112.392 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.47 163.0 34.18 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.923 2.416 . . . . 71.13 112.754 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.83 177.57 6.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.105 -0.498 . . . . 71.13 110.694 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -90.25 143.05 27.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.371 -0.377 . . . . 73.43 109.987 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -57.09 -39.59 75.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.932 0.396 . . . . 72.31 110.618 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.66 -23.8 60.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 71.51 111.243 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.8 m -77.19 -31.04 55.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.999 0.428 . . . . 74.54 109.948 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.9 mt -78.38 -40.86 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 75.43 109.968 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.03 -35.8 73.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.888 -0.596 . . . . 73.22 110.607 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.28 -4.02 48.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.733 -0.667 . . . . 52.44 112.156 -176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 74.1 mt -65.89 126.34 91.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.66 0.266 . . . . 71.44 110.349 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.03 136.27 64.31 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.958 2.439 . . . . 64.34 112.324 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.83 113.4 26.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.128 -0.487 . . . . 75.53 110.193 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.5 mt -114.72 132.45 63.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.849 -0.614 . . . . 64.44 110.01 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 47.9 tp -86.81 116.7 25.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.166 -0.309 . . . . 70.12 110.166 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 54.0 t -71.21 135.74 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.29 -0.414 . . . . 73.23 109.893 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 32.8 p -128.64 172.83 10.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.271 -0.422 . . . . 72.45 110.423 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.534 ' HG2' ' HE3' ' A' ' 52' ' ' LYS . 42.5 mm-40 -70.34 -25.13 63.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 75.3 111.152 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.95 -7.08 58.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 54.35 111.131 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.676 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 59.9 t-80 -153.18 64.6 0.77 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.712 -0.477 . . . . 65.12 109.712 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.1 -59.61 7.26 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.81 -0.632 . . . . 75.1 112.297 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.28 92.81 1.82 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.056 0.455 . . . . 61.42 109.93 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.676 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 6.4 t -63.26 -49.33 83.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 74.33 109.894 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.11 -138.88 5.1 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.655 -1.378 . . . . 61.22 109.655 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.86 -11.41 59.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.611 0.705 . . . . 75.43 109.532 171.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -83.5 100.16 10.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 75.22 110.161 171.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -91.33 -12.5 34.8 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.603 0.716 . . . . 75.44 109.208 172.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.751 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 57.2 m -138.24 131.29 30.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.035 -0.984 . . . . 54.22 109.29 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.6 t -70.93 109.09 4.51 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 123.342 0.401 . . . . 71.1 110.018 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.71 -24.47 74.78 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.782 2.322 . . . . 75.35 112.185 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.83 -25.7 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.259 0.552 . . . . 62.34 110.675 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 40.0 m -117.46 2.3 12.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.174 -0.466 . . . . 61.33 110.879 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p 42.79 35.78 0.76 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.657 0.783 . . . . 62.55 111.674 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.4 t -136.43 148.14 47.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.97 -0.559 . . . . 34.13 110.036 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.751 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 9.9 pt-20 -79.21 168.56 19.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.565 0.58 . . . . 73.24 112.565 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.2 m-85 -98.02 130.35 44.85 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 74.13 110.666 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -132.7 177.87 6.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.016 -0.365 . . . . 64.11 110.016 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 40.0 ttmt -60.06 113.06 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 71.35 110.878 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.25 -11.02 7.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.623 . . . . 32.2 112.06 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.53 131.94 36.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.853 0.359 . . . . 63.5 111.088 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -88.07 110.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.212 -0.449 . . . . 73.42 109.956 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.1 155.66 22.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.086 -0.507 . . . . 71.03 110.394 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.9 t -132.43 159.3 39.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.065 -0.516 . . . . 74.13 109.839 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -109.3 123.07 48.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.918 0.39 . . . . 64.53 111.469 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.9 mt -87.05 140.03 32.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.319 -0.993 . . . . 70.13 108.319 167.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.69 -13.02 7.43 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.304 2.669 . . . . 73.11 113.802 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.2 p -90.42 19.88 4.92 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.801 0.334 . . . . 64.34 110.71 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 60.32 54.63 3.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.91 -0.586 . . . . 74.23 112.034 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -142.3 141.29 32.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.834 -0.621 . . . . 73.12 109.373 174.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -120.39 133.47 55.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.406 0.622 . . . . 75.14 111.934 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 65.2 m-85 -139.26 175.17 9.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.298 -0.864 . . . . 74.32 108.754 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.829 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 40.4 m80 -76.45 132.14 39.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.302 -0.999 . . . . 72.12 108.302 173.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 85.5 tttt -56.25 -48.96 95.88 Favored Pre-proline 0 C--N 1.32 -0.688 0 O-C-N 123.301 0.376 . . . . 75.4 111.913 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 7.2 Cg_endo -50.45 -51.38 11.14 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.454 2.103 . . . . 64.32 113.426 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.829 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 18.9 p -77.1 -30.46 55.33 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.627 -0.429 . . . . 74.25 111.815 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 67' ' ' LYS . 5.4 p -70.75 -26.48 28.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 120.329 -0.548 . . . . 70.34 109.752 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 41.3 m -60.84 -48.23 82.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.641 -0.503 . . . . 72.2 109.641 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.441 HG22 ' HE3' ' A' ' 76' ' ' LYS . 42.7 mt -62.75 -40.51 88.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.609 -0.723 . . . . 63.3 110.625 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -66.49 -50.96 61.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.004 -0.544 . . . . 74.31 111.126 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 77' ' ' SER . 94.9 mt -66.09 -20.91 66.31 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.143 0.424 . . . . 75.21 112.143 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.9 mt-30 -79.44 -8.3 59.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 72.32 110.785 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HE3' HG22 ' A' ' 72' ' ' ILE . 10.1 mtmp? -114.43 -34.26 5.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.368 -0.378 . . . . 72.52 110.792 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 34.1 t -148.33 127.51 12.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.812 -0.44 . . . . 73.45 109.812 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.56 47.06 3.01 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.691 -0.766 . . . . 74.42 112.653 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.29 149.5 49.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.028 0.442 . . . . 53.11 111.318 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 38.6 t -74.65 114.36 33.43 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.471 -0.786 . . . . 65.15 109.512 175.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 80' ' ' CYS . 16.5 Cg_endo -57.24 -22.46 48.86 Favored 'Trans proline' 0 N--CA 1.474 0.326 0 C-N-CA 122.712 2.274 . . . . 70.05 112.84 -174.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.7 t -82.86 -31.89 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.301 0.482 . . . . 60.25 112.301 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.0 p -130.27 -11.6 4.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.686 0.625 . . . . 44.41 112.686 -173.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 70.49 13.44 7.42 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.489 0.716 . . . . 65.2 111.832 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.8 t -73.08 144.07 47.18 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.152 -0.684 . . . . 70.13 109.152 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 60.9 ttp -79.12 151.57 31.28 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.369 0.418 . . . . 54.31 111.047 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -126.42 119.59 23.26 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.84 -0.618 . . . . 62.44 109.537 173.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.48 156.0 92.23 Favored 'Cis proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.45 -1.479 . . . . 62.13 112.399 -0.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.01 155.14 46.28 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.103 2.535 . . . . 65.43 112.798 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.46 -173.21 1.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.677 2.251 . . . . 64.21 112.178 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.375 -0.821 . . . . 62.42 110.394 -179.01 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo . . . . . 0 C--O 1.234 0.294 0 CA-C-O 120.932 0.305 . . . . 73.31 112.358 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.15 162.79 40.68 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.623 2.215 . . . . 70.11 112.127 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.87 143.61 26.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.256 -0.429 . . . . 61.33 110.277 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -70.92 147.67 48.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.952 -0.388 . . . . 72.13 109.952 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -53.02 -38.38 62.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.306 -0.407 . . . . 71.11 111.267 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.4 -42.49 91.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.875 -0.602 . . . . 61.42 111.901 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.5 m -70.66 -34.41 71.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.109 0.481 . . . . 74.11 110.714 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.479 HG21 ' HA ' ' A' ' 71' ' ' SER . 68.6 mt -72.81 -42.85 61.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.978 -0.555 . . . . 64.25 111.059 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.3 -21.72 62.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.222 -0.445 . . . . 74.0 110.508 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.74 -3.89 54.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 51.01 111.622 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.454 HD13 HG21 ' A' ' 57' ' ' THR . 25.2 mt -56.52 135.32 77.11 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.602 -0.272 . . . . 52.13 111.379 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.39 129.99 36.85 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.137 2.558 . . . . 75.12 111.722 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -98.26 111.66 23.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.089 0.471 . . . . 71.43 110.732 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -112.71 109.99 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.588 -0.733 . . . . 74.42 109.758 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.79 123.52 20.37 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.514 -0.55 . . . . 62.3 109.514 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 47.2 t -74.18 114.38 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.046 0.451 . . . . 55.44 110.669 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.9 p -115.3 131.82 56.81 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.653 -0.703 . . . . 72.33 109.87 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 53.2 mt-10 -66.58 -13.97 61.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 64.42 111.251 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.23 -29.28 70.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.336 0.589 . . . . 74.03 110.012 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -92.7 -16.9 24.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.277 -0.874 . . . . 73.03 110.092 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.54 -113.72 4.36 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.41 -0.676 . . . . 75.53 111.41 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.66 132.01 40.3 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.7 -0.482 . . . . 74.43 109.7 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.57 -31.67 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.247 0.546 . . . . 64.25 110.217 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.518 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . -164.37 -118.23 0.44 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.176 -0.77 . . . . 74.22 111.176 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -64.45 -55.06 23.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.311 0.577 . . . . 74.0 110.435 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 142.02 28.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.417 -0.81 . . . . 71.22 111.702 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 ptp -112.73 7.37 18.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.496 -0.775 . . . . 72.45 109.545 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 19.6 p -126.6 149.55 49.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.401 -0.818 . . . . 62.03 109.926 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 41.3 t -110.32 101.01 46.83 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.042 -0.355 . . . . 65.43 110.042 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.7 Cg_endo -54.41 -31.98 70.69 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.412 2.741 . . . . 65.15 112.583 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.2 -34.74 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.952 -0.567 . . . . 72.21 110.883 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.0 m -98.46 -18.9 17.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 74.35 111.354 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.2 m 65.89 22.23 11.37 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.444 0.64 . . . . 62.14 110.032 -172.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -130.51 175.43 8.99 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.264 -0.88 . . . . 74.11 109.524 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 8.5 pt-20 -98.96 -175.24 2.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.048 0.452 . . . . 74.32 111.477 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.514 ' HB3' HG11 ' A' ' 30' ' ' VAL . 56.0 m-85 -100.89 120.23 39.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.966 -0.561 . . . . 75.21 110.591 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.5 m -127.29 169.35 18.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.895 -0.593 . . . . 64.11 110.783 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 33.7 ttmt -74.36 110.92 9.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.886 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.61 -26.85 2.63 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.785 -0.721 . . . . 72.34 112.413 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -86.86 160.94 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.816 -0.439 . . . . 64.12 109.816 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -108.06 126.55 64.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.905 0.383 . . . . 64.15 110.711 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.05 170.7 7.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.174 -0.467 . . . . 72.1 110.567 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.454 HG21 HD13 ' A' ' 25' ' ' LEU . 13.5 t -148.98 156.65 42.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.06 -0.518 . . . . 54.53 109.647 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -110.55 117.47 33.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.49 -0.323 . . . . 74.32 110.376 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.9 mt -75.4 156.16 85.47 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.967 -0.753 . . . . 71.34 108.967 172.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.41 -23.82 14.89 Favored 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.095 2.53 . . . . 74.5 113.56 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.6 p -90.76 15.49 11.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.462 0.171 . . . . 71.43 111.462 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 44.8 m80 67.29 24.68 8.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.911 0.485 . . . . 74.35 112.061 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -102.83 133.25 48.21 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.741 -0.466 . . . . 72.24 109.741 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 80.5 m-85 -105.63 133.28 50.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.171 -0.468 . . . . 72.33 112.011 -171.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.499 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 99.2 m-85 -138.02 175.31 9.7 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.522 -0.918 . . . . 74.42 108.522 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.876 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.6 m80 -84.02 128.28 34.44 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.864 -0.791 . . . . 74.21 108.864 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 89.0 tttt -53.35 -48.32 92.99 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 123.578 0.549 . . . . 72.33 111.828 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 73.1 Cg_exo -53.47 -47.31 28.04 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 122.334 2.023 . . . . 74.23 113.801 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.876 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 25.8 p -82.79 -36.92 25.22 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.773 -0.371 . . . . 63.51 111.942 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 8.7 p -68.39 -24.99 30.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.77 -0.455 . . . . 74.1 109.77 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.53 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 47.5 t -55.07 -50.57 68.81 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.684 -0.689 . . . . 72.42 110.626 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.7 mt -66.0 -38.76 82.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 74.41 110.507 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -62.85 -47.1 84.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.922 -0.581 . . . . 73.31 110.634 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 97.1 mt -66.22 -29.26 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 75.13 111.258 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 71' ' ' SER . 78.6 mt-30 -71.24 -13.41 61.9 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.865 0.364 . . . . 73.45 110.73 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -101.82 -45.05 5.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 72.11 110.12 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.2 p -153.19 119.9 5.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.759 -0.655 . . . . 53.14 109.897 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.16 66.14 3.85 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.656 -0.783 . . . . 42.32 112.668 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.31 144.35 34.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.804 0.335 . . . . 72.22 111.241 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.01 104.74 1.46 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.995 -0.548 . . . . 63.33 109.78 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -48.37 -37.15 32.04 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.67 2.913 . . . . 75.05 114.322 -168.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.2 -28.42 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.304 0.483 . . . . 74.54 112.304 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.3 p -127.4 -26.74 3.0 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.986 -0.447 . . . . 51.52 111.801 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.468 ' HD2' ' HA ' ' A' ' 84' ' ' ARG . 5.1 tpt180 79.86 18.99 0.66 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.558 1.143 . . . . 75.42 110.635 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.2 t -69.0 138.34 54.43 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.605 -0.887 . . . . 75.05 108.605 169.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.564 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 41.1 ttm -80.8 148.42 30.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.966 0.413 . . . . 65.4 111.794 -171.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 81.3 t80 -133.65 116.5 13.84 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.705 -0.68 . . . . 74.54 109.448 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 8.6 Cg_exo -72.05 151.95 96.44 Favored 'Cis proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.271 -1.554 . . . . 50.45 111.82 -0.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -50.08 147.64 14.94 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.272 2.648 . . . . 74.13 112.384 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 38.7 Cg_endo -65.28 149.63 88.27 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.363 2.042 . . . . 62.52 112.012 -174.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.873 -0.584 . . . . 73.44 110.213 -177.931 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo . . . . . 0 CA--C 1.532 0.396 0 CA-C-O 120.55 0.146 . . . . 64.15 111.87 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 155.43 61.87 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.644 2.229 . . . . 72.43 112.752 -175.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.92 144.76 26.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.898 -0.592 . . . . 50.11 110.641 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.3 m -65.52 145.02 56.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.978 -0.555 . . . . 70.31 110.882 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -58.22 -45.06 88.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 71.54 110.924 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -48.8 -48.12 41.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.745 -0.661 . . . . 71.24 111.259 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.0 m -67.88 -34.22 76.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 53.2 111.338 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.4 HG21 ' HA ' ' A' ' 71' ' ' SER . 60.4 mt -72.94 -44.51 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.278 0.561 . . . . 71.03 110.393 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -62.96 -35.52 80.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.782 -0.645 . . . . 62.4 110.705 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.01 5.2 17.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.801 -0.636 . . . . 65.54 112.184 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 74.2 mt -69.69 142.28 91.18 Favored Pre-proline 0 C--O 1.237 0.419 0 N-CA-C 110.252 -0.277 . . . . 73.02 110.252 175.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.25 149.0 91.09 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.955 2.437 . . . . 72.2 112.353 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -113.04 105.81 13.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 70.44 110.451 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.7 mt -100.08 121.69 51.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.93 -0.577 . . . . 75.31 110.016 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.6 tp -81.2 122.29 27.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.835 0.35 . . . . 62.22 110.467 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.575 HG11 ' HB3' ' A' ' 50' ' ' TYR . 47.0 t -88.43 134.3 28.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.248 -0.433 . . . . 75.11 110.212 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.2 p -113.35 172.81 6.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.656 -0.702 . . . . 70.04 110.831 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HG2' ' HE3' ' A' ' 52' ' ' LYS . 5.7 mm-40 -59.39 134.39 56.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.409 -0.359 . . . . 63.14 110.776 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.0 t70 53.44 74.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.322 -0.853 . . . . 73.32 110.579 -172.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -165.22 29.51 0.06 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.126 -0.943 . . . . 73.15 108.785 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 41' ' ' MET . . . -59.82 -36.65 90.67 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.468 -0.787 . . . . 53.14 111.628 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.59 84.27 5.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.31 0.576 . . . . 74.33 110.046 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.9 t -75.23 -23.25 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.571 -0.741 . . . . 71.42 109.986 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.45 -126.3 0.82 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.001 -0.84 . . . . 74.44 111.001 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -77.84 -3.5 41.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.342 0.591 . . . . 62.22 110.255 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -120.24 153.5 36.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.476 -0.784 . . . . 72.12 109.898 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.6 pmm? -134.92 9.79 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.113 -0.494 . . . . 71.54 110.262 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.6 p -147.61 151.01 35.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.149 -0.478 . . . . 60.35 111.045 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 37.4 t -101.49 100.96 15.29 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.488 -0.778 . . . . 72.33 109.296 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 16.3 Cg_endo -57.44 -31.62 91.78 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.931 2.421 . . . . 54.22 112.564 -176.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -60.95 -27.03 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 70.35 110.944 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.6 m -110.24 -15.35 14.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.33 -0.395 . . . . 72.54 111.103 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.0 m 58.32 45.1 17.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.186 -0.461 . . . . 55.32 109.964 -172.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.3 t -154.41 175.1 13.98 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.814 -0.63 . . . . 54.21 109.734 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -101.89 -169.87 1.74 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.743 0.306 . . . . 74.24 111.705 -173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.575 ' HB3' HG11 ' A' ' 30' ' ' VAL . 94.9 m-85 -111.07 134.18 52.87 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.077 -0.51 . . . . 74.44 110.781 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.9 m -136.89 -179.6 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.328 -0.397 . . . . 75.53 110.62 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.554 ' HE3' ' HG2' ' A' ' 32' ' ' GLU . 37.8 ttmt -56.73 133.28 53.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.058 0.456 . . . . 62.13 111.168 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.9 -8.65 59.65 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.798 -0.715 . . . . 71.32 112.04 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -78.58 129.11 34.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.833 0.349 . . . . 75.13 111.311 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.19 102.06 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.63 . . . . 54.04 109.463 174.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.69 162.76 13.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.827 -0.624 . . . . 73.14 110.458 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 10.5 t -140.58 155.48 46.56 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.655 -0.498 . . . . 74.13 109.655 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -116.02 117.54 30.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 44.42 110.64 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -79.29 150.2 73.64 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.988 -0.551 . . . . 72.43 109.88 176.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.8 -14.99 24.39 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.313 2.675 . . . . 72.3 113.083 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.4 p -87.24 10.99 15.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.249 -0.278 . . . . 74.23 110.249 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 62.24 77.79 0.32 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.731 -0.668 . . . . 65.32 111.161 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -160.94 149.64 16.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.258 -0.883 . . . . 72.32 109.226 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.75 132.87 55.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.943 0.402 . . . . 52.3 111.662 -173.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.465 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 91.6 m-85 -141.51 175.29 9.8 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.101 -0.703 . . . . 61.01 109.101 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.895 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 40.5 m80 -81.43 131.7 35.29 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.152 -1.055 . . . . 71.31 108.152 172.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 87.5 tttt -56.13 -49.94 90.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 O-C-N 123.334 0.396 . . . . 74.04 112.018 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 51.0 Cg_exo -56.9 -46.78 26.89 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.005 1.804 . . . . 73.53 113.537 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.895 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 25.1 p -74.57 -32.44 62.4 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.586 -0.446 . . . . 64.5 111.615 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 67' ' ' LYS . 7.5 p -73.01 -24.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.494 -0.483 . . . . 70.35 109.788 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.4 ' HA ' HG21 ' A' ' 22' ' ' ILE . 55.7 m -60.83 -43.07 98.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 72.35 110.431 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.05 -42.95 89.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 60.44 110.351 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.64 -46.24 83.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.641 -0.709 . . . . 75.24 111.42 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.37 -22.21 65.58 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.866 0.321 . . . . 75.4 111.866 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -81.15 -7.17 59.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.105 0.479 . . . . 74.22 110.714 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -109.82 -52.15 2.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.79 -0.641 . . . . 73.22 110.452 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.9 t -142.96 115.99 8.86 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.634 -0.506 . . . . 70.32 109.634 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.5 72.09 1.76 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.92 -0.657 . . . . 63.54 112.226 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.402 HG22 ' HA ' ' A' ' 84' ' ' ARG . 1.7 m -147.11 137.49 23.46 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.901 -0.407 . . . . 63.31 109.901 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.5 t -74.77 110.03 8.82 Favored Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 109.137 -0.69 . . . . 71.33 109.137 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.69 -33.65 60.5 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 122.989 2.46 . . . . 74.14 113.832 -170.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.9 t -73.52 -53.31 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.266 0.469 . . . . 64.13 112.266 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.7 p -101.44 -16.32 16.89 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.84 -0.344 . . . . 32.33 111.433 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HA ' HG22 ' A' ' 79' ' ' THR . 71.2 mtt180 69.18 23.93 6.21 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.589 -0.732 . . . . 70.2 111.993 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.6 m -80.91 149.27 29.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 74.52 109.355 170.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.5 ttp -76.39 143.67 40.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.247 -0.433 . . . . 75.25 111.871 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.612 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 78.2 t80 -137.42 126.71 15.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.924 -0.769 . . . . 75.14 108.924 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.612 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 51.7 Cg_exo -56.07 147.66 23.58 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.623 -0.99 . . . . 41.11 113.366 2.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 20.1 Cg_endo -59.29 151.12 70.04 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.243 2.629 . . . . 53.22 112.596 -175.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 89' ' ' PRO . 8.9 Cg_exo -70.42 178.79 4.61 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.677 2.252 . . . . 65.01 112.432 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.564 -0.744 . . . . 75.15 110.602 -179.234 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 CA--C 1.533 0.437 0 N-CA-C 112.817 0.276 . . . . 73.54 112.817 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.13 165.67 27.63 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.738 2.292 . . . . 63.43 112.745 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -90.17 154.01 20.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.793 -0.639 . . . . 50.24 110.433 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -70.2 135.73 49.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.453 -0.339 . . . . 61.24 110.567 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -58.87 -38.15 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.925 -0.579 . . . . 55.42 110.984 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -59.31 -46.3 88.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.927 -0.579 . . . . 74.55 110.535 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.402 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 9.8 m -63.59 -34.16 77.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 61.14 110.632 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.04 -43.53 76.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.607 . . . . 73.14 110.413 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -66.54 -37.38 84.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.142 -0.481 . . . . 71.03 110.577 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.67 3.68 11.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.747 -0.661 . . . . 60.33 111.807 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.647 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 60.1 mt -70.18 131.82 88.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.475 -0.195 . . . . 74.13 110.475 175.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 19.5 Cg_endo -58.63 135.24 66.06 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.152 2.568 . . . . 63.25 112.513 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -101.63 102.92 13.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.106 0.479 . . . . 73.44 110.006 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.1 mt -103.23 131.63 51.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.898 -0.592 . . . . 74.15 110.544 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.8 tp -79.38 121.74 25.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.893 0.378 . . . . 74.03 110.323 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 50' ' ' TYR . 42.6 t -87.46 132.33 33.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.074 -0.512 . . . . 71.44 110.67 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 36.9 p -128.59 151.42 49.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.264 -0.426 . . . . 62.35 110.297 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.671 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 30.4 mt-10 -84.51 0.6 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.23 0.538 . . . . 74.21 110.687 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.1 -22.11 29.03 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.847 -0.797 . . . . 74.05 108.847 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -133.4 55.57 1.89 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.89 -1.05 . . . . 73.1 109.265 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.95 160.1 34.97 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.38 -0.827 . . . . 72.32 112.272 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 41' ' ' MET . . . 60.16 76.62 0.35 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.399 0.618 . . . . 64.12 109.993 -174.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.71 93.77 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.45 -0.795 . . . . 62.15 111.145 -173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.42 -12.9 30.71 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.832 -0.622 . . . . 33.33 113.298 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.428 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 7.1 pt20 -156.93 -160.26 0.95 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.73 -0.276 . . . . 72.02 110.679 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.3 151.84 9.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.589 -0.732 . . . . 63.32 110.615 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.468 ' HB3' ' HB2' ' A' ' 36' ' ' ALA . 1.4 pmm? -88.77 11.91 16.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.309 -0.405 . . . . 52.44 111.645 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.1 m -118.4 141.53 48.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.208 0.528 . . . . 75.41 111.411 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 21.3 t -106.11 101.72 35.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.555 -0.748 . . . . 71.02 109.549 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 17.7 Cg_endo -59.7 -26.68 82.9 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 123.246 2.631 . . . . 71.44 113.349 -174.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.9 mt -60.83 -41.26 87.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 75.02 111.469 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 21.0 p -119.88 13.96 12.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.557 -0.292 . . . . 75.21 110.909 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p 43.37 45.14 5.13 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.942 0.776 . . . . 51.41 112.22 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.0 p -120.85 -177.71 3.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.459 -0.571 . . . . 63.44 109.459 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -106.67 -175.13 2.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.795 0.331 . . . . 73.35 110.117 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.533 ' HB3' HG11 ' A' ' 30' ' ' VAL . 70.0 m-85 -103.0 109.92 21.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.378 -0.374 . . . . 72.11 110.538 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.1 m -107.08 165.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 74.35 111.68 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.671 ' HB2' ' H ' ' A' ' 32' ' ' GLU . 22.7 ttpp -73.5 113.69 10.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 72.21 111.008 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.02 -8.74 9.1 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.943 -0.646 . . . . 63.34 112.709 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.26 166.02 15.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 110.121 -0.326 . . . . 74.22 110.121 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -115.98 116.17 51.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.13 0.49 . . . . 75.31 110.745 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.43 166.95 10.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.028 -0.533 . . . . 73.01 110.784 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.647 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.8 t -136.45 155.16 50.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.747 -0.66 . . . . 73.21 110.114 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 49.2 tt0 -107.75 117.8 35.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.98 -0.554 . . . . 73.44 109.925 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.87 146.38 59.55 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 109.031 -0.729 . . . . 73.12 109.031 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.71 -3.87 4.0 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.099 2.533 . . . . 65.14 113.807 -175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.7 p -103.22 29.29 5.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 75.03 110.472 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 63.12 31.73 15.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.878 -0.601 . . . . 74.41 112.188 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -126.52 135.01 50.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.776 0.322 . . . . 74.14 110.814 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.65 145.92 30.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.79 -0.641 . . . . 65.0 110.875 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -149.25 160.41 43.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.686 -0.688 . . . . 75.34 109.289 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.637 ' HB2' ' CB ' ' A' ' 69' ' ' CYS . 34.3 m170 -60.47 132.85 55.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.418 -0.956 . . . . 72.14 108.418 168.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -65.85 -61.51 5.55 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.943 0.719 . . . . 74.23 112.943 -171.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.36 -23.32 71.81 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.742 1.628 . . . . 62.41 111.197 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.637 ' CB ' ' HB2' ' A' ' 66' ' ' HIS . 7.7 t -67.36 -53.42 29.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.212 -1.358 . . . . 75.33 110.295 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 p -74.65 -24.7 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.782 -0.644 . . . . 65.34 110.524 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.607 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 43.6 t -54.29 -48.73 70.92 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.266 -0.424 . . . . 75.22 110.1 176.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.0 mt -57.51 -47.6 84.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.012 -0.54 . . . . 65.32 110.343 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -61.3 -44.75 96.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 74.42 111.116 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 96.8 mt -66.14 -23.07 66.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 74.34 111.456 -178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.607 ' HG3' ' O ' ' A' ' 71' ' ' SER . 78.0 mt-30 -72.33 -21.95 61.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.755 0.312 . . . . 71.3 110.485 177.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -89.56 -59.17 2.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.183 0.516 . . . . 70.32 109.625 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.0 m -140.11 124.78 18.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 64.43 110.343 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.03 75.55 2.27 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.176 -0.769 . . . . 75.53 111.176 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 84' ' ' ARG . 4.0 m -147.68 135.29 20.89 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.374 -0.232 . . . . 71.44 110.374 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 34.9 t -75.18 107.39 3.93 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.181 -0.674 . . . . 63.25 109.181 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.18 -31.98 48.02 Favored 'Trans proline' 0 N--CA 1.476 0.497 0 C-N-CA 123.152 2.568 . . . . 74.21 114.207 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.5 t -71.69 -47.9 54.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.048 0.388 . . . . 63.53 112.048 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 20.5 p -103.51 -23.83 13.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.848 0.356 . . . . 74.13 111.031 -174.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.467 ' HA ' HG22 ' A' ' 79' ' ' THR . 35.9 mtp180 71.13 29.6 2.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.316 -0.856 . . . . 73.32 110.893 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 47.6 t -85.07 138.15 32.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.536 -0.756 . . . . 73.3 108.982 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.7 ttp -72.11 143.38 49.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 62.1 111.275 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.455 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 94.0 t80 -125.88 129.69 24.23 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.309 -0.859 . . . . 75.32 108.98 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 16.7 Cg_exo -67.59 157.42 85.0 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 123.851 -1.312 . . . . 71.24 112.721 2.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.51 134.38 63.6 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.065 2.51 . . . . 65.3 112.412 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.81 -172.18 1.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.016 2.477 . . . . 64.44 112.61 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--O 1.243 0.75 0 CA-C-O 118.6 -0.714 . . . . 73.41 109.859 178.049 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 10.0 Cg_endo . . . . . 0 C--O 1.234 0.287 0 CA-C-O 120.803 0.251 . . . . 61.51 112.321 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 17.4 Cg_exo -67.54 156.15 67.26 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.986 2.458 . . . . 61.35 112.197 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.84 147.52 22.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.078 -0.51 . . . . 72.02 110.443 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -68.23 138.91 55.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.327 -0.397 . . . . 71.25 110.241 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -54.48 -33.58 60.01 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.81 0.338 . . . . 43.35 110.819 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -61.29 -28.12 68.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 64.3 111.159 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.5 t -86.82 -34.54 19.49 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.888 -0.412 . . . . 74.1 109.888 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -67.72 -49.38 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.053 -0.521 . . . . 54.44 110.837 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -72.63 -13.0 61.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 73.12 110.653 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.37 -6.43 58.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 73.25 111.173 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.526 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 84.3 mt -63.22 138.06 97.24 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.4 -0.364 . . . . 24.22 110.667 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 25.3 Cg_endo -61.85 119.06 6.01 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.183 2.589 . . . . 54.01 112.359 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -88.66 105.34 17.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.387 0.613 . . . . 55.24 110.835 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.0 mt -96.41 109.39 22.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.221 -0.9 . . . . 75.33 109.383 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.99 117.38 9.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.086 -0.507 . . . . 74.43 110.052 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 15.7 t -82.17 127.49 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.582 -0.525 . . . . 73.44 109.582 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.5 p -117.3 170.21 8.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.019 -0.537 . . . . 42.34 109.858 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 24.3 mt-10 -85.19 7.64 21.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.655 0.741 . . . . 73.11 109.865 176.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -96.39 -13.35 23.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.043 -0.981 . . . . 62.41 109.139 173.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -132.85 115.65 15.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.258 -0.883 . . . . 75.33 110.577 -173.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.61 -111.07 0.46 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.668 -0.777 . . . . 51.3 112.486 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.93 139.18 58.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.851 0.357 . . . . 75.24 110.975 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.9 t -89.21 -19.18 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.016 -0.538 . . . . 61.05 110.819 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.39 -145.16 7.05 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.646 -0.788 . . . . 71.33 111.968 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -59.99 -49.06 79.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.101 0.476 . . . . 72.12 110.716 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.91 113.4 16.99 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.452 -0.944 . . . . 74.32 108.452 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.7 ptp -101.07 4.67 42.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.262 -0.427 . . . . 71.14 111.893 -171.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.7 m -146.87 171.48 15.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.675 0.274 . . . . 73.51 110.575 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -122.41 91.02 49.41 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.203 -0.453 . . . . 71.5 109.859 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.39 -13.32 32.11 Favored 'Trans proline' 0 N--CA 1.475 0.422 0 C-N-CA 123.384 2.722 . . . . 72.2 113.019 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.3 mt -69.99 -22.28 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.063 0.458 . . . . 72.54 110.59 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 27.4 p -132.85 -14.9 2.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.946 0.351 . . . . 61.34 111.946 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 89.9 m 65.99 21.85 11.28 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 122.761 0.424 . . . . 51.34 111.309 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -104.62 142.3 34.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.22 -0.445 . . . . 75.52 109.832 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -79.04 177.36 8.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.078 0.466 . . . . 70.23 111.008 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.463 ' HB3' HG11 ' A' ' 30' ' ' VAL . 89.5 m-85 -89.64 106.27 18.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.133 0.492 . . . . 74.12 111.425 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 m -131.15 171.42 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.619 -0.719 . . . . 75.52 110.346 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.706 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -62.56 120.91 12.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 73.54 110.545 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.62 -40.92 1.51 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.776 -0.726 . . . . 51.44 112.211 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -86.96 161.52 18.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.629 -0.508 . . . . 73.23 109.629 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.89 122.9 69.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.349 -0.387 . . . . 74.41 110.278 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.1 163.44 13.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.435 -0.348 . . . . 74.33 110.397 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.5 t -144.49 155.51 43.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.955 -0.387 . . . . 54.0 109.955 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.449 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 37.0 tt0 -107.29 117.53 34.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.269 -0.423 . . . . 31.11 110.073 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.76 142.17 32.34 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.308 -0.627 . . . . 71.15 109.308 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.13 -18.68 24.17 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.369 2.713 . . . . 74.53 112.83 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.6 p -88.32 24.32 1.93 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.243 -0.435 . . . . 74.03 110.899 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.7 m80 66.22 33.7 7.11 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.094 0.558 . . . . 72.12 111.604 171.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -127.35 141.42 51.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.678 0.275 . . . . 73.0 110.859 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.47 133.2 55.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.838 -0.619 . . . . 72.44 110.485 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -143.07 175.18 10.05 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.876 -0.787 . . . . 75.32 108.876 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.647 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 32.3 m170 -82.39 131.49 35.22 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.174 -0.676 . . . . 61.4 109.174 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 85.2 tttt -60.1 -49.52 90.58 Favored Pre-proline 0 C--N 1.323 -0.568 0 O-C-N 123.377 0.423 . . . . 70.31 111.892 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 18.4 Cg_endo -60.05 -20.73 62.24 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.013 1.809 . . . . 64.33 112.637 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 60.2 m -83.6 -45.66 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.161 0.505 . . . . 55.42 110.655 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.474 HG22 ' HG ' ' A' ' 74' ' ' LEU . 9.4 p -78.32 -25.66 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 73.42 111.199 -173.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 9.0 p -58.85 -48.76 80.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 71.22 110.97 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.04 -42.82 96.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 65.44 110.372 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -62.88 -43.81 97.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.753 -0.658 . . . . 74.25 111.266 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.474 ' HG ' HG22 ' A' ' 70' ' ' VAL . 93.1 mt -65.55 -24.92 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.515 -0.312 . . . . 63.43 111.599 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 71' ' ' SER . 76.3 mt-30 -75.49 -23.44 56.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.979 0.418 . . . . 64.03 110.427 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -85.36 -48.08 9.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.35 0.595 . . . . 64.04 109.487 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.7 p -158.51 123.88 4.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.281 -0.872 . . . . 73.32 109.891 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.46 74.85 2.03 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.64 -0.79 . . . . 73.33 111.834 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.509 HG22 ' HA ' ' A' ' 84' ' ' ARG . 5.3 m -149.24 138.44 21.45 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.768 -0.254 . . . . 71.31 110.468 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 37.6 t -75.05 112.54 18.54 Favored Pre-proline 0 C--O 1.222 -0.387 0 N-CA-C 109.855 -0.424 . . . . 74.12 109.855 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.48 -38.48 64.08 Favored 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 123.13 2.553 . . . . 72.35 113.571 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.18 -31.81 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.852 0.686 . . . . 72.13 112.852 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.7 p -124.41 -16.23 6.42 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.315 -0.554 . . . . 64.14 111.894 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.509 ' HA ' HG22 ' A' ' 79' ' ' THR . 60.3 mtt180 69.4 26.24 5.3 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.222 0.609 . . . . 54.34 110.884 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.19 131.15 38.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.965 -0.754 . . . . 73.51 108.965 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 62.8 ttp -72.49 142.84 48.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.433 -0.348 . . . . 74.55 110.571 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.476 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 79.4 t80 -127.45 126.1 24.02 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.424 -0.584 . . . . 71.31 109.424 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 33.8 Cg_endo -65.24 155.39 77.51 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 123.597 -1.418 . . . . 65.3 112.68 1.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.38 142.89 21.57 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.465 2.777 . . . . 75.04 112.853 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.64 144.02 97.12 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.822 2.348 . . . . 64.34 112.155 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.454 -0.784 . . . . 71.15 110.119 -176.655 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 90.1 Cg_endo . . . . . 0 N--CA 1.459 -0.548 0 CA-C-O 120.732 0.221 . . . . 60.45 112.576 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.83 143.08 99.43 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.954 2.436 . . . . 74.42 112.228 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.15 150.99 41.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.89 -0.595 . . . . 74.31 111.276 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 22' ' ' ILE . 17.7 m -69.2 132.45 46.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.877 -0.601 . . . . 61.22 110.171 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -61.68 -36.66 81.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 73.15 112.09 -172.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -70.09 -36.98 75.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 74.13 110.389 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m -65.97 -29.14 69.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 53.04 110.566 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 18' ' ' SER . 69.5 mt -69.88 -40.7 79.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 72.13 110.713 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.505 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 34.1 t70 -70.93 -26.18 63.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.849 -0.341 . . . . 74.1 110.525 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -16.01 64.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 71.33 111.733 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.43 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 94.2 mt -63.2 141.84 97.77 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.383 -0.371 . . . . 65.34 110.798 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.68 129.39 26.19 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.059 2.506 . . . . 64.53 112.527 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -92.23 116.77 29.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.059 -0.518 . . . . 75.51 110.102 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.1 mt -114.44 130.27 69.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.142 -0.481 . . . . 73.14 109.833 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.4 tp -77.21 126.05 30.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.97 0.415 . . . . 73.42 110.317 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 53.5 t -82.12 134.14 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.012 -0.54 . . . . 70.32 110.046 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 20.4 p -126.17 126.86 44.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.311 -0.404 . . . . 72.24 110.57 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.695 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 10.7 pt-20 -80.64 -9.7 59.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 75.33 111.408 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.35 -2.05 56.45 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.199 -0.667 . . . . 74.11 109.199 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -113.97 118.4 34.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.978 -1.119 . . . . 64.12 107.978 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -41.49 -50.95 4.69 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 114.86 0.704 . . . . 71.2 114.86 -171.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -159.17 134.96 8.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.979 0.39 . . . . 32.44 110.6 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.2 t -85.41 73.25 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.935 0.398 . . . . 70.53 110.696 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.47 18.62 56.31 Favored Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.741 -0.663 . . . . 72.21 113.605 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.604 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 44.4 tp60 -159.06 171.99 18.98 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.756 -0.831 . . . . 74.52 108.756 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.24 144.83 39.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.063 -0.347 . . . . 71.25 110.063 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.1 ptp -76.37 22.45 0.17 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.091 0.404 . . . . 63.24 112.091 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.8 m -134.23 127.37 31.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.755 0.312 . . . . 35.24 110.551 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 41.3 t -96.64 106.88 33.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.571 -0.529 . . . . 54.12 109.571 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 12.0 Cg_endo -55.92 -33.69 89.66 Favored 'Trans proline' 0 N--CA 1.474 0.328 0 C-N-CA 123.254 2.636 . . . . 64.24 113.071 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.56 -20.21 22.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.174 0.512 . . . . 63.23 110.845 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 88.3 m -108.12 -30.18 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 63.54 111.659 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.7 t 70.0 17.73 7.33 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.875 0.734 . . . . 55.31 109.449 -171.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -124.28 161.57 25.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.253 -0.885 . . . . 74.54 110.673 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -85.12 -178.32 6.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 71.53 111.798 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.447 ' HB3' ' CG1' ' A' ' 30' ' ' VAL . 47.3 m-85 -94.47 109.16 21.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.701 -0.681 . . . . 71.31 110.93 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.688 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . 27.0 m -107.64 165.0 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.984 -0.553 . . . . 75.54 110.87 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.695 ' HB2' ' H ' ' A' ' 32' ' ' GLU . 28.1 ttpp -78.41 117.47 19.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.884 0.373 . . . . 75.11 110.725 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.82 -7.23 10.24 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.846 -0.615 . . . . 41.31 111.628 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -84.31 158.58 21.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.407 -0.59 . . . . 64.45 109.407 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.3 116.67 53.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.886 0.374 . . . . 71.44 110.63 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.31 167.68 10.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.075 -0.512 . . . . 55.51 110.551 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 14.0 t -149.26 157.96 43.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.011 -0.54 . . . . 64.43 109.645 176.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -108.4 117.63 34.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.344 -0.389 . . . . 53.21 110.126 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.85 150.12 88.21 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.912 -0.585 . . . . 62.11 109.458 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.16 -14.33 23.39 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.135 2.556 . . . . 71.21 112.855 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 23.9 p -91.93 15.0 14.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.384 -0.371 . . . . 72.4 110.334 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 60.14 74.78 0.43 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.329 0.585 . . . . 73.04 110.974 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -157.22 127.81 6.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.472 -0.785 . . . . 62.32 109.674 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 57' ' ' THR . 85.6 m-85 -97.93 133.21 42.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.025 -0.534 . . . . 73.24 110.693 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.33 174.84 10.25 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.867 -1.16 . . . . 74.4 107.867 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.835 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 34.1 m170 -86.29 128.58 34.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.912 -0.773 . . . . 64.11 108.912 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.531 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 87.4 tttt -53.03 -48.3 92.46 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.546 0.529 . . . . 73.41 111.914 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 76.1 Cg_exo -53.7 -45.0 44.25 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.33 2.02 . . . . 73.15 113.851 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.835 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 19.7 p -84.51 -33.67 23.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.398 -0.521 . . . . 70.34 112.209 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 67' ' ' LYS . 9.8 p -72.24 -28.7 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.817 -0.353 . . . . 72.22 110.765 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.3 p -63.96 -26.91 68.8 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.052 0.453 . . . . 71.32 110.83 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.92 -54.16 18.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 73.33 110.017 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -62.63 -33.62 75.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.053 -0.521 . . . . 73.53 111.477 -176.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 84.6 mt -66.74 -23.93 66.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.599 -0.273 . . . . 63.11 111.315 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -89.59 -11.29 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.212 0.529 . . . . 63.02 110.364 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -95.28 -57.17 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.815 -0.629 . . . . 75.23 110.761 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.2 t -110.83 -33.95 6.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.926 -0.579 . . . . 64.05 110.929 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.02 17.58 71.88 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.689 -0.767 . . . . 54.42 112.103 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 86' ' ' MET . 3.5 m -128.41 153.16 47.38 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.922 -0.399 . . . . 44.02 109.922 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.8 t -74.61 110.24 9.2 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.809 -0.811 . . . . 63.34 108.809 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.8 -25.93 63.75 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.174 2.582 . . . . 54.25 113.064 -171.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.73 -50.87 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.352 -0.386 . . . . 74.22 111.934 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.1 p -109.94 -2.55 17.08 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.267 0.469 . . . . 73.2 112.267 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? 66.53 21.57 10.74 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.29 0.478 . . . . 74.5 112.29 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.7 t -85.29 126.86 34.05 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.293 -0.632 . . . . 73.53 109.293 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.508 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 59.8 ttp -72.43 153.23 41.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.346 -0.388 . . . . 70.24 111.104 -176.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -124.77 118.61 25.84 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.563 -0.532 . . . . 74.24 109.563 173.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.34 156.76 96.6 Favored 'Cis proline' 0 C--N 1.344 0.322 0 C-N-CA 123.702 -1.374 . . . . 55.45 112.345 -0.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.24 139.6 63.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.081 2.521 . . . . 74.11 112.733 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 40.3 Cg_endo -65.64 141.7 67.61 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.72 2.28 . . . . 71.33 112.381 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.602 -0.713 . . . . 61.42 110.138 -177.112 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo . . . . . 0 C--O 1.235 0.34 0 CA-C-O 120.729 0.22 . . . . 74.01 111.856 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.29 146.41 90.06 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.844 2.363 . . . . 61.53 112.142 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 168.11 20.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.145 0.498 . . . . 64.01 111.622 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 m -78.09 150.89 33.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 53.41 110.826 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -62.37 -39.23 92.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.054 -0.521 . . . . 75.34 110.452 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.83 -35.01 79.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.71 -0.677 . . . . 75.34 111.332 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 m -61.84 -44.81 96.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 65.35 110.282 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.583 HG21 ' HA ' ' A' ' 71' ' ' SER . 25.9 mt -75.15 -38.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.738 -0.665 . . . . 71.44 110.521 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.3 -31.22 72.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.434 -0.803 . . . . 73.24 110.982 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.76 -21.68 60.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.845 -0.616 . . . . 71.03 111.576 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.44 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 98.0 mt -63.76 132.46 95.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 73.33 110.902 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.08 137.06 55.21 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.16 2.573 . . . . 73.14 112.864 -175.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.51 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 44.2 mt-10 -90.17 116.52 28.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.187 0.518 . . . . 64.42 110.751 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -109.15 129.47 63.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.315 -0.857 . . . . 72.2 109.681 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.7 tp -80.13 122.03 26.29 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.017 -0.364 . . . . 72.23 110.017 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 41.9 t -79.14 123.46 36.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.27 -0.423 . . . . 70.04 110.225 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.7 p -119.16 140.86 49.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.148 -0.478 . . . . 63.53 110.332 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 30.5 mt-10 -79.57 177.69 8.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.169 -0.469 . . . . 65.2 110.278 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 1.1 m-20 71.5 8.74 6.31 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.818 0.699 . . . . 71.5 109.807 -168.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -127.58 108.82 11.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.12 -0.945 . . . . 72.02 109.394 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.62 95.03 0.52 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.755 -0.736 . . . . 63.25 112.055 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 72.33 138.34 0.05 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.535 0.734 . . . . 61.52 111.484 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.45 -38.76 83.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 64.12 110.363 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.73 32.01 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.777 -0.725 . . . . 73.52 112.034 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -172.17 -80.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.732 0.301 . . . . 60.3 110.648 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.75 152.56 35.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.062 -0.517 . . . . 75.34 110.705 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -103.78 3.52 34.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.627 -0.715 . . . . 72.33 110.001 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 30.4 p -124.42 151.86 43.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.032 -0.531 . . . . 74.41 110.03 175.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 50.4 t -116.7 101.99 53.37 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.444 -0.576 . . . . 75.31 109.444 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -56.92 -28.57 78.29 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.116 2.544 . . . . 73.12 112.622 -173.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.4 mt -67.0 -32.14 56.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.748 -0.66 . . . . 72.53 111.618 -175.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.7 p -113.89 -4.21 13.32 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.987 -0.285 . . . . 73.24 111.22 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.8 t 67.93 4.06 3.84 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.782 -0.645 . . . . 61.13 111.256 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.8 m -105.92 163.76 12.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.8 0.333 . . . . 51.12 110.332 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.8 OUTLIER -91.71 -170.22 2.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.049 0.452 . . . . 74.43 110.89 -177.424 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.644 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 29.9 m-85 -94.47 108.84 20.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.092 -0.503 . . . . 73.21 111.397 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.31 166.72 7.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.337 -0.847 . . . . 75.11 109.612 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 39.5 ttpt -73.37 138.38 45.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.943 0.401 . . . . 74.44 110.769 -176.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.9 -9.32 47.12 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.993 -0.623 . . . . 62.31 112.342 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.78 162.06 18.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.76 -0.459 . . . . 71.51 109.76 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -110.31 122.62 65.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.846 0.355 . . . . 63.2 110.319 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -112.21 171.02 7.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.864 0.364 . . . . 75.03 110.448 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 7.2 t -148.84 168.57 22.63 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.684 -0.488 . . . . 63.52 109.684 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -113.36 117.32 31.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.817 0.341 . . . . 73.12 110.942 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.05 138.23 39.95 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.188 -0.671 . . . . 54.55 109.188 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.02 -19.27 19.42 Favored 'Trans proline' 0 N--CA 1.474 0.325 0 C-N-CA 123.708 2.938 . . . . 64.21 113.158 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.1 p -86.42 22.55 1.81 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.744 0.307 . . . . 74.11 110.682 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 65.3 36.71 6.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.274 0.559 . . . . 61.31 111.711 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.4 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 2.6 m-70 -125.11 122.62 37.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.888 -0.596 . . . . 73.44 110.315 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -99.0 133.13 43.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.239 -0.437 . . . . 71.14 110.124 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.644 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 72.9 m-85 -144.16 161.1 39.71 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.535 0.522 . . . . 73.4 110.261 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 38.2 m170 -61.88 121.26 12.49 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.367 -0.605 . . . . 72.05 109.367 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.6 tttt -58.78 -49.89 90.98 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 123.235 0.334 . . . . 70.1 111.676 -176.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 9.6 Cg_endo -53.91 -27.48 44.6 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.356 2.037 . . . . 72.41 112.613 176.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 68.2 m -82.89 -52.42 6.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 73.21 110.809 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 67' ' ' LYS . 7.1 p -69.95 -27.39 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 50.41 111.252 -173.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.583 ' HA ' HG21 ' A' ' 22' ' ' ILE . 18.4 p -64.47 -46.75 81.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.798 0.332 . . . . 72.14 110.579 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.508 HG22 ' HE2' ' A' ' 76' ' ' LYS . 75.1 mt -63.73 -37.85 80.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.152 -0.476 . . . . 73.41 110.291 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -64.65 -51.98 59.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 71.23 111.317 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.9 -24.38 66.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.388 -0.369 . . . . 72.12 111.664 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -77.5 -0.65 26.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.021 0.438 . . . . 75.34 110.756 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.508 ' HE2' HG22 ' A' ' 72' ' ' ILE . 56.5 mttm -113.46 -52.26 2.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 73.42 109.856 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.1 m -132.87 125.64 30.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.046 -0.525 . . . . 64.4 110.035 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.7 57.25 4.68 Favored Glycine 0 CA--C 1.516 0.148 0 C-N-CA 120.951 -0.642 . . . . 70.12 112.899 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 84' ' ' ARG . 39.5 m -145.77 149.21 33.96 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.283 -0.266 . . . . 75.12 110.283 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.6 t -74.41 118.08 67.02 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.926 -0.768 . . . . 71.24 108.926 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.4 -24.84 54.3 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.295 2.663 . . . . 71.22 113.477 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.28 -61.16 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.425 -0.352 . . . . 50.23 111.853 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.9 p -90.04 -1.11 57.91 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.906 0.336 . . . . 63.12 111.906 -172.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.412 ' HA ' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER 47.58 39.94 10.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.619 0.768 . . . . 75.51 111.913 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.12 148.7 22.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.73 -0.841 . . . . 73.2 108.73 170.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.5 ttp -74.19 145.75 43.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.03 0.443 . . . . 31.11 111.839 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.542 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 57.6 t80 -129.2 131.05 23.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.837 -0.801 . . . . 72.54 108.837 172.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 31.0 Cg_endo -62.86 159.67 60.45 Favored 'Cis proline' 0 C--N 1.347 0.472 0 C-N-CA 124.067 -1.222 . . . . 74.03 112.984 2.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.5 138.75 74.85 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.193 2.595 . . . . 74.03 112.818 -175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.22 151.74 84.16 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.699 2.266 . . . . 63.2 112.314 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.628 -0.701 . . . . 73.25 109.913 -179.717 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 CA--C 1.534 0.481 0 CA-C-O 121.02 0.342 . . . . 74.13 112.782 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HA ' ' H ' ' A' ' 78' ' ' GLY . 11.4 Cg_exo -71.46 168.22 24.16 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.732 2.288 . . . . 72.21 111.965 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.54 179.95 6.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.54 -0.3 . . . . 65.2 110.567 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 p -102.27 162.1 13.18 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.934 -0.395 . . . . 75.33 109.934 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -64.05 -43.9 94.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.969 0.414 . . . . 70.55 110.017 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -58.69 -47.28 85.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.414 -0.812 . . . . 72.52 112.063 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 p -64.17 -41.68 97.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.311 . . . . 73.41 110.978 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.62 -41.06 85.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.206 0.527 . . . . 74.3 110.584 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.1 -36.39 81.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 74.33 110.637 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.01 -6.25 51.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 50.21 112.187 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.463 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 34.5 mt -53.84 127.72 53.26 Favored Pre-proline 0 C--O 1.237 0.43 0 O-C-N 122.994 0.184 . . . . 75.03 111.2 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 9.8 Cg_endo -53.77 142.5 62.24 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.377 2.718 . . . . 52.44 111.694 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -113.85 106.48 14.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.099 0.476 . . . . 74.2 111.158 -173.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.5 mt -110.78 111.58 36.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.865 -0.607 . . . . 74.33 109.979 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.7 117.14 10.03 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.894 -0.41 . . . . 63.45 109.894 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 35.7 t -75.74 118.14 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.312 -0.404 . . . . 65.33 110.785 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.2 p -120.76 167.81 12.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.455 -0.572 . . . . 71.01 109.455 173.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.21 4.18 15.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.942 0.401 . . . . 72.44 111.123 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -80.26 -45.5 17.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.544 . . . . 73.23 110.333 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -77.92 -34.99 51.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 73.34 110.387 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.35 -115.77 4.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.004 -0.617 . . . . 53.35 111.706 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.0 141.64 57.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.622 -0.51 . . . . 71.51 109.622 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.21 90.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.504 -0.478 . . . . 61.34 111.234 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.511 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . 76.07 -73.54 1.73 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.565 -0.743 . . . . 64.31 113.337 171.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -107.89 -49.24 3.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.637 0.256 . . . . 71.24 110.91 -176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.4 158.55 37.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.357 0.599 . . . . 60.34 111.585 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.1 ptp -103.22 -5.77 22.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.162 -0.926 . . . . 73.35 109.902 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.827 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 85.1 m -128.14 137.92 52.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.802 -0.635 . . . . 71.23 110.421 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -93.36 112.49 56.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.04 -0.527 . . . . 62.0 109.974 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -60.77 -33.52 92.86 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.619 2.213 . . . . 72.44 111.94 -176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.49 -22.87 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.663 -0.698 . . . . 71.21 110.686 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 79.8 m -107.94 -19.36 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.979 -0.555 . . . . 44.32 111.201 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.4 m 60.8 29.27 18.9 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.48 0.657 . . . . 50.43 109.537 -170.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.6 t -141.16 155.38 46.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.254 -0.885 . . . . 71.41 109.514 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.827 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 10.7 pt-20 -77.75 -179.75 6.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.334 0.587 . . . . 72.54 111.783 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.512 ' HB3' HG11 ' A' ' 30' ' ' VAL . 73.8 m-85 -91.87 112.52 24.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.647 -0.706 . . . . 72.35 110.383 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.69 169.49 11.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 70.24 110.632 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 24.9 ttpp -72.99 113.66 10.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.74 -0.664 . . . . 74.31 110.961 -176.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.56 -36.5 1.54 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.581 -0.818 . . . . 54.11 112.758 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -87.14 162.17 17.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.12 -0.326 . . . . 72.22 110.12 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.75 129.49 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.58 -0.282 . . . . 72.34 110.38 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -101.22 163.41 12.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.825 0.345 . . . . 75.11 110.965 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 8.7 t -147.68 170.07 18.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.879 -0.601 . . . . 71.42 109.585 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 25.5 tt0 -123.39 123.24 40.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.535 -0.302 . . . . 74.42 110.694 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 61' ' ' CYS . 77.1 mt -86.02 141.16 35.18 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.416 -0.957 . . . . 73.31 108.416 169.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.93 36.19 0.17 Allowed 'Trans proline' 0 N--CA 1.479 0.623 0 C-N-CA 123.636 2.891 . . . . 52.54 113.922 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.405 ' H ' ' C ' ' A' ' 59' ' ' LEU . 29.5 p -140.06 28.07 2.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.388 -0.597 . . . . 63.0 109.388 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.8 m170 63.71 34.66 11.98 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.429 -0.805 . . . . 75.22 111.924 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -125.86 120.69 31.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.476 -0.329 . . . . 64.02 110.408 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.511 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 57.7 m-85 -101.88 137.17 40.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.954 -0.566 . . . . 72.24 111.29 -176.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.482 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 97.0 m-85 -140.72 175.36 9.67 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.738 -0.838 . . . . 74.02 108.738 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.88 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 39.1 m80 -82.61 131.79 35.2 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.172 -0.677 . . . . 61.24 109.172 173.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.53 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 86.7 tttt -55.61 -49.31 93.42 Favored Pre-proline 0 CA--C 1.539 0.532 0 O-C-N 123.49 0.494 . . . . 61.34 111.313 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 83.0 Cg_exo -51.23 -50.42 13.96 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.257 1.971 . . . . 72.41 113.52 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.88 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 21.9 p -79.69 -31.54 41.32 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.743 -0.383 . . . . 75.13 111.876 -174.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 67' ' ' LYS . 7.8 p -74.27 -28.81 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.719 -0.474 . . . . 75.23 109.719 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.706 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 27.7 t -58.46 -48.15 81.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.518 -0.549 . . . . 72.51 109.518 174.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -60.17 -40.78 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.651 -0.704 . . . . 72.11 110.705 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -67.43 -48.33 67.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.593 -0.731 . . . . 73.32 111.498 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 77' ' ' SER . 97.2 mt -67.25 -20.51 65.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.395 -0.366 . . . . 73.53 111.93 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.706 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.3 mt-30 -59.98 -40.29 88.6 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.581 -0.281 . . . . 74.0 111.391 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.77 -27.51 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.907 -0.317 . . . . 63.21 111.222 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 12.7 p -143.88 111.2 5.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.74 0.305 . . . . 64.42 110.872 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' H ' ' HA ' ' A' ' 16' ' ' PRO . . . -82.56 65.46 4.1 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.187 -0.765 . . . . 54.22 111.187 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 m -143.5 145.4 32.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.645 -0.278 . . . . 65.13 110.383 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.5 t -74.88 113.64 26.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.79 -0.819 . . . . 64.41 108.79 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.34 -34.2 79.49 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.036 2.49 . . . . 72.45 113.76 -172.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -75.13 -62.98 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.069 0.396 . . . . 71.11 112.069 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.3 p -89.12 -18.11 27.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 52.51 111.346 -173.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 63.4 71.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.801 0.81 . . . . 62.32 110.557 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t -128.81 142.58 50.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.637 -1.165 . . . . 73.43 108.067 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.531 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 61.8 ttp -68.05 149.07 50.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.989 0.423 . . . . 64.12 111.147 -174.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -127.97 121.18 21.74 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.636 -0.711 . . . . 71.01 109.39 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.61 157.83 77.21 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 124.048 -1.23 . . . . 73.31 112.855 0.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.48 135.29 63.8 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.993 2.462 . . . . 73.12 112.612 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 43.3 Cg_endo -68.44 147.47 71.24 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.867 2.378 . . . . 72.33 112.488 -177.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.322 -0.846 . . . . 74.14 109.302 177.895 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 CA--C 1.531 0.361 0 CA-C-O 120.957 0.315 . . . . 50.03 112.796 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.57 141.76 38.82 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.169 1.913 . . . . 71.25 112.106 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -81.75 149.21 28.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.991 -0.55 . . . . 44.1 110.167 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -58.97 116.44 3.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.259 -0.428 . . . . 70.11 110.478 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' A' ' 22' ' ' ILE . 6.5 ttpm? -56.8 -45.32 82.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.711 -0.677 . . . . 75.13 111.518 -176.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -54.93 -37.85 66.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.624 -0.716 . . . . 70.44 111.307 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.4 t -67.63 -41.02 84.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.076 0.465 . . . . 70.24 110.106 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 71' ' ' SER . 61.1 mt -62.61 -39.72 85.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.683 -0.689 . . . . 64.1 110.932 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -75.06 -29.18 60.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 44.01 110.759 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -12.81 60.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.332 -0.395 . . . . 73.11 111.517 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.11 145.54 85.01 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 116.409 -0.36 . . . . 72.4 111.044 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.88 160.37 49.92 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.914 2.409 . . . . 72.22 112.381 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -108.36 112.82 25.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.189 -0.459 . . . . 71.31 110.326 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.7 mt -101.68 101.74 12.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.247 -0.649 . . . . 74.44 109.247 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.55 122.54 19.25 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.813 -0.44 . . . . 64.45 109.813 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.747 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 21.4 t -77.46 105.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.123 -0.489 . . . . 62.54 110.134 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.4 p -103.68 168.2 9.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.783 -0.451 . . . . 73.5 109.783 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -76.82 -22.25 53.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.07 0.462 . . . . 74.43 110.303 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.81 -28.31 58.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.006 -0.543 . . . . 74.42 109.943 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -84.62 -44.3 13.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 74.32 109.527 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.2 -110.87 3.36 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.9 -0.591 . . . . 75.3 112.729 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.64 103.39 3.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.002 0.43 . . . . 72.11 110.376 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.2 t -68.64 -30.33 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.011 -0.541 . . . . 74.31 110.928 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 64' ' ' TYR . . . -149.89 -150.27 5.22 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.79 -0.719 . . . . 64.32 111.898 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -82.04 -24.19 35.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.672 -0.492 . . . . 71.5 109.672 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -83.99 111.79 19.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.866 -0.606 . . . . 61.24 109.75 172.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -91.28 -0.09 57.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 53.11 110.316 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 70.7 m -141.2 149.73 41.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.778 -0.647 . . . . 64.04 110.338 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 36.9 t -104.73 96.12 9.99 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.359 -0.608 . . . . 73.04 109.359 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 18.5 Cg_endo -57.27 -27.26 74.28 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.466 2.777 . . . . 61.22 112.935 -172.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.1 mt -57.74 -43.78 84.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 72.33 111.212 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.8 p -108.44 -3.23 18.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.565 -0.289 . . . . 74.34 110.713 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.1 m 60.87 40.2 15.99 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.834 -0.621 . . . . 72.45 110.716 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.9 m -135.94 146.55 47.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 75.3 110.47 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 15.4 pt-20 -81.88 -169.86 2.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 72.45 111.735 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.637 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.5 m-85 -102.97 108.77 20.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.201 0.524 . . . . 72.02 111.604 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 m -134.64 173.07 15.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.333 -0.849 . . . . 64.42 109.546 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.747 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 31.0 ttmt -64.54 125.76 25.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.042 0.448 . . . . 72.52 111.097 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.41 -42.73 1.27 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.563 -0.744 . . . . 64.53 111.731 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -86.68 165.88 15.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.875 -0.417 . . . . 64.01 109.875 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.0 133.7 65.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.684 -0.487 . . . . 75.22 109.684 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -111.76 176.01 5.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.897 0.38 . . . . 75.31 110.618 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.4 t -150.35 163.06 39.29 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.544 -0.539 . . . . 53.42 109.544 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -107.86 117.34 33.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.765 0.317 . . . . 74.35 110.667 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.8 mt -84.32 137.34 39.59 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.957 -0.757 . . . . 63.43 108.957 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.81 -8.19 7.22 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.89 2.393 . . . . 75.33 111.905 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.8 t -84.66 18.24 2.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.043 -0.98 . . . . 70.41 110.046 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 57.18 39.43 28.86 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.907 -0.588 . . . . 70.55 111.147 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -138.61 144.99 40.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.716 -0.674 . . . . 61.12 109.957 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.47 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 49.3 m-85 -121.12 132.86 55.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.794 0.33 . . . . 64.02 111.248 -172.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.637 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 89.6 m-85 -142.58 162.78 34.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 73.11 110.35 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 35.0 m170 -63.83 129.38 39.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.615 -0.513 . . . . 62.25 109.615 174.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.501 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 48.3 tttm -60.62 -51.7 77.93 Favored Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 123.326 0.391 . . . . 75.15 111.622 -175.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 27.5 Cg_endo -62.22 -22.0 73.45 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.127 1.885 . . . . 64.4 112.925 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.2 m -84.21 -46.99 11.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.225 0.536 . . . . 74.22 110.464 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.546 HG22 ' HG ' ' A' ' 74' ' ' LEU . 5.8 p -73.62 -23.78 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.786 -0.643 . . . . 75.42 110.717 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.52 ' HA ' HG21 ' A' ' 22' ' ' ILE . 19.3 p -65.74 -30.52 71.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.338 . . . . 51.25 111.083 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.92 -41.38 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 73.22 109.989 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -63.11 -47.53 82.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.448 -0.796 . . . . 74.11 111.783 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.546 ' HG ' HG22 ' A' ' 70' ' ' VAL . 98.2 mt -65.82 -20.56 66.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.342 0.497 . . . . 75.23 112.342 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 71' ' ' SER . 71.0 mt-30 -77.09 -9.59 58.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.183 0.516 . . . . 63.12 110.496 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -113.07 -42.27 3.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.61 . . . . 74.4 109.896 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -142.4 110.05 5.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.671 -0.695 . . . . 62.13 109.954 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.08 65.85 3.71 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 51.42 112.122 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.503 ' HB ' ' HA ' ' A' ' 84' ' ' ARG . 1.4 p -149.29 157.54 43.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.453 0.168 . . . . 73.03 110.991 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 44.1 m -74.45 123.09 88.87 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 108.308 -0.997 . . . . 75.42 108.308 169.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.468 ' HD2' ' CZ ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -53.22 -27.96 40.14 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.466 2.111 . . . . 74.25 112.474 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.9 t -80.23 -41.02 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.706 -0.679 . . . . 71.35 112.449 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 12.8 p -110.03 -30.15 7.91 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.699 -0.401 . . . . 73.25 111.857 -172.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.503 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 56.5 mtt85 57.23 77.14 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.749 0.785 . . . . 61.22 111.879 -168.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.2 t -131.93 140.75 49.12 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.838 -1.171 . . . . 73.51 107.838 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.5 ttp -73.97 131.53 41.5 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.988 0.736 . . . . 71.25 112.988 -165.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 88' ' ' PRO . 70.9 t80 -122.87 134.92 25.31 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.71 -1.132 . . . . 62.05 108.805 172.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 87' ' ' PHE . 9.5 Cg_exo -72.12 154.98 98.48 Favored 'Cis proline' 0 C--N 1.343 0.27 0 C-N-CA 123.855 -1.31 . . . . 73.11 112.186 -0.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.55 136.93 77.36 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.733 2.289 . . . . 71.13 112.03 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.62 153.17 76.7 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.954 2.436 . . . . 73.52 112.691 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.35 -0.833 . . . . 52.13 109.629 179.674 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 2.2 Cg_endo . . . . . 0 C--O 1.234 0.294 0 CA-C-O 121.098 0.374 . . . . 73.21 112.632 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 92.3 Cg_endo -87.51 157.66 7.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.9 2.4 . . . . 62.12 113.369 -175.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.79 146.76 26.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.605 -0.725 . . . . 31.22 109.921 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 22' ' ' ILE . 14.3 m -73.23 140.28 46.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.266 -0.425 . . . . 74.51 110.201 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 34.7 ttpt -52.81 -44.97 67.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 64.02 111.131 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.14 -40.11 92.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.951 -0.568 . . . . 71.04 110.857 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 m -66.57 -32.88 74.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 62.43 110.799 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.48 HG21 ' HA ' ' A' ' 71' ' ' SER . 54.8 mt -74.42 -39.24 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.37 0.605 . . . . 64.52 110.258 177.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.495 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 32.7 t70 -70.39 -21.41 62.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.957 -0.565 . . . . 75.04 110.667 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.57 -16.12 61.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.551 . . . . 45.23 111.227 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.54 143.01 96.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 64.42 110.84 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.37 136.62 75.6 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.104 2.536 . . . . 73.0 112.244 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -102.15 120.28 40.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.058 -0.519 . . . . 74.32 110.587 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.6 mt -112.08 111.99 38.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.091 -0.504 . . . . 62.34 109.927 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.01 118.8 10.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.86 -0.422 . . . . 64.42 109.86 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 49.0 t -71.23 114.52 9.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.141 -0.481 . . . . 64.32 110.177 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 p -95.36 147.3 23.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.728 -0.669 . . . . 63.25 110.258 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -69.67 -15.51 63.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.776 -0.647 . . . . 73.11 111.303 -174.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.34 -45.55 19.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.455 . . . . 74.11 111.248 -175.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -74.36 -47.93 31.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 53.53 110.881 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.17 -87.4 0.68 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.88 -0.676 . . . . 73.31 113.032 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 41' ' ' MET . . . -74.45 100.3 3.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.911 0.386 . . . . 63.32 110.96 -177.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.7 t -95.3 118.2 40.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.682 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.91 -64.85 2.36 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.876 -0.678 . . . . 61.32 112.919 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -154.3 -56.96 0.11 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.657 0.265 . . . . 71.14 111.013 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' OE2' ' HB3' ' A' ' 42' ' ' CYS . 30.9 tt0 -101.76 155.01 18.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.248 -0.433 . . . . 70.45 110.054 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.7 pmm? -92.56 5.5 50.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.01 0.433 . . . . 44.44 110.255 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.867 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 19.6 t -130.8 156.0 45.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.885 -0.598 . . . . 73.45 109.926 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 30.8 t -107.35 106.32 58.08 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.703 -0.48 . . . . 71.04 109.703 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.7 Cg_endo -55.46 -29.35 68.5 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.29 2.66 . . . . 51.41 112.725 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -69.22 -27.77 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.083 -0.508 . . . . 74.42 110.74 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 96.5 m -103.49 -23.57 13.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.405 -0.361 . . . . 74.43 111.319 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.6 t 63.35 22.76 13.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.998 0.904 . . . . 54.3 108.577 -167.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.1 m -131.65 148.4 52.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.453 -1.249 . . . . 70.31 109.519 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.867 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 17.3 pt-20 -81.8 -178.25 6.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.276 0.56 . . . . 64.1 112.358 -172.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -91.04 117.2 29.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.471 -0.786 . . . . 74.22 111.021 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 m -132.42 166.78 28.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 74.41 109.48 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.8 ttpt -65.49 131.91 47.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.933 0.397 . . . . 62.1 110.717 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.43 -34.89 2.94 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.034 -0.603 . . . . 62.13 111.746 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -86.97 161.28 18.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.579 -0.526 . . . . 61.52 109.579 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.79 125.5 72.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.086 -0.339 . . . . 71.31 110.086 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -95.64 165.4 12.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.838 0.351 . . . . 54.51 110.485 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 7.5 t -146.78 172.56 13.45 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.584 -0.524 . . . . 41.25 109.584 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -125.55 117.66 24.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.691 -0.485 . . . . 73.25 109.691 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -90.03 139.51 27.36 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 110.186 -0.301 . . . . 70.11 110.186 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.51 12.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.481 0.778 0 C-N-CA 123.871 3.048 . . . . 75.41 114.623 -172.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -115.03 17.34 16.86 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.593 -0.521 . . . . 64.14 109.593 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 64.12 74.84 0.4 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.258 -0.883 . . . . 63.2 110.481 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -161.66 121.23 2.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.853 -0.612 . . . . 72.01 110.303 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -99.09 133.41 43.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 74.33 110.835 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -144.58 175.35 10.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.418 -0.956 . . . . 72.2 108.418 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.956 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 35.2 m170 -81.71 129.1 34.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.693 -0.854 . . . . 72.14 108.693 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.539 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 85.1 tttt -55.81 -50.99 83.95 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 123.448 0.467 . . . . 74.01 112.125 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 44.4 Cg_exo -58.33 -41.3 67.53 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.611 1.541 . . . . 51.13 113.183 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.956 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 30.2 p -80.95 -32.38 34.5 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.528 -0.469 . . . . 73.34 111.747 -175.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.93 -29.04 24.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.581 -0.526 . . . . 61.53 109.581 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.48 ' HA ' HG21 ' A' ' 22' ' ' ILE . 32.0 t -59.01 -42.49 90.24 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.0 -0.545 . . . . 61.35 109.817 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.418 ' O ' ' HE2' ' A' ' 76' ' ' LYS . 76.0 mt -55.6 -47.91 78.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 62.01 110.476 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 41.4 t-105 -69.7 -47.03 64.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.651 . . . . 72.12 110.946 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.43 -36.22 81.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.953 0.353 . . . . 62.5 111.953 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -64.44 -16.19 61.96 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.032 0.382 . . . . 73.3 112.032 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 72' ' ' ILE . 46.7 mtmt -118.34 -59.7 1.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.687 0.279 . . . . 72.43 111.645 -177.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.1 m -88.78 -25.15 22.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.305 -0.407 . . . . 63.34 111.624 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.21 43.47 93.53 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.322 -0.466 . . . . 55.51 113.194 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.03 165.56 27.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.979 0.418 . . . . 61.23 111.576 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.534 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 47.5 t -96.99 99.9 6.65 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.509 -0.552 . . . . 55.22 109.509 174.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -35.54 -48.93 0.95 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.578 3.519 . . . . 71.21 115.535 -169.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.82 -25.28 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.905 0.706 . . . . 74.44 112.905 -173.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 28.7 p -120.48 -25.48 5.57 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.771 -0.581 . . . . 75.5 111.423 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.5 mtm-85 72.08 15.11 5.59 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.546 0.738 . . . . 73.03 111.821 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.9 144.56 50.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.555 -0.906 . . . . 73.14 108.555 168.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.403 ' HB3' ' HE2' ' A' ' 86' ' ' MET . 62.5 ttp -79.01 148.27 32.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.997 0.427 . . . . 61.34 112.01 -172.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.456 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 87.7 t80 -132.54 124.39 19.0 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.346 -0.843 . . . . 75.31 108.766 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 37.3 Cg_endo -65.58 147.69 73.23 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.768 -1.347 . . . . 75.24 112.918 2.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.48 137.57 65.49 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.597 2.865 . . . . 71.3 113.145 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.79 151.58 46.15 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.746 2.297 . . . . 75.21 112.094 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.502 -0.761 . . . . 63.43 109.481 178.214 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 60.4 Cg_endo . . . . . 0 N--CA 1.461 -0.431 0 CA-C-O 120.955 0.315 . . . . 61.42 112.204 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 18.3 Cg_exo -66.89 146.14 76.86 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.484 2.123 . . . . 72.34 111.249 175.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -78.22 147.82 34.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.876 0.369 . . . . 65.35 110.915 -177.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.0 t -74.53 153.71 38.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.934 -0.576 . . . . 73.51 109.859 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -58.83 -38.12 77.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.263 0.554 . . . . 71.14 109.735 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -70.23 -28.72 65.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.357 -0.838 . . . . 74.44 110.911 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 13.8 m -66.68 -38.1 86.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.86 -0.422 . . . . 64.04 109.86 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -77.38 -36.04 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 72.11 110.259 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.81 -37.49 84.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.578 -0.737 . . . . 52.22 111.192 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.04 4.69 49.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.053 -0.521 . . . . 74.3 112.312 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 21' ' ' SER . 57.8 mt -70.34 128.96 90.89 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 121.247 -0.181 . . . . 42.1 110.946 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 16.1 Cg_endo -58.17 153.12 47.93 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.033 2.489 . . . . 53.54 112.047 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -126.17 118.03 24.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.022 0.439 . . . . 73.41 110.857 -174.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.1 mt -120.5 118.35 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.769 -0.651 . . . . 73.52 110.366 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.45 121.05 15.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.729 -0.471 . . . . 60.32 109.729 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 45.0 t -86.05 129.88 37.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.332 -0.395 . . . . 72.03 111.228 -177.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 34' ' ' HIS . 20.3 p -117.09 141.14 48.64 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.825 -0.625 . . . . 64.24 109.792 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 52' ' ' LYS . 57.0 mt-10 -69.12 -27.78 65.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.191 0.52 . . . . 73.41 110.974 -176.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.07 -6.55 59.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.74 -0.664 . . . . 74.31 110.969 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.53 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 22.5 t60 -74.34 -47.56 33.64 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.823 -0.436 . . . . 73.3 109.823 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 -160.13 13.39 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.407 -0.677 . . . . 63.44 111.407 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.73 114.19 14.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.848 0.356 . . . . 70.34 110.723 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.21 95.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.909 -0.587 . . . . 71.22 110.607 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.83 -143.26 23.17 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.839 -0.696 . . . . 72.51 112.545 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.556 ' OE1' ' HA ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -85.2 -27.67 25.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.58 0.228 . . . . 70.22 111.275 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -96.2 125.54 40.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.757 -0.46 . . . . 52.25 109.757 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 22.7 ptp -107.72 0.04 22.1 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.477 -0.329 . . . . 64.41 111.395 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.3 m -143.39 157.67 44.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.487 . . . . 63.51 110.993 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 40.7 t -117.06 93.32 41.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.776 -0.647 . . . . 74.11 109.377 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 13.1 Cg_endo -56.49 -26.03 61.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.567 2.845 . . . . 73.04 113.078 -174.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.6 mt -60.09 -34.77 57.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 73.52 111.054 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.4 p -114.94 9.74 16.18 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.126 -0.324 . . . . 71.32 110.126 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p 41.12 46.25 2.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.02 0.928 . . . . 71.22 111.892 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -140.2 154.59 46.97 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.923 -0.58 . . . . 63.03 110.06 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.84 -169.9 1.95 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.925 -0.58 . . . . 74.14 110.923 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.428 ' HB3' HG11 ' A' ' 30' ' ' VAL . 40.4 m-85 -87.17 93.66 9.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.545 0.688 . . . . 72.54 111.497 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.93 162.73 2.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.836 -1.075 . . . . 73.41 110.321 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.9 ttpm? -79.68 133.57 36.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.02 0.438 . . . . 72.13 110.67 -176.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.65 -16.18 21.53 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.819 -0.705 . . . . 64.22 111.834 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -86.96 161.83 18.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.169 -0.678 . . . . 73.2 109.169 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.6 121.2 64.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.958 -0.386 . . . . 74.51 109.958 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.34 155.95 16.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.875 0.369 . . . . 63.2 110.742 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 12.8 t -138.11 156.01 48.18 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.961 -0.563 . . . . 74.34 109.783 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.441 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 54.2 tt0 -111.61 117.46 33.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.296 -0.411 . . . . 64.43 109.92 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.4 mt -78.41 147.87 72.87 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.037 -0.529 . . . . 75.32 109.755 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.427 ' HD2' ' CE1' ' A' ' 87' ' ' PHE . 14.6 Cg_endo -59.38 -13.35 20.1 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.117 2.545 . . . . 73.11 112.136 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.0 t -79.49 4.33 15.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.415 -0.811 . . . . 63.2 109.655 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 56.93 63.74 1.84 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 122.127 0.965 . . . . 75.13 110.684 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.556 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 1.2 m80 -148.65 123.4 9.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.184 -1.371 . . . . 74.54 109.682 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -90.75 133.19 35.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.062 -0.517 . . . . 64.51 110.779 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -146.64 168.02 22.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.584 -0.735 . . . . 72.14 109.157 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.1 m170 -75.08 122.58 23.78 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.621 -0.511 . . . . 64.4 109.621 175.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 89.1 tttt -59.0 -51.11 84.18 Favored Pre-proline 0 CA--C 1.538 0.486 0 O-C-N 123.412 0.445 . . . . 41.31 112.093 -175.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.4 Cg_endo -60.74 -20.05 63.92 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.112 1.875 . . . . 64.14 112.956 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 61.3 m -84.38 -49.9 8.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.078 0.466 . . . . 74.02 110.43 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.9 p -73.37 -25.62 21.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.672 -0.695 . . . . 55.23 111.467 -171.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.502 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 13.0 p -59.81 -30.57 69.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.746 0.308 . . . . 60.32 111.597 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.98 -36.6 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.304 0.573 . . . . 75.13 110.419 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -74.66 -41.27 60.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.709 -0.678 . . . . 71.52 111.006 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 92.8 mt -62.24 -27.48 69.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.895 -0.593 . . . . 63.03 112.038 -175.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 71' ' ' SER . 73.9 mt-30 -65.77 -25.18 67.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.087 0.47 . . . . 73.44 110.736 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.96 -39.45 9.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 75.41 110.318 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 p -163.55 125.33 2.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 72.4 110.47 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 87' ' ' PHE . . . -79.96 91.27 1.31 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.614 -0.803 . . . . 62.34 111.137 177.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 84' ' ' ARG . 2.4 m -149.66 144.55 26.21 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.677 -0.308 . . . . 73.32 110.869 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . 0.747 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 83.1 m -74.39 120.92 83.84 Favored Pre-proline 0 N--CA 1.464 0.247 0 N-CA-C 108.386 -0.968 . . . . 61.45 108.386 168.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.48 -21.81 56.05 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.551 2.168 . . . . 62.12 112.832 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.47 -51.44 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.395 -0.366 . . . . 65.22 111.861 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.9 p -94.4 -22.76 18.1 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.759 0.314 . . . . 51.12 111.712 -172.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.529 ' HA ' HG22 ' A' ' 79' ' ' THR . 59.2 mtt180 60.35 28.08 17.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.762 -0.654 . . . . 74.03 111.695 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.9 m -88.86 160.69 17.1 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.647 -0.501 . . . . 74.03 109.647 172.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 38.2 ttm -76.12 141.14 42.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.647 0.61 . . . . 72.31 112.647 -169.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.427 ' CE1' ' HD2' ' A' ' 60' ' ' PRO . 54.6 t80 -132.74 121.39 17.1 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.282 -0.872 . . . . 74.12 109.539 170.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.51 159.37 85.74 Favored 'Cis proline' 0 C--O 1.232 0.196 0 C-N-CA 123.687 -1.38 . . . . 73.03 111.827 -1.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.57 149.09 14.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.041 2.494 . . . . 73.13 112.19 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.18 135.46 47.13 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.655 2.236 . . . . 73.35 112.114 -175.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 115.485 -0.78 . . . . 72.12 109.168 179.807 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 C--O 1.237 0.437 0 CA-C-O 120.62 0.175 . . . . 73.12 111.929 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.09 146.48 96.12 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.802 2.335 . . . . 60.31 112.155 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB3' HD11 ' A' ' 22' ' ' ILE . . . -85.56 162.76 18.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.245 -0.434 . . . . 43.2 110.243 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.465 ' O ' HG13 ' A' ' 22' ' ' ILE . 14.1 m -67.25 126.06 28.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.345 -0.389 . . . . 54.5 110.786 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -45.14 82.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 71.21 111.546 -175.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.13 -36.46 83.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.748 0.309 . . . . 72.31 111.086 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -67.07 -34.72 78.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.097 0.475 . . . . 55.33 110.321 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 18' ' ' SER . 60.8 mt -74.18 -41.18 51.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 70.14 110.847 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -80.14 -12.18 59.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.024 0.44 . . . . 32.21 110.968 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.85 -13.06 60.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 65.44 110.75 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.34 138.36 94.19 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.864 -0.607 . . . . 51.14 110.328 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -58.42 134.01 58.52 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.342 2.695 . . . . 62.11 113.088 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 40.0 mt-10 -84.8 102.81 13.34 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.306 -0.628 . . . . 74.44 109.306 173.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.6 mt -92.09 117.18 34.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.119 -0.491 . . . . 73.12 110.934 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.2 tp -78.26 109.34 12.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.791 -0.64 . . . . 74.24 109.553 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 50' ' ' TYR . 49.1 t -83.05 124.82 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.938 0.399 . . . . 52.2 111.147 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.5 p -101.19 153.88 19.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.311 -0.626 . . . . 51.32 109.311 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -87.89 -177.84 5.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.229 0.455 . . . . 72.11 112.229 -168.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.7 t70 76.07 -0.09 3.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.034 -0.985 . . . . 74.34 110.92 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.438 ' HE1' ' O ' ' A' ' 50' ' ' TYR . 11.7 p-80 -71.25 -21.41 62.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.9 -0.591 . . . . 71.34 112.06 -177.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.04 -82.87 1.41 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.531 -0.843 . . . . 70.31 111.097 -174.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.12 154.28 33.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.705 -0.479 . . . . 51.33 109.705 174.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.15 -56.89 4.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.147 0.499 . . . . 74.34 110.014 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.647 ' O ' ' HG2' ' A' ' 39' ' ' GLN . . . -163.57 103.71 0.22 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.919 -0.872 . . . . 52.33 110.919 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' A' ' 38' ' ' GLY . 8.6 pt20 56.87 -67.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.375 1.47 . . . . 62.24 112.297 -176.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.13 108.11 12.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.161 0.505 . . . . 41.2 109.679 173.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.2 ptp -81.41 -12.05 59.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.885 -0.598 . . . . 71.12 110.62 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 5.9 p -137.32 148.5 46.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.742 -0.663 . . . . 51.44 109.912 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' CYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 35.8 t -88.09 107.6 17.03 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.177 -0.465 . . . . 74.31 109.939 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 19.4 Cg_endo -58.57 -28.69 86.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.173 2.582 . . . . 54.24 112.66 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.8 mt -65.05 -25.96 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.245 0.545 . . . . 64.02 110.951 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 19.8 m -119.96 -1.87 10.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.111 -0.495 . . . . 62.03 111.144 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.8 p 41.14 42.97 1.8 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.712 0.768 . . . . 71.44 110.558 -168.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 t -142.89 147.26 35.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.981 -1.008 . . . . 73.12 109.464 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 8.3 pt-20 -80.28 -169.8 2.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.457 0.646 . . . . 54.12 111.268 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.498 ' HB3' HG11 ' A' ' 30' ' ' VAL . 78.6 m-85 -102.54 109.85 21.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.572 -0.74 . . . . 70.42 109.328 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.87 170.0 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.207 -0.451 . . . . 73.23 111.994 -171.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -60.13 109.25 0.93 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.542 -0.754 . . . . 74.22 111.091 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.24 -0.49 43.87 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.665 -0.779 . . . . 65.11 112.535 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -82.18 147.29 29.09 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.244 -0.651 . . . . 74.01 109.244 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.97 114.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.248 0.547 . . . . 51.22 110.913 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.33 176.75 4.93 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.635 -0.711 . . . . 54.32 110.507 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 6.6 t -152.23 171.06 18.54 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.471 -0.566 . . . . 74.23 109.471 175.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -123.4 119.42 29.98 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.091 -0.336 . . . . 72.13 110.091 -174.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.0 150.08 54.59 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.088 -0.506 . . . . 74.34 111.125 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.09 -9.62 17.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.03 2.487 . . . . 45.21 112.979 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -95.44 8.92 41.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.54 -0.3 . . . . 74.41 110.205 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 65.33 93.0 0.07 Allowed 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 123.82 0.7 . . . . 54.52 109.72 -172.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -175.62 122.47 0.2 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.759 -0.655 . . . . 74.15 110.723 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 57' ' ' THR . 92.2 m-85 -95.53 133.26 39.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.466 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.491 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 86.8 m-85 -140.98 174.77 10.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.755 -0.832 . . . . 72.14 108.755 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.875 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 38.3 m80 -82.02 125.16 30.48 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.271 -1.011 . . . . 74.25 108.271 175.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 60.7 tttm -53.67 -47.68 95.79 Favored Pre-proline 0 C--N 1.322 -0.618 0 O-C-N 123.388 0.43 . . . . 73.34 112.022 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 10.0 Cg_endo -52.88 -50.53 13.74 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.222 1.948 . . . . 64.22 113.246 177.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.875 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 26.3 p -76.54 -35.47 58.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.806 -0.358 . . . . 73.52 111.95 -173.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -74.16 -28.65 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.337 . . . . 74.22 110.271 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.442 ' HA ' HG21 ' A' ' 22' ' ' ILE . 33.0 t -60.79 -50.01 75.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 63.34 109.941 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.1 mt -61.08 -37.43 77.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 60.25 110.615 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -68.45 -50.84 49.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.798 -0.637 . . . . 73.32 111.257 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.86 -25.55 67.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.776 0.322 . . . . 71.32 111.203 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -75.0 -1.4 22.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 41.34 110.793 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -112.24 -48.39 3.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.254 0.55 . . . . 55.04 109.676 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.9 m -145.65 119.55 9.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.669 . . . . 52.01 110.413 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.13 71.71 1.95 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.845 -0.693 . . . . 51.13 112.332 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.9 142.82 29.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.229 -0.286 . . . . 64.01 110.229 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 47.0 t -74.69 113.61 26.11 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.006 -0.738 . . . . 75.22 109.006 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.77 -24.78 77.09 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 123.073 2.516 . . . . 73.25 114.03 -171.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.47 -59.15 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.069 0.396 . . . . 64.12 112.069 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 30.6 p -95.32 -11.25 28.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.938 -0.305 . . . . 71.22 111.478 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 62.42 80.57 0.22 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.795 0.807 . . . . 61.34 111.057 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.5 t -137.82 135.94 36.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.531 -1.213 . . . . 73.52 108.24 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.569 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 50.5 ttm -72.97 141.09 47.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.837 0.351 . . . . 72.31 111.301 -173.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 87.1 t80 -133.82 114.31 13.01 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.848 -0.614 . . . . 74.02 109.856 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 71.5 Cg_endo -75.26 153.13 98.58 Favored 'Cis proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.147 -1.605 . . . . 72.14 111.861 -2.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 88' ' ' PRO . 52.2 Cg_exo -54.82 148.5 45.78 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.808 2.339 . . . . 62.22 112.633 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 31.9 Cg_endo -63.72 153.39 75.57 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.826 2.351 . . . . 71.04 112.456 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 C--O 1.246 0.917 0 CA-C-N 115.816 -0.629 . . . . 71.1 109.746 178.834 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.25 -0.278 . . . . 62.34 110.25 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.77 68.73 0.22 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.277 -0.729 . . . . 52.2 111.277 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -84.42 -40.26 18.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.835 0.35 . . . . 74.13 110.292 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -111.49 120.8 43.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.152 -0.684 . . . . 75.1 109.152 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -98.27 93.88 6.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.354 -0.384 . . . . 75.43 111.69 -174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -90.44 82.79 5.87 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.105 -1.072 . . . . 73.13 108.105 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -70.62 -36.82 73.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.092 -0.958 . . . . 75.42 111.457 -170.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -96.01 100.52 12.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.452 -0.34 . . . . 60.22 110.403 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 10' ' ' HIS . 10.0 t -86.3 164.19 17.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.154 -0.476 . . . . 71.32 110.041 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 9' ' ' SER . 9.8 m170 72.3 143.65 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.703 0.627 . . . . 74.22 111.537 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 68.6 mtt -87.49 -29.99 20.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.257 -0.646 . . . . 71.42 109.257 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.1 134.28 63.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.383 -0.826 . . . . 74.02 109.554 175.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.3 151.49 29.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.983 0.421 . . . . 74.14 111.304 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' ND2' ' HB2' ' A' ' 86' ' ' MET . 5.4 m-20 -87.94 131.66 42.43 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.833 -0.621 . . . . 62.43 110.236 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 72.5 Cg_endo -77.77 145.64 22.98 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.521 2.147 . . . . 73.02 112.553 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.6 153.36 65.11 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.608 2.205 . . . . 64.23 112.299 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.95 167.73 16.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.005 -0.543 . . . . 54.54 111.043 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -94.81 151.31 19.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.104 -0.498 . . . . 75.33 109.943 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HD2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -58.95 -37.56 77.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.493 -0.321 . . . . 74.12 110.494 -176.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -56.93 -41.87 78.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.972 -0.558 . . . . 72.31 111.125 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -72.25 -27.03 62.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 60.44 111.085 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.549 HG21 ' HA ' ' A' ' 71' ' ' SER . 42.8 mt -82.86 -38.8 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.399 0.618 . . . . 71.3 110.516 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.68 -20.68 64.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.987 -0.551 . . . . 71.22 110.505 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.9 -3.81 55.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.772 -0.649 . . . . 51.22 111.378 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.4 152.34 85.67 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.553 -0.294 . . . . 72.24 110.453 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.93 122.91 11.64 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.715 2.277 . . . . 71.41 112.175 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -86.91 118.3 26.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.024 -0.535 . . . . 62.04 110.133 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.3 mt -110.19 103.63 15.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.82 -0.627 . . . . 61.51 110.264 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 68.9 tp -68.24 114.62 6.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.549 -0.538 . . . . 75.4 109.549 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 40.0 t -70.13 111.05 3.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.971 -0.381 . . . . 74.33 109.971 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.2 p -88.19 169.74 11.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 65.13 110.379 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.37 -8.34 56.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.027 0.38 . . . . 40.31 112.027 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -91.46 -2.42 57.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.154 0.502 . . . . 75.2 109.839 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -109.21 90.68 3.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.922 -0.581 . . . . 71.2 111.102 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.93 -26.82 48.03 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.909 -0.877 . . . . 74.03 110.909 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.19 140.46 41.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.482 -0.562 . . . . 74.4 109.482 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 t -118.86 90.8 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.765 0.317 . . . . 60.41 110.727 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.92 13.9 60.17 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.976 -0.556 . . . . 74.53 113.307 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.97 -155.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.61 -0.515 . . . . 50.44 109.61 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -68.94 177.63 2.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.815 -0.439 . . . . 70.24 109.815 173.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 1.8 pmm? -84.33 0.0 50.86 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.006 -0.278 . . . . 75.31 110.468 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.7 m -116.36 131.84 56.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.079 0.466 . . . . 65.13 112.038 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 14.5 t -83.48 107.93 11.61 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.595 -0.891 . . . . 63.53 108.595 171.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 9.8 Cg_endo -51.22 -38.91 62.23 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.331 2.687 . . . . 73.01 112.878 -173.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 51.7 mt -62.29 -29.48 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.961 -0.563 . . . . 71.22 111.347 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 61.2 m -110.12 -8.62 14.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.377 -0.374 . . . . 72.31 111.623 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.4 p 45.18 34.99 1.53 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.459 0.647 . . . . 52.11 110.949 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.1 t -133.82 159.82 39.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.496 -0.775 . . . . 61.43 110.0 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 41' ' ' MET . 4.6 pt-20 -83.96 172.57 11.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.736 0.643 . . . . 64.43 112.736 -171.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -98.05 123.91 42.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.374 -0.83 . . . . 75.22 110.289 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.26 164.83 28.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.178 -0.465 . . . . 74.24 110.411 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.657 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.2 ttpt -58.77 125.64 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 60.2 111.047 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.83 -23.96 6.5 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.669 -0.777 . . . . 60.41 112.702 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.57 161.53 18.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.031 -0.359 . . . . 64.2 110.031 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.88 115.25 49.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.927 0.394 . . . . 71.51 110.351 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -100.96 168.35 9.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.211 -0.45 . . . . 62.11 110.417 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.0 t -152.76 166.2 32.97 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.229 -0.656 . . . . 73.33 109.229 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -120.39 119.71 33.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.688 0.28 . . . . 61.11 110.691 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.496 HD21 HD11 ' A' ' 74' ' ' LEU . 88.2 mt -70.39 142.36 89.3 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 108.84 -0.8 . . . . 62.31 108.84 170.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 9.6 Cg_endo -52.79 -20.84 13.68 Favored 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.663 2.908 . . . . 74.43 113.841 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.7 p -85.88 19.33 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 70.13 110.376 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 58.01 65.39 1.31 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.411 -0.813 . . . . 75.22 111.612 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -145.08 123.09 12.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.427 -0.806 . . . . 64.42 109.449 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.77 141.32 28.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.026 -0.533 . . . . 63.53 111.796 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -149.07 175.18 11.55 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.138 -1.06 . . . . 75.53 108.138 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.887 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 35.9 m170 -77.28 133.67 38.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.433 -0.951 . . . . 63.45 108.433 170.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 87.1 tttt -57.66 -50.74 86.45 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 119.481 -0.295 . . . . 55.52 111.319 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 6.6 Cg_endo -49.31 -46.88 24.32 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.566 2.177 . . . . 73.03 113.481 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.887 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 14.3 p -80.62 -34.06 35.33 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.492 -0.483 . . . . 71.32 111.933 -175.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 67' ' ' LYS . 5.5 p -73.77 -30.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.565 -0.454 . . . . 72.4 110.562 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.549 ' HA ' HG21 ' A' ' 22' ' ' ILE . 51.1 m -63.38 -32.99 74.57 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.977 0.418 . . . . 71.41 110.776 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.0 mt -79.42 -42.45 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 73.43 110.056 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -63.35 -43.82 96.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.896 -0.593 . . . . 74.52 111.363 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 87' ' ' PHE . 95.7 mt -66.74 -24.34 66.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.642 -0.254 . . . . 75.43 111.666 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -92.49 0.55 57.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.904 0.383 . . . . 72.42 110.662 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -114.95 -41.72 3.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 73.31 111.398 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.9 m -120.94 -20.38 6.91 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.815 0.302 . . . . 63.42 111.815 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.58 26.64 60.08 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.37 -0.377 . . . . 62.03 114.018 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.26 145.09 40.9 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.339 -0.506 . . . . 63.02 111.79 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.45 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 24.3 t -75.03 110.69 10.7 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.741 -0.663 . . . . 73.13 109.251 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.22 -32.99 34.53 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.211 2.608 . . . . 64.14 113.993 -171.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.93 -28.64 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.393 0.516 . . . . 75.33 112.393 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 29.4 p -125.06 -13.13 6.87 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 121.818 -0.551 . . . . 64.32 112.093 -174.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 66.36 23.07 10.72 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.029 0.532 . . . . 73.01 111.237 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.3 t -85.01 145.31 27.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.939 -0.763 . . . . 43.04 108.939 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.479 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 58.7 ttp -75.51 150.51 38.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.926 0.393 . . . . 74.24 111.447 -175.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.552 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 81.1 t80 -129.5 125.98 22.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 108.791 -0.818 . . . . 71.45 108.791 170.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.552 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 30.9 Cg_endo -61.87 153.42 61.61 Favored 'Cis proline' 0 C--N 1.348 0.523 0 C-N-CA 123.988 -1.255 . . . . 73.22 113.019 3.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 42.7 Cg_exo -55.34 138.32 79.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.033 2.489 . . . . 73.21 112.61 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.479 ' HG3' ' HB3' ' A' ' 86' ' ' MET . 6.2 Cg_exo -72.24 177.5 7.18 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.665 2.243 . . . . 70.02 111.914 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.701 -0.666 . . . . 72.35 110.231 -176.736 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.774 0.321 . . . . 74.05 110.564 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.49 116.05 3.38 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.991 -0.623 . . . . 71.51 111.703 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -147.52 146.02 29.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.581 0.229 . . . . 73.34 110.616 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -110.92 146.05 37.25 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.644 -0.502 . . . . 71.55 109.644 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -130.07 152.4 49.56 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.544 -0.298 . . . . 65.51 111.22 -174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -71.55 143.81 49.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.207 -0.451 . . . . 64.54 110.345 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -149.84 23.63 0.87 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.163 -0.68 . . . . 70.15 109.163 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -55.67 103.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.978 -1.01 . . . . 73.32 110.897 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.1 m -100.03 101.78 12.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.643 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -141.5 120.52 12.84 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.697 -0.482 . . . . 74.42 109.697 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.3 ttm 64.51 65.91 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.813 0.816 . . . . 73.12 110.385 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -126.09 108.51 19.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.005 -0.998 . . . . 51.45 110.078 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.46 -44.43 74.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.68 -0.691 . . . . 73.43 111.512 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 15' ' ' PRO . 64.0 t30 -104.78 122.9 41.83 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.891 -0.411 . . . . 74.35 109.891 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 20.4 Cg_endo -60.15 151.23 74.5 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 123.162 2.575 . . . . 72.12 113.053 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 38.0 Cg_exo -61.84 163.38 19.15 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.168 2.579 . . . . 62.04 112.239 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -86.06 153.87 21.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 72.24 110.714 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.404 ' O ' HG13 ' A' ' 22' ' ' ILE . 22.4 m -71.96 137.96 47.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.957 -0.565 . . . . 62.02 110.626 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -58.21 -41.43 84.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.105 -0.498 . . . . 63.42 110.57 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -52.17 -45.91 65.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.996 -1.002 . . . . 72.23 110.987 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.506 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 13.8 m -67.68 -42.33 82.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.083 -0.508 . . . . 72.52 110.679 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 18' ' ' SER . 66.4 mt -61.92 -40.93 88.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 73.1 110.81 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.16 -44.11 80.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.945 -0.571 . . . . 74.1 110.79 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.6 3.89 30.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.932 -0.576 . . . . 61.23 112.287 -174.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.544 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 40.5 mt -57.85 127.78 79.56 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 116.89 -0.141 . . . . 74.44 111.027 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.13 126.3 21.15 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.161 2.574 . . . . 72.14 111.77 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.97 116.46 31.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.958 -0.564 . . . . 74.31 110.783 -172.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.9 mt -104.69 129.01 57.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.673 -0.694 . . . . 71.34 110.053 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 46.8 tp -82.23 120.4 25.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.123 -0.49 . . . . 72.12 110.367 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.992 HG13 ' HA2' ' A' ' 35' ' ' GLY . 97.9 t -90.28 128.3 42.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.998 -0.546 . . . . 63.02 111.032 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' HG3' ' A' ' 52' ' ' LYS . 17.7 p -137.35 172.95 12.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.463 -0.789 . . . . 74.54 109.825 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.438 ' OE1' ' HD3' ' A' ' 52' ' ' LYS . 4.5 mp0 -59.76 130.21 45.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.404 -0.221 . . . . 64.53 110.404 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 69.01 10.94 8.18 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.928 -0.578 . . . . 54.13 111.523 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -141.32 34.76 1.68 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.568 -1.271 . . . . 63.0 107.568 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.992 ' HA2' HG13 ' A' ' 30' ' ' VAL . . . -93.9 -56.81 1.37 Allowed Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.985 -1.007 . . . . 61.04 113.461 -172.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.33 -60.57 3.22 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.659 0.23 . . . . 74.4 111.23 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t 60.51 91.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.829 -0.623 . . . . 74.45 111.422 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . 99.4 -89.32 0.88 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.388 -0.911 . . . . 64.51 113.269 175.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -141.16 -52.65 0.46 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.833 0.317 . . . . 73.52 111.625 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.39 107.24 2.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.864 0.364 . . . . 55.21 111.082 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.438 ' HG2' ' SG ' ' A' ' 42' ' ' CYS . 1.8 pmm? -84.16 -18.3 37.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.098 0.475 . . . . 71.2 110.421 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.438 ' SG ' ' HG2' ' A' ' 41' ' ' MET . 78.2 m -136.82 159.22 42.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.639 -0.71 . . . . 73.21 109.739 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.6 t -105.56 102.21 36.53 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.501 -0.555 . . . . 65.41 109.501 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.55 -28.35 86.49 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.84 2.36 . . . . 73.22 111.788 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.0 mt -61.98 -29.69 46.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.437 -0.801 . . . . 54.0 111.762 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.3 p -121.38 2.4 10.24 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.87 -0.332 . . . . 74.14 111.313 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 76.9 m 50.66 62.13 2.86 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.415 0.626 . . . . 72.14 111.027 -175.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.8 t -159.43 152.81 22.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.428 -0.805 . . . . 71.33 109.708 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.512 ' HG3' HG13 ' A' ' 51' ' ' VAL . 11.4 pt-20 -77.75 -173.04 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.288 0.566 . . . . 62.5 110.889 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.52 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 37.0 m-85 -97.96 106.68 19.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.046 -0.525 . . . . 63.54 110.65 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.512 HG13 ' HG3' ' A' ' 49' ' ' GLU . 31.2 m -118.59 162.84 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.786 -0.643 . . . . 75.31 110.889 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 34.1 ttpt -62.78 112.91 2.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.609 . . . . 71.23 110.754 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.5 -31.48 2.85 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.885 -0.674 . . . . 60.32 111.726 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.2 133.34 34.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.675 0.274 . . . . 74.34 110.301 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.65 127.59 40.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.448 -0.342 . . . . 64.44 110.764 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.4 9.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.263 -0.426 . . . . 65.01 109.995 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.544 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 13.2 t -148.51 153.31 38.27 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.899 -0.408 . . . . 75.43 109.899 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -107.49 117.7 34.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.046 0.45 . . . . 74.51 110.335 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -80.75 140.69 51.03 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.893 -0.78 . . . . 73.3 108.893 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.47 ' HB2' ' HG3' ' A' ' 89' ' ' PRO . 17.1 Cg_endo -58.81 -7.8 4.98 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.896 2.397 . . . . 71.23 112.106 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.6 t -87.42 21.34 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.241 -0.891 . . . . 74.22 109.784 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 57.44 40.33 27.37 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.803 -0.635 . . . . 72.11 111.321 176.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -138.06 148.89 45.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.536 -0.302 . . . . 72.51 111.067 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 60.8 m-85 -124.39 133.51 53.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.148 -0.478 . . . . 74.1 111.084 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.52 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 92.5 m-85 -146.49 162.52 38.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.595 . . . . 65.21 109.798 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 33.9 m170 -67.13 123.16 19.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.478 -0.564 . . . . 72.53 109.478 174.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.539 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 83.2 tttt -57.57 -48.86 96.53 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 123.349 0.406 . . . . 72.33 111.866 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 12.2 Cg_endo -56.84 -27.16 70.72 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.162 1.908 . . . . 61.35 112.844 177.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 37.3 m -84.53 -52.77 5.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.142 0.496 . . . . 65.43 111.122 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.534 HG22 ' HG ' ' A' ' 74' ' ' LEU . 9.8 p -67.17 -25.6 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 62.13 111.404 -172.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.5 p -63.49 -30.38 71.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.807 0.337 . . . . 73.23 111.437 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.4 mt -78.88 -40.15 22.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.253 0.549 . . . . 74.55 109.917 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -65.82 -43.19 89.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.453 -0.794 . . . . 71.51 111.481 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 93.1 mt -67.03 -19.33 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.953 0.353 . . . . 73.32 111.953 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -74.28 -22.27 59.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.046 0.451 . . . . 72.15 110.327 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -91.19 -45.17 8.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.713 -0.676 . . . . 64.4 109.851 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -157.37 133.05 9.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.819 -0.628 . . . . 64.11 110.247 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.01 77.61 2.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.681 -0.771 . . . . 35.45 111.226 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 m -148.52 148.85 30.68 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.169 -0.308 . . . . 54.3 110.169 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.746 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 73.7 m -75.12 119.83 78.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 108.23 -1.026 . . . . 72.03 108.23 168.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.83 -12.07 20.47 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.468 2.112 . . . . 75.23 113.04 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.6 t -96.15 -50.21 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 111.861 0.319 . . . . 74.35 111.861 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 20.4 p -96.0 -18.88 19.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.761 0.315 . . . . 55.14 111.629 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 63.08 25.57 15.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.012 -0.54 . . . . 73.51 111.887 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -92.42 151.06 20.43 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.487 -0.56 . . . . 44.05 109.487 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 52.8 ttp -76.31 146.89 38.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.033 0.753 . . . . 61.24 113.033 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.545 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 76.6 t80 -133.16 124.47 18.42 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.803 -1.089 . . . . 73.41 108.527 170.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 32.7 Cg_exo -59.6 144.48 33.62 Favored 'Cis proline' 0 C--N 1.35 0.643 0 C-N-CA 124.558 -1.017 . . . . 72.41 113.181 3.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.47 ' HG3' ' HB2' ' A' ' 60' ' ' PRO . 52.9 Cg_endo -67.48 149.76 80.2 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.059 2.506 . . . . 63.31 112.611 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.5 178.71 5.31 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.709 2.273 . . . . 65.24 111.814 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.41 -0.805 . . . . 63.32 110.266 -179.747 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.096 -0.335 . . . . 70.13 110.096 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.56 115.47 2.98 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.205 -0.758 . . . . 63.22 111.205 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -105.03 27.46 8.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.088 0.471 . . . . 73.33 110.843 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -113.91 79.81 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.863 -0.792 . . . . 74.52 108.863 172.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -88.06 -9.22 54.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.135 -0.484 . . . . 73.13 111.162 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -101.62 88.39 3.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.9 0.381 . . . . 75.45 110.591 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -91.7 138.91 31.18 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.058 0.456 . . . . 72.23 110.646 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -83.04 80.62 8.99 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.159 -0.682 . . . . 71.54 109.159 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 t -78.3 86.31 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.38 -0.827 . . . . 74.51 110.124 -176.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.9 107.55 5.09 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.381 -0.97 . . . . 74.21 108.381 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.46 ' HG3' HG23 ' A' ' 12' ' ' VAL . 23.2 ptt? -55.93 -50.56 70.4 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.358 0.411 . . . . 53.22 111.958 -172.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.46 HG23 ' HG3' ' A' ' 11' ' ' MET . 24.6 t -92.52 81.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.321 -0.622 . . . . 70.44 109.321 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -68.59 -38.05 80.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.613 -0.721 . . . . 73.4 111.28 -176.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -89.51 110.08 36.41 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.284 -0.416 . . . . 63.02 110.72 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 13' ' ' ALA . 96.8 Cg_endo -89.37 167.84 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.873 2.382 . . . . 61.12 112.056 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -73.88 136.85 23.54 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.91 1.74 . . . . 73.13 111.326 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -79.96 127.73 32.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.43 -0.35 . . . . 72.32 110.529 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 p -74.64 166.55 23.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.091 -0.504 . . . . 71.35 110.736 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -57.64 -35.17 70.15 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.248 -0.433 . . . . 62.41 110.946 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.42 -35.26 69.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.938 0.399 . . . . 65.11 111.181 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 m -85.83 -35.41 20.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.025 -0.534 . . . . 64.41 111.173 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.512 HG21 ' HA ' ' A' ' 71' ' ' SER . 68.1 mt -82.89 -44.44 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.017 0.437 . . . . 75.24 111.903 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.75 -33.73 74.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.013 -0.54 . . . . 50.01 110.762 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.77 4.93 26.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.697 -0.683 . . . . 43.32 112.186 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.44 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 66.7 mt -70.75 136.17 85.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.609 0.242 . . . . 62.13 110.511 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.61 149.37 67.9 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.256 2.637 . . . . 71.44 112.782 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.64 121.33 44.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 71.13 110.4 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.3 mt -109.44 120.55 60.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.743 -0.662 . . . . 70.2 109.883 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.0 tp -79.93 107.67 12.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.796 -0.446 . . . . 73.54 109.796 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' ' 50' ' ' TYR . 42.5 t -74.86 131.86 34.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.051 -0.522 . . . . 61.1 110.902 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 35.2 p -120.17 145.21 47.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.966 -0.561 . . . . 73.42 109.883 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.488 ' HG2' ' HD3' ' A' ' 52' ' ' LYS . 16.7 pt-20 -71.7 -17.43 62.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.705 0.288 . . . . 74.33 111.221 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -68.29 -23.03 64.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.466 -0.334 . . . . 61.23 110.382 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -90.76 -13.81 33.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 65.11 109.913 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.2 -80.38 0.98 Allowed Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.967 -0.56 . . . . 72.41 112.164 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.78 -172.8 2.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.78 -0.452 . . . . 62.01 109.78 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.87 95.42 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.085 0.469 . . . . 74.43 110.159 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.5 -110.44 3.49 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.794 -0.639 . . . . 71.14 111.756 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -98.48 -14.77 19.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.741 0.305 . . . . 72.55 111.19 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HG3' ' H ' ' A' ' 64' ' ' TYR . 58.1 mm-40 -99.36 133.69 43.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.247 0.546 . . . . 65.35 110.954 -174.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.3 ptp -121.44 -5.04 9.33 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.489 -0.778 . . . . 75.41 111.61 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.2 p -150.48 151.77 33.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.329 . . . . 74.04 110.924 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.9 t -109.79 93.01 13.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 71.44 109.57 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.15 -18.29 57.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.375 2.717 . . . . 73.35 113.006 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.6 mt -63.94 -27.93 43.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.17 -0.468 . . . . 64.23 110.632 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.6 p -127.07 -7.4 5.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.622 -0.263 . . . . 60.04 111.107 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 71.0 m 61.4 35.9 17.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.128 -0.487 . . . . 74.35 110.784 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -124.38 159.25 30.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.805 -0.634 . . . . 73.34 110.299 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.85 -174.4 5.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.817 -0.629 . . . . 75.52 111.389 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.655 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 96.4 m-85 -108.58 118.68 37.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.26 -0.427 . . . . 75.22 110.168 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.18 174.67 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.392 -0.367 . . . . 60.52 111.293 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HD3' ' HG2' ' A' ' 32' ' ' GLU . 35.9 ttpt -76.87 124.22 27.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.097 -0.501 . . . . 73.44 110.652 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.67 0.73 55.33 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.885 -0.674 . . . . 61.11 111.711 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -87.24 157.83 19.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.531 -0.544 . . . . 72.12 109.531 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.45 114.47 47.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.342 0.592 . . . . 74.33 111.166 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.5 166.64 10.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.486 -0.779 . . . . 53.15 110.066 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.491 HG21 HG11 ' A' ' 70' ' ' VAL . 7.6 t -131.01 171.71 12.92 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.832 -0.433 . . . . 72.02 109.832 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.509 ' HG2' ' CE2' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -126.4 118.35 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.342 -0.614 . . . . 75.22 109.342 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.8 mt -87.5 147.23 41.35 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.273 -0.421 . . . . 64.34 110.538 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.44 4.32 0.48 Allowed 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.048 2.499 . . . . 64.52 113.702 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.1 p -109.35 8.41 25.5 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.969 -0.382 . . . . 51.34 109.969 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.1 m170 66.59 89.13 0.1 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.757 -0.656 . . . . 73.34 110.371 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -172.53 125.4 0.49 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.52 -0.763 . . . . 72.12 110.126 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CE2' ' HG2' ' A' ' 58' ' ' GLU . 39.0 m-85 -103.83 133.28 49.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 72.24 110.047 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.655 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 90.0 m-85 -146.24 155.75 42.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.143 -0.48 . . . . 72.01 109.912 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 26.1 m170 -56.28 124.18 17.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.213 -0.662 . . . . 72.23 109.213 171.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.51 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 86.0 tttt -57.41 -49.27 94.82 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 119.297 -0.382 . . . . 70.01 111.462 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 77.6 Cg_exo -53.29 -36.22 77.44 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.865 1.71 . . . . 72.21 112.559 176.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 71.2 m -70.59 -51.59 27.31 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.428 -0.351 . . . . 62.21 111.13 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.491 HG11 HG21 ' A' ' 57' ' ' THR . 7.5 p -65.93 -26.73 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.001 -0.545 . . . . 43.43 110.3 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.512 ' HA ' HG21 ' A' ' 22' ' ' ILE . 50.3 m -60.96 -55.28 34.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.346 -0.388 . . . . 73.35 110.013 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.26 -40.63 84.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 74.03 110.789 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -64.94 -53.21 50.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 71.24 111.348 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 96.5 mt -66.41 -31.26 71.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.736 -0.211 . . . . 62.34 111.55 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -59.97 -30.71 69.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.759 0.314 . . . . 70.21 110.766 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.48 -40.29 10.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.838 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.7 p -153.79 115.21 4.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 62.14 110.683 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.83 71.38 2.88 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.864 -0.684 . . . . 73.11 112.643 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 1.3 m -146.43 141.14 26.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.781 -0.452 . . . . 73.42 109.781 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.0 t -74.56 113.01 19.98 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.091 -0.707 . . . . 74.33 109.091 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.78 -37.95 96.84 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.844 2.362 . . . . 71.02 113.378 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -71.42 -48.81 51.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.515 0.561 . . . . 74.12 112.515 -174.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.71 -8.81 13.22 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.62 -0.432 . . . . 72.55 111.992 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 63.67 91.71 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.629 0.728 . . . . 61.21 110.943 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 79' ' ' THR . 44.0 t -144.4 130.83 19.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.042 -0.981 . . . . 54.1 108.862 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.556 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 43.4 ttm -64.6 140.9 58.92 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.509 0.506 . . . . 72.43 110.391 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.44 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 70.3 t80 -131.83 116.26 15.83 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.035 -0.53 . . . . 74.41 109.69 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.99 155.12 99.74 Favored 'Cis proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.232 -1.57 . . . . 52.25 112.426 -0.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.39 151.55 29.43 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 123.264 2.643 . . . . 73.44 113.221 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 86.9 Cg_endo -80.6 170.63 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.786 2.324 . . . . 63.1 112.429 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.278 -0.868 . . . . 71.15 109.729 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.635 0.255 . . . . 64.11 110.617 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.39 22.29 75.99 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.104 -0.569 . . . . 35.3 113.254 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -106.58 134.87 49.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.508 -0.553 . . . . 74.45 109.508 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -78.8 150.64 32.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.248 -0.433 . . . . 74.42 111.414 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -85.7 24.34 1.25 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 72.11 110.771 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -65.94 -29.85 70.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.24 -0.437 . . . . 63.13 111.545 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -72.78 -8.69 56.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.033 0.445 . . . . 74.54 110.941 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -98.35 6.2 47.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.551 0.691 . . . . 65.05 109.662 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.7 t -107.76 106.02 16.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.668 -0.696 . . . . 71.25 110.435 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.3 m170 -91.2 83.8 5.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.955 -0.566 . . . . 73.41 109.546 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -119.23 19.62 12.79 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.865 -0.607 . . . . 71.21 110.413 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -66.99 108.55 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.527 0.68 . . . . 42.4 110.517 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.89 96.44 1.98 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.434 -0.803 . . . . 73.4 110.054 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.438 ' HA ' ' HE2' ' A' ' 86' ' ' MET . 55.3 m-20 70.32 101.54 0.04 OUTLIER Pre-proline 0 C--O 1.236 0.389 0 CA-C-N 115.466 -0.788 . . . . 71.45 111.287 176.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.79 172.63 13.28 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.406 2.738 . . . . 71.23 112.341 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.11 149.87 41.96 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.858 2.372 . . . . 72.14 112.5 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.45 157.98 24.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.778 -0.646 . . . . 53.13 110.993 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -67.93 139.72 56.44 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.679 -0.489 . . . . 74.13 109.679 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -61.52 -37.36 83.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 74.21 111.178 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 3.1 mp0 -60.0 -42.49 94.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.4 -0.364 . . . . 71.15 110.287 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.462 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.7 m -62.16 -40.04 94.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 65.33 110.823 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.14 -40.95 78.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.861 -0.609 . . . . 71.4 110.647 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.79 -32.89 65.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.16 -0.473 . . . . 64.44 111.179 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.65 -0.31 37.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.482 -0.326 . . . . 72.21 111.86 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.514 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 67.5 mt -64.99 123.3 83.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.605 0.241 . . . . 73.5 110.791 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.57 117.99 4.8 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.154 2.569 . . . . 72.45 112.332 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -78.4 121.99 25.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.087 -0.506 . . . . 72.53 110.808 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.4 mt -115.91 120.82 65.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.041 -0.527 . . . . 72.45 110.03 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.2 tp -75.71 119.51 19.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.74 -0.467 . . . . 73.23 109.74 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 40.3 t -85.91 121.56 37.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.072 0.463 . . . . 40.2 111.258 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.432 HG22 ' HG3' ' A' ' 52' ' ' LYS . 24.0 p -123.37 165.79 16.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.479 -0.782 . . . . 74.12 109.661 173.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.543 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 31.5 mt-10 -68.16 -30.22 69.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.937 0.398 . . . . 74.45 111.311 -173.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.31 -17.97 64.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.029 -0.532 . . . . 63.2 112.222 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -75.95 -17.52 59.7 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.044 0.387 . . . . 72.13 112.044 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.22 69.43 1.32 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.767 -0.73 . . . . 54.11 113.075 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 67.17 -2.83 1.11 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.328 0.651 . . . . 74.42 112.666 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.5 t 72.77 -64.84 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.193 0.597 . . . . 71.42 111.742 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.56 -161.57 9.06 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.657 -0.782 . . . . 74.2 112.496 -176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -62.27 -28.77 69.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.02 0.438 . . . . 55.33 110.803 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -80.52 110.6 16.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.43 -0.952 . . . . 75.44 108.43 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.1 ptp -103.8 -2.2 26.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.16 -0.473 . . . . 72.25 111.382 -173.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 82.0 m -146.42 147.52 31.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.341 -0.391 . . . . 75.14 110.571 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.0 t -103.78 94.74 6.62 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.081 -0.711 . . . . 65.1 109.081 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.87 -8.99 17.24 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.37 2.713 . . . . 43.2 112.84 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.5 mt -76.2 -32.92 23.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.019 -0.537 . . . . 75.44 110.508 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.8 p -114.86 -3.2 12.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.755 0.312 . . . . 70.55 111.045 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.0 t 67.64 23.37 8.79 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.564 -0.744 . . . . 71.04 111.103 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.1 m -129.47 158.78 38.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 63.11 110.405 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.9 OUTLIER -84.61 -169.67 2.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.171 -0.468 . . . . 64.15 111.1 -177.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 96.8 m-85 -93.94 94.23 8.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.483 0.659 . . . . 74.52 110.899 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.24 173.74 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.766 -1.106 . . . . 73.52 111.01 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 32.9 ttpt -75.48 123.24 25.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.969 -0.56 . . . . 75.11 110.806 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.63 -24.28 6.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.691 -0.766 . . . . 61.35 112.709 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -87.04 161.26 18.27 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.572 -0.529 . . . . 72.5 109.572 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.3 t -111.26 124.75 68.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.916 0.389 . . . . 74.22 110.056 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -111.73 172.69 6.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.315 -0.402 . . . . 63.13 110.777 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 12.7 t -152.76 161.13 42.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.903 -0.59 . . . . 74.4 109.59 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -108.31 117.59 34.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.85 0.357 . . . . 74.13 111.229 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.9 mt -76.84 152.94 82.98 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.913 -0.773 . . . . 73.23 108.913 171.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.83 51.04 0.62 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 122.959 2.439 . . . . 74.54 111.189 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 45.4 t -153.37 16.8 0.54 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.041 -0.982 . . . . 72.32 109.677 -172.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 56.95 18.16 3.76 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.54 -0.755 . . . . 72.14 111.775 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 3.3 m170 -111.13 115.63 29.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.189 -0.459 . . . . 71.41 110.563 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -91.99 133.26 35.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.617 -0.719 . . . . 72.3 109.728 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.605 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 74.9 m-85 -136.7 155.73 49.47 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.367 0.417 . . . . 75.23 110.143 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 32.2 m170 -65.71 121.21 14.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.225 -0.658 . . . . 75.14 109.225 174.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.5 tttt -56.57 -51.49 80.79 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 123.576 0.547 . . . . 74.41 111.966 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.0 Cg_endo -58.68 -27.97 84.89 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.237 1.958 . . . . 61.23 112.572 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 57.5 m -80.34 -50.61 9.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.069 -0.514 . . . . 74.35 110.419 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.1 p -72.52 -27.47 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.669 -0.696 . . . . 74.14 111.125 -172.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.6 t -59.3 -42.52 91.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.007 0.432 . . . . 63.35 110.448 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.93 -36.76 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.269 0.557 . . . . 73.12 110.204 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -72.29 -51.96 18.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.441 -0.799 . . . . 71.5 110.778 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 95.9 mt -60.03 -33.74 72.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.016 -0.538 . . . . 72.34 112.369 -174.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.5 -18.91 65.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.05 0.389 . . . . 63.41 112.05 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -111.4 -16.69 13.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 73.15 110.925 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 26.4 t -172.33 117.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 74.25 109.763 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.12 91.53 1.7 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.556 -0.83 . . . . 63.42 111.681 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 2.8 p -149.28 155.03 39.92 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.3 0.481 . . . . 65.3 112.3 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 35.0 m -74.79 112.0 15.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.843 -1.169 . . . . 73.24 107.843 160.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.91 -15.6 22.63 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.53 2.153 . . . . 65.23 112.379 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.6 t -89.93 -48.85 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.007 -0.542 . . . . 75.34 111.847 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 20.0 p -107.81 -3.13 19.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.62 0.6 . . . . 70.43 112.62 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? 68.06 14.71 9.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.039 0.755 . . . . 70.52 113.039 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 79' ' ' THR . 17.2 p -79.92 150.85 30.4 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.92 -0.488 . . . . 73.14 110.249 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.556 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 40.1 ttm -81.32 144.36 31.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.123 0.487 . . . . 61.41 111.376 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 77.8 t80 -135.43 123.53 15.42 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.497 -0.774 . . . . 74.01 109.547 172.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.28 152.42 84.75 Favored 'Cis proline' 0 C--N 1.343 0.272 0 C-N-CA 123.339 -1.525 . . . . 70.13 111.528 -2.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.37 149.44 56.06 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.83 2.354 . . . . 73.03 112.412 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 96.0 Cg_endo -81.82 147.29 15.17 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.66 2.24 . . . . 74.34 111.406 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.344 -0.836 . . . . 74.02 110.011 179.658 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.654 0.264 . . . . 70.22 110.304 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.4 -105.08 2.99 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.674 -0.774 . . . . 54.34 112.139 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -89.44 -7.13 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.966 0.412 . . . . 75.51 110.477 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.0 m170 -66.65 129.73 40.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.527 -0.545 . . . . 65.04 109.527 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.427 ' O ' ' HB3' ' A' ' 6' ' ' HIS . 46.7 t-80 -135.09 8.45 3.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.297 -0.411 . . . . 30.25 110.515 -171.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 5' ' ' HIS . 21.7 t-80 67.95 34.0 4.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.316 1.055 . . . . 71.24 108.651 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -105.76 129.26 53.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.785 -1.098 . . . . 73.03 110.87 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -65.27 110.63 2.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.907 -0.775 . . . . 62.24 108.907 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -132.61 110.86 10.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.516 0.562 . . . . 71.51 112.516 -171.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 62.1 m80 70.86 -34.87 0.31 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.458 1.281 . . . . 74.2 114.458 167.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.2 ptm -68.74 -6.28 25.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.938 0.347 . . . . 64.2 111.938 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.3 t -75.39 -46.67 37.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.412 -0.358 . . . . 73.13 111.215 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.04 166.1 28.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.731 0.301 . . . . 44.4 111.027 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -97.43 144.87 28.69 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.973 -0.558 . . . . 74.01 110.246 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.92 162.8 34.3 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.675 2.25 . . . . 72.31 112.149 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.42 159.81 22.67 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.041 2.494 . . . . 72.43 112.154 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.38 160.16 15.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.279 -0.419 . . . . 61.24 110.487 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -88.91 158.38 18.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.614 -0.267 . . . . 44.54 110.417 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -58.16 -45.45 87.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.176 -0.465 . . . . 73.02 111.411 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -45.71 -54.64 7.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 75.41 112.163 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.99 -23.38 67.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.155 0.428 . . . . 71.44 112.155 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.538 HG21 ' HA ' ' A' ' 71' ' ' SER . 37.2 mt -87.16 -38.46 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.48 0.657 . . . . 53.42 110.1 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -68.39 -30.5 69.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.546 -0.752 . . . . 72.41 110.884 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -19.19 65.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.164 -0.471 . . . . 53.3 111.363 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.88 144.52 97.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 63.01 110.514 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.85 159.13 26.15 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.192 2.595 . . . . 63.35 113.153 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -120.17 110.09 16.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 74.11 110.035 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 54.0 mt -104.68 129.07 57.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.711 -0.677 . . . . 74.32 110.871 -175.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.2 tp -83.82 117.07 23.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.249 -0.648 . . . . 74.35 109.249 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 49.1 t -76.67 117.28 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.054 0.454 . . . . 73.3 111.634 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 p -112.22 148.0 35.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.643 -0.708 . . . . 64.52 110.307 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 27.4 mt-10 -78.47 -26.74 46.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.914 0.388 . . . . 72.41 111.76 -174.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.98 -4.23 27.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.275 0.843 . . . . 64.1 113.275 -168.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -113.08 9.24 18.56 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.233 -0.587 . . . . 74.4 110.537 176.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.5 -130.67 23.62 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.897 -0.592 . . . . 72.12 112.122 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.21 147.37 49.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.664 0.269 . . . . 61.2 110.52 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 60.9 t -80.76 97.91 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.052 0.454 . . . . 63.53 110.109 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.16 -80.35 0.85 Allowed Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.558 -0.746 . . . . 63.44 112.21 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.794 ' HG3' ' HG2' ' A' ' 40' ' ' GLU . 15.6 pt20 -138.73 -1.77 1.8 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.683 0.278 . . . . 63.33 111.343 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.794 ' HG2' ' HG3' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -128.34 144.48 51.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.26 -0.274 . . . . 64.23 110.26 -173.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.2 ptp -123.83 -8.16 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.499 -0.318 . . . . 72.41 111.271 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 81.5 m -132.73 151.95 51.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.051 0.453 . . . . 71.21 111.142 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 38.9 t -118.16 91.93 41.46 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.758 -0.656 . . . . 73.14 109.298 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.2 Cg_endo -51.74 -30.7 38.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.833 3.022 . . . . 65.53 113.562 -173.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.8 mt -56.99 -37.34 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.334 -0.394 . . . . 71.22 111.465 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.6 p -109.31 0.11 19.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 62.44 110.298 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.1 m 60.38 16.01 5.93 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.257 -0.883 . . . . 71.3 111.49 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.3 t -117.31 165.76 13.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.785 -0.45 . . . . 71.44 109.785 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 7.2 pt-20 -99.51 -170.08 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.266 -0.425 . . . . 63.34 111.296 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.477 ' HB3' HG11 ' A' ' 30' ' ' VAL . 55.9 m-85 -95.1 110.23 22.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.213 0.53 . . . . 75.42 111.539 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.17 167.24 12.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.337 -0.847 . . . . 72.32 110.367 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 40.0 ttmt -71.51 126.33 29.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.347 -0.388 . . . . 73.54 111.198 -174.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.61 -15.44 19.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.742 . . . . 71.23 112.301 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -86.8 162.92 17.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.94 -0.393 . . . . 52.13 109.94 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -112.82 121.18 64.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.984 0.421 . . . . 71.35 110.78 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -103.97 170.19 8.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.08 -0.509 . . . . 63.34 110.697 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 8.3 t -147.7 173.35 12.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.054 -0.521 . . . . 73.35 109.711 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -118.96 119.43 34.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.675 0.274 . . . . 74.14 110.462 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.08 137.72 35.1 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.653 -0.499 . . . . 72.12 109.653 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.55 -15.77 26.82 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.287 2.658 . . . . 53.54 113.448 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 p -87.24 11.8 13.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.442 0.163 . . . . 64.41 110.897 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.3 m80 69.22 62.44 0.3 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.287 0.565 . . . . 74.22 111.015 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -150.67 152.16 33.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.438 -0.801 . . . . 74.44 109.336 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -118.78 133.23 55.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.994 0.426 . . . . 64.22 110.641 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.416 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 47.7 m-85 -143.08 157.94 44.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.659 -0.7 . . . . 74.41 109.976 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.609 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 33.3 m170 -68.4 125.91 27.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.687 -0.857 . . . . 71.51 108.687 172.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 85.5 tttt -57.57 -50.3 88.9 Favored Pre-proline 0 CA--C 1.536 0.44 0 O-C-N 123.405 0.441 . . . . 63.43 112.061 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 73.6 Cg_exo -52.59 -42.48 61.82 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.686 1.591 . . . . 72.31 112.395 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 57.9 m -63.15 -53.13 58.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.0 0.428 . . . . 62.32 110.918 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 67' ' ' LYS . 8.7 p -67.56 -27.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 64.03 110.792 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 53.1 m -61.58 -51.03 70.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.699 0.285 . . . . 53.5 110.393 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.65 -37.31 79.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.379 0.609 . . . . 71.11 110.414 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -64.31 -55.0 24.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.504 -0.771 . . . . 73.22 111.302 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.415 HD13 ' CD2' ' A' ' 87' ' ' PHE . 96.8 mt -65.58 -27.78 68.67 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.034 0.383 . . . . 74.0 112.034 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.2 mt-30 -66.31 -20.84 66.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.66 0.267 . . . . 75.2 111.007 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -101.31 -37.32 8.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.245 -0.434 . . . . 72.52 110.809 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 t -153.65 118.2 4.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 55.23 109.972 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.68 74.79 2.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.89 -0.672 . . . . 64.34 111.889 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.29 139.19 24.27 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.69 -0.3 . . . . 61.41 110.474 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.8 t -74.44 116.16 50.37 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.371 -0.603 . . . . 64.3 109.371 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.8 -38.07 46.42 Favored 'Trans proline' 0 N--CA 1.474 0.344 0 C-N-CA 123.279 2.652 . . . . 74.34 113.773 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.09 -55.99 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.12 0.415 . . . . 74.03 112.12 -175.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 28.3 p -96.13 -13.03 23.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.251 0.463 . . . . 60.22 112.251 -171.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 66.34 22.48 10.82 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.712 0.405 . . . . 74.51 111.523 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 28.3 t -74.63 141.6 44.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.077 -0.712 . . . . 65.11 109.077 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 58.7 ttp -77.41 142.18 39.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 75.41 111.301 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.519 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 61.9 t80 -129.85 126.31 22.48 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.789 -0.819 . . . . 74.41 108.789 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 34.4 Cg_endo -63.69 157.6 69.31 Favored 'Cis proline' 0 C--O 1.235 0.356 0 C-N-CA 123.823 -1.324 . . . . 71.01 112.978 2.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -47.98 147.41 7.76 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.193 3.262 . . . . 72.33 113.677 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.28 147.32 83.14 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.848 2.365 . . . . 61.3 112.649 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.411 -0.804 . . . . 75.13 109.642 178.781 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.977 -0.379 . . . . 73.31 109.977 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.26 103.58 0.75 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.839 -0.696 . . . . 54.02 111.981 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -82.46 -11.03 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 75.22 110.44 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -104.23 82.16 1.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.445 -0.946 . . . . 71.23 108.445 170.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -150.72 112.42 4.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.868 -0.606 . . . . 63.41 110.341 -174.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -84.56 154.33 22.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 74.32 110.348 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -97.86 -68.69 0.79 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.153 -0.476 . . . . 74.3 110.981 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -86.73 84.24 7.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.74 -0.467 . . . . 72.32 109.74 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.5 m -93.42 -38.48 11.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 60.11 110.8 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -84.37 118.6 24.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.937 -0.574 . . . . 65.43 110.248 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ptm -82.63 161.19 22.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.242 -0.435 . . . . 71.24 110.128 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -81.37 117.49 27.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.274 -0.421 . . . . 65.24 110.34 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.08 140.89 52.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 71.03 110.018 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' HA ' ' SD ' ' A' ' 86' ' ' MET . 48.2 m-20 -116.58 100.11 53.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.617 -0.265 . . . . 75.33 111.161 -174.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.763 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 65.3 Cg_endo -79.0 151.38 23.93 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.502 2.135 . . . . 40.02 111.844 171.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 38.1 Cg_exo -57.48 150.98 56.59 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.898 2.399 . . . . 74.52 112.685 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -79.85 146.17 32.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.907 -0.588 . . . . 74.01 110.925 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 m -74.8 142.86 44.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.631 -0.713 . . . . 73.03 110.649 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.74 -37.48 79.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 61.12 110.301 -178.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.45 -40.06 89.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.019 -0.537 . . . . 74.34 110.697 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -67.43 -38.28 84.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.959 -0.564 . . . . 64.15 110.377 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.485 ' O ' ' HE3' ' A' ' 67' ' ' LYS . 65.6 mt -66.92 -41.45 87.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.51 . . . . 33.13 110.551 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.28 -32.52 73.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 64.31 110.427 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.52 -11.6 60.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.715 -0.675 . . . . 75.14 111.795 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 91.2 mt -65.4 133.1 95.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.469 -0.332 . . . . 73.44 110.703 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 149.64 84.08 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.092 2.528 . . . . 65.34 112.143 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 55.9 mt-10 -116.77 104.8 11.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.291 0.567 . . . . 64.32 110.75 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.0 mt -106.48 117.85 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.393 -0.821 . . . . 70.31 110.356 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.5 tp -68.03 118.85 11.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.305 -0.407 . . . . 74.0 109.956 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 28.8 t -81.5 135.17 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.997 0.427 . . . . 74.25 110.631 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p -131.99 173.01 11.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.647 -0.706 . . . . 73.41 109.848 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 15.3 mm-40 -70.31 -178.67 1.77 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.598 -0.274 . . . . 71.44 110.853 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 27.9 m-20 76.14 -51.51 0.61 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.43 0.692 . . . . 70.31 111.092 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -111.38 55.74 0.65 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.026 0.441 . . . . 72.13 109.839 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 50' ' ' TYR . . . -63.79 -31.04 79.46 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.667 -0.697 . . . . 74.3 111.618 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.38 84.22 6.06 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.248 -0.649 . . . . 43.51 109.248 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.26 -28.91 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 65.14 110.882 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.02 -142.48 3.57 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.035 -0.826 . . . . 72.12 111.035 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -69.97 -20.91 63.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.063 0.458 . . . . 61.42 110.397 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -103.97 130.55 51.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 64.12 110.849 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.6 ptp -102.66 -3.91 25.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.423 -0.808 . . . . 60.4 109.842 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 8.8 p -134.59 149.31 50.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.679 -0.691 . . . . 64.33 111.051 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 28.9 t -105.97 103.51 44.89 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.713 -0.676 . . . . 74.11 109.519 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 16.1 Cg_endo -56.94 -28.71 79.25 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 123.291 2.661 . . . . 63.33 112.907 -176.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mt -68.27 -28.2 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.094 -0.503 . . . . 63.01 110.871 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 78.7 m -104.74 -18.7 14.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 60.53 110.579 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.8 t 61.65 24.94 14.95 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.252 -0.886 . . . . 73.1 109.471 -172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.9 m -128.32 171.81 11.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.166 -0.925 . . . . 75.45 109.266 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER -93.76 -171.75 2.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.844 0.354 . . . . 73.21 110.639 -178.134 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.564 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 90.5 m-85 -98.52 103.18 15.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.118 0.485 . . . . 75.0 110.578 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG13 ' HG2' ' A' ' 49' ' ' GLU . 25.2 m -121.87 167.13 15.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.648 -0.705 . . . . 64.43 111.062 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 22.8 ttpp -54.32 127.44 27.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.336 -0.847 . . . . 75.14 111.725 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.59 -34.38 3.8 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.793 -0.718 . . . . 75.41 113.031 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -86.97 165.3 15.96 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.704 -0.48 . . . . 72.14 109.704 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.42 121.13 66.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.797 0.332 . . . . 71.42 110.544 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -100.21 160.96 13.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.978 0.418 . . . . 72.14 111.075 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 11.2 t -137.25 167.49 21.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.859 -0.61 . . . . 64.01 109.646 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -120.65 118.09 29.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.011 0.434 . . . . 74.11 110.863 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.7 mt -87.0 143.42 34.99 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.846 -0.615 . . . . 64.51 109.517 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.39 -12.8 17.94 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.937 2.425 . . . . 64.43 111.687 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 45.5 t -76.0 9.17 2.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.99 -1.005 . . . . 75.1 110.592 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 65.69 28.45 11.1 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.524 0.678 . . . . 74.04 109.736 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 136.96 54.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.543 -0.753 . . . . 72.21 110.578 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -110.78 133.26 53.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.253 -0.43 . . . . 64.11 110.714 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 91.5 m-85 -145.02 175.31 10.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.365 -0.976 . . . . 73.34 108.365 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.96 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.4 m80 -88.41 130.19 35.23 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.8 -0.815 . . . . 73.23 108.8 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 84.8 tttt -57.02 -48.06 98.07 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 112.086 0.402 . . . . 75.01 112.086 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 10.0 Cg_endo -51.46 -46.2 32.99 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.486 2.124 . . . . 75.2 113.503 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.96 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 8.4 p -84.23 -34.96 23.77 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.199 0.444 . . . . 71.05 112.199 -175.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.513 HG22 ' HG ' ' A' ' 74' ' ' LEU . 5.7 p -71.72 -26.1 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 122.225 -0.297 . . . . 73.24 110.751 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -56.98 -39.71 75.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.142 0.496 . . . . 71.35 110.72 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.494 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 59.8 mt -69.65 -40.95 79.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.914 -0.584 . . . . 75.44 110.585 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -72.96 -38.91 66.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 74.43 111.326 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.513 ' HG ' HG22 ' A' ' 70' ' ' VAL . 88.8 mt -63.86 -32.84 74.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.601 -0.272 . . . . 75.43 111.252 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -77.08 -9.52 58.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.803 0.335 . . . . 74.45 111.104 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 67.9 mttm -80.92 -58.77 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 73.13 110.927 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.8 m -148.74 11.66 0.86 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.214 0.449 . . . . 71.43 112.214 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.69 65.27 3.29 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 123.25 0.343 . . . . 65.04 113.764 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.34 160.8 43.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.669 0.235 . . . . 64.12 111.142 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.71 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 84.4 m -79.34 123.28 84.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.806 -0.812 . . . . 73.11 108.806 168.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.58 -21.81 56.89 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.498 2.132 . . . . 74.05 112.522 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.4 t -84.58 -53.43 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 60.43 111.861 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 28.9 p -98.84 -19.75 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.838 0.31 . . . . 74.44 111.838 -170.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 66.65 19.78 10.77 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.034 -0.53 . . . . 62.02 111.654 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.46 143.44 33.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.923 -0.769 . . . . 71.31 108.923 171.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.763 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 51.1 ttp -75.78 145.02 41.06 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.757 0.66 . . . . 74.22 112.516 -171.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.525 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 91.5 t80 -131.21 125.05 20.78 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.139 -0.937 . . . . 73.31 109.061 171.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 31.7 Cg_exo -60.63 153.3 52.87 Favored 'Cis proline' 0 C--N 1.348 0.541 0 C-N-CA 124.03 -1.238 . . . . 74.15 112.787 0.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.57 154.41 9.07 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.606 2.871 . . . . 74.42 113.127 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.14 147.61 94.73 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.071 2.514 . . . . 44.1 112.704 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.526 -0.75 . . . . 71.22 109.934 179.144 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.933 -0.395 . . . . 71.02 109.933 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.45 49.52 0.57 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.018 -0.611 . . . . 62.34 111.713 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 58.42 78.18 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.952 0.501 . . . . 61.04 111.419 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -160.42 133.68 6.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.1 -0.5 . . . . 72.41 111.038 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -147.95 101.56 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.758 -0.655 . . . . 74.32 110.482 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -113.22 122.17 46.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.377 -0.601 . . . . 74.21 109.377 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -153.05 -178.09 6.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.094 -0.503 . . . . 71.43 110.823 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -59.98 109.68 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.664 0.602 . . . . 73.02 112.073 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -171.17 112.23 0.36 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.729 -0.841 . . . . 64.13 108.729 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -90.11 103.33 16.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.635 0.731 . . . . 71.21 112.538 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.8 ptp -94.34 124.13 38.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.395 -0.82 . . . . 62.54 109.171 172.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.36 -39.04 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 111.761 0.282 . . . . 71.11 111.761 -174.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.28 176.63 5.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.894 0.378 . . . . 64.0 111.035 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -94.43 108.64 37.91 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 71.11 110.003 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.95 161.78 23.8 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.802 2.334 . . . . 63.32 112.733 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.43 148.43 79.22 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.67 2.246 . . . . 62.54 111.251 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -76.86 139.86 40.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.405 -0.361 . . . . 64.41 110.763 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.405 ' HB3' ' OE1' ' A' ' 20' ' ' GLU . 14.6 m -61.24 129.79 43.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.955 -0.566 . . . . 64.24 110.139 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.59 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 3.2 tmmm? -58.96 -30.5 67.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.499 -0.319 . . . . 72.41 110.562 -177.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 29.2 mp0 -54.9 -41.95 71.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.962 0.411 . . . . 75.21 110.223 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.517 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 18.0 m -77.42 -34.98 54.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.858 -0.61 . . . . 75.11 110.779 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.7 -42.44 95.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.3 0.571 . . . . 42.31 110.484 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -68.68 -37.48 79.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.687 -0.688 . . . . 71.33 110.968 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.63 -6.61 49.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.11 -0.495 . . . . 21.5 111.705 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.717 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 57.3 mt -63.68 125.34 87.37 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.681 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' A' ' 57' ' ' THR . 19.4 Cg_endo -58.04 125.37 18.35 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.471 2.781 . . . . 64.22 113.228 -175.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -81.12 113.72 19.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.456 -0.793 . . . . 75.21 110.654 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.7 mt -112.56 109.42 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.279 -0.419 . . . . 54.54 110.101 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.92 118.29 10.19 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.908 -0.404 . . . . 62.03 109.908 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 50' ' ' TYR . 53.0 t -81.63 128.96 38.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.166 0.508 . . . . 73.24 111.648 -173.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.479 HG22 ' HG3' ' A' ' 52' ' ' LYS . 17.0 p -126.01 138.16 53.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.376 -0.829 . . . . 73.05 109.269 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 52' ' ' LYS . 39.4 mt-10 -63.94 -10.7 22.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.357 . . . . 74.1 111.726 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.09 -33.11 74.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.89 -0.595 . . . . 74.24 109.759 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -134.13 81.73 1.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.354 -0.839 . . . . 71.32 109.553 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.37 -36.07 31.59 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.917 -0.658 . . . . 74.54 112.942 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.37 86.0 6.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.25 0.548 . . . . 51.41 110.665 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.82 -23.73 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.685 -0.689 . . . . 71.14 110.302 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.07 -134.58 1.71 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.261 -0.736 . . . . 73.23 111.261 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -68.86 -42.41 77.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.463 0.649 . . . . 65.32 109.502 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -73.29 113.01 9.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.122 -0.945 . . . . 74.11 110.548 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -95.2 -5.05 44.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.644 0.735 . . . . 72.22 109.257 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.2 p -144.53 167.93 21.34 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.097 -0.956 . . . . 74.15 110.087 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 43.0 t -115.63 92.83 34.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.713 -0.477 . . . . 75.14 109.713 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 19.8 Cg_endo -59.11 -28.14 86.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.979 2.453 . . . . 72.13 112.358 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.0 mt -56.16 -39.24 57.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.487 -0.779 . . . . 75.31 111.609 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.7 p -117.54 6.27 12.51 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.923 -0.311 . . . . 61.22 110.54 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.1 m 53.03 67.79 0.94 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.464 -0.789 . . . . 63.52 111.407 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 p -156.67 168.28 27.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.834 -0.621 . . . . 71.34 109.522 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.74 -170.0 2.75 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.4 -0.592 . . . . 73.42 109.4 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.572 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 61.6 m-85 -93.72 89.65 6.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.382 0.611 . . . . 62.22 110.773 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 m -85.94 158.12 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.101 -0.954 . . . . 75.41 111.251 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' HG3' HG22 ' A' ' 31' ' ' THR . 38.8 ttmt -73.34 120.46 18.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.984 -0.553 . . . . 75.0 110.547 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.85 -19.66 6.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.635 -0.793 . . . . 71.31 112.491 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -84.99 166.5 16.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.981 -0.748 . . . . 72.41 108.981 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.9 t -115.19 131.18 68.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.774 -0.454 . . . . 74.21 109.774 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.57 175.46 5.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.839 0.352 . . . . 60.44 110.654 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.717 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.6 t -151.61 160.79 43.51 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.817 -0.629 . . . . 73.35 109.933 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 31.7 tt0 -107.71 126.76 52.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.474 . . . . 73.4 110.301 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.2 mt -92.06 142.56 26.48 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 108.942 -0.762 . . . . 74.43 108.942 171.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.99 -10.61 12.85 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.203 2.602 . . . . 75.31 111.745 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.13 19.34 2.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.967 -1.015 . . . . 50.03 110.289 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 56.09 37.26 28.66 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.763 -0.653 . . . . 64.0 111.458 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -132.66 141.56 48.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.564 -0.744 . . . . 75.55 110.014 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -119.87 133.42 55.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.198 -0.456 . . . . 73.12 110.754 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 98.0 m-85 -143.84 168.1 20.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.983 -0.553 . . . . 74.11 109.841 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 33.1 m170 -64.02 128.17 34.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.299 -0.63 . . . . 71.45 109.299 171.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 64.1 tttp -56.77 -53.08 68.56 Favored Pre-proline 0 CA--C 1.535 0.386 0 O-C-N 123.342 0.401 . . . . 70.13 111.376 -177.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 12.2 Cg_endo -56.97 -45.3 37.14 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.16 1.906 . . . . 62.21 112.232 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 66.2 m -61.38 -48.73 79.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.122 -0.49 . . . . 54.42 111.357 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.534 HG22 ' HG ' ' A' ' 74' ' ' LEU . 7.7 p -69.82 -27.58 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 53.53 110.618 -175.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.8 m -61.98 -37.05 83.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 51.45 110.361 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.3 mt -66.65 -43.32 90.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.514 . . . . 75.41 110.131 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -68.94 -47.15 66.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.017 -0.538 . . . . 71.43 110.904 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 94.4 mt -60.77 -36.39 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.105 0.409 . . . . 72.52 112.105 -175.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.26 -12.71 61.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.715 0.293 . . . . 74.4 111.184 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -98.77 -50.89 4.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.333 0.587 . . . . 62.32 109.593 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.7 p -151.77 113.3 4.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.383 -0.826 . . . . 62.52 109.858 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.92 85.92 0.38 Allowed Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.946 -0.645 . . . . 71.23 112.613 -176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 2.0 p -149.36 161.79 41.37 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.313 0.245 . . . . 73.13 111.271 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.764 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 95.8 m -79.24 120.52 80.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.32 -0.993 . . . . 73.31 108.32 165.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.46 -14.52 25.72 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.308 2.006 . . . . 71.53 113.044 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.23 -43.47 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.307 -0.406 . . . . 75.44 112.005 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.764 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.3 p -105.88 -17.35 14.39 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.809 -0.356 . . . . 71.41 111.599 -172.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 63.69 23.55 13.55 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.177 0.591 . . . . 73.52 111.973 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 79' ' ' THR . 34.6 t -89.05 155.53 19.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.219 -0.66 . . . . 72.22 109.219 173.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.517 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 25.7 ttm -82.28 149.61 27.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.556 0.576 . . . . 75.33 112.556 -167.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.477 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 66.0 t80 -136.93 120.22 11.89 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 114.934 -1.03 . . . . 73.13 108.803 168.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 34.0 Cg_endo -62.85 152.76 68.5 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 123.863 -1.307 . . . . 74.32 112.572 2.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.23 142.65 55.44 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.147 2.565 . . . . 72.34 112.944 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 39.4 Cg_endo -67.61 147.56 76.55 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.86 2.374 . . . . 72.35 112.232 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.42 -0.8 . . . . 62.33 110.255 -179.7 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.159 -0.311 . . . . 63.03 110.159 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.25 -76.09 0.24 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.84 -0.695 . . . . 54.11 112.154 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -108.54 -169.89 1.58 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.624 0.25 . . . . 74.33 110.513 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -93.13 169.85 10.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.0 0.429 . . . . 73.41 111.245 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -115.47 145.49 42.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.494 -0.928 . . . . 73.4 108.494 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.59 103.89 1.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.041 0.448 . . . . 61.51 110.606 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -77.99 153.96 31.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.549 -0.751 . . . . 73.33 110.278 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -79.74 115.75 19.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.058 0.456 . . . . 74.05 110.996 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 m -67.84 109.57 3.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.982 -0.553 . . . . 74.21 109.914 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -100.05 -31.07 11.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.814 -0.354 . . . . 72.33 110.495 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.4 ttp 69.57 -63.3 0.39 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.858 0.724 . . . . 44.24 111.854 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.53 137.88 22.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.252 0.549 . . . . 73.31 111.234 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.37 148.71 47.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.518 -0.765 . . . . 75.31 109.27 173.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -74.0 134.25 78.01 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.201 -0.296 . . . . 60.5 110.201 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.1 Cg_endo -48.67 147.64 9.44 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.497 2.798 . . . . 74.33 113.071 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 23.9 Cg_exo -64.27 152.28 81.95 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.934 2.423 . . . . 75.23 111.858 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -84.08 166.67 17.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.888 0.375 . . . . 42.12 110.831 -177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.3 p -87.24 144.31 26.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.072 -0.513 . . . . 54.01 110.574 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -62.47 -36.02 81.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 74.43 111.168 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.6 -28.48 69.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.022 -0.535 . . . . 61.13 111.131 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 t -82.94 -24.62 32.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.383 -0.372 . . . . 61.45 110.19 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 18' ' ' SER . 60.0 mt -79.76 -38.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.309 0.576 . . . . 74.33 110.304 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.04 -27.68 63.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.736 -0.666 . . . . 71.45 110.882 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.08 -4.36 55.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.52 111.871 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 64.3 mt -63.7 131.43 94.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.567 -0.288 . . . . 71.34 111.069 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.84 141.18 77.14 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.774 2.316 . . . . 71.53 112.094 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -104.7 119.09 38.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.184 0.516 . . . . 73.24 110.913 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 65.4 mt -112.29 120.82 63.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.47 -0.786 . . . . 72.03 110.082 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.9 tp -74.61 122.54 23.32 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.94 -0.392 . . . . 75.11 109.94 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 43.1 t -92.13 127.46 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.863 0.363 . . . . 73.4 111.337 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.4 p -128.19 172.84 10.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.687 -0.688 . . . . 74.53 110.022 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -76.9 -10.16 59.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.795 0.331 . . . . 75.34 110.7 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -84.78 -10.21 57.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.168 -0.469 . . . . 73.12 110.186 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -149.56 61.92 1.01 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.085 0.469 . . . . 71.51 110.349 -178.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.36 -43.34 79.15 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.77 -0.65 . . . . 75.03 111.513 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.59 98.76 6.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.765 -0.457 . . . . 31.13 109.765 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.0 t -82.72 -20.81 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.254 0.549 . . . . 75.24 110.229 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.73 -140.38 2.87 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.178 -0.769 . . . . 42.45 111.178 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.81 -26.35 64.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.053 0.454 . . . . 74.55 110.071 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -111.68 160.75 16.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.775 -0.648 . . . . 72.53 110.269 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -141.13 13.09 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.331 . . . . 75.12 111.267 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 71.6 m -132.42 140.07 48.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.5 -0.318 . . . . 74.42 110.704 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 41.7 t -103.3 100.15 17.14 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.636 -0.505 . . . . 52.11 109.636 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 32.1 Cg_endo -63.61 -24.76 69.59 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.921 2.414 . . . . 71.22 112.724 -175.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.4 mt -61.14 -35.24 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.073 -0.512 . . . . 51.41 110.916 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 28.2 p -112.95 10.85 18.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.41 . . . . 74.13 109.918 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.0 p 40.33 51.76 2.82 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.174 0.921 . . . . 64.51 111.911 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.1 m -150.75 150.13 30.64 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.993 -0.548 . . . . 74.0 110.103 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 13.1 pt-20 -77.92 -169.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.123 0.487 . . . . 73.23 110.955 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.476 ' HB3' HG11 ' A' ' 30' ' ' VAL . 45.4 m-85 -90.12 113.07 24.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.193 0.521 . . . . 71.33 111.433 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.44 162.4 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.318 -0.856 . . . . 65.4 110.473 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 39.5 ttmt -65.84 128.52 36.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.115 -0.493 . . . . 72.52 110.934 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.49 -24.01 11.7 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.709 -0.757 . . . . 54.34 112.873 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -82.55 159.22 22.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.739 -0.467 . . . . 62.41 109.739 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.09 119.22 57.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.488 -0.324 . . . . 72.45 110.474 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -97.85 168.27 10.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.393 -0.367 . . . . 74.31 110.955 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.51 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 14.6 t -152.59 156.8 40.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.902 -0.59 . . . . 73.43 109.717 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -116.73 118.57 32.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.78 0.324 . . . . 72.12 110.496 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.96 148.67 81.97 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.138 -0.69 . . . . 75.53 109.138 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.79 -9.72 10.23 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.899 2.399 . . . . 70.33 112.067 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.3 9.15 11.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.364 -0.835 . . . . 74.23 109.938 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m170 58.85 37.43 24.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.838 -0.619 . . . . 62.05 111.469 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -121.07 145.06 48.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.741 -0.663 . . . . 73.34 109.495 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -114.09 132.8 55.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.253 0.549 . . . . 75.05 111.609 -172.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.9 175.41 10.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.279 -0.873 . . . . 73.23 108.721 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.745 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 37.4 m80 -87.07 135.46 33.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.8 -0.815 . . . . 73.52 108.8 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.495 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.0 tttt -59.48 -50.19 88.46 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.308 0.38 . . . . 75.43 111.841 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.6 Cg_endo -60.87 -18.51 57.15 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.03 1.82 . . . . 63.44 112.911 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 64.5 m -83.9 -53.03 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.225 0.536 . . . . 63.44 110.865 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 p -70.38 -27.25 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.54 -0.755 . . . . 74.22 111.216 -172.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.555 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 6.4 p -61.16 -32.34 72.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.467 -0.333 . . . . 71.31 111.193 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.0 mt -74.99 -44.45 44.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.177 0.513 . . . . 54.42 110.272 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -62.23 -43.93 97.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.598 -0.728 . . . . 75.14 111.182 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 91.7 mt -65.19 -23.9 67.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 55.41 111.687 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.6 mt-30 -73.94 -15.26 61.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 74.43 110.884 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -106.18 -43.81 4.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.342 0.591 . . . . 65.12 109.99 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.9 p -153.32 114.62 4.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.441 -0.799 . . . . 53.31 110.397 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.87 81.35 1.02 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.558 -0.829 . . . . 74.05 112.124 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.4 164.51 34.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.507 0.194 . . . . 64.11 111.495 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.626 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 68.5 m -74.87 116.82 57.51 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 107.953 -1.128 . . . . 71.44 107.953 162.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.63 -17.29 27.91 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 122.492 2.128 . . . . 74.31 112.526 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.23 -57.44 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.78 -0.645 . . . . 74.21 111.767 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.9 p -94.48 -12.67 27.25 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.36 0.504 . . . . 64.11 112.36 -169.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' CYS . 20.8 mmt180 74.24 4.9 4.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.004 0.521 . . . . 74.12 112.015 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.4 t -73.22 145.23 46.37 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.164 -0.214 . . . . 61.5 110.425 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.545 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 36.0 ttm -74.34 145.84 43.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 63.22 112.438 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.435 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 74.1 t80 -128.8 121.43 20.98 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.409 -0.814 . . . . 73.44 109.85 171.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.07 157.41 99.55 Favored 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.999 -1.667 . . . . 73.42 111.731 -1.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.56 142.33 31.26 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.83 2.353 . . . . 64.24 112.508 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 28.5 Cg_endo -62.62 152.08 79.87 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.001 2.467 . . . . 64.11 112.185 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.541 -0.742 . . . . 73.32 110.187 -177.236 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.737 0.303 . . . . 74.12 111.101 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.25 -178.77 32.59 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.411 -0.676 . . . . 52.13 111.411 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -126.02 -57.48 1.42 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.915 0.357 . . . . 64.31 110.64 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.7 t60 57.0 71.6 0.56 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.812 -0.631 . . . . 73.52 111.353 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -143.59 147.76 34.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.844 -0.799 . . . . 73.22 108.844 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -79.87 156.8 27.16 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.702 -0.851 . . . . 64.33 108.702 174.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -70.21 119.05 13.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.868 0.366 . . . . 73.52 110.646 -173.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -80.23 88.12 5.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.896 -0.593 . . . . 75.14 110.537 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 m -139.28 163.66 31.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.957 -0.565 . . . . 51.21 110.12 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -154.77 107.59 2.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.222 -0.445 . . . . 65.11 109.917 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.647 ' HB2' ' HB3' ' A' ' 84' ' ' ARG . 25.5 mmt -112.6 137.43 50.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.039 -0.528 . . . . 74.04 110.192 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 p -150.79 -27.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.095 -0.502 . . . . 72.43 110.744 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.85 120.89 12.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.648 0.261 . . . . 13.51 110.381 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -141.57 134.0 13.94 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 110.081 -0.34 . . . . 73.31 110.081 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.64 153.03 25.26 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.17 2.58 . . . . 45.31 112.392 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.47 163.0 34.18 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.923 2.416 . . . . 71.13 112.754 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.83 177.57 6.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.105 -0.498 . . . . 71.13 110.694 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -90.25 143.05 27.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.371 -0.377 . . . . 73.43 109.987 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -57.09 -39.59 75.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.932 0.396 . . . . 72.31 110.618 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.66 -23.8 60.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 71.51 111.243 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.8 m -77.19 -31.04 55.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.999 0.428 . . . . 74.54 109.948 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.9 mt -78.38 -40.86 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 75.43 109.968 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.03 -35.8 73.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.888 -0.596 . . . . 73.22 110.607 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.28 -4.02 48.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.733 -0.667 . . . . 52.44 112.156 -176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 74.1 mt -65.89 126.34 91.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.66 0.266 . . . . 71.44 110.349 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.03 136.27 64.31 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.958 2.439 . . . . 64.34 112.324 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.83 113.4 26.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.128 -0.487 . . . . 75.53 110.193 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.5 mt -114.72 132.45 63.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.849 -0.614 . . . . 64.44 110.01 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 47.9 tp -86.81 116.7 25.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.166 -0.309 . . . . 70.12 110.166 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 54.0 t -71.21 135.74 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.29 -0.414 . . . . 73.23 109.893 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 32.8 p -128.64 172.83 10.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.271 -0.422 . . . . 72.45 110.423 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.534 ' HG2' ' HE3' ' A' ' 52' ' ' LYS . 42.5 mm-40 -70.34 -25.13 63.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 75.3 111.152 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.95 -7.08 58.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 54.35 111.131 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.676 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 59.9 t-80 -153.18 64.6 0.77 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.712 -0.477 . . . . 65.12 109.712 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.1 -59.61 7.26 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.81 -0.632 . . . . 75.1 112.297 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.28 92.81 1.82 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.056 0.455 . . . . 61.42 109.93 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.676 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 6.4 t -63.26 -49.33 83.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 74.33 109.894 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.11 -138.88 5.1 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.655 -1.378 . . . . 61.22 109.655 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.86 -11.41 59.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.611 0.705 . . . . 75.43 109.532 171.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -83.5 100.16 10.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 75.22 110.161 171.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -91.33 -12.5 34.8 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.603 0.716 . . . . 75.44 109.208 172.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.751 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 57.2 m -138.24 131.29 30.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.035 -0.984 . . . . 54.22 109.29 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.6 t -70.93 109.09 4.51 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 123.342 0.401 . . . . 71.1 110.018 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.71 -24.47 74.78 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.782 2.322 . . . . 75.35 112.185 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.83 -25.7 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.259 0.552 . . . . 62.34 110.675 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 40.0 m -117.46 2.3 12.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.174 -0.466 . . . . 61.33 110.879 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p 42.79 35.78 0.76 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.657 0.783 . . . . 62.55 111.674 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.4 t -136.43 148.14 47.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.97 -0.559 . . . . 34.13 110.036 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.751 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 9.9 pt-20 -79.21 168.56 19.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.565 0.58 . . . . 73.24 112.565 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.2 m-85 -98.02 130.35 44.85 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 74.13 110.666 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -132.7 177.87 6.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.016 -0.365 . . . . 64.11 110.016 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 40.0 ttmt -60.06 113.06 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 71.35 110.878 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.25 -11.02 7.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.623 . . . . 32.2 112.06 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.53 131.94 36.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.853 0.359 . . . . 63.5 111.088 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -88.07 110.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.212 -0.449 . . . . 73.42 109.956 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.1 155.66 22.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.086 -0.507 . . . . 71.03 110.394 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.9 t -132.43 159.3 39.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.065 -0.516 . . . . 74.13 109.839 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -109.3 123.07 48.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.918 0.39 . . . . 64.53 111.469 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.9 mt -87.05 140.03 32.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.319 -0.993 . . . . 70.13 108.319 167.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.69 -13.02 7.43 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.304 2.669 . . . . 73.11 113.802 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.2 p -90.42 19.88 4.92 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.801 0.334 . . . . 64.34 110.71 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 60.32 54.63 3.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.91 -0.586 . . . . 74.23 112.034 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -142.3 141.29 32.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.834 -0.621 . . . . 73.12 109.373 174.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -120.39 133.47 55.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.406 0.622 . . . . 75.14 111.934 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 65.2 m-85 -139.26 175.17 9.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.298 -0.864 . . . . 74.32 108.754 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.829 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 40.4 m80 -76.45 132.14 39.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.302 -0.999 . . . . 72.12 108.302 173.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 85.5 tttt -56.25 -48.96 95.88 Favored Pre-proline 0 C--N 1.32 -0.688 0 O-C-N 123.301 0.376 . . . . 75.4 111.913 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 7.2 Cg_endo -50.45 -51.38 11.14 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.454 2.103 . . . . 64.32 113.426 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.829 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 18.9 p -77.1 -30.46 55.33 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.627 -0.429 . . . . 74.25 111.815 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 67' ' ' LYS . 5.4 p -70.75 -26.48 28.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 120.329 -0.548 . . . . 70.34 109.752 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 41.3 m -60.84 -48.23 82.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.641 -0.503 . . . . 72.2 109.641 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.441 HG22 ' HE3' ' A' ' 76' ' ' LYS . 42.7 mt -62.75 -40.51 88.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.609 -0.723 . . . . 63.3 110.625 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -66.49 -50.96 61.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.004 -0.544 . . . . 74.31 111.126 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 77' ' ' SER . 94.9 mt -66.09 -20.91 66.31 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.143 0.424 . . . . 75.21 112.143 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.9 mt-30 -79.44 -8.3 59.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 72.32 110.785 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HE3' HG22 ' A' ' 72' ' ' ILE . 10.1 mtmp? -114.43 -34.26 5.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.368 -0.378 . . . . 72.52 110.792 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 34.1 t -148.33 127.51 12.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.812 -0.44 . . . . 73.45 109.812 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.56 47.06 3.01 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.691 -0.766 . . . . 74.42 112.653 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.29 149.5 49.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.028 0.442 . . . . 53.11 111.318 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 38.6 t -74.65 114.36 33.43 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.471 -0.786 . . . . 65.15 109.512 175.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 80' ' ' CYS . 16.5 Cg_endo -57.24 -22.46 48.86 Favored 'Trans proline' 0 N--CA 1.474 0.326 0 C-N-CA 122.712 2.274 . . . . 70.05 112.84 -174.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.7 t -82.86 -31.89 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.301 0.482 . . . . 60.25 112.301 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.0 p -130.27 -11.6 4.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.686 0.625 . . . . 44.41 112.686 -173.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.647 ' HB3' ' HB2' ' A' ' 11' ' ' MET . 0.4 OUTLIER 70.49 13.44 7.42 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.489 0.716 . . . . 65.2 111.832 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.8 t -73.08 144.07 47.18 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.152 -0.684 . . . . 70.13 109.152 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 60.9 ttp -79.12 151.57 31.28 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.369 0.418 . . . . 54.31 111.047 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -126.42 119.59 23.26 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.84 -0.618 . . . . 62.44 109.537 173.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.48 156.0 92.23 Favored 'Cis proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.45 -1.479 . . . . 62.13 112.399 -0.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.01 155.14 46.28 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.103 2.535 . . . . 65.43 112.798 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.46 -173.21 1.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.677 2.251 . . . . 64.21 112.178 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.375 -0.821 . . . . 62.42 110.394 -179.01 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 ttp . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 120.696 0.284 . . . . 52.33 110.326 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.46 -109.85 2.58 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.123 -0.489 . . . . 64.11 112.747 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -77.04 165.06 25.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.894 0.378 . . . . 55.41 110.626 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -79.08 104.27 9.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.909 -0.774 . . . . 72.22 108.909 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -68.63 112.22 5.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.148 -0.478 . . . . 74.14 110.915 -176.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -77.4 69.0 3.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.672 0.749 . . . . 74.34 109.552 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -116.18 3.33 13.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.049 -0.978 . . . . 72.24 108.59 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -125.53 148.52 48.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.672 -1.149 . . . . 65.34 109.185 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 t -120.31 -24.75 5.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.008 0.433 . . . . 75.31 110.256 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -133.28 146.76 51.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 71.13 110.598 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 86.9 mtp -84.74 117.12 23.63 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.451 -0.574 . . . . 52.52 109.451 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.558 HG12 ' HG2' ' A' ' 84' ' ' ARG . 24.9 m -90.09 -18.14 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.503 -0.317 . . . . 75.15 111.658 -174.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.53 105.88 17.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.97 0.414 . . . . 74.22 110.769 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.51 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 17.7 p-10 -135.13 162.25 58.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.981 -0.554 . . . . 73.44 110.191 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 14' ' ' ASN . 21.5 Cg_endo -61.37 151.98 75.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.581 2.188 . . . . 73.31 112.358 176.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.15 162.79 40.68 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.623 2.215 . . . . 70.11 112.127 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.87 143.61 26.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.256 -0.429 . . . . 61.33 110.277 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -70.92 147.67 48.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.952 -0.388 . . . . 72.13 109.952 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -53.02 -38.38 62.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.306 -0.407 . . . . 71.11 111.267 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.4 -42.49 91.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.875 -0.602 . . . . 61.42 111.901 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.5 m -70.66 -34.41 71.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.109 0.481 . . . . 74.11 110.714 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.479 HG21 ' HA ' ' A' ' 71' ' ' SER . 68.6 mt -72.81 -42.85 61.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.978 -0.555 . . . . 64.25 111.059 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.3 -21.72 62.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.222 -0.445 . . . . 74.0 110.508 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.74 -3.89 54.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 51.01 111.622 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.454 HD13 HG21 ' A' ' 57' ' ' THR . 25.2 mt -56.52 135.32 77.11 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.602 -0.272 . . . . 52.13 111.379 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.39 129.99 36.85 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.137 2.558 . . . . 75.12 111.722 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -98.26 111.66 23.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.089 0.471 . . . . 71.43 110.732 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -112.71 109.99 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.588 -0.733 . . . . 74.42 109.758 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.79 123.52 20.37 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.514 -0.55 . . . . 62.3 109.514 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 47.2 t -74.18 114.38 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.046 0.451 . . . . 55.44 110.669 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.9 p -115.3 131.82 56.81 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.653 -0.703 . . . . 72.33 109.87 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 53.2 mt-10 -66.58 -13.97 61.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 64.42 111.251 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.23 -29.28 70.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.336 0.589 . . . . 74.03 110.012 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -92.7 -16.9 24.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.277 -0.874 . . . . 73.03 110.092 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.54 -113.72 4.36 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.41 -0.676 . . . . 75.53 111.41 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.66 132.01 40.3 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.7 -0.482 . . . . 74.43 109.7 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.57 -31.67 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.247 0.546 . . . . 64.25 110.217 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.518 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . -164.37 -118.23 0.44 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.176 -0.77 . . . . 74.22 111.176 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -64.45 -55.06 23.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.311 0.577 . . . . 74.0 110.435 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 142.02 28.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.417 -0.81 . . . . 71.22 111.702 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 ptp -112.73 7.37 18.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.496 -0.775 . . . . 72.45 109.545 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 19.6 p -126.6 149.55 49.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.401 -0.818 . . . . 62.03 109.926 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 41.3 t -110.32 101.01 46.83 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.042 -0.355 . . . . 65.43 110.042 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.7 Cg_endo -54.41 -31.98 70.69 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.412 2.741 . . . . 65.15 112.583 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.2 -34.74 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.952 -0.567 . . . . 72.21 110.883 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.0 m -98.46 -18.9 17.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 74.35 111.354 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.2 m 65.89 22.23 11.37 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.444 0.64 . . . . 62.14 110.032 -172.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -130.51 175.43 8.99 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.264 -0.88 . . . . 74.11 109.524 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 8.5 pt-20 -98.96 -175.24 2.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.048 0.452 . . . . 74.32 111.477 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.514 ' HB3' HG11 ' A' ' 30' ' ' VAL . 56.0 m-85 -100.89 120.23 39.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.966 -0.561 . . . . 75.21 110.591 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.5 m -127.29 169.35 18.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.895 -0.593 . . . . 64.11 110.783 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 33.7 ttmt -74.36 110.92 9.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 74.21 110.886 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.61 -26.85 2.63 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.785 -0.721 . . . . 72.34 112.413 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -86.86 160.94 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.816 -0.439 . . . . 64.12 109.816 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -108.06 126.55 64.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.905 0.383 . . . . 64.15 110.711 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.05 170.7 7.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.174 -0.467 . . . . 72.1 110.567 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.454 HG21 HD13 ' A' ' 25' ' ' LEU . 13.5 t -148.98 156.65 42.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.06 -0.518 . . . . 54.53 109.647 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -110.55 117.47 33.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.49 -0.323 . . . . 74.32 110.376 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.9 mt -75.4 156.16 85.47 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.967 -0.753 . . . . 71.34 108.967 172.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.41 -23.82 14.89 Favored 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.095 2.53 . . . . 74.5 113.56 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.6 p -90.76 15.49 11.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.462 0.171 . . . . 71.43 111.462 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 44.8 m80 67.29 24.68 8.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.911 0.485 . . . . 74.35 112.061 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -102.83 133.25 48.21 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.741 -0.466 . . . . 72.24 109.741 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 80.5 m-85 -105.63 133.28 50.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.171 -0.468 . . . . 72.33 112.011 -171.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.499 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 99.2 m-85 -138.02 175.31 9.7 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.522 -0.918 . . . . 74.42 108.522 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.876 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.6 m80 -84.02 128.28 34.44 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.864 -0.791 . . . . 74.21 108.864 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 89.0 tttt -53.35 -48.32 92.99 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 123.578 0.549 . . . . 72.33 111.828 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 73.1 Cg_exo -53.47 -47.31 28.04 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 122.334 2.023 . . . . 74.23 113.801 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.876 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 25.8 p -82.79 -36.92 25.22 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.773 -0.371 . . . . 63.51 111.942 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 8.7 p -68.39 -24.99 30.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.77 -0.455 . . . . 74.1 109.77 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.53 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 47.5 t -55.07 -50.57 68.81 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.684 -0.689 . . . . 72.42 110.626 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.7 mt -66.0 -38.76 82.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 74.41 110.507 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -62.85 -47.1 84.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.922 -0.581 . . . . 73.31 110.634 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 97.1 mt -66.22 -29.26 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 75.13 111.258 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 71' ' ' SER . 78.6 mt-30 -71.24 -13.41 61.9 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.865 0.364 . . . . 73.45 110.73 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -101.82 -45.05 5.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 72.11 110.12 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.2 p -153.19 119.9 5.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.759 -0.655 . . . . 53.14 109.897 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.16 66.14 3.85 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.656 -0.783 . . . . 42.32 112.668 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.31 144.35 34.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.804 0.335 . . . . 72.22 111.241 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.01 104.74 1.46 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.995 -0.548 . . . . 63.33 109.78 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -48.37 -37.15 32.04 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.67 2.913 . . . . 75.05 114.322 -168.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.2 -28.42 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.304 0.483 . . . . 74.54 112.304 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.3 p -127.4 -26.74 3.0 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.986 -0.447 . . . . 51.52 111.801 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.558 ' HG2' HG12 ' A' ' 12' ' ' VAL . 5.1 tpt180 79.86 18.99 0.66 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.558 1.143 . . . . 75.42 110.635 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.2 t -69.0 138.34 54.43 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.605 -0.887 . . . . 75.05 108.605 169.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.564 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 41.1 ttm -80.8 148.42 30.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.966 0.413 . . . . 65.4 111.794 -171.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 81.3 t80 -133.65 116.5 13.84 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.705 -0.68 . . . . 74.54 109.448 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 8.6 Cg_exo -72.05 151.95 96.44 Favored 'Cis proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.271 -1.554 . . . . 50.45 111.82 -0.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -50.08 147.64 14.94 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.272 2.648 . . . . 74.13 112.384 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 38.7 Cg_endo -65.28 149.63 88.27 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.363 2.042 . . . . 62.52 112.012 -174.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.873 -0.584 . . . . 73.44 110.213 -177.931 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.718 0.294 . . . . 74.31 110.824 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.8 -73.11 0.49 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.954 -0.859 . . . . 52.35 110.954 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -113.62 -170.62 1.73 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.384 -0.598 . . . . 70.55 109.384 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -117.34 51.13 1.04 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.665 0.745 . . . . 72.42 110.018 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -72.02 128.88 37.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.943 -1.026 . . . . 74.41 109.679 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -107.42 115.76 30.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.854 0.359 . . . . 64.22 111.024 -175.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -93.03 165.3 12.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.467 -0.568 . . . . 54.11 109.467 173.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -74.63 145.82 42.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.76 -0.459 . . . . 73.51 109.76 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.9 p -56.9 103.8 0.13 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.441 0.534 . . . . 62.42 112.441 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -158.62 119.39 3.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.079 -0.711 . . . . 73.43 109.079 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.8 ttt -88.53 115.18 25.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.947 -0.57 . . . . 71.34 111.284 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.15 124.15 72.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.903 -0.59 . . . . 55.12 109.703 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.64 -54.35 8.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.426 -0.352 . . . . 62.41 111.865 -174.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -128.96 157.57 75.35 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.533 -0.303 . . . . 74.41 111.086 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -57.68 151.15 57.13 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.914 2.41 . . . . 64.15 111.87 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 155.43 61.87 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.644 2.229 . . . . 72.43 112.752 -175.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.92 144.76 26.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.898 -0.592 . . . . 50.11 110.641 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.3 m -65.52 145.02 56.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.978 -0.555 . . . . 70.31 110.882 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -58.22 -45.06 88.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 71.54 110.924 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -48.8 -48.12 41.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.745 -0.661 . . . . 71.24 111.259 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.0 m -67.88 -34.22 76.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 53.2 111.338 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.4 HG21 ' HA ' ' A' ' 71' ' ' SER . 60.4 mt -72.94 -44.51 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.278 0.561 . . . . 71.03 110.393 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -62.96 -35.52 80.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.782 -0.645 . . . . 62.4 110.705 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.01 5.2 17.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.801 -0.636 . . . . 65.54 112.184 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 74.2 mt -69.69 142.28 91.18 Favored Pre-proline 0 C--O 1.237 0.419 0 N-CA-C 110.252 -0.277 . . . . 73.02 110.252 175.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.25 149.0 91.09 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.955 2.437 . . . . 72.2 112.353 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -113.04 105.81 13.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 70.44 110.451 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.7 mt -100.08 121.69 51.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.93 -0.577 . . . . 75.31 110.016 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.6 tp -81.2 122.29 27.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.835 0.35 . . . . 62.22 110.467 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.575 HG11 ' HB3' ' A' ' 50' ' ' TYR . 47.0 t -88.43 134.3 28.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.248 -0.433 . . . . 75.11 110.212 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.2 p -113.35 172.81 6.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.656 -0.702 . . . . 70.04 110.831 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HG2' ' HE3' ' A' ' 52' ' ' LYS . 5.7 mm-40 -59.39 134.39 56.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.409 -0.359 . . . . 63.14 110.776 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.0 t70 53.44 74.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.322 -0.853 . . . . 73.32 110.579 -172.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -165.22 29.51 0.06 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.126 -0.943 . . . . 73.15 108.785 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 41' ' ' MET . . . -59.82 -36.65 90.67 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.468 -0.787 . . . . 53.14 111.628 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.59 84.27 5.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.31 0.576 . . . . 74.33 110.046 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.9 t -75.23 -23.25 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.571 -0.741 . . . . 71.42 109.986 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.45 -126.3 0.82 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.001 -0.84 . . . . 74.44 111.001 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.84 -3.5 41.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.342 0.591 . . . . 62.22 110.255 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -120.24 153.5 36.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.476 -0.784 . . . . 72.12 109.898 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.6 pmm? -134.92 9.79 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.113 -0.494 . . . . 71.54 110.262 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.6 p -147.61 151.01 35.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.149 -0.478 . . . . 60.35 111.045 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 37.4 t -101.49 100.96 15.29 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.488 -0.778 . . . . 72.33 109.296 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 16.3 Cg_endo -57.44 -31.62 91.78 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.931 2.421 . . . . 54.22 112.564 -176.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -60.95 -27.03 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 70.35 110.944 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.6 m -110.24 -15.35 14.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.33 -0.395 . . . . 72.54 111.103 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.0 m 58.32 45.1 17.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.186 -0.461 . . . . 55.32 109.964 -172.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.3 t -154.41 175.1 13.98 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.814 -0.63 . . . . 54.21 109.734 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -101.89 -169.87 1.74 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.743 0.306 . . . . 74.24 111.705 -173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.575 ' HB3' HG11 ' A' ' 30' ' ' VAL . 94.9 m-85 -111.07 134.18 52.87 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.077 -0.51 . . . . 74.44 110.781 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.9 m -136.89 -179.6 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.328 -0.397 . . . . 75.53 110.62 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.554 ' HE3' ' HG2' ' A' ' 32' ' ' GLU . 37.8 ttmt -56.73 133.28 53.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.058 0.456 . . . . 62.13 111.168 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.9 -8.65 59.65 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.798 -0.715 . . . . 71.32 112.04 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -78.58 129.11 34.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.833 0.349 . . . . 75.13 111.311 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.19 102.06 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.63 . . . . 54.04 109.463 174.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.69 162.76 13.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.827 -0.624 . . . . 73.14 110.458 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 10.5 t -140.58 155.48 46.56 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.655 -0.498 . . . . 74.13 109.655 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -116.02 117.54 30.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 44.42 110.64 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -79.29 150.2 73.64 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.988 -0.551 . . . . 72.43 109.88 176.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.8 -14.99 24.39 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.313 2.675 . . . . 72.3 113.083 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.4 p -87.24 10.99 15.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.249 -0.278 . . . . 74.23 110.249 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 62.24 77.79 0.32 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.731 -0.668 . . . . 65.32 111.161 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -160.94 149.64 16.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.258 -0.883 . . . . 72.32 109.226 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.75 132.87 55.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.943 0.402 . . . . 52.3 111.662 -173.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.465 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 91.6 m-85 -141.51 175.29 9.8 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.101 -0.703 . . . . 61.01 109.101 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.895 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 40.5 m80 -81.43 131.7 35.29 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.152 -1.055 . . . . 71.31 108.152 172.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 87.5 tttt -56.13 -49.94 90.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 O-C-N 123.334 0.396 . . . . 74.04 112.018 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 51.0 Cg_exo -56.9 -46.78 26.89 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.005 1.804 . . . . 73.53 113.537 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.895 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 25.1 p -74.57 -32.44 62.4 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.586 -0.446 . . . . 64.5 111.615 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 67' ' ' LYS . 7.5 p -73.01 -24.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.494 -0.483 . . . . 70.35 109.788 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.4 ' HA ' HG21 ' A' ' 22' ' ' ILE . 55.7 m -60.83 -43.07 98.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 72.35 110.431 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.05 -42.95 89.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 60.44 110.351 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.64 -46.24 83.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.641 -0.709 . . . . 75.24 111.42 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.37 -22.21 65.58 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.866 0.321 . . . . 75.4 111.866 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -81.15 -7.17 59.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.105 0.479 . . . . 74.22 110.714 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -109.82 -52.15 2.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.79 -0.641 . . . . 73.22 110.452 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.9 t -142.96 115.99 8.86 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.634 -0.506 . . . . 70.32 109.634 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.5 72.09 1.76 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.92 -0.657 . . . . 63.54 112.226 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.402 HG22 ' HA ' ' A' ' 84' ' ' ARG . 1.7 m -147.11 137.49 23.46 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.901 -0.407 . . . . 63.31 109.901 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.5 t -74.77 110.03 8.82 Favored Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 109.137 -0.69 . . . . 71.33 109.137 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.69 -33.65 60.5 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 122.989 2.46 . . . . 74.14 113.832 -170.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.9 t -73.52 -53.31 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.266 0.469 . . . . 64.13 112.266 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.7 p -101.44 -16.32 16.89 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.84 -0.344 . . . . 32.33 111.433 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HA ' HG22 ' A' ' 79' ' ' THR . 71.2 mtt180 69.18 23.93 6.21 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.589 -0.732 . . . . 70.2 111.993 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.6 m -80.91 149.27 29.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 74.52 109.355 170.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.5 ttp -76.39 143.67 40.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.247 -0.433 . . . . 75.25 111.871 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.612 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 78.2 t80 -137.42 126.71 15.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.924 -0.769 . . . . 75.14 108.924 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.612 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 51.7 Cg_exo -56.07 147.66 23.58 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.623 -0.99 . . . . 41.11 113.366 2.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 20.1 Cg_endo -59.29 151.12 70.04 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.243 2.629 . . . . 53.22 112.596 -175.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 89' ' ' PRO . 8.9 Cg_exo -70.42 178.79 4.61 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.677 2.252 . . . . 65.01 112.432 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.564 -0.744 . . . . 75.15 110.602 -179.234 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.7 mtp . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.003 -0.369 . . . . 75.22 110.003 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.68 -7.01 49.05 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.939 -0.648 . . . . 73.13 111.937 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -73.45 102.13 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 74.13 110.115 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -117.82 111.39 19.0 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.994 -0.548 . . . . 53.15 110.316 -176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -69.89 137.65 51.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.416 -0.587 . . . . 75.31 109.416 176.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -100.64 136.83 39.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.794 0.331 . . . . 74.25 111.059 -171.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -130.11 99.31 5.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.718 -0.674 . . . . 74.32 109.497 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -62.34 107.7 0.96 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 74.32 110.917 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.0 p -154.42 160.67 41.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 73.24 110.097 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -66.2 129.63 40.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.31 . . . . 75.41 110.644 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 89.2 mmm -90.19 85.15 6.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.061 0.458 . . . . 72.12 110.772 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.53 136.89 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.979 -0.555 . . . . 75.42 110.135 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.4 92.9 5.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.082 0.468 . . . . 64.12 110.237 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -75.74 138.26 70.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.58 -0.737 . . . . 73.15 110.455 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.15 157.88 12.94 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.215 2.61 . . . . 73.54 112.817 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.13 165.67 27.63 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.738 2.292 . . . . 63.43 112.745 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -90.17 154.01 20.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.793 -0.639 . . . . 50.24 110.433 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -70.2 135.73 49.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.453 -0.339 . . . . 61.24 110.567 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -58.87 -38.15 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.925 -0.579 . . . . 55.42 110.984 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -59.31 -46.3 88.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.927 -0.579 . . . . 74.55 110.535 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.402 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 9.8 m -63.59 -34.16 77.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 61.14 110.632 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.04 -43.53 76.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.607 . . . . 73.14 110.413 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -66.54 -37.38 84.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.142 -0.481 . . . . 71.03 110.577 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.67 3.68 11.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.747 -0.661 . . . . 60.33 111.807 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.647 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 60.1 mt -70.18 131.82 88.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.475 -0.195 . . . . 74.13 110.475 175.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 19.5 Cg_endo -58.63 135.24 66.06 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.152 2.568 . . . . 63.25 112.513 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -101.63 102.92 13.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.106 0.479 . . . . 73.44 110.006 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.1 mt -103.23 131.63 51.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.898 -0.592 . . . . 74.15 110.544 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.8 tp -79.38 121.74 25.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.893 0.378 . . . . 74.03 110.323 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 50' ' ' TYR . 42.6 t -87.46 132.33 33.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.074 -0.512 . . . . 71.44 110.67 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 36.9 p -128.59 151.42 49.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.264 -0.426 . . . . 62.35 110.297 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.671 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 30.4 mt-10 -84.51 0.6 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.23 0.538 . . . . 74.21 110.687 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.1 -22.11 29.03 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.847 -0.797 . . . . 74.05 108.847 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -133.4 55.57 1.89 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.89 -1.05 . . . . 73.1 109.265 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.95 160.1 34.97 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.38 -0.827 . . . . 72.32 112.272 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 41' ' ' MET . . . 60.16 76.62 0.35 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.399 0.618 . . . . 64.12 109.993 -174.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.71 93.77 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.45 -0.795 . . . . 62.15 111.145 -173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.42 -12.9 30.71 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.832 -0.622 . . . . 33.33 113.298 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.428 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 7.1 pt20 -156.93 -160.26 0.95 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.73 -0.276 . . . . 72.02 110.679 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.3 151.84 9.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.589 -0.732 . . . . 63.32 110.615 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.468 ' HB3' ' HB2' ' A' ' 36' ' ' ALA . 1.4 pmm? -88.77 11.91 16.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.309 -0.405 . . . . 52.44 111.645 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.1 m -118.4 141.53 48.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.208 0.528 . . . . 75.41 111.411 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 21.3 t -106.11 101.72 35.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.555 -0.748 . . . . 71.02 109.549 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 17.7 Cg_endo -59.7 -26.68 82.9 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 123.246 2.631 . . . . 71.44 113.349 -174.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.9 mt -60.83 -41.26 87.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 75.02 111.469 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 21.0 p -119.88 13.96 12.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.557 -0.292 . . . . 75.21 110.909 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p 43.37 45.14 5.13 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.942 0.776 . . . . 51.41 112.22 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.0 p -120.85 -177.71 3.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.459 -0.571 . . . . 63.44 109.459 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -106.67 -175.13 2.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.795 0.331 . . . . 73.35 110.117 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.533 ' HB3' HG11 ' A' ' 30' ' ' VAL . 70.0 m-85 -103.0 109.92 21.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.378 -0.374 . . . . 72.11 110.538 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.1 m -107.08 165.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 74.35 111.68 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.671 ' HB2' ' H ' ' A' ' 32' ' ' GLU . 22.7 ttpp -73.5 113.69 10.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 72.21 111.008 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.02 -8.74 9.1 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.943 -0.646 . . . . 63.34 112.709 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.26 166.02 15.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 110.121 -0.326 . . . . 74.22 110.121 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -115.98 116.17 51.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.13 0.49 . . . . 75.31 110.745 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.43 166.95 10.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.028 -0.533 . . . . 73.01 110.784 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.647 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.8 t -136.45 155.16 50.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.747 -0.66 . . . . 73.21 110.114 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 49.2 tt0 -107.75 117.8 35.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.98 -0.554 . . . . 73.44 109.925 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.87 146.38 59.55 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 109.031 -0.729 . . . . 73.12 109.031 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.71 -3.87 4.0 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.099 2.533 . . . . 65.14 113.807 -175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.7 p -103.22 29.29 5.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 75.03 110.472 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 63.12 31.73 15.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.878 -0.601 . . . . 74.41 112.188 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -126.52 135.01 50.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.776 0.322 . . . . 74.14 110.814 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.65 145.92 30.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.79 -0.641 . . . . 65.0 110.875 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -149.25 160.41 43.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.686 -0.688 . . . . 75.34 109.289 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.637 ' HB2' ' CB ' ' A' ' 69' ' ' CYS . 34.3 m170 -60.47 132.85 55.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.418 -0.956 . . . . 72.14 108.418 168.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -65.85 -61.51 5.55 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.943 0.719 . . . . 74.23 112.943 -171.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.36 -23.32 71.81 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.742 1.628 . . . . 62.41 111.197 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.637 ' CB ' ' HB2' ' A' ' 66' ' ' HIS . 7.7 t -67.36 -53.42 29.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.212 -1.358 . . . . 75.33 110.295 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 p -74.65 -24.7 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.782 -0.644 . . . . 65.34 110.524 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.607 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 43.6 t -54.29 -48.73 70.92 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.266 -0.424 . . . . 75.22 110.1 176.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.0 mt -57.51 -47.6 84.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.012 -0.54 . . . . 65.32 110.343 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -61.3 -44.75 96.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 74.42 111.116 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 96.8 mt -66.14 -23.07 66.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 74.34 111.456 -178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.607 ' HG3' ' O ' ' A' ' 71' ' ' SER . 78.0 mt-30 -72.33 -21.95 61.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.755 0.312 . . . . 71.3 110.485 177.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -89.56 -59.17 2.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.183 0.516 . . . . 70.32 109.625 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.0 m -140.11 124.78 18.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 64.43 110.343 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.03 75.55 2.27 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.176 -0.769 . . . . 75.53 111.176 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 84' ' ' ARG . 4.0 m -147.68 135.29 20.89 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.374 -0.232 . . . . 71.44 110.374 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 34.9 t -75.18 107.39 3.93 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.181 -0.674 . . . . 63.25 109.181 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.18 -31.98 48.02 Favored 'Trans proline' 0 N--CA 1.476 0.497 0 C-N-CA 123.152 2.568 . . . . 74.21 114.207 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.5 t -71.69 -47.9 54.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.048 0.388 . . . . 63.53 112.048 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 20.5 p -103.51 -23.83 13.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.848 0.356 . . . . 74.13 111.031 -174.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.467 ' HA ' HG22 ' A' ' 79' ' ' THR . 35.9 mtp180 71.13 29.6 2.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.316 -0.856 . . . . 73.32 110.893 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 47.6 t -85.07 138.15 32.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.536 -0.756 . . . . 73.3 108.982 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.7 ttp -72.11 143.38 49.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 62.1 111.275 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.455 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 94.0 t80 -125.88 129.69 24.23 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.309 -0.859 . . . . 75.32 108.98 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 16.7 Cg_exo -67.59 157.42 85.0 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 123.851 -1.312 . . . . 71.24 112.721 2.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.51 134.38 63.6 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.065 2.51 . . . . 65.3 112.412 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.81 -172.18 1.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.016 2.477 . . . . 64.44 112.61 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--O 1.243 0.75 0 CA-C-O 118.6 -0.714 . . . . 73.41 109.859 178.049 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.857 -0.423 . . . . 70.53 109.857 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 145.04 -43.73 0.93 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.347 -0.701 . . . . 74.33 111.347 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -88.75 102.77 15.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.059 0.457 . . . . 71.03 110.087 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -103.7 147.98 26.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.719 -0.673 . . . . 74.31 110.362 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -73.75 -40.5 63.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 75.21 110.686 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -129.0 158.81 37.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.362 -0.381 . . . . 72.14 110.939 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -164.39 122.96 1.82 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.709 -0.678 . . . . 72.44 109.898 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -132.08 98.91 4.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.006 -0.543 . . . . 64.35 109.991 176.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -94.07 89.25 5.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.423 0.63 . . . . 43.22 110.673 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -134.08 116.64 15.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.55 -0.907 . . . . 74.53 108.55 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.5 mmt -54.23 -56.45 18.21 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.561 0.538 . . . . 72.04 111.321 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.6 t -112.62 124.64 69.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.407 -0.59 . . . . 73.01 109.407 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.08 -72.72 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.802 0.334 . . . . 74.32 111.444 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.553 ' HB2' ' OG1' ' A' ' 79' ' ' THR . 80.2 m-20 -135.83 163.39 50.8 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.266 -0.425 . . . . 73.23 109.997 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 10.0 Cg_endo -54.17 143.74 62.12 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.917 2.411 . . . . 61.51 112.321 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 17.4 Cg_exo -67.54 156.15 67.26 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.986 2.458 . . . . 61.35 112.197 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.84 147.52 22.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.078 -0.51 . . . . 72.02 110.443 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -68.23 138.91 55.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.327 -0.397 . . . . 71.25 110.241 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -54.48 -33.58 60.01 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.81 0.338 . . . . 43.35 110.819 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -61.29 -28.12 68.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 64.3 111.159 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.5 t -86.82 -34.54 19.49 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.888 -0.412 . . . . 74.1 109.888 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -67.72 -49.38 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.053 -0.521 . . . . 54.44 110.837 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -72.63 -13.0 61.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 73.12 110.653 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.37 -6.43 58.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 73.25 111.173 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.526 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 84.3 mt -63.22 138.06 97.24 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.4 -0.364 . . . . 24.22 110.667 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 25.3 Cg_endo -61.85 119.06 6.01 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.183 2.589 . . . . 54.01 112.359 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -88.66 105.34 17.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.387 0.613 . . . . 55.24 110.835 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.0 mt -96.41 109.39 22.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.221 -0.9 . . . . 75.33 109.383 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.99 117.38 9.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.086 -0.507 . . . . 74.43 110.052 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 15.7 t -82.17 127.49 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.582 -0.525 . . . . 73.44 109.582 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.5 p -117.3 170.21 8.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.019 -0.537 . . . . 42.34 109.858 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 24.3 mt-10 -85.19 7.64 21.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.655 0.741 . . . . 73.11 109.865 176.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -96.39 -13.35 23.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.043 -0.981 . . . . 62.41 109.139 173.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -132.85 115.65 15.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.258 -0.883 . . . . 75.33 110.577 -173.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.61 -111.07 0.46 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.668 -0.777 . . . . 51.3 112.486 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.93 139.18 58.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.851 0.357 . . . . 75.24 110.975 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.9 t -89.21 -19.18 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.016 -0.538 . . . . 61.05 110.819 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.39 -145.16 7.05 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.646 -0.788 . . . . 71.33 111.968 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -59.99 -49.06 79.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.101 0.476 . . . . 72.12 110.716 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.91 113.4 16.99 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.452 -0.944 . . . . 74.32 108.452 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.7 ptp -101.07 4.67 42.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.262 -0.427 . . . . 71.14 111.893 -171.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.7 m -146.87 171.48 15.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.675 0.274 . . . . 73.51 110.575 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -122.41 91.02 49.41 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.203 -0.453 . . . . 71.5 109.859 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.39 -13.32 32.11 Favored 'Trans proline' 0 N--CA 1.475 0.422 0 C-N-CA 123.384 2.722 . . . . 72.2 113.019 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.3 mt -69.99 -22.28 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.063 0.458 . . . . 72.54 110.59 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 27.4 p -132.85 -14.9 2.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.946 0.351 . . . . 61.34 111.946 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 89.9 m 65.99 21.85 11.28 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 122.761 0.424 . . . . 51.34 111.309 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -104.62 142.3 34.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.22 -0.445 . . . . 75.52 109.832 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -79.04 177.36 8.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.078 0.466 . . . . 70.23 111.008 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.463 ' HB3' HG11 ' A' ' 30' ' ' VAL . 89.5 m-85 -89.64 106.27 18.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.133 0.492 . . . . 74.12 111.425 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 m -131.15 171.42 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.619 -0.719 . . . . 75.52 110.346 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.706 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -62.56 120.91 12.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 73.54 110.545 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.62 -40.92 1.51 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.776 -0.726 . . . . 51.44 112.211 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -86.96 161.52 18.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.629 -0.508 . . . . 73.23 109.629 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.89 122.9 69.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.349 -0.387 . . . . 74.41 110.278 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.1 163.44 13.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.435 -0.348 . . . . 74.33 110.397 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.5 t -144.49 155.51 43.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.955 -0.387 . . . . 54.0 109.955 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.449 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 37.0 tt0 -107.29 117.53 34.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.269 -0.423 . . . . 31.11 110.073 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.76 142.17 32.34 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.308 -0.627 . . . . 71.15 109.308 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.13 -18.68 24.17 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.369 2.713 . . . . 74.53 112.83 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.6 p -88.32 24.32 1.93 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.243 -0.435 . . . . 74.03 110.899 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.7 m80 66.22 33.7 7.11 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.094 0.558 . . . . 72.12 111.604 171.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -127.35 141.42 51.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.678 0.275 . . . . 73.0 110.859 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.47 133.2 55.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.838 -0.619 . . . . 72.44 110.485 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -143.07 175.18 10.05 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.876 -0.787 . . . . 75.32 108.876 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.647 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 32.3 m170 -82.39 131.49 35.22 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.174 -0.676 . . . . 61.4 109.174 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 85.2 tttt -60.1 -49.52 90.58 Favored Pre-proline 0 C--N 1.323 -0.568 0 O-C-N 123.377 0.423 . . . . 70.31 111.892 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 18.4 Cg_endo -60.05 -20.73 62.24 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.013 1.809 . . . . 64.33 112.637 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 60.2 m -83.6 -45.66 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.161 0.505 . . . . 55.42 110.655 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.474 HG22 ' HG ' ' A' ' 74' ' ' LEU . 9.4 p -78.32 -25.66 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 73.42 111.199 -173.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 9.0 p -58.85 -48.76 80.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 71.22 110.97 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.04 -42.82 96.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 65.44 110.372 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -62.88 -43.81 97.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.753 -0.658 . . . . 74.25 111.266 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.474 ' HG ' HG22 ' A' ' 70' ' ' VAL . 93.1 mt -65.55 -24.92 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.515 -0.312 . . . . 63.43 111.599 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 71' ' ' SER . 76.3 mt-30 -75.49 -23.44 56.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.979 0.418 . . . . 64.03 110.427 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -85.36 -48.08 9.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.35 0.595 . . . . 64.04 109.487 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.7 p -158.51 123.88 4.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.281 -0.872 . . . . 73.32 109.891 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.46 74.85 2.03 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.64 -0.79 . . . . 73.33 111.834 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 14' ' ' ASN . 5.3 m -149.24 138.44 21.45 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.768 -0.254 . . . . 71.31 110.468 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 37.6 t -75.05 112.54 18.54 Favored Pre-proline 0 C--O 1.222 -0.387 0 N-CA-C 109.855 -0.424 . . . . 74.12 109.855 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.48 -38.48 64.08 Favored 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 123.13 2.553 . . . . 72.35 113.571 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.18 -31.81 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.852 0.686 . . . . 72.13 112.852 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.7 p -124.41 -16.23 6.42 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.315 -0.554 . . . . 64.14 111.894 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.509 ' HA ' HG22 ' A' ' 79' ' ' THR . 60.3 mtt180 69.4 26.24 5.3 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.222 0.609 . . . . 54.34 110.884 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.19 131.15 38.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.965 -0.754 . . . . 73.51 108.965 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 62.8 ttp -72.49 142.84 48.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.433 -0.348 . . . . 74.55 110.571 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.476 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 79.4 t80 -127.45 126.1 24.02 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.424 -0.584 . . . . 71.31 109.424 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 33.8 Cg_endo -65.24 155.39 77.51 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 123.597 -1.418 . . . . 65.3 112.68 1.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.38 142.89 21.57 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.465 2.777 . . . . 75.04 112.853 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.64 144.02 97.12 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.822 2.348 . . . . 64.34 112.155 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.454 -0.784 . . . . 71.15 110.119 -176.655 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.497 0.189 . . . . 73.31 111.012 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 53.31 -103.94 0.17 Allowed Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.816 -0.629 . . . . 74.24 114.261 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -80.94 122.56 27.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.999 0.428 . . . . 71.33 111.431 -174.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.89 -29.94 44.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.005 -0.739 . . . . 72.23 109.005 170.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -85.0 83.08 8.18 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.715 -1.217 . . . . 72.0 107.715 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -71.9 -27.78 63.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.434 -0.803 . . . . 73.25 109.717 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -85.56 178.98 7.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.5 -0.773 . . . . 73.52 109.0 172.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -99.01 95.13 6.93 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.396 -0.522 . . . . 72.5 109.813 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 m -70.49 141.66 51.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.564 -0.744 . . . . 72.3 110.765 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -114.97 85.29 2.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.798 0.809 . . . . 63.44 110.136 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.6 mtp -113.17 106.09 14.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.268 -0.878 . . . . 72.44 109.545 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.1 t -115.59 -74.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.847 -0.615 . . . . 60.31 110.864 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.73 122.52 17.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.016 -0.538 . . . . 72.34 110.076 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -96.85 136.54 21.59 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.912 -0.586 . . . . 65.54 110.372 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 90.1 Cg_endo -84.0 150.99 12.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.752 2.301 . . . . 60.45 112.576 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.83 143.08 99.43 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.954 2.436 . . . . 74.42 112.228 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.15 150.99 41.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.89 -0.595 . . . . 74.31 111.276 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 22' ' ' ILE . 17.7 m -69.2 132.45 46.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.877 -0.601 . . . . 61.22 110.171 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -61.68 -36.66 81.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 73.15 112.09 -172.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -70.09 -36.98 75.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 74.13 110.389 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m -65.97 -29.14 69.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 53.04 110.566 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 18' ' ' SER . 69.5 mt -69.88 -40.7 79.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 72.13 110.713 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.505 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 34.1 t70 -70.93 -26.18 63.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.849 -0.341 . . . . 74.1 110.525 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -16.01 64.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 71.33 111.733 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.43 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 94.2 mt -63.2 141.84 97.77 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.383 -0.371 . . . . 65.34 110.798 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.68 129.39 26.19 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.059 2.506 . . . . 64.53 112.527 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -92.23 116.77 29.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.059 -0.518 . . . . 75.51 110.102 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.1 mt -114.44 130.27 69.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.142 -0.481 . . . . 73.14 109.833 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.4 tp -77.21 126.05 30.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.97 0.415 . . . . 73.42 110.317 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 53.5 t -82.12 134.14 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.012 -0.54 . . . . 70.32 110.046 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 20.4 p -126.17 126.86 44.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.311 -0.404 . . . . 72.24 110.57 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.695 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 10.7 pt-20 -80.64 -9.7 59.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 75.33 111.408 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.35 -2.05 56.45 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.199 -0.667 . . . . 74.11 109.199 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -113.97 118.4 34.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.978 -1.119 . . . . 64.12 107.978 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -41.49 -50.95 4.69 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 114.86 0.704 . . . . 71.2 114.86 -171.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -159.17 134.96 8.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.979 0.39 . . . . 32.44 110.6 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.2 t -85.41 73.25 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.935 0.398 . . . . 70.53 110.696 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.47 18.62 56.31 Favored Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.741 -0.663 . . . . 72.21 113.605 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.604 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 44.4 tp60 -159.06 171.99 18.98 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.756 -0.831 . . . . 74.52 108.756 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.24 144.83 39.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.063 -0.347 . . . . 71.25 110.063 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.1 ptp -76.37 22.45 0.17 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.091 0.404 . . . . 63.24 112.091 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.8 m -134.23 127.37 31.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.755 0.312 . . . . 35.24 110.551 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 41.3 t -96.64 106.88 33.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.571 -0.529 . . . . 54.12 109.571 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 12.0 Cg_endo -55.92 -33.69 89.66 Favored 'Trans proline' 0 N--CA 1.474 0.328 0 C-N-CA 123.254 2.636 . . . . 64.24 113.071 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.56 -20.21 22.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.174 0.512 . . . . 63.23 110.845 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 88.3 m -108.12 -30.18 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 63.54 111.659 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.7 t 70.0 17.73 7.33 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.875 0.734 . . . . 55.31 109.449 -171.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -124.28 161.57 25.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.253 -0.885 . . . . 74.54 110.673 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -85.12 -178.32 6.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 71.53 111.798 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.447 ' HB3' ' CG1' ' A' ' 30' ' ' VAL . 47.3 m-85 -94.47 109.16 21.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.701 -0.681 . . . . 71.31 110.93 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.688 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . 27.0 m -107.64 165.0 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.984 -0.553 . . . . 75.54 110.87 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.695 ' HB2' ' H ' ' A' ' 32' ' ' GLU . 28.1 ttpp -78.41 117.47 19.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.884 0.373 . . . . 75.11 110.725 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.82 -7.23 10.24 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.846 -0.615 . . . . 41.31 111.628 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -84.31 158.58 21.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.407 -0.59 . . . . 64.45 109.407 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.3 116.67 53.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.886 0.374 . . . . 71.44 110.63 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.31 167.68 10.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.075 -0.512 . . . . 55.51 110.551 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 14.0 t -149.26 157.96 43.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.011 -0.54 . . . . 64.43 109.645 176.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -108.4 117.63 34.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.344 -0.389 . . . . 53.21 110.126 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.85 150.12 88.21 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.912 -0.585 . . . . 62.11 109.458 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.16 -14.33 23.39 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.135 2.556 . . . . 71.21 112.855 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 23.9 p -91.93 15.0 14.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.384 -0.371 . . . . 72.4 110.334 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 60.14 74.78 0.43 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.329 0.585 . . . . 73.04 110.974 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -157.22 127.81 6.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.472 -0.785 . . . . 62.32 109.674 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 57' ' ' THR . 85.6 m-85 -97.93 133.21 42.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.025 -0.534 . . . . 73.24 110.693 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.33 174.84 10.25 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.867 -1.16 . . . . 74.4 107.867 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.835 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 34.1 m170 -86.29 128.58 34.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.912 -0.773 . . . . 64.11 108.912 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.531 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 87.4 tttt -53.03 -48.3 92.46 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.546 0.529 . . . . 73.41 111.914 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 76.1 Cg_exo -53.7 -45.0 44.25 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.33 2.02 . . . . 73.15 113.851 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.835 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 19.7 p -84.51 -33.67 23.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.398 -0.521 . . . . 70.34 112.209 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 67' ' ' LYS . 9.8 p -72.24 -28.7 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.817 -0.353 . . . . 72.22 110.765 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.3 p -63.96 -26.91 68.8 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.052 0.453 . . . . 71.32 110.83 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.92 -54.16 18.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 73.33 110.017 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -62.63 -33.62 75.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.053 -0.521 . . . . 73.53 111.477 -176.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 84.6 mt -66.74 -23.93 66.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.599 -0.273 . . . . 63.11 111.315 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -89.59 -11.29 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.212 0.529 . . . . 63.02 110.364 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -95.28 -57.17 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.815 -0.629 . . . . 75.23 110.761 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.2 t -110.83 -33.95 6.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.926 -0.579 . . . . 64.05 110.929 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.02 17.58 71.88 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.689 -0.767 . . . . 54.42 112.103 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 86' ' ' MET . 3.5 m -128.41 153.16 47.38 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.922 -0.399 . . . . 44.02 109.922 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.8 t -74.61 110.24 9.2 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.809 -0.811 . . . . 63.34 108.809 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.8 -25.93 63.75 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.174 2.582 . . . . 54.25 113.064 -171.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.73 -50.87 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.352 -0.386 . . . . 74.22 111.934 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.1 p -109.94 -2.55 17.08 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.267 0.469 . . . . 73.2 112.267 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? 66.53 21.57 10.74 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.29 0.478 . . . . 74.5 112.29 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.7 t -85.29 126.86 34.05 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.293 -0.632 . . . . 73.53 109.293 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.508 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 59.8 ttp -72.43 153.23 41.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.346 -0.388 . . . . 70.24 111.104 -176.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -124.77 118.61 25.84 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.563 -0.532 . . . . 74.24 109.563 173.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.34 156.76 96.6 Favored 'Cis proline' 0 C--N 1.344 0.322 0 C-N-CA 123.702 -1.374 . . . . 55.45 112.345 -0.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.24 139.6 63.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.081 2.521 . . . . 74.11 112.733 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 40.3 Cg_endo -65.64 141.7 67.61 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.72 2.28 . . . . 71.33 112.381 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.602 -0.713 . . . . 61.42 110.138 -177.112 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.575 -0.528 . . . . 55.14 109.575 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.14 107.65 3.57 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.889 -0.672 . . . . 64.04 112.153 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -88.54 108.65 19.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.374 0.607 . . . . 45.13 110.804 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -149.44 99.19 2.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.448 -0.796 . . . . 72.51 109.541 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -102.72 -44.99 5.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.146 -0.479 . . . . 64.12 110.695 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.9 m170 -116.92 158.18 24.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.867 -0.606 . . . . 72.22 109.424 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -129.46 59.64 1.59 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.351 0.596 . . . . 75.44 111.465 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -85.8 97.2 10.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.869 -0.605 . . . . 75.43 109.413 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.3 p -76.02 124.9 28.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.607 -0.724 . . . . 74.0 111.662 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -130.54 91.13 3.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.498 -0.927 . . . . 74.44 108.498 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -63.45 -24.52 67.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 63.32 112.434 -171.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.48 92.05 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.165 0.507 . . . . 74.41 109.847 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.94 -18.06 14.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.8 -0.636 . . . . 52.42 110.996 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 68.29 152.07 0.13 Allowed Pre-proline 0 N--CA 1.468 0.439 0 O-C-N 123.854 0.722 . . . . 73.52 111.511 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.01 150.64 83.14 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.36 2.04 . . . . 74.01 111.856 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.29 146.41 90.06 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.844 2.363 . . . . 61.53 112.142 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 168.11 20.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.145 0.498 . . . . 64.01 111.622 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 m -78.09 150.89 33.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 53.41 110.826 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -62.37 -39.23 92.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.054 -0.521 . . . . 75.34 110.452 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.83 -35.01 79.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.71 -0.677 . . . . 75.34 111.332 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 m -61.84 -44.81 96.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 65.35 110.282 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.583 HG21 ' HA ' ' A' ' 71' ' ' SER . 25.9 mt -75.15 -38.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.738 -0.665 . . . . 71.44 110.521 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.3 -31.22 72.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.434 -0.803 . . . . 73.24 110.982 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.76 -21.68 60.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.845 -0.616 . . . . 71.03 111.576 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.44 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 98.0 mt -63.76 132.46 95.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 73.33 110.902 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.08 137.06 55.21 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.16 2.573 . . . . 73.14 112.864 -175.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.51 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 44.2 mt-10 -90.17 116.52 28.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.187 0.518 . . . . 64.42 110.751 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -109.15 129.47 63.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.315 -0.857 . . . . 72.2 109.681 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.7 tp -80.13 122.03 26.29 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.017 -0.364 . . . . 72.23 110.017 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 41.9 t -79.14 123.46 36.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.27 -0.423 . . . . 70.04 110.225 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.7 p -119.16 140.86 49.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.148 -0.478 . . . . 63.53 110.332 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 30.5 mt-10 -79.57 177.69 8.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.169 -0.469 . . . . 65.2 110.278 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 1.1 m-20 71.5 8.74 6.31 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.818 0.699 . . . . 71.5 109.807 -168.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -127.58 108.82 11.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.12 -0.945 . . . . 72.02 109.394 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.62 95.03 0.52 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.755 -0.736 . . . . 63.25 112.055 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 72.33 138.34 0.05 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.535 0.734 . . . . 61.52 111.484 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.45 -38.76 83.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 64.12 110.363 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.73 32.01 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.777 -0.725 . . . . 73.52 112.034 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.671 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 56.3 tp60 -172.17 -80.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.732 0.301 . . . . 60.3 110.648 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.75 152.56 35.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.062 -0.517 . . . . 75.34 110.705 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -103.78 3.52 34.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.627 -0.715 . . . . 72.33 110.001 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 30.4 p -124.42 151.86 43.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.032 -0.531 . . . . 74.41 110.03 175.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 50.4 t -116.7 101.99 53.37 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.444 -0.576 . . . . 75.31 109.444 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -56.92 -28.57 78.29 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.116 2.544 . . . . 73.12 112.622 -173.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.4 mt -67.0 -32.14 56.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.748 -0.66 . . . . 72.53 111.618 -175.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.7 p -113.89 -4.21 13.32 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.987 -0.285 . . . . 73.24 111.22 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.8 t 67.93 4.06 3.84 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.782 -0.645 . . . . 61.13 111.256 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.8 m -105.92 163.76 12.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.8 0.333 . . . . 51.12 110.332 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.8 OUTLIER -91.71 -170.22 2.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.049 0.452 . . . . 74.43 110.89 -177.424 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.644 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 29.9 m-85 -94.47 108.84 20.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.092 -0.503 . . . . 73.21 111.397 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.31 166.72 7.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.337 -0.847 . . . . 75.11 109.612 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 39.5 ttpt -73.37 138.38 45.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.943 0.401 . . . . 74.44 110.769 -176.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.9 -9.32 47.12 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.993 -0.623 . . . . 62.31 112.342 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.78 162.06 18.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.76 -0.459 . . . . 71.51 109.76 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -110.31 122.62 65.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.846 0.355 . . . . 63.2 110.319 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -112.21 171.02 7.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.864 0.364 . . . . 75.03 110.448 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 7.2 t -148.84 168.57 22.63 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.684 -0.488 . . . . 63.52 109.684 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -113.36 117.32 31.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.817 0.341 . . . . 73.12 110.942 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.05 138.23 39.95 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.188 -0.671 . . . . 54.55 109.188 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.02 -19.27 19.42 Favored 'Trans proline' 0 N--CA 1.474 0.325 0 C-N-CA 123.708 2.938 . . . . 64.21 113.158 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.1 p -86.42 22.55 1.81 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.744 0.307 . . . . 74.11 110.682 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 65.3 36.71 6.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.274 0.559 . . . . 61.31 111.711 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.671 ' HD2' ' HG2' ' A' ' 39' ' ' GLN . 4.8 m170 -125.11 122.62 37.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.888 -0.596 . . . . 73.44 110.315 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -99.0 133.13 43.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.239 -0.437 . . . . 71.14 110.124 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.644 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 72.9 m-85 -144.16 161.1 39.71 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.535 0.522 . . . . 73.4 110.261 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 38.2 m170 -61.88 121.26 12.49 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.367 -0.605 . . . . 72.05 109.367 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.6 tttt -58.78 -49.89 90.98 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 123.235 0.334 . . . . 70.1 111.676 -176.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 9.6 Cg_endo -53.91 -27.48 44.6 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.356 2.037 . . . . 72.41 112.613 176.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 68.2 m -82.89 -52.42 6.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 73.21 110.809 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 67' ' ' LYS . 7.1 p -69.95 -27.39 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 50.41 111.252 -173.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.583 ' HA ' HG21 ' A' ' 22' ' ' ILE . 18.4 p -64.47 -46.75 81.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.798 0.332 . . . . 72.14 110.579 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.508 HG22 ' HE2' ' A' ' 76' ' ' LYS . 75.1 mt -63.73 -37.85 80.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.152 -0.476 . . . . 73.41 110.291 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -64.65 -51.98 59.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 71.23 111.317 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.9 -24.38 66.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.388 -0.369 . . . . 72.12 111.664 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -77.5 -0.65 26.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.021 0.438 . . . . 75.34 110.756 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.508 ' HE2' HG22 ' A' ' 72' ' ' ILE . 56.5 mttm -113.46 -52.26 2.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 73.42 109.856 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.1 m -132.87 125.64 30.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.046 -0.525 . . . . 64.4 110.035 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.7 57.25 4.68 Favored Glycine 0 CA--C 1.516 0.148 0 C-N-CA 120.951 -0.642 . . . . 70.12 112.899 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 84' ' ' ARG . 39.5 m -145.77 149.21 33.96 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.283 -0.266 . . . . 75.12 110.283 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.6 t -74.41 118.08 67.02 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.926 -0.768 . . . . 71.24 108.926 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.4 -24.84 54.3 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.295 2.663 . . . . 71.22 113.477 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.28 -61.16 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.425 -0.352 . . . . 50.23 111.853 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.9 p -90.04 -1.11 57.91 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.906 0.336 . . . . 63.12 111.906 -172.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.412 ' HA ' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER 47.58 39.94 10.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.619 0.768 . . . . 75.51 111.913 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.12 148.7 22.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.73 -0.841 . . . . 73.2 108.73 170.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.5 ttp -74.19 145.75 43.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.03 0.443 . . . . 31.11 111.839 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.542 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 57.6 t80 -129.2 131.05 23.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.837 -0.801 . . . . 72.54 108.837 172.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 31.0 Cg_endo -62.86 159.67 60.45 Favored 'Cis proline' 0 C--N 1.347 0.472 0 C-N-CA 124.067 -1.222 . . . . 74.03 112.984 2.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.5 138.75 74.85 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.193 2.595 . . . . 74.03 112.818 -175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.22 151.74 84.16 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.699 2.266 . . . . 63.2 112.314 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.628 -0.701 . . . . 73.25 109.913 -179.717 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.717 0.294 . . . . 73.41 110.603 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.99 64.78 4.01 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.725 -0.75 . . . . 52.3 113.205 -173.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -100.68 119.45 38.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.017 0.437 . . . . 72.04 110.266 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -143.45 146.67 33.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.925 -0.58 . . . . 74.42 109.719 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -126.72 73.45 1.4 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.283 0.563 . . . . 72.41 111.526 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -134.2 10.07 3.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.541 -0.754 . . . . 74.12 109.208 172.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -128.56 127.52 42.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.085 -0.961 . . . . 74.12 109.886 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -153.82 158.92 41.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.167 -0.679 . . . . 74.1 109.167 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 m -61.77 94.71 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.917 0.389 . . . . 53.11 111.683 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -64.47 -29.02 70.07 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.704 0.764 . . . . 75.22 109.428 173.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 84' ' ' ARG . 1.3 pmm? -98.74 38.09 1.41 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.704 -1.135 . . . . 71.12 110.541 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.88 -35.51 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.794 -0.639 . . . . 63.21 111.126 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.72 -61.86 1.04 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.321 -0.4 . . . . 73.25 110.029 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.7 t30 73.05 129.8 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.421 0 O-C-N 124.012 0.82 . . . . 72.03 111.65 176.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 14' ' ' ASN . 16.8 Cg_exo -67.75 166.09 25.48 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.107 2.538 . . . . 74.13 112.782 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HA ' ' H ' ' A' ' 78' ' ' GLY . 11.4 Cg_exo -71.46 168.22 24.16 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.732 2.288 . . . . 72.21 111.965 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.54 179.95 6.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.54 -0.3 . . . . 65.2 110.567 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 p -102.27 162.1 13.18 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.934 -0.395 . . . . 75.33 109.934 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -64.05 -43.9 94.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.969 0.414 . . . . 70.55 110.017 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -58.69 -47.28 85.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.414 -0.812 . . . . 72.52 112.063 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 p -64.17 -41.68 97.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.311 . . . . 73.41 110.978 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.62 -41.06 85.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.206 0.527 . . . . 74.3 110.584 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.1 -36.39 81.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 74.33 110.637 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.01 -6.25 51.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 50.21 112.187 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.463 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 34.5 mt -53.84 127.72 53.26 Favored Pre-proline 0 C--O 1.237 0.43 0 O-C-N 122.994 0.184 . . . . 75.03 111.2 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 9.8 Cg_endo -53.77 142.5 62.24 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.377 2.718 . . . . 52.44 111.694 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -113.85 106.48 14.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.099 0.476 . . . . 74.2 111.158 -173.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.5 mt -110.78 111.58 36.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.865 -0.607 . . . . 74.33 109.979 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.7 117.14 10.03 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.894 -0.41 . . . . 63.45 109.894 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 35.7 t -75.74 118.14 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.312 -0.404 . . . . 65.33 110.785 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.2 p -120.76 167.81 12.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.455 -0.572 . . . . 71.01 109.455 173.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.21 4.18 15.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.942 0.401 . . . . 72.44 111.123 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -80.26 -45.5 17.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.544 . . . . 73.23 110.333 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -77.92 -34.99 51.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 73.34 110.387 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.35 -115.77 4.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.004 -0.617 . . . . 53.35 111.706 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.0 141.64 57.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.622 -0.51 . . . . 71.51 109.622 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.21 90.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.504 -0.478 . . . . 61.34 111.234 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.511 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . 76.07 -73.54 1.73 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.565 -0.743 . . . . 64.31 113.337 171.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.526 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 61.4 tp60 -107.89 -49.24 3.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.637 0.256 . . . . 71.24 110.91 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.4 158.55 37.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.357 0.599 . . . . 60.34 111.585 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.1 ptp -103.22 -5.77 22.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.162 -0.926 . . . . 73.35 109.902 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.827 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 85.1 m -128.14 137.92 52.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.802 -0.635 . . . . 71.23 110.421 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -93.36 112.49 56.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.04 -0.527 . . . . 62.0 109.974 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -60.77 -33.52 92.86 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.619 2.213 . . . . 72.44 111.94 -176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.49 -22.87 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.663 -0.698 . . . . 71.21 110.686 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 79.8 m -107.94 -19.36 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.979 -0.555 . . . . 44.32 111.201 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.4 m 60.8 29.27 18.9 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.48 0.657 . . . . 50.43 109.537 -170.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.6 t -141.16 155.38 46.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.254 -0.885 . . . . 71.41 109.514 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.827 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 10.7 pt-20 -77.75 -179.75 6.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.334 0.587 . . . . 72.54 111.783 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.512 ' HB3' HG11 ' A' ' 30' ' ' VAL . 73.8 m-85 -91.87 112.52 24.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.647 -0.706 . . . . 72.35 110.383 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.69 169.49 11.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 70.24 110.632 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 24.9 ttpp -72.99 113.66 10.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.74 -0.664 . . . . 74.31 110.961 -176.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.56 -36.5 1.54 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.581 -0.818 . . . . 54.11 112.758 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -87.14 162.17 17.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.12 -0.326 . . . . 72.22 110.12 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.75 129.49 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.58 -0.282 . . . . 72.34 110.38 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -101.22 163.41 12.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.825 0.345 . . . . 75.11 110.965 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 8.7 t -147.68 170.07 18.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.879 -0.601 . . . . 71.42 109.585 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 25.5 tt0 -123.39 123.24 40.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.535 -0.302 . . . . 74.42 110.694 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 61' ' ' CYS . 77.1 mt -86.02 141.16 35.18 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.416 -0.957 . . . . 73.31 108.416 169.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.93 36.19 0.17 Allowed 'Trans proline' 0 N--CA 1.479 0.623 0 C-N-CA 123.636 2.891 . . . . 52.54 113.922 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.405 ' H ' ' C ' ' A' ' 59' ' ' LEU . 29.5 p -140.06 28.07 2.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.388 -0.597 . . . . 63.0 109.388 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.8 m170 63.71 34.66 11.98 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.429 -0.805 . . . . 75.22 111.924 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.526 ' HD2' ' HG2' ' A' ' 39' ' ' GLN . 11.2 m170 -125.86 120.69 31.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.476 -0.329 . . . . 64.02 110.408 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.511 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 57.7 m-85 -101.88 137.17 40.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.954 -0.566 . . . . 72.24 111.29 -176.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.482 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 97.0 m-85 -140.72 175.36 9.67 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.738 -0.838 . . . . 74.02 108.738 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.88 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 39.1 m80 -82.61 131.79 35.2 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.172 -0.677 . . . . 61.24 109.172 173.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.53 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 86.7 tttt -55.61 -49.31 93.42 Favored Pre-proline 0 CA--C 1.539 0.532 0 O-C-N 123.49 0.494 . . . . 61.34 111.313 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 83.0 Cg_exo -51.23 -50.42 13.96 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.257 1.971 . . . . 72.41 113.52 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.88 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 21.9 p -79.69 -31.54 41.32 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.743 -0.383 . . . . 75.13 111.876 -174.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 67' ' ' LYS . 7.8 p -74.27 -28.81 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.719 -0.474 . . . . 75.23 109.719 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.706 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 27.7 t -58.46 -48.15 81.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.518 -0.549 . . . . 72.51 109.518 174.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -60.17 -40.78 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.651 -0.704 . . . . 72.11 110.705 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -67.43 -48.33 67.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.593 -0.731 . . . . 73.32 111.498 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 77' ' ' SER . 97.2 mt -67.25 -20.51 65.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.395 -0.366 . . . . 73.53 111.93 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.706 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.3 mt-30 -59.98 -40.29 88.6 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.581 -0.281 . . . . 74.0 111.391 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.77 -27.51 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.907 -0.317 . . . . 63.21 111.222 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 12.7 p -143.88 111.2 5.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.74 0.305 . . . . 64.42 110.872 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' H ' ' HA ' ' A' ' 16' ' ' PRO . . . -82.56 65.46 4.1 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.187 -0.765 . . . . 54.22 111.187 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 m -143.5 145.4 32.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.645 -0.278 . . . . 65.13 110.383 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.5 t -74.88 113.64 26.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.79 -0.819 . . . . 64.41 108.79 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.34 -34.2 79.49 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.036 2.49 . . . . 72.45 113.76 -172.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -75.13 -62.98 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.069 0.396 . . . . 71.11 112.069 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.3 p -89.12 -18.11 27.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 52.51 111.346 -173.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 11' ' ' MET . 17.3 mtp180 63.4 71.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.801 0.81 . . . . 62.32 110.557 -175.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t -128.81 142.58 50.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.637 -1.165 . . . . 73.43 108.067 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.531 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 61.8 ttp -68.05 149.07 50.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.989 0.423 . . . . 64.12 111.147 -174.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -127.97 121.18 21.74 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.636 -0.711 . . . . 71.01 109.39 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.61 157.83 77.21 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 124.048 -1.23 . . . . 73.31 112.855 0.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.48 135.29 63.8 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.993 2.462 . . . . 73.12 112.612 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 43.3 Cg_endo -68.44 147.47 71.24 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.867 2.378 . . . . 72.33 112.488 -177.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.322 -0.846 . . . . 74.14 109.302 177.895 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.782 0.325 . . . . 72.21 110.712 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.68 140.07 5.28 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.001 -0.619 . . . . 72.13 112.499 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -102.23 169.67 8.57 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.415 -0.217 . . . . 71.11 110.415 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -155.69 145.18 21.03 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.009 -0.367 . . . . 74.11 110.009 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -101.58 -169.77 1.73 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.862 -0.421 . . . . 73.2 109.862 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -100.8 167.74 10.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.104 -0.702 . . . . 72.21 109.104 172.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -82.17 153.05 26.19 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.302 -0.999 . . . . 75.01 108.302 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -74.9 80.96 2.15 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.726 -0.842 . . . . 72.1 108.726 176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 t -46.86 -48.36 21.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.784 -1.098 . . . . 74.21 112.105 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -125.17 110.52 14.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.212 0.53 . . . . 52.31 110.219 174.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -125.6 148.73 48.85 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.131 -0.941 . . . . 63.01 109.532 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 14' ' ' ASN . 14.5 p -131.08 128.89 62.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.075 0.464 . . . . 72.21 110.9 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.19 63.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 63.12 109.419 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.475 ' N ' HG22 ' A' ' 12' ' ' VAL . 22.9 t-20 71.67 136.37 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 114.846 -1.07 . . . . 72.54 112.004 172.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 14' ' ' ASN . 31.7 Cg_exo -60.97 159.45 29.5 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.06 2.507 . . . . 50.03 112.796 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.57 141.76 38.82 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.169 1.913 . . . . 71.25 112.106 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -81.75 149.21 28.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.991 -0.55 . . . . 44.1 110.167 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -58.97 116.44 3.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.259 -0.428 . . . . 70.11 110.478 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' A' ' 22' ' ' ILE . 6.5 ttpm? -56.8 -45.32 82.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.711 -0.677 . . . . 75.13 111.518 -176.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -54.93 -37.85 66.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.624 -0.716 . . . . 70.44 111.307 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.4 t -67.63 -41.02 84.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.076 0.465 . . . . 70.24 110.106 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 71' ' ' SER . 61.1 mt -62.61 -39.72 85.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.683 -0.689 . . . . 64.1 110.932 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -75.06 -29.18 60.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 44.01 110.759 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -12.81 60.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.332 -0.395 . . . . 73.11 111.517 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.11 145.54 85.01 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 116.409 -0.36 . . . . 72.4 111.044 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.88 160.37 49.92 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.914 2.409 . . . . 72.22 112.381 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -108.36 112.82 25.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.189 -0.459 . . . . 71.31 110.326 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.7 mt -101.68 101.74 12.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.247 -0.649 . . . . 74.44 109.247 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.55 122.54 19.25 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.813 -0.44 . . . . 64.45 109.813 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.747 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 21.4 t -77.46 105.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.123 -0.489 . . . . 62.54 110.134 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.4 p -103.68 168.2 9.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.783 -0.451 . . . . 73.5 109.783 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -76.82 -22.25 53.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.07 0.462 . . . . 74.43 110.303 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.81 -28.31 58.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.006 -0.543 . . . . 74.42 109.943 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -84.62 -44.3 13.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 74.32 109.527 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.2 -110.87 3.36 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.9 -0.591 . . . . 75.3 112.729 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.64 103.39 3.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.002 0.43 . . . . 72.11 110.376 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.2 t -68.64 -30.33 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.011 -0.541 . . . . 74.31 110.928 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 64' ' ' TYR . . . -149.89 -150.27 5.22 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.79 -0.719 . . . . 64.32 111.898 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -82.04 -24.19 35.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.672 -0.492 . . . . 71.5 109.672 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -83.99 111.79 19.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.866 -0.606 . . . . 61.24 109.75 172.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -91.28 -0.09 57.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 53.11 110.316 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 70.7 m -141.2 149.73 41.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.778 -0.647 . . . . 64.04 110.338 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 36.9 t -104.73 96.12 9.99 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.359 -0.608 . . . . 73.04 109.359 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 18.5 Cg_endo -57.27 -27.26 74.28 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.466 2.777 . . . . 61.22 112.935 -172.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.1 mt -57.74 -43.78 84.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 72.33 111.212 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.8 p -108.44 -3.23 18.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.565 -0.289 . . . . 74.34 110.713 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.1 m 60.87 40.2 15.99 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.834 -0.621 . . . . 72.45 110.716 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.9 m -135.94 146.55 47.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 75.3 110.47 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 15.4 pt-20 -81.88 -169.86 2.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 72.45 111.735 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.637 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.5 m-85 -102.97 108.77 20.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.201 0.524 . . . . 72.02 111.604 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 m -134.64 173.07 15.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.333 -0.849 . . . . 64.42 109.546 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.747 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 31.0 ttmt -64.54 125.76 25.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.042 0.448 . . . . 72.52 111.097 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.41 -42.73 1.27 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.563 -0.744 . . . . 64.53 111.731 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -86.68 165.88 15.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.875 -0.417 . . . . 64.01 109.875 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.0 133.7 65.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.684 -0.487 . . . . 75.22 109.684 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -111.76 176.01 5.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.897 0.38 . . . . 75.31 110.618 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.4 t -150.35 163.06 39.29 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.544 -0.539 . . . . 53.42 109.544 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -107.86 117.34 33.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.765 0.317 . . . . 74.35 110.667 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.8 mt -84.32 137.34 39.59 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.957 -0.757 . . . . 63.43 108.957 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.81 -8.19 7.22 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.89 2.393 . . . . 75.33 111.905 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.8 t -84.66 18.24 2.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.043 -0.98 . . . . 70.41 110.046 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 57.18 39.43 28.86 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.907 -0.588 . . . . 70.55 111.147 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -138.61 144.99 40.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.716 -0.674 . . . . 61.12 109.957 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.47 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 49.3 m-85 -121.12 132.86 55.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.794 0.33 . . . . 64.02 111.248 -172.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.637 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 89.6 m-85 -142.58 162.78 34.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 73.11 110.35 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 35.0 m170 -63.83 129.38 39.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.615 -0.513 . . . . 62.25 109.615 174.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.501 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 48.3 tttm -60.62 -51.7 77.93 Favored Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 123.326 0.391 . . . . 75.15 111.622 -175.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 27.5 Cg_endo -62.22 -22.0 73.45 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.127 1.885 . . . . 64.4 112.925 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.2 m -84.21 -46.99 11.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.225 0.536 . . . . 74.22 110.464 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.546 HG22 ' HG ' ' A' ' 74' ' ' LEU . 5.8 p -73.62 -23.78 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.786 -0.643 . . . . 75.42 110.717 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.52 ' HA ' HG21 ' A' ' 22' ' ' ILE . 19.3 p -65.74 -30.52 71.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.338 . . . . 51.25 111.083 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.92 -41.38 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 73.22 109.989 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -63.11 -47.53 82.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.448 -0.796 . . . . 74.11 111.783 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.546 ' HG ' HG22 ' A' ' 70' ' ' VAL . 98.2 mt -65.82 -20.56 66.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.342 0.497 . . . . 75.23 112.342 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 71' ' ' SER . 71.0 mt-30 -77.09 -9.59 58.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.183 0.516 . . . . 63.12 110.496 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -113.07 -42.27 3.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.61 . . . . 74.4 109.896 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -142.4 110.05 5.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.671 -0.695 . . . . 62.13 109.954 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.08 65.85 3.71 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 51.42 112.122 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.503 ' HB ' ' HA ' ' A' ' 84' ' ' ARG . 1.4 p -149.29 157.54 43.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.453 0.168 . . . . 73.03 110.991 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 44.1 m -74.45 123.09 88.87 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 108.308 -0.997 . . . . 75.42 108.308 169.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.468 ' HD2' ' CZ ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -53.22 -27.96 40.14 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.466 2.111 . . . . 74.25 112.474 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.9 t -80.23 -41.02 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.706 -0.679 . . . . 71.35 112.449 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 12.8 p -110.03 -30.15 7.91 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.699 -0.401 . . . . 73.25 111.857 -172.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.503 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 56.5 mtt85 57.23 77.14 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.749 0.785 . . . . 61.22 111.879 -168.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.2 t -131.93 140.75 49.12 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.838 -1.171 . . . . 73.51 107.838 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.5 ttp -73.97 131.53 41.5 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.988 0.736 . . . . 71.25 112.988 -165.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 88' ' ' PRO . 70.9 t80 -122.87 134.92 25.31 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.71 -1.132 . . . . 62.05 108.805 172.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 87' ' ' PHE . 9.5 Cg_exo -72.12 154.98 98.48 Favored 'Cis proline' 0 C--N 1.343 0.27 0 C-N-CA 123.855 -1.31 . . . . 73.11 112.186 -0.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.55 136.93 77.36 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.733 2.289 . . . . 71.13 112.03 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.62 153.17 76.7 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.954 2.436 . . . . 73.52 112.691 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.35 -0.833 . . . . 52.13 109.629 179.674 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.505 ' SD ' ' HA ' ' A' ' 48' ' ' SER . 24.3 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.651 0.262 . . . . 74.13 110.93 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.62 ' HA3' ' SG ' ' A' ' 47' ' ' CYS . . . -91.2 100.57 2.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.745 -0.741 . . . . 64.0 111.67 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -73.6 -33.66 64.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.66 0.267 . . . . 73.13 110.624 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -154.87 157.14 37.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.267 -0.424 . . . . 75.45 110.43 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -168.27 145.2 4.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.443 -0.577 . . . . 63.33 109.443 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -72.16 104.89 3.78 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.136 -0.32 . . . . 72.14 110.136 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -134.32 83.91 2.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.91 0.862 . . . . 72.32 112.403 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -129.62 55.46 1.77 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.305 -1.369 . . . . 71.14 107.305 165.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.9 p -99.12 -179.27 4.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.422 -1.263 . . . . 51.3 111.895 -169.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -138.14 122.3 18.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.281 -0.872 . . . . 74.31 109.526 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 54.2 ttp -71.42 112.01 7.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.306 -0.406 . . . . 70.31 110.138 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.71 126.62 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.987 -0.551 . . . . 74.1 111.624 -176.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.18 85.3 7.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.982 -0.748 . . . . 64.35 108.982 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -128.17 146.67 60.36 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.413 -0.812 . . . . 64.11 109.982 -170.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 2.2 Cg_endo -42.15 127.66 4.05 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.631 2.887 . . . . 73.21 112.632 175.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 92.3 Cg_endo -87.51 157.66 7.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.9 2.4 . . . . 62.12 113.369 -175.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.79 146.76 26.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.605 -0.725 . . . . 31.22 109.921 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 22' ' ' ILE . 14.3 m -73.23 140.28 46.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.266 -0.425 . . . . 74.51 110.201 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 34.7 ttpt -52.81 -44.97 67.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 64.02 111.131 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.14 -40.11 92.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.951 -0.568 . . . . 71.04 110.857 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 m -66.57 -32.88 74.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 62.43 110.799 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.48 HG21 ' HA ' ' A' ' 71' ' ' SER . 54.8 mt -74.42 -39.24 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.37 0.605 . . . . 64.52 110.258 177.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.495 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 32.7 t70 -70.39 -21.41 62.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.957 -0.565 . . . . 75.04 110.667 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.57 -16.12 61.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.551 . . . . 45.23 111.227 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.54 143.01 96.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 64.42 110.84 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.37 136.62 75.6 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.104 2.536 . . . . 73.0 112.244 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -102.15 120.28 40.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.058 -0.519 . . . . 74.32 110.587 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.6 mt -112.08 111.99 38.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.091 -0.504 . . . . 62.34 109.927 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.01 118.8 10.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.86 -0.422 . . . . 64.42 109.86 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 49.0 t -71.23 114.52 9.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.141 -0.481 . . . . 64.32 110.177 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 p -95.36 147.3 23.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.728 -0.669 . . . . 63.25 110.258 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -69.67 -15.51 63.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.776 -0.647 . . . . 73.11 111.303 -174.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.34 -45.55 19.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.455 . . . . 74.11 111.248 -175.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.6 t-80 -74.36 -47.93 31.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 53.53 110.881 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.17 -87.4 0.68 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.88 -0.676 . . . . 73.31 113.032 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 41' ' ' MET . . . -74.45 100.3 3.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.911 0.386 . . . . 63.32 110.96 -177.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.7 t -95.3 118.2 40.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.138 -0.483 . . . . 74.41 110.682 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.91 -64.85 2.36 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.876 -0.678 . . . . 61.32 112.919 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -154.3 -56.96 0.11 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.657 0.265 . . . . 71.14 111.013 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' OE2' ' HB3' ' A' ' 42' ' ' CYS . 30.9 tt0 -101.76 155.01 18.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.248 -0.433 . . . . 70.45 110.054 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.7 pmm? -92.56 5.5 50.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.01 0.433 . . . . 44.44 110.255 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.867 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 19.6 t -130.8 156.0 45.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.885 -0.598 . . . . 73.45 109.926 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 30.8 t -107.35 106.32 58.08 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.703 -0.48 . . . . 71.04 109.703 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.7 Cg_endo -55.46 -29.35 68.5 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.29 2.66 . . . . 51.41 112.725 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -69.22 -27.77 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.083 -0.508 . . . . 74.42 110.74 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 96.5 m -103.49 -23.57 13.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.405 -0.361 . . . . 74.43 111.319 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.62 ' SG ' ' HA3' ' A' ' 2' ' ' GLY . 31.6 t 63.35 22.76 13.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.998 0.904 . . . . 54.3 108.577 -167.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.505 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 15.1 m -131.65 148.4 52.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.453 -1.249 . . . . 70.31 109.519 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.867 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 17.3 pt-20 -81.8 -178.25 6.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.276 0.56 . . . . 64.1 112.358 -172.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -91.04 117.2 29.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.471 -0.786 . . . . 74.22 111.021 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 m -132.42 166.78 28.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 74.41 109.48 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.8 ttpt -65.49 131.91 47.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.933 0.397 . . . . 62.1 110.717 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.43 -34.89 2.94 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.034 -0.603 . . . . 62.13 111.746 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -86.97 161.28 18.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.579 -0.526 . . . . 61.52 109.579 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.79 125.5 72.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.086 -0.339 . . . . 71.31 110.086 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -95.64 165.4 12.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.838 0.351 . . . . 54.51 110.485 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 7.5 t -146.78 172.56 13.45 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.584 -0.524 . . . . 41.25 109.584 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -125.55 117.66 24.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.691 -0.485 . . . . 73.25 109.691 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -90.03 139.51 27.36 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 110.186 -0.301 . . . . 70.11 110.186 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.51 12.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.481 0.778 0 C-N-CA 123.871 3.048 . . . . 75.41 114.623 -172.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -115.03 17.34 16.86 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.593 -0.521 . . . . 64.14 109.593 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 64.12 74.84 0.4 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.258 -0.883 . . . . 63.2 110.481 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -161.66 121.23 2.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.853 -0.612 . . . . 72.01 110.303 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -99.09 133.41 43.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 74.33 110.835 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -144.58 175.35 10.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.418 -0.956 . . . . 72.2 108.418 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.956 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 35.2 m170 -81.71 129.1 34.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.693 -0.854 . . . . 72.14 108.693 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.539 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 85.1 tttt -55.81 -50.99 83.95 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 123.448 0.467 . . . . 74.01 112.125 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 44.4 Cg_exo -58.33 -41.3 67.53 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.611 1.541 . . . . 51.13 113.183 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.956 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 30.2 p -80.95 -32.38 34.5 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.528 -0.469 . . . . 73.34 111.747 -175.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.93 -29.04 24.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.581 -0.526 . . . . 61.53 109.581 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.48 ' HA ' HG21 ' A' ' 22' ' ' ILE . 32.0 t -59.01 -42.49 90.24 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.0 -0.545 . . . . 61.35 109.817 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.418 ' O ' ' HE2' ' A' ' 76' ' ' LYS . 76.0 mt -55.6 -47.91 78.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 62.01 110.476 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 41.4 t-105 -69.7 -47.03 64.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.651 . . . . 72.12 110.946 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.43 -36.22 81.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.953 0.353 . . . . 62.5 111.953 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -64.44 -16.19 61.96 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.032 0.382 . . . . 73.3 112.032 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 72' ' ' ILE . 46.7 mtmt -118.34 -59.7 1.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.687 0.279 . . . . 72.43 111.645 -177.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.1 m -88.78 -25.15 22.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.305 -0.407 . . . . 63.34 111.624 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.21 43.47 93.53 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.322 -0.466 . . . . 55.51 113.194 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.03 165.56 27.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.979 0.418 . . . . 61.23 111.576 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.534 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 47.5 t -96.99 99.9 6.65 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.509 -0.552 . . . . 55.22 109.509 174.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -35.54 -48.93 0.95 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.578 3.519 . . . . 71.21 115.535 -169.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.82 -25.28 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.905 0.706 . . . . 74.44 112.905 -173.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 28.7 p -120.48 -25.48 5.57 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.771 -0.581 . . . . 75.5 111.423 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.5 mtm-85 72.08 15.11 5.59 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.546 0.738 . . . . 73.03 111.821 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.9 144.56 50.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.555 -0.906 . . . . 73.14 108.555 168.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.403 ' HB3' ' HE2' ' A' ' 86' ' ' MET . 62.5 ttp -79.01 148.27 32.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.997 0.427 . . . . 61.34 112.01 -172.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.456 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 87.7 t80 -132.54 124.39 19.0 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.346 -0.843 . . . . 75.31 108.766 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 37.3 Cg_endo -65.58 147.69 73.23 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.768 -1.347 . . . . 75.24 112.918 2.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.48 137.57 65.49 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.597 2.865 . . . . 71.3 113.145 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.79 151.58 46.15 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.746 2.297 . . . . 75.21 112.094 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.502 -0.761 . . . . 63.43 109.481 178.214 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 109.925 -0.398 . . . . 72.11 109.925 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.42 -170.3 46.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.612 -0.804 . . . . 65.13 111.241 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -58.48 -68.56 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.049 0.425 . . . . 62.44 110.92 178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -159.34 119.33 3.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.05 0.452 . . . . 62.33 110.847 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -177.06 150.62 0.76 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.223 -0.899 . . . . 75.35 108.921 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -79.46 167.63 20.55 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.548 -0.461 . . . . 65.34 109.786 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -71.82 8.15 1.29 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.45 0.907 . . . . 72.33 113.45 -167.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -134.13 112.19 10.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.913 0.387 . . . . 73.04 110.352 175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 t -143.19 133.85 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.687 -0.486 . . . . 63.41 109.687 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -88.25 119.42 28.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.414 -0.357 . . . . 73.44 110.389 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -75.36 147.96 39.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.181 -0.463 . . . . 74.15 110.073 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.1 t -113.8 89.21 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.96 0.41 . . . . 73.41 110.682 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.03 3.57 55.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.208 0.528 . . . . 55.25 110.419 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -100.97 108.16 53.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.595 -0.73 . . . . 63.33 110.013 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 60.4 Cg_endo -73.46 148.72 43.28 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.447 2.098 . . . . 61.42 112.204 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 18.3 Cg_exo -66.89 146.14 76.86 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.484 2.123 . . . . 72.34 111.249 175.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -78.22 147.82 34.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.876 0.369 . . . . 65.35 110.915 -177.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.0 t -74.53 153.71 38.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.934 -0.576 . . . . 73.51 109.859 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -58.83 -38.12 77.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.263 0.554 . . . . 71.14 109.735 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -70.23 -28.72 65.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.357 -0.838 . . . . 74.44 110.911 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 13.8 m -66.68 -38.1 86.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.86 -0.422 . . . . 64.04 109.86 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -77.38 -36.04 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 72.11 110.259 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.81 -37.49 84.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.578 -0.737 . . . . 52.22 111.192 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.04 4.69 49.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.053 -0.521 . . . . 74.3 112.312 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 21' ' ' SER . 57.8 mt -70.34 128.96 90.89 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 121.247 -0.181 . . . . 42.1 110.946 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 16.1 Cg_endo -58.17 153.12 47.93 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.033 2.489 . . . . 53.54 112.047 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -126.17 118.03 24.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.022 0.439 . . . . 73.41 110.857 -174.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.1 mt -120.5 118.35 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.769 -0.651 . . . . 73.52 110.366 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.45 121.05 15.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.729 -0.471 . . . . 60.32 109.729 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 45.0 t -86.05 129.88 37.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.332 -0.395 . . . . 72.03 111.228 -177.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 34' ' ' HIS . 20.3 p -117.09 141.14 48.64 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.825 -0.625 . . . . 64.24 109.792 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 52' ' ' LYS . 57.0 mt-10 -69.12 -27.78 65.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.191 0.52 . . . . 73.41 110.974 -176.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.07 -6.55 59.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.74 -0.664 . . . . 74.31 110.969 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.53 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 22.5 t60 -74.34 -47.56 33.64 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.823 -0.436 . . . . 73.3 109.823 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 -160.13 13.39 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.407 -0.677 . . . . 63.44 111.407 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.73 114.19 14.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.848 0.356 . . . . 70.34 110.723 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.21 95.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.909 -0.587 . . . . 71.22 110.607 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.83 -143.26 23.17 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.839 -0.696 . . . . 72.51 112.545 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.556 ' OE1' ' HA ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -85.2 -27.67 25.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.58 0.228 . . . . 70.22 111.275 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -96.2 125.54 40.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.757 -0.46 . . . . 52.25 109.757 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 22.7 ptp -107.72 0.04 22.1 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.477 -0.329 . . . . 64.41 111.395 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.3 m -143.39 157.67 44.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.487 . . . . 63.51 110.993 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 40.7 t -117.06 93.32 41.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.776 -0.647 . . . . 74.11 109.377 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 13.1 Cg_endo -56.49 -26.03 61.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.567 2.845 . . . . 73.04 113.078 -174.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.6 mt -60.09 -34.77 57.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 73.52 111.054 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.4 p -114.94 9.74 16.18 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.126 -0.324 . . . . 71.32 110.126 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p 41.12 46.25 2.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.02 0.928 . . . . 71.22 111.892 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -140.2 154.59 46.97 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.923 -0.58 . . . . 63.03 110.06 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.84 -169.9 1.95 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.925 -0.58 . . . . 74.14 110.923 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.428 ' HB3' HG11 ' A' ' 30' ' ' VAL . 40.4 m-85 -87.17 93.66 9.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.545 0.688 . . . . 72.54 111.497 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.93 162.73 2.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.836 -1.075 . . . . 73.41 110.321 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.9 ttpm? -79.68 133.57 36.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.02 0.438 . . . . 72.13 110.67 -176.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.65 -16.18 21.53 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.819 -0.705 . . . . 64.22 111.834 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -86.96 161.83 18.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.169 -0.678 . . . . 73.2 109.169 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.6 121.2 64.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.958 -0.386 . . . . 74.51 109.958 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.34 155.95 16.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.875 0.369 . . . . 63.2 110.742 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 12.8 t -138.11 156.01 48.18 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.961 -0.563 . . . . 74.34 109.783 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.441 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 54.2 tt0 -111.61 117.46 33.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.296 -0.411 . . . . 64.43 109.92 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.4 mt -78.41 147.87 72.87 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.037 -0.529 . . . . 75.32 109.755 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' HD2' ' CE1' ' A' ' 87' ' ' PHE . 14.6 Cg_endo -59.38 -13.35 20.1 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.117 2.545 . . . . 73.11 112.136 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.0 t -79.49 4.33 15.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.415 -0.811 . . . . 63.2 109.655 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 56.93 63.74 1.84 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 122.127 0.965 . . . . 75.13 110.684 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.556 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 1.2 m80 -148.65 123.4 9.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.184 -1.371 . . . . 74.54 109.682 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -90.75 133.19 35.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.062 -0.517 . . . . 64.51 110.779 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -146.64 168.02 22.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.584 -0.735 . . . . 72.14 109.157 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.1 m170 -75.08 122.58 23.78 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.621 -0.511 . . . . 64.4 109.621 175.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 89.1 tttt -59.0 -51.11 84.18 Favored Pre-proline 0 CA--C 1.538 0.486 0 O-C-N 123.412 0.445 . . . . 41.31 112.093 -175.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.4 Cg_endo -60.74 -20.05 63.92 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.112 1.875 . . . . 64.14 112.956 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 61.3 m -84.38 -49.9 8.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.078 0.466 . . . . 74.02 110.43 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.9 p -73.37 -25.62 21.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.672 -0.695 . . . . 55.23 111.467 -171.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.502 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 13.0 p -59.81 -30.57 69.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.746 0.308 . . . . 60.32 111.597 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.98 -36.6 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.304 0.573 . . . . 75.13 110.419 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -74.66 -41.27 60.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.709 -0.678 . . . . 71.52 111.006 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 92.8 mt -62.24 -27.48 69.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.895 -0.593 . . . . 63.03 112.038 -175.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 71' ' ' SER . 73.9 mt-30 -65.77 -25.18 67.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.087 0.47 . . . . 73.44 110.736 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.96 -39.45 9.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 75.41 110.318 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 p -163.55 125.33 2.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 72.4 110.47 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 87' ' ' PHE . . . -79.96 91.27 1.31 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.614 -0.803 . . . . 62.34 111.137 177.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 84' ' ' ARG . 2.4 m -149.66 144.55 26.21 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.677 -0.308 . . . . 73.32 110.869 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . 0.747 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 83.1 m -74.39 120.92 83.84 Favored Pre-proline 0 N--CA 1.464 0.247 0 N-CA-C 108.386 -0.968 . . . . 61.45 108.386 168.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.48 -21.81 56.05 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.551 2.168 . . . . 62.12 112.832 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.47 -51.44 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.395 -0.366 . . . . 65.22 111.861 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.9 p -94.4 -22.76 18.1 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.759 0.314 . . . . 51.12 111.712 -172.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.529 ' HA ' HG22 ' A' ' 79' ' ' THR . 59.2 mtt180 60.35 28.08 17.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.762 -0.654 . . . . 74.03 111.695 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.9 m -88.86 160.69 17.1 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.647 -0.501 . . . . 74.03 109.647 172.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 38.2 ttm -76.12 141.14 42.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.647 0.61 . . . . 72.31 112.647 -169.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.427 ' CE1' ' HD2' ' A' ' 60' ' ' PRO . 54.6 t80 -132.74 121.39 17.1 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.282 -0.872 . . . . 74.12 109.539 170.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.51 159.37 85.74 Favored 'Cis proline' 0 C--O 1.232 0.196 0 C-N-CA 123.687 -1.38 . . . . 73.03 111.827 -1.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.57 149.09 14.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.041 2.494 . . . . 73.13 112.19 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.18 135.46 47.13 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.655 2.236 . . . . 73.35 112.114 -175.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 115.485 -0.78 . . . . 72.12 109.168 179.807 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.672 0.272 . . . . 55.14 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.26 65.78 3.56 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.158 -0.544 . . . . 41.45 113.067 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -119.2 90.83 3.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.962 0.41 . . . . 60.52 109.921 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -79.23 124.96 28.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.78 -0.645 . . . . 75.14 111.032 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -100.23 116.53 32.44 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.033 -0.729 . . . . 73.34 109.033 172.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -80.89 128.02 33.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.244 0.545 . . . . 74.4 110.9 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.407 ' CE1' ' HB3' ' A' ' 9' ' ' SER . 7.2 t-80 -144.22 111.09 5.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.285 -0.871 . . . . 65.25 108.689 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -60.93 -22.7 64.64 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.008 0.432 . . . . 74.34 110.862 -175.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.407 ' HB3' ' CE1' ' A' ' 7' ' ' HIS . 39.8 t -91.23 74.22 6.2 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.196 -1.039 . . . . 75.32 108.196 167.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -67.21 -27.21 67.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.611 -0.722 . . . . 72.33 111.797 -172.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.453 ' SD ' ' HB2' ' A' ' 86' ' ' MET . 47.3 ttm 41.18 87.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.369 1.043 . . . . 73.32 113.814 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.46 176.12 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.988 -0.551 . . . . 71.44 110.415 175.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.49 17.2 10.61 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.658 0.599 . . . . 51.21 111.702 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -65.98 139.09 96.55 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 72.54 111.02 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.01 161.85 40.77 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.7 2.267 . . . . 73.12 111.929 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.09 146.48 96.12 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.802 2.335 . . . . 60.31 112.155 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB3' HD11 ' A' ' 22' ' ' ILE . . . -85.56 162.76 18.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.245 -0.434 . . . . 43.2 110.243 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.465 ' O ' HG13 ' A' ' 22' ' ' ILE . 14.1 m -67.25 126.06 28.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.345 -0.389 . . . . 54.5 110.786 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -45.14 82.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 71.21 111.546 -175.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.13 -36.46 83.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.748 0.309 . . . . 72.31 111.086 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -67.07 -34.72 78.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.097 0.475 . . . . 55.33 110.321 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 18' ' ' SER . 60.8 mt -74.18 -41.18 51.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 70.14 110.847 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -80.14 -12.18 59.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.024 0.44 . . . . 32.21 110.968 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.85 -13.06 60.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 65.44 110.75 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.34 138.36 94.19 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.864 -0.607 . . . . 51.14 110.328 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -58.42 134.01 58.52 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.342 2.695 . . . . 62.11 113.088 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 40.0 mt-10 -84.8 102.81 13.34 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.306 -0.628 . . . . 74.44 109.306 173.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.6 mt -92.09 117.18 34.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.119 -0.491 . . . . 73.12 110.934 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.2 tp -78.26 109.34 12.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.791 -0.64 . . . . 74.24 109.553 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 50' ' ' TYR . 49.1 t -83.05 124.82 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.938 0.399 . . . . 52.2 111.147 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.5 p -101.19 153.88 19.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.311 -0.626 . . . . 51.32 109.311 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -87.89 -177.84 5.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.229 0.455 . . . . 72.11 112.229 -168.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.7 t70 76.07 -0.09 3.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.034 -0.985 . . . . 74.34 110.92 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.438 ' HE1' ' O ' ' A' ' 50' ' ' TYR . 11.7 p-80 -71.25 -21.41 62.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.9 -0.591 . . . . 71.34 112.06 -177.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.04 -82.87 1.41 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.531 -0.843 . . . . 70.31 111.097 -174.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.12 154.28 33.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.705 -0.479 . . . . 51.33 109.705 174.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.15 -56.89 4.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.147 0.499 . . . . 74.34 110.014 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.647 ' O ' ' HG2' ' A' ' 39' ' ' GLN . . . -163.57 103.71 0.22 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.919 -0.872 . . . . 52.33 110.919 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' A' ' 38' ' ' GLY . 8.6 pt20 56.87 -67.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.375 1.47 . . . . 62.24 112.297 -176.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.13 108.11 12.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.161 0.505 . . . . 41.2 109.679 173.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.2 ptp -81.41 -12.05 59.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.885 -0.598 . . . . 71.12 110.62 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 5.9 p -137.32 148.5 46.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.742 -0.663 . . . . 51.44 109.912 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' CYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 35.8 t -88.09 107.6 17.03 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.177 -0.465 . . . . 74.31 109.939 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 19.4 Cg_endo -58.57 -28.69 86.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.173 2.582 . . . . 54.24 112.66 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.8 mt -65.05 -25.96 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.245 0.545 . . . . 64.02 110.951 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 19.8 m -119.96 -1.87 10.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.111 -0.495 . . . . 62.03 111.144 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.8 p 41.14 42.97 1.8 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.712 0.768 . . . . 71.44 110.558 -168.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 t -142.89 147.26 35.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.981 -1.008 . . . . 73.12 109.464 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 8.3 pt-20 -80.28 -169.8 2.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.457 0.646 . . . . 54.12 111.268 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.498 ' HB3' HG11 ' A' ' 30' ' ' VAL . 78.6 m-85 -102.54 109.85 21.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.572 -0.74 . . . . 70.42 109.328 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.87 170.0 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.207 -0.451 . . . . 73.23 111.994 -171.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -60.13 109.25 0.93 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.542 -0.754 . . . . 74.22 111.091 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.24 -0.49 43.87 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.665 -0.779 . . . . 65.11 112.535 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -82.18 147.29 29.09 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.244 -0.651 . . . . 74.01 109.244 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.97 114.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.248 0.547 . . . . 51.22 110.913 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.33 176.75 4.93 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.635 -0.711 . . . . 54.32 110.507 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 6.6 t -152.23 171.06 18.54 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.471 -0.566 . . . . 74.23 109.471 175.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -123.4 119.42 29.98 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.091 -0.336 . . . . 72.13 110.091 -174.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.0 150.08 54.59 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.088 -0.506 . . . . 74.34 111.125 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.09 -9.62 17.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.03 2.487 . . . . 45.21 112.979 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -95.44 8.92 41.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.54 -0.3 . . . . 74.41 110.205 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 65.33 93.0 0.07 Allowed 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 123.82 0.7 . . . . 54.52 109.72 -172.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -175.62 122.47 0.2 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.759 -0.655 . . . . 74.15 110.723 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 57' ' ' THR . 92.2 m-85 -95.53 133.26 39.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.204 -0.453 . . . . 75.44 110.466 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.491 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 86.8 m-85 -140.98 174.77 10.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.755 -0.832 . . . . 72.14 108.755 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.875 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 38.3 m80 -82.02 125.16 30.48 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.271 -1.011 . . . . 74.25 108.271 175.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 60.7 tttm -53.67 -47.68 95.79 Favored Pre-proline 0 C--N 1.322 -0.618 0 O-C-N 123.388 0.43 . . . . 73.34 112.022 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 10.0 Cg_endo -52.88 -50.53 13.74 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.222 1.948 . . . . 64.22 113.246 177.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.875 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 26.3 p -76.54 -35.47 58.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.806 -0.358 . . . . 73.52 111.95 -173.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -74.16 -28.65 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.337 . . . . 74.22 110.271 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.442 ' HA ' HG21 ' A' ' 22' ' ' ILE . 33.0 t -60.79 -50.01 75.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 63.34 109.941 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.1 mt -61.08 -37.43 77.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 60.25 110.615 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -68.45 -50.84 49.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.798 -0.637 . . . . 73.32 111.257 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.86 -25.55 67.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.776 0.322 . . . . 71.32 111.203 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -75.0 -1.4 22.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 41.34 110.793 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -112.24 -48.39 3.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.254 0.55 . . . . 55.04 109.676 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.9 m -145.65 119.55 9.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.669 . . . . 52.01 110.413 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.13 71.71 1.95 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.845 -0.693 . . . . 51.13 112.332 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.9 142.82 29.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.229 -0.286 . . . . 64.01 110.229 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 47.0 t -74.69 113.61 26.11 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.006 -0.738 . . . . 75.22 109.006 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.77 -24.78 77.09 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 123.073 2.516 . . . . 73.25 114.03 -171.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.47 -59.15 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.069 0.396 . . . . 64.12 112.069 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 30.6 p -95.32 -11.25 28.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.938 -0.305 . . . . 71.22 111.478 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 62.42 80.57 0.22 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.795 0.807 . . . . 61.34 111.057 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.5 t -137.82 135.94 36.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.531 -1.213 . . . . 73.52 108.24 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.569 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 50.5 ttm -72.97 141.09 47.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.837 0.351 . . . . 72.31 111.301 -173.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 87.1 t80 -133.82 114.31 13.01 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.848 -0.614 . . . . 74.02 109.856 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 71.5 Cg_endo -75.26 153.13 98.58 Favored 'Cis proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.147 -1.605 . . . . 72.14 111.861 -2.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 88' ' ' PRO . 52.2 Cg_exo -54.82 148.5 45.78 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.808 2.339 . . . . 62.22 112.633 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 31.9 Cg_endo -63.72 153.39 75.57 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.826 2.351 . . . . 71.04 112.456 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 C--O 1.246 0.917 0 CA-C-N 115.816 -0.629 . . . . 71.1 109.746 178.834 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 72.5 Cg_endo . . . . . 0 N--CA 1.461 -0.383 0 CA-C-O 120.872 0.28 . . . . 73.019999999999996 112.553 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.6 153.36 65.11 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.608 2.205 . . . . 64.230000000000004 112.299 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.95 167.73 16.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.005 -0.543 . . . . 54.539999999999999 111.043 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -94.81 151.31 19.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.104 -0.498 . . . . 75.329999999999998 109.943 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -58.95 -37.56 77.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.493 -0.321 . . . . 74.120000000000005 110.494 -176.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -56.93 -41.87 78.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.972 -0.558 . . . . 72.310000000000002 111.125 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -72.25 -27.03 62.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 60.439999999999998 111.085 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.549 HG21 ' HA ' ' A' ' 71' ' ' SER . 42.8 mt -82.86 -38.8 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.399 0.618 . . . . 71.299999999999997 110.516 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.68 -20.68 64.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.987 -0.551 . . . . 71.219999999999999 110.505 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.9 -3.81 55.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.772 -0.649 . . . . 51.219999999999999 111.378 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.4 152.34 85.67 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.553 -0.294 . . . . 72.239999999999995 110.453 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.93 122.91 11.64 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.715 2.277 . . . . 71.409999999999997 112.175 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -86.91 118.3 26.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.024 -0.535 . . . . 62.039999999999999 110.133 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.3 mt -110.19 103.63 15.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.82 -0.627 . . . . 61.509999999999998 110.264 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 68.9 tp -68.24 114.62 6.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.549 -0.538 . . . . 75.400000000000006 109.549 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 40.0 t -70.13 111.05 3.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.971 -0.381 . . . . 74.329999999999998 109.971 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.2 p -88.19 169.74 11.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 65.129999999999995 110.379 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.37 -8.34 56.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.027 0.38 . . . . 40.310000000000002 112.027 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -91.46 -2.42 57.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.154 0.502 . . . . 75.200000000000003 109.839 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -109.21 90.68 3.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.922 -0.581 . . . . 71.200000000000003 111.102 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.93 -26.82 48.03 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.909 -0.877 . . . . 74.030000000000001 110.909 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.19 140.46 41.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.482 -0.562 . . . . 74.400000000000006 109.482 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 t -118.86 90.8 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.765 0.317 . . . . 60.409999999999997 110.727 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.92 13.9 60.17 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.976 -0.556 . . . . 74.530000000000001 113.307 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.97 -155.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.61 -0.515 . . . . 50.439999999999998 109.61 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -68.94 177.63 2.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.815 -0.439 . . . . 70.239999999999995 109.815 173.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 1.8 pmm? -84.33 0.0 50.86 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.006 -0.278 . . . . 75.310000000000002 110.468 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.7 m -116.36 131.84 56.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.079 0.466 . . . . 65.129999999999995 112.038 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 14.5 t -83.48 107.93 11.61 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.595 -0.891 . . . . 63.530000000000001 108.595 171.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 9.8 Cg_endo -51.22 -38.91 62.23 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.331 2.687 . . . . 73.010000000000005 112.878 -173.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 51.7 mt -62.29 -29.48 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.961 -0.563 . . . . 71.219999999999999 111.347 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 61.2 m -110.12 -8.62 14.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.377 -0.374 . . . . 72.310000000000002 111.623 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.4 p 45.18 34.99 1.53 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.459 0.647 . . . . 52.109999999999999 110.949 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.1 t -133.82 159.82 39.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.496 -0.775 . . . . 61.43 110.0 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 41' ' ' MET . 4.6 pt-20 -83.96 172.57 11.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.736 0.643 . . . . 64.430000000000007 112.736 -171.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -98.05 123.91 42.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.374 -0.83 . . . . 75.219999999999999 110.289 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.26 164.83 28.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.178 -0.465 . . . . 74.239999999999995 110.411 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.657 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.2 ttpt -58.77 125.64 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 60.200000000000003 111.047 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.83 -23.96 6.5 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.669 -0.777 . . . . 60.409999999999997 112.702 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.57 161.53 18.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.031 -0.359 . . . . 64.200000000000003 110.031 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.88 115.25 49.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.927 0.394 . . . . 71.510000000000005 110.351 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -100.96 168.35 9.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.211 -0.45 . . . . 62.109999999999999 110.417 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.0 t -152.76 166.2 32.97 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.229 -0.656 . . . . 73.329999999999998 109.229 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -120.39 119.71 33.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.688 0.28 . . . . 61.109999999999999 110.691 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.496 HD21 HD11 ' A' ' 74' ' ' LEU . 88.2 mt -70.39 142.36 89.3 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 108.84 -0.8 . . . . 62.310000000000002 108.84 170.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 9.6 Cg_endo -52.79 -20.84 13.68 Favored 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.663 2.908 . . . . 74.430000000000007 113.841 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.7 p -85.88 19.33 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 70.129999999999995 110.376 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 58.01 65.39 1.31 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.411 -0.813 . . . . 75.219999999999999 111.612 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -145.08 123.09 12.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.427 -0.806 . . . . 64.420000000000002 109.449 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.77 141.32 28.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.026 -0.533 . . . . 63.530000000000001 111.796 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -149.07 175.18 11.55 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.138 -1.06 . . . . 75.530000000000001 108.138 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.887 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 35.9 m170 -77.28 133.67 38.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.433 -0.951 . . . . 63.450000000000003 108.433 170.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 87.1 tttt -57.66 -50.74 86.45 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 119.481 -0.295 . . . . 55.520000000000003 111.319 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 6.6 Cg_endo -49.31 -46.88 24.32 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.566 2.177 . . . . 73.030000000000001 113.481 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.887 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 14.3 p -80.62 -34.06 35.33 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.492 -0.483 . . . . 71.319999999999993 111.933 -175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 67' ' ' LYS . 5.5 p -73.77 -30.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.565 -0.454 . . . . 72.400000000000006 110.562 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.549 ' HA ' HG21 ' A' ' 22' ' ' ILE . 51.1 m -63.38 -32.99 74.57 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.977 0.418 . . . . 71.409999999999997 110.776 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.0 mt -79.42 -42.45 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 73.430000000000007 110.056 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -63.35 -43.82 96.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.896 -0.593 . . . . 74.519999999999996 111.363 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 87' ' ' PHE . 95.7 mt -66.74 -24.34 66.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.642 -0.254 . . . . 75.430000000000007 111.666 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -92.49 0.55 57.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.904 0.383 . . . . 72.420000000000002 110.662 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -114.95 -41.72 3.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.398 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.9 m -120.94 -20.38 6.91 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.815 0.302 . . . . 63.420000000000002 111.815 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.58 26.64 60.08 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.37 -0.377 . . . . 62.030000000000001 114.018 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.26 145.09 40.9 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.339 -0.506 . . . . 63.020000000000003 111.79 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.45 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 24.3 t -75.03 110.69 10.7 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.741 -0.663 . . . . 73.129999999999995 109.251 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.22 -32.99 34.53 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.211 2.608 . . . . 64.140000000000001 113.993 -171.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.93 -28.64 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.393 0.516 . . . . 75.329999999999998 112.393 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 29.4 p -125.06 -13.13 6.87 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 121.818 -0.551 . . . . 64.319999999999993 112.093 -174.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 66.36 23.07 10.72 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.029 0.532 . . . . 73.010000000000005 111.237 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.3 t -85.01 145.31 27.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.939 -0.763 . . . . 43.039999999999999 108.939 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.479 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 58.7 ttp -75.51 150.51 38.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.926 0.393 . . . . 74.239999999999995 111.447 -175.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.552 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 81.1 t80 -129.5 125.98 22.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 108.791 -0.818 . . . . 71.450000000000003 108.791 170.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.552 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 30.9 Cg_endo -61.87 153.42 61.61 Favored 'Cis proline' 0 C--N 1.348 0.523 0 C-N-CA 123.988 -1.255 . . . . 73.219999999999999 113.019 3.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 42.7 Cg_exo -55.34 138.32 79.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.033 2.489 . . . . 73.209999999999994 112.61 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.479 ' HG3' ' HB3' ' A' ' 86' ' ' MET . 6.2 Cg_exo -72.24 177.5 7.18 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.665 2.243 . . . . 70.019999999999996 111.914 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.701 -0.666 . . . . 72.349999999999994 110.231 -176.736 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 20.4 Cg_endo . . . . . 0 C--O 1.236 0.391 0 N-CA-C 113.053 0.366 . . . . 72.120000000000005 113.053 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 38.0 Cg_exo -61.84 163.38 19.15 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.168 2.579 . . . . 62.039999999999999 112.239 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -86.06 153.87 21.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 72.239999999999995 110.714 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.404 ' O ' HG13 ' A' ' 22' ' ' ILE . 22.4 m -71.96 137.96 47.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.957 -0.565 . . . . 62.020000000000003 110.626 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -58.21 -41.43 84.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.105 -0.498 . . . . 63.420000000000002 110.57 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -52.17 -45.91 65.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.996 -1.002 . . . . 72.230000000000004 110.987 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.506 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 13.8 m -67.68 -42.33 82.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.083 -0.508 . . . . 72.519999999999996 110.679 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 18' ' ' SER . 66.4 mt -61.92 -40.93 88.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 73.099999999999994 110.81 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.16 -44.11 80.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.945 -0.571 . . . . 74.099999999999994 110.79 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.6 3.89 30.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.932 -0.576 . . . . 61.229999999999997 112.287 -174.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.544 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 40.5 mt -57.85 127.78 79.56 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 116.89 -0.141 . . . . 74.439999999999998 111.027 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.13 126.3 21.15 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.161 2.574 . . . . 72.140000000000001 111.77 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.97 116.46 31.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.958 -0.564 . . . . 74.310000000000002 110.783 -172.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.9 mt -104.69 129.01 57.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.673 -0.694 . . . . 71.340000000000003 110.053 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 46.8 tp -82.23 120.4 25.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.123 -0.49 . . . . 72.120000000000005 110.367 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.992 HG13 ' HA2' ' A' ' 35' ' ' GLY . 97.9 t -90.28 128.3 42.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.998 -0.546 . . . . 63.020000000000003 111.032 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' HG3' ' A' ' 52' ' ' LYS . 17.7 p -137.35 172.95 12.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.463 -0.789 . . . . 74.540000000000006 109.825 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.438 ' OE1' ' HD3' ' A' ' 52' ' ' LYS . 4.5 mp0 -59.76 130.21 45.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.404 -0.221 . . . . 64.530000000000001 110.404 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 69.01 10.94 8.18 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.928 -0.578 . . . . 54.130000000000003 111.523 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -141.32 34.76 1.68 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.568 -1.271 . . . . 63.0 107.568 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.992 ' HA2' HG13 ' A' ' 30' ' ' VAL . . . -93.9 -56.81 1.37 Allowed Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.985 -1.007 . . . . 61.039999999999999 113.461 -172.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.33 -60.57 3.22 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.659 0.23 . . . . 74.400000000000006 111.23 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t 60.51 91.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.829 -0.623 . . . . 74.450000000000003 111.422 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . 99.4 -89.32 0.88 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.388 -0.911 . . . . 64.510000000000005 113.269 175.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -141.16 -52.65 0.46 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.833 0.317 . . . . 73.519999999999996 111.625 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.39 107.24 2.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.864 0.364 . . . . 55.210000000000001 111.082 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.438 ' HG2' ' SG ' ' A' ' 42' ' ' CYS . 1.8 pmm? -84.16 -18.3 37.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.098 0.475 . . . . 71.200000000000003 110.421 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.438 ' SG ' ' HG2' ' A' ' 41' ' ' MET . 78.2 m -136.82 159.22 42.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.639 -0.71 . . . . 73.209999999999994 109.739 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.6 t -105.56 102.21 36.53 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.501 -0.555 . . . . 65.409999999999997 109.501 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.55 -28.35 86.49 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.84 2.36 . . . . 73.219999999999999 111.788 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.0 mt -61.98 -29.69 46.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.437 -0.801 . . . . 54.0 111.762 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.3 p -121.38 2.4 10.24 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.87 -0.332 . . . . 74.140000000000001 111.313 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 76.9 m 50.66 62.13 2.86 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.415 0.626 . . . . 72.140000000000001 111.027 -175.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.8 t -159.43 152.81 22.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.428 -0.805 . . . . 71.329999999999998 109.708 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.512 ' HG3' HG13 ' A' ' 51' ' ' VAL . 11.4 pt-20 -77.75 -173.04 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.288 0.566 . . . . 62.5 110.889 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.52 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 37.0 m-85 -97.96 106.68 19.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.046 -0.525 . . . . 63.539999999999999 110.65 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.512 HG13 ' HG3' ' A' ' 49' ' ' GLU . 31.2 m -118.59 162.84 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.786 -0.643 . . . . 75.310000000000002 110.889 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 34.1 ttpt -62.78 112.91 2.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.609 . . . . 71.230000000000004 110.754 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.5 -31.48 2.85 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.885 -0.674 . . . . 60.32 111.726 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.2 133.34 34.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.675 0.274 . . . . 74.340000000000003 110.301 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.65 127.59 40.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.448 -0.342 . . . . 64.439999999999998 110.764 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.4 9.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.263 -0.426 . . . . 65.010000000000005 109.995 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.544 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 13.2 t -148.51 153.31 38.27 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.899 -0.408 . . . . 75.430000000000007 109.899 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -107.49 117.7 34.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.046 0.45 . . . . 74.510000000000005 110.335 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -80.75 140.69 51.03 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.893 -0.78 . . . . 73.299999999999997 108.893 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.47 ' HB2' ' HG3' ' A' ' 89' ' ' PRO . 17.1 Cg_endo -58.81 -7.8 4.98 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.896 2.397 . . . . 71.230000000000004 112.106 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.6 t -87.42 21.34 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.241 -0.891 . . . . 74.219999999999999 109.784 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 57.44 40.33 27.37 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.803 -0.635 . . . . 72.109999999999999 111.321 176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -138.06 148.89 45.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.536 -0.302 . . . . 72.510000000000005 111.067 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 60.8 m-85 -124.39 133.51 53.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.148 -0.478 . . . . 74.099999999999994 111.084 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.52 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 92.5 m-85 -146.49 162.52 38.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.595 . . . . 65.209999999999994 109.798 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 33.9 m170 -67.13 123.16 19.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.478 -0.564 . . . . 72.530000000000001 109.478 174.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.539 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 83.2 tttt -57.57 -48.86 96.53 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 123.349 0.406 . . . . 72.329999999999998 111.866 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 12.2 Cg_endo -56.84 -27.16 70.72 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.162 1.908 . . . . 61.350000000000001 112.844 177.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 37.3 m -84.53 -52.77 5.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.142 0.496 . . . . 65.430000000000007 111.122 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.534 HG22 ' HG ' ' A' ' 74' ' ' LEU . 9.8 p -67.17 -25.6 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 62.130000000000003 111.404 -172.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.5 p -63.49 -30.38 71.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.807 0.337 . . . . 73.230000000000004 111.437 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.4 mt -78.88 -40.15 22.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.253 0.549 . . . . 74.549999999999997 109.917 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -65.82 -43.19 89.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.453 -0.794 . . . . 71.510000000000005 111.481 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 93.1 mt -67.03 -19.33 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.953 0.353 . . . . 73.319999999999993 111.953 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -74.28 -22.27 59.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.046 0.451 . . . . 72.150000000000006 110.327 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -91.19 -45.17 8.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.713 -0.676 . . . . 64.400000000000006 109.851 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -157.37 133.05 9.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.819 -0.628 . . . . 64.109999999999999 110.247 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.01 77.61 2.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.681 -0.771 . . . . 35.450000000000003 111.226 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 m -148.52 148.85 30.68 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.169 -0.308 . . . . 54.299999999999997 110.169 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.752 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 73.7 m -75.12 119.83 78.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 108.23 -1.026 . . . . 72.030000000000001 108.23 168.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.83 -12.07 20.47 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.468 2.112 . . . . 75.230000000000004 113.04 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.6 t -96.15 -50.21 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 111.861 0.319 . . . . 74.349999999999994 111.861 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 20.4 p -96.0 -18.88 19.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.761 0.315 . . . . 55.140000000000001 111.629 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 63.08 25.57 15.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.012 -0.54 . . . . 73.510000000000005 111.887 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -92.42 151.06 20.43 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.487 -0.56 . . . . 44.049999999999997 109.487 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 52.8 ttp -76.31 146.89 38.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.033 0.753 . . . . 61.240000000000002 113.033 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.545 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 76.6 t80 -133.16 124.47 18.42 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.803 -1.089 . . . . 73.409999999999997 108.527 170.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 32.7 Cg_exo -59.6 144.48 33.62 Favored 'Cis proline' 0 C--N 1.35 0.643 0 C-N-CA 124.558 -1.017 . . . . 72.409999999999997 113.181 3.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.47 ' HG3' ' HB2' ' A' ' 60' ' ' PRO . 52.9 Cg_endo -67.48 149.76 80.2 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.059 2.506 . . . . 63.310000000000002 112.611 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.5 178.71 5.31 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.709 2.273 . . . . 65.239999999999995 111.814 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.41 -0.805 . . . . 63.32 110.266 -179.747 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 N--CA 1.455 -0.782 0 CA-C-O 120.504 0.127 . . . . 61.119999999999997 112.056 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -73.88 136.85 23.54 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.91 1.74 . . . . 73.129999999999995 111.326 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -79.96 127.73 32.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.43 -0.35 . . . . 72.319999999999993 110.529 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 p -74.64 166.55 23.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.091 -0.504 . . . . 71.349999999999994 110.736 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -57.64 -35.17 70.15 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.248 -0.433 . . . . 62.409999999999997 110.946 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.42 -35.26 69.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.938 0.399 . . . . 65.109999999999999 111.181 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 m -85.83 -35.41 20.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.025 -0.534 . . . . 64.409999999999997 111.173 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.512 HG21 ' HA ' ' A' ' 71' ' ' SER . 68.1 mt -82.89 -44.44 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.017 0.437 . . . . 75.239999999999995 111.903 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.75 -33.73 74.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.013 -0.54 . . . . 50.009999999999998 110.762 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.77 4.93 26.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.697 -0.683 . . . . 43.32 112.186 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.44 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 66.7 mt -70.75 136.17 85.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.609 0.242 . . . . 62.130000000000003 110.511 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.61 149.37 67.9 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.256 2.637 . . . . 71.439999999999998 112.782 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.64 121.33 44.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 71.129999999999995 110.4 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.3 mt -109.44 120.55 60.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.743 -0.662 . . . . 70.200000000000003 109.883 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.0 tp -79.93 107.67 12.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.796 -0.446 . . . . 73.540000000000006 109.796 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' ' 50' ' ' TYR . 42.5 t -74.86 131.86 34.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.051 -0.522 . . . . 61.100000000000001 110.902 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 35.2 p -120.17 145.21 47.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.966 -0.561 . . . . 73.420000000000002 109.883 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.488 ' HG2' ' HD3' ' A' ' 52' ' ' LYS . 16.7 pt-20 -71.7 -17.43 62.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.705 0.288 . . . . 74.329999999999998 111.221 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -68.29 -23.03 64.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.466 -0.334 . . . . 61.229999999999997 110.382 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -90.76 -13.81 33.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 65.109999999999999 109.913 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.2 -80.38 0.98 Allowed Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.967 -0.56 . . . . 72.409999999999997 112.164 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.78 -172.8 2.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.78 -0.452 . . . . 62.009999999999998 109.78 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.87 95.42 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.085 0.469 . . . . 74.430000000000007 110.159 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.5 -110.44 3.49 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.794 -0.639 . . . . 71.140000000000001 111.756 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -98.48 -14.77 19.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.741 0.305 . . . . 72.549999999999997 111.19 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HG3' ' H ' ' A' ' 64' ' ' TYR . 58.1 mm-40 -99.36 133.69 43.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.247 0.546 . . . . 65.349999999999994 110.954 -174.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.3 ptp -121.44 -5.04 9.33 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.489 -0.778 . . . . 75.409999999999997 111.61 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.2 p -150.48 151.77 33.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.329 . . . . 74.040000000000006 110.924 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.9 t -109.79 93.01 13.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 71.439999999999998 109.57 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.15 -18.29 57.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.375 2.717 . . . . 73.349999999999994 113.006 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.6 mt -63.94 -27.93 43.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.17 -0.468 . . . . 64.230000000000004 110.632 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.6 p -127.07 -7.4 5.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.622 -0.263 . . . . 60.039999999999999 111.107 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 71.0 m 61.4 35.9 17.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.128 -0.487 . . . . 74.349999999999994 110.784 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -124.38 159.25 30.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.805 -0.634 . . . . 73.340000000000003 110.299 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.85 -174.4 5.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.817 -0.629 . . . . 75.519999999999996 111.389 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.655 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 96.4 m-85 -108.58 118.68 37.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.26 -0.427 . . . . 75.219999999999999 110.168 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.18 174.67 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.392 -0.367 . . . . 60.520000000000003 111.293 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HD3' ' HG2' ' A' ' 32' ' ' GLU . 35.9 ttpt -76.87 124.22 27.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.097 -0.501 . . . . 73.439999999999998 110.652 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.67 0.73 55.33 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.885 -0.674 . . . . 61.109999999999999 111.711 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -87.24 157.83 19.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.531 -0.544 . . . . 72.120000000000005 109.531 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.45 114.47 47.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.342 0.592 . . . . 74.329999999999998 111.166 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.5 166.64 10.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.486 -0.779 . . . . 53.149999999999999 110.066 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.491 HG21 HG11 ' A' ' 70' ' ' VAL . 7.6 t -131.01 171.71 12.92 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.832 -0.433 . . . . 72.019999999999996 109.832 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.509 ' HG2' ' CE2' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -126.4 118.35 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.342 -0.614 . . . . 75.219999999999999 109.342 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.8 mt -87.5 147.23 41.35 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.273 -0.421 . . . . 64.340000000000003 110.538 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.44 4.32 0.48 Allowed 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.048 2.499 . . . . 64.519999999999996 113.702 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.1 p -109.35 8.41 25.5 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.969 -0.382 . . . . 51.340000000000003 109.969 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.1 m170 66.59 89.13 0.1 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.757 -0.656 . . . . 73.340000000000003 110.371 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -172.53 125.4 0.49 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.52 -0.763 . . . . 72.120000000000005 110.126 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CE2' ' HG2' ' A' ' 58' ' ' GLU . 39.0 m-85 -103.83 133.28 49.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 72.239999999999995 110.047 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.655 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 90.0 m-85 -146.24 155.75 42.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.143 -0.48 . . . . 72.010000000000005 109.912 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 26.1 m170 -56.28 124.18 17.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.213 -0.662 . . . . 72.230000000000004 109.213 171.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.51 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 86.0 tttt -57.41 -49.27 94.82 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 119.297 -0.382 . . . . 70.010000000000005 111.462 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 77.6 Cg_exo -53.29 -36.22 77.44 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.865 1.71 . . . . 72.209999999999994 112.559 176.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 71.2 m -70.59 -51.59 27.31 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.428 -0.351 . . . . 62.210000000000001 111.13 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.491 HG11 HG21 ' A' ' 57' ' ' THR . 7.5 p -65.93 -26.73 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.001 -0.545 . . . . 43.43 110.3 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.512 ' HA ' HG21 ' A' ' 22' ' ' ILE . 50.3 m -60.96 -55.28 34.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.346 -0.388 . . . . 73.349999999999994 110.013 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.26 -40.63 84.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 74.030000000000001 110.789 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -64.94 -53.21 50.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 71.239999999999995 111.348 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 96.5 mt -66.41 -31.26 71.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.736 -0.211 . . . . 62.340000000000003 111.55 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -59.97 -30.71 69.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.759 0.314 . . . . 70.209999999999994 110.766 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.48 -40.29 10.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 74.439999999999998 110.838 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.7 p -153.79 115.21 4.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 62.140000000000001 110.683 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.83 71.38 2.88 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.864 -0.684 . . . . 73.109999999999999 112.643 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 1.3 m -146.43 141.14 26.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.781 -0.452 . . . . 73.420000000000002 109.781 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.0 t -74.56 113.01 19.98 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.091 -0.707 . . . . 74.329999999999998 109.091 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.78 -37.95 96.84 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.844 2.362 . . . . 71.019999999999996 113.378 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -71.42 -48.81 51.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.515 0.561 . . . . 74.120000000000005 112.515 -174.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.71 -8.81 13.22 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.62 -0.432 . . . . 72.549999999999997 111.992 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 63.67 91.71 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.629 0.728 . . . . 61.210000000000001 110.943 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 79' ' ' THR . 44.0 t -144.4 130.83 19.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.042 -0.981 . . . . 54.100000000000001 108.862 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.556 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 43.4 ttm -64.6 140.9 58.92 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.509 0.506 . . . . 72.430000000000007 110.391 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.44 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 70.3 t80 -131.83 116.26 15.83 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.035 -0.53 . . . . 74.409999999999997 109.69 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.99 155.12 99.74 Favored 'Cis proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.232 -1.57 . . . . 52.25 112.426 -0.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.39 151.55 29.43 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 123.264 2.643 . . . . 73.439999999999998 113.221 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 86.9 Cg_endo -80.6 170.63 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.786 2.324 . . . . 63.100000000000001 112.429 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.278 -0.868 . . . . 71.150000000000006 109.729 -179.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 CA--C 1.532 0.389 0 CA-C-O 120.67 0.196 . . . . 71.230000000000004 112.341 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.11 149.87 41.96 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.858 2.372 . . . . 72.140000000000001 112.5 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.45 157.98 24.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.778 -0.646 . . . . 53.130000000000003 110.993 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -67.93 139.72 56.44 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.679 -0.489 . . . . 74.129999999999995 109.679 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -61.52 -37.36 83.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 74.209999999999994 111.178 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 3.1 mp0 -60.0 -42.49 94.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.4 -0.364 . . . . 71.150000000000006 110.287 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.462 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.7 m -62.16 -40.04 94.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 65.329999999999998 110.823 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.14 -40.95 78.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.861 -0.609 . . . . 71.400000000000006 110.647 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.79 -32.89 65.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.16 -0.473 . . . . 64.439999999999998 111.179 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.65 -0.31 37.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.482 -0.326 . . . . 72.209999999999994 111.86 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.514 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 67.5 mt -64.99 123.3 83.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.605 0.241 . . . . 73.5 110.791 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.57 117.99 4.8 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.154 2.569 . . . . 72.450000000000003 112.332 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -78.4 121.99 25.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.087 -0.506 . . . . 72.530000000000001 110.808 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.4 mt -115.91 120.82 65.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.041 -0.527 . . . . 72.450000000000003 110.03 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.2 tp -75.71 119.51 19.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.74 -0.467 . . . . 73.230000000000004 109.74 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 40.3 t -85.91 121.56 37.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.072 0.463 . . . . 40.200000000000003 111.258 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.432 HG22 ' HG3' ' A' ' 52' ' ' LYS . 24.0 p -123.37 165.79 16.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.479 -0.782 . . . . 74.120000000000005 109.661 173.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.543 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 31.5 mt-10 -68.16 -30.22 69.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.937 0.398 . . . . 74.450000000000003 111.311 -173.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.31 -17.97 64.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.029 -0.532 . . . . 63.200000000000003 112.222 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -75.95 -17.52 59.7 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.044 0.387 . . . . 72.129999999999995 112.044 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.22 69.43 1.32 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.767 -0.73 . . . . 54.109999999999999 113.075 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 67.17 -2.83 1.11 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.328 0.651 . . . . 74.420000000000002 112.666 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.5 t 72.77 -64.84 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.193 0.597 . . . . 71.420000000000002 111.742 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.56 -161.57 9.06 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.657 -0.782 . . . . 74.200000000000003 112.496 -176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -62.27 -28.77 69.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.02 0.438 . . . . 55.329999999999998 110.803 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -80.52 110.6 16.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.43 -0.952 . . . . 75.439999999999998 108.43 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.1 ptp -103.8 -2.2 26.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.16 -0.473 . . . . 72.25 111.382 -173.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 82.0 m -146.42 147.52 31.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.341 -0.391 . . . . 75.140000000000001 110.571 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.0 t -103.78 94.74 6.62 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.081 -0.711 . . . . 65.099999999999994 109.081 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.87 -8.99 17.24 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.37 2.713 . . . . 43.200000000000003 112.84 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.5 mt -76.2 -32.92 23.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.019 -0.537 . . . . 75.439999999999998 110.508 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.8 p -114.86 -3.2 12.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.755 0.312 . . . . 70.549999999999997 111.045 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.0 t 67.64 23.37 8.79 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.564 -0.744 . . . . 71.040000000000006 111.103 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.1 m -129.47 158.78 38.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 63.109999999999999 110.405 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.9 OUTLIER -84.61 -169.67 2.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.171 -0.468 . . . . 64.150000000000006 111.1 -177.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 96.8 m-85 -93.94 94.23 8.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.483 0.659 . . . . 74.519999999999996 110.899 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.24 173.74 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.766 -1.106 . . . . 73.519999999999996 111.01 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 32.9 ttpt -75.48 123.24 25.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.969 -0.56 . . . . 75.109999999999999 110.806 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.63 -24.28 6.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.691 -0.766 . . . . 61.350000000000001 112.709 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -87.04 161.26 18.27 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.572 -0.529 . . . . 72.5 109.572 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.3 t -111.26 124.75 68.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.916 0.389 . . . . 74.219999999999999 110.056 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -111.73 172.69 6.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.315 -0.402 . . . . 63.130000000000003 110.777 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 12.7 t -152.76 161.13 42.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.903 -0.59 . . . . 74.400000000000006 109.59 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -108.31 117.59 34.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.85 0.357 . . . . 74.129999999999995 111.229 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.9 mt -76.84 152.94 82.98 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.913 -0.773 . . . . 73.230000000000004 108.913 171.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.83 51.04 0.62 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 122.959 2.439 . . . . 74.540000000000006 111.189 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 45.4 t -153.37 16.8 0.54 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.041 -0.982 . . . . 72.319999999999993 109.677 -172.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 56.95 18.16 3.76 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.54 -0.755 . . . . 72.140000000000001 111.775 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 3.3 m170 -111.13 115.63 29.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.189 -0.459 . . . . 71.409999999999997 110.563 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -91.99 133.26 35.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.617 -0.719 . . . . 72.299999999999997 109.728 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.605 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 74.9 m-85 -136.7 155.73 49.47 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.367 0.417 . . . . 75.230000000000004 110.143 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 32.2 m170 -65.71 121.21 14.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.225 -0.658 . . . . 75.140000000000001 109.225 174.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.5 tttt -56.57 -51.49 80.79 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 123.576 0.547 . . . . 74.409999999999997 111.966 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.0 Cg_endo -58.68 -27.97 84.89 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.237 1.958 . . . . 61.229999999999997 112.572 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 57.5 m -80.34 -50.61 9.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.069 -0.514 . . . . 74.349999999999994 110.419 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.1 p -72.52 -27.47 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.669 -0.696 . . . . 74.140000000000001 111.125 -172.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.6 t -59.3 -42.52 91.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.007 0.432 . . . . 63.350000000000001 110.448 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.93 -36.76 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.269 0.557 . . . . 73.120000000000005 110.204 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -72.29 -51.96 18.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.441 -0.799 . . . . 71.5 110.778 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 95.9 mt -60.03 -33.74 72.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.016 -0.538 . . . . 72.340000000000003 112.369 -174.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.5 -18.91 65.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.05 0.389 . . . . 63.409999999999997 112.05 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -111.4 -16.69 13.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 73.150000000000006 110.925 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 26.4 t -172.33 117.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 74.25 109.763 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.12 91.53 1.7 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.556 -0.83 . . . . 63.420000000000002 111.681 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 2.8 p -149.28 155.03 39.92 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.3 0.481 . . . . 65.299999999999997 112.3 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 35.0 m -74.79 112.0 15.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.843 -1.169 . . . . 73.239999999999995 107.843 160.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.91 -15.6 22.63 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.53 2.153 . . . . 65.230000000000004 112.379 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.6 t -89.93 -48.85 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.007 -0.542 . . . . 75.340000000000003 111.847 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 20.0 p -107.81 -3.13 19.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.62 0.6 . . . . 70.430000000000007 112.62 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? 68.06 14.71 9.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.039 0.755 . . . . 70.519999999999996 113.039 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 79' ' ' THR . 17.2 p -79.92 150.85 30.4 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.92 -0.488 . . . . 73.140000000000001 110.249 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.556 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 40.1 ttm -81.32 144.36 31.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.123 0.487 . . . . 61.409999999999997 111.376 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 77.8 t80 -135.43 123.53 15.42 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.497 -0.774 . . . . 74.010000000000005 109.547 172.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.28 152.42 84.75 Favored 'Cis proline' 0 C--N 1.343 0.272 0 C-N-CA 123.339 -1.525 . . . . 70.129999999999995 111.528 -2.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.37 149.44 56.06 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.83 2.354 . . . . 73.030000000000001 112.412 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 96.0 Cg_endo -81.82 147.29 15.17 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.66 2.24 . . . . 74.340000000000003 111.406 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.344 -0.836 . . . . 74.019999999999996 110.011 179.658 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo . . . . . 0 CA--C 1.53 0.282 0 CA-C-O 120.479 0.116 . . . . 72.310000000000002 112.149 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.42 159.81 22.67 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.041 2.494 . . . . 72.430000000000007 112.154 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.38 160.16 15.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.279 -0.419 . . . . 61.240000000000002 110.487 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -88.91 158.38 18.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.614 -0.267 . . . . 44.539999999999999 110.417 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -58.16 -45.45 87.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.176 -0.465 . . . . 73.019999999999996 111.411 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -45.71 -54.64 7.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 75.409999999999997 112.163 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.99 -23.38 67.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.155 0.428 . . . . 71.439999999999998 112.155 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.538 HG21 ' HA ' ' A' ' 71' ' ' SER . 37.2 mt -87.16 -38.46 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.48 0.657 . . . . 53.420000000000002 110.1 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -68.39 -30.5 69.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.546 -0.752 . . . . 72.409999999999997 110.884 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -19.19 65.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.164 -0.471 . . . . 53.299999999999997 111.363 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.88 144.52 97.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 63.009999999999998 110.514 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.85 159.13 26.15 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.192 2.595 . . . . 63.350000000000001 113.153 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -120.17 110.09 16.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 74.109999999999999 110.035 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 54.0 mt -104.68 129.07 57.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.711 -0.677 . . . . 74.319999999999993 110.871 -175.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.2 tp -83.82 117.07 23.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.249 -0.648 . . . . 74.349999999999994 109.249 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 49.1 t -76.67 117.28 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.054 0.454 . . . . 73.299999999999997 111.634 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 p -112.22 148.0 35.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.643 -0.708 . . . . 64.519999999999996 110.307 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 27.4 mt-10 -78.47 -26.74 46.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.914 0.388 . . . . 72.409999999999997 111.76 -174.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.98 -4.23 27.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.275 0.843 . . . . 64.099999999999994 113.275 -168.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.696 ' HE1' ' HA ' ' A' ' 37' ' ' VAL . 22.3 p80 -113.08 9.24 18.56 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.233 -0.587 . . . . 74.400000000000006 110.537 176.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.5 -130.67 23.62 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.897 -0.592 . . . . 72.120000000000005 112.122 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.21 147.37 49.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.664 0.269 . . . . 61.200000000000003 110.52 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.696 ' HA ' ' HE1' ' A' ' 34' ' ' HIS . 60.9 t -80.76 97.91 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.052 0.454 . . . . 63.530000000000001 110.109 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.16 -80.35 0.85 Allowed Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.558 -0.746 . . . . 63.439999999999998 112.21 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.794 ' HG3' ' HG2' ' A' ' 40' ' ' GLU . 15.6 pt20 -138.73 -1.77 1.8 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.683 0.278 . . . . 63.329999999999998 111.343 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.794 ' HG2' ' HG3' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -128.34 144.48 51.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.26 -0.274 . . . . 64.230000000000004 110.26 -173.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.2 ptp -123.83 -8.16 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.499 -0.318 . . . . 72.409999999999997 111.271 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 81.5 m -132.73 151.95 51.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.051 0.453 . . . . 71.209999999999994 111.142 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 38.9 t -118.16 91.93 41.46 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.758 -0.656 . . . . 73.140000000000001 109.298 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.2 Cg_endo -51.74 -30.7 38.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.833 3.022 . . . . 65.530000000000001 113.562 -173.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.8 mt -56.99 -37.34 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.334 -0.394 . . . . 71.219999999999999 111.465 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.6 p -109.31 0.11 19.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 62.439999999999998 110.298 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.1 m 60.38 16.01 5.93 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.257 -0.883 . . . . 71.299999999999997 111.49 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.3 t -117.31 165.76 13.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.785 -0.45 . . . . 71.439999999999998 109.785 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 7.2 pt-20 -99.51 -170.08 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.266 -0.425 . . . . 63.340000000000003 111.296 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.477 ' HB3' HG11 ' A' ' 30' ' ' VAL . 55.9 m-85 -95.1 110.23 22.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.213 0.53 . . . . 75.420000000000002 111.539 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.17 167.24 12.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.337 -0.847 . . . . 72.319999999999993 110.367 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 40.0 ttmt -71.51 126.33 29.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.347 -0.388 . . . . 73.540000000000006 111.198 -174.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.61 -15.44 19.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.742 . . . . 71.230000000000004 112.301 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -86.8 162.92 17.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.94 -0.393 . . . . 52.130000000000003 109.94 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -112.82 121.18 64.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.984 0.421 . . . . 71.349999999999994 110.78 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -103.97 170.19 8.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.08 -0.509 . . . . 63.340000000000003 110.697 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 8.3 t -147.7 173.35 12.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.054 -0.521 . . . . 73.349999999999994 109.711 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -118.96 119.43 34.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.675 0.274 . . . . 74.140000000000001 110.462 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.08 137.72 35.1 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.653 -0.499 . . . . 72.120000000000005 109.653 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.55 -15.77 26.82 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.287 2.658 . . . . 53.539999999999999 113.448 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 p -87.24 11.8 13.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.442 0.163 . . . . 64.409999999999997 110.897 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.3 m80 69.22 62.44 0.3 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.287 0.565 . . . . 74.219999999999999 111.015 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -150.67 152.16 33.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.438 -0.801 . . . . 74.439999999999998 109.336 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -118.78 133.23 55.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.994 0.426 . . . . 64.219999999999999 110.641 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.416 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 47.7 m-85 -143.08 157.94 44.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.659 -0.7 . . . . 74.409999999999997 109.976 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.609 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 33.3 m170 -68.4 125.91 27.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.687 -0.857 . . . . 71.510000000000005 108.687 172.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 85.5 tttt -57.57 -50.3 88.9 Favored Pre-proline 0 CA--C 1.536 0.44 0 O-C-N 123.405 0.441 . . . . 63.43 112.061 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 73.6 Cg_exo -52.59 -42.48 61.82 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.686 1.591 . . . . 72.310000000000002 112.395 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 57.9 m -63.15 -53.13 58.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.0 0.428 . . . . 62.32 110.918 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 67' ' ' LYS . 8.7 p -67.56 -27.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 64.030000000000001 110.792 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 53.1 m -61.58 -51.03 70.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.699 0.285 . . . . 53.5 110.393 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.65 -37.31 79.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.379 0.609 . . . . 71.109999999999999 110.414 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -64.31 -55.0 24.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.504 -0.771 . . . . 73.219999999999999 111.302 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.415 HD13 ' CD2' ' A' ' 87' ' ' PHE . 96.8 mt -65.58 -27.78 68.67 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.034 0.383 . . . . 74.0 112.034 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.2 mt-30 -66.31 -20.84 66.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.66 0.267 . . . . 75.200000000000003 111.007 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -101.31 -37.32 8.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.245 -0.434 . . . . 72.519999999999996 110.809 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 t -153.65 118.2 4.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 55.229999999999997 109.972 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.68 74.79 2.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.89 -0.672 . . . . 64.340000000000003 111.889 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.29 139.19 24.27 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.69 -0.3 . . . . 61.409999999999997 110.474 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.8 t -74.44 116.16 50.37 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.371 -0.603 . . . . 64.299999999999997 109.371 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.8 -38.07 46.42 Favored 'Trans proline' 0 N--CA 1.474 0.344 0 C-N-CA 123.279 2.652 . . . . 74.340000000000003 113.773 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.09 -55.99 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.12 0.415 . . . . 74.030000000000001 112.12 -175.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 28.3 p -96.13 -13.03 23.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.251 0.463 . . . . 60.219999999999999 112.251 -171.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 66.34 22.48 10.82 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.712 0.405 . . . . 74.510000000000005 111.523 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 28.3 t -74.63 141.6 44.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.077 -0.712 . . . . 65.109999999999999 109.077 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 58.7 ttp -77.41 142.18 39.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 75.409999999999997 111.301 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.519 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 61.9 t80 -129.85 126.31 22.48 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.789 -0.819 . . . . 74.409999999999997 108.789 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 34.4 Cg_endo -63.69 157.6 69.31 Favored 'Cis proline' 0 C--O 1.235 0.356 0 C-N-CA 123.823 -1.324 . . . . 71.010000000000005 112.978 2.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -47.98 147.41 7.76 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.193 3.262 . . . . 72.329999999999998 113.677 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.28 147.32 83.14 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.848 2.365 . . . . 61.299999999999997 112.649 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.411 -0.804 . . . . 75.129999999999995 109.642 178.781 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.763 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 65.3 Cg_endo . . . . . 0 N--CA 1.461 -0.39 0 N-CA-C 111.844 -0.098 . . . . 40.020000000000003 111.844 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 38.1 Cg_exo -57.48 150.98 56.59 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.898 2.399 . . . . 74.519999999999996 112.685 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -79.85 146.17 32.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.907 -0.588 . . . . 74.010000000000005 110.925 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 m -74.8 142.86 44.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.631 -0.713 . . . . 73.030000000000001 110.649 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.74 -37.48 79.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 61.119999999999997 110.301 -178.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.45 -40.06 89.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.019 -0.537 . . . . 74.340000000000003 110.697 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -67.43 -38.28 84.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.959 -0.564 . . . . 64.150000000000006 110.377 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.485 ' O ' ' HE3' ' A' ' 67' ' ' LYS . 65.6 mt -66.92 -41.45 87.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.51 . . . . 33.130000000000003 110.551 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.28 -32.52 73.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 64.310000000000002 110.427 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.52 -11.6 60.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.715 -0.675 . . . . 75.140000000000001 111.795 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 91.2 mt -65.4 133.1 95.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.469 -0.332 . . . . 73.439999999999998 110.703 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 149.64 84.08 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.092 2.528 . . . . 65.340000000000003 112.143 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 55.9 mt-10 -116.77 104.8 11.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.291 0.567 . . . . 64.319999999999993 110.75 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.0 mt -106.48 117.85 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.393 -0.821 . . . . 70.310000000000002 110.356 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.5 tp -68.03 118.85 11.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.305 -0.407 . . . . 74.0 109.956 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 28.8 t -81.5 135.17 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.997 0.427 . . . . 74.25 110.631 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p -131.99 173.01 11.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.647 -0.706 . . . . 73.409999999999997 109.848 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 15.3 mm-40 -70.31 -178.67 1.77 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.598 -0.274 . . . . 71.439999999999998 110.853 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 27.9 m-20 76.14 -51.51 0.61 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.43 0.692 . . . . 70.310000000000002 111.092 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -111.38 55.74 0.65 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.026 0.441 . . . . 72.129999999999995 109.839 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 50' ' ' TYR . . . -63.79 -31.04 79.46 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.667 -0.697 . . . . 74.299999999999997 111.618 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.38 84.22 6.06 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.248 -0.649 . . . . 43.509999999999998 109.248 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.26 -28.91 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 65.140000000000001 110.882 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.02 -142.48 3.57 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.035 -0.826 . . . . 72.120000000000005 111.035 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.97 -20.91 63.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.063 0.458 . . . . 61.420000000000002 110.397 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -103.97 130.55 51.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 64.120000000000005 110.849 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.6 ptp -102.66 -3.91 25.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.423 -0.808 . . . . 60.399999999999999 109.842 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 8.8 p -134.59 149.31 50.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.679 -0.691 . . . . 64.329999999999998 111.051 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 28.9 t -105.97 103.51 44.89 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.713 -0.676 . . . . 74.109999999999999 109.519 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 16.1 Cg_endo -56.94 -28.71 79.25 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 123.291 2.661 . . . . 63.329999999999998 112.907 -176.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mt -68.27 -28.2 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.094 -0.503 . . . . 63.009999999999998 110.871 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 78.7 m -104.74 -18.7 14.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 60.530000000000001 110.579 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.8 t 61.65 24.94 14.95 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.252 -0.886 . . . . 73.099999999999994 109.471 -172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.9 m -128.32 171.81 11.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.166 -0.925 . . . . 75.450000000000003 109.266 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER -93.76 -171.75 2.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.844 0.354 . . . . 73.209999999999994 110.639 -178.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.564 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 90.5 m-85 -98.52 103.18 15.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.118 0.485 . . . . 75.0 110.578 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.516 HG13 ' HG2' ' A' ' 49' ' ' GLU . 25.2 m -121.87 167.13 15.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.648 -0.705 . . . . 64.430000000000007 111.062 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 22.8 ttpp -54.32 127.44 27.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.336 -0.847 . . . . 75.140000000000001 111.725 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.59 -34.38 3.8 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.793 -0.718 . . . . 75.409999999999997 113.031 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -86.97 165.3 15.96 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.704 -0.48 . . . . 72.140000000000001 109.704 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.42 121.13 66.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.797 0.332 . . . . 71.420000000000002 110.544 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -100.21 160.96 13.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.978 0.418 . . . . 72.140000000000001 111.075 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 11.2 t -137.25 167.49 21.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.859 -0.61 . . . . 64.010000000000005 109.646 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -120.65 118.09 29.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.011 0.434 . . . . 74.109999999999999 110.863 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.7 mt -87.0 143.42 34.99 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.846 -0.615 . . . . 64.510000000000005 109.517 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.39 -12.8 17.94 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.937 2.425 . . . . 64.430000000000007 111.687 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 45.5 t -76.0 9.17 2.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.99 -1.005 . . . . 75.099999999999994 110.592 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 65.69 28.45 11.1 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.524 0.678 . . . . 74.040000000000006 109.736 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 136.96 54.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.543 -0.753 . . . . 72.209999999999994 110.578 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -110.78 133.26 53.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.253 -0.43 . . . . 64.109999999999999 110.714 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.541 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 91.5 m-85 -145.02 175.31 10.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.365 -0.976 . . . . 73.340000000000003 108.365 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.96 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.4 m80 -88.41 130.19 35.23 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.8 -0.815 . . . . 73.230000000000004 108.8 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 84.8 tttt -57.02 -48.06 98.07 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 112.086 0.402 . . . . 75.010000000000005 112.086 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 10.0 Cg_endo -51.46 -46.2 32.99 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.486 2.124 . . . . 75.200000000000003 113.503 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.96 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 8.4 p -84.23 -34.96 23.77 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.199 0.444 . . . . 71.049999999999997 112.199 -175.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.513 HG22 ' HG ' ' A' ' 74' ' ' LEU . 5.7 p -71.72 -26.1 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 122.225 -0.297 . . . . 73.239999999999995 110.751 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -56.98 -39.71 75.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.142 0.496 . . . . 71.349999999999994 110.72 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.494 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 59.8 mt -69.65 -40.95 79.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.914 -0.584 . . . . 75.439999999999998 110.585 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -72.96 -38.91 66.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 74.430000000000007 111.326 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.513 ' HG ' HG22 ' A' ' 70' ' ' VAL . 88.8 mt -63.86 -32.84 74.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.601 -0.272 . . . . 75.430000000000007 111.252 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -77.08 -9.52 58.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.803 0.335 . . . . 74.450000000000003 111.104 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 67.9 mttm -80.92 -58.77 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 73.129999999999995 110.927 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.8 m -148.74 11.66 0.86 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.214 0.449 . . . . 71.430000000000007 112.214 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.69 65.27 3.29 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 123.25 0.343 . . . . 65.040000000000006 113.764 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.34 160.8 43.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.669 0.235 . . . . 64.120000000000005 111.142 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.71 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 84.4 m -79.34 123.28 84.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.806 -0.812 . . . . 73.109999999999999 108.806 168.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.58 -21.81 56.89 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.498 2.132 . . . . 74.049999999999997 112.522 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.4 t -84.58 -53.43 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 60.43 111.861 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 28.9 p -98.84 -19.75 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.838 0.31 . . . . 74.439999999999998 111.838 -170.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 66.65 19.78 10.77 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.034 -0.53 . . . . 62.020000000000003 111.654 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.46 143.44 33.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.923 -0.769 . . . . 71.310000000000002 108.923 171.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.763 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 51.1 ttp -75.78 145.02 41.06 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.757 0.66 . . . . 74.219999999999999 112.516 -171.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.525 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 91.5 t80 -131.21 125.05 20.78 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.139 -0.937 . . . . 73.310000000000002 109.061 171.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 31.7 Cg_exo -60.63 153.3 52.87 Favored 'Cis proline' 0 C--N 1.348 0.541 0 C-N-CA 124.03 -1.238 . . . . 74.150000000000006 112.787 0.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.57 154.41 9.07 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.606 2.871 . . . . 74.420000000000002 113.127 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.14 147.61 94.73 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.071 2.514 . . . . 44.100000000000001 112.704 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.526 -0.75 . . . . 71.219999999999999 109.934 179.144 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo . . . . . 0 N--CA 1.461 -0.393 0 CA-C-O 121.033 0.347 . . . . 63.32 112.733 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.43 148.43 79.22 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.67 2.246 . . . . 62.539999999999999 111.251 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -76.86 139.86 40.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.405 -0.361 . . . . 64.409999999999997 110.763 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.405 ' HB3' ' OE1' ' A' ' 20' ' ' GLU . 14.6 m -61.24 129.79 43.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.955 -0.566 . . . . 64.239999999999995 110.139 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.59 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 3.2 tmmm? -58.96 -30.5 67.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.499 -0.319 . . . . 72.409999999999997 110.562 -177.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 29.2 mp0 -54.9 -41.95 71.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.962 0.411 . . . . 75.209999999999994 110.223 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.517 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 18.0 m -77.42 -34.98 54.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.858 -0.61 . . . . 75.109999999999999 110.779 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.7 -42.44 95.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.3 0.571 . . . . 42.310000000000002 110.484 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -68.68 -37.48 79.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.687 -0.688 . . . . 71.329999999999998 110.968 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.63 -6.61 49.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.11 -0.495 . . . . 21.5 111.705 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.717 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 57.3 mt -63.68 125.34 87.37 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 116.245 -0.434 . . . . 74.129999999999995 110.681 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' A' ' 57' ' ' THR . 19.4 Cg_endo -58.04 125.37 18.35 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.471 2.781 . . . . 64.219999999999999 113.228 -175.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -81.12 113.72 19.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.456 -0.793 . . . . 75.209999999999994 110.654 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.7 mt -112.56 109.42 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.279 -0.419 . . . . 54.539999999999999 110.101 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.92 118.29 10.19 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.908 -0.404 . . . . 62.030000000000001 109.908 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 50' ' ' TYR . 53.0 t -81.63 128.96 38.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.166 0.508 . . . . 73.239999999999995 111.648 -173.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.479 HG22 ' HG3' ' A' ' 52' ' ' LYS . 17.0 p -126.01 138.16 53.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.376 -0.829 . . . . 73.049999999999997 109.269 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 52' ' ' LYS . 39.4 mt-10 -63.94 -10.7 22.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.357 . . . . 74.099999999999994 111.726 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.09 -33.11 74.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.89 -0.595 . . . . 74.239999999999995 109.759 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 40.3 t-80 -134.13 81.73 1.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.354 -0.839 . . . . 71.319999999999993 109.553 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.37 -36.07 31.59 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.917 -0.658 . . . . 74.540000000000006 112.942 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.37 86.0 6.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.25 0.548 . . . . 51.409999999999997 110.665 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.5 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 6.3 t -74.82 -23.73 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.685 -0.689 . . . . 71.140000000000001 110.302 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.07 -134.58 1.71 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.261 -0.736 . . . . 73.230000000000004 111.261 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -68.86 -42.41 77.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.463 0.649 . . . . 65.319999999999993 109.502 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -73.29 113.01 9.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.122 -0.945 . . . . 74.109999999999999 110.548 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -95.2 -5.05 44.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.644 0.735 . . . . 72.219999999999999 109.257 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.2 p -144.53 167.93 21.34 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.097 -0.956 . . . . 74.150000000000006 110.087 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 43.0 t -115.63 92.83 34.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.713 -0.477 . . . . 75.140000000000001 109.713 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 19.8 Cg_endo -59.11 -28.14 86.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.979 2.453 . . . . 72.129999999999995 112.358 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.0 mt -56.16 -39.24 57.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.487 -0.779 . . . . 75.310000000000002 111.609 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.7 p -117.54 6.27 12.51 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.923 -0.311 . . . . 61.219999999999999 110.54 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.1 m 53.03 67.79 0.94 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.464 -0.789 . . . . 63.520000000000003 111.407 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 p -156.67 168.28 27.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.834 -0.621 . . . . 71.340000000000003 109.522 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.74 -170.0 2.75 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.4 -0.592 . . . . 73.420000000000002 109.4 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.572 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 61.6 m-85 -93.72 89.65 6.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.382 0.611 . . . . 62.219999999999999 110.773 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 m -85.94 158.12 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.101 -0.954 . . . . 75.409999999999997 111.251 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' HG3' HG22 ' A' ' 31' ' ' THR . 38.8 ttmt -73.34 120.46 18.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.984 -0.553 . . . . 75.0 110.547 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.85 -19.66 6.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.635 -0.793 . . . . 71.310000000000002 112.491 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -84.99 166.5 16.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.981 -0.748 . . . . 72.409999999999997 108.981 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.9 t -115.19 131.18 68.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.774 -0.454 . . . . 74.209999999999994 109.774 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.57 175.46 5.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.839 0.352 . . . . 60.439999999999998 110.654 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.717 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.6 t -151.61 160.79 43.51 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.817 -0.629 . . . . 73.349999999999994 109.933 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 31.7 tt0 -107.71 126.76 52.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.474 . . . . 73.400000000000006 110.301 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.2 mt -92.06 142.56 26.48 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 108.942 -0.762 . . . . 74.430000000000007 108.942 171.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.99 -10.61 12.85 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.203 2.602 . . . . 75.310000000000002 111.745 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.13 19.34 2.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.967 -1.015 . . . . 50.030000000000001 110.289 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 56.09 37.26 28.66 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.763 -0.653 . . . . 64.0 111.458 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -132.66 141.56 48.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.564 -0.744 . . . . 75.549999999999997 110.014 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -119.87 133.42 55.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.198 -0.456 . . . . 73.120000000000005 110.754 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.572 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 98.0 m-85 -143.84 168.1 20.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.983 -0.553 . . . . 74.109999999999999 109.841 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 33.1 m170 -64.02 128.17 34.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.299 -0.63 . . . . 71.450000000000003 109.299 171.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 64.1 tttp -56.77 -53.08 68.56 Favored Pre-proline 0 CA--C 1.535 0.386 0 O-C-N 123.342 0.401 . . . . 70.129999999999995 111.376 -177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 12.2 Cg_endo -56.97 -45.3 37.14 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.16 1.906 . . . . 62.210000000000001 112.232 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 66.2 m -61.38 -48.73 79.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.122 -0.49 . . . . 54.420000000000002 111.357 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.534 HG22 ' HG ' ' A' ' 74' ' ' LEU . 7.7 p -69.82 -27.58 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 53.530000000000001 110.618 -175.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.8 m -61.98 -37.05 83.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 51.450000000000003 110.361 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.3 mt -66.65 -43.32 90.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.514 . . . . 75.409999999999997 110.131 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -68.94 -47.15 66.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.017 -0.538 . . . . 71.430000000000007 110.904 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 94.4 mt -60.77 -36.39 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.105 0.409 . . . . 72.519999999999996 112.105 -175.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.26 -12.71 61.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.715 0.293 . . . . 74.400000000000006 111.184 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -98.77 -50.89 4.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.333 0.587 . . . . 62.32 109.593 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.7 p -151.77 113.3 4.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.383 -0.826 . . . . 62.520000000000003 109.858 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.92 85.92 0.38 Allowed Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.946 -0.645 . . . . 71.230000000000004 112.613 -176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 2.0 p -149.36 161.79 41.37 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.313 0.245 . . . . 73.129999999999995 111.271 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.772 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 95.8 m -79.24 120.52 80.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.32 -0.993 . . . . 73.310000000000002 108.32 165.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.46 -14.52 25.72 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.308 2.006 . . . . 71.530000000000001 113.044 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.23 -43.47 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.307 -0.406 . . . . 75.439999999999998 112.005 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.772 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.3 p -105.88 -17.35 14.39 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.809 -0.356 . . . . 71.409999999999997 111.599 -172.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 63.69 23.55 13.55 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.177 0.591 . . . . 73.519999999999996 111.973 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 79' ' ' THR . 34.6 t -89.05 155.53 19.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.219 -0.66 . . . . 72.219999999999999 109.219 173.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.517 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 25.7 ttm -82.28 149.61 27.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.556 0.576 . . . . 75.329999999999998 112.556 -167.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.477 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 66.0 t80 -136.93 120.22 11.89 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 114.934 -1.03 . . . . 73.129999999999995 108.803 168.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 34.0 Cg_endo -62.85 152.76 68.5 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 123.863 -1.307 . . . . 74.319999999999993 112.572 2.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.23 142.65 55.44 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.147 2.565 . . . . 72.340000000000003 112.944 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 39.4 Cg_endo -67.61 147.56 76.55 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.86 2.374 . . . . 72.349999999999994 112.232 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.42 -0.8 . . . . 62.329999999999998 110.255 -179.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.1 Cg_endo . . . . . 0 C--O 1.236 0.387 0 N-CA-C 113.071 0.374 . . . . 74.329999999999998 113.071 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 23.9 Cg_exo -64.27 152.28 81.95 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.934 2.423 . . . . 75.230000000000004 111.858 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -84.08 166.67 17.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.888 0.375 . . . . 42.119999999999997 110.831 -177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.3 p -87.24 144.31 26.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.072 -0.513 . . . . 54.009999999999998 110.574 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -62.47 -36.02 81.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 74.430000000000007 111.168 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.6 -28.48 69.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.022 -0.535 . . . . 61.130000000000003 111.131 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 t -82.94 -24.62 32.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.383 -0.372 . . . . 61.450000000000003 110.19 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 18' ' ' SER . 60.0 mt -79.76 -38.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.309 0.576 . . . . 74.329999999999998 110.304 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.04 -27.68 63.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.736 -0.666 . . . . 71.450000000000003 110.882 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.08 -4.36 55.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.519999999999996 111.871 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 64.3 mt -63.7 131.43 94.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.567 -0.288 . . . . 71.340000000000003 111.069 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.84 141.18 77.14 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.774 2.316 . . . . 71.530000000000001 112.094 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -104.7 119.09 38.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.184 0.516 . . . . 73.239999999999995 110.913 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 65.4 mt -112.29 120.82 63.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.47 -0.786 . . . . 72.030000000000001 110.082 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.9 tp -74.61 122.54 23.32 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.94 -0.392 . . . . 75.109999999999999 109.94 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 43.1 t -92.13 127.46 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.863 0.363 . . . . 73.400000000000006 111.337 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.4 p -128.19 172.84 10.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.687 -0.688 . . . . 74.530000000000001 110.022 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -76.9 -10.16 59.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.795 0.331 . . . . 75.340000000000003 110.7 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -84.78 -10.21 57.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 110.186 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 21.1 t-80 -149.56 61.92 1.01 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.085 0.469 . . . . 71.510000000000005 110.349 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.36 -43.34 79.15 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.77 -0.65 . . . . 75.030000000000001 111.513 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.59 98.76 6.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.765 -0.457 . . . . 31.129999999999999 109.765 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.496 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 14.0 t -82.72 -20.81 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.254 0.549 . . . . 75.239999999999995 110.229 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.73 -140.38 2.87 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.178 -0.769 . . . . 42.450000000000003 111.178 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.81 -26.35 64.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.053 0.454 . . . . 74.549999999999997 110.071 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -111.68 160.75 16.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.775 -0.648 . . . . 72.530000000000001 110.269 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -141.13 13.09 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.331 . . . . 75.120000000000005 111.267 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 71.6 m -132.42 140.07 48.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.5 -0.318 . . . . 74.420000000000002 110.704 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 41.7 t -103.3 100.15 17.14 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.636 -0.505 . . . . 52.109999999999999 109.636 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 32.1 Cg_endo -63.61 -24.76 69.59 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.921 2.414 . . . . 71.219999999999999 112.724 -175.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.4 mt -61.14 -35.24 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.073 -0.512 . . . . 51.409999999999997 110.916 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 28.2 p -112.95 10.85 18.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.41 . . . . 74.129999999999995 109.918 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.0 p 40.33 51.76 2.82 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.174 0.921 . . . . 64.510000000000005 111.911 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.1 m -150.75 150.13 30.64 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.993 -0.548 . . . . 74.0 110.103 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 13.1 pt-20 -77.92 -169.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.123 0.487 . . . . 73.230000000000004 110.955 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.476 ' HB3' HG11 ' A' ' 30' ' ' VAL . 45.4 m-85 -90.12 113.07 24.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.193 0.521 . . . . 71.329999999999998 111.433 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.44 162.4 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.318 -0.856 . . . . 65.400000000000006 110.473 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 39.5 ttmt -65.84 128.52 36.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.115 -0.493 . . . . 72.519999999999996 110.934 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.49 -24.01 11.7 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.709 -0.757 . . . . 54.340000000000003 112.873 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -82.55 159.22 22.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.739 -0.467 . . . . 62.409999999999997 109.739 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.09 119.22 57.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.488 -0.324 . . . . 72.450000000000003 110.474 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -97.85 168.27 10.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.393 -0.367 . . . . 74.310000000000002 110.955 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.51 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 14.6 t -152.59 156.8 40.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.902 -0.59 . . . . 73.430000000000007 109.717 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -116.73 118.57 32.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.78 0.324 . . . . 72.120000000000005 110.496 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.96 148.67 81.97 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.138 -0.69 . . . . 75.530000000000001 109.138 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.79 -9.72 10.23 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.899 2.399 . . . . 70.329999999999998 112.067 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.3 9.15 11.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.364 -0.835 . . . . 74.230000000000004 109.938 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m170 58.85 37.43 24.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.838 -0.619 . . . . 62.049999999999997 111.469 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -121.07 145.06 48.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.741 -0.663 . . . . 73.340000000000003 109.495 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -114.09 132.8 55.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.253 0.549 . . . . 75.049999999999997 111.609 -172.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.9 175.41 10.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.279 -0.873 . . . . 73.230000000000004 108.721 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.745 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 37.4 m80 -87.07 135.46 33.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.8 -0.815 . . . . 73.519999999999996 108.8 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.495 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.0 tttt -59.48 -50.19 88.46 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.308 0.38 . . . . 75.430000000000007 111.841 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.6 Cg_endo -60.87 -18.51 57.15 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.03 1.82 . . . . 63.439999999999998 112.911 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 64.5 m -83.9 -53.03 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.225 0.536 . . . . 63.439999999999998 110.865 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 p -70.38 -27.25 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.54 -0.755 . . . . 74.219999999999999 111.216 -172.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.555 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 6.4 p -61.16 -32.34 72.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.467 -0.333 . . . . 71.310000000000002 111.193 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.0 mt -74.99 -44.45 44.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.177 0.513 . . . . 54.420000000000002 110.272 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -62.23 -43.93 97.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.598 -0.728 . . . . 75.140000000000001 111.182 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 91.7 mt -65.19 -23.9 67.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 55.409999999999997 111.687 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.6 mt-30 -73.94 -15.26 61.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 74.430000000000007 110.884 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -106.18 -43.81 4.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.342 0.591 . . . . 65.120000000000005 109.99 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.9 p -153.32 114.62 4.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.441 -0.799 . . . . 53.310000000000002 110.397 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.87 81.35 1.02 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.558 -0.829 . . . . 74.049999999999997 112.124 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.4 164.51 34.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.507 0.194 . . . . 64.109999999999999 111.495 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.626 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 68.5 m -74.87 116.82 57.51 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 107.953 -1.128 . . . . 71.439999999999998 107.953 162.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.63 -17.29 27.91 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 122.492 2.128 . . . . 74.310000000000002 112.526 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.23 -57.44 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.78 -0.645 . . . . 74.209999999999994 111.767 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.9 p -94.48 -12.67 27.25 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.36 0.504 . . . . 64.109999999999999 112.36 -169.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' CYS . 20.8 mmt180 74.24 4.9 4.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.004 0.521 . . . . 74.120000000000005 112.015 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.4 t -73.22 145.23 46.37 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.164 -0.214 . . . . 61.5 110.425 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.545 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 36.0 ttm -74.34 145.84 43.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 63.219999999999999 112.438 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.435 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 74.1 t80 -128.8 121.43 20.98 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.409 -0.814 . . . . 73.439999999999998 109.85 171.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.07 157.41 99.55 Favored 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.999 -1.667 . . . . 73.420000000000002 111.731 -1.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.56 142.33 31.26 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.83 2.353 . . . . 64.239999999999995 112.508 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 28.5 Cg_endo -62.62 152.08 79.87 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.001 2.467 . . . . 64.109999999999999 112.185 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.541 -0.742 . . . . 73.319999999999993 110.187 -177.236 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo . . . . . 0 C--O 1.235 0.332 0 CA-C-O 120.593 0.164 . . . . 45.310000000000002 112.392 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.47 163.0 34.18 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.923 2.416 . . . . 71.129999999999995 112.754 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.83 177.57 6.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.105 -0.498 . . . . 71.129999999999995 110.694 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -90.25 143.05 27.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.371 -0.377 . . . . 73.430000000000007 109.987 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -57.09 -39.59 75.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.932 0.396 . . . . 72.310000000000002 110.618 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.66 -23.8 60.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 71.510000000000005 111.243 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.8 m -77.19 -31.04 55.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.999 0.428 . . . . 74.540000000000006 109.948 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.9 mt -78.38 -40.86 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 75.430000000000007 109.968 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.03 -35.8 73.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.888 -0.596 . . . . 73.219999999999999 110.607 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.28 -4.02 48.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.733 -0.667 . . . . 52.439999999999998 112.156 -176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 74.1 mt -65.89 126.34 91.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.66 0.266 . . . . 71.439999999999998 110.349 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.03 136.27 64.31 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.958 2.439 . . . . 64.340000000000003 112.324 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.83 113.4 26.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.128 -0.487 . . . . 75.530000000000001 110.193 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.5 mt -114.72 132.45 63.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.849 -0.614 . . . . 64.439999999999998 110.01 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 47.9 tp -86.81 116.7 25.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.166 -0.309 . . . . 70.120000000000005 110.166 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 54.0 t -71.21 135.74 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.29 -0.414 . . . . 73.230000000000004 109.893 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 32.8 p -128.64 172.83 10.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.271 -0.422 . . . . 72.450000000000003 110.423 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.534 ' HG2' ' HE3' ' A' ' 52' ' ' LYS . 42.5 mm-40 -70.34 -25.13 63.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 75.299999999999997 111.152 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.95 -7.08 58.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 54.350000000000001 111.131 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.676 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 59.9 t-80 -153.18 64.6 0.77 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.712 -0.477 . . . . 65.120000000000005 109.712 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.1 -59.61 7.26 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.81 -0.632 . . . . 75.099999999999994 112.297 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.28 92.81 1.82 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.056 0.455 . . . . 61.420000000000002 109.93 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.676 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 6.4 t -63.26 -49.33 83.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 74.329999999999998 109.894 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.11 -138.88 5.1 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.655 -1.378 . . . . 61.219999999999999 109.655 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.86 -11.41 59.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.611 0.705 . . . . 75.430000000000007 109.532 171.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -83.5 100.16 10.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 75.219999999999999 110.161 171.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -91.33 -12.5 34.8 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.603 0.716 . . . . 75.439999999999998 109.208 172.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.751 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 57.2 m -138.24 131.29 30.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.035 -0.984 . . . . 54.219999999999999 109.29 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.6 t -70.93 109.09 4.51 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 123.342 0.401 . . . . 71.099999999999994 110.018 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.71 -24.47 74.78 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.782 2.322 . . . . 75.349999999999994 112.185 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.83 -25.7 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.259 0.552 . . . . 62.340000000000003 110.675 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 40.0 m -117.46 2.3 12.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.174 -0.466 . . . . 61.329999999999998 110.879 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p 42.79 35.78 0.76 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.657 0.783 . . . . 62.549999999999997 111.674 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.4 t -136.43 148.14 47.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.97 -0.559 . . . . 34.130000000000003 110.036 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.751 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 9.9 pt-20 -79.21 168.56 19.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.565 0.58 . . . . 73.239999999999995 112.565 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.2 m-85 -98.02 130.35 44.85 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 74.129999999999995 110.666 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -132.7 177.87 6.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.016 -0.365 . . . . 64.109999999999999 110.016 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 40.0 ttmt -60.06 113.06 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 71.349999999999994 110.878 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.25 -11.02 7.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.623 . . . . 32.200000000000003 112.06 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.53 131.94 36.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.853 0.359 . . . . 63.5 111.088 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -88.07 110.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.212 -0.449 . . . . 73.420000000000002 109.956 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.1 155.66 22.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.086 -0.507 . . . . 71.030000000000001 110.394 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.9 t -132.43 159.3 39.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.065 -0.516 . . . . 74.129999999999995 109.839 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -109.3 123.07 48.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.918 0.39 . . . . 64.530000000000001 111.469 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.9 mt -87.05 140.03 32.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.319 -0.993 . . . . 70.129999999999995 108.319 167.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.69 -13.02 7.43 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.304 2.669 . . . . 73.109999999999999 113.802 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.2 p -90.42 19.88 4.92 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.801 0.334 . . . . 64.340000000000003 110.71 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 60.32 54.63 3.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.91 -0.586 . . . . 74.230000000000004 112.034 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -142.3 141.29 32.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.834 -0.621 . . . . 73.120000000000005 109.373 174.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -120.39 133.47 55.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.406 0.622 . . . . 75.140000000000001 111.934 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.563 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 65.2 m-85 -139.26 175.17 9.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.298 -0.864 . . . . 74.319999999999993 108.754 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.829 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 40.4 m80 -76.45 132.14 39.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.302 -0.999 . . . . 72.120000000000005 108.302 173.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 85.5 tttt -56.25 -48.96 95.88 Favored Pre-proline 0 C--N 1.32 -0.688 0 O-C-N 123.301 0.376 . . . . 75.400000000000006 111.913 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 7.2 Cg_endo -50.45 -51.38 11.14 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.454 2.103 . . . . 64.319999999999993 113.426 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.829 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 18.9 p -77.1 -30.46 55.33 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.627 -0.429 . . . . 74.25 111.815 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 67' ' ' LYS . 5.4 p -70.75 -26.48 28.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 120.329 -0.548 . . . . 70.340000000000003 109.752 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 41.3 m -60.84 -48.23 82.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.641 -0.503 . . . . 72.200000000000003 109.641 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.441 HG22 ' HE3' ' A' ' 76' ' ' LYS . 42.7 mt -62.75 -40.51 88.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.609 -0.723 . . . . 63.299999999999997 110.625 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -66.49 -50.96 61.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.004 -0.544 . . . . 74.310000000000002 111.126 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 77' ' ' SER . 94.9 mt -66.09 -20.91 66.31 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.143 0.424 . . . . 75.209999999999994 112.143 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.9 mt-30 -79.44 -8.3 59.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 72.319999999999993 110.785 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HE3' HG22 ' A' ' 72' ' ' ILE . 10.1 mtmp? -114.43 -34.26 5.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.368 -0.378 . . . . 72.519999999999996 110.792 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 34.1 t -148.33 127.51 12.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.812 -0.44 . . . . 73.450000000000003 109.812 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.56 47.06 3.01 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.691 -0.766 . . . . 74.420000000000002 112.653 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.29 149.5 49.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.028 0.442 . . . . 53.109999999999999 111.318 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 38.6 t -74.65 114.36 33.43 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.471 -0.786 . . . . 65.150000000000006 109.512 175.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 80' ' ' CYS . 16.5 Cg_endo -57.24 -22.46 48.86 Favored 'Trans proline' 0 N--CA 1.474 0.326 0 C-N-CA 122.712 2.274 . . . . 70.049999999999997 112.84 -174.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.7 t -82.86 -31.89 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.301 0.482 . . . . 60.25 112.301 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.0 p -130.27 -11.6 4.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.686 0.625 . . . . 44.409999999999997 112.686 -173.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 70.49 13.44 7.42 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.489 0.716 . . . . 65.200000000000003 111.832 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.8 t -73.08 144.07 47.18 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.152 -0.684 . . . . 70.129999999999995 109.152 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 60.9 ttp -79.12 151.57 31.28 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.369 0.418 . . . . 54.310000000000002 111.047 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -126.42 119.59 23.26 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.84 -0.618 . . . . 62.439999999999998 109.537 173.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.48 156.0 92.23 Favored 'Cis proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.45 -1.479 . . . . 62.130000000000003 112.399 -0.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.01 155.14 46.28 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.103 2.535 . . . . 65.430000000000007 112.798 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.46 -173.21 1.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.677 2.251 . . . . 64.209999999999994 112.178 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.375 -0.821 . . . . 62.420000000000002 110.394 -179.01 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo . . . . . 0 C--O 1.234 0.294 0 CA-C-O 120.932 0.305 . . . . 73.310000000000002 112.358 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.15 162.79 40.68 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.623 2.215 . . . . 70.109999999999999 112.127 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.87 143.61 26.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.256 -0.429 . . . . 61.329999999999998 110.277 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -70.92 147.67 48.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.952 -0.388 . . . . 72.129999999999995 109.952 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -53.02 -38.38 62.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.306 -0.407 . . . . 71.109999999999999 111.267 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.4 -42.49 91.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.875 -0.602 . . . . 61.420000000000002 111.901 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.5 m -70.66 -34.41 71.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.109 0.481 . . . . 74.109999999999999 110.714 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.479 HG21 ' HA ' ' A' ' 71' ' ' SER . 68.6 mt -72.81 -42.85 61.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.978 -0.555 . . . . 64.25 111.059 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.3 -21.72 62.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.222 -0.445 . . . . 74.0 110.508 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.74 -3.89 54.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 51.009999999999998 111.622 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.454 HD13 HG21 ' A' ' 57' ' ' THR . 25.2 mt -56.52 135.32 77.11 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.602 -0.272 . . . . 52.130000000000003 111.379 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.39 129.99 36.85 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.137 2.558 . . . . 75.120000000000005 111.722 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -98.26 111.66 23.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.089 0.471 . . . . 71.430000000000007 110.732 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -112.71 109.99 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.588 -0.733 . . . . 74.420000000000002 109.758 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.79 123.52 20.37 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.514 -0.55 . . . . 62.299999999999997 109.514 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 47.2 t -74.18 114.38 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.046 0.451 . . . . 55.439999999999998 110.669 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.9 p -115.3 131.82 56.81 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.653 -0.703 . . . . 72.329999999999998 109.87 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 53.2 mt-10 -66.58 -13.97 61.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 64.420000000000002 111.251 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.23 -29.28 70.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.336 0.589 . . . . 74.030000000000001 110.012 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -92.7 -16.9 24.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.277 -0.874 . . . . 73.030000000000001 110.092 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.54 -113.72 4.36 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.41 -0.676 . . . . 75.530000000000001 111.41 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.66 132.01 40.3 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.7 -0.482 . . . . 74.430000000000007 109.7 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.57 -31.67 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.247 0.546 . . . . 64.25 110.217 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.518 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . -164.37 -118.23 0.44 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.176 -0.77 . . . . 74.219999999999999 111.176 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -64.45 -55.06 23.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.311 0.577 . . . . 74.0 110.435 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 142.02 28.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.417 -0.81 . . . . 71.219999999999999 111.702 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 ptp -112.73 7.37 18.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.496 -0.775 . . . . 72.450000000000003 109.545 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 19.6 p -126.6 149.55 49.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.401 -0.818 . . . . 62.030000000000001 109.926 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 41.3 t -110.32 101.01 46.83 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.042 -0.355 . . . . 65.430000000000007 110.042 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.7 Cg_endo -54.41 -31.98 70.69 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.412 2.741 . . . . 65.150000000000006 112.583 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.2 -34.74 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.952 -0.567 . . . . 72.209999999999994 110.883 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.0 m -98.46 -18.9 17.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 111.354 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.2 m 65.89 22.23 11.37 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.444 0.64 . . . . 62.140000000000001 110.032 -172.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -130.51 175.43 8.99 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.264 -0.88 . . . . 74.109999999999999 109.524 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 8.5 pt-20 -98.96 -175.24 2.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.048 0.452 . . . . 74.319999999999993 111.477 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.514 ' HB3' HG11 ' A' ' 30' ' ' VAL . 56.0 m-85 -100.89 120.23 39.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.966 -0.561 . . . . 75.209999999999994 110.591 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.5 m -127.29 169.35 18.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.895 -0.593 . . . . 64.109999999999999 110.783 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 33.7 ttmt -74.36 110.92 9.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 74.209999999999994 110.886 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.61 -26.85 2.63 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.785 -0.721 . . . . 72.340000000000003 112.413 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -86.86 160.94 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.816 -0.439 . . . . 64.120000000000005 109.816 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -108.06 126.55 64.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.905 0.383 . . . . 64.150000000000006 110.711 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.05 170.7 7.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.174 -0.467 . . . . 72.099999999999994 110.567 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.454 HG21 HD13 ' A' ' 25' ' ' LEU . 13.5 t -148.98 156.65 42.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.06 -0.518 . . . . 54.530000000000001 109.647 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -110.55 117.47 33.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.49 -0.323 . . . . 74.319999999999993 110.376 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.9 mt -75.4 156.16 85.47 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.967 -0.753 . . . . 71.340000000000003 108.967 172.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.41 -23.82 14.89 Favored 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.095 2.53 . . . . 74.5 113.56 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.6 p -90.76 15.49 11.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.462 0.171 . . . . 71.430000000000007 111.462 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 44.8 m80 67.29 24.68 8.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.911 0.485 . . . . 74.349999999999994 112.061 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -102.83 133.25 48.21 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.741 -0.466 . . . . 72.239999999999995 109.741 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 80.5 m-85 -105.63 133.28 50.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.171 -0.468 . . . . 72.329999999999998 112.011 -171.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.499 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 99.2 m-85 -138.02 175.31 9.7 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.522 -0.918 . . . . 74.420000000000002 108.522 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.876 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.6 m80 -84.02 128.28 34.44 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.864 -0.791 . . . . 74.209999999999994 108.864 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 89.0 tttt -53.35 -48.32 92.99 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 123.578 0.549 . . . . 72.329999999999998 111.828 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 73.1 Cg_exo -53.47 -47.31 28.04 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 122.334 2.023 . . . . 74.230000000000004 113.801 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.876 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 25.8 p -82.79 -36.92 25.22 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.773 -0.371 . . . . 63.509999999999998 111.942 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 8.7 p -68.39 -24.99 30.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.77 -0.455 . . . . 74.099999999999994 109.77 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.53 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 47.5 t -55.07 -50.57 68.81 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.684 -0.689 . . . . 72.420000000000002 110.626 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.7 mt -66.0 -38.76 82.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 74.409999999999997 110.507 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -62.85 -47.1 84.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.922 -0.581 . . . . 73.310000000000002 110.634 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 97.1 mt -66.22 -29.26 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 75.129999999999995 111.258 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 71' ' ' SER . 78.6 mt-30 -71.24 -13.41 61.9 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.865 0.364 . . . . 73.450000000000003 110.73 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -101.82 -45.05 5.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 72.109999999999999 110.12 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.2 p -153.19 119.9 5.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.759 -0.655 . . . . 53.140000000000001 109.897 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.16 66.14 3.85 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.656 -0.783 . . . . 42.32 112.668 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.31 144.35 34.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.804 0.335 . . . . 72.219999999999999 111.241 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.01 104.74 1.46 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.995 -0.548 . . . . 63.329999999999998 109.78 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -48.37 -37.15 32.04 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.67 2.913 . . . . 75.049999999999997 114.322 -168.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.2 -28.42 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.304 0.483 . . . . 74.540000000000006 112.304 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.3 p -127.4 -26.74 3.0 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.986 -0.447 . . . . 51.520000000000003 111.801 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.468 ' HD2' ' HA ' ' A' ' 84' ' ' ARG . 5.1 tpt180 79.86 18.99 0.66 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.558 1.143 . . . . 75.420000000000002 110.635 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.2 t -69.0 138.34 54.43 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.605 -0.887 . . . . 75.049999999999997 108.605 169.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.564 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 41.1 ttm -80.8 148.42 30.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.966 0.413 . . . . 65.400000000000006 111.794 -171.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 81.3 t80 -133.65 116.5 13.84 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.705 -0.68 . . . . 74.540000000000006 109.448 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 8.6 Cg_exo -72.05 151.95 96.44 Favored 'Cis proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.271 -1.554 . . . . 50.450000000000003 111.82 -0.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -50.08 147.64 14.94 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.272 2.648 . . . . 74.129999999999995 112.384 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 38.7 Cg_endo -65.28 149.63 88.27 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.363 2.042 . . . . 62.520000000000003 112.012 -174.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.873 -0.584 . . . . 73.439999999999998 110.213 -177.931 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo . . . . . 0 CA--C 1.532 0.396 0 CA-C-O 120.55 0.146 . . . . 64.150000000000006 111.87 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 155.43 61.87 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.644 2.229 . . . . 72.430000000000007 112.752 -175.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.92 144.76 26.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.898 -0.592 . . . . 50.109999999999999 110.641 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.3 m -65.52 145.02 56.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.978 -0.555 . . . . 70.310000000000002 110.882 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -58.22 -45.06 88.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 71.540000000000006 110.924 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -48.8 -48.12 41.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.745 -0.661 . . . . 71.239999999999995 111.259 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.0 m -67.88 -34.22 76.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 53.200000000000003 111.338 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.4 HG21 ' HA ' ' A' ' 71' ' ' SER . 60.4 mt -72.94 -44.51 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.278 0.561 . . . . 71.030000000000001 110.393 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -62.96 -35.52 80.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.782 -0.645 . . . . 62.399999999999999 110.705 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.01 5.2 17.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.801 -0.636 . . . . 65.540000000000006 112.184 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 74.2 mt -69.69 142.28 91.18 Favored Pre-proline 0 C--O 1.237 0.419 0 N-CA-C 110.252 -0.277 . . . . 73.019999999999996 110.252 175.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.25 149.0 91.09 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.955 2.437 . . . . 72.200000000000003 112.353 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -113.04 105.81 13.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 70.439999999999998 110.451 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.7 mt -100.08 121.69 51.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.93 -0.577 . . . . 75.310000000000002 110.016 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.6 tp -81.2 122.29 27.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.835 0.35 . . . . 62.219999999999999 110.467 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.575 HG11 ' HB3' ' A' ' 50' ' ' TYR . 47.0 t -88.43 134.3 28.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.248 -0.433 . . . . 75.109999999999999 110.212 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.2 p -113.35 172.81 6.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.656 -0.702 . . . . 70.040000000000006 110.831 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HG2' ' HE3' ' A' ' 52' ' ' LYS . 5.7 mm-40 -59.39 134.39 56.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.409 -0.359 . . . . 63.140000000000001 110.776 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.0 t70 53.44 74.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.322 -0.853 . . . . 73.319999999999993 110.579 -172.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -165.22 29.51 0.06 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.126 -0.943 . . . . 73.150000000000006 108.785 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 41' ' ' MET . . . -59.82 -36.65 90.67 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.468 -0.787 . . . . 53.140000000000001 111.628 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.59 84.27 5.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.31 0.576 . . . . 74.329999999999998 110.046 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.9 t -75.23 -23.25 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.571 -0.741 . . . . 71.420000000000002 109.986 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.45 -126.3 0.82 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.001 -0.84 . . . . 74.439999999999998 111.001 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.84 -3.5 41.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.342 0.591 . . . . 62.219999999999999 110.255 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -120.24 153.5 36.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.476 -0.784 . . . . 72.120000000000005 109.898 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.6 pmm? -134.92 9.79 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.113 -0.494 . . . . 71.540000000000006 110.262 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.6 p -147.61 151.01 35.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.149 -0.478 . . . . 60.350000000000001 111.045 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 37.4 t -101.49 100.96 15.29 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.488 -0.778 . . . . 72.329999999999998 109.296 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 16.3 Cg_endo -57.44 -31.62 91.78 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.931 2.421 . . . . 54.219999999999999 112.564 -176.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -60.95 -27.03 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 70.349999999999994 110.944 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.6 m -110.24 -15.35 14.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.33 -0.395 . . . . 72.540000000000006 111.103 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.0 m 58.32 45.1 17.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.186 -0.461 . . . . 55.32 109.964 -172.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.3 t -154.41 175.1 13.98 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.814 -0.63 . . . . 54.210000000000001 109.734 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -101.89 -169.87 1.74 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.743 0.306 . . . . 74.239999999999995 111.705 -173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.575 ' HB3' HG11 ' A' ' 30' ' ' VAL . 94.9 m-85 -111.07 134.18 52.87 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.077 -0.51 . . . . 74.439999999999998 110.781 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.9 m -136.89 -179.6 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.328 -0.397 . . . . 75.530000000000001 110.62 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.554 ' HE3' ' HG2' ' A' ' 32' ' ' GLU . 37.8 ttmt -56.73 133.28 53.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.058 0.456 . . . . 62.130000000000003 111.168 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.9 -8.65 59.65 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.798 -0.715 . . . . 71.319999999999993 112.04 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -78.58 129.11 34.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.833 0.349 . . . . 75.129999999999995 111.311 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.19 102.06 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.63 . . . . 54.039999999999999 109.463 174.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.69 162.76 13.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.827 -0.624 . . . . 73.140000000000001 110.458 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 10.5 t -140.58 155.48 46.56 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.655 -0.498 . . . . 74.129999999999995 109.655 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -116.02 117.54 30.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 44.420000000000002 110.64 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -79.29 150.2 73.64 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.988 -0.551 . . . . 72.430000000000007 109.88 176.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.8 -14.99 24.39 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.313 2.675 . . . . 72.299999999999997 113.083 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.4 p -87.24 10.99 15.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.249 -0.278 . . . . 74.230000000000004 110.249 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 62.24 77.79 0.32 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.731 -0.668 . . . . 65.319999999999993 111.161 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -160.94 149.64 16.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.258 -0.883 . . . . 72.319999999999993 109.226 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.75 132.87 55.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.943 0.402 . . . . 52.299999999999997 111.662 -173.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.465 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 91.6 m-85 -141.51 175.29 9.8 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.101 -0.703 . . . . 61.009999999999998 109.101 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.895 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 40.5 m80 -81.43 131.7 35.29 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.152 -1.055 . . . . 71.310000000000002 108.152 172.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 87.5 tttt -56.13 -49.94 90.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 O-C-N 123.334 0.396 . . . . 74.040000000000006 112.018 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 51.0 Cg_exo -56.9 -46.78 26.89 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.005 1.804 . . . . 73.530000000000001 113.537 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.895 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 25.1 p -74.57 -32.44 62.4 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.586 -0.446 . . . . 64.5 111.615 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 67' ' ' LYS . 7.5 p -73.01 -24.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.494 -0.483 . . . . 70.349999999999994 109.788 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.4 ' HA ' HG21 ' A' ' 22' ' ' ILE . 55.7 m -60.83 -43.07 98.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 72.349999999999994 110.431 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.05 -42.95 89.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 60.439999999999998 110.351 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.64 -46.24 83.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.641 -0.709 . . . . 75.239999999999995 111.42 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.37 -22.21 65.58 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.866 0.321 . . . . 75.400000000000006 111.866 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -81.15 -7.17 59.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.105 0.479 . . . . 74.219999999999999 110.714 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -109.82 -52.15 2.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.79 -0.641 . . . . 73.219999999999999 110.452 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.9 t -142.96 115.99 8.86 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.634 -0.506 . . . . 70.319999999999993 109.634 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.5 72.09 1.76 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.92 -0.657 . . . . 63.539999999999999 112.226 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.402 HG22 ' HA ' ' A' ' 84' ' ' ARG . 1.7 m -147.11 137.49 23.46 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.901 -0.407 . . . . 63.310000000000002 109.901 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.5 t -74.77 110.03 8.82 Favored Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 109.137 -0.69 . . . . 71.329999999999998 109.137 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.69 -33.65 60.5 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 122.989 2.46 . . . . 74.140000000000001 113.832 -170.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.9 t -73.52 -53.31 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.266 0.469 . . . . 64.129999999999995 112.266 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.7 p -101.44 -16.32 16.89 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.84 -0.344 . . . . 32.329999999999998 111.433 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HA ' HG22 ' A' ' 79' ' ' THR . 71.2 mtt180 69.18 23.93 6.21 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.589 -0.732 . . . . 70.200000000000003 111.993 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.6 m -80.91 149.27 29.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 74.519999999999996 109.355 170.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.5 ttp -76.39 143.67 40.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.247 -0.433 . . . . 75.25 111.871 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.612 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 78.2 t80 -137.42 126.71 15.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.924 -0.769 . . . . 75.140000000000001 108.924 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.612 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 51.7 Cg_exo -56.07 147.66 23.58 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.623 -0.99 . . . . 41.109999999999999 113.366 2.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 20.1 Cg_endo -59.29 151.12 70.04 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.243 2.629 . . . . 53.219999999999999 112.596 -175.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 89' ' ' PRO . 8.9 Cg_exo -70.42 178.79 4.61 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.677 2.252 . . . . 65.010000000000005 112.432 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.564 -0.744 . . . . 75.150000000000006 110.602 -179.234 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 CA--C 1.533 0.437 0 N-CA-C 112.817 0.276 . . . . 73.540000000000006 112.817 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.13 165.67 27.63 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.738 2.292 . . . . 63.43 112.745 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -90.17 154.01 20.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.793 -0.639 . . . . 50.240000000000002 110.433 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -70.2 135.73 49.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.453 -0.339 . . . . 61.240000000000002 110.567 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -58.87 -38.15 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.925 -0.579 . . . . 55.420000000000002 110.984 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -59.31 -46.3 88.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.927 -0.579 . . . . 74.549999999999997 110.535 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.402 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 9.8 m -63.59 -34.16 77.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 61.140000000000001 110.632 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.04 -43.53 76.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.607 . . . . 73.140000000000001 110.413 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -66.54 -37.38 84.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.142 -0.481 . . . . 71.030000000000001 110.577 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.67 3.68 11.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.747 -0.661 . . . . 60.329999999999998 111.807 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.647 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 60.1 mt -70.18 131.82 88.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.475 -0.195 . . . . 74.129999999999995 110.475 175.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 19.5 Cg_endo -58.63 135.24 66.06 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.152 2.568 . . . . 63.25 112.513 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -101.63 102.92 13.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.106 0.479 . . . . 73.439999999999998 110.006 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.1 mt -103.23 131.63 51.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.898 -0.592 . . . . 74.150000000000006 110.544 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.8 tp -79.38 121.74 25.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.893 0.378 . . . . 74.030000000000001 110.323 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 50' ' ' TYR . 42.6 t -87.46 132.33 33.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.074 -0.512 . . . . 71.439999999999998 110.67 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 36.9 p -128.59 151.42 49.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.264 -0.426 . . . . 62.350000000000001 110.297 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.671 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 30.4 mt-10 -84.51 0.6 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.23 0.538 . . . . 74.209999999999994 110.687 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.1 -22.11 29.03 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.847 -0.797 . . . . 74.049999999999997 108.847 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -133.4 55.57 1.89 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.89 -1.05 . . . . 73.099999999999994 109.265 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.95 160.1 34.97 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.38 -0.827 . . . . 72.319999999999993 112.272 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 41' ' ' MET . . . 60.16 76.62 0.35 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.399 0.618 . . . . 64.120000000000005 109.993 -174.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.71 93.77 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.45 -0.795 . . . . 62.149999999999999 111.145 -173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.42 -12.9 30.71 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.832 -0.622 . . . . 33.329999999999998 113.298 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.428 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 3.0 pt20 -156.93 -160.26 0.95 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.73 -0.276 . . . . 72.019999999999996 110.679 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.3 151.84 9.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.589 -0.732 . . . . 63.32 110.615 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.468 ' HB3' ' HB2' ' A' ' 36' ' ' ALA . 1.4 pmm? -88.77 11.91 16.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.309 -0.405 . . . . 52.439999999999998 111.645 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.1 m -118.4 141.53 48.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.208 0.528 . . . . 75.409999999999997 111.411 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 21.3 t -106.11 101.72 35.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.555 -0.748 . . . . 71.019999999999996 109.549 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 17.7 Cg_endo -59.7 -26.68 82.9 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 123.246 2.631 . . . . 71.439999999999998 113.349 -174.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.9 mt -60.83 -41.26 87.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 75.019999999999996 111.469 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 21.0 p -119.88 13.96 12.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.557 -0.292 . . . . 75.209999999999994 110.909 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p 43.37 45.14 5.13 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.942 0.776 . . . . 51.409999999999997 112.22 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.0 p -120.85 -177.71 3.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.459 -0.571 . . . . 63.439999999999998 109.459 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -106.67 -175.13 2.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.795 0.331 . . . . 73.349999999999994 110.117 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.533 ' HB3' HG11 ' A' ' 30' ' ' VAL . 70.0 m-85 -103.0 109.92 21.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.378 -0.374 . . . . 72.109999999999999 110.538 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.1 m -107.08 165.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 74.349999999999994 111.68 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.671 ' HB2' ' H ' ' A' ' 32' ' ' GLU . 22.7 ttpp -73.5 113.69 10.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 72.209999999999994 111.008 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.02 -8.74 9.1 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.943 -0.646 . . . . 63.340000000000003 112.709 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.26 166.02 15.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 110.121 -0.326 . . . . 74.219999999999999 110.121 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -115.98 116.17 51.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.13 0.49 . . . . 75.310000000000002 110.745 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.43 166.95 10.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.028 -0.533 . . . . 73.010000000000005 110.784 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.647 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.8 t -136.45 155.16 50.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.747 -0.66 . . . . 73.209999999999994 110.114 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 49.2 tt0 -107.75 117.8 35.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.98 -0.554 . . . . 73.439999999999998 109.925 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.87 146.38 59.55 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 109.031 -0.729 . . . . 73.120000000000005 109.031 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.71 -3.87 4.0 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.099 2.533 . . . . 65.140000000000001 113.807 -175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.7 p -103.22 29.29 5.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 75.030000000000001 110.472 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 63.12 31.73 15.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.878 -0.601 . . . . 74.409999999999997 112.188 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -126.52 135.01 50.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.776 0.322 . . . . 74.140000000000001 110.814 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.65 145.92 30.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.79 -0.641 . . . . 65.0 110.875 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -149.25 160.41 43.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.686 -0.688 . . . . 75.340000000000003 109.289 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.637 ' HB2' ' CB ' ' A' ' 69' ' ' CYS . 34.3 m170 -60.47 132.85 55.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.418 -0.956 . . . . 72.140000000000001 108.418 168.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -65.85 -61.51 5.55 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.943 0.719 . . . . 74.230000000000004 112.943 -171.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.36 -23.32 71.81 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.742 1.628 . . . . 62.409999999999997 111.197 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.637 ' CB ' ' HB2' ' A' ' 66' ' ' HIS . 7.7 t -67.36 -53.42 29.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.212 -1.358 . . . . 75.329999999999998 110.295 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 p -74.65 -24.7 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.782 -0.644 . . . . 65.340000000000003 110.524 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.607 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 43.6 t -54.29 -48.73 70.92 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.266 -0.424 . . . . 75.219999999999999 110.1 176.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.0 mt -57.51 -47.6 84.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.012 -0.54 . . . . 65.319999999999993 110.343 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -61.3 -44.75 96.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 74.420000000000002 111.116 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 96.8 mt -66.14 -23.07 66.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 74.340000000000003 111.456 -178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.607 ' HG3' ' O ' ' A' ' 71' ' ' SER . 78.0 mt-30 -72.33 -21.95 61.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.755 0.312 . . . . 71.299999999999997 110.485 177.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -89.56 -59.17 2.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.183 0.516 . . . . 70.319999999999993 109.625 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.0 m -140.11 124.78 18.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 64.430000000000007 110.343 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.03 75.55 2.27 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.176 -0.769 . . . . 75.530000000000001 111.176 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 84' ' ' ARG . 4.0 m -147.68 135.29 20.89 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.374 -0.232 . . . . 71.439999999999998 110.374 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 34.9 t -75.18 107.39 3.93 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.181 -0.674 . . . . 63.25 109.181 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.18 -31.98 48.02 Favored 'Trans proline' 0 N--CA 1.476 0.497 0 C-N-CA 123.152 2.568 . . . . 74.209999999999994 114.207 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.5 t -71.69 -47.9 54.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.048 0.388 . . . . 63.530000000000001 112.048 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 20.5 p -103.51 -23.83 13.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.848 0.356 . . . . 74.129999999999995 111.031 -174.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.467 ' HA ' HG22 ' A' ' 79' ' ' THR . 35.9 mtp180 71.13 29.6 2.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.316 -0.856 . . . . 73.319999999999993 110.893 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 47.6 t -85.07 138.15 32.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.536 -0.756 . . . . 73.299999999999997 108.982 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.7 ttp -72.11 143.38 49.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 62.100000000000001 111.275 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.455 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 94.0 t80 -125.88 129.69 24.23 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.309 -0.859 . . . . 75.319999999999993 108.98 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 16.7 Cg_exo -67.59 157.42 85.0 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 123.851 -1.312 . . . . 71.239999999999995 112.721 2.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.51 134.38 63.6 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.065 2.51 . . . . 65.299999999999997 112.412 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.81 -172.18 1.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.016 2.477 . . . . 64.439999999999998 112.61 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--O 1.243 0.75 0 CA-C-O 118.6 -0.714 . . . . 73.409999999999997 109.859 178.049 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 10.0 Cg_endo . . . . . 0 C--O 1.234 0.287 0 CA-C-O 120.803 0.251 . . . . 61.509999999999998 112.321 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 17.4 Cg_exo -67.54 156.15 67.26 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.986 2.458 . . . . 61.350000000000001 112.197 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.84 147.52 22.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.078 -0.51 . . . . 72.019999999999996 110.443 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -68.23 138.91 55.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.327 -0.397 . . . . 71.25 110.241 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -54.48 -33.58 60.01 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.81 0.338 . . . . 43.350000000000001 110.819 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -61.29 -28.12 68.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 64.299999999999997 111.159 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.5 t -86.82 -34.54 19.49 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.888 -0.412 . . . . 74.099999999999994 109.888 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -67.72 -49.38 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.053 -0.521 . . . . 54.439999999999998 110.837 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -72.63 -13.0 61.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 73.120000000000005 110.653 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.37 -6.43 58.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 73.25 111.173 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.526 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 84.3 mt -63.22 138.06 97.24 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.4 -0.364 . . . . 24.219999999999999 110.667 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 25.3 Cg_endo -61.85 119.06 6.01 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.183 2.589 . . . . 54.009999999999998 112.359 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -88.66 105.34 17.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.387 0.613 . . . . 55.240000000000002 110.835 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.0 mt -96.41 109.39 22.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.221 -0.9 . . . . 75.329999999999998 109.383 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.99 117.38 9.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.086 -0.507 . . . . 74.430000000000007 110.052 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 15.7 t -82.17 127.49 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.582 -0.525 . . . . 73.439999999999998 109.582 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.5 p -117.3 170.21 8.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.019 -0.537 . . . . 42.340000000000003 109.858 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 24.3 mt-10 -85.19 7.64 21.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.655 0.741 . . . . 73.109999999999999 109.865 176.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -96.39 -13.35 23.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.043 -0.981 . . . . 62.409999999999997 109.139 173.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.6 ' HE1' ' HA ' ' A' ' 37' ' ' VAL . 28.8 t-80 -132.85 115.65 15.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.258 -0.883 . . . . 75.329999999999998 110.577 -173.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.61 -111.07 0.46 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.668 -0.777 . . . . 51.299999999999997 112.486 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.93 139.18 58.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.851 0.357 . . . . 75.239999999999995 110.975 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.6 ' HA ' ' HE1' ' A' ' 34' ' ' HIS . 10.9 t -89.21 -19.18 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.016 -0.538 . . . . 61.049999999999997 110.819 -176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.39 -145.16 7.05 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.646 -0.788 . . . . 71.329999999999998 111.968 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -59.99 -49.06 79.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.101 0.476 . . . . 72.120000000000005 110.716 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.91 113.4 16.99 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.452 -0.944 . . . . 74.319999999999993 108.452 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.7 ptp -101.07 4.67 42.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.262 -0.427 . . . . 71.140000000000001 111.893 -171.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.7 m -146.87 171.48 15.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.675 0.274 . . . . 73.510000000000005 110.575 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -122.41 91.02 49.41 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.203 -0.453 . . . . 71.5 109.859 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.39 -13.32 32.11 Favored 'Trans proline' 0 N--CA 1.475 0.422 0 C-N-CA 123.384 2.722 . . . . 72.200000000000003 113.019 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.3 mt -69.99 -22.28 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.063 0.458 . . . . 72.540000000000006 110.59 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 27.4 p -132.85 -14.9 2.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.946 0.351 . . . . 61.340000000000003 111.946 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 89.9 m 65.99 21.85 11.28 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 122.761 0.424 . . . . 51.340000000000003 111.309 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -104.62 142.3 34.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.22 -0.445 . . . . 75.519999999999996 109.832 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -79.04 177.36 8.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.078 0.466 . . . . 70.230000000000004 111.008 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.463 ' HB3' HG11 ' A' ' 30' ' ' VAL . 89.5 m-85 -89.64 106.27 18.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.133 0.492 . . . . 74.120000000000005 111.425 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 m -131.15 171.42 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.619 -0.719 . . . . 75.519999999999996 110.346 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.706 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -62.56 120.91 12.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 73.540000000000006 110.545 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.62 -40.92 1.51 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.776 -0.726 . . . . 51.439999999999998 112.211 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -86.96 161.52 18.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.629 -0.508 . . . . 73.230000000000004 109.629 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.89 122.9 69.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.349 -0.387 . . . . 74.409999999999997 110.278 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.1 163.44 13.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.435 -0.348 . . . . 74.329999999999998 110.397 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.5 t -144.49 155.51 43.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.955 -0.387 . . . . 54.0 109.955 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.449 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 37.0 tt0 -107.29 117.53 34.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.269 -0.423 . . . . 31.109999999999999 110.073 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.76 142.17 32.34 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.308 -0.627 . . . . 71.150000000000006 109.308 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.13 -18.68 24.17 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.369 2.713 . . . . 74.530000000000001 112.83 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.6 p -88.32 24.32 1.93 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.243 -0.435 . . . . 74.030000000000001 110.899 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.7 m80 66.22 33.7 7.11 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.094 0.558 . . . . 72.120000000000005 111.604 171.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -127.35 141.42 51.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.678 0.275 . . . . 73.0 110.859 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.47 133.2 55.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.838 -0.619 . . . . 72.439999999999998 110.485 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -143.07 175.18 10.05 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.876 -0.787 . . . . 75.319999999999993 108.876 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.647 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 32.3 m170 -82.39 131.49 35.22 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.174 -0.676 . . . . 61.399999999999999 109.174 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 85.2 tttt -60.1 -49.52 90.58 Favored Pre-proline 0 C--N 1.323 -0.568 0 O-C-N 123.377 0.423 . . . . 70.310000000000002 111.892 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 18.4 Cg_endo -60.05 -20.73 62.24 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.013 1.809 . . . . 64.329999999999998 112.637 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 60.2 m -83.6 -45.66 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.161 0.505 . . . . 55.420000000000002 110.655 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.474 HG22 ' HG ' ' A' ' 74' ' ' LEU . 9.4 p -78.32 -25.66 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 73.420000000000002 111.199 -173.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 9.0 p -58.85 -48.76 80.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 71.219999999999999 110.97 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.04 -42.82 96.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 65.439999999999998 110.372 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -62.88 -43.81 97.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.753 -0.658 . . . . 74.25 111.266 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.474 ' HG ' HG22 ' A' ' 70' ' ' VAL . 93.1 mt -65.55 -24.92 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.515 -0.312 . . . . 63.43 111.599 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 71' ' ' SER . 76.3 mt-30 -75.49 -23.44 56.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.979 0.418 . . . . 64.030000000000001 110.427 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -85.36 -48.08 9.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.35 0.595 . . . . 64.040000000000006 109.487 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.7 p -158.51 123.88 4.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.281 -0.872 . . . . 73.319999999999993 109.891 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.46 74.85 2.03 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.64 -0.79 . . . . 73.329999999999998 111.834 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.509 HG22 ' HA ' ' A' ' 84' ' ' ARG . 5.3 m -149.24 138.44 21.45 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.768 -0.254 . . . . 71.310000000000002 110.468 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 37.6 t -75.05 112.54 18.54 Favored Pre-proline 0 C--O 1.222 -0.387 0 N-CA-C 109.855 -0.424 . . . . 74.120000000000005 109.855 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.48 -38.48 64.08 Favored 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 123.13 2.553 . . . . 72.349999999999994 113.571 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.18 -31.81 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.852 0.686 . . . . 72.129999999999995 112.852 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.7 p -124.41 -16.23 6.42 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.315 -0.554 . . . . 64.140000000000001 111.894 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.509 ' HA ' HG22 ' A' ' 79' ' ' THR . 60.3 mtt180 69.4 26.24 5.3 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.222 0.609 . . . . 54.340000000000003 110.884 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.19 131.15 38.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.965 -0.754 . . . . 73.510000000000005 108.965 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 62.8 ttp -72.49 142.84 48.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.433 -0.348 . . . . 74.549999999999997 110.571 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.476 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 79.4 t80 -127.45 126.1 24.02 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.424 -0.584 . . . . 71.310000000000002 109.424 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 33.8 Cg_endo -65.24 155.39 77.51 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 123.597 -1.418 . . . . 65.299999999999997 112.68 1.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.38 142.89 21.57 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.465 2.777 . . . . 75.040000000000006 112.853 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.64 144.02 97.12 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.822 2.348 . . . . 64.340000000000003 112.155 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.454 -0.784 . . . . 71.150000000000006 110.119 -176.655 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 90.1 Cg_endo . . . . . 0 N--CA 1.459 -0.548 0 CA-C-O 120.732 0.221 . . . . 60.450000000000003 112.576 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.83 143.08 99.43 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.954 2.436 . . . . 74.420000000000002 112.228 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.15 150.99 41.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.89 -0.595 . . . . 74.310000000000002 111.276 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 22' ' ' ILE . 17.7 m -69.2 132.45 46.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.877 -0.601 . . . . 61.219999999999999 110.171 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -61.68 -36.66 81.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 112.09 -172.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -70.09 -36.98 75.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 74.129999999999995 110.389 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m -65.97 -29.14 69.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 53.039999999999999 110.566 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 18' ' ' SER . 69.5 mt -69.88 -40.7 79.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 72.129999999999995 110.713 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.505 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 34.1 t70 -70.93 -26.18 63.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.849 -0.341 . . . . 74.099999999999994 110.525 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -16.01 64.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 71.329999999999998 111.733 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.43 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 94.2 mt -63.2 141.84 97.77 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.383 -0.371 . . . . 65.340000000000003 110.798 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.68 129.39 26.19 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.059 2.506 . . . . 64.530000000000001 112.527 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -92.23 116.77 29.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.059 -0.518 . . . . 75.510000000000005 110.102 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.1 mt -114.44 130.27 69.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 109.833 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.4 tp -77.21 126.05 30.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.97 0.415 . . . . 73.420000000000002 110.317 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 53.5 t -82.12 134.14 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.012 -0.54 . . . . 70.319999999999993 110.046 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 20.4 p -126.17 126.86 44.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.311 -0.404 . . . . 72.239999999999995 110.57 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.695 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 10.7 pt-20 -80.64 -9.7 59.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 75.329999999999998 111.408 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.35 -2.05 56.45 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.199 -0.667 . . . . 74.109999999999999 109.199 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -113.97 118.4 34.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.978 -1.119 . . . . 64.120000000000005 107.978 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -41.49 -50.95 4.69 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 114.86 0.704 . . . . 71.200000000000003 114.86 -171.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -159.17 134.96 8.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.979 0.39 . . . . 32.439999999999998 110.6 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.2 t -85.41 73.25 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.935 0.398 . . . . 70.530000000000001 110.696 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.47 18.62 56.31 Favored Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.741 -0.663 . . . . 72.209999999999994 113.605 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.604 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 7.6 tp-100 -159.06 171.99 18.98 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.756 -0.831 . . . . 74.519999999999996 108.756 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.24 144.83 39.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.063 -0.347 . . . . 71.25 110.063 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.1 ptp -76.37 22.45 0.17 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.091 0.404 . . . . 63.240000000000002 112.091 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.8 m -134.23 127.37 31.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.755 0.312 . . . . 35.240000000000002 110.551 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 41.3 t -96.64 106.88 33.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.571 -0.529 . . . . 54.119999999999997 109.571 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 12.0 Cg_endo -55.92 -33.69 89.66 Favored 'Trans proline' 0 N--CA 1.474 0.328 0 C-N-CA 123.254 2.636 . . . . 64.239999999999995 113.071 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.56 -20.21 22.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.174 0.512 . . . . 63.229999999999997 110.845 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 88.3 m -108.12 -30.18 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 63.539999999999999 111.659 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.7 t 70.0 17.73 7.33 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.875 0.734 . . . . 55.310000000000002 109.449 -171.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -124.28 161.57 25.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.253 -0.885 . . . . 74.540000000000006 110.673 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -85.12 -178.32 6.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 71.530000000000001 111.798 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.447 ' HB3' ' CG1' ' A' ' 30' ' ' VAL . 47.3 m-85 -94.47 109.16 21.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.701 -0.681 . . . . 71.310000000000002 110.93 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.688 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . 27.0 m -107.64 165.0 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.984 -0.553 . . . . 75.540000000000006 110.87 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.695 ' HB2' ' H ' ' A' ' 32' ' ' GLU . 28.1 ttpp -78.41 117.47 19.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.884 0.373 . . . . 75.109999999999999 110.725 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.82 -7.23 10.24 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.846 -0.615 . . . . 41.310000000000002 111.628 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -84.31 158.58 21.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.407 -0.59 . . . . 64.450000000000003 109.407 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.3 116.67 53.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.886 0.374 . . . . 71.439999999999998 110.63 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.31 167.68 10.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.075 -0.512 . . . . 55.509999999999998 110.551 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 14.0 t -149.26 157.96 43.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.011 -0.54 . . . . 64.430000000000007 109.645 176.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -108.4 117.63 34.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.344 -0.389 . . . . 53.210000000000001 110.126 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.85 150.12 88.21 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.912 -0.585 . . . . 62.109999999999999 109.458 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.16 -14.33 23.39 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.135 2.556 . . . . 71.209999999999994 112.855 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 23.9 p -91.93 15.0 14.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.384 -0.371 . . . . 72.400000000000006 110.334 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 60.14 74.78 0.43 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.329 0.585 . . . . 73.040000000000006 110.974 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -157.22 127.81 6.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.472 -0.785 . . . . 62.32 109.674 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 57' ' ' THR . 85.6 m-85 -97.93 133.21 42.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.025 -0.534 . . . . 73.239999999999995 110.693 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.33 174.84 10.25 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.867 -1.16 . . . . 74.400000000000006 107.867 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.835 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 34.1 m170 -86.29 128.58 34.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.912 -0.773 . . . . 64.109999999999999 108.912 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.531 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 87.4 tttt -53.03 -48.3 92.46 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.546 0.529 . . . . 73.409999999999997 111.914 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 76.1 Cg_exo -53.7 -45.0 44.25 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.33 2.02 . . . . 73.150000000000006 113.851 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.835 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 19.7 p -84.51 -33.67 23.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.398 -0.521 . . . . 70.340000000000003 112.209 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 67' ' ' LYS . 9.8 p -72.24 -28.7 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.817 -0.353 . . . . 72.219999999999999 110.765 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.3 p -63.96 -26.91 68.8 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.052 0.453 . . . . 71.319999999999993 110.83 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.92 -54.16 18.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 73.329999999999998 110.017 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -62.63 -33.62 75.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.053 -0.521 . . . . 73.530000000000001 111.477 -176.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 84.6 mt -66.74 -23.93 66.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.599 -0.273 . . . . 63.109999999999999 111.315 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -89.59 -11.29 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.212 0.529 . . . . 63.020000000000003 110.364 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -95.28 -57.17 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.815 -0.629 . . . . 75.230000000000004 110.761 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.2 t -110.83 -33.95 6.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.926 -0.579 . . . . 64.049999999999997 110.929 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.02 17.58 71.88 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.689 -0.767 . . . . 54.420000000000002 112.103 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 86' ' ' MET . 3.5 m -128.41 153.16 47.38 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.922 -0.399 . . . . 44.020000000000003 109.922 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.8 t -74.61 110.24 9.2 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.809 -0.811 . . . . 63.340000000000003 108.809 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.8 -25.93 63.75 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.174 2.582 . . . . 54.25 113.064 -171.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.73 -50.87 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.352 -0.386 . . . . 74.219999999999999 111.934 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.1 p -109.94 -2.55 17.08 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.267 0.469 . . . . 73.200000000000003 112.267 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? 66.53 21.57 10.74 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.29 0.478 . . . . 74.5 112.29 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.7 t -85.29 126.86 34.05 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.293 -0.632 . . . . 73.530000000000001 109.293 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.508 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 59.8 ttp -72.43 153.23 41.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.346 -0.388 . . . . 70.239999999999995 111.104 -176.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -124.77 118.61 25.84 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.563 -0.532 . . . . 74.239999999999995 109.563 173.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.34 156.76 96.6 Favored 'Cis proline' 0 C--N 1.344 0.322 0 C-N-CA 123.702 -1.374 . . . . 55.450000000000003 112.345 -0.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.24 139.6 63.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.081 2.521 . . . . 74.109999999999999 112.733 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 40.3 Cg_endo -65.64 141.7 67.61 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.72 2.28 . . . . 71.329999999999998 112.381 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.602 -0.713 . . . . 61.420000000000002 110.138 -177.112 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo . . . . . 0 C--O 1.235 0.34 0 CA-C-O 120.729 0.22 . . . . 74.010000000000005 111.856 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.29 146.41 90.06 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.844 2.363 . . . . 61.530000000000001 112.142 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 168.11 20.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.145 0.498 . . . . 64.010000000000005 111.622 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 m -78.09 150.89 33.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 53.409999999999997 110.826 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -62.37 -39.23 92.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.054 -0.521 . . . . 75.340000000000003 110.452 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.83 -35.01 79.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.71 -0.677 . . . . 75.340000000000003 111.332 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 m -61.84 -44.81 96.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 65.349999999999994 110.282 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.583 HG21 ' HA ' ' A' ' 71' ' ' SER . 25.9 mt -75.15 -38.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.738 -0.665 . . . . 71.439999999999998 110.521 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.3 -31.22 72.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.434 -0.803 . . . . 73.239999999999995 110.982 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.76 -21.68 60.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.845 -0.616 . . . . 71.030000000000001 111.576 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.44 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 98.0 mt -63.76 132.46 95.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 73.329999999999998 110.902 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.08 137.06 55.21 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.16 2.573 . . . . 73.140000000000001 112.864 -175.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.51 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 44.2 mt-10 -90.17 116.52 28.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.187 0.518 . . . . 64.420000000000002 110.751 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -109.15 129.47 63.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.315 -0.857 . . . . 72.200000000000003 109.681 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.7 tp -80.13 122.03 26.29 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.017 -0.364 . . . . 72.230000000000004 110.017 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 41.9 t -79.14 123.46 36.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.27 -0.423 . . . . 70.040000000000006 110.225 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.7 p -119.16 140.86 49.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.148 -0.478 . . . . 63.530000000000001 110.332 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 30.5 mt-10 -79.57 177.69 8.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.169 -0.469 . . . . 65.200000000000003 110.278 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 1.1 m-20 71.5 8.74 6.31 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.818 0.699 . . . . 71.5 109.807 -168.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -127.58 108.82 11.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.12 -0.945 . . . . 72.019999999999996 109.394 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.62 95.03 0.52 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.755 -0.736 . . . . 63.25 112.055 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 72.33 138.34 0.05 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.535 0.734 . . . . 61.520000000000003 111.484 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.45 -38.76 83.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 64.120000000000005 110.363 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.73 32.01 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.777 -0.725 . . . . 73.519999999999996 112.034 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.671 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 8.4 tp-100 -172.17 -80.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.732 0.301 . . . . 60.299999999999997 110.648 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.75 152.56 35.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.062 -0.517 . . . . 75.340000000000003 110.705 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -103.78 3.52 34.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.627 -0.715 . . . . 72.329999999999998 110.001 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 30.4 p -124.42 151.86 43.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.032 -0.531 . . . . 74.409999999999997 110.03 175.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 50.4 t -116.7 101.99 53.37 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.444 -0.576 . . . . 75.310000000000002 109.444 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -56.92 -28.57 78.29 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.116 2.544 . . . . 73.120000000000005 112.622 -173.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.4 mt -67.0 -32.14 56.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.748 -0.66 . . . . 72.530000000000001 111.618 -175.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.7 p -113.89 -4.21 13.32 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.987 -0.285 . . . . 73.239999999999995 111.22 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.8 t 67.93 4.06 3.84 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.782 -0.645 . . . . 61.130000000000003 111.256 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.8 m -105.92 163.76 12.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.8 0.333 . . . . 51.119999999999997 110.332 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.8 OUTLIER -91.71 -170.22 2.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.049 0.452 . . . . 74.430000000000007 110.89 -177.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.644 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 29.9 m-85 -94.47 108.84 20.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.092 -0.503 . . . . 73.209999999999994 111.397 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.31 166.72 7.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.337 -0.847 . . . . 75.109999999999999 109.612 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 39.5 ttpt -73.37 138.38 45.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.943 0.401 . . . . 74.439999999999998 110.769 -176.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.9 -9.32 47.12 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.993 -0.623 . . . . 62.310000000000002 112.342 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.78 162.06 18.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.76 -0.459 . . . . 71.510000000000005 109.76 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -110.31 122.62 65.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.846 0.355 . . . . 63.200000000000003 110.319 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -112.21 171.02 7.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.864 0.364 . . . . 75.030000000000001 110.448 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 7.2 t -148.84 168.57 22.63 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.684 -0.488 . . . . 63.520000000000003 109.684 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -113.36 117.32 31.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.817 0.341 . . . . 73.120000000000005 110.942 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.05 138.23 39.95 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.188 -0.671 . . . . 54.549999999999997 109.188 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.02 -19.27 19.42 Favored 'Trans proline' 0 N--CA 1.474 0.325 0 C-N-CA 123.708 2.938 . . . . 64.209999999999994 113.158 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.1 p -86.42 22.55 1.81 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.744 0.307 . . . . 74.109999999999999 110.682 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 65.3 36.71 6.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.274 0.559 . . . . 61.310000000000002 111.711 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.671 ' HD2' ' HG2' ' A' ' 39' ' ' GLN . 4.8 m170 -125.11 122.62 37.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.888 -0.596 . . . . 73.439999999999998 110.315 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -99.0 133.13 43.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.239 -0.437 . . . . 71.140000000000001 110.124 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.644 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 72.9 m-85 -144.16 161.1 39.71 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.535 0.522 . . . . 73.400000000000006 110.261 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 38.2 m170 -61.88 121.26 12.49 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.367 -0.605 . . . . 72.049999999999997 109.367 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.6 tttt -58.78 -49.89 90.98 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 123.235 0.334 . . . . 70.099999999999994 111.676 -176.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 9.6 Cg_endo -53.91 -27.48 44.6 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.356 2.037 . . . . 72.409999999999997 112.613 176.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 68.2 m -82.89 -52.42 6.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 73.209999999999994 110.809 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 67' ' ' LYS . 7.1 p -69.95 -27.39 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 50.409999999999997 111.252 -173.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.583 ' HA ' HG21 ' A' ' 22' ' ' ILE . 18.4 p -64.47 -46.75 81.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.798 0.332 . . . . 72.140000000000001 110.579 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.508 HG22 ' HE2' ' A' ' 76' ' ' LYS . 75.1 mt -63.73 -37.85 80.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.152 -0.476 . . . . 73.409999999999997 110.291 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -64.65 -51.98 59.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 71.230000000000004 111.317 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.9 -24.38 66.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.388 -0.369 . . . . 72.120000000000005 111.664 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -77.5 -0.65 26.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.021 0.438 . . . . 75.340000000000003 110.756 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.508 ' HE2' HG22 ' A' ' 72' ' ' ILE . 56.5 mttm -113.46 -52.26 2.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 73.420000000000002 109.856 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.1 m -132.87 125.64 30.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.046 -0.525 . . . . 64.400000000000006 110.035 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.7 57.25 4.68 Favored Glycine 0 CA--C 1.516 0.148 0 C-N-CA 120.951 -0.642 . . . . 70.120000000000005 112.899 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 84' ' ' ARG . 39.5 m -145.77 149.21 33.96 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.283 -0.266 . . . . 75.120000000000005 110.283 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.6 t -74.41 118.08 67.02 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.926 -0.768 . . . . 71.239999999999995 108.926 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.4 -24.84 54.3 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.295 2.663 . . . . 71.219999999999999 113.477 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.28 -61.16 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.425 -0.352 . . . . 50.229999999999997 111.853 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.9 p -90.04 -1.11 57.91 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.906 0.336 . . . . 63.119999999999997 111.906 -172.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.412 ' HA ' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER 47.58 39.94 10.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.619 0.768 . . . . 75.510000000000005 111.913 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.12 148.7 22.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.73 -0.841 . . . . 73.200000000000003 108.73 170.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.5 ttp -74.19 145.75 43.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.03 0.443 . . . . 31.109999999999999 111.839 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.542 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 57.6 t80 -129.2 131.05 23.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.837 -0.801 . . . . 72.540000000000006 108.837 172.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 31.0 Cg_endo -62.86 159.67 60.45 Favored 'Cis proline' 0 C--N 1.347 0.472 0 C-N-CA 124.067 -1.222 . . . . 74.030000000000001 112.984 2.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.5 138.75 74.85 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.193 2.595 . . . . 74.030000000000001 112.818 -175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.22 151.74 84.16 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.699 2.266 . . . . 63.200000000000003 112.314 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.628 -0.701 . . . . 73.25 109.913 -179.717 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo . . . . . 0 CA--C 1.534 0.481 0 CA-C-O 121.02 0.342 . . . . 74.129999999999995 112.782 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HA ' ' H ' ' A' ' 78' ' ' GLY . 11.4 Cg_exo -71.46 168.22 24.16 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.732 2.288 . . . . 72.209999999999994 111.965 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.54 179.95 6.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.54 -0.3 . . . . 65.200000000000003 110.567 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 p -102.27 162.1 13.18 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.934 -0.395 . . . . 75.329999999999998 109.934 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -64.05 -43.9 94.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.969 0.414 . . . . 70.549999999999997 110.017 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -58.69 -47.28 85.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.414 -0.812 . . . . 72.519999999999996 112.063 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 p -64.17 -41.68 97.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.311 . . . . 73.409999999999997 110.978 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.62 -41.06 85.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.206 0.527 . . . . 74.299999999999997 110.584 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.1 -36.39 81.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 74.329999999999998 110.637 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.01 -6.25 51.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 50.210000000000001 112.187 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.463 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 34.5 mt -53.84 127.72 53.26 Favored Pre-proline 0 C--O 1.237 0.43 0 O-C-N 122.994 0.184 . . . . 75.030000000000001 111.2 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 9.8 Cg_endo -53.77 142.5 62.24 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.377 2.718 . . . . 52.439999999999998 111.694 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -113.85 106.48 14.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.099 0.476 . . . . 74.200000000000003 111.158 -173.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.5 mt -110.78 111.58 36.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.865 -0.607 . . . . 74.329999999999998 109.979 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.7 117.14 10.03 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.894 -0.41 . . . . 63.450000000000003 109.894 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 35.7 t -75.74 118.14 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.312 -0.404 . . . . 65.329999999999998 110.785 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.2 p -120.76 167.81 12.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.455 -0.572 . . . . 71.010000000000005 109.455 173.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.21 4.18 15.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.942 0.401 . . . . 72.439999999999998 111.123 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -80.26 -45.5 17.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.544 . . . . 73.230000000000004 110.333 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -77.92 -34.99 51.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 73.340000000000003 110.387 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.35 -115.77 4.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.004 -0.617 . . . . 53.350000000000001 111.706 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.0 141.64 57.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.622 -0.51 . . . . 71.510000000000005 109.622 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.21 90.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.504 -0.478 . . . . 61.340000000000003 111.234 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.511 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . 76.07 -73.54 1.73 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.565 -0.743 . . . . 64.310000000000002 113.337 171.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.526 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 8.5 tp-100 -107.89 -49.24 3.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.637 0.256 . . . . 71.239999999999995 110.91 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.4 158.55 37.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.357 0.599 . . . . 60.340000000000003 111.585 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.1 ptp -103.22 -5.77 22.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.162 -0.926 . . . . 73.349999999999994 109.902 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.827 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 85.1 m -128.14 137.92 52.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.802 -0.635 . . . . 71.230000000000004 110.421 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -93.36 112.49 56.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.04 -0.527 . . . . 62.0 109.974 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -60.77 -33.52 92.86 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.619 2.213 . . . . 72.439999999999998 111.94 -176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.49 -22.87 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.663 -0.698 . . . . 71.209999999999994 110.686 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 79.8 m -107.94 -19.36 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.979 -0.555 . . . . 44.32 111.201 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.4 m 60.8 29.27 18.9 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.48 0.657 . . . . 50.43 109.537 -170.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.6 t -141.16 155.38 46.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.254 -0.885 . . . . 71.409999999999997 109.514 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.827 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 10.7 pt-20 -77.75 -179.75 6.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.334 0.587 . . . . 72.540000000000006 111.783 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.512 ' HB3' HG11 ' A' ' 30' ' ' VAL . 73.8 m-85 -91.87 112.52 24.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.647 -0.706 . . . . 72.349999999999994 110.383 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.69 169.49 11.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 70.239999999999995 110.632 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 24.9 ttpp -72.99 113.66 10.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.74 -0.664 . . . . 74.310000000000002 110.961 -176.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.56 -36.5 1.54 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.581 -0.818 . . . . 54.109999999999999 112.758 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -87.14 162.17 17.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.12 -0.326 . . . . 72.219999999999999 110.12 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.75 129.49 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.58 -0.282 . . . . 72.340000000000003 110.38 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -101.22 163.41 12.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.825 0.345 . . . . 75.109999999999999 110.965 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 8.7 t -147.68 170.07 18.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.879 -0.601 . . . . 71.420000000000002 109.585 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 25.5 tt0 -123.39 123.24 40.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.535 -0.302 . . . . 74.420000000000002 110.694 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 61' ' ' CYS . 77.1 mt -86.02 141.16 35.18 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.416 -0.957 . . . . 73.310000000000002 108.416 169.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.93 36.19 0.17 Allowed 'Trans proline' 0 N--CA 1.479 0.623 0 C-N-CA 123.636 2.891 . . . . 52.539999999999999 113.922 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.405 ' H ' ' C ' ' A' ' 59' ' ' LEU . 29.5 p -140.06 28.07 2.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.388 -0.597 . . . . 63.0 109.388 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.8 m170 63.71 34.66 11.98 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.429 -0.805 . . . . 75.219999999999999 111.924 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.526 ' HD2' ' HG2' ' A' ' 39' ' ' GLN . 11.2 m170 -125.86 120.69 31.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.476 -0.329 . . . . 64.019999999999996 110.408 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.511 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 57.7 m-85 -101.88 137.17 40.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.954 -0.566 . . . . 72.239999999999995 111.29 -176.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.482 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 97.0 m-85 -140.72 175.36 9.67 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.738 -0.838 . . . . 74.019999999999996 108.738 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.88 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 39.1 m80 -82.61 131.79 35.2 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.172 -0.677 . . . . 61.240000000000002 109.172 173.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.53 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 86.7 tttt -55.61 -49.31 93.42 Favored Pre-proline 0 CA--C 1.539 0.532 0 O-C-N 123.49 0.494 . . . . 61.340000000000003 111.313 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 83.0 Cg_exo -51.23 -50.42 13.96 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.257 1.971 . . . . 72.409999999999997 113.52 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.88 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 21.9 p -79.69 -31.54 41.32 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.743 -0.383 . . . . 75.129999999999995 111.876 -174.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 67' ' ' LYS . 7.8 p -74.27 -28.81 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.719 -0.474 . . . . 75.230000000000004 109.719 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.706 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 27.7 t -58.46 -48.15 81.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.518 -0.549 . . . . 72.510000000000005 109.518 174.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -60.17 -40.78 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.651 -0.704 . . . . 72.109999999999999 110.705 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -67.43 -48.33 67.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.593 -0.731 . . . . 73.319999999999993 111.498 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 77' ' ' SER . 97.2 mt -67.25 -20.51 65.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.395 -0.366 . . . . 73.530000000000001 111.93 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.706 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.3 mt-30 -59.98 -40.29 88.6 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.581 -0.281 . . . . 74.0 111.391 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.77 -27.51 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.907 -0.317 . . . . 63.210000000000001 111.222 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 12.7 p -143.88 111.2 5.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.74 0.305 . . . . 64.420000000000002 110.872 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' H ' ' HA ' ' A' ' 16' ' ' PRO . . . -82.56 65.46 4.1 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.187 -0.765 . . . . 54.219999999999999 111.187 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 m -143.5 145.4 32.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.645 -0.278 . . . . 65.129999999999995 110.383 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.5 t -74.88 113.64 26.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.79 -0.819 . . . . 64.409999999999997 108.79 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.34 -34.2 79.49 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.036 2.49 . . . . 72.450000000000003 113.76 -172.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -75.13 -62.98 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.069 0.396 . . . . 71.109999999999999 112.069 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.3 p -89.12 -18.11 27.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 52.509999999999998 111.346 -173.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 17.3 mtp180 63.4 71.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.801 0.81 . . . . 62.32 110.557 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t -128.81 142.58 50.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.637 -1.165 . . . . 73.430000000000007 108.067 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.531 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 61.8 ttp -68.05 149.07 50.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.989 0.423 . . . . 64.120000000000005 111.147 -174.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -127.97 121.18 21.74 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.636 -0.711 . . . . 71.010000000000005 109.39 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.61 157.83 77.21 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 124.048 -1.23 . . . . 73.310000000000002 112.855 0.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.48 135.29 63.8 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.993 2.462 . . . . 73.120000000000005 112.612 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 43.3 Cg_endo -68.44 147.47 71.24 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.867 2.378 . . . . 72.329999999999998 112.488 -177.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.322 -0.846 . . . . 74.140000000000001 109.302 177.895 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo . . . . . 0 CA--C 1.531 0.361 0 CA-C-O 120.957 0.315 . . . . 50.030000000000001 112.796 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.57 141.76 38.82 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.169 1.913 . . . . 71.25 112.106 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -81.75 149.21 28.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.991 -0.55 . . . . 44.100000000000001 110.167 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -58.97 116.44 3.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.259 -0.428 . . . . 70.109999999999999 110.478 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' A' ' 22' ' ' ILE . 6.5 ttpm? -56.8 -45.32 82.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.711 -0.677 . . . . 75.129999999999995 111.518 -176.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -54.93 -37.85 66.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.624 -0.716 . . . . 70.439999999999998 111.307 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.4 t -67.63 -41.02 84.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.076 0.465 . . . . 70.239999999999995 110.106 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 71' ' ' SER . 61.1 mt -62.61 -39.72 85.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.683 -0.689 . . . . 64.099999999999994 110.932 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -75.06 -29.18 60.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 44.009999999999998 110.759 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -12.81 60.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.332 -0.395 . . . . 73.109999999999999 111.517 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.11 145.54 85.01 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 116.409 -0.36 . . . . 72.400000000000006 111.044 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.88 160.37 49.92 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.914 2.409 . . . . 72.219999999999999 112.381 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -108.36 112.82 25.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.189 -0.459 . . . . 71.310000000000002 110.326 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.7 mt -101.68 101.74 12.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.247 -0.649 . . . . 74.439999999999998 109.247 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.55 122.54 19.25 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.813 -0.44 . . . . 64.450000000000003 109.813 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.747 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 21.4 t -77.46 105.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.123 -0.489 . . . . 62.539999999999999 110.134 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.4 p -103.68 168.2 9.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.783 -0.451 . . . . 73.5 109.783 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -76.82 -22.25 53.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.07 0.462 . . . . 74.430000000000007 110.303 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.81 -28.31 58.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.006 -0.543 . . . . 74.420000000000002 109.943 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -84.62 -44.3 13.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 74.319999999999993 109.527 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.2 -110.87 3.36 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.9 -0.591 . . . . 75.299999999999997 112.729 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.64 103.39 3.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.002 0.43 . . . . 72.109999999999999 110.376 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.2 t -68.64 -30.33 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.011 -0.541 . . . . 74.310000000000002 110.928 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 64' ' ' TYR . . . -149.89 -150.27 5.22 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.79 -0.719 . . . . 64.319999999999993 111.898 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -82.04 -24.19 35.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.672 -0.492 . . . . 71.5 109.672 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -83.99 111.79 19.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.866 -0.606 . . . . 61.240000000000002 109.75 172.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -91.28 -0.09 57.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 53.109999999999999 110.316 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 70.7 m -141.2 149.73 41.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.778 -0.647 . . . . 64.040000000000006 110.338 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 36.9 t -104.73 96.12 9.99 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.359 -0.608 . . . . 73.040000000000006 109.359 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 18.5 Cg_endo -57.27 -27.26 74.28 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.466 2.777 . . . . 61.219999999999999 112.935 -172.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.1 mt -57.74 -43.78 84.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 72.329999999999998 111.212 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.8 p -108.44 -3.23 18.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.565 -0.289 . . . . 74.340000000000003 110.713 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.1 m 60.87 40.2 15.99 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.834 -0.621 . . . . 72.450000000000003 110.716 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.9 m -135.94 146.55 47.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 75.299999999999997 110.47 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 15.4 pt-20 -81.88 -169.86 2.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 72.450000000000003 111.735 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.637 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.5 m-85 -102.97 108.77 20.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.201 0.524 . . . . 72.019999999999996 111.604 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 m -134.64 173.07 15.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.333 -0.849 . . . . 64.420000000000002 109.546 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.747 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 31.0 ttmt -64.54 125.76 25.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.042 0.448 . . . . 72.519999999999996 111.097 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.41 -42.73 1.27 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.563 -0.744 . . . . 64.530000000000001 111.731 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -86.68 165.88 15.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.875 -0.417 . . . . 64.010000000000005 109.875 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.0 133.7 65.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.684 -0.487 . . . . 75.219999999999999 109.684 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -111.76 176.01 5.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.897 0.38 . . . . 75.310000000000002 110.618 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.4 t -150.35 163.06 39.29 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.544 -0.539 . . . . 53.420000000000002 109.544 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -107.86 117.34 33.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.765 0.317 . . . . 74.349999999999994 110.667 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.8 mt -84.32 137.34 39.59 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.957 -0.757 . . . . 63.43 108.957 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.81 -8.19 7.22 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.89 2.393 . . . . 75.329999999999998 111.905 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.8 t -84.66 18.24 2.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.043 -0.98 . . . . 70.409999999999997 110.046 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 57.18 39.43 28.86 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.907 -0.588 . . . . 70.549999999999997 111.147 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -138.61 144.99 40.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.716 -0.674 . . . . 61.119999999999997 109.957 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.47 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 49.3 m-85 -121.12 132.86 55.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.794 0.33 . . . . 64.019999999999996 111.248 -172.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.637 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 89.6 m-85 -142.58 162.78 34.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 73.109999999999999 110.35 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 35.0 m170 -63.83 129.38 39.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.615 -0.513 . . . . 62.25 109.615 174.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.501 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 48.3 tttm -60.62 -51.7 77.93 Favored Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 123.326 0.391 . . . . 75.150000000000006 111.622 -175.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 27.5 Cg_endo -62.22 -22.0 73.45 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.127 1.885 . . . . 64.400000000000006 112.925 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.2 m -84.21 -46.99 11.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.225 0.536 . . . . 74.219999999999999 110.464 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.546 HG22 ' HG ' ' A' ' 74' ' ' LEU . 5.8 p -73.62 -23.78 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.786 -0.643 . . . . 75.420000000000002 110.717 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.52 ' HA ' HG21 ' A' ' 22' ' ' ILE . 19.3 p -65.74 -30.52 71.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.338 . . . . 51.25 111.083 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.92 -41.38 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 73.219999999999999 109.989 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -63.11 -47.53 82.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.448 -0.796 . . . . 74.109999999999999 111.783 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.546 ' HG ' HG22 ' A' ' 70' ' ' VAL . 98.2 mt -65.82 -20.56 66.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.342 0.497 . . . . 75.230000000000004 112.342 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 71' ' ' SER . 71.0 mt-30 -77.09 -9.59 58.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.183 0.516 . . . . 63.119999999999997 110.496 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -113.07 -42.27 3.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.61 . . . . 74.400000000000006 109.896 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -142.4 110.05 5.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.671 -0.695 . . . . 62.130000000000003 109.954 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.08 65.85 3.71 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 51.420000000000002 112.122 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.503 ' HB ' ' HA ' ' A' ' 84' ' ' ARG . 1.4 p -149.29 157.54 43.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.453 0.168 . . . . 73.030000000000001 110.991 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.592 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 44.1 m -74.45 123.09 88.87 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 108.308 -0.997 . . . . 75.420000000000002 108.308 169.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.468 ' HD2' ' CZ ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -53.22 -27.96 40.14 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.466 2.111 . . . . 74.25 112.474 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.9 t -80.23 -41.02 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.706 -0.679 . . . . 71.349999999999994 112.449 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.592 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 12.8 p -110.03 -30.15 7.91 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.699 -0.401 . . . . 73.25 111.857 -172.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.503 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 56.5 mtt85 57.23 77.14 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.749 0.785 . . . . 61.219999999999999 111.879 -168.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.2 t -131.93 140.75 49.12 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.838 -1.171 . . . . 73.510000000000005 107.838 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.5 ttp -73.97 131.53 41.5 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.988 0.736 . . . . 71.25 112.988 -165.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 88' ' ' PRO . 70.9 t80 -122.87 134.92 25.31 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.71 -1.132 . . . . 62.049999999999997 108.805 172.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 87' ' ' PHE . 9.5 Cg_exo -72.12 154.98 98.48 Favored 'Cis proline' 0 C--N 1.343 0.27 0 C-N-CA 123.855 -1.31 . . . . 73.109999999999999 112.186 -0.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.55 136.93 77.36 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.733 2.289 . . . . 71.129999999999995 112.03 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.62 153.17 76.7 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.954 2.436 . . . . 73.519999999999996 112.691 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.35 -0.833 . . . . 52.130000000000003 109.629 179.674 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 2.2 Cg_endo . . . . . 0 C--O 1.234 0.294 0 CA-C-O 121.098 0.374 . . . . 73.209999999999994 112.632 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 92.3 Cg_endo -87.51 157.66 7.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.9 2.4 . . . . 62.119999999999997 113.369 -175.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.79 146.76 26.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.605 -0.725 . . . . 31.219999999999999 109.921 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 22' ' ' ILE . 14.3 m -73.23 140.28 46.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.266 -0.425 . . . . 74.510000000000005 110.201 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 34.7 ttpt -52.81 -44.97 67.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 64.019999999999996 111.131 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.14 -40.11 92.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.951 -0.568 . . . . 71.040000000000006 110.857 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 m -66.57 -32.88 74.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 62.43 110.799 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.48 HG21 ' HA ' ' A' ' 71' ' ' SER . 54.8 mt -74.42 -39.24 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.37 0.605 . . . . 64.519999999999996 110.258 177.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.495 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 32.7 t70 -70.39 -21.41 62.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.957 -0.565 . . . . 75.040000000000006 110.667 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.57 -16.12 61.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.551 . . . . 45.229999999999997 111.227 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.54 143.01 96.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 64.420000000000002 110.84 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.37 136.62 75.6 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.104 2.536 . . . . 73.0 112.244 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -102.15 120.28 40.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.058 -0.519 . . . . 74.319999999999993 110.587 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.6 mt -112.08 111.99 38.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.091 -0.504 . . . . 62.340000000000003 109.927 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.01 118.8 10.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.86 -0.422 . . . . 64.420000000000002 109.86 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 49.0 t -71.23 114.52 9.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.141 -0.481 . . . . 64.319999999999993 110.177 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 p -95.36 147.3 23.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.728 -0.669 . . . . 63.25 110.258 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -69.67 -15.51 63.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.776 -0.647 . . . . 73.109999999999999 111.303 -174.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.34 -45.55 19.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.248 -175.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -74.36 -47.93 31.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 53.530000000000001 110.881 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.17 -87.4 0.68 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.88 -0.676 . . . . 73.310000000000002 113.032 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 41' ' ' MET . . . -74.45 100.3 3.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.911 0.386 . . . . 63.32 110.96 -177.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.7 t -95.3 118.2 40.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 110.682 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.91 -64.85 2.36 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.876 -0.678 . . . . 61.32 112.919 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -154.3 -56.96 0.11 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.657 0.265 . . . . 71.140000000000001 111.013 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' OE2' ' HB3' ' A' ' 42' ' ' CYS . 30.9 tt0 -101.76 155.01 18.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.248 -0.433 . . . . 70.450000000000003 110.054 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.7 pmm? -92.56 5.5 50.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.01 0.433 . . . . 44.439999999999998 110.255 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.867 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 19.6 t -130.8 156.0 45.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.885 -0.598 . . . . 73.450000000000003 109.926 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 30.8 t -107.35 106.32 58.08 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.703 -0.48 . . . . 71.040000000000006 109.703 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.7 Cg_endo -55.46 -29.35 68.5 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.29 2.66 . . . . 51.409999999999997 112.725 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -69.22 -27.77 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.083 -0.508 . . . . 74.420000000000002 110.74 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 96.5 m -103.49 -23.57 13.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.405 -0.361 . . . . 74.430000000000007 111.319 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.6 t 63.35 22.76 13.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.998 0.904 . . . . 54.299999999999997 108.577 -167.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.1 m -131.65 148.4 52.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.453 -1.249 . . . . 70.310000000000002 109.519 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.867 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 17.3 pt-20 -81.8 -178.25 6.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.276 0.56 . . . . 64.099999999999994 112.358 -172.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -91.04 117.2 29.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.471 -0.786 . . . . 74.219999999999999 111.021 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 m -132.42 166.78 28.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 74.409999999999997 109.48 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.8 ttpt -65.49 131.91 47.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.933 0.397 . . . . 62.100000000000001 110.717 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.43 -34.89 2.94 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.034 -0.603 . . . . 62.130000000000003 111.746 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -86.97 161.28 18.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.579 -0.526 . . . . 61.520000000000003 109.579 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.79 125.5 72.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.086 -0.339 . . . . 71.310000000000002 110.086 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -95.64 165.4 12.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.838 0.351 . . . . 54.509999999999998 110.485 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 7.5 t -146.78 172.56 13.45 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.584 -0.524 . . . . 41.25 109.584 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -125.55 117.66 24.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.691 -0.485 . . . . 73.25 109.691 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -90.03 139.51 27.36 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 110.186 -0.301 . . . . 70.109999999999999 110.186 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.51 12.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.481 0.778 0 C-N-CA 123.871 3.048 . . . . 75.409999999999997 114.623 -172.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -115.03 17.34 16.86 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.593 -0.521 . . . . 64.140000000000001 109.593 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 64.12 74.84 0.4 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.258 -0.883 . . . . 63.200000000000003 110.481 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -161.66 121.23 2.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.853 -0.612 . . . . 72.010000000000005 110.303 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -99.09 133.41 43.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 74.329999999999998 110.835 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -144.58 175.35 10.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.418 -0.956 . . . . 72.200000000000003 108.418 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.956 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 35.2 m170 -81.71 129.1 34.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.693 -0.854 . . . . 72.140000000000001 108.693 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.539 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 85.1 tttt -55.81 -50.99 83.95 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 123.448 0.467 . . . . 74.010000000000005 112.125 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 44.4 Cg_exo -58.33 -41.3 67.53 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.611 1.541 . . . . 51.130000000000003 113.183 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.956 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 30.2 p -80.95 -32.38 34.5 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.528 -0.469 . . . . 73.340000000000003 111.747 -175.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.93 -29.04 24.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.581 -0.526 . . . . 61.530000000000001 109.581 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.48 ' HA ' HG21 ' A' ' 22' ' ' ILE . 32.0 t -59.01 -42.49 90.24 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.0 -0.545 . . . . 61.350000000000001 109.817 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.418 ' O ' ' HE2' ' A' ' 76' ' ' LYS . 76.0 mt -55.6 -47.91 78.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 62.009999999999998 110.476 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 41.4 t-105 -69.7 -47.03 64.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.651 . . . . 72.120000000000005 110.946 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.43 -36.22 81.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.953 0.353 . . . . 62.5 111.953 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -64.44 -16.19 61.96 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.032 0.382 . . . . 73.299999999999997 112.032 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 72' ' ' ILE . 46.7 mtmt -118.34 -59.7 1.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.687 0.279 . . . . 72.430000000000007 111.645 -177.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.1 m -88.78 -25.15 22.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.305 -0.407 . . . . 63.340000000000003 111.624 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.21 43.47 93.53 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.322 -0.466 . . . . 55.509999999999998 113.194 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.03 165.56 27.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.979 0.418 . . . . 61.229999999999997 111.576 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.534 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 47.5 t -96.99 99.9 6.65 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.509 -0.552 . . . . 55.219999999999999 109.509 174.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -35.54 -48.93 0.95 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.578 3.519 . . . . 71.209999999999994 115.535 -169.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.82 -25.28 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.905 0.706 . . . . 74.439999999999998 112.905 -173.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 28.7 p -120.48 -25.48 5.57 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.771 -0.581 . . . . 75.5 111.423 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.5 mtm-85 72.08 15.11 5.59 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.546 0.738 . . . . 73.030000000000001 111.821 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.9 144.56 50.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.555 -0.906 . . . . 73.140000000000001 108.555 168.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.403 ' HB3' ' HE2' ' A' ' 86' ' ' MET . 62.5 ttp -79.01 148.27 32.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.997 0.427 . . . . 61.340000000000003 112.01 -172.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.456 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 87.7 t80 -132.54 124.39 19.0 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.346 -0.843 . . . . 75.310000000000002 108.766 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 37.3 Cg_endo -65.58 147.69 73.23 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.768 -1.347 . . . . 75.239999999999995 112.918 2.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.48 137.57 65.49 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.597 2.865 . . . . 71.299999999999997 113.145 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.79 151.58 46.15 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.746 2.297 . . . . 75.209999999999994 112.094 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.502 -0.761 . . . . 63.43 109.481 178.214 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 60.4 Cg_endo . . . . . 0 N--CA 1.461 -0.431 0 CA-C-O 120.955 0.315 . . . . 61.420000000000002 112.204 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 18.3 Cg_exo -66.89 146.14 76.86 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.484 2.123 . . . . 72.340000000000003 111.249 175.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -78.22 147.82 34.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.876 0.369 . . . . 65.349999999999994 110.915 -177.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.0 t -74.53 153.71 38.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.934 -0.576 . . . . 73.510000000000005 109.859 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -58.83 -38.12 77.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.263 0.554 . . . . 71.140000000000001 109.735 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -70.23 -28.72 65.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.357 -0.838 . . . . 74.439999999999998 110.911 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 13.8 m -66.68 -38.1 86.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.86 -0.422 . . . . 64.040000000000006 109.86 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -77.38 -36.04 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 72.109999999999999 110.259 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.81 -37.49 84.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.578 -0.737 . . . . 52.219999999999999 111.192 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.04 4.69 49.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.053 -0.521 . . . . 74.299999999999997 112.312 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 21' ' ' SER . 57.8 mt -70.34 128.96 90.89 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 121.247 -0.181 . . . . 42.100000000000001 110.946 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 16.1 Cg_endo -58.17 153.12 47.93 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.033 2.489 . . . . 53.539999999999999 112.047 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -126.17 118.03 24.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.022 0.439 . . . . 73.409999999999997 110.857 -174.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.1 mt -120.5 118.35 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.769 -0.651 . . . . 73.519999999999996 110.366 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.45 121.05 15.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.729 -0.471 . . . . 60.32 109.729 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 45.0 t -86.05 129.88 37.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.332 -0.395 . . . . 72.030000000000001 111.228 -177.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 34' ' ' HIS . 20.3 p -117.09 141.14 48.64 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.825 -0.625 . . . . 64.239999999999995 109.792 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 52' ' ' LYS . 57.0 mt-10 -69.12 -27.78 65.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.191 0.52 . . . . 73.409999999999997 110.974 -176.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.07 -6.55 59.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.74 -0.664 . . . . 74.310000000000002 110.969 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.53 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 22.5 t60 -74.34 -47.56 33.64 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.823 -0.436 . . . . 73.299999999999997 109.823 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 -160.13 13.39 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.407 -0.677 . . . . 63.439999999999998 111.407 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.73 114.19 14.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.848 0.356 . . . . 70.340000000000003 110.723 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.21 95.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.909 -0.587 . . . . 71.219999999999999 110.607 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.83 -143.26 23.17 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.839 -0.696 . . . . 72.510000000000005 112.545 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.556 ' OE1' ' HA ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -85.2 -27.67 25.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.58 0.228 . . . . 70.219999999999999 111.275 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -96.2 125.54 40.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.757 -0.46 . . . . 52.25 109.757 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 22.7 ptp -107.72 0.04 22.1 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.477 -0.329 . . . . 64.409999999999997 111.395 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.3 m -143.39 157.67 44.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.487 . . . . 63.509999999999998 110.993 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 40.7 t -117.06 93.32 41.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.776 -0.647 . . . . 74.109999999999999 109.377 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 13.1 Cg_endo -56.49 -26.03 61.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.567 2.845 . . . . 73.040000000000006 113.078 -174.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.6 mt -60.09 -34.77 57.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 73.519999999999996 111.054 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.4 p -114.94 9.74 16.18 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.126 -0.324 . . . . 71.319999999999993 110.126 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p 41.12 46.25 2.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.02 0.928 . . . . 71.219999999999999 111.892 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -140.2 154.59 46.97 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.923 -0.58 . . . . 63.030000000000001 110.06 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.84 -169.9 1.95 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.925 -0.58 . . . . 74.140000000000001 110.923 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.428 ' HB3' HG11 ' A' ' 30' ' ' VAL . 40.4 m-85 -87.17 93.66 9.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.545 0.688 . . . . 72.540000000000006 111.497 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.93 162.73 2.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.836 -1.075 . . . . 73.409999999999997 110.321 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.9 ttpm? -79.68 133.57 36.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.02 0.438 . . . . 72.129999999999995 110.67 -176.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.65 -16.18 21.53 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.819 -0.705 . . . . 64.219999999999999 111.834 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -86.96 161.83 18.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.169 -0.678 . . . . 73.200000000000003 109.169 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.6 121.2 64.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.958 -0.386 . . . . 74.510000000000005 109.958 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.34 155.95 16.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.875 0.369 . . . . 63.200000000000003 110.742 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 12.8 t -138.11 156.01 48.18 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.961 -0.563 . . . . 74.340000000000003 109.783 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.441 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 54.2 tt0 -111.61 117.46 33.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.296 -0.411 . . . . 64.430000000000007 109.92 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.4 mt -78.41 147.87 72.87 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.037 -0.529 . . . . 75.319999999999993 109.755 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.427 ' HD2' ' CE1' ' A' ' 87' ' ' PHE . 14.6 Cg_endo -59.38 -13.35 20.1 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.117 2.545 . . . . 73.109999999999999 112.136 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.0 t -79.49 4.33 15.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.415 -0.811 . . . . 63.200000000000003 109.655 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 56.93 63.74 1.84 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 122.127 0.965 . . . . 75.129999999999995 110.684 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.556 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 1.2 m80 -148.65 123.4 9.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.184 -1.371 . . . . 74.540000000000006 109.682 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -90.75 133.19 35.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.062 -0.517 . . . . 64.510000000000005 110.779 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -146.64 168.02 22.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.584 -0.735 . . . . 72.140000000000001 109.157 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.1 m170 -75.08 122.58 23.78 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.621 -0.511 . . . . 64.400000000000006 109.621 175.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 89.1 tttt -59.0 -51.11 84.18 Favored Pre-proline 0 CA--C 1.538 0.486 0 O-C-N 123.412 0.445 . . . . 41.310000000000002 112.093 -175.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.4 Cg_endo -60.74 -20.05 63.92 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.112 1.875 . . . . 64.140000000000001 112.956 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 61.3 m -84.38 -49.9 8.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.078 0.466 . . . . 74.019999999999996 110.43 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.9 p -73.37 -25.62 21.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.672 -0.695 . . . . 55.229999999999997 111.467 -171.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.502 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 13.0 p -59.81 -30.57 69.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.746 0.308 . . . . 60.32 111.597 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.98 -36.6 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.304 0.573 . . . . 75.129999999999995 110.419 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -74.66 -41.27 60.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.709 -0.678 . . . . 71.519999999999996 111.006 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 92.8 mt -62.24 -27.48 69.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.895 -0.593 . . . . 63.030000000000001 112.038 -175.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 71' ' ' SER . 73.9 mt-30 -65.77 -25.18 67.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.087 0.47 . . . . 73.439999999999998 110.736 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.96 -39.45 9.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 75.409999999999997 110.318 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 p -163.55 125.33 2.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 72.400000000000006 110.47 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 87' ' ' PHE . . . -79.96 91.27 1.31 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.614 -0.803 . . . . 62.340000000000003 111.137 177.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 84' ' ' ARG . 2.4 m -149.66 144.55 26.21 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.677 -0.308 . . . . 73.319999999999993 110.869 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . 0.747 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 83.1 m -74.39 120.92 83.84 Favored Pre-proline 0 N--CA 1.464 0.247 0 N-CA-C 108.386 -0.968 . . . . 61.450000000000003 108.386 168.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.48 -21.81 56.05 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.551 2.168 . . . . 62.119999999999997 112.832 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.47 -51.44 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.395 -0.366 . . . . 65.219999999999999 111.861 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.9 p -94.4 -22.76 18.1 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.759 0.314 . . . . 51.119999999999997 111.712 -172.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.529 ' HA ' HG22 ' A' ' 79' ' ' THR . 59.2 mtt180 60.35 28.08 17.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.762 -0.654 . . . . 74.030000000000001 111.695 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.9 m -88.86 160.69 17.1 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.647 -0.501 . . . . 74.030000000000001 109.647 172.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 38.2 ttm -76.12 141.14 42.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.647 0.61 . . . . 72.310000000000002 112.647 -169.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.427 ' CE1' ' HD2' ' A' ' 60' ' ' PRO . 54.6 t80 -132.74 121.39 17.1 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.282 -0.872 . . . . 74.120000000000005 109.539 170.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.51 159.37 85.74 Favored 'Cis proline' 0 C--O 1.232 0.196 0 C-N-CA 123.687 -1.38 . . . . 73.030000000000001 111.827 -1.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.57 149.09 14.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.041 2.494 . . . . 73.129999999999995 112.19 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.18 135.46 47.13 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.655 2.236 . . . . 73.349999999999994 112.114 -175.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 115.485 -0.78 . . . . 72.120000000000005 109.168 179.807 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo . . . . . 0 C--O 1.237 0.437 0 CA-C-O 120.62 0.175 . . . . 73.120000000000005 111.929 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.09 146.48 96.12 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.802 2.335 . . . . 60.310000000000002 112.155 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB3' HD11 ' A' ' 22' ' ' ILE . . . -85.56 162.76 18.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.245 -0.434 . . . . 43.200000000000003 110.243 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.465 ' O ' HG13 ' A' ' 22' ' ' ILE . 14.1 m -67.25 126.06 28.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.345 -0.389 . . . . 54.5 110.786 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -45.14 82.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 71.209999999999994 111.546 -175.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.13 -36.46 83.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.748 0.309 . . . . 72.310000000000002 111.086 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -67.07 -34.72 78.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.097 0.475 . . . . 55.329999999999998 110.321 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 18' ' ' SER . 60.8 mt -74.18 -41.18 51.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 70.140000000000001 110.847 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -80.14 -12.18 59.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.024 0.44 . . . . 32.210000000000001 110.968 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.85 -13.06 60.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 65.439999999999998 110.75 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.34 138.36 94.19 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.864 -0.607 . . . . 51.140000000000001 110.328 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -58.42 134.01 58.52 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.342 2.695 . . . . 62.109999999999999 113.088 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 40.0 mt-10 -84.8 102.81 13.34 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.306 -0.628 . . . . 74.439999999999998 109.306 173.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.6 mt -92.09 117.18 34.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.119 -0.491 . . . . 73.120000000000005 110.934 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.2 tp -78.26 109.34 12.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.791 -0.64 . . . . 74.239999999999995 109.553 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 50' ' ' TYR . 49.1 t -83.05 124.82 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.938 0.399 . . . . 52.200000000000003 111.147 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.5 p -101.19 153.88 19.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.311 -0.626 . . . . 51.32 109.311 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -87.89 -177.84 5.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.229 0.455 . . . . 72.109999999999999 112.229 -168.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.7 t70 76.07 -0.09 3.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.034 -0.985 . . . . 74.340000000000003 110.92 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.438 ' HE1' ' O ' ' A' ' 50' ' ' TYR . 11.7 p-80 -71.25 -21.41 62.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.9 -0.591 . . . . 71.340000000000003 112.06 -177.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.04 -82.87 1.41 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.531 -0.843 . . . . 70.310000000000002 111.097 -174.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.12 154.28 33.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.705 -0.479 . . . . 51.329999999999998 109.705 174.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.15 -56.89 4.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.147 0.499 . . . . 74.340000000000003 110.014 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.647 ' O ' ' HG2' ' A' ' 39' ' ' GLN . . . -163.57 103.71 0.22 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.919 -0.872 . . . . 52.329999999999998 110.919 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' A' ' 38' ' ' GLY . 8.6 pt20 56.87 -67.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.375 1.47 . . . . 62.240000000000002 112.297 -176.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.13 108.11 12.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.161 0.505 . . . . 41.200000000000003 109.679 173.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.2 ptp -81.41 -12.05 59.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.885 -0.598 . . . . 71.120000000000005 110.62 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 5.9 p -137.32 148.5 46.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.742 -0.663 . . . . 51.439999999999998 109.912 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' CYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 35.8 t -88.09 107.6 17.03 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 109.939 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 19.4 Cg_endo -58.57 -28.69 86.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.173 2.582 . . . . 54.240000000000002 112.66 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.8 mt -65.05 -25.96 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.245 0.545 . . . . 64.019999999999996 110.951 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 19.8 m -119.96 -1.87 10.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.111 -0.495 . . . . 62.030000000000001 111.144 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.8 p 41.14 42.97 1.8 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.712 0.768 . . . . 71.439999999999998 110.558 -168.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 t -142.89 147.26 35.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.981 -1.008 . . . . 73.120000000000005 109.464 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 8.3 pt-20 -80.28 -169.8 2.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.457 0.646 . . . . 54.119999999999997 111.268 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.498 ' HB3' HG11 ' A' ' 30' ' ' VAL . 78.6 m-85 -102.54 109.85 21.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.572 -0.74 . . . . 70.420000000000002 109.328 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.87 170.0 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 111.994 -171.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -60.13 109.25 0.93 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.542 -0.754 . . . . 74.219999999999999 111.091 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.24 -0.49 43.87 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.665 -0.779 . . . . 65.109999999999999 112.535 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -82.18 147.29 29.09 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.244 -0.651 . . . . 74.010000000000005 109.244 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.97 114.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.248 0.547 . . . . 51.219999999999999 110.913 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.33 176.75 4.93 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.635 -0.711 . . . . 54.32 110.507 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 6.6 t -152.23 171.06 18.54 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.471 -0.566 . . . . 74.230000000000004 109.471 175.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -123.4 119.42 29.98 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.091 -0.336 . . . . 72.129999999999995 110.091 -174.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.0 150.08 54.59 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.088 -0.506 . . . . 74.340000000000003 111.125 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.09 -9.62 17.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.03 2.487 . . . . 45.210000000000001 112.979 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -95.44 8.92 41.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.54 -0.3 . . . . 74.409999999999997 110.205 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 65.33 93.0 0.07 Allowed 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 123.82 0.7 . . . . 54.520000000000003 109.72 -172.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -175.62 122.47 0.2 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.759 -0.655 . . . . 74.150000000000006 110.723 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 57' ' ' THR . 92.2 m-85 -95.53 133.26 39.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.204 -0.453 . . . . 75.439999999999998 110.466 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.491 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 86.8 m-85 -140.98 174.77 10.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.755 -0.832 . . . . 72.140000000000001 108.755 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.875 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 38.3 m80 -82.02 125.16 30.48 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.271 -1.011 . . . . 74.25 108.271 175.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 60.7 tttm -53.67 -47.68 95.79 Favored Pre-proline 0 C--N 1.322 -0.618 0 O-C-N 123.388 0.43 . . . . 73.340000000000003 112.022 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 10.0 Cg_endo -52.88 -50.53 13.74 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.222 1.948 . . . . 64.219999999999999 113.246 177.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.875 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 26.3 p -76.54 -35.47 58.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.806 -0.358 . . . . 73.519999999999996 111.95 -173.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -74.16 -28.65 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.337 . . . . 74.219999999999999 110.271 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.442 ' HA ' HG21 ' A' ' 22' ' ' ILE . 33.0 t -60.79 -50.01 75.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 63.340000000000003 109.941 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.1 mt -61.08 -37.43 77.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 60.25 110.615 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -68.45 -50.84 49.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.798 -0.637 . . . . 73.319999999999993 111.257 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.86 -25.55 67.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.776 0.322 . . . . 71.319999999999993 111.203 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -75.0 -1.4 22.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 41.340000000000003 110.793 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -112.24 -48.39 3.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.254 0.55 . . . . 55.039999999999999 109.676 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.9 m -145.65 119.55 9.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.669 . . . . 52.009999999999998 110.413 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.13 71.71 1.95 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.845 -0.693 . . . . 51.130000000000003 112.332 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.9 142.82 29.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.229 -0.286 . . . . 64.010000000000005 110.229 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 47.0 t -74.69 113.61 26.11 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.006 -0.738 . . . . 75.219999999999999 109.006 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.77 -24.78 77.09 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 123.073 2.516 . . . . 73.25 114.03 -171.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.47 -59.15 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.069 0.396 . . . . 64.120000000000005 112.069 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 30.6 p -95.32 -11.25 28.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.938 -0.305 . . . . 71.219999999999999 111.478 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 62.42 80.57 0.22 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.795 0.807 . . . . 61.340000000000003 111.057 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.5 t -137.82 135.94 36.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.531 -1.213 . . . . 73.519999999999996 108.24 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.569 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 50.5 ttm -72.97 141.09 47.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.837 0.351 . . . . 72.310000000000002 111.301 -173.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 87.1 t80 -133.82 114.31 13.01 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.848 -0.614 . . . . 74.019999999999996 109.856 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 71.5 Cg_endo -75.26 153.13 98.58 Favored 'Cis proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.147 -1.605 . . . . 72.140000000000001 111.861 -2.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 88' ' ' PRO . 52.2 Cg_exo -54.82 148.5 45.78 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.808 2.339 . . . . 62.219999999999999 112.633 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 31.9 Cg_endo -63.72 153.39 75.57 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.826 2.351 . . . . 71.040000000000006 112.456 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 C--O 1.246 0.917 0 CA-C-N 115.816 -0.629 . . . . 71.099999999999994 109.746 178.834 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 110.25 -0.278 . . . . 62.340000000000003 110.25 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.77 68.73 0.22 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.277 -0.729 . . . . 52.200000000000003 111.277 176.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -84.42 -40.26 18.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.835 0.35 . . . . 74.129999999999995 110.292 -175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -111.49 120.8 43.36 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.152 -0.684 . . . . 75.099999999999994 109.152 175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -98.27 93.88 6.46 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.354 -0.384 . . . . 75.430000000000007 111.69 -174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -90.44 82.79 5.87 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.105 -1.072 . . . . 73.129999999999995 108.105 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -70.62 -36.82 73.69 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.092 -0.958 . . . . 75.420000000000002 111.457 -170.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -96.01 100.52 12.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.452 -0.34 . . . . 60.219999999999999 110.403 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 10' ' ' HIS . 10.0 t -86.3 164.19 17.26 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.154 -0.476 . . . . 71.319999999999993 110.041 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 9' ' ' SER . 9.8 m170 72.3 143.65 0.06 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.703 0.627 . . . . 74.219999999999999 111.537 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 68.6 mtt -87.49 -29.99 20.96 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.257 -0.646 . . . . 71.420000000000002 109.257 172.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.1 134.28 63.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.383 -0.826 . . . . 74.019999999999996 109.554 175.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.3 151.49 29.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.983 0.421 . . . . 74.140000000000001 111.304 -174.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' ND2' ' HB2' ' A' ' 86' ' ' MET . 5.4 m-20 -87.94 131.66 42.43 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.833 -0.621 . . . . 62.43 110.236 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 72.5 Cg_endo -77.77 145.64 22.98 Favored 'Trans proline' 0 N--CA 1.461 -0.383 0 C-N-CA 122.521 2.147 . . . . 73.019999999999996 112.553 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.6 153.36 65.11 Favored 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 122.608 2.205 . . . . 64.230000000000004 112.299 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.95 167.73 16.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.005 -0.543 . . . . 54.539999999999999 111.043 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.8 m -94.81 151.31 19.35 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.104 -0.498 . . . . 75.329999999999998 109.943 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HD2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -58.95 -37.56 77.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.493 -0.321 . . . . 74.120000000000005 110.494 -176.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -56.93 -41.87 78.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.972 -0.558 . . . . 72.310000000000002 111.125 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.2 m -72.25 -27.03 62.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.183 -0.462 . . . . 60.439999999999998 111.085 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.549 HG21 ' HA ' ' A' ' 71' ' ' SER . 42.8 mt -82.86 -38.8 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.399 0.618 . . . . 71.299999999999997 110.516 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.68 -20.68 64.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.987 -0.551 . . . . 71.219999999999999 110.505 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.9 -3.81 55.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.772 -0.649 . . . . 51.219999999999999 111.378 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.6 mt -75.4 152.34 85.67 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.553 -0.294 . . . . 72.239999999999995 110.453 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.93 122.91 11.64 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.715 2.277 . . . . 71.409999999999997 112.175 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -86.91 118.3 26.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.024 -0.535 . . . . 62.039999999999999 110.133 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.3 mt -110.19 103.63 15.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.82 -0.627 . . . . 61.509999999999998 110.264 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 68.9 tp -68.24 114.62 6.87 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.549 -0.538 . . . . 75.400000000000006 109.549 176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.657 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 40.0 t -70.13 111.05 3.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.971 -0.381 . . . . 74.329999999999998 109.971 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.2 p -88.19 169.74 11.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 65.129999999999995 110.379 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.37 -8.34 56.91 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.027 0.38 . . . . 40.310000000000002 112.027 -173.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -91.46 -2.42 57.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.154 0.502 . . . . 75.200000000000003 109.839 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 26.3 m80 -109.21 90.68 3.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.922 -0.581 . . . . 71.200000000000003 111.102 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.93 -26.82 48.03 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.909 -0.877 . . . . 74.030000000000001 110.909 175.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -137.19 140.46 41.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.482 -0.562 . . . . 74.400000000000006 109.482 176.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.3 t -118.86 90.8 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.765 0.317 . . . . 60.409999999999997 110.727 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.92 13.9 60.17 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.976 -0.556 . . . . 74.530000000000001 113.307 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.97 -155.87 0.43 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.61 -0.515 . . . . 50.439999999999998 109.61 -177.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -68.94 177.63 2.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.815 -0.439 . . . . 70.239999999999995 109.815 173.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.621 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 1.8 pmm? -84.33 0.0 50.86 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 121.006 -0.278 . . . . 75.310000000000002 110.468 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.7 m -116.36 131.84 56.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.079 0.466 . . . . 65.129999999999995 112.038 -173.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 14.5 t -83.48 107.93 11.61 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 108.595 -0.891 . . . . 63.530000000000001 108.595 171.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 9.8 Cg_endo -51.22 -38.91 62.23 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.331 2.687 . . . . 73.010000000000005 112.878 -173.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 51.7 mt -62.29 -29.48 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-N 115.961 -0.563 . . . . 71.219999999999999 111.347 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 61.2 m -110.12 -8.62 14.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.377 -0.374 . . . . 72.310000000000002 111.623 -174.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 30.4 p 45.18 34.99 1.53 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.459 0.647 . . . . 52.109999999999999 110.949 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.1 t -133.82 159.82 39.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.496 -0.775 . . . . 61.43 110.0 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 41' ' ' MET . 4.6 pt-20 -83.96 172.57 11.94 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.736 0.643 . . . . 64.430000000000007 112.736 -171.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -98.05 123.91 42.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.374 -0.83 . . . . 75.219999999999999 110.289 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.3 m -137.26 164.83 28.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.178 -0.465 . . . . 74.239999999999995 110.411 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.657 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.2 ttpt -58.77 125.64 24.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 60.200000000000003 111.047 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.83 -23.96 6.5 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.669 -0.777 . . . . 60.409999999999997 112.702 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.57 161.53 18.49 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 110.031 -0.359 . . . . 64.200000000000003 110.031 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -110.88 115.25 49.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.927 0.394 . . . . 71.510000000000005 110.351 -177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -100.96 168.35 9.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.211 -0.45 . . . . 62.109999999999999 110.417 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 11.0 t -152.76 166.2 32.97 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.229 -0.656 . . . . 73.329999999999998 109.229 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -120.39 119.71 33.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.688 0.28 . . . . 61.109999999999999 110.691 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.496 HD21 HD11 ' A' ' 74' ' ' LEU . 88.2 mt -70.39 142.36 89.3 Favored Pre-proline 0 N--CA 1.448 -0.559 0 N-CA-C 108.84 -0.8 . . . . 62.310000000000002 108.84 170.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.439 ' HG2' ' HG3' ' A' ' 89' ' ' PRO . 9.6 Cg_endo -52.79 -20.84 13.68 Favored 'Trans proline' 0 N--CA 1.476 0.488 0 C-N-CA 123.663 2.908 . . . . 74.430000000000007 113.841 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.7 p -85.88 19.33 2.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.955 0.407 . . . . 70.129999999999995 110.376 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 58.01 65.39 1.31 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.411 -0.813 . . . . 75.219999999999999 111.612 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -145.08 123.09 12.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.427 -0.806 . . . . 64.420000000000002 109.449 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -94.77 141.32 28.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.026 -0.533 . . . . 63.530000000000001 111.796 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -149.07 175.18 11.55 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.138 -1.06 . . . . 75.530000000000001 108.138 174.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.887 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 35.9 m170 -77.28 133.67 38.75 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.433 -0.951 . . . . 63.450000000000003 108.433 170.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 87.1 tttt -57.66 -50.74 86.45 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-O 119.481 -0.295 . . . . 55.520000000000003 111.319 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 6.6 Cg_endo -49.31 -46.88 24.32 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.566 2.177 . . . . 73.030000000000001 113.481 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.887 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 14.3 p -80.62 -34.06 35.33 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.492 -0.483 . . . . 71.319999999999993 111.933 -175.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 67' ' ' LYS . 5.5 p -73.77 -30.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.565 -0.454 . . . . 72.400000000000006 110.562 -178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.549 ' HA ' HG21 ' A' ' 22' ' ' ILE . 51.1 m -63.38 -32.99 74.57 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.977 0.418 . . . . 71.409999999999997 110.776 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.0 mt -79.42 -42.45 23.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.09 -0.504 . . . . 73.430000000000007 110.056 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -63.35 -43.82 96.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.896 -0.593 . . . . 74.519999999999996 111.363 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.498 HD13 ' CD2' ' A' ' 87' ' ' PHE . 95.7 mt -66.74 -24.34 66.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.642 -0.254 . . . . 75.430000000000007 111.666 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -92.49 0.55 57.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.904 0.383 . . . . 72.420000000000002 110.662 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -114.95 -41.72 3.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.398 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.9 m -120.94 -20.38 6.91 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.815 0.302 . . . . 63.420000000000002 111.815 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 58.58 26.64 60.08 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 116.37 -0.377 . . . . 62.030000000000001 114.018 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.26 145.09 40.9 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.339 -0.506 . . . . 63.020000000000003 111.79 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.45 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 24.3 t -75.03 110.69 10.7 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.741 -0.663 . . . . 73.129999999999995 109.251 176.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -50.22 -32.99 34.53 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.211 2.608 . . . . 64.140000000000001 113.993 -171.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.93 -28.64 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.393 0.516 . . . . 75.329999999999998 112.393 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 29.4 p -125.06 -13.13 6.87 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 121.818 -0.551 . . . . 64.319999999999993 112.093 -174.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 66.36 23.07 10.72 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.029 0.532 . . . . 73.010000000000005 111.237 176.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 35.3 t -85.01 145.31 27.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.939 -0.763 . . . . 43.039999999999999 108.939 173.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.479 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 58.7 ttp -75.51 150.51 38.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.926 0.393 . . . . 74.239999999999995 111.447 -175.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.552 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 81.1 t80 -129.5 125.98 22.62 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 108.791 -0.818 . . . . 71.450000000000003 108.791 170.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.552 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 30.9 Cg_endo -61.87 153.42 61.61 Favored 'Cis proline' 0 C--N 1.348 0.523 0 C-N-CA 123.988 -1.255 . . . . 73.219999999999999 113.019 3.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.472 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 42.7 Cg_exo -55.34 138.32 79.47 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.033 2.489 . . . . 73.209999999999994 112.61 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.479 ' HG3' ' HB3' ' A' ' 86' ' ' MET . 6.2 Cg_exo -72.24 177.5 7.18 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.665 2.243 . . . . 70.019999999999996 111.914 179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.701 -0.666 . . . . 72.349999999999994 110.231 -176.736 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.774 0.321 . . . . 74.049999999999997 110.564 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -117.49 116.05 3.38 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.991 -0.623 . . . . 71.510000000000005 111.703 177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -147.52 146.02 29.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.581 0.229 . . . . 73.340000000000003 110.616 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -110.92 146.05 37.25 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.644 -0.502 . . . . 71.549999999999997 109.644 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -130.07 152.4 49.56 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.544 -0.298 . . . . 65.510000000000005 111.22 -174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -71.55 143.81 49.78 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.207 -0.451 . . . . 64.540000000000006 110.345 176.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -149.84 23.63 0.87 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.163 -0.68 . . . . 70.150000000000006 109.163 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -55.67 103.63 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.978 -1.01 . . . . 73.319999999999993 110.897 -179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.1 m -100.03 101.78 12.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.643 -176.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -141.5 120.52 12.84 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.697 -0.482 . . . . 74.420000000000002 109.697 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.3 ttm 64.51 65.91 0.62 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.813 0.816 . . . . 73.120000000000005 110.385 -178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 m -126.09 108.51 19.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.005 -0.998 . . . . 51.450000000000003 110.078 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.46 -44.43 74.88 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.68 -0.691 . . . . 73.430000000000007 111.512 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 15' ' ' PRO . 64.0 t30 -104.78 122.9 41.83 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.891 -0.411 . . . . 74.349999999999994 109.891 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 20.4 Cg_endo -60.15 151.23 74.5 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 123.162 2.575 . . . . 72.120000000000005 113.053 -177.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 38.0 Cg_exo -61.84 163.38 19.15 Favored 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 123.168 2.579 . . . . 62.039999999999999 112.239 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -86.06 153.87 21.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.127 -0.488 . . . . 72.239999999999995 110.714 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.404 ' O ' HG13 ' A' ' 22' ' ' ILE . 22.4 m -71.96 137.96 47.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.957 -0.565 . . . . 62.020000000000003 110.626 179.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 ttpm? -58.21 -41.43 84.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.105 -0.498 . . . . 63.420000000000002 110.57 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -52.17 -45.91 65.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.996 -1.002 . . . . 72.230000000000004 110.987 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.506 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 13.8 m -67.68 -42.33 82.28 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.083 -0.508 . . . . 72.519999999999996 110.679 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 18' ' ' SER . 66.4 mt -61.92 -40.93 88.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.011 -0.54 . . . . 73.099999999999994 110.81 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -67.16 -44.11 80.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.945 -0.571 . . . . 74.099999999999994 110.79 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.6 3.89 30.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.932 -0.576 . . . . 61.229999999999997 112.287 -174.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.544 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 40.5 mt -57.85 127.78 79.56 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 116.89 -0.141 . . . . 74.439999999999998 111.027 177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.13 126.3 21.15 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.161 2.574 . . . . 72.140000000000001 111.77 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -98.97 116.46 31.27 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.958 -0.564 . . . . 74.310000000000002 110.783 -172.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 65.9 mt -104.69 129.01 57.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.673 -0.694 . . . . 71.340000000000003 110.053 -178.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 46.8 tp -82.23 120.4 25.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.123 -0.49 . . . . 72.120000000000005 110.367 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.992 HG13 ' HA2' ' A' ' 35' ' ' GLY . 97.9 t -90.28 128.3 42.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.998 -0.546 . . . . 63.020000000000003 111.032 -178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.422 HG22 ' HG3' ' A' ' 52' ' ' LYS . 17.7 p -137.35 172.95 12.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.463 -0.789 . . . . 74.540000000000006 109.825 178.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.438 ' OE1' ' HD3' ' A' ' 52' ' ' LYS . 4.5 mp0 -59.76 130.21 45.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.404 -0.221 . . . . 64.530000000000001 110.404 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 69.01 10.94 8.18 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.928 -0.578 . . . . 54.130000000000003 111.523 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -141.32 34.76 1.68 Allowed 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.568 -1.271 . . . . 63.0 107.568 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.992 ' HA2' HG13 ' A' ' 30' ' ' VAL . . . -93.9 -56.81 1.37 Allowed Glycine 0 N--CA 1.442 -0.95 0 CA-C-N 114.985 -1.007 . . . . 61.039999999999999 113.461 -172.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.33 -60.57 3.22 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.659 0.23 . . . . 74.400000000000006 111.23 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.2 t 60.51 91.79 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.829 -0.623 . . . . 74.450000000000003 111.422 177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . 99.4 -89.32 0.88 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.388 -0.911 . . . . 64.510000000000005 113.269 175.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -141.16 -52.65 0.46 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.833 0.317 . . . . 73.519999999999996 111.625 -173.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.39 107.24 2.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.864 0.364 . . . . 55.210000000000001 111.082 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.438 ' HG2' ' SG ' ' A' ' 42' ' ' CYS . 1.8 pmm? -84.16 -18.3 37.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.098 0.475 . . . . 71.200000000000003 110.421 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.438 ' SG ' ' HG2' ' A' ' 41' ' ' MET . 78.2 m -136.82 159.22 42.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.639 -0.71 . . . . 73.209999999999994 109.739 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 41.6 t -105.56 102.21 36.53 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 109.501 -0.555 . . . . 65.409999999999997 109.501 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.55 -28.35 86.49 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.84 2.36 . . . . 73.219999999999999 111.788 -176.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 48.0 mt -61.98 -29.69 46.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.437 -0.801 . . . . 54.0 111.762 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.3 p -121.38 2.4 10.24 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 120.87 -0.332 . . . . 74.140000000000001 111.313 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 76.9 m 50.66 62.13 2.86 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.415 0.626 . . . . 72.140000000000001 111.027 -175.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.8 t -159.43 152.81 22.44 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.428 -0.805 . . . . 71.329999999999998 109.708 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.512 ' HG3' HG13 ' A' ' 51' ' ' VAL . 11.4 pt-20 -77.75 -173.04 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.288 0.566 . . . . 62.5 110.889 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.52 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 37.0 m-85 -97.96 106.68 19.01 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.046 -0.525 . . . . 63.539999999999999 110.65 177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.512 HG13 ' HG3' ' A' ' 49' ' ' GLU . 31.2 m -118.59 162.84 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.786 -0.643 . . . . 75.310000000000002 110.889 -177.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 34.1 ttpt -62.78 112.91 2.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.861 -0.609 . . . . 71.230000000000004 110.754 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.5 -31.48 2.85 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.885 -0.674 . . . . 60.32 111.726 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.2 133.34 34.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.675 0.274 . . . . 74.340000000000003 110.301 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.65 127.59 40.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.448 -0.342 . . . . 64.439999999999998 110.764 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.25 168.4 9.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.263 -0.426 . . . . 65.010000000000005 109.995 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.544 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 13.2 t -148.51 153.31 38.27 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.899 -0.408 . . . . 75.430000000000007 109.899 177.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -107.49 117.7 34.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.046 0.45 . . . . 74.510000000000005 110.335 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -80.75 140.69 51.03 Favored Pre-proline 0 C--N 1.317 -0.818 0 N-CA-C 108.893 -0.78 . . . . 73.299999999999997 108.893 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.47 ' HB2' ' HG3' ' A' ' 89' ' ' PRO . 17.1 Cg_endo -58.81 -7.8 4.98 Favored 'Trans proline' 0 N--CA 1.475 0.388 0 C-N-CA 122.896 2.397 . . . . 71.230000000000004 112.106 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.6 t -87.42 21.34 2.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.241 -0.891 . . . . 74.219999999999999 109.784 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 57.44 40.33 27.37 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.803 -0.635 . . . . 72.109999999999999 111.321 176.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -138.06 148.89 45.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.536 -0.302 . . . . 72.510000000000005 111.067 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 60.8 m-85 -124.39 133.51 53.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.148 -0.478 . . . . 74.099999999999994 111.084 -171.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.52 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 92.5 m-85 -146.49 162.52 38.13 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.89 -0.595 . . . . 65.209999999999994 109.798 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 33.9 m170 -67.13 123.16 19.48 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.478 -0.564 . . . . 72.530000000000001 109.478 174.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.539 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 83.2 tttt -57.57 -48.86 96.53 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 123.349 0.406 . . . . 72.329999999999998 111.866 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 12.2 Cg_endo -56.84 -27.16 70.72 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 122.162 1.908 . . . . 61.350000000000001 112.844 177.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 37.3 m -84.53 -52.77 5.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.142 0.496 . . . . 65.430000000000007 111.122 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.534 HG22 ' HG ' ' A' ' 74' ' ' LEU . 9.8 p -67.17 -25.6 34.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 62.130000000000003 111.404 -172.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.5 p -63.49 -30.38 71.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.807 0.337 . . . . 73.230000000000004 111.437 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.4 mt -78.88 -40.15 22.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.253 0.549 . . . . 74.549999999999997 109.917 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -65.82 -43.19 89.33 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.453 -0.794 . . . . 71.510000000000005 111.481 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 93.1 mt -67.03 -19.33 65.67 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.953 0.353 . . . . 73.319999999999993 111.953 -177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -74.28 -22.27 59.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.046 0.451 . . . . 72.150000000000006 110.327 175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -91.19 -45.17 8.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.713 -0.676 . . . . 64.400000000000006 109.851 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 37.2 p -157.37 133.05 9.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.819 -0.628 . . . . 64.109999999999999 110.247 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.01 77.61 2.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.681 -0.771 . . . . 35.450000000000003 111.226 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 m -148.52 148.85 30.68 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.169 -0.308 . . . . 54.299999999999997 110.169 -174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.746 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 73.7 m -75.12 119.83 78.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 108.23 -1.026 . . . . 72.030000000000001 108.23 168.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.83 -12.07 20.47 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 122.468 2.112 . . . . 75.230000000000004 113.04 -177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 86.6 t -96.15 -50.21 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 111.861 0.319 . . . . 74.349999999999994 111.861 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.746 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 20.4 p -96.0 -18.88 19.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.761 0.315 . . . . 55.140000000000001 111.629 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 63.08 25.57 15.01 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.012 -0.54 . . . . 73.510000000000005 111.887 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.7 t -92.42 151.06 20.43 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.487 -0.56 . . . . 44.049999999999997 109.487 172.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 52.8 ttp -76.31 146.89 38.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.033 0.753 . . . . 61.240000000000002 113.033 -169.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.545 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 76.6 t80 -133.16 124.47 18.42 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 114.803 -1.089 . . . . 73.409999999999997 108.527 170.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 32.7 Cg_exo -59.6 144.48 33.62 Favored 'Cis proline' 0 C--N 1.35 0.643 0 C-N-CA 124.558 -1.017 . . . . 72.409999999999997 113.181 3.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.47 ' HG3' ' HB2' ' A' ' 60' ' ' PRO . 52.9 Cg_endo -67.48 149.76 80.2 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 123.059 2.506 . . . . 63.310000000000002 112.611 -174.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.5 178.71 5.31 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.709 2.273 . . . . 65.239999999999995 111.814 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.41 -0.805 . . . . 63.32 110.266 -179.747 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 110.096 -0.335 . . . . 70.129999999999995 110.096 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.56 115.47 2.98 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 111.205 -0.758 . . . . 63.219999999999999 111.205 -175.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -105.03 27.46 8.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.088 0.471 . . . . 73.329999999999998 110.843 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -113.91 79.81 1.3 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.863 -0.792 . . . . 74.519999999999996 108.863 172.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -88.06 -9.22 54.03 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.135 -0.484 . . . . 73.129999999999995 111.162 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -101.62 88.39 3.41 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.9 0.381 . . . . 75.450000000000003 110.591 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -91.7 138.91 31.18 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.058 0.456 . . . . 72.230000000000004 110.646 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -83.04 80.62 8.99 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.159 -0.682 . . . . 71.540000000000006 109.159 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.9 t -78.3 86.31 4.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.38 -0.827 . . . . 74.510000000000005 110.124 -176.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.9 107.55 5.09 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.381 -0.97 . . . . 74.209999999999994 108.381 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.46 ' HG3' HG23 ' A' ' 12' ' ' VAL . 23.2 ptt? -55.93 -50.56 70.4 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 123.358 0.411 . . . . 53.219999999999999 111.958 -172.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.46 HG23 ' HG3' ' A' ' 11' ' ' MET . 24.6 t -92.52 81.1 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.321 -0.622 . . . . 70.439999999999998 109.321 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 15' ' ' PRO . . . -68.59 -38.05 80.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.613 -0.721 . . . . 73.400000000000006 111.28 -176.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -89.51 110.08 36.41 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.284 -0.416 . . . . 63.020000000000003 110.72 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 13' ' ' ALA . 96.8 Cg_endo -89.37 167.84 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.873 2.382 . . . . 61.119999999999997 112.056 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -73.88 136.85 23.54 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 121.91 1.74 . . . . 73.129999999999995 111.326 172.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -79.96 127.73 32.62 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.43 -0.35 . . . . 72.319999999999993 110.529 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 p -74.64 166.55 23.37 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.091 -0.504 . . . . 71.349999999999994 110.736 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -57.64 -35.17 70.15 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.248 -0.433 . . . . 62.409999999999997 110.946 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.42 -35.26 69.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.938 0.399 . . . . 65.109999999999999 111.181 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.3 m -85.83 -35.41 20.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.025 -0.534 . . . . 64.409999999999997 111.173 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.512 HG21 ' HA ' ' A' ' 71' ' ' SER . 68.1 mt -82.89 -44.44 18.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.017 0.437 . . . . 75.239999999999995 111.903 -175.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -61.75 -33.73 74.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.013 -0.54 . . . . 50.009999999999998 110.762 -175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.77 4.93 26.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.697 -0.683 . . . . 43.32 112.186 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.44 HD21 ' CZ ' ' A' ' 87' ' ' PHE . 66.7 mt -70.75 136.17 85.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 120.609 0.242 . . . . 62.130000000000003 110.511 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -57.61 149.37 67.9 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.256 2.637 . . . . 71.439999999999998 112.782 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.64 121.33 44.46 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.026 -0.534 . . . . 71.129999999999995 110.4 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 60.3 mt -109.44 120.55 60.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.743 -0.662 . . . . 70.200000000000003 109.883 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.0 tp -79.93 107.67 12.9 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.796 -0.446 . . . . 73.540000000000006 109.796 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.583 HG11 ' HB3' ' A' ' 50' ' ' TYR . 42.5 t -74.86 131.86 34.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.051 -0.522 . . . . 61.100000000000001 110.902 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 52' ' ' LYS . 35.2 p -120.17 145.21 47.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.966 -0.561 . . . . 73.420000000000002 109.883 175.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.488 ' HG2' ' HD3' ' A' ' 52' ' ' LYS . 16.7 pt-20 -71.7 -17.43 62.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.705 0.288 . . . . 74.329999999999998 111.221 -173.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -68.29 -23.03 64.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.466 -0.334 . . . . 61.229999999999997 110.382 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -90.76 -13.81 33.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.307 -0.406 . . . . 65.109999999999999 109.913 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.2 -80.38 0.98 Allowed Glycine 0 N--CA 1.453 -0.23 0 CA-C-N 115.967 -0.56 . . . . 72.409999999999997 112.164 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.78 -172.8 2.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.78 -0.452 . . . . 62.009999999999998 109.78 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 26.3 t -117.87 95.42 3.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.085 0.469 . . . . 74.430000000000007 110.159 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.5 -110.44 3.49 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.794 -0.639 . . . . 71.140000000000001 111.756 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -98.48 -14.77 19.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.741 0.305 . . . . 72.549999999999997 111.19 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' HG3' ' H ' ' A' ' 64' ' ' TYR . 58.1 mm-40 -99.36 133.69 43.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.247 0.546 . . . . 65.349999999999994 110.954 -174.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.3 ptp -121.44 -5.04 9.33 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.489 -0.778 . . . . 75.409999999999997 111.61 -175.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 6.2 p -150.48 151.77 33.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.329 . . . . 74.040000000000006 110.924 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 42.9 t -109.79 93.01 13.49 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.964 -0.562 . . . . 71.439999999999998 109.57 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.15 -18.29 57.38 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 123.375 2.717 . . . . 73.349999999999994 113.006 -173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 49.6 mt -63.94 -27.93 43.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.17 -0.468 . . . . 64.230000000000004 110.632 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.6 p -127.07 -7.4 5.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.622 -0.263 . . . . 60.039999999999999 111.107 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 71.0 m 61.4 35.9 17.62 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.128 -0.487 . . . . 74.349999999999994 110.784 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.9 m -124.38 159.25 30.81 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.805 -0.634 . . . . 73.340000000000003 110.299 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.85 -174.4 5.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.817 -0.629 . . . . 75.519999999999996 111.389 -177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.655 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 96.4 m-85 -108.58 118.68 37.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.26 -0.427 . . . . 75.219999999999999 110.168 176.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.4 m -107.18 174.67 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.392 -0.367 . . . . 60.520000000000003 111.293 -177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' HD3' ' HG2' ' A' ' 32' ' ' GLU . 35.9 ttpt -76.87 124.22 27.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.097 -0.501 . . . . 73.439999999999998 110.652 -178.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.67 0.73 55.33 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.885 -0.674 . . . . 61.109999999999999 111.711 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -87.24 157.83 19.24 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.531 -0.544 . . . . 72.120000000000005 109.531 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 88.2 t -111.45 114.47 47.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.342 0.592 . . . . 74.329999999999998 111.166 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.5 166.64 10.52 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.486 -0.779 . . . . 53.149999999999999 110.066 176.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.491 HG21 HG11 ' A' ' 70' ' ' VAL . 7.6 t -131.01 171.71 12.92 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.832 -0.433 . . . . 72.019999999999996 109.832 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.509 ' HG2' ' CE2' ' A' ' 64' ' ' TYR . 0.8 OUTLIER -126.4 118.35 24.83 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.342 -0.614 . . . . 75.219999999999999 109.342 -177.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.8 mt -87.5 147.23 41.35 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.273 -0.421 . . . . 64.340000000000003 110.538 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -63.44 4.32 0.48 Allowed 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.048 2.499 . . . . 64.519999999999996 113.702 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.1 p -109.35 8.41 25.5 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.969 -0.382 . . . . 51.340000000000003 109.969 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.1 m170 66.59 89.13 0.1 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.757 -0.656 . . . . 73.340000000000003 110.371 -173.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -172.53 125.4 0.49 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.52 -0.763 . . . . 72.120000000000005 110.126 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CE2' ' HG2' ' A' ' 58' ' ' GLU . 39.0 m-85 -103.83 133.28 49.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.978 -0.555 . . . . 72.239999999999995 110.047 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.655 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 90.0 m-85 -146.24 155.75 42.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.143 -0.48 . . . . 72.010000000000005 109.912 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.457 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 26.1 m170 -56.28 124.18 17.12 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.213 -0.662 . . . . 72.230000000000004 109.213 171.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.51 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 86.0 tttt -57.41 -49.27 94.82 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-O 119.297 -0.382 . . . . 70.010000000000005 111.462 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 77.6 Cg_exo -53.29 -36.22 77.44 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 121.865 1.71 . . . . 72.209999999999994 112.559 176.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 71.2 m -70.59 -51.59 27.31 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.428 -0.351 . . . . 62.210000000000001 111.13 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.491 HG11 HG21 ' A' ' 57' ' ' THR . 7.5 p -65.93 -26.73 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.001 -0.545 . . . . 43.43 110.3 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.512 ' HA ' HG21 ' A' ' 22' ' ' ILE . 50.3 m -60.96 -55.28 34.76 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.346 -0.388 . . . . 73.349999999999994 110.013 175.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.26 -40.63 84.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.984 -0.553 . . . . 74.030000000000001 110.789 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -64.94 -53.21 50.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 71.239999999999995 111.348 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 96.5 mt -66.41 -31.26 71.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.736 -0.211 . . . . 62.340000000000003 111.55 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -59.97 -30.71 69.29 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.759 0.314 . . . . 70.209999999999994 110.766 176.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -92.48 -40.29 10.92 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.234 -0.439 . . . . 74.439999999999998 110.838 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.7 p -153.79 115.21 4.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.434 . . . . 62.140000000000001 110.683 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.83 71.38 2.88 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.864 -0.684 . . . . 73.109999999999999 112.643 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 1.3 m -146.43 141.14 26.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.781 -0.452 . . . . 73.420000000000002 109.781 176.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.0 t -74.56 113.01 19.98 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 109.091 -0.707 . . . . 74.329999999999998 109.091 176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.78 -37.95 96.84 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.844 2.362 . . . . 71.019999999999996 113.378 -172.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 45.4 t -71.42 -48.81 51.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.515 0.561 . . . . 74.120000000000005 112.515 -174.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.1 p -113.71 -8.81 13.22 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 120.62 -0.432 . . . . 72.549999999999997 111.992 -171.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 63.67 91.71 0.07 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.629 0.728 . . . . 61.210000000000001 110.943 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 79' ' ' THR . 44.0 t -144.4 130.83 19.84 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.042 -0.981 . . . . 54.100000000000001 108.862 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.556 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 43.4 ttm -64.6 140.9 58.92 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.509 0.506 . . . . 72.430000000000007 110.391 -178.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.44 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 70.3 t80 -131.83 116.26 15.83 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.035 -0.53 . . . . 74.409999999999997 109.69 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.99 155.12 99.74 Favored 'Cis proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.232 -1.57 . . . . 52.25 112.426 -0.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.39 151.55 29.43 Favored 'Trans proline' 0 CA--C 1.531 0.374 0 C-N-CA 123.264 2.643 . . . . 73.439999999999998 113.221 -178.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 86.9 Cg_endo -80.6 170.63 15.55 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.786 2.324 . . . . 63.100000000000001 112.429 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.278 -0.868 . . . . 71.150000000000006 109.729 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 120.635 0.255 . . . . 64.109999999999999 110.617 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.39 22.29 75.99 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.104 -0.569 . . . . 35.299999999999997 113.254 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -106.58 134.87 49.06 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.508 -0.553 . . . . 74.450000000000003 109.508 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -78.8 150.64 32.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.248 -0.433 . . . . 74.420000000000002 111.414 -172.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -85.7 24.34 1.25 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.807 -0.633 . . . . 72.109999999999999 110.771 -176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -65.94 -29.85 70.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.24 -0.437 . . . . 63.130000000000003 111.545 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -72.78 -8.69 56.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.033 0.445 . . . . 74.540000000000006 110.941 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -98.35 6.2 47.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.551 0.691 . . . . 65.049999999999997 109.662 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.7 t -107.76 106.02 16.13 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.668 -0.696 . . . . 71.25 110.435 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 66.3 m170 -91.2 83.8 5.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.955 -0.566 . . . . 73.409999999999997 109.546 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -119.23 19.62 12.79 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.865 -0.607 . . . . 71.209999999999994 110.413 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.4 m -66.99 108.55 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 121.527 0.68 . . . . 42.399999999999999 110.517 178.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.89 96.44 1.98 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.434 -0.803 . . . . 73.400000000000006 110.054 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.438 ' HA ' ' HE2' ' A' ' 86' ' ' MET . 55.3 m-20 70.32 101.54 0.04 OUTLIER Pre-proline 0 C--O 1.236 0.389 0 CA-C-N 115.466 -0.788 . . . . 71.450000000000003 111.287 176.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.79 172.63 13.28 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 123.406 2.738 . . . . 71.230000000000004 112.341 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.11 149.87 41.96 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.858 2.372 . . . . 72.140000000000001 112.5 174.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.45 157.98 24.72 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.778 -0.646 . . . . 53.130000000000003 110.993 -178.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 4.2 m -67.93 139.72 56.44 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.679 -0.489 . . . . 74.129999999999995 109.679 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -61.52 -37.36 83.44 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.64 0.257 . . . . 74.209999999999994 111.178 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.477 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 3.1 mp0 -60.0 -42.49 94.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.4 -0.364 . . . . 71.150000000000006 110.287 178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.462 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 3.7 m -62.16 -40.04 94.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 65.329999999999998 110.823 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 58.7 mt -70.14 -40.95 78.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.861 -0.609 . . . . 71.400000000000006 110.647 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -72.79 -32.89 65.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.16 -0.473 . . . . 64.439999999999998 111.179 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.65 -0.31 37.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.482 -0.326 . . . . 72.209999999999994 111.86 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.514 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 67.5 mt -64.99 123.3 83.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 120.605 0.241 . . . . 73.5 110.791 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.57 117.99 4.8 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.154 2.569 . . . . 72.450000000000003 112.332 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -78.4 121.99 25.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.087 -0.506 . . . . 72.530000000000001 110.808 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 56.4 mt -115.91 120.82 65.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.041 -0.527 . . . . 72.450000000000003 110.03 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 59.2 tp -75.71 119.51 19.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.74 -0.467 . . . . 73.230000000000004 109.74 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 40.3 t -85.91 121.56 37.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.072 0.463 . . . . 40.200000000000003 111.258 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.432 HG22 ' HG3' ' A' ' 52' ' ' LYS . 24.0 p -123.37 165.79 16.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.479 -0.782 . . . . 74.120000000000005 109.661 173.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.543 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 31.5 mt-10 -68.16 -30.22 69.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.937 0.398 . . . . 74.450000000000003 111.311 -173.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -64.31 -17.97 64.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.029 -0.532 . . . . 63.200000000000003 112.222 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -75.95 -17.52 59.7 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.044 0.387 . . . . 72.129999999999995 112.044 -175.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.22 69.43 1.32 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.767 -0.73 . . . . 54.109999999999999 113.075 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 67.17 -2.83 1.11 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.328 0.651 . . . . 74.420000000000002 112.666 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 62.5 t 72.77 -64.84 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 123.193 0.597 . . . . 71.420000000000002 111.742 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.56 -161.57 9.06 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.657 -0.782 . . . . 74.200000000000003 112.496 -176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -62.27 -28.77 69.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.02 0.438 . . . . 55.329999999999998 110.803 178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -80.52 110.6 16.14 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.43 -0.952 . . . . 75.439999999999998 108.43 174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.1 ptp -103.8 -2.2 26.72 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.16 -0.473 . . . . 72.25 111.382 -173.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 82.0 m -146.42 147.52 31.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.341 -0.391 . . . . 75.140000000000001 110.571 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 47.0 t -103.78 94.74 6.62 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.081 -0.711 . . . . 65.099999999999994 109.081 176.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.87 -8.99 17.24 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.37 2.713 . . . . 43.200000000000003 112.84 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.5 mt -76.2 -32.92 23.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.019 -0.537 . . . . 75.439999999999998 110.508 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.8 p -114.86 -3.2 12.76 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.755 0.312 . . . . 70.549999999999997 111.045 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.0 t 67.64 23.37 8.79 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.564 -0.744 . . . . 71.040000000000006 111.103 177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.1 m -129.47 158.78 38.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 63.109999999999999 110.405 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.9 OUTLIER -84.61 -169.67 2.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.171 -0.468 . . . . 64.150000000000006 111.1 -177.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.605 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 96.8 m-85 -93.94 94.23 8.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.483 0.659 . . . . 74.519999999999996 110.899 -177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.6 m -103.24 173.74 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 114.766 -1.106 . . . . 73.519999999999996 111.01 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 32.9 ttpt -75.48 123.24 25.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.969 -0.56 . . . . 75.109999999999999 110.806 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.63 -24.28 6.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.691 -0.766 . . . . 61.350000000000001 112.709 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -87.04 161.26 18.27 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.572 -0.529 . . . . 72.5 109.572 -179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.3 t -111.26 124.75 68.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.916 0.389 . . . . 74.219999999999999 110.056 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -111.73 172.69 6.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.315 -0.402 . . . . 63.130000000000003 110.777 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 12.7 t -152.76 161.13 42.97 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.903 -0.59 . . . . 74.400000000000006 109.59 176.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -108.31 117.59 34.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.85 0.357 . . . . 74.129999999999995 111.229 -177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.9 mt -76.84 152.94 82.98 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 108.913 -0.773 . . . . 73.230000000000004 108.913 171.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.83 51.04 0.62 Allowed 'Trans proline' 0 N--CA 1.474 0.377 0 C-N-CA 122.959 2.439 . . . . 74.540000000000006 111.189 175.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 45.4 t -153.37 16.8 0.54 Allowed 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.041 -0.982 . . . . 72.319999999999993 109.677 -172.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 56.95 18.16 3.76 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.54 -0.755 . . . . 72.140000000000001 111.775 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.412 ' HB3' ' CE2' ' A' ' 65' ' ' PHE . 3.3 m170 -111.13 115.63 29.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.189 -0.459 . . . . 71.409999999999997 110.563 -178.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -91.99 133.26 35.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.617 -0.719 . . . . 72.299999999999997 109.728 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.605 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 74.9 m-85 -136.7 155.73 49.47 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 123.367 0.417 . . . . 75.230000000000004 110.143 177.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 32.2 m170 -65.71 121.21 14.46 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.225 -0.658 . . . . 75.140000000000001 109.225 174.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.5 tttt -56.57 -51.49 80.79 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 123.576 0.547 . . . . 74.409999999999997 111.966 -175.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.0 Cg_endo -58.68 -27.97 84.89 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.237 1.958 . . . . 61.229999999999997 112.572 179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 57.5 m -80.34 -50.61 9.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.069 -0.514 . . . . 74.349999999999994 110.419 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.531 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.1 p -72.52 -27.47 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.669 -0.696 . . . . 74.140000000000001 111.125 -172.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.6 t -59.3 -42.52 91.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.007 0.432 . . . . 63.350000000000001 110.448 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.93 -36.76 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.269 0.557 . . . . 73.120000000000005 110.204 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -72.29 -51.96 18.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.441 -0.799 . . . . 71.5 110.778 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 95.9 mt -60.03 -33.74 72.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.016 -0.538 . . . . 72.340000000000003 112.369 -174.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -66.5 -18.91 65.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.05 0.389 . . . . 63.409999999999997 112.05 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -111.4 -16.69 13.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.946 0.403 . . . . 73.150000000000006 110.925 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 26.4 t -172.33 117.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.018 -0.537 . . . . 74.25 109.763 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -85.12 91.53 1.7 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.556 -0.83 . . . . 63.420000000000002 111.681 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 2.8 p -149.28 155.03 39.92 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.3 0.481 . . . . 65.299999999999997 112.3 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.574 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 35.0 m -74.79 112.0 15.73 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 107.843 -1.169 . . . . 73.239999999999995 107.843 160.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -57.91 -15.6 22.63 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 122.53 2.153 . . . . 65.230000000000004 112.379 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.6 t -89.93 -48.85 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.007 -0.542 . . . . 75.340000000000003 111.847 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 20.0 p -107.81 -3.13 19.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.62 0.6 . . . . 70.430000000000007 112.62 -169.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? 68.06 14.71 9.37 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.039 0.755 . . . . 70.519999999999996 113.039 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 79' ' ' THR . 17.2 p -79.92 150.85 30.4 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.92 -0.488 . . . . 73.140000000000001 110.249 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.556 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 40.1 ttm -81.32 144.36 31.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.123 0.487 . . . . 61.409999999999997 111.376 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.406 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 77.8 t80 -135.43 123.53 15.42 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.497 -0.774 . . . . 74.010000000000005 109.547 172.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.28 152.42 84.75 Favored 'Cis proline' 0 C--N 1.343 0.272 0 C-N-CA 123.339 -1.525 . . . . 70.129999999999995 111.528 -2.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.37 149.44 56.06 Favored 'Trans proline' 0 C--O 1.236 0.416 0 C-N-CA 122.83 2.354 . . . . 73.030000000000001 112.412 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 96.0 Cg_endo -81.82 147.29 15.17 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.66 2.24 . . . . 74.340000000000003 111.406 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.344 -0.836 . . . . 74.019999999999996 110.011 179.658 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 N--CA 1.477 0.89 0 CA-C-O 120.654 0.264 . . . . 70.219999999999999 110.304 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -107.4 -105.08 2.99 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.674 -0.774 . . . . 54.340000000000003 112.139 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -89.44 -7.13 55.74 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.966 0.412 . . . . 75.510000000000005 110.477 -178.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.0 m170 -66.65 129.73 40.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.527 -0.545 . . . . 65.040000000000006 109.527 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.427 ' O ' ' HB3' ' A' ' 6' ' ' HIS . 46.7 t-80 -135.09 8.45 3.47 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.297 -0.411 . . . . 30.25 110.515 -171.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 5' ' ' HIS . 21.7 t-80 67.95 34.0 4.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.316 1.055 . . . . 71.239999999999995 108.651 -173.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -105.76 129.26 53.99 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.785 -1.098 . . . . 73.030000000000001 110.87 -175.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.7 m170 -65.27 110.63 2.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.907 -0.775 . . . . 62.240000000000002 108.907 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -132.61 110.86 10.74 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.516 0.562 . . . . 71.510000000000005 112.516 -171.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 70.86 -34.87 0.31 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.458 1.281 . . . . 74.200000000000003 114.458 167.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.2 ptm -68.74 -6.28 25.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.938 0.347 . . . . 64.200000000000003 111.938 -175.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.3 t -75.39 -46.67 37.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.412 -0.358 . . . . 73.129999999999995 111.215 -176.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.04 166.1 28.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.731 0.301 . . . . 44.399999999999999 111.027 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -97.43 144.87 28.69 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.973 -0.558 . . . . 74.010000000000005 110.246 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.92 162.8 34.3 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.675 2.25 . . . . 72.310000000000002 112.149 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.42 159.81 22.67 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 123.041 2.494 . . . . 72.430000000000007 112.154 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.38 160.16 15.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.279 -0.419 . . . . 61.240000000000002 110.487 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -88.91 158.38 18.1 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.614 -0.267 . . . . 44.539999999999999 110.417 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -58.16 -45.45 87.41 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.176 -0.465 . . . . 73.019999999999996 111.411 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.8 mm-40 -45.71 -54.64 7.56 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.814 -0.63 . . . . 75.409999999999997 112.163 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.99 -23.38 67.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.155 0.428 . . . . 71.439999999999998 112.155 -176.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.538 HG21 ' HA ' ' A' ' 71' ' ' SER . 37.2 mt -87.16 -38.46 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.48 0.657 . . . . 53.420000000000002 110.1 179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -68.39 -30.5 69.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.546 -0.752 . . . . 72.409999999999997 110.884 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -19.19 65.57 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.164 -0.471 . . . . 53.299999999999997 111.363 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 94.9 mt -67.88 144.52 97.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 63.009999999999998 110.514 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -59.85 159.13 26.15 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.192 2.595 . . . . 63.350000000000001 113.153 -176.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -120.17 110.09 16.21 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.919 -0.582 . . . . 74.109999999999999 110.035 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 54.0 mt -104.68 129.07 57.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.711 -0.677 . . . . 74.319999999999993 110.871 -175.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.2 tp -83.82 117.07 23.05 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.249 -0.648 . . . . 74.349999999999994 109.249 174.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 49.1 t -76.67 117.28 21.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.054 0.454 . . . . 73.299999999999997 111.634 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.2 p -112.22 148.0 35.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.643 -0.708 . . . . 64.519999999999996 110.307 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 27.4 mt-10 -78.47 -26.74 46.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.914 0.388 . . . . 72.409999999999997 111.76 -174.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -71.98 -4.23 27.3 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.275 0.843 . . . . 64.099999999999994 113.275 -168.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.696 ' HE1' ' HA ' ' A' ' 37' ' ' VAL . 22.3 p80 -113.08 9.24 18.56 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.233 -0.587 . . . . 74.400000000000006 110.537 176.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.5 -130.67 23.62 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.897 -0.592 . . . . 72.120000000000005 112.122 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.21 147.37 49.88 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.664 0.269 . . . . 61.200000000000003 110.52 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.696 ' HA ' ' HE1' ' A' ' 34' ' ' HIS . 60.9 t -80.76 97.91 3.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.052 0.454 . . . . 63.530000000000001 110.109 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.16 -80.35 0.85 Allowed Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.558 -0.746 . . . . 63.439999999999998 112.21 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.794 ' HG3' ' HG2' ' A' ' 40' ' ' GLU . 15.6 pt20 -138.73 -1.77 1.8 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.683 0.278 . . . . 63.329999999999998 111.343 -176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.794 ' HG2' ' HG3' ' A' ' 39' ' ' GLN . 0.5 OUTLIER -128.34 144.48 51.14 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.26 -0.274 . . . . 64.230000000000004 110.26 -173.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.2 ptp -123.83 -8.16 7.85 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.499 -0.318 . . . . 72.409999999999997 111.271 -177.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 81.5 m -132.73 151.95 51.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.051 0.453 . . . . 71.209999999999994 111.142 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 38.9 t -118.16 91.93 41.46 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.758 -0.656 . . . . 73.140000000000001 109.298 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.2 Cg_endo -51.74 -30.7 38.6 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.833 3.022 . . . . 65.530000000000001 113.562 -173.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.8 mt -56.99 -37.34 54.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.334 -0.394 . . . . 71.219999999999999 111.465 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.6 p -109.31 0.11 19.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.115 0.483 . . . . 62.439999999999998 110.298 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.1 m 60.38 16.01 5.93 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.257 -0.883 . . . . 71.299999999999997 111.49 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.3 t -117.31 165.76 13.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.785 -0.45 . . . . 71.439999999999998 109.785 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.697 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 7.2 pt-20 -99.51 -170.08 1.85 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.266 -0.425 . . . . 63.340000000000003 111.296 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.477 ' HB3' HG11 ' A' ' 30' ' ' VAL . 55.9 m-85 -95.1 110.23 22.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.213 0.53 . . . . 75.420000000000002 111.539 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.4 m -119.17 167.24 12.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.337 -0.847 . . . . 72.319999999999993 110.367 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 40.0 ttmt -71.51 126.33 29.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.347 -0.388 . . . . 73.540000000000006 111.198 -174.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.61 -15.44 19.69 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.741 -0.742 . . . . 71.230000000000004 112.301 178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -86.8 162.92 17.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.94 -0.393 . . . . 52.130000000000003 109.94 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -112.82 121.18 64.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 120.984 0.421 . . . . 71.349999999999994 110.78 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.534 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -103.97 170.19 8.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.08 -0.509 . . . . 63.340000000000003 110.697 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 8.3 t -147.7 173.35 12.84 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.054 -0.521 . . . . 73.349999999999994 109.711 177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -118.96 119.43 34.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.675 0.274 . . . . 74.140000000000001 110.462 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.6 mt -86.08 137.72 35.1 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.653 -0.499 . . . . 72.120000000000005 109.653 174.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.55 -15.77 26.82 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 123.287 2.658 . . . . 53.539999999999999 113.448 -176.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 22.9 p -87.24 11.8 13.33 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.442 0.163 . . . . 64.409999999999997 110.897 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 36.3 m80 69.22 62.44 0.3 Allowed 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.287 0.565 . . . . 74.219999999999999 111.015 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -150.67 152.16 33.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.438 -0.801 . . . . 74.439999999999998 109.336 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -118.78 133.23 55.99 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.994 0.426 . . . . 64.219999999999999 110.641 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.416 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 47.7 m-85 -143.08 157.94 44.06 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.659 -0.7 . . . . 74.409999999999997 109.976 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.609 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 33.3 m170 -68.4 125.91 27.96 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.687 -0.857 . . . . 71.510000000000005 108.687 172.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 85.5 tttt -57.57 -50.3 88.9 Favored Pre-proline 0 CA--C 1.536 0.44 0 O-C-N 123.405 0.441 . . . . 63.43 112.061 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 73.6 Cg_exo -52.59 -42.48 61.82 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.686 1.591 . . . . 72.310000000000002 112.395 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.609 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 57.9 m -63.15 -53.13 58.21 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.0 0.428 . . . . 62.32 110.918 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 67' ' ' LYS . 8.7 p -67.56 -27.84 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.876 -0.602 . . . . 64.030000000000001 110.792 -174.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.544 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 53.1 m -61.58 -51.03 70.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.699 0.285 . . . . 53.5 110.393 176.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.9 mt -65.65 -37.31 79.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 121.379 0.609 . . . . 71.109999999999999 110.414 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 74.5 t-105 -64.31 -55.0 24.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.504 -0.771 . . . . 73.219999999999999 111.302 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.415 HD13 ' CD2' ' A' ' 87' ' ' PHE . 96.8 mt -65.58 -27.78 68.67 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.034 0.383 . . . . 74.0 112.034 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.2 mt-30 -66.31 -20.84 66.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.66 0.267 . . . . 75.200000000000003 111.007 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -101.31 -37.32 8.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.245 -0.434 . . . . 72.519999999999996 110.809 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 22.9 t -153.65 118.2 4.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 55.229999999999997 109.972 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.68 74.79 2.41 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.89 -0.672 . . . . 64.340000000000003 111.889 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.29 139.19 24.27 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.69 -0.3 . . . . 61.409999999999997 110.474 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 45.8 t -74.44 116.16 50.37 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.371 -0.603 . . . . 64.299999999999997 109.371 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -49.8 -38.07 46.42 Favored 'Trans proline' 0 N--CA 1.474 0.344 0 C-N-CA 123.279 2.652 . . . . 74.340000000000003 113.773 -173.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.09 -55.99 8.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.12 0.415 . . . . 74.030000000000001 112.12 -175.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 28.3 p -96.13 -13.03 23.89 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.251 0.463 . . . . 60.219999999999999 112.251 -171.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 66.34 22.48 10.82 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 122.712 0.405 . . . . 74.510000000000005 111.523 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 28.3 t -74.63 141.6 44.63 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.077 -0.712 . . . . 65.109999999999999 109.077 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 58.7 ttp -77.41 142.18 39.39 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 75.409999999999997 111.301 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.519 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 61.9 t80 -129.85 126.31 22.48 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.789 -0.819 . . . . 74.409999999999997 108.789 174.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.519 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 34.4 Cg_endo -63.69 157.6 69.31 Favored 'Cis proline' 0 C--O 1.235 0.356 0 C-N-CA 123.823 -1.324 . . . . 71.010000000000005 112.978 2.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -47.98 147.41 7.76 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 124.193 3.262 . . . . 72.329999999999998 113.677 -176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.28 147.32 83.14 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.848 2.365 . . . . 61.299999999999997 112.649 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.411 -0.804 . . . . 75.129999999999995 109.642 178.781 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.984 0 N-CA-C 109.977 -0.379 . . . . 73.310000000000002 109.977 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.26 103.58 0.75 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.839 -0.696 . . . . 54.020000000000003 111.981 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -82.46 -11.03 58.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.03 0.443 . . . . 75.219999999999999 110.44 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -104.23 82.16 1.92 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.445 -0.946 . . . . 71.230000000000004 108.445 170.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -150.72 112.42 4.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.868 -0.606 . . . . 63.409999999999997 110.341 -174.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -84.56 154.33 22.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.348 177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -97.86 -68.69 0.79 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.153 -0.476 . . . . 74.299999999999997 110.981 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -86.73 84.24 7.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.74 -0.467 . . . . 72.319999999999993 109.74 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 51.5 m -93.42 -38.48 11.42 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.79 -0.641 . . . . 60.109999999999999 110.8 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -84.37 118.6 24.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.937 -0.574 . . . . 65.430000000000007 110.248 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.9 ptm -82.63 161.19 22.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.242 -0.435 . . . . 71.239999999999995 110.128 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.1 t -81.37 117.49 27.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.274 -0.421 . . . . 65.239999999999995 110.34 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.08 140.89 52.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.142 -0.481 . . . . 71.030000000000001 110.018 176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' A' ' 86' ' ' MET . 9.5 m120 -116.58 100.11 53.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.617 -0.265 . . . . 75.329999999999998 111.161 -174.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.763 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 65.3 Cg_endo -79.0 151.38 23.93 Favored 'Trans proline' 0 N--CA 1.461 -0.39 0 C-N-CA 122.502 2.135 . . . . 40.020000000000003 111.844 171.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 38.1 Cg_exo -57.48 150.98 56.59 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.898 2.399 . . . . 74.519999999999996 112.685 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -79.85 146.17 32.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.907 -0.588 . . . . 74.010000000000005 110.925 -178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 16.0 m -74.8 142.86 44.2 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.631 -0.713 . . . . 73.030000000000001 110.649 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -59.74 -37.48 79.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 61.119999999999997 110.301 -178.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.45 -40.06 89.79 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.019 -0.537 . . . . 74.340000000000003 110.697 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.3 m -67.43 -38.28 84.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.959 -0.564 . . . . 64.150000000000006 110.377 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.485 ' O ' ' HE3' ' A' ' 67' ' ' LYS . 65.6 mt -66.92 -41.45 87.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.077 -0.51 . . . . 33.130000000000003 110.551 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -66.28 -32.52 73.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 64.310000000000002 110.427 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.52 -11.6 60.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.715 -0.675 . . . . 75.140000000000001 111.795 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 91.2 mt -65.4 133.1 95.3 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.469 -0.332 . . . . 73.439999999999998 110.703 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 149.64 84.08 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.092 2.528 . . . . 65.340000000000003 112.143 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.446 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 55.9 mt-10 -116.77 104.8 11.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.291 0.567 . . . . 64.319999999999993 110.75 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.0 mt -106.48 117.85 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.393 -0.821 . . . . 70.310000000000002 110.356 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 57.5 tp -68.03 118.85 11.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.305 -0.407 . . . . 74.0 109.956 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 28.8 t -81.5 135.17 25.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.997 0.427 . . . . 74.25 110.631 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.1 p -131.99 173.01 11.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.647 -0.706 . . . . 73.409999999999997 109.848 177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 15.3 mm-40 -70.31 -178.67 1.77 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.598 -0.274 . . . . 71.439999999999998 110.853 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 27.9 m-20 76.14 -51.51 0.61 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.43 0.692 . . . . 70.310000000000002 111.092 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.4 t-80 -111.38 55.74 0.65 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.026 0.441 . . . . 72.129999999999995 109.839 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 50' ' ' TYR . . . -63.79 -31.04 79.46 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.667 -0.697 . . . . 74.299999999999997 111.618 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.38 84.22 6.06 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.248 -0.649 . . . . 43.509999999999998 109.248 172.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 24.4 t -67.26 -28.91 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.801 -0.636 . . . . 65.140000000000001 110.882 -177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.02 -142.48 3.57 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.035 -0.826 . . . . 72.120000000000005 111.035 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -69.97 -20.91 63.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.063 0.458 . . . . 61.420000000000002 110.397 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -103.97 130.55 51.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.863 -0.608 . . . . 64.120000000000005 110.849 177.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.6 ptp -102.66 -3.91 25.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.423 -0.808 . . . . 60.399999999999999 109.842 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 8.8 p -134.59 149.31 50.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.679 -0.691 . . . . 64.329999999999998 111.051 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.451 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 28.9 t -105.97 103.51 44.89 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.713 -0.676 . . . . 74.109999999999999 109.519 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 16.1 Cg_endo -56.94 -28.71 79.25 Favored 'Trans proline' 0 N--CA 1.473 0.309 0 C-N-CA 123.291 2.661 . . . . 63.329999999999998 112.907 -176.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 41.3 mt -68.27 -28.2 39.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.094 -0.503 . . . . 63.009999999999998 110.871 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 78.7 m -104.74 -18.7 14.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 60.530000000000001 110.579 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 5.8 t 61.65 24.94 14.95 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.252 -0.886 . . . . 73.099999999999994 109.471 -172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.9 m -128.32 171.81 11.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.166 -0.925 . . . . 75.450000000000003 109.266 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.59 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.5 OUTLIER -93.76 -171.75 2.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.844 0.354 . . . . 73.209999999999994 110.639 -178.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.564 ' HB2' ' O ' ' A' ' 35' ' ' GLY . 90.5 m-85 -98.52 103.18 15.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.118 0.485 . . . . 75.0 110.578 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.516 HG13 ' HG2' ' A' ' 49' ' ' GLU . 25.2 m -121.87 167.13 15.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.648 -0.705 . . . . 64.430000000000007 111.062 -178.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.665 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 22.8 ttpp -54.32 127.44 27.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.336 -0.847 . . . . 75.140000000000001 111.725 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.59 -34.38 3.8 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.793 -0.718 . . . . 75.409999999999997 113.031 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -86.97 165.3 15.96 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.704 -0.48 . . . . 72.140000000000001 109.704 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.42 121.13 66.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 120.797 0.332 . . . . 71.420000000000002 110.544 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -100.21 160.96 13.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.978 0.418 . . . . 72.140000000000001 111.075 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 11.2 t -137.25 167.49 21.47 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.859 -0.61 . . . . 64.010000000000005 109.646 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -120.65 118.09 29.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.011 0.434 . . . . 74.109999999999999 110.863 -177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.7 mt -87.0 143.42 34.99 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.846 -0.615 . . . . 64.510000000000005 109.517 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.39 -12.8 17.94 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.937 2.425 . . . . 64.430000000000007 111.687 176.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 45.5 t -76.0 9.17 2.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.99 -1.005 . . . . 75.099999999999994 110.592 175.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 87.7 m-70 65.69 28.45 11.1 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.524 0.678 . . . . 74.040000000000006 109.736 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.0 136.96 54.35 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.543 -0.753 . . . . 72.209999999999994 110.578 -175.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -110.78 133.26 53.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.253 -0.43 . . . . 64.109999999999999 110.714 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.541 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 91.5 m-85 -145.02 175.31 10.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.365 -0.976 . . . . 73.340000000000003 108.365 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.96 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.4 m80 -88.41 130.19 35.23 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.8 -0.815 . . . . 73.230000000000004 108.8 176.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 84.8 tttt -57.02 -48.06 98.07 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 112.086 0.402 . . . . 75.010000000000005 112.086 -176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 10.0 Cg_endo -51.46 -46.2 32.99 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.486 2.124 . . . . 75.200000000000003 113.503 178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.96 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 8.4 p -84.23 -34.96 23.77 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 112.199 0.444 . . . . 71.049999999999997 112.199 -175.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.513 HG22 ' HG ' ' A' ' 74' ' ' LEU . 5.7 p -71.72 -26.1 25.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 O-C-N 122.225 -0.297 . . . . 73.239999999999995 110.751 -176.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.2 t -56.98 -39.71 75.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.142 0.496 . . . . 71.349999999999994 110.72 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.494 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 59.8 mt -69.65 -40.95 79.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.914 -0.584 . . . . 75.439999999999998 110.585 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -72.96 -38.91 66.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.207 -0.451 . . . . 74.430000000000007 111.326 -177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.513 ' HG ' HG22 ' A' ' 70' ' ' VAL . 88.8 mt -63.86 -32.84 74.5 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.601 -0.272 . . . . 75.430000000000007 111.252 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -77.08 -9.52 58.79 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.803 0.335 . . . . 74.450000000000003 111.104 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 72' ' ' ILE . 67.9 mttm -80.92 -58.77 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 73.129999999999995 110.927 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 49.8 m -148.74 11.66 0.86 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 112.214 0.449 . . . . 71.430000000000007 112.214 -178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 51.69 65.27 3.29 Favored Glycine 0 C--N 1.335 0.5 0 O-C-N 123.25 0.343 . . . . 65.040000000000006 113.764 175.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -149.34 160.8 43.1 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.669 0.235 . . . . 64.120000000000005 111.142 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.71 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 84.4 m -79.34 123.28 84.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.806 -0.812 . . . . 73.109999999999999 108.806 168.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -58.58 -21.81 56.89 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.498 2.132 . . . . 74.049999999999997 112.522 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.4 t -84.58 -53.43 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.099 -0.501 . . . . 60.43 111.861 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.71 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 28.9 p -98.84 -19.75 17.23 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.838 0.31 . . . . 74.439999999999998 111.838 -170.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 66.65 19.78 10.77 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.034 -0.53 . . . . 62.020000000000003 111.654 -175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.5 t -80.46 143.44 33.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.923 -0.769 . . . . 71.310000000000002 108.923 171.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.763 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 51.1 ttp -75.78 145.02 41.06 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.757 0.66 . . . . 74.219999999999999 112.516 -171.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.525 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 91.5 t80 -131.21 125.05 20.78 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.139 -0.937 . . . . 73.310000000000002 109.061 171.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.525 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 31.7 Cg_exo -60.63 153.3 52.87 Favored 'Cis proline' 0 C--N 1.348 0.541 0 C-N-CA 124.03 -1.238 . . . . 74.150000000000006 112.787 0.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -51.57 154.41 9.07 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 123.606 2.871 . . . . 74.420000000000002 113.127 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.14 147.61 94.73 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 123.071 2.514 . . . . 44.100000000000001 112.704 -177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.526 -0.75 . . . . 71.219999999999999 109.934 179.144 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.2 mtp . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.933 -0.395 . . . . 71.019999999999996 109.933 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.45 49.52 0.57 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.018 -0.611 . . . . 62.340000000000003 111.713 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 58.42 78.18 0.26 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.952 0.501 . . . . 61.039999999999999 111.419 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -160.42 133.68 6.73 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.1 -0.5 . . . . 72.409999999999997 111.038 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -147.95 101.56 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.758 -0.655 . . . . 74.319999999999993 110.482 177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.6 p-80 -113.22 122.17 46.67 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.377 -0.601 . . . . 74.209999999999994 109.377 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -153.05 -178.09 6.71 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.094 -0.503 . . . . 71.430000000000007 110.823 -175.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -59.98 109.68 1.01 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.664 0.602 . . . . 73.019999999999996 112.073 -172.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -171.17 112.23 0.36 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.729 -0.841 . . . . 64.129999999999995 108.729 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -90.11 103.33 16.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.635 0.731 . . . . 71.209999999999994 112.538 -173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.8 ptp -94.34 124.13 38.17 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.395 -0.82 . . . . 62.539999999999999 109.171 172.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.36 -39.04 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 111.761 0.282 . . . . 71.109999999999999 111.761 -174.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.28 176.63 5.31 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.894 0.378 . . . . 64.0 111.035 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -94.43 108.64 37.91 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.01 -0.541 . . . . 71.109999999999999 110.003 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -79.95 161.78 23.8 Favored 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.802 2.334 . . . . 63.32 112.733 -176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -67.43 148.43 79.22 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.67 2.246 . . . . 62.539999999999999 111.251 173.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -76.86 139.86 40.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.405 -0.361 . . . . 64.409999999999997 110.763 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.405 ' HB3' ' OE1' ' A' ' 20' ' ' GLU . 14.6 m -61.24 129.79 43.03 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.955 -0.566 . . . . 64.239999999999995 110.139 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.59 ' O ' ' HD2' ' A' ' 19' ' ' LYS . 3.2 tmmm? -58.96 -30.5 67.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.499 -0.319 . . . . 72.409999999999997 110.562 -177.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 20' ' ' GLU . 29.2 mp0 -54.9 -41.95 71.55 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.962 0.411 . . . . 75.209999999999994 110.223 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.517 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 18.0 m -77.42 -34.98 54.52 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.858 -0.61 . . . . 75.109999999999999 110.779 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.2 mt -64.7 -42.44 95.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 121.3 0.571 . . . . 42.310000000000002 110.484 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -68.68 -37.48 79.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.687 -0.688 . . . . 71.329999999999998 110.968 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.63 -6.61 49.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.11 -0.495 . . . . 21.5 111.705 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.717 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 57.3 mt -63.68 125.34 87.37 Favored Pre-proline 0 C--O 1.236 0.381 0 CA-C-N 116.245 -0.434 . . . . 74.129999999999995 110.681 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.442 ' O ' ' HA ' ' A' ' 57' ' ' THR . 19.4 Cg_endo -58.04 125.37 18.35 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.471 2.781 . . . . 64.219999999999999 113.228 -175.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -81.12 113.72 19.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.456 -0.793 . . . . 75.209999999999994 110.654 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.7 mt -112.56 109.42 28.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.279 -0.419 . . . . 54.539999999999999 110.101 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.92 118.29 10.19 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.908 -0.404 . . . . 62.030000000000001 109.908 178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.456 ' CG1' ' HB3' ' A' ' 50' ' ' TYR . 53.0 t -81.63 128.96 38.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.166 0.508 . . . . 73.239999999999995 111.648 -173.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.479 HG22 ' HG3' ' A' ' 52' ' ' LYS . 17.0 p -126.01 138.16 53.71 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.376 -0.829 . . . . 73.049999999999997 109.269 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 52' ' ' LYS . 39.4 mt-10 -63.94 -10.7 22.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.851 0.357 . . . . 74.099999999999994 111.726 -178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -63.09 -33.11 74.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.89 -0.595 . . . . 74.239999999999995 109.759 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 40.3 t-80 -134.13 81.73 1.93 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.354 -0.839 . . . . 71.319999999999993 109.553 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.37 -36.07 31.59 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.917 -0.658 . . . . 74.540000000000006 112.942 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -88.37 86.0 6.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.25 0.548 . . . . 51.409999999999997 110.665 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.5 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 6.3 t -74.82 -23.73 17.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.685 -0.689 . . . . 71.140000000000001 110.302 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.07 -134.58 1.71 Allowed Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.261 -0.736 . . . . 73.230000000000004 111.261 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -68.86 -42.41 77.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.463 0.649 . . . . 65.319999999999993 109.502 174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -73.29 113.01 9.88 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.122 -0.945 . . . . 74.109999999999999 110.548 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -95.2 -5.05 44.77 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.644 0.735 . . . . 72.219999999999999 109.257 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.2 p -144.53 167.93 21.34 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.097 -0.956 . . . . 74.150000000000006 110.087 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 43.0 t -115.63 92.83 34.91 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.713 -0.477 . . . . 75.140000000000001 109.713 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 19.8 Cg_endo -59.11 -28.14 86.98 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.979 2.453 . . . . 72.129999999999995 112.358 -177.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.0 mt -56.16 -39.24 57.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.487 -0.779 . . . . 75.310000000000002 111.609 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 26.7 p -117.54 6.27 12.51 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.923 -0.311 . . . . 61.219999999999999 110.54 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.1 m 53.03 67.79 0.94 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.464 -0.789 . . . . 63.520000000000003 111.407 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.8 p -156.67 168.28 27.88 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.834 -0.621 . . . . 71.340000000000003 109.522 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -88.74 -170.0 2.75 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.4 -0.592 . . . . 73.420000000000002 109.4 171.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.572 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 61.6 m-85 -93.72 89.65 6.27 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.382 0.611 . . . . 62.219999999999999 110.773 177.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.7 m -85.94 158.12 3.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.101 -0.954 . . . . 75.409999999999997 111.251 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' HG3' HG22 ' A' ' 31' ' ' THR . 38.8 ttmt -73.34 120.46 18.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.984 -0.553 . . . . 75.0 110.547 -177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.85 -19.66 6.91 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.635 -0.793 . . . . 71.310000000000002 112.491 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -84.99 166.5 16.68 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.981 -0.748 . . . . 72.409999999999997 108.981 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.9 t -115.19 131.18 68.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 109.774 -0.454 . . . . 74.209999999999994 109.774 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.57 175.46 5.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.839 0.352 . . . . 60.439999999999998 110.654 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.717 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.6 t -151.61 160.79 43.51 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.817 -0.629 . . . . 73.349999999999994 109.933 178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 31.7 tt0 -107.71 126.76 52.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.158 -0.474 . . . . 73.400000000000006 110.301 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.2 mt -92.06 142.56 26.48 Favored Pre-proline 0 C--N 1.318 -0.789 0 N-CA-C 108.942 -0.762 . . . . 74.430000000000007 108.942 171.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.99 -10.61 12.85 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.203 2.602 . . . . 75.310000000000002 111.745 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.9 t -85.13 19.34 2.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.967 -1.015 . . . . 50.030000000000001 110.289 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 56.09 37.26 28.66 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.763 -0.653 . . . . 64.0 111.458 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.2 m170 -132.66 141.56 48.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.564 -0.744 . . . . 75.549999999999997 110.014 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -119.87 133.42 55.59 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.198 -0.456 . . . . 73.120000000000005 110.754 -172.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.572 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 98.0 m-85 -143.84 168.1 20.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.983 -0.553 . . . . 74.109999999999999 109.841 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 33.1 m170 -64.02 128.17 34.63 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.299 -0.63 . . . . 71.450000000000003 109.299 171.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 64.1 tttp -56.77 -53.08 68.56 Favored Pre-proline 0 CA--C 1.535 0.386 0 O-C-N 123.342 0.401 . . . . 70.129999999999995 111.376 -177.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 12.2 Cg_endo -56.97 -45.3 37.14 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 122.16 1.906 . . . . 62.210000000000001 112.232 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 66.2 m -61.38 -48.73 79.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.122 -0.49 . . . . 54.420000000000002 111.357 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.534 HG22 ' HG ' ' A' ' 74' ' ' LEU . 7.7 p -69.82 -27.58 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.298 -0.41 . . . . 53.530000000000001 110.618 -175.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 51.8 m -61.98 -37.05 83.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.841 0.353 . . . . 51.450000000000003 110.361 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 60.3 mt -66.65 -43.32 90.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.068 -0.514 . . . . 75.409999999999997 110.131 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.1 t-105 -68.94 -47.15 66.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.017 -0.538 . . . . 71.430000000000007 110.904 -179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 94.4 mt -60.77 -36.39 78.83 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.105 0.409 . . . . 72.519999999999996 112.105 -175.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.26 -12.71 61.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.715 0.293 . . . . 74.400000000000006 111.184 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -98.77 -50.89 4.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.333 0.587 . . . . 62.32 109.593 174.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.7 p -151.77 113.3 4.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.383 -0.826 . . . . 62.520000000000003 109.858 179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.92 85.92 0.38 Allowed Glycine 0 C--N 1.329 0.178 0 C-N-CA 120.946 -0.645 . . . . 71.230000000000004 112.613 -176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 85' ' ' CYS . 2.0 p -149.36 161.79 41.37 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.313 0.245 . . . . 73.129999999999995 111.271 -178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.764 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 95.8 m -79.24 120.52 80.84 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 108.32 -0.993 . . . . 73.310000000000002 108.32 165.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.46 -14.52 25.72 Favored 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 122.308 2.006 . . . . 71.530000000000001 113.044 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.23 -43.47 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 116.307 -0.406 . . . . 75.439999999999998 112.005 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.764 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.3 p -105.88 -17.35 14.39 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 120.809 -0.356 . . . . 71.409999999999997 111.599 -172.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 63.69 23.55 13.55 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 123.177 0.591 . . . . 73.519999999999996 111.973 -177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 79' ' ' THR . 34.6 t -89.05 155.53 19.41 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.219 -0.66 . . . . 72.219999999999999 109.219 173.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.517 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 25.7 ttm -82.28 149.61 27.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.556 0.576 . . . . 75.329999999999998 112.556 -167.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.477 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 66.0 t80 -136.93 120.22 11.89 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 114.934 -1.03 . . . . 73.129999999999995 108.803 168.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 34.0 Cg_endo -62.85 152.76 68.5 Favored 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 123.863 -1.307 . . . . 74.319999999999993 112.572 2.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.23 142.65 55.44 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 123.147 2.565 . . . . 72.340000000000003 112.944 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.517 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 39.4 Cg_endo -67.61 147.56 76.55 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.86 2.374 . . . . 72.349999999999994 112.232 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 C--O 1.246 0.915 0 CA-C-O 118.42 -0.8 . . . . 62.329999999999998 110.255 -179.7 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.159 -0.311 . . . . 63.030000000000001 110.159 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.25 -76.09 0.24 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.84 -0.695 . . . . 54.109999999999999 112.154 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.9 p80 -108.54 -169.89 1.58 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.624 0.25 . . . . 74.329999999999998 110.513 -178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -93.13 169.85 10.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.0 0.429 . . . . 73.409999999999997 111.245 -174.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -115.47 145.49 42.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.494 -0.928 . . . . 73.400000000000006 108.494 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -67.59 103.89 1.47 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.041 0.448 . . . . 61.509999999999998 110.606 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -77.99 153.96 31.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.549 -0.751 . . . . 73.329999999999998 110.278 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 69.3 t60 -79.74 115.75 19.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.058 0.456 . . . . 74.049999999999997 110.996 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.2 m -67.84 109.57 3.45 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.982 -0.553 . . . . 74.209999999999994 109.914 175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -100.05 -31.07 11.62 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.814 -0.354 . . . . 72.329999999999998 110.495 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.4 ttp 69.57 -63.3 0.39 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.858 0.724 . . . . 44.240000000000002 111.854 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.7 p -71.53 137.88 22.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.252 0.549 . . . . 73.310000000000002 111.234 -176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.37 148.71 47.99 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.518 -0.765 . . . . 75.310000000000002 109.27 173.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -74.0 134.25 78.01 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 110.201 -0.296 . . . . 60.5 110.201 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 6.1 Cg_endo -48.67 147.64 9.44 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 123.497 2.798 . . . . 74.329999999999998 113.071 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 23.9 Cg_exo -64.27 152.28 81.95 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.934 2.423 . . . . 75.230000000000004 111.858 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -84.08 166.67 17.5 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.888 0.375 . . . . 42.119999999999997 110.831 -177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 22' ' ' ILE . 3.3 p -87.24 144.31 26.87 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.072 -0.513 . . . . 54.009999999999998 110.574 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -62.47 -36.02 81.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.973 -0.558 . . . . 74.430000000000007 111.168 -174.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -64.6 -28.48 69.66 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.022 -0.535 . . . . 61.130000000000003 111.131 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.4 t -82.94 -24.62 32.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.383 -0.372 . . . . 61.450000000000003 110.19 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 18' ' ' SER . 60.0 mt -79.76 -38.75 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.309 0.576 . . . . 74.329999999999998 110.304 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.04 -27.68 63.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.736 -0.666 . . . . 71.450000000000003 110.882 -178.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.08 -4.36 55.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.519999999999996 111.871 -177.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 64.3 mt -63.7 131.43 94.88 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.567 -0.288 . . . . 71.340000000000003 111.069 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.84 141.18 77.14 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.774 2.316 . . . . 71.530000000000001 112.094 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -104.7 119.09 38.18 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.184 0.516 . . . . 73.239999999999995 110.913 -178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 56' ' ' ALA . 65.4 mt -112.29 120.82 63.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.47 -0.786 . . . . 72.030000000000001 110.082 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.9 tp -74.61 122.54 23.32 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.94 -0.392 . . . . 75.109999999999999 109.94 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 43.1 t -92.13 127.46 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 120.863 0.363 . . . . 73.400000000000006 111.337 -176.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.4 p -128.19 172.84 10.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.687 -0.688 . . . . 74.530000000000001 110.022 176.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -76.9 -10.16 59.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.795 0.331 . . . . 75.340000000000003 110.7 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -84.78 -10.21 57.44 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 110.186 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 21.1 t-80 -149.56 61.92 1.01 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.085 0.469 . . . . 71.510000000000005 110.349 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.36 -43.34 79.15 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.77 -0.65 . . . . 75.030000000000001 111.513 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.59 98.76 6.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.765 -0.457 . . . . 31.129999999999999 109.765 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.496 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 14.0 t -82.72 -20.81 9.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.254 0.549 . . . . 75.239999999999995 110.229 -178.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.73 -140.38 2.87 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 111.178 -0.769 . . . . 42.450000000000003 111.178 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.81 -26.35 64.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.053 0.454 . . . . 74.549999999999997 110.071 178.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -111.68 160.75 16.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.775 -0.648 . . . . 72.530000000000001 110.269 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -141.13 13.09 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.473 -0.331 . . . . 75.120000000000005 111.267 -176.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 71.6 m -132.42 140.07 48.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.5 -0.318 . . . . 74.420000000000002 110.704 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 41.7 t -103.3 100.15 17.14 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 109.636 -0.505 . . . . 52.109999999999999 109.636 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 32.1 Cg_endo -63.61 -24.76 69.59 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.921 2.414 . . . . 71.219999999999999 112.724 -175.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 25.4 mt -61.14 -35.24 64.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.073 -0.512 . . . . 51.409999999999997 110.916 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 28.2 p -112.95 10.85 18.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.299 -0.41 . . . . 74.129999999999995 109.918 178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 11.0 p 40.33 51.76 2.82 Favored 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.174 0.921 . . . . 64.510000000000005 111.911 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 40.1 m -150.75 150.13 30.64 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.993 -0.548 . . . . 74.0 110.103 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.647 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 13.1 pt-20 -77.92 -169.99 1.74 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.123 0.487 . . . . 73.230000000000004 110.955 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.476 ' HB3' HG11 ' A' ' 30' ' ' VAL . 45.4 m-85 -90.12 113.07 24.75 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.193 0.521 . . . . 71.329999999999998 111.433 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.2 m -115.44 162.4 13.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.318 -0.856 . . . . 65.400000000000006 110.473 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 39.5 ttmt -65.84 128.52 36.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.115 -0.493 . . . . 72.519999999999996 110.934 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.49 -24.01 11.7 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.709 -0.757 . . . . 54.340000000000003 112.873 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -82.55 159.22 22.84 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.739 -0.467 . . . . 62.409999999999997 109.739 -178.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.2 t -108.09 119.22 57.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.488 -0.324 . . . . 72.450000000000003 110.474 -177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -97.85 168.27 10.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.393 -0.367 . . . . 74.310000000000002 110.955 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.51 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 14.6 t -152.59 156.8 40.01 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.902 -0.59 . . . . 73.430000000000007 109.717 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -116.73 118.57 32.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.78 0.324 . . . . 72.120000000000005 110.496 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.96 148.67 81.97 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.138 -0.69 . . . . 75.530000000000001 109.138 174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.79 -9.72 10.23 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.899 2.399 . . . . 70.329999999999998 112.067 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.3 9.15 11.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.364 -0.835 . . . . 74.230000000000004 109.938 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 2.2 m170 58.85 37.43 24.83 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.838 -0.619 . . . . 62.049999999999997 111.469 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -121.07 145.06 48.19 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.741 -0.663 . . . . 73.340000000000003 109.495 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -114.09 132.8 55.91 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.253 0.549 . . . . 75.049999999999997 111.609 -172.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -144.9 175.41 10.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.279 -0.873 . . . . 73.230000000000004 108.721 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.745 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 37.4 m80 -87.07 135.46 33.28 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.8 -0.815 . . . . 73.519999999999996 108.8 173.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.495 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.0 tttt -59.48 -50.19 88.46 Favored Pre-proline 0 CA--C 1.537 0.475 0 O-C-N 123.308 0.38 . . . . 75.430000000000007 111.841 -175.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.6 Cg_endo -60.87 -18.51 57.15 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.03 1.82 . . . . 63.439999999999998 112.911 176.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.745 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 64.5 m -83.9 -53.03 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.225 0.536 . . . . 63.439999999999998 110.865 177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 p -70.38 -27.25 30.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.54 -0.755 . . . . 74.219999999999999 111.216 -172.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.555 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 6.4 p -61.16 -32.34 72.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.467 -0.333 . . . . 71.310000000000002 111.193 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.0 mt -74.99 -44.45 44.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 121.177 0.513 . . . . 54.420000000000002 110.272 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.5 t-105 -62.23 -43.93 97.72 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.598 -0.728 . . . . 75.140000000000001 111.182 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 91.7 mt -65.19 -23.9 67.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 55.409999999999997 111.687 -176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.6 mt-30 -73.94 -15.26 61.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 74.430000000000007 110.884 179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -106.18 -43.81 4.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.342 0.591 . . . . 65.120000000000005 109.99 178.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.9 p -153.32 114.62 4.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.441 -0.799 . . . . 53.310000000000002 110.397 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.87 81.35 1.02 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.558 -0.829 . . . . 74.049999999999997 112.124 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -149.4 164.51 34.74 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.507 0.194 . . . . 64.109999999999999 111.495 -177.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.626 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 68.5 m -74.87 116.82 57.51 Favored Pre-proline 0 C--N 1.333 -0.151 0 N-CA-C 107.953 -1.128 . . . . 71.439999999999998 107.953 162.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.63 -17.29 27.91 Favored 'Trans proline' 0 N--CA 1.473 0.289 0 C-N-CA 122.492 2.128 . . . . 74.310000000000002 112.526 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -89.23 -57.44 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 115.78 -0.645 . . . . 74.209999999999994 111.767 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.626 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.9 p -94.48 -12.67 27.25 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.36 0.504 . . . . 64.109999999999999 112.36 -169.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 83' ' ' CYS . 20.8 mmt180 74.24 4.9 4.61 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.004 0.521 . . . . 74.120000000000005 112.015 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 44.4 t -73.22 145.23 46.37 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.164 -0.214 . . . . 61.5 110.425 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.545 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 36.0 ttm -74.34 145.84 43.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.779 -0.646 . . . . 63.219999999999999 112.438 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.435 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 74.1 t80 -128.8 121.43 20.98 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.409 -0.814 . . . . 73.439999999999998 109.85 171.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -75.07 157.41 99.55 Favored 'Cis proline' 0 C--N 1.342 0.209 0 C-N-CA 122.999 -1.667 . . . . 73.420000000000002 111.731 -1.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.56 142.33 31.26 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 122.83 2.353 . . . . 64.239999999999995 112.508 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 28.5 Cg_endo -62.62 152.08 79.87 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.001 2.467 . . . . 64.109999999999999 112.185 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.541 -0.742 . . . . 73.319999999999993 110.187 -177.236 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.737 0.303 . . . . 74.120000000000005 111.101 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.25 -178.77 32.59 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 111.411 -0.676 . . . . 52.130000000000003 111.411 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.5 m170 -126.02 -57.48 1.42 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.915 0.357 . . . . 64.310000000000002 110.64 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 65.7 t60 57.0 71.6 0.56 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.812 -0.631 . . . . 73.519999999999996 111.353 -177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -143.59 147.76 34.88 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.844 -0.799 . . . . 73.219999999999999 108.844 174.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.9 p-80 -79.87 156.8 27.16 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.702 -0.851 . . . . 64.329999999999998 108.702 174.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -70.21 119.05 13.82 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.868 0.366 . . . . 73.519999999999996 110.646 -173.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.4 t60 -80.23 88.12 5.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.896 -0.593 . . . . 75.140000000000001 110.537 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 m -139.28 163.66 31.87 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.957 -0.565 . . . . 51.210000000000001 110.12 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -154.77 107.59 2.8 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.222 -0.445 . . . . 65.109999999999999 109.917 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.647 ' HB2' ' HB3' ' A' ' 84' ' ' ARG . 25.5 mmt -112.6 137.43 50.85 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.039 -0.528 . . . . 74.040000000000006 110.192 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 p -150.79 -27.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.095 -0.502 . . . . 72.430000000000007 110.744 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.85 120.89 12.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.648 0.261 . . . . 13.51 110.381 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -141.57 134.0 13.94 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 110.081 -0.34 . . . . 73.310000000000002 110.081 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.64 153.03 25.26 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.17 2.58 . . . . 45.310000000000002 112.392 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.47 163.0 34.18 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.923 2.416 . . . . 71.129999999999995 112.754 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.83 177.57 6.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.105 -0.498 . . . . 71.129999999999995 110.694 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 22.6 t -90.25 143.05 27.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.371 -0.377 . . . . 73.430000000000007 109.987 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -57.09 -39.59 75.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.932 0.396 . . . . 72.310000000000002 110.618 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -72.66 -23.8 60.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.996 -0.547 . . . . 71.510000000000005 111.243 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.8 m -77.19 -31.04 55.07 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.999 0.428 . . . . 74.540000000000006 109.948 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.9 mt -78.38 -40.86 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.807 -0.633 . . . . 75.430000000000007 109.968 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -59.03 -35.8 73.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.888 -0.596 . . . . 73.219999999999999 110.607 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.28 -4.02 48.75 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.733 -0.667 . . . . 52.439999999999998 112.156 -176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.575 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 74.1 mt -65.89 126.34 91.59 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.66 0.266 . . . . 71.439999999999998 110.349 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -61.03 136.27 64.31 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.958 2.439 . . . . 64.340000000000003 112.324 -177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -100.83 113.4 26.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.128 -0.487 . . . . 75.530000000000001 110.193 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.5 mt -114.72 132.45 63.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.849 -0.614 . . . . 64.439999999999998 110.01 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 47.9 tp -86.81 116.7 25.07 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.166 -0.309 . . . . 70.120000000000005 110.166 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 54.0 t -71.21 135.74 27.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.29 -0.414 . . . . 73.230000000000004 109.893 177.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 32.8 p -128.64 172.83 10.84 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.271 -0.422 . . . . 72.450000000000003 110.423 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.534 ' HG2' ' HE3' ' A' ' 52' ' ' LYS . 42.5 mm-40 -70.34 -25.13 63.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 75.299999999999997 111.152 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -79.95 -7.08 58.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 54.350000000000001 111.131 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.676 ' CE1' ' HA ' ' A' ' 37' ' ' VAL . 59.9 t-80 -153.18 64.6 0.77 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.712 -0.477 . . . . 65.120000000000005 109.712 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.1 -59.61 7.26 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.81 -0.632 . . . . 75.099999999999994 112.297 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.28 92.81 1.82 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.056 0.455 . . . . 61.420000000000002 109.93 175.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.676 ' HA ' ' CE1' ' A' ' 34' ' ' HIS . 6.4 t -63.26 -49.33 83.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.866 -0.606 . . . . 74.329999999999998 109.894 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -125.11 -138.88 5.1 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.655 -1.378 . . . . 61.219999999999999 109.655 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.86 -11.41 59.59 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.611 0.705 . . . . 75.430000000000007 109.532 171.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -83.5 100.16 10.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.747 -0.661 . . . . 75.219999999999999 110.161 171.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -91.33 -12.5 34.8 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.603 0.716 . . . . 75.439999999999998 109.208 172.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.751 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 57.2 m -138.24 131.29 30.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.035 -0.984 . . . . 54.219999999999999 109.29 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.6 t -70.93 109.09 4.51 Favored Pre-proline 0 C--N 1.328 -0.352 0 O-C-N 123.342 0.401 . . . . 71.099999999999994 110.018 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.71 -24.47 74.78 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.782 2.322 . . . . 75.349999999999994 112.185 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.83 -25.7 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.259 0.552 . . . . 62.340000000000003 110.675 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 40.0 m -117.46 2.3 12.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.174 -0.466 . . . . 61.329999999999998 110.879 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.3 p 42.79 35.78 0.76 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.657 0.783 . . . . 62.549999999999997 111.674 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.4 t -136.43 148.14 47.6 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.97 -0.559 . . . . 34.130000000000003 110.036 -176.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.751 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 9.9 pt-20 -79.21 168.56 19.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.565 0.58 . . . . 73.239999999999995 112.565 -172.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.563 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.2 m-85 -98.02 130.35 44.85 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.618 -0.719 . . . . 74.129999999999995 110.666 178.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 31.3 m -132.7 177.87 6.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.016 -0.365 . . . . 64.109999999999999 110.016 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 40.0 ttmt -60.06 113.06 2.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.881 0.372 . . . . 71.349999999999994 110.878 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.25 -11.02 7.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.993 -0.623 . . . . 32.200000000000003 112.06 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.53 131.94 36.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.853 0.359 . . . . 63.5 111.088 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.2 t -88.07 110.25 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.212 -0.449 . . . . 73.420000000000002 109.956 174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.1 155.66 22.49 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.086 -0.507 . . . . 71.030000000000001 110.394 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.575 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.9 t -132.43 159.3 39.72 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.065 -0.516 . . . . 74.129999999999995 109.839 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -109.3 123.07 48.68 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.918 0.39 . . . . 64.530000000000001 111.469 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.9 mt -87.05 140.03 32.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 108.319 -0.993 . . . . 70.129999999999995 108.319 167.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.69 -13.02 7.43 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 123.304 2.669 . . . . 73.109999999999999 113.802 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.2 p -90.42 19.88 4.92 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.801 0.334 . . . . 64.340000000000003 110.71 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 60.32 54.63 3.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.91 -0.586 . . . . 74.230000000000004 112.034 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -142.3 141.29 32.39 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.834 -0.621 . . . . 73.120000000000005 109.373 174.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -120.39 133.47 55.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.406 0.622 . . . . 75.140000000000001 111.934 -171.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.563 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 65.2 m-85 -139.26 175.17 9.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.298 -0.864 . . . . 74.319999999999993 108.754 178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.829 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 40.4 m80 -76.45 132.14 39.46 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.302 -0.999 . . . . 72.120000000000005 108.302 173.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 85.5 tttt -56.25 -48.96 95.88 Favored Pre-proline 0 C--N 1.32 -0.688 0 O-C-N 123.301 0.376 . . . . 75.400000000000006 111.913 -178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 7.2 Cg_endo -50.45 -51.38 11.14 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.454 2.103 . . . . 64.319999999999993 113.426 177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.829 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 18.9 p -77.1 -30.46 55.33 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.627 -0.429 . . . . 74.25 111.815 -174.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 67' ' ' LYS . 5.4 p -70.75 -26.48 28.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 C-N-CA 120.329 -0.548 . . . . 70.340000000000003 109.752 178.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 41.3 m -60.84 -48.23 82.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.641 -0.503 . . . . 72.200000000000003 109.641 174.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.441 HG22 ' HE3' ' A' ' 76' ' ' LYS . 42.7 mt -62.75 -40.51 88.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.609 -0.723 . . . . 63.299999999999997 110.625 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -66.49 -50.96 61.54 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.004 -0.544 . . . . 74.310000000000002 111.126 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 77' ' ' SER . 94.9 mt -66.09 -20.91 66.31 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.143 0.424 . . . . 75.209999999999994 112.143 -175.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.9 mt-30 -79.44 -8.3 59.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.926 0.393 . . . . 72.319999999999993 110.785 176.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.441 ' HE3' HG22 ' A' ' 72' ' ' ILE . 10.1 mtmp? -114.43 -34.26 5.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.368 -0.378 . . . . 72.519999999999996 110.792 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.412 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 34.1 t -148.33 127.51 12.92 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.812 -0.44 . . . . 73.450000000000003 109.812 178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.56 47.06 3.01 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.691 -0.766 . . . . 74.420000000000002 112.653 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.29 149.5 49.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.028 0.442 . . . . 53.109999999999999 111.318 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 81' ' ' PRO . 38.6 t -74.65 114.36 33.43 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 115.471 -0.786 . . . . 65.150000000000006 109.512 175.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 80' ' ' CYS . 16.5 Cg_endo -57.24 -22.46 48.86 Favored 'Trans proline' 0 N--CA 1.474 0.326 0 C-N-CA 122.712 2.274 . . . . 70.049999999999997 112.84 -174.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 44.7 t -82.86 -31.89 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 112.301 0.482 . . . . 60.25 112.301 -176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.0 p -130.27 -11.6 4.1 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.686 0.625 . . . . 44.409999999999997 112.686 -173.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.647 ' HB3' ' HB2' ' A' ' 11' ' ' MET . 0.4 OUTLIER 70.49 13.44 7.42 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 123.489 0.716 . . . . 65.200000000000003 111.832 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 46.8 t -73.08 144.07 47.18 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.152 -0.684 . . . . 70.129999999999995 109.152 173.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 60.9 ttp -79.12 151.57 31.28 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.369 0.418 . . . . 54.310000000000002 111.047 -175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -126.42 119.59 23.26 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.84 -0.618 . . . . 62.439999999999998 109.537 173.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.48 156.0 92.23 Favored 'Cis proline' 0 CA--C 1.532 0.375 0 C-N-CA 123.45 -1.479 . . . . 62.130000000000003 112.399 -0.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -60.01 155.14 46.28 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 123.103 2.535 . . . . 65.430000000000007 112.798 -176.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -75.46 -173.21 1.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.677 2.251 . . . . 64.209999999999994 112.178 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.375 -0.821 . . . . 62.420000000000002 110.394 -179.01 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.5 ttp . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 120.696 0.284 . . . . 52.329999999999998 110.326 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.46 -109.85 2.58 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 116.123 -0.489 . . . . 64.109999999999999 112.747 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.8 m170 -77.04 165.06 25.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.894 0.378 . . . . 55.409999999999997 110.626 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.0 m170 -79.08 104.27 9.6 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.909 -0.774 . . . . 72.219999999999999 108.909 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -68.63 112.22 5.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.148 -0.478 . . . . 74.140000000000001 110.915 -176.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -77.4 69.0 3.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.672 0.749 . . . . 74.340000000000003 109.552 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.8 t60 -116.18 3.33 13.47 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.049 -0.978 . . . . 72.239999999999995 108.59 175.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -125.53 148.52 48.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.672 -1.149 . . . . 65.340000000000003 109.185 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.2 t -120.31 -24.75 5.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.008 0.433 . . . . 75.310000000000002 110.256 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -133.28 146.76 51.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 71.129999999999995 110.598 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 86.9 mtp -84.74 117.12 23.63 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.451 -0.574 . . . . 52.520000000000003 109.451 173.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.558 HG12 ' HG2' ' A' ' 84' ' ' ARG . 24.9 m -90.09 -18.14 7.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.503 -0.317 . . . . 75.150000000000006 111.658 -174.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.53 105.88 17.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.97 0.414 . . . . 74.219999999999999 110.769 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.51 ' HB2' ' HD2' ' A' ' 15' ' ' PRO . 17.7 p-10 -135.13 162.25 58.7 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.981 -0.554 . . . . 73.439999999999998 110.191 178.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 14' ' ' ASN . 21.5 Cg_endo -61.37 151.98 75.78 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.581 2.188 . . . . 73.310000000000002 112.358 176.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.15 162.79 40.68 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.623 2.215 . . . . 70.109999999999999 112.127 176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.87 143.61 26.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.256 -0.429 . . . . 61.329999999999998 110.277 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -70.92 147.67 48.52 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.952 -0.388 . . . . 72.129999999999995 109.952 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -53.02 -38.38 62.32 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.306 -0.407 . . . . 71.109999999999999 111.267 -176.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -59.4 -42.49 91.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.875 -0.602 . . . . 61.420000000000002 111.901 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.5 m -70.66 -34.41 71.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.109 0.481 . . . . 74.109999999999999 110.714 178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.479 HG21 ' HA ' ' A' ' 71' ' ' SER . 68.6 mt -72.81 -42.85 61.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.978 -0.555 . . . . 64.25 111.059 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.3 -21.72 62.04 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.222 -0.445 . . . . 74.0 110.508 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.74 -3.89 54.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 51.009999999999998 111.622 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.454 HD13 HG21 ' A' ' 57' ' ' THR . 25.2 mt -56.52 135.32 77.11 Favored Pre-proline 0 C--O 1.236 0.36 0 CA-C-N 116.602 -0.272 . . . . 52.130000000000003 111.379 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.39 129.99 36.85 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.137 2.558 . . . . 75.120000000000005 111.722 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -98.26 111.66 23.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.089 0.471 . . . . 71.430000000000007 110.732 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -112.71 109.99 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.588 -0.733 . . . . 74.420000000000002 109.758 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.79 123.52 20.37 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.514 -0.55 . . . . 62.299999999999997 109.514 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 47.2 t -74.18 114.38 13.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.046 0.451 . . . . 55.439999999999998 110.669 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.9 p -115.3 131.82 56.81 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.653 -0.703 . . . . 72.329999999999998 109.87 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 53.2 mt-10 -66.58 -13.97 61.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 64.420000000000002 111.251 -177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.23 -29.28 70.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.336 0.589 . . . . 74.030000000000001 110.012 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -92.7 -16.9 24.93 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.277 -0.874 . . . . 73.030000000000001 110.092 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.54 -113.72 4.36 Favored Glycine 0 N--CA 1.451 -0.343 0 N-CA-C 111.41 -0.676 . . . . 75.530000000000001 111.41 -177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.66 132.01 40.3 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.7 -0.482 . . . . 74.430000000000007 109.7 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 22.1 t -61.57 -31.67 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.247 0.546 . . . . 64.25 110.217 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.518 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . -164.37 -118.23 0.44 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.176 -0.77 . . . . 74.219999999999999 111.176 176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -64.45 -55.06 23.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.311 0.577 . . . . 74.0 110.435 176.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.15 142.02 28.09 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.417 -0.81 . . . . 71.219999999999999 111.702 -175.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.1 ptp -112.73 7.37 18.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.496 -0.775 . . . . 72.450000000000003 109.545 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 19.6 p -126.6 149.55 49.39 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.401 -0.818 . . . . 62.030000000000001 109.926 176.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 41.3 t -110.32 101.01 46.83 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 110.042 -0.355 . . . . 65.430000000000007 110.042 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.7 Cg_endo -54.41 -31.98 70.69 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.412 2.741 . . . . 65.150000000000006 112.583 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.1 mt -65.2 -34.74 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.952 -0.567 . . . . 72.209999999999994 110.883 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.0 m -98.46 -18.9 17.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 111.354 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 73.2 m 65.89 22.23 11.37 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.444 0.64 . . . . 62.140000000000001 110.032 -172.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -130.51 175.43 8.99 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.264 -0.88 . . . . 74.109999999999999 109.524 -177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 8.5 pt-20 -98.96 -175.24 2.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.048 0.452 . . . . 74.319999999999993 111.477 -173.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.514 ' HB3' HG11 ' A' ' 30' ' ' VAL . 56.0 m-85 -100.89 120.23 39.84 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.966 -0.561 . . . . 75.209999999999994 110.591 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 26.5 m -127.29 169.35 18.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.895 -0.593 . . . . 64.109999999999999 110.783 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 33.7 ttmt -74.36 110.92 9.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.247 -0.433 . . . . 74.209999999999994 110.886 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.61 -26.85 2.63 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.785 -0.721 . . . . 72.340000000000003 112.413 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.0 t0 -86.86 160.94 18.57 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.816 -0.439 . . . . 64.120000000000005 109.816 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -108.06 126.55 64.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.905 0.383 . . . . 64.150000000000006 110.711 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.05 170.7 7.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.174 -0.467 . . . . 72.099999999999994 110.567 178.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.454 HG21 HD13 ' A' ' 25' ' ' LEU . 13.5 t -148.98 156.65 42.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.06 -0.518 . . . . 54.530000000000001 109.647 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -110.55 117.47 33.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.49 -0.323 . . . . 74.319999999999993 110.376 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.9 mt -75.4 156.16 85.47 Favored Pre-proline 0 C--N 1.324 -0.541 0 N-CA-C 108.967 -0.753 . . . . 71.340000000000003 108.967 172.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -51.41 -23.82 14.89 Favored 'Trans proline' 0 N--CA 1.475 0.426 0 C-N-CA 123.095 2.53 . . . . 74.5 113.56 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.6 p -90.76 15.49 11.06 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.462 0.171 . . . . 71.430000000000007 111.462 -178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 44.8 m80 67.29 24.68 8.99 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.911 0.485 . . . . 74.349999999999994 112.061 175.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.6 m170 -102.83 133.25 48.21 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.741 -0.466 . . . . 72.239999999999995 109.741 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.518 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 80.5 m-85 -105.63 133.28 50.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.171 -0.468 . . . . 72.329999999999998 112.011 -171.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.499 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 99.2 m-85 -138.02 175.31 9.7 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.522 -0.918 . . . . 74.420000000000002 108.522 175.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.876 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.6 m80 -84.02 128.28 34.44 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.864 -0.791 . . . . 74.209999999999994 108.864 174.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.535 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 89.0 tttt -53.35 -48.32 92.99 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 123.578 0.549 . . . . 72.329999999999998 111.828 -179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 73.1 Cg_exo -53.47 -47.31 28.04 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 122.334 2.023 . . . . 74.230000000000004 113.801 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.876 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 25.8 p -82.79 -36.92 25.22 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 120.773 -0.371 . . . . 63.509999999999998 111.942 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 8.7 p -68.39 -24.99 30.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.77 -0.455 . . . . 74.099999999999994 109.77 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.53 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 47.5 t -55.07 -50.57 68.81 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.684 -0.689 . . . . 72.420000000000002 110.626 176.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.7 mt -66.0 -38.76 82.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 74.409999999999997 110.507 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -62.85 -47.1 84.83 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.922 -0.581 . . . . 73.310000000000002 110.634 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 97.1 mt -66.22 -29.26 69.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.408 -0.36 . . . . 75.129999999999995 111.258 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 71' ' ' SER . 78.6 mt-30 -71.24 -13.41 61.9 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 120.865 0.364 . . . . 73.450000000000003 110.73 177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -101.82 -45.05 5.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 72.109999999999999 110.12 176.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.2 p -153.19 119.9 5.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.759 -0.655 . . . . 53.140000000000001 109.897 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.16 66.14 3.85 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.656 -0.783 . . . . 42.32 112.668 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.31 144.35 34.56 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.804 0.335 . . . . 72.219999999999999 111.241 178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 48.4 t -75.01 104.74 1.46 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.995 -0.548 . . . . 63.329999999999998 109.78 176.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -48.37 -37.15 32.04 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 123.67 2.913 . . . . 75.049999999999997 114.322 -168.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.3 t -69.2 -28.42 38.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 112.304 0.483 . . . . 74.540000000000006 112.304 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.3 p -127.4 -26.74 3.0 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.986 -0.447 . . . . 51.520000000000003 111.801 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.558 ' HG2' HG12 ' A' ' 12' ' ' VAL . 5.1 tpt180 79.86 18.99 0.66 Allowed 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.558 1.143 . . . . 75.420000000000002 110.635 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 53.2 t -69.0 138.34 54.43 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.605 -0.887 . . . . 75.049999999999997 108.605 169.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.564 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 41.1 ttm -80.8 148.42 30.02 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.966 0.413 . . . . 65.400000000000006 111.794 -171.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 81.3 t80 -133.65 116.5 13.84 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.705 -0.68 . . . . 74.540000000000006 109.448 172.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 8.6 Cg_exo -72.05 151.95 96.44 Favored 'Cis proline' 0 CA--C 1.53 0.296 0 C-N-CA 123.271 -1.554 . . . . 50.450000000000003 111.82 -0.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -50.08 147.64 14.94 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.272 2.648 . . . . 74.129999999999995 112.384 -178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 38.7 Cg_endo -65.28 149.63 88.27 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.363 2.042 . . . . 62.520000000000003 112.012 -174.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.873 -0.584 . . . . 73.439999999999998 110.213 -177.931 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.718 0.294 . . . . 74.310000000000002 110.824 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.8 -73.11 0.49 Allowed Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.954 -0.859 . . . . 52.350000000000001 110.954 177.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -113.62 -170.62 1.73 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.384 -0.598 . . . . 70.549999999999997 109.384 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -117.34 51.13 1.04 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.665 0.745 . . . . 72.420000000000002 110.018 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -72.02 128.88 37.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.943 -1.026 . . . . 74.409999999999997 109.679 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -107.42 115.76 30.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.854 0.359 . . . . 64.219999999999999 111.024 -175.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -93.03 165.3 12.92 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.467 -0.568 . . . . 54.109999999999999 109.467 173.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -74.63 145.82 42.96 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.76 -0.459 . . . . 73.510000000000005 109.76 -178.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.9 p -56.9 103.8 0.13 Allowed 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.441 0.534 . . . . 62.420000000000002 112.441 -178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 -158.62 119.39 3.33 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.079 -0.711 . . . . 73.430000000000007 109.079 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.8 ttt -88.53 115.18 25.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.947 -0.57 . . . . 71.340000000000003 111.284 -173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -118.15 124.15 72.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.903 -0.59 . . . . 55.119999999999997 109.703 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.64 -54.35 8.35 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.426 -0.352 . . . . 62.409999999999997 111.865 -174.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -128.96 157.57 75.35 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.533 -0.303 . . . . 74.409999999999997 111.086 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -57.68 151.15 57.13 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 122.914 2.41 . . . . 64.150000000000006 111.87 175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.0 155.43 61.87 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.644 2.229 . . . . 72.430000000000007 112.752 -175.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.92 144.76 26.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.898 -0.592 . . . . 50.109999999999999 110.641 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.3 m -65.52 145.02 56.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.978 -0.555 . . . . 70.310000000000002 110.882 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -58.22 -45.06 88.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 71.540000000000006 110.924 -176.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -48.8 -48.12 41.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.745 -0.661 . . . . 71.239999999999995 111.259 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.0 m -67.88 -34.22 76.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.177 -0.465 . . . . 53.200000000000003 111.338 -177.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.4 HG21 ' HA ' ' A' ' 71' ' ' SER . 60.4 mt -72.94 -44.51 57.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.278 0.561 . . . . 71.030000000000001 110.393 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -62.96 -35.52 80.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.782 -0.645 . . . . 62.399999999999999 110.705 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.01 5.2 17.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.801 -0.636 . . . . 65.540000000000006 112.184 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 74.2 mt -69.69 142.28 91.18 Favored Pre-proline 0 C--O 1.237 0.419 0 N-CA-C 110.252 -0.277 . . . . 73.019999999999996 110.252 175.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.25 149.0 91.09 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.955 2.437 . . . . 72.200000000000003 112.353 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -113.04 105.81 13.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 70.439999999999998 110.451 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.7 mt -100.08 121.69 51.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.93 -0.577 . . . . 75.310000000000002 110.016 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.6 tp -81.2 122.29 27.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.835 0.35 . . . . 62.219999999999999 110.467 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.575 HG11 ' HB3' ' A' ' 50' ' ' TYR . 47.0 t -88.43 134.3 28.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.248 -0.433 . . . . 75.109999999999999 110.212 176.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.2 p -113.35 172.81 6.73 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.656 -0.702 . . . . 70.040000000000006 110.831 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HG2' ' HE3' ' A' ' 52' ' ' LYS . 5.7 mm-40 -59.39 134.39 56.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.409 -0.359 . . . . 63.140000000000001 110.776 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.0 t70 53.44 74.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.322 -0.853 . . . . 73.319999999999993 110.579 -172.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -165.22 29.51 0.06 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.126 -0.943 . . . . 73.150000000000006 108.785 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 41' ' ' MET . . . -59.82 -36.65 90.67 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.468 -0.787 . . . . 53.140000000000001 111.628 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.59 84.27 5.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.31 0.576 . . . . 74.329999999999998 110.046 175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.9 t -75.23 -23.25 17.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.571 -0.741 . . . . 71.420000000000002 109.986 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -165.45 -126.3 0.82 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.001 -0.84 . . . . 74.439999999999998 111.001 178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -77.84 -3.5 41.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.342 0.591 . . . . 62.219999999999999 110.255 174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -120.24 153.5 36.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.476 -0.784 . . . . 72.120000000000005 109.898 177.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 35' ' ' GLY . 1.6 pmm? -134.92 9.79 3.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.113 -0.494 . . . . 71.540000000000006 110.262 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 11.6 p -147.61 151.01 35.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.149 -0.478 . . . . 60.350000000000001 111.045 -176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 37.4 t -101.49 100.96 15.29 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.488 -0.778 . . . . 72.329999999999998 109.296 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 16.3 Cg_endo -57.44 -31.62 91.78 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.931 2.421 . . . . 54.219999999999999 112.564 -176.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -60.95 -27.03 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 70.349999999999994 110.944 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 73.6 m -110.24 -15.35 14.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.33 -0.395 . . . . 72.540000000000006 111.103 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 74.0 m 58.32 45.1 17.52 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.186 -0.461 . . . . 55.32 109.964 -172.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.3 t -154.41 175.1 13.98 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.814 -0.63 . . . . 54.210000000000001 109.734 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -101.89 -169.87 1.74 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.743 0.306 . . . . 74.239999999999995 111.705 -173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.575 ' HB3' HG11 ' A' ' 30' ' ' VAL . 94.9 m-85 -111.07 134.18 52.87 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.077 -0.51 . . . . 74.439999999999998 110.781 -178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.9 m -136.89 -179.6 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.328 -0.397 . . . . 75.530000000000001 110.62 178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.554 ' HE3' ' HG2' ' A' ' 32' ' ' GLU . 37.8 ttmt -56.73 133.28 53.96 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.058 0.456 . . . . 62.130000000000003 111.168 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.9 -8.65 59.65 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.798 -0.715 . . . . 71.319999999999993 112.04 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -78.58 129.11 34.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.833 0.349 . . . . 75.129999999999995 111.311 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.2 t -96.19 102.06 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.813 -0.63 . . . . 54.039999999999999 109.463 174.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -95.69 162.76 13.47 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.827 -0.624 . . . . 73.140000000000001 110.458 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 10.5 t -140.58 155.48 46.56 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.655 -0.498 . . . . 74.129999999999995 109.655 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -116.02 117.54 30.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.907 0.384 . . . . 44.420000000000002 110.64 -177.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -79.29 150.2 73.64 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.988 -0.551 . . . . 72.430000000000007 109.88 176.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.8 -14.99 24.39 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.313 2.675 . . . . 72.299999999999997 113.083 -178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 18.4 p -87.24 10.99 15.26 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.249 -0.278 . . . . 74.230000000000004 110.249 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 62.24 77.79 0.32 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.731 -0.668 . . . . 65.319999999999993 111.161 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -160.94 149.64 16.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.258 -0.883 . . . . 72.319999999999993 109.226 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -120.75 132.87 55.29 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.943 0.402 . . . . 52.299999999999997 111.662 -173.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.465 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 91.6 m-85 -141.51 175.29 9.8 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.101 -0.703 . . . . 61.009999999999998 109.101 177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.895 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 40.5 m80 -81.43 131.7 35.29 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.152 -1.055 . . . . 71.310000000000002 108.152 172.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 87.5 tttt -56.13 -49.94 90.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 O-C-N 123.334 0.396 . . . . 74.040000000000006 112.018 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 51.0 Cg_exo -56.9 -46.78 26.89 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.005 1.804 . . . . 73.530000000000001 113.537 -179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.895 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 25.1 p -74.57 -32.44 62.4 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.586 -0.446 . . . . 64.5 111.615 -174.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 67' ' ' LYS . 7.5 p -73.01 -24.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.494 -0.483 . . . . 70.349999999999994 109.788 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.4 ' HA ' HG21 ' A' ' 22' ' ' ILE . 55.7 m -60.83 -43.07 98.75 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.273 -0.421 . . . . 72.349999999999994 110.431 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 75.8 mt -67.05 -42.95 89.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.163 -0.471 . . . . 60.439999999999998 110.351 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -64.64 -46.24 83.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.641 -0.709 . . . . 75.239999999999995 111.42 -177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.6 mt -67.37 -22.21 65.58 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.866 0.321 . . . . 75.400000000000006 111.866 -176.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -81.15 -7.17 59.51 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.105 0.479 . . . . 74.219999999999999 110.714 177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -109.82 -52.15 2.8 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.79 -0.641 . . . . 73.219999999999999 110.452 -179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 23.9 t -142.96 115.99 8.86 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.634 -0.506 . . . . 70.319999999999993 109.634 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -75.5 72.09 1.76 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.92 -0.657 . . . . 63.539999999999999 112.226 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.402 HG22 ' HA ' ' A' ' 84' ' ' ARG . 1.7 m -147.11 137.49 23.46 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.901 -0.407 . . . . 63.310000000000002 109.901 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 50.5 t -74.77 110.03 8.82 Favored Pre-proline 0 C--O 1.219 -0.545 0 N-CA-C 109.137 -0.69 . . . . 71.329999999999998 109.137 176.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.69 -33.65 60.5 Favored 'Trans proline' 0 N--CA 1.475 0.437 0 C-N-CA 122.989 2.46 . . . . 74.140000000000001 113.832 -170.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 56.9 t -73.52 -53.31 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 112.266 0.469 . . . . 64.129999999999995 112.266 -176.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.7 p -101.44 -16.32 16.89 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.84 -0.344 . . . . 32.329999999999998 111.433 -174.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HA ' HG22 ' A' ' 79' ' ' THR . 71.2 mtt180 69.18 23.93 6.21 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.589 -0.732 . . . . 70.200000000000003 111.993 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.6 m -80.91 149.27 29.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 74.519999999999996 109.355 170.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.5 ttp -76.39 143.67 40.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.247 -0.433 . . . . 75.25 111.871 -173.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.612 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 78.2 t80 -137.42 126.71 15.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 108.924 -0.769 . . . . 75.140000000000001 108.924 174.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.612 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 51.7 Cg_exo -56.07 147.66 23.58 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 124.623 -0.99 . . . . 41.109999999999999 113.366 2.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 20.1 Cg_endo -59.29 151.12 70.04 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.243 2.629 . . . . 53.219999999999999 112.596 -175.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 89' ' ' PRO . 8.9 Cg_exo -70.42 178.79 4.61 Favored 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 122.677 2.252 . . . . 65.010000000000005 112.432 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 C--O 1.248 0.988 0 CA-C-N 115.564 -0.744 . . . . 75.150000000000006 110.602 -179.234 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.7 mtp . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.003 -0.369 . . . . 75.219999999999999 110.003 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.68 -7.01 49.05 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.939 -0.648 . . . . 73.129999999999995 111.937 177.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -73.45 102.13 3.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.912 0.387 . . . . 74.129999999999995 110.115 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.419 ' HD2' ' O ' ' A' ' 5' ' ' HIS . 3.4 t-160 -117.82 111.39 19.0 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.994 -0.548 . . . . 53.149999999999999 110.316 -176.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.419 ' O ' ' HD2' ' A' ' 4' ' ' HIS . 51.0 t-80 -69.89 137.65 51.82 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.416 -0.587 . . . . 75.310000000000002 109.416 176.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -100.64 136.83 39.9 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.794 0.331 . . . . 74.25 111.059 -171.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -130.11 99.31 5.02 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.718 -0.674 . . . . 74.319999999999993 109.497 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.0 t-160 -62.34 107.7 0.96 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 74.319999999999993 110.917 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.0 p -154.42 160.67 41.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.001 -0.545 . . . . 73.239999999999995 110.097 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -66.2 129.63 40.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.31 . . . . 75.409999999999997 110.644 178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 89.2 mmm -90.19 85.15 6.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.061 0.458 . . . . 72.120000000000005 110.772 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.7 m -103.53 136.89 34.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.979 -0.555 . . . . 75.420000000000002 110.135 176.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.4 92.9 5.27 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.082 0.468 . . . . 64.120000000000005 110.237 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -75.74 138.26 70.07 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.58 -0.737 . . . . 73.150000000000006 110.455 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.15 157.88 12.94 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.215 2.61 . . . . 73.540000000000006 112.817 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.13 165.67 27.63 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.738 2.292 . . . . 63.43 112.745 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -90.17 154.01 20.08 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.793 -0.639 . . . . 50.240000000000002 110.433 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.3 m -70.2 135.73 49.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.453 -0.339 . . . . 61.240000000000002 110.567 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -58.87 -38.15 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.925 -0.579 . . . . 55.420000000000002 110.984 -176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 28.5 mp0 -59.31 -46.3 88.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.927 -0.579 . . . . 74.549999999999997 110.535 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.402 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 9.8 m -63.59 -34.16 77.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.907 -0.588 . . . . 61.140000000000001 110.632 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -71.04 -43.53 76.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.866 -0.607 . . . . 73.140000000000001 110.413 179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -66.54 -37.38 84.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.142 -0.481 . . . . 71.030000000000001 110.577 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.67 3.68 11.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.747 -0.661 . . . . 60.329999999999998 111.807 -178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.647 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 60.1 mt -70.18 131.82 88.51 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 110.475 -0.195 . . . . 74.129999999999995 110.475 175.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 19.5 Cg_endo -58.63 135.24 66.06 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.152 2.568 . . . . 63.25 112.513 -179.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -101.63 102.92 13.7 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.106 0.479 . . . . 73.439999999999998 110.006 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.1 mt -103.23 131.63 51.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.898 -0.592 . . . . 74.150000000000006 110.544 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.8 tp -79.38 121.74 25.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.893 0.378 . . . . 74.030000000000001 110.323 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 50' ' ' TYR . 42.6 t -87.46 132.33 33.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.074 -0.512 . . . . 71.439999999999998 110.67 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 36.9 p -128.59 151.42 49.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.264 -0.426 . . . . 62.350000000000001 110.297 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.671 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 30.4 mt-10 -84.51 0.6 49.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.23 0.538 . . . . 74.209999999999994 110.687 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -85.1 -22.11 29.03 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.847 -0.797 . . . . 74.049999999999997 108.847 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -133.4 55.57 1.89 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.89 -1.05 . . . . 73.099999999999994 109.265 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -62.95 160.1 34.97 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.38 -0.827 . . . . 72.319999999999993 112.272 -178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 41' ' ' MET . . . 60.16 76.62 0.35 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.399 0.618 . . . . 64.120000000000005 109.993 -174.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.9 t -79.71 93.77 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.45 -0.795 . . . . 62.149999999999999 111.145 -173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.42 -12.9 30.71 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.832 -0.622 . . . . 33.329999999999998 113.298 175.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.428 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 3.0 pt20 -156.93 -160.26 0.95 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 122.73 -0.276 . . . . 72.019999999999996 110.679 -176.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -55.3 151.84 9.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.589 -0.732 . . . . 63.32 110.615 175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.468 ' HB3' ' HB2' ' A' ' 36' ' ' ALA . 1.4 pmm? -88.77 11.91 16.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.309 -0.405 . . . . 52.439999999999998 111.645 -174.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 82.1 m -118.4 141.53 48.46 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.208 0.528 . . . . 75.409999999999997 111.411 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 21.3 t -106.11 101.72 35.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.555 -0.748 . . . . 71.019999999999996 109.549 177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 17.7 Cg_endo -59.7 -26.68 82.9 Favored 'Trans proline' 0 N--CA 1.473 0.278 0 C-N-CA 123.246 2.631 . . . . 71.439999999999998 113.349 -174.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 56.9 mt -60.83 -41.26 87.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 75.019999999999996 111.469 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 21.0 p -119.88 13.96 12.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.557 -0.292 . . . . 75.209999999999994 110.909 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p 43.37 45.14 5.13 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 123.942 0.776 . . . . 51.409999999999997 112.22 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.0 p -120.85 -177.71 3.55 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.459 -0.571 . . . . 63.439999999999998 109.459 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -106.67 -175.13 2.71 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.795 0.331 . . . . 73.349999999999994 110.117 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.533 ' HB3' HG11 ' A' ' 30' ' ' VAL . 70.0 m-85 -103.0 109.92 21.64 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.378 -0.374 . . . . 72.109999999999999 110.538 178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.1 m -107.08 165.16 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 74.349999999999994 111.68 -175.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.671 ' HB2' ' H ' ' A' ' 32' ' ' GLU . 22.7 ttpp -73.5 113.69 10.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.754 -0.657 . . . . 72.209999999999994 111.008 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.02 -8.74 9.1 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.943 -0.646 . . . . 63.340000000000003 112.709 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -87.26 166.02 15.23 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 110.121 -0.326 . . . . 74.219999999999999 110.121 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -115.98 116.17 51.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.13 0.49 . . . . 75.310000000000002 110.745 -177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.43 166.95 10.39 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.028 -0.533 . . . . 73.010000000000005 110.784 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.647 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.8 t -136.45 155.16 50.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.747 -0.66 . . . . 73.209999999999994 110.114 177.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 49.2 tt0 -107.75 117.8 35.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.98 -0.554 . . . . 73.439999999999998 109.925 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.87 146.38 59.55 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 109.031 -0.729 . . . . 73.120000000000005 109.031 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.71 -3.87 4.0 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.099 2.533 . . . . 65.140000000000001 113.807 -175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.7 p -103.22 29.29 5.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.872 0.368 . . . . 75.030000000000001 110.472 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 63.12 31.73 15.61 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.878 -0.601 . . . . 74.409999999999997 112.188 174.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -126.52 135.01 50.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.776 0.322 . . . . 74.140000000000001 110.814 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -105.65 145.92 30.4 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.79 -0.641 . . . . 65.0 110.875 -177.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -149.25 160.41 43.41 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.686 -0.688 . . . . 75.340000000000003 109.289 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.637 ' HB2' ' CB ' ' A' ' 69' ' ' CYS . 34.3 m170 -60.47 132.85 55.21 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.418 -0.956 . . . . 72.140000000000001 108.418 168.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -65.85 -61.51 5.55 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.943 0.719 . . . . 74.230000000000004 112.943 -171.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.36 -23.32 71.81 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.742 1.628 . . . . 62.409999999999997 111.197 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.637 ' CB ' ' HB2' ' A' ' 66' ' ' HIS . 7.7 t -67.36 -53.42 29.64 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.212 -1.358 . . . . 75.329999999999998 110.295 178.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 7.2 p -74.65 -24.7 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.782 -0.644 . . . . 65.340000000000003 110.524 -177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.607 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 43.6 t -54.29 -48.73 70.92 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.266 -0.424 . . . . 75.219999999999999 110.1 176.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.0 mt -57.51 -47.6 84.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.012 -0.54 . . . . 65.319999999999993 110.343 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -61.3 -44.75 96.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 74.420000000000002 111.116 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 17' ' ' ALA . 96.8 mt -66.14 -23.07 66.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.438 . . . . 74.340000000000003 111.456 -178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.607 ' HG3' ' O ' ' A' ' 71' ' ' SER . 78.0 mt-30 -72.33 -21.95 61.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.755 0.312 . . . . 71.299999999999997 110.485 177.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -89.56 -59.17 2.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.183 0.516 . . . . 70.319999999999993 109.625 173.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 52.0 m -140.11 124.78 18.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.748 -0.66 . . . . 64.430000000000007 110.343 -179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -81.03 75.55 2.27 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.176 -0.769 . . . . 75.530000000000001 111.176 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 84' ' ' ARG . 4.0 m -147.68 135.29 20.89 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.374 -0.232 . . . . 71.439999999999998 110.374 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 34.9 t -75.18 107.39 3.93 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.181 -0.674 . . . . 63.25 109.181 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.18 -31.98 48.02 Favored 'Trans proline' 0 N--CA 1.476 0.497 0 C-N-CA 123.152 2.568 . . . . 74.209999999999994 114.207 -169.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.5 t -71.69 -47.9 54.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 112.048 0.388 . . . . 63.530000000000001 112.048 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 20.5 p -103.51 -23.83 13.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.848 0.356 . . . . 74.129999999999995 111.031 -174.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.467 ' HA ' HG22 ' A' ' 79' ' ' THR . 35.9 mtp180 71.13 29.6 2.86 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.316 -0.856 . . . . 73.319999999999993 110.893 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 47.6 t -85.07 138.15 32.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.536 -0.756 . . . . 73.299999999999997 108.982 169.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.7 ttp -72.11 143.38 49.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.98 0.419 . . . . 62.100000000000001 111.275 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.455 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 94.0 t80 -125.88 129.69 24.23 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.309 -0.859 . . . . 75.319999999999993 108.98 175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 16.7 Cg_exo -67.59 157.42 85.0 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 123.851 -1.312 . . . . 71.239999999999995 112.721 2.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.51 134.38 63.6 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 123.065 2.51 . . . . 65.299999999999997 112.412 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.81 -172.18 1.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.016 2.477 . . . . 64.439999999999998 112.61 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 98.8 mt . . . . . 0 C--O 1.243 0.75 0 CA-C-O 118.6 -0.714 . . . . 73.409999999999997 109.859 178.049 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.8 ttp . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 109.857 -0.423 . . . . 70.530000000000001 109.857 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 145.04 -43.73 0.93 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.347 -0.701 . . . . 74.329999999999998 111.347 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -88.75 102.77 15.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.059 0.457 . . . . 71.030000000000001 110.087 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -103.7 147.98 26.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.719 -0.673 . . . . 74.310000000000002 110.362 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -73.75 -40.5 63.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.184 -0.462 . . . . 75.209999999999994 110.686 -178.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -129.0 158.81 37.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.362 -0.381 . . . . 72.140000000000001 110.939 -177.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -164.39 122.96 1.82 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.709 -0.678 . . . . 72.439999999999998 109.898 177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.2 m80 -132.08 98.91 4.56 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.006 -0.543 . . . . 64.349999999999994 109.991 176.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.4 p -94.07 89.25 5.95 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.423 0.63 . . . . 43.219999999999999 110.673 -179.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.2 t-80 -134.08 116.64 15.7 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.55 -0.907 . . . . 74.530000000000001 108.55 177.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.5 mmt -54.23 -56.45 18.21 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.561 0.538 . . . . 72.040000000000006 111.321 -174.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 40.6 t -112.62 124.64 69.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.407 -0.59 . . . . 73.010000000000005 109.407 176.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.08 -72.72 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.802 0.334 . . . . 74.319999999999993 111.444 -178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.553 ' HB2' ' OG1' ' A' ' 79' ' ' THR . 80.2 m-20 -135.83 163.39 50.8 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.266 -0.425 . . . . 73.230000000000004 109.997 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.447 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 10.0 Cg_endo -54.17 143.74 62.12 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.917 2.411 . . . . 61.509999999999998 112.321 176.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 17.4 Cg_exo -67.54 156.15 67.26 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 122.986 2.458 . . . . 61.350000000000001 112.197 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.84 147.52 22.78 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.078 -0.51 . . . . 72.019999999999996 110.443 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 6.2 m -68.23 138.91 55.94 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.327 -0.397 . . . . 71.25 110.241 178.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -54.48 -33.58 60.01 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.81 0.338 . . . . 43.350000000000001 110.819 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -61.29 -28.12 68.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 64.299999999999997 111.159 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.5 t -86.82 -34.54 19.49 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.888 -0.412 . . . . 74.099999999999994 109.888 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.3 mt -67.72 -49.38 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.053 -0.521 . . . . 54.439999999999998 110.837 -178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -72.63 -13.0 61.27 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.291 -0.413 . . . . 73.120000000000005 110.653 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.37 -6.43 58.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 73.25 111.173 178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.526 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 84.3 mt -63.22 138.06 97.24 Favored Pre-proline 0 C--O 1.236 0.366 0 CA-C-N 116.4 -0.364 . . . . 24.219999999999999 110.667 177.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 25.3 Cg_endo -61.85 119.06 6.01 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.183 2.589 . . . . 54.009999999999998 112.359 -177.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -88.66 105.34 17.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.387 0.613 . . . . 55.240000000000002 110.835 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.0 mt -96.41 109.39 22.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.221 -0.9 . . . . 75.329999999999998 109.383 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.99 117.38 9.77 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.086 -0.507 . . . . 74.430000000000007 110.052 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.706 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 15.7 t -82.17 127.49 39.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 109.582 -0.525 . . . . 73.439999999999998 109.582 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 65.5 p -117.3 170.21 8.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.019 -0.537 . . . . 42.340000000000003 109.858 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 52' ' ' LYS . 24.3 mt-10 -85.19 7.64 21.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.655 0.741 . . . . 73.109999999999999 109.865 176.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -96.39 -13.35 23.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.043 -0.981 . . . . 62.409999999999997 109.139 173.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.6 ' HE1' ' HA ' ' A' ' 37' ' ' VAL . 28.8 t-80 -132.85 115.65 15.54 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.258 -0.883 . . . . 75.329999999999998 110.577 -173.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.61 -111.07 0.46 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.668 -0.777 . . . . 51.299999999999997 112.486 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.93 139.18 58.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.851 0.357 . . . . 75.239999999999995 110.975 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.6 ' HA ' ' HE1' ' A' ' 34' ' ' HIS . 10.9 t -89.21 -19.18 7.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.016 -0.538 . . . . 61.049999999999997 110.819 -176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 177.39 -145.16 7.05 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.646 -0.788 . . . . 71.329999999999998 111.968 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -59.99 -49.06 79.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.101 0.476 . . . . 72.120000000000005 110.716 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.91 113.4 16.99 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.452 -0.944 . . . . 74.319999999999993 108.452 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.7 ptp -101.07 4.67 42.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.262 -0.427 . . . . 71.140000000000001 111.893 -171.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.7 m -146.87 171.48 15.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.675 0.274 . . . . 73.510000000000005 110.575 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 44.5 t -122.41 91.02 49.41 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.203 -0.453 . . . . 71.5 109.859 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.39 -13.32 32.11 Favored 'Trans proline' 0 N--CA 1.475 0.422 0 C-N-CA 123.384 2.722 . . . . 72.200000000000003 113.019 -175.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.3 mt -69.99 -22.28 24.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.063 0.458 . . . . 72.540000000000006 110.59 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 27.4 p -132.85 -14.9 2.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 111.946 0.351 . . . . 61.340000000000003 111.946 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 89.9 m 65.99 21.85 11.28 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 122.761 0.424 . . . . 51.340000000000003 111.309 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.5 m -104.62 142.3 34.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.22 -0.445 . . . . 75.519999999999996 109.832 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -79.04 177.36 8.86 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.078 0.466 . . . . 70.230000000000004 111.008 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.463 ' HB3' HG11 ' A' ' 30' ' ' VAL . 89.5 m-85 -89.64 106.27 18.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.133 0.492 . . . . 74.120000000000005 111.425 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.3 m -131.15 171.42 17.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.619 -0.719 . . . . 75.519999999999996 110.346 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.706 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -62.56 120.91 12.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.849 0.357 . . . . 73.540000000000006 110.545 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 134.62 -40.92 1.51 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.776 -0.726 . . . . 51.439999999999998 112.211 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -86.96 161.52 18.19 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.629 -0.508 . . . . 73.230000000000004 109.629 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.89 122.9 69.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.349 -0.387 . . . . 74.409999999999997 110.278 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -96.1 163.44 13.11 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.435 -0.348 . . . . 74.329999999999998 110.397 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 9.5 t -144.49 155.51 43.74 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.955 -0.387 . . . . 54.0 109.955 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.449 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 37.0 tt0 -107.29 117.53 34.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.269 -0.423 . . . . 31.109999999999999 110.073 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.76 142.17 32.34 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.308 -0.627 . . . . 71.150000000000006 109.308 174.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.13 -18.68 24.17 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.369 2.713 . . . . 74.530000000000001 112.83 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 20.6 p -88.32 24.32 1.93 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.243 -0.435 . . . . 74.030000000000001 110.899 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.7 m80 66.22 33.7 7.11 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.094 0.558 . . . . 72.120000000000005 111.604 171.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -127.35 141.42 51.7 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.678 0.275 . . . . 73.0 110.859 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -113.47 133.2 55.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.838 -0.619 . . . . 72.439999999999998 110.485 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -143.07 175.18 10.05 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.876 -0.787 . . . . 75.319999999999993 108.876 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.647 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 32.3 m170 -82.39 131.49 35.22 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.174 -0.676 . . . . 61.399999999999999 109.174 173.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.528 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 85.2 tttt -60.1 -49.52 90.58 Favored Pre-proline 0 C--N 1.323 -0.568 0 O-C-N 123.377 0.423 . . . . 70.310000000000002 111.892 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 18.4 Cg_endo -60.05 -20.73 62.24 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.013 1.809 . . . . 64.329999999999998 112.637 178.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.647 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 60.2 m -83.6 -45.66 13.25 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.161 0.505 . . . . 55.420000000000002 110.655 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.474 HG22 ' HG ' ' A' ' 74' ' ' LEU . 9.4 p -78.32 -25.66 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.979 -0.555 . . . . 73.420000000000002 111.199 -173.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 9.0 p -58.85 -48.76 80.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 71.219999999999999 110.97 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.9 mt -62.04 -42.82 96.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.177 -0.465 . . . . 65.439999999999998 110.372 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 67.7 t-105 -62.88 -43.81 97.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.753 -0.658 . . . . 74.25 111.266 -178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.474 ' HG ' HG22 ' A' ' 70' ' ' VAL . 93.1 mt -65.55 -24.92 67.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.515 -0.312 . . . . 63.43 111.599 -177.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 71' ' ' SER . 76.3 mt-30 -75.49 -23.44 56.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.979 0.418 . . . . 64.030000000000001 110.427 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -85.36 -48.08 9.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.35 0.595 . . . . 64.040000000000006 109.487 176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.7 p -158.51 123.88 4.38 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.281 -0.872 . . . . 73.319999999999993 109.891 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -78.46 74.85 2.03 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.64 -0.79 . . . . 73.329999999999998 111.834 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' A' ' 14' ' ' ASN . 5.3 m -149.24 138.44 21.45 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.768 -0.254 . . . . 71.310000000000002 110.468 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 37.6 t -75.05 112.54 18.54 Favored Pre-proline 0 C--O 1.222 -0.387 0 N-CA-C 109.855 -0.424 . . . . 74.120000000000005 109.855 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.48 -38.48 64.08 Favored 'Trans proline' 0 N--CA 1.476 0.472 0 C-N-CA 123.13 2.553 . . . . 72.349999999999994 113.571 -172.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 62.1 t -73.18 -31.81 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 112.852 0.686 . . . . 72.129999999999995 112.852 -173.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 27.7 p -124.41 -16.23 6.42 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.315 -0.554 . . . . 64.140000000000001 111.894 -173.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.509 ' HA ' HG22 ' A' ' 79' ' ' THR . 60.3 mtt180 69.4 26.24 5.3 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.222 0.609 . . . . 54.340000000000003 110.884 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.19 131.15 38.1 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.965 -0.754 . . . . 73.510000000000005 108.965 171.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 62.8 ttp -72.49 142.84 48.55 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.433 -0.348 . . . . 74.549999999999997 110.571 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.476 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 79.4 t80 -127.45 126.1 24.02 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.424 -0.584 . . . . 71.310000000000002 109.424 177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.476 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 33.8 Cg_endo -65.24 155.39 77.51 Favored 'Cis proline' 0 C--N 1.346 0.443 0 C-N-CA 123.597 -1.418 . . . . 65.299999999999997 112.68 1.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.38 142.89 21.57 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.465 2.777 . . . . 75.040000000000006 112.853 -176.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -61.64 144.02 97.12 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.822 2.348 . . . . 64.340000000000003 112.155 -178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.2 mt . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.454 -0.784 . . . . 71.150000000000006 110.119 -176.655 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.497 0.189 . . . . 73.310000000000002 111.012 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 53.31 -103.94 0.17 Allowed Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.816 -0.629 . . . . 74.239999999999995 114.261 174.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -80.94 122.56 27.41 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.999 0.428 . . . . 71.329999999999998 111.431 -174.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -78.89 -29.94 44.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.005 -0.739 . . . . 72.230000000000004 109.005 170.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -85.0 83.08 8.18 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 107.715 -1.217 . . . . 72.0 107.715 167.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.4 t-160 -71.9 -27.78 63.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.434 -0.803 . . . . 73.25 109.717 -175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 -85.56 178.98 7.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.5 -0.773 . . . . 73.519999999999996 109.0 172.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -99.01 95.13 6.93 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 120.396 -0.522 . . . . 72.5 109.813 177.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.1 m -70.49 141.66 51.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.564 -0.744 . . . . 72.299999999999997 110.765 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -114.97 85.29 2.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.798 0.809 . . . . 63.439999999999998 110.136 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.6 mtp -113.17 106.09 14.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.268 -0.878 . . . . 72.439999999999998 109.545 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 56.1 t -115.59 -74.32 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.847 -0.615 . . . . 60.310000000000002 110.864 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.73 122.52 17.62 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.016 -0.538 . . . . 72.340000000000003 110.076 -178.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -96.85 136.54 21.59 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.912 -0.586 . . . . 65.540000000000006 110.372 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.508 ' HD2' ' SD ' ' A' ' 86' ' ' MET . 90.1 Cg_endo -84.0 150.99 12.52 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.752 2.301 . . . . 60.450000000000003 112.576 178.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.83 143.08 99.43 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.954 2.436 . . . . 74.420000000000002 112.228 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.15 150.99 41.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.89 -0.595 . . . . 74.310000000000002 111.276 -175.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.521 ' O ' HG13 ' A' ' 22' ' ' ILE . 17.7 m -69.2 132.45 46.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.877 -0.601 . . . . 61.219999999999999 110.171 179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -61.68 -36.66 81.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.157 -0.474 . . . . 73.150000000000006 112.09 -172.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -70.09 -36.98 75.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.055 0.455 . . . . 74.129999999999995 110.389 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.1 m -65.97 -29.14 69.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.816 -0.629 . . . . 53.039999999999999 110.566 179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 18' ' ' SER . 69.5 mt -69.88 -40.7 79.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.996 -0.547 . . . . 72.129999999999995 110.713 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.505 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 34.1 t70 -70.93 -26.18 63.08 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.849 -0.341 . . . . 74.099999999999994 110.525 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.14 -16.01 64.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.913 -0.585 . . . . 71.329999999999998 111.733 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.43 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 94.2 mt -63.2 141.84 97.77 Favored Pre-proline 0 C--O 1.235 0.297 0 CA-C-N 116.383 -0.371 . . . . 65.340000000000003 110.798 178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -62.68 129.39 26.19 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 123.059 2.506 . . . . 64.530000000000001 112.527 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -92.23 116.77 29.25 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.059 -0.518 . . . . 75.510000000000005 110.102 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 62.1 mt -114.44 130.27 69.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 109.833 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.4 tp -77.21 126.05 30.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.97 0.415 . . . . 73.420000000000002 110.317 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.613 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 53.5 t -82.12 134.14 27.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 116.012 -0.54 . . . . 70.319999999999993 110.046 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 20.4 p -126.17 126.86 44.8 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.311 -0.404 . . . . 72.239999999999995 110.57 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.695 ' H ' ' HB2' ' A' ' 52' ' ' LYS . 10.7 pt-20 -80.64 -9.7 59.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 75.329999999999998 111.408 -175.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.35 -2.05 56.45 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.199 -0.667 . . . . 74.109999999999999 109.199 174.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -113.97 118.4 34.04 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.978 -1.119 . . . . 64.120000000000005 107.978 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -41.49 -50.95 4.69 Favored Glycine 0 C--N 1.334 0.426 0 N-CA-C 114.86 0.704 . . . . 71.200000000000003 114.86 -171.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -159.17 134.96 8.7 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.979 0.39 . . . . 32.439999999999998 110.6 -179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.2 t -85.41 73.25 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.935 0.398 . . . . 70.530000000000001 110.696 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.47 18.62 56.31 Favored Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.741 -0.663 . . . . 72.209999999999994 113.605 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.604 ' O ' ' HB1' ' A' ' 36' ' ' ALA . 7.6 tp-100 -159.06 171.99 18.98 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.756 -0.831 . . . . 74.519999999999996 108.756 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -58.24 144.83 39.62 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.063 -0.347 . . . . 71.25 110.063 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 18.1 ptp -76.37 22.45 0.17 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.091 0.404 . . . . 63.240000000000002 112.091 -176.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 59.8 m -134.23 127.37 31.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.755 0.312 . . . . 35.240000000000002 110.551 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 41.3 t -96.64 106.88 33.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.571 -0.529 . . . . 54.119999999999997 109.571 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 12.0 Cg_endo -55.92 -33.69 89.66 Favored 'Trans proline' 0 N--CA 1.474 0.328 0 C-N-CA 123.254 2.636 . . . . 64.239999999999995 113.071 -174.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.56 -20.21 22.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.174 0.512 . . . . 63.229999999999997 110.845 -178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 88.3 m -108.12 -30.18 8.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.299 -0.41 . . . . 63.539999999999999 111.659 -177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 47.7 t 70.0 17.73 7.33 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.875 0.734 . . . . 55.310000000000002 109.449 -171.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.1 m -124.28 161.57 25.54 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.253 -0.885 . . . . 74.540000000000006 110.673 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -85.12 -178.32 6.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.861 -0.609 . . . . 71.530000000000001 111.798 -176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.447 ' HB3' ' CG1' ' A' ' 30' ' ' VAL . 47.3 m-85 -94.47 109.16 21.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.701 -0.681 . . . . 71.310000000000002 110.93 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.688 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . 27.0 m -107.64 165.0 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.984 -0.553 . . . . 75.540000000000006 110.87 -178.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.695 ' HB2' ' H ' ' A' ' 32' ' ' GLU . 28.1 ttpp -78.41 117.47 19.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.884 0.373 . . . . 75.109999999999999 110.725 -176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.82 -7.23 10.24 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.846 -0.615 . . . . 41.310000000000002 111.628 -177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -84.31 158.58 21.14 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.407 -0.59 . . . . 64.450000000000003 109.407 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.3 116.67 53.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 120.886 0.374 . . . . 71.439999999999998 110.63 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.31 167.68 10.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.075 -0.512 . . . . 55.509999999999998 110.551 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 14.0 t -149.26 157.96 43.78 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.011 -0.54 . . . . 64.430000000000007 109.645 176.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -108.4 117.63 34.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.344 -0.389 . . . . 53.210000000000001 110.126 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.8 mt -73.85 150.12 88.21 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.912 -0.585 . . . . 62.109999999999999 109.458 174.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.16 -14.33 23.39 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.135 2.556 . . . . 71.209999999999994 112.855 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 23.9 p -91.93 15.0 14.06 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.384 -0.371 . . . . 72.400000000000006 110.334 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 60.14 74.78 0.43 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.329 0.585 . . . . 73.040000000000006 110.974 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -157.22 127.81 6.53 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.472 -0.785 . . . . 62.32 109.674 177.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 57' ' ' THR . 85.6 m-85 -97.93 133.21 42.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.025 -0.534 . . . . 73.239999999999995 110.693 -177.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -142.33 174.84 10.25 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 107.867 -1.16 . . . . 74.400000000000006 107.867 174.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.835 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 34.1 m170 -86.29 128.58 34.94 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.912 -0.773 . . . . 64.109999999999999 108.912 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.531 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 87.4 tttt -53.03 -48.3 92.46 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.546 0.529 . . . . 73.409999999999997 111.914 -178.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 76.1 Cg_exo -53.7 -45.0 44.25 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.33 2.02 . . . . 73.150000000000006 113.851 178.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.835 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 19.7 p -84.51 -33.67 23.49 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.398 -0.521 . . . . 70.340000000000003 112.209 -176.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 67' ' ' LYS . 9.8 p -72.24 -28.7 29.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 120.817 -0.353 . . . . 72.219999999999999 110.765 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.3 p -63.96 -26.91 68.8 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.052 0.453 . . . . 71.319999999999993 110.83 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.2 mt -70.92 -54.16 18.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 73.329999999999998 110.017 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -62.63 -33.62 75.39 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.053 -0.521 . . . . 73.530000000000001 111.477 -176.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 84.6 mt -66.74 -23.93 66.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.599 -0.273 . . . . 63.109999999999999 111.315 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -89.59 -11.29 43.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.212 0.529 . . . . 63.020000000000003 110.364 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -95.28 -57.17 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.815 -0.629 . . . . 75.230000000000004 110.761 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 40.2 t -110.83 -33.95 6.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.926 -0.579 . . . . 64.049999999999997 110.929 -176.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.02 17.58 71.88 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.689 -0.767 . . . . 54.420000000000002 112.103 -178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 86' ' ' MET . 3.5 m -128.41 153.16 47.38 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.922 -0.399 . . . . 44.020000000000003 109.922 -178.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.8 t -74.61 110.24 9.2 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.809 -0.811 . . . . 63.340000000000003 108.809 176.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -56.8 -25.93 63.75 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 123.174 2.582 . . . . 54.25 113.064 -171.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.73 -50.87 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.352 -0.386 . . . . 74.219999999999999 111.934 -177.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 25.1 p -109.94 -2.55 17.08 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.267 0.469 . . . . 73.200000000000003 112.267 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.1 mpt_? 66.53 21.57 10.74 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.29 0.478 . . . . 74.5 112.29 175.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.7 t -85.29 126.86 34.05 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.293 -0.632 . . . . 73.530000000000001 109.293 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.508 ' SD ' ' HD2' ' A' ' 15' ' ' PRO . 59.8 ttp -72.43 153.23 41.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.346 -0.388 . . . . 70.239999999999995 111.104 -176.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -124.77 118.61 25.84 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.563 -0.532 . . . . 74.239999999999995 109.563 173.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -71.34 156.76 96.6 Favored 'Cis proline' 0 C--N 1.344 0.322 0 C-N-CA 123.702 -1.374 . . . . 55.450000000000003 112.345 -0.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.24 139.6 63.15 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.081 2.521 . . . . 74.109999999999999 112.733 -178.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 40.3 Cg_endo -65.64 141.7 67.61 Favored 'Trans proline' 0 C--O 1.236 0.423 0 C-N-CA 122.72 2.28 . . . . 71.329999999999998 112.381 -179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.4 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.602 -0.713 . . . . 61.420000000000002 110.138 -177.112 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.575 -0.528 . . . . 55.140000000000001 109.575 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.14 107.65 3.57 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.889 -0.672 . . . . 64.040000000000006 112.153 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -88.54 108.65 19.53 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.374 0.607 . . . . 45.130000000000003 110.804 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -149.44 99.19 2.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.448 -0.796 . . . . 72.510000000000005 109.541 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -102.72 -44.99 5.14 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.146 -0.479 . . . . 64.120000000000005 110.695 -175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.9 m170 -116.92 158.18 24.46 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.867 -0.606 . . . . 72.219999999999999 109.424 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -129.46 59.64 1.59 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.351 0.596 . . . . 75.439999999999998 111.465 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -85.8 97.2 10.04 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.869 -0.605 . . . . 75.430000000000007 109.413 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.3 p -76.02 124.9 28.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.607 -0.724 . . . . 74.0 111.662 -175.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -130.54 91.13 3.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.498 -0.927 . . . . 74.439999999999998 108.498 174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -63.45 -24.52 67.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.937 -0.574 . . . . 63.32 112.434 -171.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.2 t -75.48 92.05 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.165 0.507 . . . . 74.409999999999997 109.847 177.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.94 -18.06 14.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.8 -0.636 . . . . 52.420000000000002 110.996 -176.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 68.29 152.07 0.13 Allowed Pre-proline 0 N--CA 1.468 0.439 0 O-C-N 123.854 0.722 . . . . 73.519999999999996 111.511 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.01 150.64 83.14 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.36 2.04 . . . . 74.010000000000005 111.856 178.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.29 146.41 90.06 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.844 2.363 . . . . 61.530000000000001 112.142 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.19 168.11 20.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.145 0.498 . . . . 64.010000000000005 111.622 -174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 m -78.09 150.89 33.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 53.409999999999997 110.826 179.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -62.37 -39.23 92.48 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.054 -0.521 . . . . 75.340000000000003 110.452 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -66.83 -35.01 79.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.71 -0.677 . . . . 75.340000000000003 111.332 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.0 m -61.84 -44.81 96.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 65.349999999999994 110.282 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.583 HG21 ' HA ' ' A' ' 71' ' ' SER . 25.9 mt -75.15 -38.34 41.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.738 -0.665 . . . . 71.439999999999998 110.521 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.3 -31.22 72.32 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.434 -0.803 . . . . 73.239999999999995 110.982 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.76 -21.68 60.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.845 -0.616 . . . . 71.030000000000001 111.576 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.44 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 98.0 mt -63.76 132.46 95.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.292 -0.413 . . . . 73.329999999999998 110.902 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.08 137.06 55.21 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 123.16 2.573 . . . . 73.140000000000001 112.864 -175.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.51 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 44.2 mt-10 -90.17 116.52 28.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.187 0.518 . . . . 64.420000000000002 110.751 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 57.4 mt -109.15 129.47 63.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.315 -0.857 . . . . 72.200000000000003 109.681 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.7 tp -80.13 122.03 26.29 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 110.017 -0.364 . . . . 72.230000000000004 110.017 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.62 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 41.9 t -79.14 123.46 36.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.27 -0.423 . . . . 70.040000000000006 110.225 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.7 p -119.16 140.86 49.46 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.148 -0.478 . . . . 63.530000000000001 110.332 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.505 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 30.5 mt-10 -79.57 177.69 8.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.169 -0.469 . . . . 65.200000000000003 110.278 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 1.1 m-20 71.5 8.74 6.31 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.818 0.699 . . . . 71.5 109.807 -168.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -127.58 108.82 11.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.12 -0.945 . . . . 72.019999999999996 109.394 177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.62 95.03 0.52 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.755 -0.736 . . . . 63.25 112.055 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 72.33 138.34 0.05 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 123.535 0.734 . . . . 61.520000000000003 111.484 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.8 t -63.45 -38.76 83.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 64.120000000000005 110.363 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.73 32.01 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.777 -0.725 . . . . 73.519999999999996 112.034 178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.671 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 8.4 tp-100 -172.17 -80.59 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.732 0.301 . . . . 60.299999999999997 110.648 -177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.75 152.56 35.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.062 -0.517 . . . . 75.340000000000003 110.705 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -103.78 3.52 34.13 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.627 -0.715 . . . . 72.329999999999998 110.001 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 30.4 p -124.42 151.86 43.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.032 -0.531 . . . . 74.409999999999997 110.03 175.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 50.4 t -116.7 101.99 53.37 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 109.444 -0.576 . . . . 75.310000000000002 109.444 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -56.92 -28.57 78.29 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.116 2.544 . . . . 73.120000000000005 112.622 -173.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 55.4 mt -67.0 -32.14 56.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.748 -0.66 . . . . 72.530000000000001 111.618 -175.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 20.7 p -113.89 -4.21 13.32 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.987 -0.285 . . . . 73.239999999999995 111.22 -179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.8 t 67.93 4.06 3.84 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.782 -0.645 . . . . 61.130000000000003 111.256 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.8 m -105.92 163.76 12.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.8 0.333 . . . . 51.119999999999997 110.332 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.657 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 0.8 OUTLIER -91.71 -170.22 2.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.049 0.452 . . . . 74.430000000000007 110.89 -177.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.644 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 29.9 m-85 -94.47 108.84 20.76 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.092 -0.503 . . . . 73.209999999999994 111.397 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.8 m -114.31 166.72 7.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.337 -0.847 . . . . 75.109999999999999 109.612 176.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 39.5 ttpt -73.37 138.38 45.29 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.943 0.401 . . . . 74.439999999999998 110.769 -176.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.9 -9.32 47.12 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.993 -0.623 . . . . 62.310000000000002 112.342 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -86.78 162.06 18.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.76 -0.459 . . . . 71.510000000000005 109.76 177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.1 t -110.31 122.62 65.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.846 0.355 . . . . 63.200000000000003 110.319 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -112.21 171.02 7.76 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.864 0.364 . . . . 75.030000000000001 110.448 178.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 7.2 t -148.84 168.57 22.63 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.684 -0.488 . . . . 63.520000000000003 109.684 177.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -113.36 117.32 31.44 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.817 0.341 . . . . 73.120000000000005 110.942 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.3 mt -84.05 138.23 39.95 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.188 -0.671 . . . . 54.549999999999997 109.188 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -55.02 -19.27 19.42 Favored 'Trans proline' 0 N--CA 1.474 0.325 0 C-N-CA 123.708 2.938 . . . . 64.209999999999994 113.158 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.1 p -86.42 22.55 1.81 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.744 0.307 . . . . 74.109999999999999 110.682 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 65.3 36.71 6.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.274 0.559 . . . . 61.310000000000002 111.711 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.671 ' HD2' ' HG2' ' A' ' 39' ' ' GLN . 4.8 m170 -125.11 122.62 37.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.888 -0.596 . . . . 73.439999999999998 110.315 177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -99.0 133.13 43.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.239 -0.437 . . . . 71.140000000000001 110.124 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.644 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 72.9 m-85 -144.16 161.1 39.71 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.535 0.522 . . . . 73.400000000000006 110.261 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 38.2 m170 -61.88 121.26 12.49 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.367 -0.605 . . . . 72.049999999999997 109.367 173.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 88.6 tttt -58.78 -49.89 90.98 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 123.235 0.334 . . . . 70.099999999999994 111.676 -176.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 9.6 Cg_endo -53.91 -27.48 44.6 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.356 2.037 . . . . 72.409999999999997 112.613 176.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 68.2 m -82.89 -52.42 6.73 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.899 0.38 . . . . 73.209999999999994 110.809 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 67' ' ' LYS . 7.1 p -69.95 -27.39 32.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 50.409999999999997 111.252 -173.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.583 ' HA ' HG21 ' A' ' 22' ' ' ILE . 18.4 p -64.47 -46.75 81.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.798 0.332 . . . . 72.140000000000001 110.579 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.508 HG22 ' HE2' ' A' ' 76' ' ' LYS . 75.1 mt -63.73 -37.85 80.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.152 -0.476 . . . . 73.409999999999997 110.291 178.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -64.65 -51.98 59.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.884 -0.598 . . . . 71.230000000000004 111.317 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.9 mt -65.9 -24.38 66.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.388 -0.369 . . . . 72.120000000000005 111.664 -175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -77.5 -0.65 26.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.021 0.438 . . . . 75.340000000000003 110.756 176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.508 ' HE2' HG22 ' A' ' 72' ' ' ILE . 56.5 mttm -113.46 -52.26 2.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.215 -0.448 . . . . 73.420000000000002 109.856 174.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 20.1 m -132.87 125.64 30.41 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.046 -0.525 . . . . 64.400000000000006 110.035 179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -86.7 57.25 4.68 Favored Glycine 0 CA--C 1.516 0.148 0 C-N-CA 120.951 -0.642 . . . . 70.120000000000005 112.899 -175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 84' ' ' ARG . 39.5 m -145.77 149.21 33.96 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.283 -0.266 . . . . 75.120000000000005 110.283 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.6 t -74.41 118.08 67.02 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 108.926 -0.768 . . . . 71.239999999999995 108.926 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -56.4 -24.84 54.3 Favored 'Trans proline' 0 N--CA 1.474 0.365 0 C-N-CA 123.295 2.663 . . . . 71.219999999999999 113.477 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.28 -61.16 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.425 -0.352 . . . . 50.229999999999997 111.853 -177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 31.9 p -90.04 -1.11 57.91 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.906 0.336 . . . . 63.119999999999997 111.906 -172.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.412 ' HA ' HG22 ' A' ' 79' ' ' THR . 0.0 OUTLIER 47.58 39.94 10.68 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.619 0.768 . . . . 75.510000000000005 111.913 179.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.12 148.7 22.77 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.73 -0.841 . . . . 73.200000000000003 108.73 170.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 51.5 ttp -74.19 145.75 43.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.03 0.443 . . . . 31.109999999999999 111.839 -173.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.542 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 57.6 t80 -129.2 131.05 23.43 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 108.837 -0.801 . . . . 72.540000000000006 108.837 172.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.542 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 31.0 Cg_endo -62.86 159.67 60.45 Favored 'Cis proline' 0 C--N 1.347 0.472 0 C-N-CA 124.067 -1.222 . . . . 74.030000000000001 112.984 2.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.5 138.75 74.85 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.193 2.595 . . . . 74.030000000000001 112.818 -175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -64.22 151.74 84.16 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.699 2.266 . . . . 63.200000000000003 112.314 178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.0 mt . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.628 -0.701 . . . . 73.25 109.913 -179.717 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.717 0.294 . . . . 73.409999999999997 110.603 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -85.99 64.78 4.01 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.725 -0.75 . . . . 52.299999999999997 113.205 -173.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.2 p-80 -100.68 119.45 38.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.017 0.437 . . . . 72.040000000000006 110.266 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -143.45 146.67 33.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.925 -0.58 . . . . 74.420000000000002 109.719 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.7 p-80 -126.72 73.45 1.4 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.283 0.563 . . . . 72.409999999999997 111.526 -178.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.1 m80 -134.2 10.07 3.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.541 -0.754 . . . . 74.120000000000005 109.208 172.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 44.9 t60 -128.56 127.52 42.49 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.085 -0.961 . . . . 74.120000000000005 109.886 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.437 ' O ' ' HD2' ' A' ' 10' ' ' HIS . 20.0 t-80 -153.82 158.92 41.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.167 -0.679 . . . . 74.099999999999994 109.167 175.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.2 m -61.77 94.71 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.917 0.389 . . . . 53.109999999999999 111.683 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HD2' ' O ' ' A' ' 8' ' ' HIS . 16.6 m-70 -64.47 -29.02 70.07 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.704 0.764 . . . . 75.219999999999999 109.428 173.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 84' ' ' ARG . 1.3 pmm? -98.74 38.09 1.41 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.704 -1.135 . . . . 71.120000000000005 110.541 -178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -56.88 -35.51 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.794 -0.639 . . . . 63.210000000000001 111.126 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -128.72 -61.86 1.04 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.321 -0.4 . . . . 73.25 110.029 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.7 t30 73.05 129.8 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.421 0 O-C-N 124.012 0.82 . . . . 72.030000000000001 111.65 176.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 14' ' ' ASN . 16.8 Cg_exo -67.75 166.09 25.48 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.107 2.538 . . . . 74.129999999999995 112.782 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HA ' ' H ' ' A' ' 78' ' ' GLY . 11.4 Cg_exo -71.46 168.22 24.16 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.732 2.288 . . . . 72.209999999999994 111.965 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.54 179.95 6.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.54 -0.3 . . . . 65.200000000000003 110.567 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.5 p -102.27 162.1 13.18 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.934 -0.395 . . . . 75.329999999999998 109.934 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.5 ttpp -64.05 -43.9 94.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.969 0.414 . . . . 70.549999999999997 110.017 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -58.69 -47.28 85.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.414 -0.812 . . . . 72.519999999999996 112.063 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.5 p -64.17 -41.68 97.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.311 . . . . 73.409999999999997 110.978 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.9 mt -67.62 -41.06 85.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.206 0.527 . . . . 74.299999999999997 110.584 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.1 -36.39 81.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.055 -0.52 . . . . 74.329999999999998 110.637 -178.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.01 -6.25 51.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 50.210000000000001 112.187 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.463 ' HB3' ' OG1' ' A' ' 57' ' ' THR . 34.5 mt -53.84 127.72 53.26 Favored Pre-proline 0 C--O 1.237 0.43 0 O-C-N 122.994 0.184 . . . . 75.030000000000001 111.2 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.446 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 9.8 Cg_endo -53.77 142.5 62.24 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.377 2.718 . . . . 52.439999999999998 111.694 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -113.85 106.48 14.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.099 0.476 . . . . 74.200000000000003 111.158 -173.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.5 mt -110.78 111.58 36.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.865 -0.607 . . . . 74.329999999999998 109.979 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 64.4 tp -68.7 117.14 10.03 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.894 -0.41 . . . . 63.450000000000003 109.894 177.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 35.7 t -75.74 118.14 21.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.312 -0.404 . . . . 65.329999999999998 110.785 -177.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 68.2 p -120.76 167.81 12.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.455 -0.572 . . . . 71.010000000000005 109.455 173.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -79.21 4.18 15.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.942 0.401 . . . . 72.439999999999998 111.123 -177.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -80.26 -45.5 17.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.002 -0.544 . . . . 73.230000000000004 110.333 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -77.92 -34.99 51.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.847 -0.615 . . . . 73.340000000000003 110.387 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.35 -115.77 4.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.004 -0.617 . . . . 53.350000000000001 111.706 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.0 141.64 57.94 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.622 -0.51 . . . . 71.510000000000005 109.622 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.21 90.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 120.504 -0.478 . . . . 61.340000000000003 111.234 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.511 ' HA3' ' CE1' ' A' ' 64' ' ' TYR . . . 76.07 -73.54 1.73 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.565 -0.743 . . . . 64.310000000000002 113.337 171.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.526 ' HG2' ' HD2' ' A' ' 63' ' ' HIS . 8.5 tp-100 -107.89 -49.24 3.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.637 0.256 . . . . 71.239999999999995 110.91 -176.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.4 158.55 37.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.357 0.599 . . . . 60.340000000000003 111.585 -174.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.1 ptp -103.22 -5.77 22.79 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.162 -0.926 . . . . 73.349999999999994 109.902 177.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.827 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 85.1 m -128.14 137.92 52.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.802 -0.635 . . . . 71.230000000000004 110.421 179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . . . . . . . . . 34.9 t -93.36 112.49 56.69 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.04 -0.527 . . . . 62.0 109.974 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -60.77 -33.52 92.86 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.619 2.213 . . . . 72.439999999999998 111.94 -176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.1 mt -66.49 -22.87 30.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.663 -0.698 . . . . 71.209999999999994 110.686 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 79.8 m -107.94 -19.36 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.979 -0.555 . . . . 44.32 111.201 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 64.4 m 60.8 29.27 18.9 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.48 0.657 . . . . 50.43 109.537 -170.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.6 t -141.16 155.38 46.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.254 -0.885 . . . . 71.409999999999997 109.514 -176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.827 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 10.7 pt-20 -77.75 -179.75 6.15 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.334 0.587 . . . . 72.540000000000006 111.783 -175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.512 ' HB3' HG11 ' A' ' 30' ' ' VAL . 73.8 m-85 -91.87 112.52 24.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.647 -0.706 . . . . 72.349999999999994 110.383 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 27.2 m -120.69 169.49 11.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.855 -0.611 . . . . 70.239999999999995 110.632 -179.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 24.9 ttpp -72.99 113.66 10.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.74 -0.664 . . . . 74.310000000000002 110.961 -176.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 143.56 -36.5 1.54 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.581 -0.818 . . . . 54.109999999999999 112.758 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -87.14 162.17 17.67 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.12 -0.326 . . . . 72.219999999999999 110.12 -179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.1 t -104.75 129.49 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.58 -0.282 . . . . 72.340000000000003 110.38 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -101.22 163.41 12.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.825 0.345 . . . . 75.109999999999999 110.965 178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 25' ' ' LEU . 8.7 t -147.68 170.07 18.33 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.879 -0.601 . . . . 71.420000000000002 109.585 178.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 25.5 tt0 -123.39 123.24 40.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.535 -0.302 . . . . 74.420000000000002 110.694 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 61' ' ' CYS . 77.1 mt -86.02 141.16 35.18 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.416 -0.957 . . . . 73.310000000000002 108.416 169.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.93 36.19 0.17 Allowed 'Trans proline' 0 N--CA 1.479 0.623 0 C-N-CA 123.636 2.891 . . . . 52.539999999999999 113.922 -174.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.405 ' H ' ' C ' ' A' ' 59' ' ' LEU . 29.5 p -140.06 28.07 2.13 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.388 -0.597 . . . . 63.0 109.388 175.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.8 m170 63.71 34.66 11.98 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.429 -0.805 . . . . 75.219999999999999 111.924 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.526 ' HD2' ' HG2' ' A' ' 39' ' ' GLN . 11.2 m170 -125.86 120.69 31.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.476 -0.329 . . . . 64.019999999999996 110.408 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.511 ' CE1' ' HA3' ' A' ' 38' ' ' GLY . 57.7 m-85 -101.88 137.17 40.52 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.954 -0.566 . . . . 72.239999999999995 111.29 -176.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.482 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 97.0 m-85 -140.72 175.36 9.67 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.738 -0.838 . . . . 74.019999999999996 108.738 177.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.88 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 39.1 m80 -82.61 131.79 35.2 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.172 -0.677 . . . . 61.240000000000002 109.172 173.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.53 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 86.7 tttt -55.61 -49.31 93.42 Favored Pre-proline 0 CA--C 1.539 0.532 0 O-C-N 123.49 0.494 . . . . 61.340000000000003 111.313 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 83.0 Cg_exo -51.23 -50.42 13.96 Favored 'Trans proline' 0 C--N 1.358 1.073 0 C-N-CA 122.257 1.971 . . . . 72.409999999999997 113.52 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.88 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 21.9 p -79.69 -31.54 41.32 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.743 -0.383 . . . . 75.129999999999995 111.876 -174.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 67' ' ' LYS . 7.8 p -74.27 -28.81 23.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.719 -0.474 . . . . 75.230000000000004 109.719 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.706 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 27.7 t -58.46 -48.15 81.7 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.518 -0.549 . . . . 72.510000000000005 109.518 174.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -60.17 -40.78 84.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.651 -0.704 . . . . 72.109999999999999 110.705 178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -67.43 -48.33 67.59 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.593 -0.731 . . . . 73.319999999999993 111.498 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 77' ' ' SER . 97.2 mt -67.25 -20.51 65.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.395 -0.366 . . . . 73.530000000000001 111.93 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.706 ' HG3' ' O ' ' A' ' 71' ' ' SER . 79.3 mt-30 -59.98 -40.29 88.6 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.581 -0.281 . . . . 74.0 111.391 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -99.77 -27.51 13.6 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.907 -0.317 . . . . 63.210000000000001 111.222 -179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 74' ' ' LEU . 12.7 p -143.88 111.2 5.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.74 0.305 . . . . 64.420000000000002 110.872 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' H ' ' HA ' ' A' ' 16' ' ' PRO . . . -82.56 65.46 4.1 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 111.187 -0.765 . . . . 54.219999999999999 111.187 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.4 m -143.5 145.4 32.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.645 -0.278 . . . . 65.129999999999995 110.383 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 36.5 t -74.88 113.64 26.71 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 108.79 -0.819 . . . . 64.409999999999997 108.79 174.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.34 -34.2 79.49 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.036 2.49 . . . . 72.450000000000003 113.76 -172.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.7 t -75.13 -62.98 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.069 0.396 . . . . 71.109999999999999 112.069 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 26.3 p -89.12 -18.11 27.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.907 0.384 . . . . 52.509999999999998 111.346 -173.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 11' ' ' MET . 17.3 mtp180 63.4 71.35 0.5 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.801 0.81 . . . . 62.32 110.557 -175.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.5 t -128.81 142.58 50.93 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.637 -1.165 . . . . 73.430000000000007 108.067 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.531 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 61.8 ttp -68.05 149.07 50.12 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.989 0.423 . . . . 64.120000000000005 111.147 -174.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -127.97 121.18 21.74 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.636 -0.711 . . . . 71.010000000000005 109.39 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.61 157.83 77.21 Favored 'Cis proline' 0 C--N 1.347 0.479 0 C-N-CA 124.048 -1.23 . . . . 73.310000000000002 112.855 0.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -59.48 135.29 63.8 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.993 2.462 . . . . 73.120000000000005 112.612 -176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 43.3 Cg_endo -68.44 147.47 71.24 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.867 2.378 . . . . 72.329999999999998 112.488 -177.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.322 -0.846 . . . . 74.140000000000001 109.302 177.895 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.782 0.325 . . . . 72.209999999999994 110.712 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 125.68 140.07 5.28 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.001 -0.619 . . . . 72.129999999999995 112.499 177.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 80.6 m80 -102.23 169.67 8.57 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.415 -0.217 . . . . 71.109999999999999 110.415 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -155.69 145.18 21.03 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.009 -0.367 . . . . 74.109999999999999 110.009 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -101.58 -169.77 1.73 Allowed 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.862 -0.421 . . . . 73.200000000000003 109.862 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 64.2 m-70 -100.8 167.74 10.1 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.104 -0.702 . . . . 72.209999999999994 109.104 172.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.8 m170 -82.17 153.05 26.19 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.302 -0.999 . . . . 75.010000000000005 108.302 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.9 80.96 2.15 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.726 -0.842 . . . . 72.099999999999994 108.726 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.5 t -46.86 -48.36 21.04 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.784 -1.098 . . . . 74.209999999999994 112.105 -172.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.5 m80 -125.17 110.52 14.19 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.212 0.53 . . . . 52.310000000000002 110.219 174.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.8 ptt? -125.6 148.73 48.85 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.131 -0.941 . . . . 63.009999999999998 109.532 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 14' ' ' ASN . 14.5 p -131.08 128.89 62.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.075 0.464 . . . . 72.209999999999994 110.9 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.34 -31.19 63.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.858 -0.61 . . . . 63.119999999999997 109.419 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.475 ' N ' HG22 ' A' ' 12' ' ' VAL . 22.9 t-20 71.67 136.37 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.34 0 CA-C-N 114.846 -1.07 . . . . 72.540000000000006 112.004 172.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 14' ' ' ASN . 31.7 Cg_exo -60.97 159.45 29.5 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.06 2.507 . . . . 50.030000000000001 112.796 177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.57 141.76 38.82 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.169 1.913 . . . . 71.25 112.106 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -81.75 149.21 28.54 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.991 -0.55 . . . . 44.100000000000001 110.167 178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.2 t -58.97 116.44 3.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.259 -0.428 . . . . 70.109999999999999 110.478 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HA ' HD12 ' A' ' 22' ' ' ILE . 6.5 ttpm? -56.8 -45.32 82.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.711 -0.677 . . . . 75.129999999999995 111.518 -176.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -54.93 -37.85 66.93 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.624 -0.716 . . . . 70.439999999999998 111.307 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.4 t -67.63 -41.02 84.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.076 0.465 . . . . 70.239999999999995 110.106 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 71' ' ' SER . 61.1 mt -62.61 -39.72 85.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.683 -0.689 . . . . 64.099999999999994 110.932 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -75.06 -29.18 60.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 44.009999999999998 110.759 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.68 -12.81 60.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.332 -0.395 . . . . 73.109999999999999 111.517 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.11 145.54 85.01 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 116.409 -0.36 . . . . 72.400000000000006 111.044 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.88 160.37 49.92 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.914 2.409 . . . . 72.219999999999999 112.381 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -108.36 112.82 25.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.189 -0.459 . . . . 71.310000000000002 110.326 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 58.7 mt -101.68 101.74 12.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.247 -0.649 . . . . 74.439999999999998 109.247 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 62.2 tp -69.55 122.54 19.25 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.813 -0.44 . . . . 64.450000000000003 109.813 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.747 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 21.4 t -77.46 105.25 6.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.123 -0.489 . . . . 62.539999999999999 110.134 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 82.4 p -103.68 168.2 9.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.783 -0.451 . . . . 73.5 109.783 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -76.82 -22.25 53.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.07 0.462 . . . . 74.430000000000007 110.303 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.81 -28.31 58.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.006 -0.543 . . . . 74.420000000000002 109.943 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -84.62 -44.3 13.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.837 -0.62 . . . . 74.319999999999993 109.527 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.2 -110.87 3.36 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.9 -0.591 . . . . 75.299999999999997 112.729 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.64 103.39 3.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.002 0.43 . . . . 72.109999999999999 110.376 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.2 t -68.64 -30.33 46.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.011 -0.541 . . . . 74.310000000000002 110.928 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' HA3' ' CD1' ' A' ' 64' ' ' TYR . . . -149.89 -150.27 5.22 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.79 -0.719 . . . . 64.319999999999993 111.898 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -82.04 -24.19 35.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.672 -0.492 . . . . 71.5 109.672 178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -83.99 111.79 19.59 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.866 -0.606 . . . . 61.240000000000002 109.75 172.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -91.28 -0.09 57.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.155 -0.475 . . . . 53.109999999999999 110.316 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.693 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 70.7 m -141.2 149.73 41.79 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.778 -0.647 . . . . 64.040000000000006 110.338 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 36.9 t -104.73 96.12 9.99 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.359 -0.608 . . . . 73.040000000000006 109.359 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 18.5 Cg_endo -57.27 -27.26 74.28 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.466 2.777 . . . . 61.219999999999999 112.935 -172.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.1 mt -57.74 -43.78 84.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.947 -0.57 . . . . 72.329999999999998 111.212 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 24.8 p -108.44 -3.23 18.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.565 -0.289 . . . . 74.340000000000003 110.713 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 58.1 m 60.87 40.2 15.99 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.834 -0.621 . . . . 72.450000000000003 110.716 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.9 m -135.94 146.55 47.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.805 -0.634 . . . . 75.299999999999997 110.47 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 15.4 pt-20 -81.88 -169.86 2.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 72.450000000000003 111.735 -177.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.637 ' OH ' ' HA ' ' A' ' 65' ' ' PHE . 78.5 m-85 -102.97 108.77 20.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.201 0.524 . . . . 72.019999999999996 111.604 -177.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.9 m -134.64 173.07 15.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.333 -0.849 . . . . 64.420000000000002 109.546 175.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.747 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 31.0 ttmt -64.54 125.76 25.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.042 0.448 . . . . 72.519999999999996 111.097 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.41 -42.73 1.27 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.563 -0.744 . . . . 64.530000000000001 111.731 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -86.68 165.88 15.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.875 -0.417 . . . . 64.010000000000005 109.875 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.0 133.7 65.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.684 -0.487 . . . . 75.219999999999999 109.684 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -111.76 176.01 5.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.897 0.38 . . . . 75.310000000000002 110.618 179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 12.4 t -150.35 163.06 39.29 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.544 -0.539 . . . . 53.420000000000002 109.544 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -107.86 117.34 33.87 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.765 0.317 . . . . 74.349999999999994 110.667 -178.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.8 mt -84.32 137.34 39.59 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 108.957 -0.757 . . . . 63.43 108.957 172.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -59.81 -8.19 7.22 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.89 2.393 . . . . 75.329999999999998 111.905 177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.8 t -84.66 18.24 2.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.043 -0.98 . . . . 70.409999999999997 110.046 176.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 57.18 39.43 28.86 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.907 -0.588 . . . . 70.549999999999997 111.147 176.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -138.61 144.99 40.0 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.716 -0.674 . . . . 61.119999999999997 109.957 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.47 ' CD1' ' HA3' ' A' ' 38' ' ' GLY . 49.3 m-85 -121.12 132.86 55.11 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.794 0.33 . . . . 64.019999999999996 111.248 -172.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.637 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 89.6 m-85 -142.58 162.78 34.57 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.043 -0.526 . . . . 73.109999999999999 110.35 178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 56' ' ' ALA . 35.0 m170 -63.83 129.38 39.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.615 -0.513 . . . . 62.25 109.615 174.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.501 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 48.3 tttm -60.62 -51.7 77.93 Favored Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 123.326 0.391 . . . . 75.150000000000006 111.622 -175.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 27.5 Cg_endo -62.22 -22.0 73.45 Favored 'Trans proline' 0 C--N 1.357 1.016 0 C-N-CA 122.127 1.885 . . . . 64.400000000000006 112.925 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.2 m -84.21 -46.99 11.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.225 0.536 . . . . 74.219999999999999 110.464 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.546 HG22 ' HG ' ' A' ' 74' ' ' LEU . 5.8 p -73.62 -23.78 19.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.786 -0.643 . . . . 75.420000000000002 110.717 -174.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.52 ' HA ' HG21 ' A' ' 22' ' ' ILE . 19.3 p -65.74 -30.52 71.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.809 0.338 . . . . 51.25 111.083 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.3 mt -82.92 -41.38 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.171 0.51 . . . . 73.219999999999999 109.989 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 70.2 t-105 -63.11 -47.53 82.39 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.448 -0.796 . . . . 74.109999999999999 111.783 -177.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.546 ' HG ' HG22 ' A' ' 70' ' ' VAL . 98.2 mt -65.82 -20.56 66.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.342 0.497 . . . . 75.230000000000004 112.342 -173.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 71' ' ' SER . 71.0 mt-30 -77.09 -9.59 58.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.183 0.516 . . . . 63.119999999999997 110.496 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -113.07 -42.27 3.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.859 -0.61 . . . . 74.400000000000006 109.896 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.0 m -142.4 110.05 5.77 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.671 -0.695 . . . . 62.130000000000003 109.954 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -80.08 65.85 3.71 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 51.420000000000002 112.122 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.503 ' HB ' ' HA ' ' A' ' 84' ' ' ARG . 1.4 p -149.29 157.54 43.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.453 0.168 . . . . 73.030000000000001 110.991 -176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.591 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 44.1 m -74.45 123.09 88.87 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 108.308 -0.997 . . . . 75.420000000000002 108.308 169.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.468 ' HD2' ' CZ ' ' A' ' 65' ' ' PHE . 53.2 Cg_exo -53.22 -27.96 40.14 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.466 2.111 . . . . 74.25 112.474 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.9 t -80.23 -41.02 20.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 115.706 -0.679 . . . . 71.349999999999994 112.449 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 12.8 p -110.03 -30.15 7.91 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 120.699 -0.401 . . . . 73.25 111.857 -172.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.503 ' HA ' ' HB ' ' A' ' 79' ' ' THR . 56.5 mtt85 57.23 77.14 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.749 0.785 . . . . 61.219999999999999 111.879 -168.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 42.2 t -131.93 140.75 49.12 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.838 -1.171 . . . . 73.510000000000005 107.838 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 56.5 ttp -73.97 131.53 41.5 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.988 0.736 . . . . 71.25 112.988 -165.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 88' ' ' PRO . 70.9 t80 -122.87 134.92 25.31 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 114.71 -1.132 . . . . 62.049999999999997 108.805 172.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 87' ' ' PHE . 9.5 Cg_exo -72.12 154.98 98.48 Favored 'Cis proline' 0 C--N 1.343 0.27 0 C-N-CA 123.855 -1.31 . . . . 73.109999999999999 112.186 -0.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.55 136.93 77.36 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.733 2.289 . . . . 71.129999999999995 112.03 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.62 153.17 76.7 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.954 2.436 . . . . 73.519999999999996 112.691 -176.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 88.7 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.35 -0.833 . . . . 52.130000000000003 109.629 179.674 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.505 ' SD ' ' HA ' ' A' ' 48' ' ' SER . 24.3 ptp . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.651 0.262 . . . . 74.129999999999995 110.93 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.62 ' HA3' ' SG ' ' A' ' 47' ' ' CYS . . . -91.2 100.57 2.7 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.745 -0.741 . . . . 64.0 111.67 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.9 t-160 -73.6 -33.66 64.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.66 0.267 . . . . 73.129999999999995 110.624 -176.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -154.87 157.14 37.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.267 -0.424 . . . . 75.450000000000003 110.43 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -168.27 145.2 4.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.443 -0.577 . . . . 63.329999999999998 109.443 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -72.16 104.89 3.78 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.136 -0.32 . . . . 72.140000000000001 110.136 -177.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -134.32 83.91 2.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.91 0.862 . . . . 72.319999999999993 112.403 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -129.62 55.46 1.77 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.305 -1.369 . . . . 71.140000000000001 107.305 165.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.9 p -99.12 -179.27 4.2 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.422 -1.263 . . . . 51.299999999999997 111.895 -169.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -138.14 122.3 18.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.281 -0.872 . . . . 74.310000000000002 109.526 175.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 54.2 ttp -71.42 112.01 7.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.306 -0.406 . . . . 70.310000000000002 110.138 -178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.8 m -66.71 126.62 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.987 -0.551 . . . . 74.099999999999994 111.624 -176.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.18 85.3 7.38 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.982 -0.748 . . . . 64.349999999999994 108.982 173.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -128.17 146.67 60.36 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.413 -0.812 . . . . 64.109999999999999 109.982 -170.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 2.2 Cg_endo -42.15 127.66 4.05 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.631 2.887 . . . . 73.209999999999994 112.632 175.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 92.3 Cg_endo -87.51 157.66 7.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.9 2.4 . . . . 62.119999999999997 113.369 -175.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.79 146.76 26.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.605 -0.725 . . . . 31.219999999999999 109.921 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.446 ' O ' HG13 ' A' ' 22' ' ' ILE . 14.3 m -73.23 140.28 46.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.266 -0.425 . . . . 74.510000000000005 110.201 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 34.7 ttpt -52.81 -44.97 67.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.1 -0.5 . . . . 64.019999999999996 111.131 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -61.14 -40.11 92.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.951 -0.568 . . . . 71.040000000000006 110.857 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 m -66.57 -32.88 74.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 62.43 110.799 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.48 HG21 ' HA ' ' A' ' 71' ' ' SER . 54.8 mt -74.42 -39.24 48.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.37 0.605 . . . . 64.519999999999996 110.258 177.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.495 ' HA ' ' HE3' ' A' ' 67' ' ' LYS . 32.7 t70 -70.39 -21.41 62.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.957 -0.565 . . . . 75.040000000000006 110.667 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.57 -16.12 61.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.551 . . . . 45.229999999999997 111.227 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.7 mt -67.54 143.01 96.71 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 64.420000000000002 110.84 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.37 136.62 75.6 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.104 2.536 . . . . 73.0 112.244 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -102.15 120.28 40.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.058 -0.519 . . . . 74.319999999999993 110.587 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 54.6 mt -112.08 111.99 38.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 116.091 -0.504 . . . . 62.340000000000003 109.927 177.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.01 118.8 10.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.86 -0.422 . . . . 64.420000000000002 109.86 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 49.0 t -71.23 114.52 9.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.141 -0.481 . . . . 64.319999999999993 110.177 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.3 p -95.36 147.3 23.65 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.728 -0.669 . . . . 63.25 110.258 178.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -69.67 -15.51 63.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.776 -0.647 . . . . 73.109999999999999 111.303 -174.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.34 -45.55 19.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.248 -175.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -74.36 -47.93 31.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.358 -0.383 . . . . 53.530000000000001 110.881 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.17 -87.4 0.68 Allowed Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.88 -0.676 . . . . 73.310000000000002 113.032 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 41' ' ' MET . . . -74.45 100.3 3.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.911 0.386 . . . . 63.32 110.96 -177.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.7 t -95.3 118.2 40.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 116.138 -0.483 . . . . 74.409999999999997 110.682 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 91.91 -64.85 2.36 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.876 -0.678 . . . . 61.32 112.919 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -154.3 -56.96 0.11 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.657 0.265 . . . . 71.140000000000001 111.013 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' OE2' ' HB3' ' A' ' 42' ' ' CYS . 30.9 tt0 -101.76 155.01 18.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.248 -0.433 . . . . 70.450000000000003 110.054 -177.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.548 ' HA ' ' HA ' ' A' ' 36' ' ' ALA . 1.7 pmm? -92.56 5.5 50.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.01 0.433 . . . . 44.439999999999998 110.255 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.867 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 19.6 t -130.8 156.0 45.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.885 -0.598 . . . . 73.450000000000003 109.926 -176.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.443 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 30.8 t -107.35 106.32 58.08 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 109.703 -0.48 . . . . 71.040000000000006 109.703 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 10.7 Cg_endo -55.46 -29.35 68.5 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.29 2.66 . . . . 51.409999999999997 112.725 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.3 mt -69.22 -27.77 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.083 -0.508 . . . . 74.420000000000002 110.74 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 96.5 m -103.49 -23.57 13.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.405 -0.361 . . . . 74.430000000000007 111.319 -177.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.62 ' SG ' ' HA3' ' A' ' 2' ' ' GLY . 31.6 t 63.35 22.76 13.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.998 0.904 . . . . 54.299999999999997 108.577 -167.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.505 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 15.1 m -131.65 148.4 52.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 114.453 -1.249 . . . . 70.310000000000002 109.519 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.867 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 17.3 pt-20 -81.8 -178.25 6.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.276 0.56 . . . . 64.099999999999994 112.358 -172.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -91.04 117.2 29.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.471 -0.786 . . . . 74.219999999999999 111.021 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.6 m -132.42 166.78 28.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.649 -0.705 . . . . 74.409999999999997 109.48 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 37.8 ttpt -65.49 131.91 47.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.933 0.397 . . . . 62.100000000000001 110.717 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.43 -34.89 2.94 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 121.034 -0.603 . . . . 62.130000000000003 111.746 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -86.97 161.28 18.31 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.579 -0.526 . . . . 61.520000000000003 109.579 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.79 125.5 72.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 110.086 -0.339 . . . . 71.310000000000002 110.086 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -95.64 165.4 12.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.838 0.351 . . . . 54.509999999999998 110.485 179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 7.5 t -146.78 172.56 13.45 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.584 -0.524 . . . . 41.25 109.584 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -125.55 117.66 24.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.691 -0.485 . . . . 73.25 109.691 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 86.0 mt -90.03 139.51 27.36 Favored Pre-proline 0 C--N 1.323 -0.571 0 N-CA-C 110.186 -0.301 . . . . 70.109999999999999 110.186 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.51 12.91 0.08 OUTLIER 'Trans proline' 0 N--CA 1.481 0.778 0 C-N-CA 123.871 3.048 . . . . 75.409999999999997 114.623 -172.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -115.03 17.34 16.86 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.593 -0.521 . . . . 64.140000000000001 109.593 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 64.12 74.84 0.4 Allowed 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.258 -0.883 . . . . 63.200000000000003 110.481 -177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -161.66 121.23 2.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.853 -0.612 . . . . 72.010000000000005 110.303 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -99.09 133.41 43.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.017 -0.538 . . . . 74.329999999999998 110.835 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -144.58 175.35 10.21 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.418 -0.956 . . . . 72.200000000000003 108.418 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.956 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 35.2 m170 -81.71 129.1 34.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.693 -0.854 . . . . 72.140000000000001 108.693 174.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.539 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . 85.1 tttt -55.81 -50.99 83.95 Favored Pre-proline 0 C--N 1.323 -0.564 0 O-C-N 123.448 0.467 . . . . 74.010000000000005 112.125 -176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 67' ' ' LYS . 44.4 Cg_exo -58.33 -41.3 67.53 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.611 1.541 . . . . 51.130000000000003 113.183 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.956 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 30.2 p -80.95 -32.38 34.5 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 120.528 -0.469 . . . . 73.340000000000003 111.747 -175.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.7 p -73.93 -29.04 24.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 109.581 -0.526 . . . . 61.530000000000001 109.581 177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.48 ' HA ' HG21 ' A' ' 22' ' ' ILE . 32.0 t -59.01 -42.49 90.24 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.0 -0.545 . . . . 61.350000000000001 109.817 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.418 ' O ' ' HE2' ' A' ' 76' ' ' LYS . 76.0 mt -55.6 -47.91 78.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.043 -0.526 . . . . 62.009999999999998 110.476 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 41.4 t-105 -69.7 -47.03 64.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.769 -0.651 . . . . 72.120000000000005 110.946 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.9 mt -62.43 -36.22 81.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.953 0.353 . . . . 62.5 111.953 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -64.44 -16.19 61.96 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.032 0.382 . . . . 73.299999999999997 112.032 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 72' ' ' ILE . 46.7 mtmt -118.34 -59.7 1.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.687 0.279 . . . . 72.430000000000007 111.645 -177.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 9.1 m -88.78 -25.15 22.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.305 -0.407 . . . . 63.340000000000003 111.624 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.21 43.47 93.53 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 121.322 -0.466 . . . . 55.509999999999998 113.194 178.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.03 165.56 27.21 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.979 0.418 . . . . 61.229999999999997 111.576 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.534 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 47.5 t -96.99 99.9 6.65 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.509 -0.552 . . . . 55.219999999999999 109.509 174.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -35.54 -48.93 0.95 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 124.578 3.519 . . . . 71.209999999999994 115.535 -169.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 61.0 t -70.82 -25.28 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 112.905 0.706 . . . . 74.439999999999998 112.905 -173.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.534 ' SG ' ' HB3' ' A' ' 80' ' ' CYS . 28.7 p -120.48 -25.48 5.57 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.771 -0.581 . . . . 75.5 111.423 -177.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.5 mtm-85 72.08 15.11 5.59 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 123.546 0.738 . . . . 73.030000000000001 111.821 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 60.4 m -70.9 144.56 50.59 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.555 -0.906 . . . . 73.140000000000001 108.555 168.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.403 ' HB3' ' HE2' ' A' ' 86' ' ' MET . 62.5 ttp -79.01 148.27 32.58 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.997 0.427 . . . . 61.340000000000003 112.01 -172.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.456 ' HA ' ' C ' ' A' ' 88' ' ' PRO . 87.7 t80 -132.54 124.39 19.0 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.346 -0.843 . . . . 75.310000000000002 108.766 173.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 87' ' ' PHE . 37.3 Cg_endo -65.58 147.69 73.23 Favored 'Cis proline' 0 C--N 1.349 0.578 0 C-N-CA 123.768 -1.347 . . . . 75.239999999999995 112.918 2.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.48 137.57 65.49 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.597 2.865 . . . . 71.299999999999997 113.145 -175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.79 151.58 46.15 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.746 2.297 . . . . 75.209999999999994 112.094 178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.502 -0.761 . . . . 63.43 109.481 178.214 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 109.925 -0.398 . . . . 72.109999999999999 109.925 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -83.42 -170.3 46.1 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.612 -0.804 . . . . 65.129999999999995 111.241 174.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -58.48 -68.56 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.049 0.425 . . . . 62.439999999999998 110.92 178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -159.34 119.33 3.06 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.05 0.452 . . . . 62.329999999999998 110.847 174.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.9 p-80 -177.06 150.62 0.76 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.223 -0.899 . . . . 75.349999999999994 108.921 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -79.46 167.63 20.55 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.548 -0.461 . . . . 65.340000000000003 109.786 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -71.82 8.15 1.29 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.45 0.907 . . . . 72.329999999999998 113.45 -167.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 85.5 m-70 -134.13 112.19 10.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.913 0.387 . . . . 73.040000000000006 110.352 175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.8 t -143.19 133.85 25.12 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.687 -0.486 . . . . 63.409999999999997 109.687 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -88.25 119.42 28.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.414 -0.357 . . . . 73.439999999999998 110.389 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -75.36 147.96 39.62 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.181 -0.463 . . . . 74.150000000000006 110.073 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.1 t -113.8 89.21 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 120.96 0.41 . . . . 73.409999999999997 110.682 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.03 3.57 55.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.208 0.528 . . . . 55.25 110.419 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -100.97 108.16 53.08 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.595 -0.73 . . . . 63.329999999999998 110.013 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . 60.4 Cg_endo -73.46 148.72 43.28 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.447 2.098 . . . . 61.420000000000002 112.204 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 15' ' ' PRO . 18.3 Cg_exo -66.89 146.14 76.86 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.484 2.123 . . . . 72.340000000000003 111.249 175.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 74' ' ' LEU . . . -78.22 147.82 34.26 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.876 0.369 . . . . 65.349999999999994 110.915 -177.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.0 t -74.53 153.71 38.95 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.934 -0.576 . . . . 73.510000000000005 109.859 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -58.83 -38.12 77.97 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.263 0.554 . . . . 71.140000000000001 109.735 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -70.23 -28.72 65.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.357 -0.838 . . . . 74.439999999999998 110.911 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.51 ' O ' ' HG ' ' A' ' 25' ' ' LEU . 13.8 m -66.68 -38.1 86.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.86 -0.422 . . . . 64.040000000000006 109.86 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 56.6 mt -77.38 -36.04 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 72.109999999999999 110.259 177.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -61.81 -37.49 84.59 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.578 -0.737 . . . . 52.219999999999999 111.192 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.04 4.69 49.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.053 -0.521 . . . . 74.299999999999997 112.312 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 21' ' ' SER . 57.8 mt -70.34 128.96 90.89 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 121.247 -0.181 . . . . 42.100000000000001 110.946 178.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HG2' ' H ' ' A' ' 58' ' ' GLU . 16.1 Cg_endo -58.17 153.12 47.93 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.033 2.489 . . . . 53.539999999999999 112.047 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -126.17 118.03 24.35 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.022 0.439 . . . . 73.409999999999997 110.857 -174.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.1 mt -120.5 118.35 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.769 -0.651 . . . . 73.519999999999996 110.366 -178.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 56.9 tp -68.45 121.05 15.52 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.729 -0.471 . . . . 60.32 109.729 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 52' ' ' LYS . 45.0 t -86.05 129.88 37.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.332 -0.395 . . . . 72.030000000000001 111.228 -177.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 34' ' ' HIS . 20.3 p -117.09 141.14 48.64 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.825 -0.625 . . . . 64.239999999999995 109.792 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 52' ' ' LYS . 57.0 mt-10 -69.12 -27.78 65.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.191 0.52 . . . . 73.409999999999997 110.974 -176.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.07 -6.55 59.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.74 -0.664 . . . . 74.310000000000002 110.969 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.53 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 22.5 t60 -74.34 -47.56 33.64 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.823 -0.436 . . . . 73.299999999999997 109.823 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.34 -160.13 13.39 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.407 -0.677 . . . . 63.439999999999998 111.407 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.73 114.19 14.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.848 0.356 . . . . 70.340000000000003 110.723 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.21 95.95 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.909 -0.587 . . . . 71.219999999999999 110.607 -178.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.83 -143.26 23.17 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.839 -0.696 . . . . 72.510000000000005 112.545 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.556 ' OE1' ' HA ' ' A' ' 63' ' ' HIS . 0.0 OUTLIER -85.2 -27.67 25.96 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.58 0.228 . . . . 70.219999999999999 111.275 -176.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -96.2 125.54 40.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.757 -0.46 . . . . 52.25 109.757 -176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 22.7 ptp -107.72 0.04 22.1 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 116.477 -0.329 . . . . 64.409999999999997 111.395 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 83.3 m -143.39 157.67 44.27 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.122 0.487 . . . . 63.509999999999998 110.993 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 40.7 t -117.06 93.32 41.85 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.776 -0.647 . . . . 74.109999999999999 109.377 177.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 13.1 Cg_endo -56.49 -26.03 61.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.567 2.845 . . . . 73.040000000000006 113.078 -174.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 52.6 mt -60.09 -34.77 57.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 73.519999999999996 111.054 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 23.4 p -114.94 9.74 16.18 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 110.126 -0.324 . . . . 71.319999999999993 110.126 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 22.0 p 41.12 46.25 2.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.02 0.928 . . . . 71.219999999999999 111.892 -175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -140.2 154.59 46.97 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 115.923 -0.58 . . . . 63.030000000000001 110.06 -179.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.84 -169.9 1.95 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.925 -0.58 . . . . 74.140000000000001 110.923 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.428 ' HB3' HG11 ' A' ' 30' ' ' VAL . 40.4 m-85 -87.17 93.66 9.44 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.545 0.688 . . . . 72.540000000000006 111.497 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.93 162.73 2.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 114.836 -1.075 . . . . 73.409999999999997 110.321 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 30' ' ' VAL . 7.9 ttpm? -79.68 133.57 36.38 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.02 0.438 . . . . 72.129999999999995 110.67 -176.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.65 -16.18 21.53 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.819 -0.705 . . . . 64.219999999999999 111.834 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -86.96 161.83 18.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.169 -0.678 . . . . 73.200000000000003 109.169 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.6 121.2 64.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.958 -0.386 . . . . 74.510000000000005 109.958 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.34 155.95 16.97 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.875 0.369 . . . . 63.200000000000003 110.742 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 67' ' ' LYS . 12.8 t -138.11 156.01 48.18 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.961 -0.563 . . . . 74.340000000000003 109.783 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.441 ' H ' ' HG2' ' A' ' 26' ' ' PRO . 54.2 tt0 -111.61 117.46 33.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.296 -0.411 . . . . 64.430000000000007 109.92 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.4 mt -78.41 147.87 72.87 Favored Pre-proline 0 C--N 1.318 -0.793 0 CA-C-N 116.037 -0.529 . . . . 75.319999999999993 109.755 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' HD2' ' CE1' ' A' ' 87' ' ' PHE . 14.6 Cg_endo -59.38 -13.35 20.1 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.117 2.545 . . . . 73.109999999999999 112.136 174.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.0 t -79.49 4.33 15.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.415 -0.811 . . . . 63.200000000000003 109.655 173.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 56.93 63.74 1.84 Allowed 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 122.127 0.965 . . . . 75.129999999999995 110.684 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.556 ' HA ' ' OE1' ' A' ' 39' ' ' GLN . 1.2 m80 -148.65 123.4 9.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.184 -1.371 . . . . 74.540000000000006 109.682 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -90.75 133.19 35.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.062 -0.517 . . . . 64.510000000000005 110.779 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -146.64 168.02 22.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.584 -0.735 . . . . 72.140000000000001 109.157 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.468 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 36.1 m170 -75.08 122.58 23.78 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.621 -0.511 . . . . 64.400000000000006 109.621 175.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 57' ' ' THR . 89.1 tttt -59.0 -51.11 84.18 Favored Pre-proline 0 CA--C 1.538 0.486 0 O-C-N 123.412 0.445 . . . . 41.310000000000002 112.093 -175.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 19.4 Cg_endo -60.74 -20.05 63.92 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.112 1.875 . . . . 64.140000000000001 112.956 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 61.3 m -84.38 -49.9 8.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.078 0.466 . . . . 74.019999999999996 110.43 177.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.605 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 9.9 p -73.37 -25.62 21.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.672 -0.695 . . . . 55.229999999999997 111.467 -171.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.502 ' O ' ' HG3' ' A' ' 75' ' ' GLN . 13.0 p -59.81 -30.57 69.01 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.746 0.308 . . . . 60.32 111.597 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.8 mt -75.98 -36.6 32.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.304 0.573 . . . . 75.129999999999995 110.419 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -74.66 -41.27 60.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.709 -0.678 . . . . 71.519999999999996 111.006 -178.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 70' ' ' VAL . 92.8 mt -62.24 -27.48 69.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.895 -0.593 . . . . 63.030000000000001 112.038 -175.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 71' ' ' SER . 73.9 mt-30 -65.77 -25.18 67.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.087 0.47 . . . . 73.439999999999998 110.736 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.96 -39.45 9.36 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.819 -0.628 . . . . 75.409999999999997 110.318 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.0 p -163.55 125.33 2.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.921 -0.581 . . . . 72.400000000000006 110.47 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 87' ' ' PHE . . . -79.96 91.27 1.31 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.614 -0.803 . . . . 62.340000000000003 111.137 177.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 84' ' ' ARG . 2.4 m -149.66 144.55 26.21 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 122.677 -0.308 . . . . 73.319999999999993 110.869 -177.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . 0.747 ' HB2' ' SG ' ' A' ' 83' ' ' CYS . 83.1 m -74.39 120.92 83.84 Favored Pre-proline 0 N--CA 1.464 0.247 0 N-CA-C 108.386 -0.968 . . . . 61.450000000000003 108.386 168.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -58.48 -21.81 56.05 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.551 2.168 . . . . 62.119999999999997 112.832 -178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.7 t -85.47 -51.44 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.395 -0.366 . . . . 65.219999999999999 111.861 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.747 ' SG ' ' HB2' ' A' ' 80' ' ' CYS . 18.9 p -94.4 -22.76 18.1 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.759 0.314 . . . . 51.119999999999997 111.712 -172.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.529 ' HA ' HG22 ' A' ' 79' ' ' THR . 59.2 mtt180 60.35 28.08 17.69 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.762 -0.654 . . . . 74.030000000000001 111.695 -176.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 59.9 m -88.86 160.69 17.1 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.647 -0.501 . . . . 74.030000000000001 109.647 172.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 38.2 ttm -76.12 141.14 42.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.647 0.61 . . . . 72.310000000000002 112.647 -169.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.427 ' CE1' ' HD2' ' A' ' 60' ' ' PRO . 54.6 t80 -132.74 121.39 17.1 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.282 -0.872 . . . . 74.120000000000005 109.539 170.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -68.51 159.37 85.74 Favored 'Cis proline' 0 C--O 1.232 0.196 0 C-N-CA 123.687 -1.38 . . . . 73.030000000000001 111.827 -1.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -50.57 149.09 14.09 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.041 2.494 . . . . 73.129999999999995 112.19 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.18 135.46 47.13 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.655 2.236 . . . . 73.349999999999994 112.114 -175.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--O 1.248 1.017 0 CA-C-N 115.485 -0.78 . . . . 72.120000000000005 109.168 179.807 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 N--CA 1.48 1.075 0 CA-C-O 120.672 0.272 . . . . 55.140000000000001 110.588 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.26 65.78 3.56 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.158 -0.544 . . . . 41.450000000000003 113.067 -174.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -119.2 90.83 3.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.962 0.41 . . . . 60.520000000000003 109.921 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -79.23 124.96 28.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.78 -0.645 . . . . 75.140000000000001 111.032 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 58.1 m-70 -100.23 116.53 32.44 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.033 -0.729 . . . . 73.340000000000003 109.033 172.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -80.89 128.02 33.2 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.244 0.545 . . . . 74.400000000000006 110.9 -178.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.407 ' CE1' ' HB3' ' A' ' 9' ' ' SER . 7.2 t-80 -144.22 111.09 5.72 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.285 -0.871 . . . . 65.25 108.689 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -60.93 -22.7 64.64 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.008 0.432 . . . . 74.340000000000003 110.862 -175.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.407 ' HB3' ' CE1' ' A' ' 7' ' ' HIS . 39.8 t -91.23 74.22 6.2 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.196 -1.039 . . . . 75.319999999999993 108.196 167.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -67.21 -27.21 67.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.611 -0.722 . . . . 72.329999999999998 111.797 -172.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.453 ' SD ' ' HB2' ' A' ' 86' ' ' MET . 47.3 ttm 41.18 87.67 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 124.369 1.043 . . . . 73.319999999999993 113.814 172.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.46 176.12 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.988 -0.551 . . . . 71.439999999999998 110.415 175.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 66.49 17.2 10.61 Favored 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.658 0.599 . . . . 51.210000000000001 111.702 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -65.98 139.09 96.55 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.098 -0.501 . . . . 72.540000000000006 111.02 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.01 161.85 40.77 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.7 2.267 . . . . 73.120000000000005 111.929 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -62.09 146.48 96.12 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 122.802 2.335 . . . . 60.310000000000002 112.155 177.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' HB3' HD11 ' A' ' 22' ' ' ILE . . . -85.56 162.76 18.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.245 -0.434 . . . . 43.200000000000003 110.243 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.465 ' O ' HG13 ' A' ' 22' ' ' ILE . 14.1 m -67.25 126.06 28.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.345 -0.389 . . . . 54.5 110.786 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 -45.14 82.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.016 -0.538 . . . . 71.209999999999994 111.546 -175.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.13 -36.46 83.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.748 0.309 . . . . 72.310000000000002 111.086 -179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -67.07 -34.72 78.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.097 0.475 . . . . 55.329999999999998 110.321 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 18' ' ' SER . 60.8 mt -74.18 -41.18 51.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.811 -0.631 . . . . 70.140000000000001 110.847 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -80.14 -12.18 59.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.024 0.44 . . . . 32.210000000000001 110.968 -176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.85 -13.06 60.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 65.439999999999998 110.75 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 91.8 mt -67.34 138.36 94.19 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.864 -0.607 . . . . 51.140000000000001 110.328 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -58.42 134.01 58.52 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 123.342 2.695 . . . . 62.109999999999999 113.088 -174.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' HG2' ' HD3' ' A' ' 67' ' ' LYS . 40.0 mt-10 -84.8 102.81 13.34 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.306 -0.628 . . . . 74.439999999999998 109.306 173.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 69.6 mt -92.09 117.18 34.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.119 -0.491 . . . . 73.120000000000005 110.934 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 53.2 tp -78.26 109.34 12.3 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.791 -0.64 . . . . 74.239999999999995 109.553 175.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.498 HG11 ' HB3' ' A' ' 50' ' ' TYR . 49.1 t -83.05 124.82 39.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.938 0.399 . . . . 52.200000000000003 111.147 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.5 p -101.19 153.88 19.23 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.311 -0.626 . . . . 51.32 109.311 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -87.89 -177.84 5.88 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.229 0.455 . . . . 72.109999999999999 112.229 -168.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.7 t70 76.07 -0.09 3.2 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.034 -0.985 . . . . 74.340000000000003 110.92 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.438 ' HE1' ' O ' ' A' ' 50' ' ' TYR . 11.7 p-80 -71.25 -21.41 62.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.9 -0.591 . . . . 71.340000000000003 112.06 -177.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.04 -82.87 1.41 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.531 -0.843 . . . . 70.310000000000002 111.097 -174.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.12 154.28 33.49 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.705 -0.479 . . . . 51.329999999999998 109.705 174.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.5 t -96.15 -56.89 4.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.147 0.499 . . . . 74.340000000000003 110.014 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.647 ' O ' ' HG2' ' A' ' 39' ' ' GLN . . . -163.57 103.71 0.22 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.919 -0.872 . . . . 52.329999999999998 110.919 178.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' A' ' 38' ' ' GLY . 8.6 pt20 56.87 -67.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.375 1.47 . . . . 62.240000000000002 112.297 -176.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.13 108.11 12.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.161 0.505 . . . . 41.200000000000003 109.679 173.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 21.2 ptp -81.41 -12.05 59.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.885 -0.598 . . . . 71.120000000000005 110.62 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 5.9 p -137.32 148.5 46.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.742 -0.663 . . . . 51.439999999999998 109.912 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' CYS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 44' ' ' PRO . 35.8 t -88.09 107.6 17.03 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 109.939 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 43' ' ' CYS . 19.4 Cg_endo -58.57 -28.69 86.7 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 123.173 2.582 . . . . 54.240000000000002 112.66 -175.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 54.8 mt -65.05 -25.96 38.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.245 0.545 . . . . 64.019999999999996 110.951 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 19.8 m -119.96 -1.87 10.37 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.111 -0.495 . . . . 62.030000000000001 111.144 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 26.8 p 41.14 42.97 1.8 Allowed 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.712 0.768 . . . . 71.439999999999998 110.558 -168.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.2 t -142.89 147.26 35.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.981 -1.008 . . . . 73.120000000000005 109.464 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 42' ' ' CYS . 8.3 pt-20 -80.28 -169.8 2.24 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.457 0.646 . . . . 54.119999999999997 111.268 -176.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.498 ' HB3' HG11 ' A' ' 30' ' ' VAL . 78.6 m-85 -102.54 109.85 21.6 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.572 -0.74 . . . . 70.420000000000002 109.328 178.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.87 170.0 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.207 -0.451 . . . . 73.230000000000004 111.994 -171.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -60.13 109.25 0.93 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.542 -0.754 . . . . 74.219999999999999 111.091 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.24 -0.49 43.87 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.665 -0.779 . . . . 65.109999999999999 112.535 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -82.18 147.29 29.09 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.244 -0.651 . . . . 74.010000000000005 109.244 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.97 114.84 37.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.248 0.547 . . . . 51.219999999999999 110.913 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 66' ' ' HIS . . . -110.33 176.75 4.93 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.635 -0.711 . . . . 54.32 110.507 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 64' ' ' TYR . 6.6 t -152.23 171.06 18.54 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.471 -0.566 . . . . 74.230000000000004 109.471 175.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -123.4 119.42 29.98 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 110.091 -0.336 . . . . 72.129999999999995 110.091 -174.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 74.2 mt -85.0 150.08 54.59 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.088 -0.506 . . . . 74.340000000000003 111.125 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.09 -9.62 17.74 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.03 2.487 . . . . 45.210000000000001 112.979 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.8 p -95.44 8.92 41.82 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.54 -0.3 . . . . 74.409999999999997 110.205 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 65.33 93.0 0.07 Allowed 'General case' 0 CA--C 1.52 -0.204 0 O-C-N 123.82 0.7 . . . . 54.520000000000003 109.72 -172.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -175.62 122.47 0.2 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.759 -0.655 . . . . 74.150000000000006 110.723 -177.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 57' ' ' THR . 92.2 m-85 -95.53 133.26 39.74 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.204 -0.453 . . . . 75.439999999999998 110.466 177.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.491 ' HA ' ' OH ' ' A' ' 50' ' ' TYR . 86.8 m-85 -140.98 174.77 10.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.755 -0.832 . . . . 72.140000000000001 108.755 174.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.875 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 38.3 m80 -82.02 125.16 30.48 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.271 -1.011 . . . . 74.25 108.271 175.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 68' ' ' PRO . 60.7 tttm -53.67 -47.68 95.79 Favored Pre-proline 0 C--N 1.322 -0.618 0 O-C-N 123.388 0.43 . . . . 73.340000000000003 112.022 -177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 67' ' ' LYS . 10.0 Cg_endo -52.88 -50.53 13.74 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 122.222 1.948 . . . . 64.219999999999999 113.246 177.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.875 ' SG ' ' HB2' ' A' ' 66' ' ' HIS . 26.3 p -76.54 -35.47 58.23 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.806 -0.358 . . . . 73.519999999999996 111.95 -173.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -74.16 -28.65 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.807 0.337 . . . . 74.219999999999999 110.271 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.442 ' HA ' HG21 ' A' ' 22' ' ' ILE . 33.0 t -60.79 -50.01 75.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.291 -0.413 . . . . 63.340000000000003 109.941 177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.1 mt -61.08 -37.43 77.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.498 . . . . 60.25 110.615 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 58.3 t-105 -68.45 -50.84 49.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.798 -0.637 . . . . 73.319999999999993 111.257 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 96.2 mt -65.86 -25.55 67.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.776 0.322 . . . . 71.319999999999993 111.203 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -75.0 -1.4 22.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.389 -0.369 . . . . 41.340000000000003 110.793 175.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -112.24 -48.39 3.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.254 0.55 . . . . 55.039999999999999 109.676 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 60.9 m -145.65 119.55 9.32 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.669 . . . . 52.009999999999998 110.413 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -76.13 71.71 1.95 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.845 -0.693 . . . . 51.130000000000003 112.332 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.9 142.82 29.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.229 -0.286 . . . . 64.010000000000005 110.229 177.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 47.0 t -74.69 113.61 26.11 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.006 -0.738 . . . . 75.219999999999999 109.006 174.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.77 -24.78 77.09 Favored 'Trans proline' 0 N--CA 1.474 0.366 0 C-N-CA 123.073 2.516 . . . . 73.25 114.03 -171.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.47 -59.15 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.069 0.396 . . . . 64.120000000000005 112.069 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 30.6 p -95.32 -11.25 28.15 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.938 -0.305 . . . . 71.219999999999999 111.478 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 62.42 80.57 0.22 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.795 0.807 . . . . 61.340000000000003 111.057 -179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 51.5 t -137.82 135.94 36.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.531 -1.213 . . . . 73.519999999999996 108.24 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.569 ' HB3' ' HD3' ' A' ' 90' ' ' PRO . 50.5 ttm -72.97 141.09 47.77 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.837 0.351 . . . . 72.310000000000002 111.301 -173.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 88' ' ' PRO . 87.1 t80 -133.82 114.31 13.01 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.848 -0.614 . . . . 74.019999999999996 109.856 176.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 87' ' ' PHE . 71.5 Cg_endo -75.26 153.13 98.58 Favored 'Cis proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.147 -1.605 . . . . 72.140000000000001 111.861 -2.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 88' ' ' PRO . 52.2 Cg_exo -54.82 148.5 45.78 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 122.808 2.339 . . . . 62.219999999999999 112.633 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 86' ' ' MET . 31.9 Cg_endo -63.72 153.39 75.57 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.826 2.351 . . . . 71.040000000000006 112.456 -177.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 97.9 mt . . . . . 0 C--O 1.246 0.917 0 CA-C-N 115.816 -0.629 . . . . 71.099999999999994 109.746 178.834 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_